targetID;kegg_pathwayID;kegg_pathwayName
TTDC00005;hsa04110;Cell cycle
TTDC00005;hsa04115;p53 signaling pathway
TTDC00005;hsa05166;HTLV-I infection
TTDC00005;hsa05203;Viral carcinogenesis
TTDC00006;hsa04114;Oocyte meiosis
TTDC00007;hsa04620;Toll-like receptor signaling pathway
TTDC00007;hsa05160;Hepatitis C
TTDC00007;hsa05161;Hepatitis B
TTDC00007;hsa05164;Influenza A
TTDC00007;hsa05168;Herpes simplex infection
TTDC00009;hsa04726;Serotonergic synapse
TTDC00010;hsa04110;Cell cycle
TTDC00010;hsa04115;p53 signaling pathway
TTDC00010;hsa05166;HTLV-I infection
TTDC00012;hsa04151;PI3K-Akt signaling pathway
TTDC00012;hsa04510;Focal adhesion
TTDC00012;hsa04512;ECM-receptor interaction
TTDC00012;hsa04810;Regulation of actin cytoskeleton
TTDC00012;hsa05100;Bacterial invasion of epithelial cells
TTDC00012;hsa05146;Amoebiasis
TTDC00012;hsa05200;Pathways in cancer
TTDC00012;hsa05205;Proteoglycans in cancer
TTDC00012;hsa05222;Small cell lung cancer
TTDC00013;hsa04610;Complement and coagulation cascades
TTDC00014;hsa00511;Other glycan degradation
TTDC00014;hsa00600;Sphingolipid metabolism
TTDC00014;hsa01100;Metabolic pathways
TTDC00014;hsa04142;Lysosome
TTDC00015;hsa04010;MAPK signaling pathway
TTDC00015;hsa04012;ErbB signaling pathway
TTDC00015;hsa04014;Ras signaling pathway
TTDC00015;hsa04015;Rap1 signaling pathway
TTDC00015;hsa04020;Calcium signaling pathway
TTDC00015;hsa04066;HIF-1 signaling pathway
TTDC00015;hsa04070;Phosphatidylinositol signaling system
TTDC00015;hsa04071;Sphingolipid signaling pathway
TTDC00015;hsa04150;mTOR signaling pathway
TTDC00015;hsa04270;Vascular smooth muscle contraction
TTDC00015;hsa04310;Wnt signaling pathway
TTDC00015;hsa04370;VEGF signaling pathway
TTDC00015;hsa04510;Focal adhesion
TTDC00015;hsa04530;Tight junction
TTDC00015;hsa04540;Gap junction
TTDC00015;hsa04650;Natural killer cell mediated cytotoxicity
TTDC00015;hsa04666;Fc gamma R-mediated phagocytosis
TTDC00015;hsa04670;Leukocyte transendothelial migration
TTDC00015;hsa04713;Circadian entrainment
TTDC00015;hsa04720;Long-term potentiation
TTDC00015;hsa04723;Retrograde endocannabinoid signaling
TTDC00015;hsa04724;Glutamatergic synapse
TTDC00015;hsa04725;Cholinergic synapse
TTDC00015;hsa04726;Serotonergic synapse
TTDC00015;hsa04727;GABAergic synapse
TTDC00015;hsa04728;Dopaminergic synapse
TTDC00015;hsa04730;Long-term depression
TTDC00015;hsa04750;Inflammatory mediator regulation of TRP channels
TTDC00015;hsa04911;Insulin secretion
TTDC00015;hsa04916;Melanogenesis
TTDC00015;hsa04918;Thyroid hormone synthesis
TTDC00015;hsa04919;Thyroid hormone signaling pathway
TTDC00015;hsa04921;Oxytocin signaling pathway
TTDC00015;hsa04960;Aldosterone-regulated sodium reabsorption
TTDC00015;hsa04961;Endocrine and other factor-regulated calcium reabsorption
TTDC00015;hsa04970;Salivary secretion
TTDC00015;hsa04971;Gastric acid secretion
TTDC00015;hsa04972;Pancreatic secretion
TTDC00015;hsa05031;Amphetamine addiction
TTDC00015;hsa05032;Morphine addiction
TTDC00015;hsa05110;Vibrio cholerae infection
TTDC00015;hsa05143;African trypanosomiasis
TTDC00015;hsa05146;Amoebiasis
TTDC00015;hsa05161;Hepatitis B
TTDC00015;hsa05200;Pathways in cancer
TTDC00015;hsa05205;Proteoglycans in cancer
TTDC00015;hsa05206;MicroRNAs in cancer
TTDC00015;hsa05214;Glioma
TTDC00015;hsa05223;Non-small cell lung cancer
TTDC00015;hsa05231;Choline metabolism in cancer
TTDC00016;hsa00052;Galactose metabolism
TTDC00016;hsa00561;Glycerolipid metabolism
TTDC00016;hsa00600;Sphingolipid metabolism
TTDC00016;hsa00603;Glycosphingolipid biosynthesis - globo series
TTDC00016;hsa04142;Lysosome
TTDC00018;hsa04141;Protein processing in endoplasmic reticulum
TTDC00018;hsa04151;PI3K-Akt signaling pathway
TTDC00018;hsa04612;Antigen processing and presentation
TTDC00018;hsa04621;NOD-like receptor signaling pathway
TTDC00018;hsa04914;Progesterone-mediated oocyte maturation
TTDC00018;hsa04915;Estrogen signaling pathway
TTDC00018;hsa05200;Pathways in cancer
TTDC00018;hsa05215;Prostate cancer
TTDC00019;hsa04080;Neuroactive ligand-receptor interaction
TTDC00019;hsa04142;Lysosome
TTDC00019;hsa04614;Renin-angiotensin system
TTDC00019;hsa05146;Amoebiasis
TTDC00019;hsa05322;Systemic lupus erythematosus
TTDC00020;hsa04145;Phagosome
TTDC00020;hsa04151;PI3K-Akt signaling pathway
TTDC00020;hsa04510;Focal adhesion
TTDC00020;hsa04512;ECM-receptor interaction
TTDC00020;hsa04640;Hematopoietic cell lineage
TTDC00020;hsa04810;Regulation of actin cytoskeleton
TTDC00020;hsa05100;Bacterial invasion of epithelial cells
TTDC00020;hsa05131;Shigellosis
TTDC00020;hsa05133;Pertussis
TTDC00020;hsa05205;Proteoglycans in cancer
TTDC00020;hsa05206;MicroRNAs in cancer
TTDC00020;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDC00020;hsa05412;Arrhythmogenic right ventricular cardiomyopathy (ARVC)
TTDC00020;hsa05414;Dilated cardiomyopathy
TTDC00022;hsa04151;PI3K-Akt signaling pathway
TTDC00022;hsa05166;HTLV-I infection
TTDC00023;hsa00052;Galactose metabolism
TTDC00023;hsa00500;Starch and sucrose metabolism
TTDC00023;hsa01100;Metabolic pathways
TTDC00023;hsa04142;Lysosome
TTDC00024;hsa04010;MAPK signaling pathway
TTDC00024;hsa04014;Ras signaling pathway
TTDC00024;hsa04015;Rap1 signaling pathway
TTDC00024;hsa04151;PI3K-Akt signaling pathway
TTDC00024;hsa04520;Adherens junction
TTDC00024;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDC00024;hsa04810;Regulation of actin cytoskeleton
TTDC00024;hsa05200;Pathways in cancer
TTDC00024;hsa05205;Proteoglycans in cancer
TTDC00024;hsa05215;Prostate cancer
TTDC00024;hsa05218;Melanoma
TTDC00024;hsa05230;Central carbon metabolism in cancer
TTDC00025;hsa00564;Glycerophospholipid metabolism
TTDC00025;hsa00565;Ether lipid metabolism
TTDC00025;hsa00590;Arachidonic acid metabolism
TTDC00025;hsa00591;Linoleic acid metabolism
TTDC00025;hsa00592;alpha-Linolenic acid metabolism
TTDC00025;hsa01100;Metabolic pathways
TTDC00025;hsa04014;Ras signaling pathway
TTDC00025;hsa04270;Vascular smooth muscle contraction
TTDC00025;hsa04972;Pancreatic secretion
TTDC00025;hsa04975;Fat digestion and absorption
TTDC00026;hsa04060;Cytokine-cytokine receptor interaction
TTDC00026;hsa04144;Endocytosis
TTDC00026;hsa04151;PI3K-Akt signaling pathway
TTDC00026;hsa04630;Jak-STAT signaling pathway
TTDC00026;hsa05162;Measles
TTDC00026;hsa05166;HTLV-I infection
TTDC00026;hsa05202;Transcriptional misregulation in cancer
TTDC00027;hsa00340;Histidine metabolism
TTDC00027;hsa01100;Metabolic pathways
TTDC00028;hsa04961;Endocrine and other factor-regulated calcium reabsorption
TTDC00029;hsa00230;Purine metabolism
TTDC00029;hsa04022;cGMP-PKG signaling pathway
TTDC00029;hsa04270;Vascular smooth muscle contraction
TTDC00029;hsa04921;Oxytocin signaling pathway
TTDC00030;hsa02010;ABC transporters
TTDC00030;hsa04976;Bile secretion
TTDC00031;hsa04151;PI3K-Akt signaling pathway
TTDC00031;hsa04510;Focal adhesion
TTDC00031;hsa04512;ECM-receptor interaction
TTDC00031;hsa04514;Cell adhesion molecules (CAMs)
TTDC00031;hsa04672;Intestinal immune network for IgA production
TTDC00031;hsa04810;Regulation of actin cytoskeleton
TTDC00031;hsa05202;Transcriptional misregulation in cancer
TTDC00031;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDC00031;hsa05412;Arrhythmogenic right ventricular cardiomyopathy (ARVC)
TTDC00031;hsa05414;Dilated cardiomyopathy
TTDC00032;hsa04520;Adherens junction
TTDC00032;hsa04630;Jak-STAT signaling pathway
TTDC00032;hsa04650;Natural killer cell mediated cytotoxicity
TTDC00032;hsa04660;T cell receptor signaling pathway
TTDC00032;hsa04662;B cell receptor signaling pathway
TTDC00032;hsa05140;Leishmaniasis
TTDC00032;hsa05205;Proteoglycans in cancer
TTDC00033;hsa04060;Cytokine-cytokine receptor interaction
TTDC00033;hsa04620;Toll-like receptor signaling pathway
TTDC00033;hsa04622;RIG-I-like receptor signaling pathway
TTDC00033;hsa04630;Jak-STAT signaling pathway
TTDC00033;hsa04940;Type I diabetes mellitus
TTDC00033;hsa05133;Pertussis
TTDC00033;hsa05134;Legionellosis
TTDC00033;hsa05140;Leishmaniasis
TTDC00033;hsa05142;Chagas disease (American trypanosomiasis)
TTDC00033;hsa05143;African trypanosomiasis
TTDC00033;hsa05144;Malaria
TTDC00033;hsa05145;Toxoplasmosis
TTDC00033;hsa05146;Amoebiasis
TTDC00033;hsa05152;Tuberculosis
TTDC00033;hsa05162;Measles
TTDC00033;hsa05164;Influenza A
TTDC00033;hsa05168;Herpes simplex infection
TTDC00033;hsa05321;Inflammatory bowel disease (IBD)
TTDC00033;hsa05330;Allograft rejection
TTDC00034;hsa04080;Neuroactive ligand-receptor interaction
TTDC00037;hsa04020;Calcium signaling pathway
TTDC00037;hsa04024;cAMP signaling pathway
TTDC00037;hsa04080;Neuroactive ligand-receptor interaction
TTDC00037;hsa04923;Regulation of lipolysis in adipocytes
TTDC00037;hsa05200;Pathways in cancer
TTDC00038;hsa04020;Calcium signaling pathway
TTDC00038;hsa04022;cGMP-PKG signaling pathway
TTDC00038;hsa05012;Parkinson's disease
TTDC00038;hsa05016;Huntington's disease
TTDC00038;hsa05166;HTLV-I infection
TTDC00039;hsa04080;Neuroactive ligand-receptor interaction
TTDC00040;hsa04080;Neuroactive ligand-receptor interaction
TTDC00041;hsa04080;Neuroactive ligand-receptor interaction
TTDC00042;hsa04668;TNF signaling pathway
TTDC00042;hsa04912;GnRH signaling pathway
TTDC00043;hsa04080;Neuroactive ligand-receptor interaction
TTDC00044;hsa04010;MAPK signaling pathway
TTDC00044;hsa04015;Rap1 signaling pathway
TTDC00044;hsa04068;FoxO signaling pathway
TTDC00044;hsa04071;Sphingolipid signaling pathway
TTDC00044;hsa04114;Oocyte meiosis
TTDC00044;hsa04261;Adrenergic signaling in cardiomyocytes
TTDC00044;hsa04370;VEGF signaling pathway
TTDC00044;hsa04380;Osteoclast differentiation
TTDC00044;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDC00044;hsa04611;Platelet activation
TTDC00044;hsa04620;Toll-like receptor signaling pathway
TTDC00044;hsa04621;NOD-like receptor signaling pathway
TTDC00044;hsa04622;RIG-I-like receptor signaling pathway
TTDC00044;hsa04660;T cell receptor signaling pathway
TTDC00044;hsa04664;Fc epsilon RI signaling pathway
TTDC00044;hsa04668;TNF signaling pathway
TTDC00044;hsa04670;Leukocyte transendothelial migration
TTDC00044;hsa04722;Neurotrophin signaling pathway
TTDC00044;hsa04723;Retrograde endocannabinoid signaling
TTDC00044;hsa04728;Dopaminergic synapse
TTDC00044;hsa04750;Inflammatory mediator regulation of TRP channels
TTDC00044;hsa04912;GnRH signaling pathway
TTDC00044;hsa04914;Progesterone-mediated oocyte maturation
TTDC00044;hsa04917;Prolactin signaling pathway
TTDC00044;hsa05014;Amyotrophic lateral sclerosis (ALS)
TTDC00044;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDC00044;hsa05131;Shigellosis
TTDC00044;hsa05132;Salmonella infection
TTDC00044;hsa05133;Pertussis
TTDC00044;hsa05140;Leishmaniasis
TTDC00044;hsa05142;Chagas disease (American trypanosomiasis)
TTDC00044;hsa05145;Toxoplasmosis
TTDC00044;hsa05152;Tuberculosis
TTDC00044;hsa05160;Hepatitis C
TTDC00044;hsa05164;Influenza A
TTDC00044;hsa05169;Epstein-Barr virus infection
TTDC00044;hsa05205;Proteoglycans in cancer
TTDC00045;hsa04360;Axon guidance
TTDC00046;hsa04010;MAPK signaling pathway
TTDC00046;hsa04064;NF-kappa B signaling pathway
TTDC00046;hsa04380;Osteoclast differentiation
TTDC00046;hsa05134;Legionellosis
TTDC00046;hsa05166;HTLV-I infection
TTDC00046;hsa05169;Epstein-Barr virus infection
TTDC00046;hsa05200;Pathways in cancer
TTDC00046;hsa05203;Viral carcinogenesis
TTDC00048;hsa04151;PI3K-Akt signaling pathway
TTDC00048;hsa05206;MicroRNAs in cancer
TTDC00049;hsa04080;Neuroactive ligand-receptor interaction
TTDC00049;hsa04750;Inflammatory mediator regulation of TRP channels
TTDC00050;hsa04024;cAMP signaling pathway
TTDC00050;hsa04911;Insulin secretion
TTDC00051;hsa04330;Notch signaling pathway
TTDC00051;hsa05010;Alzheimer's disease
TTDC00052;hsa04068;FoxO signaling pathway
TTDC00052;hsa04152;AMPK signaling pathway
TTDC00052;hsa04922;Glucagon signaling pathway
TTDC00052;hsa05031;Amphetamine addiction
TTDC00052;hsa05206;MicroRNAs in cancer
TTDC00053;hsa04610;Complement and coagulation cascades
TTDC00053;hsa04972;Pancreatic secretion
TTDC00053;hsa04974;Protein digestion and absorption
TTDC00054;hsa04066;HIF-1 signaling pathway
TTDC00054;hsa05200;Pathways in cancer
TTDC00054;hsa05211;Renal cell carcinoma
TTDC00056;hsa04620;Toll-like receptor signaling pathway
TTDC00057;hsa00600;Sphingolipid metabolism
TTDC00057;hsa01100;Metabolic pathways
TTDC00058;hsa00600;Sphingolipid metabolism
TTDC00058;hsa01100;Metabolic pathways
TTDC00058;hsa04020;Calcium signaling pathway
TTDC00058;hsa04071;Sphingolipid signaling pathway
TTDC00058;hsa04370;VEGF signaling pathway
TTDC00058;hsa04666;Fc gamma R-mediated phagocytosis
TTDC00058;hsa05152;Tuberculosis
TTDC00060;hsa00531;Glycosaminoglycan degradation
TTDC00060;hsa01100;Metabolic pathways
TTDC00060;hsa05205;Proteoglycans in cancer
TTDC00061;hsa04020;Calcium signaling pathway
TTDC00061;hsa04022;cGMP-PKG signaling pathway
TTDC00061;hsa05012;Parkinson's disease
TTDC00061;hsa05016;Huntington's disease
TTDC00061;hsa05161;Hepatitis B
TTDC00061;hsa05166;HTLV-I infection
TTDC00061;hsa05203;Viral carcinogenesis
TTDC00063;hsa00330;Arginine and proline metabolism
TTDC00063;hsa01100;Metabolic pathways
TTDC00063;hsa04020;Calcium signaling pathway
TTDC00063;hsa04145;Phagosome
TTDC00063;hsa04713;Circadian entrainment
TTDC00063;hsa04730;Long-term depression
TTDC00063;hsa04970;Salivary secretion
TTDC00063;hsa05010;Alzheimer's disease
TTDC00063;hsa05014;Amyotrophic lateral sclerosis (ALS)
TTDC00065;hsa00900;Terpenoid backbone biosynthesis
TTDC00065;hsa01130;Biosynthesis of antibiotics
TTDC00066;hsa04022;cGMP-PKG signaling pathway
TTDC00066;hsa04071;Sphingolipid signaling pathway
TTDC00066;hsa04270;Vascular smooth muscle contraction
TTDC00066;hsa04530;Tight junction
TTDC00066;hsa04664;Fc epsilon RI signaling pathway
TTDC00066;hsa04666;Fc gamma R-mediated phagocytosis
TTDC00066;hsa04750;Inflammatory mediator regulation of TRP channels
TTDC00066;hsa04930;Type II diabetes mellitus
TTDC00066;hsa05206;MicroRNAs in cancer
TTDC00067;hsa04142;Lysosome
TTDC00067;hsa04145;Phagosome
TTDC00067;hsa04612;Antigen processing and presentation
TTDC00067;hsa05152;Tuberculosis
TTDC00068;hsa04142;Lysosome
TTDC00068;hsa04380;Osteoclast differentiation
TTDC00068;hsa04620;Toll-like receptor signaling pathway
TTDC00068;hsa05323;Rheumatoid arthritis
TTDC00069;hsa03320;PPAR signaling pathway
TTDC00069;hsa04310;Wnt signaling pathway
TTDC00069;hsa05200;Pathways in cancer
TTDC00069;hsa05221;Acute myeloid leukemia
TTDC00070;hsa00140;Steroid hormone biosynthesis
TTDC00070;hsa00980;Metabolism of xenobiotics by cytochrome P450
TTDC00070;hsa01100;Metabolic pathways
TTDC00070;hsa05204;Chemical carcinogenesis
TTDC00071;hsa04015;Rap1 signaling pathway
TTDC00071;hsa04020;Calcium signaling pathway
TTDC00071;hsa04024;cAMP signaling pathway
TTDC00071;hsa04080;Neuroactive ligand-receptor interaction
TTDC00071;hsa04144;Endocytosis
TTDC00071;hsa04151;PI3K-Akt signaling pathway
TTDC00071;hsa04610;Complement and coagulation cascades
TTDC00071;hsa04611;Platelet activation
TTDC00071;hsa04810;Regulation of actin cytoskeleton
TTDC00071;hsa05200;Pathways in cancer
TTDC00072;hsa04080;Neuroactive ligand-receptor interaction
TTDC00073;hsa04080;Neuroactive ligand-receptor interaction
TTDC00073;hsa04730;Long-term depression
TTDC00074;hsa04080;Neuroactive ligand-receptor interaction
TTDC00076;hsa04668;TNF signaling pathway
TTDC00076;hsa04670;Leukocyte transendothelial migration
TTDC00076;hsa04915;Estrogen signaling pathway
TTDC00076;hsa05161;Hepatitis B
TTDC00076;hsa05200;Pathways in cancer
TTDC00076;hsa05202;Transcriptional misregulation in cancer
TTDC00076;hsa05205;Proteoglycans in cancer
TTDC00076;hsa05206;MicroRNAs in cancer
TTDC00076;hsa05219;Bladder cancer
TTDC00077;hsa04062;Chemokine signaling pathway
TTDC00077;hsa04270;Vascular smooth muscle contraction
TTDC00077;hsa04530;Tight junction
TTDC00077;hsa04664;Fc epsilon RI signaling pathway
TTDC00077;hsa04666;Fc gamma R-mediated phagocytosis
TTDC00077;hsa04722;Neurotrophin signaling pathway
TTDC00077;hsa04750;Inflammatory mediator regulation of TRP channels
TTDC00077;hsa04912;GnRH signaling pathway
TTDC00077;hsa04915;Estrogen signaling pathway
TTDC00077;hsa04930;Type II diabetes mellitus
TTDC00078;hsa04610;Complement and coagulation cascades
TTDC00079;hsa04080;Neuroactive ligand-receptor interaction
TTDC00080;hsa04060;Cytokine-cytokine receptor interaction
TTDC00080;hsa04066;HIF-1 signaling pathway
TTDC00080;hsa04068;FoxO signaling pathway
TTDC00080;hsa04151;PI3K-Akt signaling pathway
TTDC00080;hsa04620;Toll-like receptor signaling pathway
TTDC00080;hsa04621;NOD-like receptor signaling pathway
TTDC00080;hsa04623;Cytosolic DNA-sensing pathway
TTDC00080;hsa04630;Jak-STAT signaling pathway
TTDC00080;hsa04640;Hematopoietic cell lineage
TTDC00080;hsa04668;TNF signaling pathway
TTDC00080;hsa04672;Intestinal immune network for IgA production
TTDC00080;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDC00080;hsa05020;Prion diseases
TTDC00080;hsa05132;Salmonella infection
TTDC00080;hsa05133;Pertussis
TTDC00080;hsa05134;Legionellosis
TTDC00080;hsa05142;Chagas disease (American trypanosomiasis)
TTDC00080;hsa05143;African trypanosomiasis
TTDC00080;hsa05144;Malaria
TTDC00080;hsa05146;Amoebiasis
TTDC00080;hsa05152;Tuberculosis
TTDC00080;hsa05161;Hepatitis B
TTDC00080;hsa05162;Measles
TTDC00080;hsa05164;Influenza A
TTDC00080;hsa05166;HTLV-I infection
TTDC00080;hsa05168;Herpes simplex infection
TTDC00080;hsa05200;Pathways in cancer
TTDC00080;hsa05202;Transcriptional misregulation in cancer
TTDC00080;hsa05321;Inflammatory bowel disease (IBD)
TTDC00080;hsa05323;Rheumatoid arthritis
TTDC00080;hsa05332;Graft-versus-host disease
TTDC00080;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDC00081;hsa04060;Cytokine-cytokine receptor interaction
TTDC00081;hsa04151;PI3K-Akt signaling pathway
TTDC00081;hsa04630;Jak-STAT signaling pathway
TTDC00081;hsa04640;Hematopoietic cell lineage
TTDC00081;hsa05321;Inflammatory bowel disease (IBD)
TTDC00082;hsa04020;Calcium signaling pathway
TTDC00082;hsa04080;Neuroactive ligand-receptor interaction
TTDC00082;hsa04911;Insulin secretion
TTDC00082;hsa04972;Pancreatic secretion
TTDC00084;hsa04062;Chemokine signaling pathway
TTDC00084;hsa04151;PI3K-Akt signaling pathway
TTDC00084;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDC00084;hsa04630;Jak-STAT signaling pathway
TTDC00084;hsa05162;Measles
TTDC00084;hsa05166;HTLV-I infection
TTDC00084;hsa05169;Epstein-Barr virus infection
TTDC00084;hsa05203;Viral carcinogenesis
TTDC00084;hsa05340;Primary immunodeficiency
TTDC00085;hsa04610;Complement and coagulation cascades
TTDC00085;hsa05133;Pertussis
TTDC00085;hsa05150;Staphylococcus aureus infection
TTDC00085;hsa05322;Systemic lupus erythematosus
TTDC00086;hsa00590;Arachidonic acid metabolism
TTDC00086;hsa01100;Metabolic pathways
TTDC00086;hsa04611;Platelet activation
TTDC00087;hsa04060;Cytokine-cytokine receptor interaction
TTDC00087;hsa04062;Chemokine signaling pathway
TTDC00087;hsa04144;Endocytosis
TTDC00087;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDC00088;hsa04068;FoxO signaling pathway
TTDC00088;hsa04110;Cell cycle
TTDC00088;hsa04114;Oocyte meiosis
TTDC00088;hsa04115;p53 signaling pathway
TTDC00088;hsa04151;PI3K-Akt signaling pathway
TTDC00088;hsa04914;Progesterone-mediated oocyte maturation
TTDC00088;hsa05161;Hepatitis B
TTDC00088;hsa05162;Measles
TTDC00088;hsa05168;Herpes simplex infection
TTDC00088;hsa05169;Epstein-Barr virus infection
TTDC00088;hsa05200;Pathways in cancer
TTDC00088;hsa05203;Viral carcinogenesis
TTDC00088;hsa05215;Prostate cancer
TTDC00088;hsa05222;Small cell lung cancer
TTDC00089;hsa04080;Neuroactive ligand-receptor interaction
TTDC00090;hsa04020;Calcium signaling pathway
TTDC00090;hsa04080;Neuroactive ligand-receptor interaction
TTDC00091;hsa00230;Purine metabolism
TTDC00091;hsa00240;Pyrimidine metabolism
TTDC00091;hsa00760;Nicotinate and nicotinamide metabolism
TTDC00091;hsa01100;Metabolic pathways
TTDC00093;hsa04080;Neuroactive ligand-receptor interaction
TTDC00093;hsa04270;Vascular smooth muscle contraction
TTDC00094;hsa03022;Basal transcription factors
TTDC00094;hsa03420;Nucleotide excision repair
TTDC00094;hsa04110;Cell cycle
TTDC00095;hsa05202;Transcriptional misregulation in cancer
TTDC00096;hsa03050;Proteasome
TTDC00096;hsa04060;Cytokine-cytokine receptor interaction
TTDC00096;hsa04066;HIF-1 signaling pathway
TTDC00096;hsa04140;Regulation of autophagy
TTDC00096;hsa04350;TGF-beta signaling pathway
TTDC00096;hsa04380;Osteoclast differentiation
TTDC00096;hsa04612;Antigen processing and presentation
TTDC00096;hsa04630;Jak-STAT signaling pathway
TTDC00096;hsa04650;Natural killer cell mediated cytotoxicity
TTDC00096;hsa04660;T cell receptor signaling pathway
TTDC00096;hsa04940;Type I diabetes mellitus
TTDC00096;hsa05132;Salmonella infection
TTDC00096;hsa05140;Leishmaniasis
TTDC00096;hsa05142;Chagas disease (American trypanosomiasis)
TTDC00096;hsa05143;African trypanosomiasis
TTDC00096;hsa05144;Malaria
TTDC00096;hsa05145;Toxoplasmosis
TTDC00096;hsa05146;Amoebiasis
TTDC00096;hsa05152;Tuberculosis
TTDC00096;hsa05162;Measles
TTDC00096;hsa05164;Influenza A
TTDC00096;hsa05168;Herpes simplex infection
TTDC00096;hsa05169;Epstein-Barr virus infection
TTDC00096;hsa05321;Inflammatory bowel disease (IBD)
TTDC00096;hsa05322;Systemic lupus erythematosus
TTDC00096;hsa05323;Rheumatoid arthritis
TTDC00096;hsa05330;Allograft rejection
TTDC00096;hsa05332;Graft-versus-host disease
TTDC00097;hsa00330;Arginine and proline metabolism
TTDC00097;hsa01100;Metabolic pathways
TTDC00097;hsa04020;Calcium signaling pathway
TTDC00097;hsa04022;cGMP-PKG signaling pathway
TTDC00097;hsa04066;HIF-1 signaling pathway
TTDC00097;hsa04071;Sphingolipid signaling pathway
TTDC00097;hsa04151;PI3K-Akt signaling pathway
TTDC00097;hsa04370;VEGF signaling pathway
TTDC00097;hsa04611;Platelet activation
TTDC00097;hsa04915;Estrogen signaling pathway
TTDC00097;hsa04921;Oxytocin signaling pathway
TTDC00098;hsa04514;Cell adhesion molecules (CAMs)
TTDC00098;hsa04668;TNF signaling pathway
TTDC00098;hsa05143;African trypanosomiasis
TTDC00098;hsa05144;Malaria
TTDC00099;hsa00500;Starch and sucrose metabolism
TTDC00099;hsa01100;Metabolic pathways
TTDC00099;hsa04910;Insulin signaling pathway
TTDC00099;hsa04922;Glucagon signaling pathway
TTDC00100;hsa04020;Calcium signaling pathway
TTDC00100;hsa04080;Neuroactive ligand-receptor interaction
TTDC00100;hsa04540;Gap junction
TTDC00100;hsa04720;Long-term potentiation
TTDC00100;hsa04723;Retrograde endocannabinoid signaling
TTDC00100;hsa04724;Glutamatergic synapse
TTDC00100;hsa05016;Huntington's disease
TTDC00101;hsa04066;HIF-1 signaling pathway
TTDC00101;hsa04150;mTOR signaling pathway
TTDC00101;hsa04919;Thyroid hormone signaling pathway
TTDC00101;hsa05200;Pathways in cancer
TTDC00101;hsa05205;Proteoglycans in cancer
TTDC00101;hsa05211;Renal cell carcinoma
TTDC00101;hsa05230;Central carbon metabolism in cancer
TTDC00101;hsa05231;Choline metabolism in cancer
TTDC00102;hsa04010;MAPK signaling pathway
TTDC00102;hsa04012;ErbB signaling pathway
TTDC00102;hsa04014;Ras signaling pathway
TTDC00102;hsa04024;cAMP signaling pathway
TTDC00102;hsa04068;FoxO signaling pathway
TTDC00102;hsa04071;Sphingolipid signaling pathway
TTDC00102;hsa04141;Protein processing in endoplasmic reticulum
TTDC00102;hsa04310;Wnt signaling pathway
TTDC00102;hsa04380;Osteoclast differentiation
TTDC00102;hsa04510;Focal adhesion
TTDC00102;hsa04620;Toll-like receptor signaling pathway
TTDC00102;hsa04621;NOD-like receptor signaling pathway
TTDC00102;hsa04622;RIG-I-like receptor signaling pathway
TTDC00102;hsa04664;Fc epsilon RI signaling pathway
TTDC00102;hsa04668;TNF signaling pathway
TTDC00102;hsa04722;Neurotrophin signaling pathway
TTDC00102;hsa04723;Retrograde endocannabinoid signaling
TTDC00102;hsa04728;Dopaminergic synapse
TTDC00102;hsa04750;Inflammatory mediator regulation of TRP channels
TTDC00102;hsa04910;Insulin signaling pathway
TTDC00102;hsa04912;GnRH signaling pathway
TTDC00102;hsa04914;Progesterone-mediated oocyte maturation
TTDC00102;hsa04917;Prolactin signaling pathway
TTDC00102;hsa04920;Adipocytokine signaling pathway
TTDC00102;hsa04930;Type II diabetes mellitus
TTDC00102;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDC00102;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDC00102;hsa05131;Shigellosis
TTDC00102;hsa05132;Salmonella infection
TTDC00102;hsa05133;Pertussis
TTDC00102;hsa05142;Chagas disease (American trypanosomiasis)
TTDC00102;hsa05145;Toxoplasmosis
TTDC00102;hsa05152;Tuberculosis
TTDC00102;hsa05160;Hepatitis C
TTDC00102;hsa05161;Hepatitis B
TTDC00102;hsa05164;Influenza A
TTDC00102;hsa05166;HTLV-I infection
TTDC00102;hsa05168;Herpes simplex infection
TTDC00102;hsa05169;Epstein-Barr virus infection
TTDC00102;hsa05200;Pathways in cancer
TTDC00102;hsa05210;Colorectal cancer
TTDC00102;hsa05212;Pancreatic cancer
TTDC00102;hsa05231;Choline metabolism in cancer
TTDC00103;hsa00350;Tyrosine metabolism
TTDC00103;hsa00360;Phenylalanine metabolism
TTDC00104;hsa04670;Leukocyte transendothelial migration
TTDC00104;hsa04912;GnRH signaling pathway
TTDC00104;hsa04915;Estrogen signaling pathway
TTDC00104;hsa05200;Pathways in cancer
TTDC00104;hsa05205;Proteoglycans in cancer
TTDC00104;hsa05219;Bladder cancer
TTDC00105;hsa04668;TNF signaling pathway
TTDC00105;hsa05202;Transcriptional misregulation in cancer
TTDC00105;hsa05323;Rheumatoid arthritis
TTDC00106;hsa00100;Steroid biosynthesis
TTDC00106;hsa01100;Metabolic pathways
TTDC00106;hsa01130;Biosynthesis of antibiotics
TTDC00107;hsa04620;Toll-like receptor signaling pathway
TTDC00107;hsa05142;Chagas disease (American trypanosomiasis)
TTDC00107;hsa05143;African trypanosomiasis
TTDC00107;hsa05144;Malaria
TTDC00107;hsa05152;Tuberculosis
TTDC00107;hsa05162;Measles
TTDC00107;hsa05168;Herpes simplex infection
TTDC00108;hsa04151;PI3K-Akt signaling pathway
TTDC00108;hsa04510;Focal adhesion
TTDC00108;hsa04512;ECM-receptor interaction
TTDC00108;hsa04610;Complement and coagulation cascades
TTDC00108;hsa04611;Platelet activation
TTDC00110;hsa04014;Ras signaling pathway
TTDC00110;hsa04015;Rap1 signaling pathway
TTDC00110;hsa04060;Cytokine-cytokine receptor interaction
TTDC00110;hsa04144;Endocytosis
TTDC00110;hsa04151;PI3K-Akt signaling pathway
TTDC00110;hsa04360;Axon guidance
TTDC00110;hsa04510;Focal adhesion
TTDC00110;hsa04520;Adherens junction
TTDC00110;hsa05100;Bacterial invasion of epithelial cells
TTDC00110;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDC00110;hsa05144;Malaria
TTDC00110;hsa05200;Pathways in cancer
TTDC00110;hsa05202;Transcriptional misregulation in cancer
TTDC00110;hsa05205;Proteoglycans in cancer
TTDC00110;hsa05206;MicroRNAs in cancer
TTDC00110;hsa05211;Renal cell carcinoma
TTDC00110;hsa05218;Melanoma
TTDC00110;hsa05230;Central carbon metabolism in cancer
TTDC00111;hsa04020;Calcium signaling pathway
TTDC00111;hsa04022;cGMP-PKG signaling pathway
TTDC00111;hsa04071;Sphingolipid signaling pathway
TTDC00111;hsa04080;Neuroactive ligand-receptor interaction
TTDC00111;hsa04610;Complement and coagulation cascades
TTDC00111;hsa04750;Inflammatory mediator regulation of TRP channels
TTDC00111;hsa04810;Regulation of actin cytoskeleton
TTDC00111;hsa04961;Endocrine and other factor-regulated calcium reabsorption
TTDC00111;hsa05142;Chagas disease (American trypanosomiasis)
TTDC00111;hsa05200;Pathways in cancer
TTDC00112;hsa04024;cAMP signaling pathway
TTDC00112;hsa04080;Neuroactive ligand-receptor interaction
TTDC00113;hsa04062;Chemokine signaling pathway
TTDC00113;hsa04380;Osteoclast differentiation
TTDC00113;hsa04620;Toll-like receptor signaling pathway
TTDC00113;hsa04630;Jak-STAT signaling pathway
TTDC00113;hsa04917;Prolactin signaling pathway
TTDC00113;hsa04919;Thyroid hormone signaling pathway
TTDC00113;hsa05140;Leishmaniasis
TTDC00113;hsa05145;Toxoplasmosis
TTDC00113;hsa05152;Tuberculosis
TTDC00113;hsa05160;Hepatitis C
TTDC00113;hsa05161;Hepatitis B
TTDC00113;hsa05162;Measles
TTDC00113;hsa05164;Influenza A
TTDC00113;hsa05168;Herpes simplex infection
TTDC00113;hsa05200;Pathways in cancer
TTDC00113;hsa05212;Pancreatic cancer
TTDC00113;hsa05321;Inflammatory bowel disease (IBD)
TTDC00114;hsa04012;ErbB signaling pathway
TTDC00114;hsa04020;Calcium signaling pathway
TTDC00114;hsa04144;Endocytosis
TTDC00114;hsa05205;Proteoglycans in cancer
TTDC00116;hsa00565;Ether lipid metabolism
TTDC00116;hsa01100;Metabolic pathways
TTDC00116;hsa01130;Biosynthesis of antibiotics
TTDC00117;hsa04020;Calcium signaling pathway
TTDC00117;hsa04080;Neuroactive ligand-receptor interaction
TTDC00118;hsa04010;MAPK signaling pathway
TTDC00118;hsa04071;Sphingolipid signaling pathway
TTDC00118;hsa04110;Cell cycle
TTDC00118;hsa04115;p53 signaling pathway
TTDC00118;hsa04151;PI3K-Akt signaling pathway
TTDC00118;hsa04210;Apoptosis
TTDC00118;hsa04310;Wnt signaling pathway
TTDC00118;hsa04722;Neurotrophin signaling pathway
TTDC00118;hsa04919;Thyroid hormone signaling pathway
TTDC00118;hsa05014;Amyotrophic lateral sclerosis (ALS)
TTDC00118;hsa05016;Huntington's disease
TTDC00118;hsa05160;Hepatitis C
TTDC00118;hsa05161;Hepatitis B
TTDC00118;hsa05162;Measles
TTDC00118;hsa05166;HTLV-I infection
TTDC00118;hsa05168;Herpes simplex infection
TTDC00118;hsa05169;Epstein-Barr virus infection
TTDC00118;hsa05200;Pathways in cancer
TTDC00118;hsa05202;Transcriptional misregulation in cancer
TTDC00118;hsa05203;Viral carcinogenesis
TTDC00118;hsa05205;Proteoglycans in cancer
TTDC00118;hsa05206;MicroRNAs in cancer
TTDC00118;hsa05210;Colorectal cancer
TTDC00118;hsa05212;Pancreatic cancer
TTDC00118;hsa05213;Endometrial cancer
TTDC00118;hsa05214;Glioma
TTDC00118;hsa05215;Prostate cancer
TTDC00118;hsa05216;Thyroid cancer
TTDC00118;hsa05217;Basal cell carcinoma
TTDC00118;hsa05218;Melanoma
TTDC00118;hsa05219;Bladder cancer
TTDC00118;hsa05220;Chronic myeloid leukemia
TTDC00118;hsa05222;Small cell lung cancer
TTDC00118;hsa05223;Non-small cell lung cancer
TTDC00118;hsa05230;Central carbon metabolism in cancer
TTDC00119;hsa04010;MAPK signaling pathway
TTDC00119;hsa04012;ErbB signaling pathway
TTDC00119;hsa04024;cAMP signaling pathway
TTDC00119;hsa04310;Wnt signaling pathway
TTDC00119;hsa04380;Osteoclast differentiation
TTDC00119;hsa04510;Focal adhesion
TTDC00119;hsa04620;Toll-like receptor signaling pathway
TTDC00119;hsa04660;T cell receptor signaling pathway
TTDC00119;hsa04662;B cell receptor signaling pathway
TTDC00119;hsa04668;TNF signaling pathway
TTDC00119;hsa04722;Neurotrophin signaling pathway
TTDC00119;hsa04912;GnRH signaling pathway
TTDC00119;hsa04915;Estrogen signaling pathway
TTDC00119;hsa04921;Oxytocin signaling pathway
TTDC00119;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDC00119;hsa05030;Cocaine addiction
TTDC00119;hsa05031;Amphetamine addiction
TTDC00119;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDC00119;hsa05132;Salmonella infection
TTDC00119;hsa05133;Pertussis
TTDC00119;hsa05140;Leishmaniasis
TTDC00119;hsa05142;Chagas disease (American trypanosomiasis)
TTDC00119;hsa05161;Hepatitis B
TTDC00119;hsa05164;Influenza A
TTDC00119;hsa05166;HTLV-I infection
TTDC00119;hsa05168;Herpes simplex infection
TTDC00119;hsa05169;Epstein-Barr virus infection
TTDC00119;hsa05200;Pathways in cancer
TTDC00119;hsa05203;Viral carcinogenesis
TTDC00119;hsa05210;Colorectal cancer
TTDC00119;hsa05211;Renal cell carcinoma
TTDC00119;hsa05231;Choline metabolism in cancer
TTDC00119;hsa05321;Inflammatory bowel disease (IBD)
TTDC00119;hsa05323;Rheumatoid arthritis
TTDC00120;hsa05016;Huntington's disease
TTDC00121;hsa04060;Cytokine-cytokine receptor interaction
TTDC00121;hsa04062;Chemokine signaling pathway
TTDC00121;hsa04144;Endocytosis
TTDC00121;hsa04360;Axon guidance
TTDC00121;hsa04670;Leukocyte transendothelial migration
TTDC00121;hsa04672;Intestinal immune network for IgA production
TTDC00121;hsa05200;Pathways in cancer
TTDC00122;hsa04060;Cytokine-cytokine receptor interaction
TTDC00122;hsa04062;Chemokine signaling pathway
TTDC00123;hsa04975;Fat digestion and absorption
TTDC00125;hsa04060;Cytokine-cytokine receptor interaction
TTDC00125;hsa04062;Chemokine signaling pathway
TTDC00126;hsa04080;Neuroactive ligand-receptor interaction
TTDC00126;hsa04724;Glutamatergic synapse
TTDC00126;hsa05030;Cocaine addiction
TTDC00127;hsa04024;cAMP signaling pathway
TTDC00127;hsa04080;Neuroactive ligand-receptor interaction
TTDC00128;hsa04725;Cholinergic synapse
TTDC00129;hsa04080;Neuroactive ligand-receptor interaction
TTDC00130;hsa00590;Arachidonic acid metabolism
TTDC00130;hsa01100;Metabolic pathways
TTDC00131;hsa04010;MAPK signaling pathway
TTDC00131;hsa04014;Ras signaling pathway
TTDC00131;hsa04015;Rap1 signaling pathway
TTDC00131;hsa04144;Endocytosis
TTDC00131;hsa04151;PI3K-Akt signaling pathway
TTDC00131;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDC00131;hsa04810;Regulation of actin cytoskeleton
TTDC00131;hsa05200;Pathways in cancer
TTDC00131;hsa05206;MicroRNAs in cancer
TTDC00131;hsa05219;Bladder cancer
TTDC00131;hsa05230;Central carbon metabolism in cancer
TTDC00132;hsa04010;MAPK signaling pathway
TTDC00132;hsa04012;ErbB signaling pathway
TTDC00132;hsa04014;Ras signaling pathway
TTDC00132;hsa04015;Rap1 signaling pathway
TTDC00132;hsa04022;cGMP-PKG signaling pathway
TTDC00132;hsa04024;cAMP signaling pathway
TTDC00132;hsa04062;Chemokine signaling pathway
TTDC00132;hsa04066;HIF-1 signaling pathway
TTDC00132;hsa04068;FoxO signaling pathway
TTDC00132;hsa04071;Sphingolipid signaling pathway
TTDC00132;hsa04150;mTOR signaling pathway
TTDC00132;hsa04151;PI3K-Akt signaling pathway
TTDC00132;hsa04152;AMPK signaling pathway
TTDC00132;hsa04210;Apoptosis
TTDC00132;hsa04261;Adrenergic signaling in cardiomyocytes
TTDC00132;hsa04370;VEGF signaling pathway
TTDC00132;hsa04380;Osteoclast differentiation
TTDC00132;hsa04510;Focal adhesion
TTDC00132;hsa04530;Tight junction
TTDC00132;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDC00132;hsa04611;Platelet activation
TTDC00132;hsa04620;Toll-like receptor signaling pathway
TTDC00132;hsa04630;Jak-STAT signaling pathway
TTDC00132;hsa04660;T cell receptor signaling pathway
TTDC00132;hsa04662;B cell receptor signaling pathway
TTDC00132;hsa04664;Fc epsilon RI signaling pathway
TTDC00132;hsa04666;Fc gamma R-mediated phagocytosis
TTDC00132;hsa04668;TNF signaling pathway
TTDC00132;hsa04722;Neurotrophin signaling pathway
TTDC00132;hsa04725;Cholinergic synapse
TTDC00132;hsa04728;Dopaminergic synapse
TTDC00132;hsa04910;Insulin signaling pathway
TTDC00132;hsa04914;Progesterone-mediated oocyte maturation
TTDC00132;hsa04915;Estrogen signaling pathway
TTDC00132;hsa04917;Prolactin signaling pathway
TTDC00132;hsa04919;Thyroid hormone signaling pathway
TTDC00132;hsa04920;Adipocytokine signaling pathway
TTDC00132;hsa04922;Glucagon signaling pathway
TTDC00132;hsa04923;Regulation of lipolysis in adipocytes
TTDC00132;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDC00132;hsa04973;Carbohydrate digestion and absorption
TTDC00132;hsa05142;Chagas disease (American trypanosomiasis)
TTDC00132;hsa05145;Toxoplasmosis
TTDC00132;hsa05152;Tuberculosis
TTDC00132;hsa05160;Hepatitis C
TTDC00132;hsa05161;Hepatitis B
TTDC00132;hsa05162;Measles
TTDC00132;hsa05164;Influenza A
TTDC00132;hsa05166;HTLV-I infection
TTDC00132;hsa05169;Epstein-Barr virus infection
TTDC00132;hsa05200;Pathways in cancer
TTDC00132;hsa05205;Proteoglycans in cancer
TTDC00132;hsa05210;Colorectal cancer
TTDC00132;hsa05211;Renal cell carcinoma
TTDC00132;hsa05212;Pancreatic cancer
TTDC00132;hsa05213;Endometrial cancer
TTDC00132;hsa05214;Glioma
TTDC00132;hsa05215;Prostate cancer
TTDC00132;hsa05218;Melanoma
TTDC00132;hsa05220;Chronic myeloid leukemia
TTDC00132;hsa05221;Acute myeloid leukemia
TTDC00132;hsa05222;Small cell lung cancer
TTDC00132;hsa05223;Non-small cell lung cancer
TTDC00132;hsa05230;Central carbon metabolism in cancer
TTDC00132;hsa05231;Choline metabolism in cancer
TTDC00133;hsa04080;Neuroactive ligand-receptor interaction
TTDC00134;hsa00860;Porphyrin and chlorophyll metabolism
TTDC00134;hsa04066;HIF-1 signaling pathway
TTDC00134;hsa04978;Mineral absorption
TTDC00134;hsa05206;MicroRNAs in cancer
TTDC00135;hsa04151;PI3K-Akt signaling pathway
TTDC00135;hsa04640;Hematopoietic cell lineage
TTDC00135;hsa04662;B cell receptor signaling pathway
TTDC00135;hsa05169;Epstein-Barr virus infection
TTDC00135;hsa05340;Primary immunodeficiency
TTDC00136;hsa04060;Cytokine-cytokine receptor interaction
TTDC00136;hsa04068;FoxO signaling pathway
TTDC00136;hsa04151;PI3K-Akt signaling pathway
TTDC00136;hsa04630;Jak-STAT signaling pathway
TTDC00136;hsa04640;Hematopoietic cell lineage
TTDC00136;hsa05340;Primary immunodeficiency
TTDC00137;hsa04514;Cell adhesion molecules (CAMs)
TTDC00137;hsa05412;Arrhythmogenic right ventricular cardiomyopathy (ARVC)
TTDC00140;hsa00562;Inositol phosphate metabolism
TTDC00140;hsa04012;ErbB signaling pathway
TTDC00140;hsa04014;Ras signaling pathway
TTDC00140;hsa04015;Rap1 signaling pathway
TTDC00140;hsa04022;cGMP-PKG signaling pathway
TTDC00140;hsa04024;cAMP signaling pathway
TTDC00140;hsa04062;Chemokine signaling pathway
TTDC00140;hsa04066;HIF-1 signaling pathway
TTDC00140;hsa04068;FoxO signaling pathway
TTDC00140;hsa04070;Phosphatidylinositol signaling system
TTDC00140;hsa04071;Sphingolipid signaling pathway
TTDC00140;hsa04150;mTOR signaling pathway
TTDC00140;hsa04151;PI3K-Akt signaling pathway
TTDC00140;hsa04152;AMPK signaling pathway
TTDC00140;hsa04210;Apoptosis
TTDC00140;hsa04261;Adrenergic signaling in cardiomyocytes
TTDC00140;hsa04370;VEGF signaling pathway
TTDC00140;hsa04380;Osteoclast differentiation
TTDC00140;hsa04510;Focal adhesion
TTDC00140;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDC00140;hsa04611;Platelet activation
TTDC00140;hsa04620;Toll-like receptor signaling pathway
TTDC00140;hsa04630;Jak-STAT signaling pathway
TTDC00140;hsa04650;Natural killer cell mediated cytotoxicity
TTDC00140;hsa04660;T cell receptor signaling pathway
TTDC00140;hsa04662;B cell receptor signaling pathway
TTDC00140;hsa04664;Fc epsilon RI signaling pathway
TTDC00140;hsa04666;Fc gamma R-mediated phagocytosis
TTDC00140;hsa04668;TNF signaling pathway
TTDC00140;hsa04670;Leukocyte transendothelial migration
TTDC00140;hsa04722;Neurotrophin signaling pathway
TTDC00140;hsa04725;Cholinergic synapse
TTDC00140;hsa04750;Inflammatory mediator regulation of TRP channels
TTDC00140;hsa04810;Regulation of actin cytoskeleton
TTDC00140;hsa04910;Insulin signaling pathway
TTDC00140;hsa04914;Progesterone-mediated oocyte maturation
TTDC00140;hsa04915;Estrogen signaling pathway
TTDC00140;hsa04917;Prolactin signaling pathway
TTDC00140;hsa04919;Thyroid hormone signaling pathway
TTDC00140;hsa04921;Oxytocin signaling pathway
TTDC00140;hsa04923;Regulation of lipolysis in adipocytes
TTDC00140;hsa04930;Type II diabetes mellitus
TTDC00140;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDC00140;hsa04960;Aldosterone-regulated sodium reabsorption
TTDC00140;hsa04973;Carbohydrate digestion and absorption
TTDC00140;hsa05100;Bacterial invasion of epithelial cells
TTDC00140;hsa05142;Chagas disease (American trypanosomiasis)
TTDC00140;hsa05145;Toxoplasmosis
TTDC00140;hsa05146;Amoebiasis
TTDC00140;hsa05160;Hepatitis C
TTDC00140;hsa05161;Hepatitis B
TTDC00140;hsa05162;Measles
TTDC00140;hsa05164;Influenza A
TTDC00140;hsa05166;HTLV-I infection
TTDC00140;hsa05169;Epstein-Barr virus infection
TTDC00140;hsa05200;Pathways in cancer
TTDC00140;hsa05203;Viral carcinogenesis
TTDC00140;hsa05205;Proteoglycans in cancer
TTDC00140;hsa05210;Colorectal cancer
TTDC00140;hsa05211;Renal cell carcinoma
TTDC00140;hsa05212;Pancreatic cancer
TTDC00140;hsa05213;Endometrial cancer
TTDC00140;hsa05214;Glioma
TTDC00140;hsa05215;Prostate cancer
TTDC00140;hsa05218;Melanoma
TTDC00140;hsa05220;Chronic myeloid leukemia
TTDC00140;hsa05221;Acute myeloid leukemia
TTDC00140;hsa05222;Small cell lung cancer
TTDC00140;hsa05223;Non-small cell lung cancer
TTDC00140;hsa05230;Central carbon metabolism in cancer
TTDC00140;hsa05231;Choline metabolism in cancer
TTDC00141;hsa00010;Glycolysis / Gluconeogenesis
TTDC00141;hsa00052;Galactose metabolism
TTDC00141;hsa00500;Starch and sucrose metabolism
TTDC00141;hsa00520;Amino sugar and nucleotide sugar metabolism
TTDC00141;hsa00524;Butirosin and neomycin biosynthesis
TTDC00141;hsa01100;Metabolic pathways
TTDC00141;hsa01130;Biosynthesis of antibiotics
TTDC00141;hsa01200;Carbon metabolism
TTDC00141;hsa04910;Insulin signaling pathway
TTDC00141;hsa04911;Insulin secretion
TTDC00141;hsa04917;Prolactin signaling pathway
TTDC00141;hsa04922;Glucagon signaling pathway
TTDC00141;hsa04930;Type II diabetes mellitus
TTDC00141;hsa04950;Maturity onset diabetes of the young
TTDC00141;hsa05230;Central carbon metabolism in cancer
TTDC00144;hsa04020;Calcium signaling pathway
TTDC00144;hsa04080;Neuroactive ligand-receptor interaction
TTDC00145;hsa04012;ErbB signaling pathway
TTDC00145;hsa04066;HIF-1 signaling pathway
TTDC00145;hsa04150;mTOR signaling pathway
TTDC00145;hsa04151;PI3K-Akt signaling pathway
TTDC00145;hsa04152;AMPK signaling pathway
TTDC00145;hsa04350;TGF-beta signaling pathway
TTDC00145;hsa04666;Fc gamma R-mediated phagocytosis
TTDC00145;hsa04910;Insulin signaling pathway
TTDC00145;hsa05205;Proteoglycans in cancer
TTDC00145;hsa05221;Acute myeloid leukemia
TTDC00145;hsa05231;Choline metabolism in cancer
TTDC00147;hsa03320;PPAR signaling pathway
TTDC00147;hsa05200;Pathways in cancer
TTDC00147;hsa05219;Bladder cancer
TTDC00147;hsa05323;Rheumatoid arthritis
TTDC00148;hsa04015;Rap1 signaling pathway
TTDC00148;hsa04145;Phagosome
TTDC00148;hsa04151;PI3K-Akt signaling pathway
TTDC00148;hsa04360;Axon guidance
TTDC00148;hsa04510;Focal adhesion
TTDC00148;hsa04512;ECM-receptor interaction
TTDC00148;hsa04514;Cell adhesion molecules (CAMs)
TTDC00148;hsa04611;Platelet activation
TTDC00148;hsa04670;Leukocyte transendothelial migration
TTDC00148;hsa04810;Regulation of actin cytoskeleton
TTDC00148;hsa05100;Bacterial invasion of epithelial cells
TTDC00148;hsa05130;Pathogenic Escherichia coli infection
TTDC00148;hsa05131;Shigellosis
TTDC00148;hsa05133;Pertussis
TTDC00148;hsa05140;Leishmaniasis
TTDC00148;hsa05145;Toxoplasmosis
TTDC00148;hsa05200;Pathways in cancer
TTDC00148;hsa05205;Proteoglycans in cancer
TTDC00148;hsa05222;Small cell lung cancer
TTDC00148;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDC00148;hsa05412;Arrhythmogenic right ventricular cardiomyopathy (ARVC)
TTDC00148;hsa05414;Dilated cardiomyopathy
TTDC00149;hsa00140;Steroid hormone biosynthesis
TTDC00151;hsa04080;Neuroactive ligand-receptor interaction
TTDC00151;hsa04750;Inflammatory mediator regulation of TRP channels
TTDC00151;hsa04924;Renin secretion
TTDC00151;hsa05200;Pathways in cancer
TTDC00152;hsa00010;Glycolysis / Gluconeogenesis
TTDC00152;hsa00030;Pentose phosphate pathway
TTDC00152;hsa00051;Fructose and mannose metabolism
TTDC00152;hsa01100;Metabolic pathways
TTDC00152;hsa01130;Biosynthesis of antibiotics
TTDC00152;hsa01200;Carbon metabolism
TTDC00152;hsa04152;AMPK signaling pathway
TTDC00152;hsa04910;Insulin signaling pathway
TTDC00152;hsa04922;Glucagon signaling pathway
TTDC00153;hsa04080;Neuroactive ligand-receptor interaction
TTDC00155;hsa04080;Neuroactive ligand-receptor interaction
TTDC00156;hsa04064;NF-kappa B signaling pathway
TTDC00156;hsa04151;PI3K-Akt signaling pathway
TTDC00156;hsa04380;Osteoclast differentiation
TTDC00156;hsa04611;Platelet activation
TTDC00156;hsa04650;Natural killer cell mediated cytotoxicity
TTDC00156;hsa04662;B cell receptor signaling pathway
TTDC00156;hsa04664;Fc epsilon RI signaling pathway
TTDC00156;hsa04666;Fc gamma R-mediated phagocytosis
TTDC00156;hsa05152;Tuberculosis
TTDC00156;hsa05169;Epstein-Barr virus infection
TTDC00156;hsa05203;Viral carcinogenesis
TTDC00159;hsa05034;Alcoholism
TTDC00159;hsa05169;Epstein-Barr virus infection
TTDC00159;hsa05203;Viral carcinogenesis
TTDC00159;hsa05206;MicroRNAs in cancer
TTDC00160;hsa04068;FoxO signaling pathway
TTDC00160;hsa04110;Cell cycle
TTDC00160;hsa04114;Oocyte meiosis
TTDC00160;hsa04914;Progesterone-mediated oocyte maturation
TTDC00161;hsa04014;Ras signaling pathway
TTDC00161;hsa04015;Rap1 signaling pathway
TTDC00161;hsa04066;HIF-1 signaling pathway
TTDC00161;hsa04151;PI3K-Akt signaling pathway
TTDC00161;hsa05323;Rheumatoid arthritis
TTDC00162;hsa04012;ErbB signaling pathway
TTDC00162;hsa04062;Chemokine signaling pathway
TTDC00162;hsa04110;Cell cycle
TTDC00162;hsa04151;PI3K-Akt signaling pathway
TTDC00162;hsa04310;Wnt signaling pathway
TTDC00162;hsa04340;Hedgehog signaling pathway
TTDC00162;hsa04360;Axon guidance
TTDC00162;hsa04390;Hippo signaling pathway
TTDC00162;hsa04510;Focal adhesion
TTDC00162;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDC00162;hsa04660;T cell receptor signaling pathway
TTDC00162;hsa04662;B cell receptor signaling pathway
TTDC00162;hsa04722;Neurotrophin signaling pathway
TTDC00162;hsa04728;Dopaminergic synapse
TTDC00162;hsa04910;Insulin signaling pathway
TTDC00162;hsa04916;Melanogenesis
TTDC00162;hsa04917;Prolactin signaling pathway
TTDC00162;hsa04919;Thyroid hormone signaling pathway
TTDC00162;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDC00162;hsa05010;Alzheimer's disease
TTDC00162;hsa05160;Hepatitis C
TTDC00162;hsa05162;Measles
TTDC00162;hsa05164;Influenza A
TTDC00162;hsa05166;HTLV-I infection
TTDC00162;hsa05169;Epstein-Barr virus infection
TTDC00162;hsa05200;Pathways in cancer
TTDC00162;hsa05210;Colorectal cancer
TTDC00162;hsa05213;Endometrial cancer
TTDC00162;hsa05215;Prostate cancer
TTDC00162;hsa05217;Basal cell carcinoma
TTDC00163;hsa04010;MAPK signaling pathway
TTDC00163;hsa04012;ErbB signaling pathway
TTDC00163;hsa04014;Ras signaling pathway
TTDC00163;hsa04015;Rap1 signaling pathway
TTDC00163;hsa04020;Calcium signaling pathway
TTDC00163;hsa04062;Chemokine signaling pathway
TTDC00163;hsa04064;NF-kappa B signaling pathway
TTDC00163;hsa04066;HIF-1 signaling pathway
TTDC00163;hsa04070;Phosphatidylinositol signaling system
TTDC00163;hsa04071;Sphingolipid signaling pathway
TTDC00163;hsa04150;mTOR signaling pathway
TTDC00163;hsa04270;Vascular smooth muscle contraction
TTDC00163;hsa04310;Wnt signaling pathway
TTDC00163;hsa04370;VEGF signaling pathway
TTDC00163;hsa04510;Focal adhesion
TTDC00163;hsa04530;Tight junction
TTDC00163;hsa04540;Gap junction
TTDC00163;hsa04650;Natural killer cell mediated cytotoxicity
TTDC00163;hsa04662;B cell receptor signaling pathway
TTDC00163;hsa04664;Fc epsilon RI signaling pathway
TTDC00163;hsa04666;Fc gamma R-mediated phagocytosis
TTDC00163;hsa04670;Leukocyte transendothelial migration
TTDC00163;hsa04713;Circadian entrainment
TTDC00163;hsa04720;Long-term potentiation
TTDC00163;hsa04723;Retrograde endocannabinoid signaling
TTDC00163;hsa04724;Glutamatergic synapse
TTDC00163;hsa04725;Cholinergic synapse
TTDC00163;hsa04726;Serotonergic synapse
TTDC00163;hsa04727;GABAergic synapse
TTDC00163;hsa04728;Dopaminergic synapse
TTDC00163;hsa04730;Long-term depression
TTDC00163;hsa04750;Inflammatory mediator regulation of TRP channels
TTDC00163;hsa04911;Insulin secretion
TTDC00163;hsa04912;GnRH signaling pathway
TTDC00163;hsa04916;Melanogenesis
TTDC00163;hsa04918;Thyroid hormone synthesis
TTDC00163;hsa04919;Thyroid hormone signaling pathway
TTDC00163;hsa04921;Oxytocin signaling pathway
TTDC00163;hsa04960;Aldosterone-regulated sodium reabsorption
TTDC00163;hsa04961;Endocrine and other factor-regulated calcium reabsorption
TTDC00163;hsa04970;Salivary secretion
TTDC00163;hsa04971;Gastric acid secretion
TTDC00163;hsa04972;Pancreatic secretion
TTDC00163;hsa04973;Carbohydrate digestion and absorption
TTDC00163;hsa05031;Amphetamine addiction
TTDC00163;hsa05032;Morphine addiction
TTDC00163;hsa05110;Vibrio cholerae infection
TTDC00163;hsa05140;Leishmaniasis
TTDC00163;hsa05143;African trypanosomiasis
TTDC00163;hsa05146;Amoebiasis
TTDC00163;hsa05161;Hepatitis B
TTDC00163;hsa05164;Influenza A
TTDC00163;hsa05200;Pathways in cancer
TTDC00163;hsa05205;Proteoglycans in cancer
TTDC00163;hsa05206;MicroRNAs in cancer
TTDC00163;hsa05214;Glioma
TTDC00163;hsa05223;Non-small cell lung cancer
TTDC00163;hsa05231;Choline metabolism in cancer
TTDC00165;hsa04110;Cell cycle
TTDC00165;hsa04115;p53 signaling pathway
TTDC00165;hsa04151;PI3K-Akt signaling pathway
TTDC00165;hsa04530;Tight junction
TTDC00165;hsa04660;T cell receptor signaling pathway
TTDC00165;hsa05161;Hepatitis B
TTDC00165;hsa05162;Measles
TTDC00165;hsa05166;HTLV-I infection
TTDC00165;hsa05200;Pathways in cancer
TTDC00165;hsa05203;Viral carcinogenesis
TTDC00165;hsa05212;Pancreatic cancer
TTDC00165;hsa05214;Glioma
TTDC00165;hsa05218;Melanoma
TTDC00165;hsa05219;Bladder cancer
TTDC00165;hsa05220;Chronic myeloid leukemia
TTDC00165;hsa05222;Small cell lung cancer
TTDC00165;hsa05223;Non-small cell lung cancer
TTDC00166;hsa04110;Cell cycle
TTDC00166;hsa04114;Oocyte meiosis
TTDC00166;hsa04115;p53 signaling pathway
TTDC00166;hsa04540;Gap junction
TTDC00166;hsa04914;Progesterone-mediated oocyte maturation
TTDC00166;hsa05168;Herpes simplex infection
TTDC00166;hsa05169;Epstein-Barr virus infection
TTDC00166;hsa05203;Viral carcinogenesis
TTDC00168;hsa04014;Ras signaling pathway
TTDC00168;hsa04064;NF-kappa B signaling pathway
TTDC00168;hsa04151;PI3K-Akt signaling pathway
TTDC00168;hsa04210;Apoptosis
TTDC00168;hsa04630;Jak-STAT signaling pathway
TTDC00168;hsa05014;Amyotrophic lateral sclerosis (ALS)
TTDC00168;hsa05145;Toxoplasmosis
TTDC00168;hsa05166;HTLV-I infection
TTDC00168;hsa05200;Pathways in cancer
TTDC00168;hsa05202;Transcriptional misregulation in cancer
TTDC00168;hsa05212;Pancreatic cancer
TTDC00168;hsa05220;Chronic myeloid leukemia
TTDC00168;hsa05222;Small cell lung cancer
TTDC00169;hsa04110;Cell cycle
TTDC00169;hsa04115;p53 signaling pathway
TTDC00169;hsa04151;PI3K-Akt signaling pathway
TTDC00169;hsa05161;Hepatitis B
TTDC00169;hsa05162;Measles
TTDC00169;hsa05200;Pathways in cancer
TTDC00169;hsa05203;Viral carcinogenesis
TTDC00169;hsa05206;MicroRNAs in cancer
TTDC00169;hsa05212;Pancreatic cancer
TTDC00169;hsa05214;Glioma
TTDC00169;hsa05218;Melanoma
TTDC00169;hsa05220;Chronic myeloid leukemia
TTDC00169;hsa05222;Small cell lung cancer
TTDC00169;hsa05223;Non-small cell lung cancer
TTDC00171;hsa00230;Purine metabolism
TTDC00176;hsa04014;Ras signaling pathway
TTDC00176;hsa04015;Rap1 signaling pathway
TTDC00176;hsa04151;PI3K-Akt signaling pathway
TTDC00176;hsa04510;Focal adhesion
TTDC00176;hsa05200;Pathways in cancer
TTDC00177;hsa04060;Cytokine-cytokine receptor interaction
TTDC00177;hsa04630;Jak-STAT signaling pathway
TTDC00177;hsa04664;Fc epsilon RI signaling pathway
TTDC00177;hsa05162;Measles
TTDC00177;hsa05310;Asthma
TTDC00177;hsa05321;Inflammatory bowel disease (IBD)
TTDC00178;hsa04064;NF-kappa B signaling pathway
TTDC00178;hsa04270;Vascular smooth muscle contraction
TTDC00178;hsa04530;Tight junction
TTDC00178;hsa04660;T cell receptor signaling pathway
TTDC00178;hsa04750;Inflammatory mediator regulation of TRP channels
TTDC00178;hsa04920;Adipocytokine signaling pathway
TTDC00178;hsa05162;Measles
TTDC00179;hsa04080;Neuroactive ligand-receptor interaction
TTDC00179;hsa04750;Inflammatory mediator regulation of TRP channels
TTDC00180;hsa04330;Notch signaling pathway
TTDC00180;hsa05010;Alzheimer's disease
TTDC00182;hsa04010;MAPK signaling pathway
TTDC00182;hsa04012;ErbB signaling pathway
TTDC00182;hsa04014;Ras signaling pathway
TTDC00182;hsa04015;Rap1 signaling pathway
TTDC00182;hsa04020;Calcium signaling pathway
TTDC00182;hsa04066;HIF-1 signaling pathway
TTDC00182;hsa04070;Phosphatidylinositol signaling system
TTDC00182;hsa04071;Sphingolipid signaling pathway
TTDC00182;hsa04150;mTOR signaling pathway
TTDC00182;hsa04151;PI3K-Akt signaling pathway
TTDC00182;hsa04261;Adrenergic signaling in cardiomyocytes
TTDC00182;hsa04270;Vascular smooth muscle contraction
TTDC00182;hsa04310;Wnt signaling pathway
TTDC00182;hsa04370;VEGF signaling pathway
TTDC00182;hsa04510;Focal adhesion
TTDC00182;hsa04530;Tight junction
TTDC00182;hsa04540;Gap junction
TTDC00182;hsa04650;Natural killer cell mediated cytotoxicity
TTDC00182;hsa04664;Fc epsilon RI signaling pathway
TTDC00182;hsa04666;Fc gamma R-mediated phagocytosis
TTDC00182;hsa04670;Leukocyte transendothelial migration
TTDC00182;hsa04713;Circadian entrainment
TTDC00182;hsa04720;Long-term potentiation
TTDC00182;hsa04723;Retrograde endocannabinoid signaling
TTDC00182;hsa04724;Glutamatergic synapse
TTDC00182;hsa04725;Cholinergic synapse
TTDC00182;hsa04726;Serotonergic synapse
TTDC00182;hsa04727;GABAergic synapse
TTDC00182;hsa04728;Dopaminergic synapse
TTDC00182;hsa04730;Long-term depression
TTDC00182;hsa04750;Inflammatory mediator regulation of TRP channels
TTDC00182;hsa04911;Insulin secretion
TTDC00182;hsa04912;GnRH signaling pathway
TTDC00182;hsa04916;Melanogenesis
TTDC00182;hsa04918;Thyroid hormone synthesis
TTDC00182;hsa04919;Thyroid hormone signaling pathway
TTDC00182;hsa04921;Oxytocin signaling pathway
TTDC00182;hsa04960;Aldosterone-regulated sodium reabsorption
TTDC00182;hsa04961;Endocrine and other factor-regulated calcium reabsorption
TTDC00182;hsa04970;Salivary secretion
TTDC00182;hsa04971;Gastric acid secretion
TTDC00182;hsa04972;Pancreatic secretion
TTDC00182;hsa05031;Amphetamine addiction
TTDC00182;hsa05032;Morphine addiction
TTDC00182;hsa05110;Vibrio cholerae infection
TTDC00182;hsa05130;Pathogenic Escherichia coli infection
TTDC00182;hsa05143;African trypanosomiasis
TTDC00182;hsa05146;Amoebiasis
TTDC00182;hsa05161;Hepatitis B
TTDC00182;hsa05164;Influenza A
TTDC00182;hsa05200;Pathways in cancer
TTDC00182;hsa05205;Proteoglycans in cancer
TTDC00182;hsa05206;MicroRNAs in cancer
TTDC00182;hsa05214;Glioma
TTDC00182;hsa05223;Non-small cell lung cancer
TTDC00182;hsa05231;Choline metabolism in cancer
TTDC00183;hsa04360;Axon guidance
TTDC00183;hsa05166;HTLV-I infection
TTDC00184;hsa04020;Calcium signaling pathway
TTDC00184;hsa04022;cGMP-PKG signaling pathway
TTDC00184;hsa04080;Neuroactive ligand-receptor interaction
TTDC00184;hsa04144;Endocytosis
TTDC00184;hsa04970;Salivary secretion
TTDC00185;hsa04020;Calcium signaling pathway
TTDC00185;hsa04024;cAMP signaling pathway
TTDC00185;hsa04080;Neuroactive ligand-receptor interaction
TTDC00185;hsa04726;Serotonergic synapse
TTDC00186;hsa04060;Cytokine-cytokine receptor interaction
TTDC00186;hsa04630;Jak-STAT signaling pathway
TTDC00186;hsa05310;Asthma
TTDC00187;hsa04062;Chemokine signaling pathway
TTDC00187;hsa04151;PI3K-Akt signaling pathway
TTDC00187;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDC00187;hsa04630;Jak-STAT signaling pathway
TTDC00187;hsa04725;Cholinergic synapse
TTDC00187;hsa04917;Prolactin signaling pathway
TTDC00187;hsa04920;Adipocytokine signaling pathway
TTDC00187;hsa05140;Leishmaniasis
TTDC00187;hsa05145;Toxoplasmosis
TTDC00187;hsa05152;Tuberculosis
TTDC00187;hsa05162;Measles
TTDC00187;hsa05164;Influenza A
TTDC00187;hsa05168;Herpes simplex infection
TTDC00188;hsa04060;Cytokine-cytokine receptor interaction
TTDC00188;hsa04064;NF-kappa B signaling pathway
TTDC00188;hsa04514;Cell adhesion molecules (CAMs)
TTDC00188;hsa04620;Toll-like receptor signaling pathway
TTDC00188;hsa04672;Intestinal immune network for IgA production
TTDC00188;hsa05144;Malaria
TTDC00188;hsa05145;Toxoplasmosis
TTDC00188;hsa05166;HTLV-I infection
TTDC00188;hsa05169;Epstein-Barr virus infection
TTDC00188;hsa05202;Transcriptional misregulation in cancer
TTDC00188;hsa05310;Asthma
TTDC00188;hsa05320;Autoimmune thyroid disease
TTDC00188;hsa05322;Systemic lupus erythematosus
TTDC00188;hsa05330;Allograft rejection
TTDC00188;hsa05340;Primary immunodeficiency
TTDC00188;hsa05416;Viral myocarditis
TTDC00189;hsa04014;Ras signaling pathway
TTDC00189;hsa04015;Rap1 signaling pathway
TTDC00189;hsa04060;Cytokine-cytokine receptor interaction
TTDC00189;hsa04151;PI3K-Akt signaling pathway
TTDC00189;hsa04722;Neurotrophin signaling pathway
TTDC00189;hsa05202;Transcriptional misregulation in cancer
TTDC00190;hsa04060;Cytokine-cytokine receptor interaction
TTDC00190;hsa04062;Chemokine signaling pathway
TTDC00190;hsa04144;Endocytosis
TTDC00190;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDC00191;hsa04520;Adherens junction
TTDC00191;hsa04910;Insulin signaling pathway
TTDC00192;hsa04064;NF-kappa B signaling pathway
TTDC00192;hsa04514;Cell adhesion molecules (CAMs)
TTDC00192;hsa04650;Natural killer cell mediated cytotoxicity
TTDC00192;hsa04668;TNF signaling pathway
TTDC00192;hsa04670;Leukocyte transendothelial migration
TTDC00192;hsa05143;African trypanosomiasis
TTDC00192;hsa05144;Malaria
TTDC00192;hsa05150;Staphylococcus aureus infection
TTDC00192;hsa05164;Influenza A
TTDC00192;hsa05166;HTLV-I infection
TTDC00192;hsa05169;Epstein-Barr virus infection
TTDC00192;hsa05323;Rheumatoid arthritis
TTDC00192;hsa05416;Viral myocarditis
TTDC00193;hsa04024;cAMP signaling pathway
TTDC00193;hsa04080;Neuroactive ligand-receptor interaction
TTDC00194;hsa04014;Ras signaling pathway
TTDC00194;hsa04015;Rap1 signaling pathway
TTDC00194;hsa04060;Cytokine-cytokine receptor interaction
TTDC00194;hsa04151;PI3K-Akt signaling pathway
TTDC00194;hsa04510;Focal adhesion
TTDC00194;hsa05144;Malaria
TTDC00194;hsa05200;Pathways in cancer
TTDC00194;hsa05205;Proteoglycans in cancer
TTDC00194;hsa05211;Renal cell carcinoma
TTDC00194;hsa05218;Melanoma
TTDC00196;hsa04060;Cytokine-cytokine receptor interaction
TTDC00196;hsa04064;NF-kappa B signaling pathway
TTDC00196;hsa04672;Intestinal immune network for IgA production
TTDC00196;hsa05323;Rheumatoid arthritis
TTDC00197;hsa04514;Cell adhesion molecules (CAMs)
TTDC00197;hsa05144;Malaria
TTDC00197;hsa05150;Staphylococcus aureus infection
TTDC00199;hsa04145;Phagosome
TTDC00199;hsa05202;Transcriptional misregulation in cancer
TTDC00200;hsa00130;Ubiquinone and other terpenoid-quinone biosynthesis
TTDC00201;hsa04010;MAPK signaling pathway
TTDC00201;hsa04015;Rap1 signaling pathway
TTDC00201;hsa04068;FoxO signaling pathway
TTDC00201;hsa04071;Sphingolipid signaling pathway
TTDC00201;hsa04261;Adrenergic signaling in cardiomyocytes
TTDC00201;hsa04370;VEGF signaling pathway
TTDC00201;hsa04380;Osteoclast differentiation
TTDC00201;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDC00201;hsa04611;Platelet activation
TTDC00201;hsa04620;Toll-like receptor signaling pathway
TTDC00201;hsa04621;NOD-like receptor signaling pathway
TTDC00201;hsa04622;RIG-I-like receptor signaling pathway
TTDC00201;hsa04660;T cell receptor signaling pathway
TTDC00201;hsa04664;Fc epsilon RI signaling pathway
TTDC00201;hsa04668;TNF signaling pathway
TTDC00201;hsa04670;Leukocyte transendothelial migration
TTDC00201;hsa04722;Neurotrophin signaling pathway
TTDC00201;hsa04723;Retrograde endocannabinoid signaling
TTDC00201;hsa04728;Dopaminergic synapse
TTDC00201;hsa04750;Inflammatory mediator regulation of TRP channels
TTDC00201;hsa04912;GnRH signaling pathway
TTDC00201;hsa04914;Progesterone-mediated oocyte maturation
TTDC00201;hsa04917;Prolactin signaling pathway
TTDC00201;hsa05014;Amyotrophic lateral sclerosis (ALS)
TTDC00201;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDC00201;hsa05131;Shigellosis
TTDC00201;hsa05132;Salmonella infection
TTDC00201;hsa05133;Pertussis
TTDC00201;hsa05140;Leishmaniasis
TTDC00201;hsa05142;Chagas disease (American trypanosomiasis)
TTDC00201;hsa05145;Toxoplasmosis
TTDC00201;hsa05152;Tuberculosis
TTDC00201;hsa05160;Hepatitis C
TTDC00201;hsa05164;Influenza A
TTDC00201;hsa05169;Epstein-Barr virus infection
TTDC00201;hsa05205;Proteoglycans in cancer
TTDC00202;hsa04022;cGMP-PKG signaling pathway
TTDC00202;hsa04024;cAMP signaling pathway
TTDC00202;hsa04062;Chemokine signaling pathway
TTDC00202;hsa04071;Sphingolipid signaling pathway
TTDC00202;hsa04270;Vascular smooth muscle contraction
TTDC00202;hsa04350;TGF-beta signaling pathway
TTDC00202;hsa04360;Axon guidance
TTDC00202;hsa04510;Focal adhesion
TTDC00202;hsa04611;Platelet activation
TTDC00202;hsa04670;Leukocyte transendothelial migration
TTDC00202;hsa04810;Regulation of actin cytoskeleton
TTDC00202;hsa04921;Oxytocin signaling pathway
TTDC00202;hsa05130;Pathogenic Escherichia coli infection
TTDC00202;hsa05131;Shigellosis
TTDC00202;hsa05132;Salmonella infection
TTDC00202;hsa05200;Pathways in cancer
TTDC00202;hsa05205;Proteoglycans in cancer
TTDC00202;hsa05206;MicroRNAs in cancer
TTDC00204;hsa04080;Neuroactive ligand-receptor interaction
TTDC00205;hsa04911;Insulin secretion
TTDC00205;hsa04922;Glucagon signaling pathway
TTDC00206;hsa04068;FoxO signaling pathway
TTDC00206;hsa04110;Cell cycle
TTDC00206;hsa04115;p53 signaling pathway
TTDC00206;hsa04120;Ubiquitin mediated proteolysis
TTDC00206;hsa04144;Endocytosis
TTDC00206;hsa04151;PI3K-Akt signaling pathway
TTDC00206;hsa04919;Thyroid hormone signaling pathway
TTDC00206;hsa05169;Epstein-Barr virus infection
TTDC00206;hsa05200;Pathways in cancer
TTDC00206;hsa05202;Transcriptional misregulation in cancer
TTDC00206;hsa05203;Viral carcinogenesis
TTDC00206;hsa05205;Proteoglycans in cancer
TTDC00206;hsa05206;MicroRNAs in cancer
TTDC00206;hsa05214;Glioma
TTDC00206;hsa05215;Prostate cancer
TTDC00206;hsa05218;Melanoma
TTDC00206;hsa05219;Bladder cancer
TTDC00206;hsa05220;Chronic myeloid leukemia
TTDC00207;hsa04060;Cytokine-cytokine receptor interaction
TTDC00207;hsa04062;Chemokine signaling pathway
TTDC00207;hsa05203;Viral carcinogenesis
TTDC00208;hsa04514;Cell adhesion molecules (CAMs)
TTDC00208;hsa04660;T cell receptor signaling pathway
TTDC00208;hsa04672;Intestinal immune network for IgA production
TTDC00208;hsa04940;Type I diabetes mellitus
TTDC00208;hsa05162;Measles
TTDC00208;hsa05320;Autoimmune thyroid disease
TTDC00208;hsa05322;Systemic lupus erythematosus
TTDC00208;hsa05323;Rheumatoid arthritis
TTDC00208;hsa05330;Allograft rejection
TTDC00208;hsa05332;Graft-versus-host disease
TTDC00208;hsa05416;Viral myocarditis
TTDC00209;hsa04064;NF-kappa B signaling pathway
TTDC00209;hsa04066;HIF-1 signaling pathway
TTDC00209;hsa04145;Phagosome
TTDC00209;hsa04151;PI3K-Akt signaling pathway
TTDC00209;hsa04620;Toll-like receptor signaling pathway
TTDC00209;hsa05130;Pathogenic Escherichia coli infection
TTDC00209;hsa05132;Salmonella infection
TTDC00209;hsa05133;Pertussis
TTDC00209;hsa05134;Legionellosis
TTDC00209;hsa05140;Leishmaniasis
TTDC00209;hsa05142;Chagas disease (American trypanosomiasis)
TTDC00209;hsa05144;Malaria
TTDC00209;hsa05145;Toxoplasmosis
TTDC00209;hsa05146;Amoebiasis
TTDC00209;hsa05152;Tuberculosis
TTDC00209;hsa05161;Hepatitis B
TTDC00209;hsa05162;Measles
TTDC00209;hsa05164;Influenza A
TTDC00209;hsa05205;Proteoglycans in cancer
TTDC00209;hsa05321;Inflammatory bowel disease (IBD)
TTDC00209;hsa05323;Rheumatoid arthritis
TTDC00210;hsa04014;Ras signaling pathway
TTDC00210;hsa04015;Rap1 signaling pathway
TTDC00210;hsa04066;HIF-1 signaling pathway
TTDC00210;hsa04151;PI3K-Akt signaling pathway
TTDC00213;hsa04390;Hippo signaling pathway
TTDC00214;hsa04060;Cytokine-cytokine receptor interaction
TTDC00214;hsa05321;Inflammatory bowel disease (IBD)
TTDC00214;hsa05323;Rheumatoid arthritis
TTDC00215;hsa04060;Cytokine-cytokine receptor interaction
TTDC00215;hsa04062;Chemokine signaling pathway
TTDC00217;hsa04060;Cytokine-cytokine receptor interaction
TTDC00217;hsa04630;Jak-STAT signaling pathway
TTDC00217;hsa04640;Hematopoietic cell lineage
TTDC00218;hsa04020;Calcium signaling pathway
TTDC00218;hsa04080;Neuroactive ligand-receptor interaction
TTDC00219;hsa04060;Cytokine-cytokine receptor interaction
TTDC00220;hsa04020;Calcium signaling pathway
TTDC00220;hsa04068;FoxO signaling pathway
TTDC00220;hsa04080;Neuroactive ligand-receptor interaction
TTDC00220;hsa04540;Gap junction
TTDC00220;hsa04720;Long-term potentiation
TTDC00220;hsa04723;Retrograde endocannabinoid signaling
TTDC00220;hsa04724;Glutamatergic synapse
TTDC00220;hsa04730;Long-term depression
TTDC00220;hsa04915;Estrogen signaling pathway
TTDC00221;hsa04060;Cytokine-cytokine receptor interaction
TTDC00221;hsa04621;NOD-like receptor signaling pathway
TTDC00221;hsa04623;Cytosolic DNA-sensing pathway
TTDC00221;hsa05132;Salmonella infection
TTDC00221;hsa05134;Legionellosis
TTDC00221;hsa05143;African trypanosomiasis
TTDC00221;hsa05144;Malaria
TTDC00221;hsa05152;Tuberculosis
TTDC00221;hsa05164;Influenza A
TTDC00221;hsa05321;Inflammatory bowel disease (IBD)
TTDC00221;hsa05323;Rheumatoid arthritis
TTDC00224;hsa04060;Cytokine-cytokine receptor interaction
TTDC00224;hsa04064;NF-kappa B signaling pathway
TTDC00224;hsa04380;Osteoclast differentiation
TTDC00224;hsa04917;Prolactin signaling pathway
TTDC00224;hsa05323;Rheumatoid arthritis
TTDC00225;hsa04060;Cytokine-cytokine receptor interaction
TTDC00225;hsa04062;Chemokine signaling pathway
TTDC00225;hsa04064;NF-kappa B signaling pathway
TTDC00225;hsa04621;NOD-like receptor signaling pathway
TTDC00225;hsa04668;TNF signaling pathway
TTDC00225;hsa05132;Salmonella infection
TTDC00225;hsa05134;Legionellosis
TTDC00226;hsa04060;Cytokine-cytokine receptor interaction
TTDC00226;hsa04062;Chemokine signaling pathway
TTDC00226;hsa05203;Viral carcinogenesis
TTDC00228;hsa03013;RNA transport
TTDC00228;hsa04066;HIF-1 signaling pathway
TTDC00228;hsa04150;mTOR signaling pathway
TTDC00228;hsa04151;PI3K-Akt signaling pathway
TTDC00228;hsa04910;Insulin signaling pathway
TTDC00230;hsa04020;Calcium signaling pathway
TTDC00230;hsa04080;Neuroactive ligand-receptor interaction
TTDC00231;hsa04080;Neuroactive ligand-receptor interaction
TTDC00232;hsa00830;Retinol metabolism
TTDC00232;hsa01100;Metabolic pathways
TTDC00234;hsa04010;MAPK signaling pathway
TTDC00234;hsa04060;Cytokine-cytokine receptor interaction
TTDC00234;hsa04640;Hematopoietic cell lineage
TTDC00234;hsa05146;Amoebiasis
TTDC00234;hsa05166;HTLV-I infection
TTDC00234;hsa05202;Transcriptional misregulation in cancer
TTDC00239;hsa04080;Neuroactive ligand-receptor interaction
TTDC00240;hsa04010;MAPK signaling pathway
TTDC00240;hsa04260;Cardiac muscle contraction
TTDC00240;hsa04261;Adrenergic signaling in cardiomyocytes
TTDC00240;hsa04921;Oxytocin signaling pathway
TTDC00240;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDC00240;hsa05412;Arrhythmogenic right ventricular cardiomyopathy (ARVC)
TTDC00240;hsa05414;Dilated cardiomyopathy
TTDC00241;hsa04150;mTOR signaling pathway
TTDC00241;hsa04151;PI3K-Akt signaling pathway
TTDC00241;hsa05206;MicroRNAs in cancer
TTDC00242;hsa04080;Neuroactive ligand-receptor interaction
TTDC00244;hsa05206;MicroRNAs in cancer
TTDC00245;hsa04120;Ubiquitin mediated proteolysis
TTDC00246;hsa04512;ECM-receptor interaction
TTDC00247;hsa04014;Ras signaling pathway
TTDC00247;hsa04015;Rap1 signaling pathway
TTDC00247;hsa04066;HIF-1 signaling pathway
TTDC00247;hsa04151;PI3K-Akt signaling pathway
TTDC00247;hsa05323;Rheumatoid arthritis
TTDC00248;hsa04514;Cell adhesion molecules (CAMs)
TTDC00248;hsa04672;Intestinal immune network for IgA production
TTDC00250;hsa04024;cAMP signaling pathway
TTDC00250;hsa04080;Neuroactive ligand-receptor interaction
TTDC00250;hsa04713;Circadian entrainment
TTDC00250;hsa04720;Long-term potentiation
TTDC00250;hsa04723;Retrograde endocannabinoid signaling
TTDC00250;hsa04724;Glutamatergic synapse
TTDC00250;hsa04728;Dopaminergic synapse
TTDC00250;hsa04730;Long-term depression
TTDC00250;hsa05014;Amyotrophic lateral sclerosis (ALS)
TTDC00250;hsa05031;Amphetamine addiction
TTDC00250;hsa05033;Nicotine addiction
TTDC00251;hsa04060;Cytokine-cytokine receptor interaction
TTDC00251;hsa04630;Jak-STAT signaling pathway
TTDC00251;hsa04668;TNF signaling pathway
TTDC00251;hsa04672;Intestinal immune network for IgA production
TTDC00251;hsa05166;HTLV-I infection
TTDC00251;hsa05168;Herpes simplex infection
TTDC00251;hsa05323;Rheumatoid arthritis
TTDC00253;hsa04024;cAMP signaling pathway
TTDC00253;hsa04080;Neuroactive ligand-receptor interaction
TTDC00254;hsa04080;Neuroactive ligand-receptor interaction
TTDC00255;hsa04726;Serotonergic synapse
TTDC00256;hsa04110;Cell cycle
TTDC00257;hsa04060;Cytokine-cytokine receptor interaction
TTDC00257;hsa04630;Jak-STAT signaling pathway
TTDC00258;hsa04068;FoxO signaling pathway
TTDC00258;hsa04071;Sphingolipid signaling pathway
TTDC00258;hsa04080;Neuroactive ligand-receptor interaction
TTDC00259;hsa04514;Cell adhesion molecules (CAMs)
TTDC00259;hsa04660;T cell receptor signaling pathway
TTDC00259;hsa05320;Autoimmune thyroid disease
TTDC00259;hsa05323;Rheumatoid arthritis
TTDC00260;hsa04973;Carbohydrate digestion and absorption
TTDC00260;hsa04976;Bile secretion
TTDC00260;hsa04978;Mineral absorption
TTDC00263;hsa04014;Ras signaling pathway
TTDC00263;hsa04015;Rap1 signaling pathway
TTDC00263;hsa04060;Cytokine-cytokine receptor interaction
TTDC00263;hsa04151;PI3K-Akt signaling pathway
TTDC00263;hsa04380;Osteoclast differentiation
TTDC00263;hsa04640;Hematopoietic cell lineage
TTDC00263;hsa04668;TNF signaling pathway
TTDC00263;hsa05323;Rheumatoid arthritis
TTDC00265;hsa04514;Cell adhesion molecules (CAMs)
TTDC00265;hsa04612;Antigen processing and presentation
TTDC00265;hsa04640;Hematopoietic cell lineage
TTDC00265;hsa04660;T cell receptor signaling pathway
TTDC00265;hsa05340;Primary immunodeficiency
TTDC00266;hsa04060;Cytokine-cytokine receptor interaction
TTDC00266;hsa04115;p53 signaling pathway
TTDC00266;hsa04210;Apoptosis
TTDC00266;hsa04650;Natural killer cell mediated cytotoxicity
TTDC00266;hsa05162;Measles
TTDC00266;hsa05164;Influenza A
TTDC00267;hsa04060;Cytokine-cytokine receptor interaction
TTDC00267;hsa04210;Apoptosis
TTDC00267;hsa04650;Natural killer cell mediated cytotoxicity
TTDC00267;hsa05162;Measles
TTDC00267;hsa05164;Influenza A
TTDC00269;hsa04010;MAPK signaling pathway
TTDC00269;hsa04370;VEGF signaling pathway
TTDC00269;hsa05146;Amoebiasis
TTDC00269;hsa05169;Epstein-Barr virus infection
TTDC00271;hsa04010;MAPK signaling pathway
TTDC00271;hsa04012;ErbB signaling pathway
TTDC00271;hsa04110;Cell cycle
TTDC00271;hsa04151;PI3K-Akt signaling pathway
TTDC00271;hsa04310;Wnt signaling pathway
TTDC00271;hsa04350;TGF-beta signaling pathway
TTDC00271;hsa04390;Hippo signaling pathway
TTDC00271;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDC00271;hsa04630;Jak-STAT signaling pathway
TTDC00271;hsa04919;Thyroid hormone signaling pathway
TTDC00271;hsa05161;Hepatitis B
TTDC00271;hsa05166;HTLV-I infection
TTDC00271;hsa05169;Epstein-Barr virus infection
TTDC00271;hsa05200;Pathways in cancer
TTDC00271;hsa05202;Transcriptional misregulation in cancer
TTDC00271;hsa05205;Proteoglycans in cancer
TTDC00271;hsa05206;MicroRNAs in cancer
TTDC00271;hsa05210;Colorectal cancer
TTDC00271;hsa05213;Endometrial cancer
TTDC00271;hsa05216;Thyroid cancer
TTDC00271;hsa05219;Bladder cancer
TTDC00271;hsa05220;Chronic myeloid leukemia
TTDC00271;hsa05221;Acute myeloid leukemia
TTDC00271;hsa05222;Small cell lung cancer
TTDC00271;hsa05230;Central carbon metabolism in cancer
TTDC00272;hsa04010;MAPK signaling pathway
TTDC00272;hsa04060;Cytokine-cytokine receptor interaction
TTDC00272;hsa04068;FoxO signaling pathway
TTDC00272;hsa04110;Cell cycle
TTDC00272;hsa04144;Endocytosis
TTDC00272;hsa04350;TGF-beta signaling pathway
TTDC00272;hsa04380;Osteoclast differentiation
TTDC00272;hsa04390;Hippo signaling pathway
TTDC00272;hsa05140;Leishmaniasis
TTDC00272;hsa05142;Chagas disease (American trypanosomiasis)
TTDC00272;hsa05144;Malaria
TTDC00272;hsa05145;Toxoplasmosis
TTDC00272;hsa05146;Amoebiasis
TTDC00272;hsa05152;Tuberculosis
TTDC00272;hsa05161;Hepatitis B
TTDC00272;hsa05166;HTLV-I infection
TTDC00272;hsa05200;Pathways in cancer
TTDC00272;hsa05205;Proteoglycans in cancer
TTDC00272;hsa05206;MicroRNAs in cancer
TTDC00272;hsa05210;Colorectal cancer
TTDC00272;hsa05211;Renal cell carcinoma
TTDC00272;hsa05212;Pancreatic cancer
TTDC00272;hsa05220;Chronic myeloid leukemia
TTDC00272;hsa05321;Inflammatory bowel disease (IBD)
TTDC00272;hsa05323;Rheumatoid arthritis
TTDC00272;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDC00272;hsa05414;Dilated cardiomyopathy
TTDC00273;hsa04390;Hippo signaling pathway
TTDC00273;hsa05161;Hepatitis B
TTDC00273;hsa05200;Pathways in cancer
TTDC00273;hsa05210;Colorectal cancer
TTDC00280;hsa04064;NF-kappa B signaling pathway
TTDC00280;hsa04120;Ubiquitin mediated proteolysis
TTDC00280;hsa04210;Apoptosis
TTDC00280;hsa04510;Focal adhesion
TTDC00280;hsa05145;Toxoplasmosis
TTDC00280;hsa05166;HTLV-I infection
TTDC00280;hsa05200;Pathways in cancer
TTDC00280;hsa05222;Small cell lung cancer
TTDC00290;hsa04014;Ras signaling pathway
TTDC00290;hsa04015;Rap1 signaling pathway
TTDC00290;hsa04060;Cytokine-cytokine receptor interaction
TTDC00290;hsa04151;PI3K-Akt signaling pathway
TTDC00290;hsa04510;Focal adhesion
TTDC00291;hsa04080;Neuroactive ligand-receptor interaction
TTDC00291;hsa04728;Dopaminergic synapse
TTDC00292;hsa04020;Calcium signaling pathway
TTDC00292;hsa04022;cGMP-PKG signaling pathway
TTDC00292;hsa04080;Neuroactive ligand-receptor interaction
TTDC00292;hsa04152;AMPK signaling pathway
TTDC00292;hsa04261;Adrenergic signaling in cardiomyocytes
TTDC00292;hsa04270;Vascular smooth muscle contraction
TTDC00292;hsa04970;Salivary secretion
TTDC00293;hsa04022;cGMP-PKG signaling pathway
TTDC00293;hsa04080;Neuroactive ligand-receptor interaction
TTDC00295;hsa00561;Glycerolipid metabolism
TTDC00295;hsa01100;Metabolic pathways
TTDC00295;hsa04972;Pancreatic secretion
TTDC00295;hsa04975;Fat digestion and absorption
TTDC00295;hsa04977;Vitamin digestion and absorption
TTDC00298;hsa04020;Calcium signaling pathway
TTDC00298;hsa04080;Neuroactive ligand-receptor interaction
TTDC00298;hsa04270;Vascular smooth muscle contraction
TTDC00299;hsa04014;Ras signaling pathway
TTDC00299;hsa04015;Rap1 signaling pathway
TTDC00299;hsa04024;cAMP signaling pathway
TTDC00299;hsa04080;Neuroactive ligand-receptor interaction
TTDC00299;hsa04713;Circadian entrainment
TTDC00299;hsa04720;Long-term potentiation
TTDC00299;hsa04724;Glutamatergic synapse
TTDC00299;hsa04728;Dopaminergic synapse
TTDC00299;hsa05010;Alzheimer's disease
TTDC00299;hsa05014;Amyotrophic lateral sclerosis (ALS)
TTDC00299;hsa05016;Huntington's disease
TTDC00299;hsa05030;Cocaine addiction
TTDC00299;hsa05031;Amphetamine addiction
TTDC00299;hsa05033;Nicotine addiction
TTDC00299;hsa05034;Alcoholism
TTDC00299;hsa05322;Systemic lupus erythematosus
TTDC00301;hsa04080;Neuroactive ligand-receptor interaction
TTDC00301;hsa04725;Cholinergic synapse
TTDC00301;hsa05033;Nicotine addiction
TTDC00310;hsa04010;MAPK signaling pathway
TTDC00310;hsa04012;ErbB signaling pathway
TTDC00310;hsa04014;Ras signaling pathway
TTDC00310;hsa04015;Rap1 signaling pathway
TTDC00310;hsa04022;cGMP-PKG signaling pathway
TTDC00310;hsa04024;cAMP signaling pathway
TTDC00310;hsa04062;Chemokine signaling pathway
TTDC00310;hsa04068;FoxO signaling pathway
TTDC00310;hsa04071;Sphingolipid signaling pathway
TTDC00310;hsa04151;PI3K-Akt signaling pathway
TTDC00310;hsa04270;Vascular smooth muscle contraction
TTDC00310;hsa04370;VEGF signaling pathway
TTDC00310;hsa04510;Focal adhesion
TTDC00310;hsa04540;Gap junction
TTDC00310;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDC00310;hsa04650;Natural killer cell mediated cytotoxicity
TTDC00310;hsa04660;T cell receptor signaling pathway
TTDC00310;hsa04662;B cell receptor signaling pathway
TTDC00310;hsa04664;Fc epsilon RI signaling pathway
TTDC00310;hsa04666;Fc gamma R-mediated phagocytosis
TTDC00310;hsa04720;Long-term potentiation
TTDC00310;hsa04722;Neurotrophin signaling pathway
TTDC00310;hsa04726;Serotonergic synapse
TTDC00310;hsa04730;Long-term depression
TTDC00310;hsa04810;Regulation of actin cytoskeleton
TTDC00310;hsa04910;Insulin signaling pathway
TTDC00310;hsa04912;GnRH signaling pathway
TTDC00310;hsa04914;Progesterone-mediated oocyte maturation
TTDC00310;hsa04915;Estrogen signaling pathway
TTDC00310;hsa04916;Melanogenesis
TTDC00310;hsa04917;Prolactin signaling pathway
TTDC00310;hsa04919;Thyroid hormone signaling pathway
TTDC00310;hsa04921;Oxytocin signaling pathway
TTDC00310;hsa05034;Alcoholism
TTDC00310;hsa05152;Tuberculosis
TTDC00310;hsa05160;Hepatitis C
TTDC00310;hsa05161;Hepatitis B
TTDC00310;hsa05164;Influenza A
TTDC00310;hsa05200;Pathways in cancer
TTDC00310;hsa05205;Proteoglycans in cancer
TTDC00310;hsa05206;MicroRNAs in cancer
TTDC00310;hsa05210;Colorectal cancer
TTDC00310;hsa05211;Renal cell carcinoma
TTDC00310;hsa05212;Pancreatic cancer
TTDC00310;hsa05213;Endometrial cancer
TTDC00310;hsa05214;Glioma
TTDC00310;hsa05215;Prostate cancer
TTDC00310;hsa05218;Melanoma
TTDC00310;hsa05219;Bladder cancer
TTDC00310;hsa05220;Chronic myeloid leukemia
TTDC00310;hsa05221;Acute myeloid leukemia
TTDC00310;hsa05223;Non-small cell lung cancer
TTDC00310;hsa05230;Central carbon metabolism in cancer
TTDC00310;hsa05231;Choline metabolism in cancer
TTDC00311;hsa04010;MAPK signaling pathway
TTDC00311;hsa04014;Ras signaling pathway
TTDC00311;hsa04015;Rap1 signaling pathway
TTDC00311;hsa04020;Calcium signaling pathway
TTDC00311;hsa04060;Cytokine-cytokine receptor interaction
TTDC00311;hsa04144;Endocytosis
TTDC00311;hsa04151;PI3K-Akt signaling pathway
TTDC00311;hsa04510;Focal adhesion
TTDC00311;hsa04540;Gap junction
TTDC00311;hsa04810;Regulation of actin cytoskeleton
TTDC00311;hsa05166;HTLV-I infection
TTDC00311;hsa05200;Pathways in cancer
TTDC00311;hsa05206;MicroRNAs in cancer
TTDC00311;hsa05214;Glioma
TTDC00311;hsa05215;Prostate cancer
TTDC00311;hsa05218;Melanoma
TTDC00311;hsa05230;Central carbon metabolism in cancer
TTDC00311;hsa05231;Choline metabolism in cancer
TTDC00312;hsa04064;NF-kappa B signaling pathway
TTDC00312;hsa04610;Complement and coagulation cascades
TTDC00312;hsa05202;Transcriptional misregulation in cancer
TTDC00312;hsa05205;Proteoglycans in cancer
TTDC00312;hsa05206;MicroRNAs in cancer
TTDC00313;hsa00071;Fatty acid degradation
TTDC00313;hsa00072;Synthesis and degradation of ketone bodies
TTDC00313;hsa00280;Valine, leucine and isoleucine degradation
TTDC00313;hsa00310;Lysine degradation
TTDC00313;hsa00380;Tryptophan metabolism
TTDC00313;hsa00620;Pyruvate metabolism
TTDC00313;hsa00630;Glyoxylate and dicarboxylate metabolism
TTDC00313;hsa00640;Propanoate metabolism
TTDC00313;hsa00650;Butanoate metabolism
TTDC00313;hsa00900;Terpenoid backbone biosynthesis
TTDC00313;hsa01100;Metabolic pathways
TTDC00313;hsa01130;Biosynthesis of antibiotics
TTDC00313;hsa01200;Carbon metabolism
TTDC00313;hsa01212;Fatty acid metabolism
TTDC00314;hsa04080;Neuroactive ligand-receptor interaction
TTDC00318;hsa04010;MAPK signaling pathway
TTDC00318;hsa04144;Endocytosis
TTDC00318;hsa04210;Apoptosis
TTDC00318;hsa04722;Neurotrophin signaling pathway
TTDC00318;hsa04750;Inflammatory mediator regulation of TRP channels
TTDC00318;hsa05200;Pathways in cancer
TTDC00318;hsa05202;Transcriptional misregulation in cancer
TTDC00318;hsa05216;Thyroid cancer
TTDC00318;hsa05230;Central carbon metabolism in cancer
TTDC00319;hsa04064;NF-kappa B signaling pathway
TTDC00319;hsa04066;HIF-1 signaling pathway
TTDC00319;hsa04071;Sphingolipid signaling pathway
TTDC00319;hsa04141;Protein processing in endoplasmic reticulum
TTDC00319;hsa04151;PI3K-Akt signaling pathway
TTDC00319;hsa04210;Apoptosis
TTDC00319;hsa04261;Adrenergic signaling in cardiomyocytes
TTDC00319;hsa04510;Focal adhesion
TTDC00319;hsa04722;Neurotrophin signaling pathway
TTDC00319;hsa04725;Cholinergic synapse
TTDC00319;hsa05014;Amyotrophic lateral sclerosis (ALS)
TTDC00319;hsa05145;Toxoplasmosis
TTDC00319;hsa05152;Tuberculosis
TTDC00319;hsa05161;Hepatitis B
TTDC00319;hsa05169;Epstein-Barr virus infection
TTDC00319;hsa05200;Pathways in cancer
TTDC00319;hsa05206;MicroRNAs in cancer
TTDC00319;hsa05210;Colorectal cancer
TTDC00319;hsa05215;Prostate cancer
TTDC00319;hsa05222;Small cell lung cancer
TTDC00325;hsa04146;Peroxisome
TTDC00325;hsa05014;Amyotrophic lateral sclerosis (ALS)
TTDC00325;hsa05016;Huntington's disease
TTDC00325;hsa05020;Prion diseases
TTDC00326;hsa04610;Complement and coagulation cascades
TTDC00326;hsa05150;Staphylococcus aureus infection
TTDC00327;hsa04060;Cytokine-cytokine receptor interaction
TTDC00327;hsa04064;NF-kappa B signaling pathway
TTDC00327;hsa04668;TNF signaling pathway
TTDC00327;hsa04940;Type I diabetes mellitus
TTDC00327;hsa05166;HTLV-I infection
TTDC00327;hsa05168;Herpes simplex infection
TTDC00328;hsa03320;PPAR signaling pathway
TTDC00330;hsa04610;Complement and coagulation cascades
TTDC00331;hsa04975;Fat digestion and absorption
TTDC00331;hsa04977;Vitamin digestion and absorption
TTDC00332;hsa04114;Oocyte meiosis
TTDC00332;hsa05200;Pathways in cancer
TTDC00332;hsa05215;Prostate cancer
TTDC00333;hsa04060;Cytokine-cytokine receptor interaction
TTDC00333;hsa04080;Neuroactive ligand-receptor interaction
TTDC00333;hsa04151;PI3K-Akt signaling pathway
TTDC00333;hsa04630;Jak-STAT signaling pathway
TTDC00333;hsa04917;Prolactin signaling pathway
TTDC00334;hsa04014;Ras signaling pathway
TTDC00334;hsa04015;Rap1 signaling pathway
TTDC00334;hsa04060;Cytokine-cytokine receptor interaction
TTDC00334;hsa04066;HIF-1 signaling pathway
TTDC00334;hsa04144;Endocytosis
TTDC00334;hsa04151;PI3K-Akt signaling pathway
TTDC00334;hsa04510;Focal adhesion
TTDC00334;hsa05202;Transcriptional misregulation in cancer
TTDC00334;hsa05323;Rheumatoid arthritis
TTDC00335;hsa04390;Hippo signaling pathway
TTDC00337;hsa04060;Cytokine-cytokine receptor interaction
TTDC00340;hsa05231;Choline metabolism in cancer
TTDC00341;hsa03018;RNA degradation
TTDC00342;hsa04020;Calcium signaling pathway
TTDC00342;hsa04024;cAMP signaling pathway
TTDC00342;hsa04611;Platelet activation
TTDC00342;hsa05340;Primary immunodeficiency
TTDC00343;hsa04520;Adherens junction
TTDC00344;hsa04340;Hedgehog signaling pathway
TTDC00344;hsa05200;Pathways in cancer
TTDC00344;hsa05205;Proteoglycans in cancer
TTDC00344;hsa05217;Basal cell carcinoma
TTDC00345;hsa04060;Cytokine-cytokine receptor interaction
TTDC00345;hsa04080;Neuroactive ligand-receptor interaction
TTDC00345;hsa04151;PI3K-Akt signaling pathway
TTDC00345;hsa04630;Jak-STAT signaling pathway
TTDI00319;hsa00230;Purine metabolism
TTDI00319;hsa00240;Pyrimidine metabolism
TTDI00319;hsa00760;Nicotinate and nicotinamide metabolism
TTDI00319;hsa01100;Metabolic pathways
TTDI00342;hsa04060;Cytokine-cytokine receptor interaction
TTDI00342;hsa04062;Chemokine signaling pathway
TTDI00342;hsa04144;Endocytosis
TTDI00342;hsa04360;Axon guidance
TTDI00342;hsa04670;Leukocyte transendothelial migration
TTDI00342;hsa04672;Intestinal immune network for IgA production
TTDI00342;hsa05200;Pathways in cancer
TTDI00350;hsa04010;MAPK signaling pathway
TTDI00350;hsa04012;ErbB signaling pathway
TTDI00350;hsa04014;Ras signaling pathway
TTDI00350;hsa04015;Rap1 signaling pathway
TTDI00350;hsa04022;cGMP-PKG signaling pathway
TTDI00350;hsa04024;cAMP signaling pathway
TTDI00350;hsa04062;Chemokine signaling pathway
TTDI00350;hsa04066;HIF-1 signaling pathway
TTDI00350;hsa04068;FoxO signaling pathway
TTDI00350;hsa04071;Sphingolipid signaling pathway
TTDI00350;hsa04150;mTOR signaling pathway
TTDI00350;hsa04151;PI3K-Akt signaling pathway
TTDI00350;hsa04152;AMPK signaling pathway
TTDI00350;hsa04210;Apoptosis
TTDI00350;hsa04261;Adrenergic signaling in cardiomyocytes
TTDI00350;hsa04370;VEGF signaling pathway
TTDI00350;hsa04380;Osteoclast differentiation
TTDI00350;hsa04510;Focal adhesion
TTDI00350;hsa04530;Tight junction
TTDI00350;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDI00350;hsa04611;Platelet activation
TTDI00350;hsa04620;Toll-like receptor signaling pathway
TTDI00350;hsa04630;Jak-STAT signaling pathway
TTDI00350;hsa04660;T cell receptor signaling pathway
TTDI00350;hsa04662;B cell receptor signaling pathway
TTDI00350;hsa04664;Fc epsilon RI signaling pathway
TTDI00350;hsa04666;Fc gamma R-mediated phagocytosis
TTDI00350;hsa04668;TNF signaling pathway
TTDI00350;hsa04722;Neurotrophin signaling pathway
TTDI00350;hsa04725;Cholinergic synapse
TTDI00350;hsa04728;Dopaminergic synapse
TTDI00350;hsa04910;Insulin signaling pathway
TTDI00350;hsa04914;Progesterone-mediated oocyte maturation
TTDI00350;hsa04915;Estrogen signaling pathway
TTDI00350;hsa04917;Prolactin signaling pathway
TTDI00350;hsa04919;Thyroid hormone signaling pathway
TTDI00350;hsa04920;Adipocytokine signaling pathway
TTDI00350;hsa04922;Glucagon signaling pathway
TTDI00350;hsa04923;Regulation of lipolysis in adipocytes
TTDI00350;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDI00350;hsa04973;Carbohydrate digestion and absorption
TTDI00350;hsa05142;Chagas disease (American trypanosomiasis)
TTDI00350;hsa05145;Toxoplasmosis
TTDI00350;hsa05152;Tuberculosis
TTDI00350;hsa05160;Hepatitis C
TTDI00350;hsa05161;Hepatitis B
TTDI00350;hsa05162;Measles
TTDI00350;hsa05164;Influenza A
TTDI00350;hsa05166;HTLV-I infection
TTDI00350;hsa05169;Epstein-Barr virus infection
TTDI00350;hsa05200;Pathways in cancer
TTDI00350;hsa05205;Proteoglycans in cancer
TTDI00350;hsa05210;Colorectal cancer
TTDI00350;hsa05211;Renal cell carcinoma
TTDI00350;hsa05212;Pancreatic cancer
TTDI00350;hsa05213;Endometrial cancer
TTDI00350;hsa05214;Glioma
TTDI00350;hsa05215;Prostate cancer
TTDI00350;hsa05218;Melanoma
TTDI00350;hsa05220;Chronic myeloid leukemia
TTDI00350;hsa05221;Acute myeloid leukemia
TTDI00350;hsa05222;Small cell lung cancer
TTDI00350;hsa05223;Non-small cell lung cancer
TTDI00350;hsa05230;Central carbon metabolism in cancer
TTDI00350;hsa05231;Choline metabolism in cancer
TTDI00462;hsa04024;cAMP signaling pathway
TTDI00587;hsa00790;Folate biosynthesis
TTDI00587;hsa01100;Metabolic pathways
TTDI00605;hsa03030;DNA replication
TTDI00605;hsa03410;Base excision repair
TTDI00605;hsa03420;Nucleotide excision repair
TTDI00605;hsa03430;Mismatch repair
TTDI00605;hsa04110;Cell cycle
TTDI00605;hsa05161;Hepatitis B
TTDI00605;hsa05166;HTLV-I infection
TTDI00607;hsa00590;Arachidonic acid metabolism
TTDI00607;hsa00591;Linoleic acid metabolism
TTDI00607;hsa01100;Metabolic pathways
TTDI00607;hsa04726;Serotonergic synapse
TTDI00641;hsa03015;mRNA surveillance pathway
TTDI00641;hsa04071;Sphingolipid signaling pathway
TTDI00641;hsa04114;Oocyte meiosis
TTDI00641;hsa04151;PI3K-Akt signaling pathway
TTDI00641;hsa04152;AMPK signaling pathway
TTDI00641;hsa04261;Adrenergic signaling in cardiomyocytes
TTDI00641;hsa04350;TGF-beta signaling pathway
TTDI00641;hsa04390;Hippo signaling pathway
TTDI00641;hsa04530;Tight junction
TTDI00641;hsa04728;Dopaminergic synapse
TTDI00641;hsa04730;Long-term depression
TTDI00641;hsa05142;Chagas disease (American trypanosomiasis)
TTDI00641;hsa05160;Hepatitis C
TTDI00747;hsa01040;Biosynthesis of unsaturated fatty acids
TTDI00747;hsa01212;Fatty acid metabolism
TTDI00747;hsa03320;PPAR signaling pathway
TTDI00747;hsa04152;AMPK signaling pathway
TTDI00816;hsa00480;Glutathione metabolism
TTDI00816;hsa04918;Thyroid hormone synthesis
TTDI00862;hsa00240;Pyrimidine metabolism
TTDI00862;hsa01100;Metabolic pathways
TTDI00909;hsa04020;Calcium signaling pathway
TTDI00909;hsa04713;Circadian entrainment
TTDI00909;hsa04730;Long-term depression
TTDI00909;hsa04921;Oxytocin signaling pathway
TTDI00915;hsa04614;Renin-angiotensin system
TTDI00915;hsa05142;Chagas disease (American trypanosomiasis)
TTDI00915;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDI00931;hsa00670;One carbon pool by folate
TTDI00931;hsa00790;Folate biosynthesis
TTDI00931;hsa01100;Metabolic pathways
TTDI00934;mtu00230;Purine metabolism
TTDI00934;mtu00240;Pyrimidine metabolism
TTDI00934;mtu01100;Metabolic pathways
TTDI00934;mtu03020;RNA polymerase
TTDI00939;hsa04915;Estrogen signaling pathway
TTDI00939;hsa04917;Prolactin signaling pathway
TTDI00939;hsa04919;Thyroid hormone signaling pathway
TTDI00939;hsa04961;Endocrine and other factor-regulated calcium reabsorption
TTDI00939;hsa05205;Proteoglycans in cancer
TTDI00956;hsa04146;Peroxisome
TTDI00964;hsa00240;Pyrimidine metabolism
TTDI00964;hsa00670;One carbon pool by folate
TTDI00964;hsa01100;Metabolic pathways
TTDI00965;hsa00100;Steroid biosynthesis
TTDI00965;hsa01100;Metabolic pathways
TTDI00965;hsa01130;Biosynthesis of antibiotics
TTDI00967;hsa04145;Phagosome
TTDI00967;hsa04540;Gap junction
TTDI00967;hsa05130;Pathogenic Escherichia coli infection
TTDI00990;hsa00900;Terpenoid backbone biosynthesis
TTDI00990;hsa01100;Metabolic pathways
TTDI00990;hsa01130;Biosynthesis of antibiotics
TTDI00990;hsa05164;Influenza A
TTDI00990;hsa05166;HTLV-I infection
TTDI01008;hsa04010;MAPK signaling pathway
TTDI01008;hsa04260;Cardiac muscle contraction
TTDI01008;hsa04261;Adrenergic signaling in cardiomyocytes
TTDI01008;hsa04921;Oxytocin signaling pathway
TTDI01008;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDI01008;hsa05412;Arrhythmogenic right ventricular cardiomyopathy (ARVC)
TTDI01008;hsa05414;Dilated cardiomyopathy
TTDI01014;hsa00071;Fatty acid degradation
TTDI01014;hsa01212;Fatty acid metabolism
TTDI01014;hsa03320;PPAR signaling pathway
TTDI01014;hsa04152;AMPK signaling pathway
TTDI01014;hsa04920;Adipocytokine signaling pathway
TTDI01014;hsa04922;Glucagon signaling pathway
TTDI01022;hsa04015;Rap1 signaling pathway
TTDI01022;hsa04514;Cell adhesion molecules (CAMs)
TTDI01022;hsa04650;Natural killer cell mediated cytotoxicity
TTDI01022;hsa04670;Leukocyte transendothelial migration
TTDI01022;hsa04810;Regulation of actin cytoskeleton
TTDI01022;hsa05144;Malaria
TTDI01022;hsa05150;Staphylococcus aureus infection
TTDI01022;hsa05166;HTLV-I infection
TTDI01022;hsa05169;Epstein-Barr virus infection
TTDI01022;hsa05323;Rheumatoid arthritis
TTDI01022;hsa05416;Viral myocarditis
TTDI01040;hsa05143;African trypanosomiasis
TTDI01040;hsa05144;Malaria
TTDI01041;hsa05143;African trypanosomiasis
TTDI01041;hsa05144;Malaria
TTDI01743;hsa04020;Calcium signaling pathway
TTDI01743;hsa04080;Neuroactive ligand-receptor interaction
TTDI01743;hsa04540;Gap junction
TTDI01743;hsa04726;Serotonergic synapse
TTDI01743;hsa04750;Inflammatory mediator regulation of TRP channels
TTDI01746;hsa04060;Cytokine-cytokine receptor interaction
TTDI01746;hsa04620;Toll-like receptor signaling pathway
TTDI01746;hsa04622;RIG-I-like receptor signaling pathway
TTDI01746;hsa04630;Jak-STAT signaling pathway
TTDI01746;hsa04940;Type I diabetes mellitus
TTDI01746;hsa05133;Pertussis
TTDI01746;hsa05134;Legionellosis
TTDI01746;hsa05140;Leishmaniasis
TTDI01746;hsa05142;Chagas disease (American trypanosomiasis)
TTDI01746;hsa05143;African trypanosomiasis
TTDI01746;hsa05144;Malaria
TTDI01746;hsa05145;Toxoplasmosis
TTDI01746;hsa05146;Amoebiasis
TTDI01746;hsa05152;Tuberculosis
TTDI01746;hsa05162;Measles
TTDI01746;hsa05164;Influenza A
TTDI01746;hsa05168;Herpes simplex infection
TTDI01746;hsa05321;Inflammatory bowel disease (IBD)
TTDI01746;hsa05330;Allograft rejection
TTDI01748;hsa04151;PI3K-Akt signaling pathway
TTDI01748;hsa04380;Osteoclast differentiation
TTDI01748;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDI01748;hsa04630;Jak-STAT signaling pathway
TTDI01748;hsa05140;Leishmaniasis
TTDI01748;hsa05145;Toxoplasmosis
TTDI01748;hsa05152;Tuberculosis
TTDI01748;hsa05160;Hepatitis C
TTDI01748;hsa05161;Hepatitis B
TTDI01748;hsa05162;Measles
TTDI01748;hsa05164;Influenza A
TTDI01748;hsa05166;HTLV-I infection
TTDI01748;hsa05168;Herpes simplex infection
TTDI01748;hsa05169;Epstein-Barr virus infection
TTDI01748;hsa05200;Pathways in cancer
TTDI01748;hsa05203;Viral carcinogenesis
TTDI01748;hsa05212;Pancreatic cancer
TTDI01749;hsa04020;Calcium signaling pathway
TTDI01749;hsa04024;cAMP signaling pathway
TTDI01749;hsa04080;Neuroactive ligand-receptor interaction
TTDI01749;hsa04151;PI3K-Akt signaling pathway
TTDI01749;hsa04725;Cholinergic synapse
TTDI01749;hsa04810;Regulation of actin cytoskeleton
TTDI01750;hsa04022;cGMP-PKG signaling pathway
TTDI01750;hsa04080;Neuroactive ligand-receptor interaction
TTDI01751;hsa04020;Calcium signaling pathway
TTDI01751;hsa04022;cGMP-PKG signaling pathway
TTDI01751;hsa04080;Neuroactive ligand-receptor interaction
TTDI01751;hsa04261;Adrenergic signaling in cardiomyocytes
TTDI01751;hsa04270;Vascular smooth muscle contraction
TTDI01751;hsa04614;Renin-angiotensin system
TTDI01751;hsa04924;Renin secretion
TTDI01751;hsa05200;Pathways in cancer
TTDI01752;hsa04080;Neuroactive ligand-receptor interaction
TTDI01753;hsa00061;Fatty acid biosynthesis
TTDI01753;hsa00620;Pyruvate metabolism
TTDI01753;hsa00640;Propanoate metabolism
TTDI01753;hsa01100;Metabolic pathways
TTDI01753;hsa01212;Fatty acid metabolism
TTDI01753;hsa04152;AMPK signaling pathway
TTDI01753;hsa04910;Insulin signaling pathway
TTDI01753;hsa04922;Glucagon signaling pathway
TTDI01754;hsa04066;HIF-1 signaling pathway
TTDI01754;hsa04115;p53 signaling pathway
TTDI01754;hsa04390;Hippo signaling pathway
TTDI01754;hsa04610;Complement and coagulation cascades
TTDI01754;hsa05142;Chagas disease (American trypanosomiasis)
TTDI01755;hsa04080;Neuroactive ligand-receptor interaction
TTDI01756;hsa04020;Calcium signaling pathway
TTDI01756;hsa04022;cGMP-PKG signaling pathway
TTDI01756;hsa04024;cAMP signaling pathway
TTDI01756;hsa04080;Neuroactive ligand-receptor interaction
TTDI01756;hsa04144;Endocytosis
TTDI01756;hsa04261;Adrenergic signaling in cardiomyocytes
TTDI01756;hsa04540;Gap junction
TTDI01756;hsa04970;Salivary secretion
TTDI01756;hsa05414;Dilated cardiomyopathy
TTDI01757;hsa04024;cAMP signaling pathway
TTDI01757;hsa04260;Cardiac muscle contraction
TTDI01757;hsa04261;Adrenergic signaling in cardiomyocytes
TTDI01757;hsa04810;Regulation of actin cytoskeleton
TTDI01757;hsa04919;Thyroid hormone signaling pathway
TTDI01757;hsa04970;Salivary secretion
TTDI01757;hsa04971;Gastric acid secretion
TTDI01757;hsa04972;Pancreatic secretion
TTDI01757;hsa04976;Bile secretion
TTDI01757;hsa05205;Proteoglycans in cancer
TTDI01758;hsa04022;cGMP-PKG signaling pathway
TTDI01758;hsa04024;cAMP signaling pathway
TTDI01758;hsa04260;Cardiac muscle contraction
TTDI01758;hsa04261;Adrenergic signaling in cardiomyocytes
TTDI01758;hsa04911;Insulin secretion
TTDI01758;hsa04918;Thyroid hormone synthesis
TTDI01758;hsa04919;Thyroid hormone signaling pathway
TTDI01758;hsa04960;Aldosterone-regulated sodium reabsorption
TTDI01758;hsa04961;Endocrine and other factor-regulated calcium reabsorption
TTDI01758;hsa04964;Proximal tubule bicarbonate reclamation
TTDI01758;hsa04970;Salivary secretion
TTDI01758;hsa04971;Gastric acid secretion
TTDI01758;hsa04972;Pancreatic secretion
TTDI01758;hsa04973;Carbohydrate digestion and absorption
TTDI01758;hsa04974;Protein digestion and absorption
TTDI01758;hsa04976;Bile secretion
TTDI01758;hsa04978;Mineral absorption
TTDI01759;hsa04020;Calcium signaling pathway
TTDI01759;hsa04080;Neuroactive ligand-receptor interaction
TTDI01759;hsa05162;Measles
TTDI01761;hsa00562;Inositol phosphate metabolism
TTDI01761;hsa01100;Metabolic pathways
TTDI01761;hsa04015;Rap1 signaling pathway
TTDI01761;hsa04020;Calcium signaling pathway
TTDI01761;hsa04022;cGMP-PKG signaling pathway
TTDI01761;hsa04062;Chemokine signaling pathway
TTDI01761;hsa04070;Phosphatidylinositol signaling system
TTDI01761;hsa04071;Sphingolipid signaling pathway
TTDI01761;hsa04261;Adrenergic signaling in cardiomyocytes
TTDI01761;hsa04270;Vascular smooth muscle contraction
TTDI01761;hsa04310;Wnt signaling pathway
TTDI01761;hsa04540;Gap junction
TTDI01761;hsa04611;Platelet activation
TTDI01761;hsa04713;Circadian entrainment
TTDI01761;hsa04720;Long-term potentiation
TTDI01761;hsa04723;Retrograde endocannabinoid signaling
TTDI01761;hsa04724;Glutamatergic synapse
TTDI01761;hsa04725;Cholinergic synapse
TTDI01761;hsa04726;Serotonergic synapse
TTDI01761;hsa04728;Dopaminergic synapse
TTDI01761;hsa04730;Long-term depression
TTDI01761;hsa04750;Inflammatory mediator regulation of TRP channels
TTDI01761;hsa04911;Insulin secretion
TTDI01761;hsa04912;GnRH signaling pathway
TTDI01761;hsa04915;Estrogen signaling pathway
TTDI01761;hsa04916;Melanogenesis
TTDI01761;hsa04918;Thyroid hormone synthesis
TTDI01761;hsa04919;Thyroid hormone signaling pathway
TTDI01761;hsa04921;Oxytocin signaling pathway
TTDI01761;hsa04922;Glucagon signaling pathway
TTDI01761;hsa04924;Renin secretion
TTDI01761;hsa04961;Endocrine and other factor-regulated calcium reabsorption
TTDI01761;hsa04970;Salivary secretion
TTDI01761;hsa04971;Gastric acid secretion
TTDI01761;hsa04972;Pancreatic secretion
TTDI01761;hsa05010;Alzheimer's disease
TTDI01761;hsa05016;Huntington's disease
TTDI01761;hsa05142;Chagas disease (American trypanosomiasis)
TTDI01761;hsa05143;African trypanosomiasis
TTDI01761;hsa05146;Amoebiasis
TTDI01761;hsa05200;Pathways in cancer
TTDI01762;hsa04020;Calcium signaling pathway
TTDI01762;hsa04022;cGMP-PKG signaling pathway
TTDI01762;hsa04080;Neuroactive ligand-receptor interaction
TTDI01762;hsa04152;AMPK signaling pathway
TTDI01762;hsa04261;Adrenergic signaling in cardiomyocytes
TTDI01762;hsa04270;Vascular smooth muscle contraction
TTDI01762;hsa04970;Salivary secretion
TTDI01763;hsa04080;Neuroactive ligand-receptor interaction
TTDI01763;hsa04730;Long-term depression
TTDI01764;hsa04020;Calcium signaling pathway
TTDI01764;hsa04022;cGMP-PKG signaling pathway
TTDI01764;hsa04080;Neuroactive ligand-receptor interaction
TTDI01764;hsa04152;AMPK signaling pathway
TTDI01764;hsa04261;Adrenergic signaling in cardiomyocytes
TTDI01764;hsa04270;Vascular smooth muscle contraction
TTDI01764;hsa04970;Salivary secretion
TTDI01765;hsa04610;Complement and coagulation cascades
TTDI01765;hsa04611;Platelet activation
TTDI01766;hsa04080;Neuroactive ligand-receptor interaction
TTDI01766;hsa04713;Circadian entrainment
TTDI01768;hsa04145;Phagosome
TTDI01768;hsa04151;PI3K-Akt signaling pathway
TTDI01768;hsa04510;Focal adhesion
TTDI01768;hsa04512;ECM-receptor interaction
TTDI01768;hsa04640;Hematopoietic cell lineage
TTDI01768;hsa04810;Regulation of actin cytoskeleton
TTDI01768;hsa05100;Bacterial invasion of epithelial cells
TTDI01768;hsa05131;Shigellosis
TTDI01768;hsa05133;Pertussis
TTDI01768;hsa05205;Proteoglycans in cancer
TTDI01768;hsa05206;MicroRNAs in cancer
TTDI01768;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDI01768;hsa05412;Arrhythmogenic right ventricular cardiomyopathy (ARVC)
TTDI01768;hsa05414;Dilated cardiomyopathy
TTDI01769;hsa04020;Calcium signaling pathway
TTDI01769;hsa04080;Neuroactive ligand-receptor interaction
TTDI01769;hsa04610;Complement and coagulation cascades
TTDI01769;hsa04750;Inflammatory mediator regulation of TRP channels
TTDI01769;hsa04810;Regulation of actin cytoskeleton
TTDI01769;hsa05200;Pathways in cancer
TTDI01770;hsa00330;Arginine and proline metabolism
TTDI01770;hsa01100;Metabolic pathways
TTDI01770;hsa04020;Calcium signaling pathway
TTDI01770;hsa04145;Phagosome
TTDI01770;hsa04713;Circadian entrainment
TTDI01770;hsa04730;Long-term depression
TTDI01770;hsa04970;Salivary secretion
TTDI01770;hsa05010;Alzheimer's disease
TTDI01770;hsa05014;Amyotrophic lateral sclerosis (ALS)
TTDI01771;hsa00230;Purine metabolism
TTDI01771;hsa00983;Drug metabolism - other enzymes
TTDI01771;hsa01100;Metabolic pathways
TTDI01772;hsa04060;Cytokine-cytokine receptor interaction
TTDI01772;hsa04062;Chemokine signaling pathway
TTDI01773;hsa04514;Cell adhesion molecules (CAMs)
TTDI01773;hsa04668;TNF signaling pathway
TTDI01773;hsa05143;African trypanosomiasis
TTDI01773;hsa05144;Malaria
TTDI01774;hsa04080;Neuroactive ligand-receptor interaction
TTDI01774;hsa04723;Retrograde endocannabinoid signaling
TTDI01774;hsa04727;GABAergic synapse
TTDI01774;hsa05032;Morphine addiction
TTDI01774;hsa05033;Nicotine addiction
TTDI01775;hsa04010;MAPK signaling pathway
TTDI01775;hsa04012;ErbB signaling pathway
TTDI01775;hsa04014;Ras signaling pathway
TTDI01775;hsa04015;Rap1 signaling pathway
TTDI01775;hsa04022;cGMP-PKG signaling pathway
TTDI01775;hsa04024;cAMP signaling pathway
TTDI01775;hsa04062;Chemokine signaling pathway
TTDI01775;hsa04066;HIF-1 signaling pathway
TTDI01775;hsa04068;FoxO signaling pathway
TTDI01775;hsa04071;Sphingolipid signaling pathway
TTDI01775;hsa04114;Oocyte meiosis
TTDI01775;hsa04151;PI3K-Akt signaling pathway
TTDI01775;hsa04270;Vascular smooth muscle contraction
TTDI01775;hsa04320;Dorso-ventral axis formation
TTDI01775;hsa04370;VEGF signaling pathway
TTDI01775;hsa04380;Osteoclast differentiation
TTDI01775;hsa04510;Focal adhesion
TTDI01775;hsa04540;Gap junction
TTDI01775;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDI01775;hsa04620;Toll-like receptor signaling pathway
TTDI01775;hsa04650;Natural killer cell mediated cytotoxicity
TTDI01775;hsa04660;T cell receptor signaling pathway
TTDI01775;hsa04662;B cell receptor signaling pathway
TTDI01775;hsa04664;Fc epsilon RI signaling pathway
TTDI01775;hsa04666;Fc gamma R-mediated phagocytosis
TTDI01775;hsa04668;TNF signaling pathway
TTDI01775;hsa04720;Long-term potentiation
TTDI01775;hsa04722;Neurotrophin signaling pathway
TTDI01775;hsa04725;Cholinergic synapse
TTDI01775;hsa04726;Serotonergic synapse
TTDI01775;hsa04730;Long-term depression
TTDI01775;hsa04810;Regulation of actin cytoskeleton
TTDI01775;hsa04910;Insulin signaling pathway
TTDI01775;hsa04912;GnRH signaling pathway
TTDI01775;hsa04914;Progesterone-mediated oocyte maturation
TTDI01775;hsa04915;Estrogen signaling pathway
TTDI01775;hsa04916;Melanogenesis
TTDI01775;hsa04917;Prolactin signaling pathway
TTDI01775;hsa04919;Thyroid hormone signaling pathway
TTDI01775;hsa04921;Oxytocin signaling pathway
TTDI01775;hsa05020;Prion diseases
TTDI01775;hsa05034;Alcoholism
TTDI01775;hsa05161;Hepatitis B
TTDI01775;hsa05164;Influenza A
TTDI01775;hsa05200;Pathways in cancer
TTDI01775;hsa05205;Proteoglycans in cancer
TTDI01775;hsa05206;MicroRNAs in cancer
TTDI01775;hsa05210;Colorectal cancer
TTDI01775;hsa05211;Renal cell carcinoma
TTDI01775;hsa05212;Pancreatic cancer
TTDI01775;hsa05213;Endometrial cancer
TTDI01775;hsa05214;Glioma
TTDI01775;hsa05215;Prostate cancer
TTDI01775;hsa05216;Thyroid cancer
TTDI01775;hsa05218;Melanoma
TTDI01775;hsa05219;Bladder cancer
TTDI01775;hsa05220;Chronic myeloid leukemia
TTDI01775;hsa05221;Acute myeloid leukemia
TTDI01775;hsa05223;Non-small cell lung cancer
TTDI01775;hsa05230;Central carbon metabolism in cancer
TTDI01775;hsa05231;Choline metabolism in cancer
TTDI01776;hsa00230;Purine metabolism
TTDI01776;hsa05032;Morphine addiction
TTDI01777;hsa04114;Oocyte meiosis
TTDI01778;hsa04080;Neuroactive ligand-receptor interaction
TTDI01779;hsa04320;Dorso-ventral axis formation
TTDI01779;hsa04330;Notch signaling pathway
TTDI01779;hsa04919;Thyroid hormone signaling pathway
TTDI01779;hsa05020;Prion diseases
TTDI01779;hsa05206;MicroRNAs in cancer
TTDI01780;hsa04014;Ras signaling pathway
TTDI01780;hsa04015;Rap1 signaling pathway
TTDI01780;hsa04060;Cytokine-cytokine receptor interaction
TTDI01780;hsa04066;HIF-1 signaling pathway
TTDI01780;hsa04144;Endocytosis
TTDI01780;hsa04151;PI3K-Akt signaling pathway
TTDI01780;hsa04510;Focal adhesion
TTDI01780;hsa05202;Transcriptional misregulation in cancer
TTDI01780;hsa05323;Rheumatoid arthritis
TTDI01782;hsa04020;Calcium signaling pathway
TTDI01782;hsa04022;cGMP-PKG signaling pathway
TTDI01782;hsa04972;Pancreatic secretion
TTDI01782;hsa05010;Alzheimer's disease
TTDI01783;hsa04912;GnRH signaling pathway
TTDI01784;hsa04015;Rap1 signaling pathway
TTDI01784;hsa04020;Calcium signaling pathway
TTDI01784;hsa04024;cAMP signaling pathway
TTDI01784;hsa04080;Neuroactive ligand-receptor interaction
TTDI01784;hsa04270;Vascular smooth muscle contraction
TTDI01784;hsa05012;Parkinson's disease
TTDI01784;hsa05034;Alcoholism
TTDI01785;hsa04080;Neuroactive ligand-receptor interaction
TTDI01789;hsa04145;Phagosome
TTDI01789;hsa04151;PI3K-Akt signaling pathway
TTDI01789;hsa04510;Focal adhesion
TTDI01789;hsa04512;ECM-receptor interaction
TTDI01789;hsa04640;Hematopoietic cell lineage
TTDI01789;hsa04810;Regulation of actin cytoskeleton
TTDI01789;hsa05100;Bacterial invasion of epithelial cells
TTDI01789;hsa05131;Shigellosis
TTDI01789;hsa05133;Pertussis
TTDI01789;hsa05205;Proteoglycans in cancer
TTDI01789;hsa05206;MicroRNAs in cancer
TTDI01789;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDI01789;hsa05412;Arrhythmogenic right ventricular cardiomyopathy (ARVC)
TTDI01789;hsa05414;Dilated cardiomyopathy
TTDI01791;hsa04261;Adrenergic signaling in cardiomyocytes
TTDI01791;hsa04725;Cholinergic synapse
TTDI01791;hsa04971;Gastric acid secretion
TTDI01791;hsa04972;Pancreatic secretion
TTDI01791;hsa04974;Protein digestion and absorption
TTDI01791;hsa05110;Vibrio cholerae infection
TTDI01792;hsa00380;Tryptophan metabolism
TTDI01792;hsa01100;Metabolic pathways
TTDI01792;hsa04726;Serotonergic synapse
TTDI01793;hsa00860;Porphyrin and chlorophyll metabolism
TTDI01793;hsa04066;HIF-1 signaling pathway
TTDI01793;hsa04978;Mineral absorption
TTDI01793;hsa05206;MicroRNAs in cancer
TTDI01794;hsa04630;Jak-STAT signaling pathway
TTDI01794;hsa05206;MicroRNAs in cancer
TTDI01794;hsa05221;Acute myeloid leukemia
TTDI01795;hsa04145;Phagosome
TTDI01795;hsa04151;PI3K-Akt signaling pathway
TTDI01795;hsa04510;Focal adhesion
TTDI01795;hsa04512;ECM-receptor interaction
TTDI01795;hsa04640;Hematopoietic cell lineage
TTDI01795;hsa04810;Regulation of actin cytoskeleton
TTDI01795;hsa05100;Bacterial invasion of epithelial cells
TTDI01795;hsa05131;Shigellosis
TTDI01795;hsa05133;Pertussis
TTDI01795;hsa05205;Proteoglycans in cancer
TTDI01795;hsa05206;MicroRNAs in cancer
TTDI01795;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDI01795;hsa05412;Arrhythmogenic right ventricular cardiomyopathy (ARVC)
TTDI01795;hsa05414;Dilated cardiomyopathy
TTDI01796;hsa04060;Cytokine-cytokine receptor interaction
TTDI01796;hsa05321;Inflammatory bowel disease (IBD)
TTDI01796;hsa05323;Rheumatoid arthritis
TTDI01797;hsa04151;PI3K-Akt signaling pathway
TTDI01797;hsa04510;Focal adhesion
TTDI01797;hsa04512;ECM-receptor interaction
TTDI01797;hsa04514;Cell adhesion molecules (CAMs)
TTDI01797;hsa04640;Hematopoietic cell lineage
TTDI01797;hsa04670;Leukocyte transendothelial migration
TTDI01797;hsa04672;Intestinal immune network for IgA production
TTDI01797;hsa04810;Regulation of actin cytoskeleton
TTDI01797;hsa05140;Leishmaniasis
TTDI01797;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDI01797;hsa05412;Arrhythmogenic right ventricular cardiomyopathy (ARVC)
TTDI01797;hsa05414;Dilated cardiomyopathy
TTDI01799;hsa04060;Cytokine-cytokine receptor interaction
TTDI01799;hsa04140;Regulation of autophagy
TTDI01799;hsa04151;PI3K-Akt signaling pathway
TTDI01799;hsa04620;Toll-like receptor signaling pathway
TTDI01799;hsa04622;RIG-I-like receptor signaling pathway
TTDI01799;hsa04623;Cytosolic DNA-sensing pathway
TTDI01799;hsa04630;Jak-STAT signaling pathway
TTDI01799;hsa04650;Natural killer cell mediated cytotoxicity
TTDI01799;hsa05152;Tuberculosis
TTDI01799;hsa05160;Hepatitis C
TTDI01799;hsa05161;Hepatitis B
TTDI01799;hsa05162;Measles
TTDI01799;hsa05164;Influenza A
TTDI01799;hsa05168;Herpes simplex infection
TTDI01799;hsa05320;Autoimmune thyroid disease
TTDI01800;hsa04060;Cytokine-cytokine receptor interaction
TTDI01800;hsa04151;PI3K-Akt signaling pathway
TTDI01800;hsa04210;Apoptosis
TTDI01800;hsa04630;Jak-STAT signaling pathway
TTDI01800;hsa04640;Hematopoietic cell lineage
TTDI01801;hsa04068;FoxO signaling pathway
TTDI01801;hsa04110;Cell cycle
TTDI01801;hsa04115;p53 signaling pathway
TTDI01801;hsa04151;PI3K-Akt signaling pathway
TTDI01801;hsa04152;AMPK signaling pathway
TTDI01801;hsa04310;Wnt signaling pathway
TTDI01801;hsa04390;Hippo signaling pathway
TTDI01801;hsa04510;Focal adhesion
TTDI01801;hsa04630;Jak-STAT signaling pathway
TTDI01801;hsa04917;Prolactin signaling pathway
TTDI01801;hsa04919;Thyroid hormone signaling pathway
TTDI01801;hsa04921;Oxytocin signaling pathway
TTDI01801;hsa05161;Hepatitis B
TTDI01801;hsa05162;Measles
TTDI01801;hsa05166;HTLV-I infection
TTDI01801;hsa05200;Pathways in cancer
TTDI01801;hsa05203;Viral carcinogenesis
TTDI01801;hsa05205;Proteoglycans in cancer
TTDI01801;hsa05206;MicroRNAs in cancer
TTDI01801;hsa05210;Colorectal cancer
TTDI01801;hsa05212;Pancreatic cancer
TTDI01801;hsa05213;Endometrial cancer
TTDI01801;hsa05214;Glioma
TTDI01801;hsa05215;Prostate cancer
TTDI01801;hsa05216;Thyroid cancer
TTDI01801;hsa05218;Melanoma
TTDI01801;hsa05219;Bladder cancer
TTDI01801;hsa05220;Chronic myeloid leukemia
TTDI01801;hsa05221;Acute myeloid leukemia
TTDI01801;hsa05222;Small cell lung cancer
TTDI01801;hsa05223;Non-small cell lung cancer
TTDI01801;hsa05416;Viral myocarditis
TTDI01803;hsa04080;Neuroactive ligand-receptor interaction
TTDI01804;hsa04060;Cytokine-cytokine receptor interaction
TTDI01804;hsa04062;Chemokine signaling pathway
TTDI01804;hsa04144;Endocytosis
TTDI01804;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDI01805;hsa04151;PI3K-Akt signaling pathway
TTDI01805;hsa04510;Focal adhesion
TTDI01805;hsa04512;ECM-receptor interaction
TTDI01805;hsa04640;Hematopoietic cell lineage
TTDI01805;hsa04810;Regulation of actin cytoskeleton
TTDI01805;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDI01805;hsa05412;Arrhythmogenic right ventricular cardiomyopathy (ARVC)
TTDI01805;hsa05414;Dilated cardiomyopathy
TTDI01806;hsa04080;Neuroactive ligand-receptor interaction
TTDI01808;hsa04060;Cytokine-cytokine receptor interaction
TTDI01808;hsa04620;Toll-like receptor signaling pathway
TTDI01808;hsa04622;RIG-I-like receptor signaling pathway
TTDI01808;hsa04630;Jak-STAT signaling pathway
TTDI01808;hsa04940;Type I diabetes mellitus
TTDI01808;hsa05133;Pertussis
TTDI01808;hsa05134;Legionellosis
TTDI01808;hsa05140;Leishmaniasis
TTDI01808;hsa05142;Chagas disease (American trypanosomiasis)
TTDI01808;hsa05143;African trypanosomiasis
TTDI01808;hsa05144;Malaria
TTDI01808;hsa05145;Toxoplasmosis
TTDI01808;hsa05146;Amoebiasis
TTDI01808;hsa05152;Tuberculosis
TTDI01808;hsa05162;Measles
TTDI01808;hsa05164;Influenza A
TTDI01808;hsa05168;Herpes simplex infection
TTDI01808;hsa05321;Inflammatory bowel disease (IBD)
TTDI01808;hsa05330;Allograft rejection
TTDI01809;hsa04151;PI3K-Akt signaling pathway
TTDI01809;hsa04510;Focal adhesion
TTDI01809;hsa04512;ECM-receptor interaction
TTDI01809;hsa04640;Hematopoietic cell lineage
TTDI01809;hsa04810;Regulation of actin cytoskeleton
TTDI01809;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDI01809;hsa05412;Arrhythmogenic right ventricular cardiomyopathy (ARVC)
TTDI01809;hsa05414;Dilated cardiomyopathy
TTDI01817;hsa04060;Cytokine-cytokine receptor interaction
TTDI01817;hsa04350;TGF-beta signaling pathway
TTDI01817;hsa04390;Hippo signaling pathway
TTDI01817;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDI01818;hsa04080;Neuroactive ligand-receptor interaction
TTDI01819;hsa00230;Purine metabolism
TTDI01819;hsa04022;cGMP-PKG signaling pathway
TTDI01819;hsa04024;cAMP signaling pathway
TTDI01819;hsa04270;Vascular smooth muscle contraction
TTDI01819;hsa04921;Oxytocin signaling pathway
TTDI01821;hsa04750;Inflammatory mediator regulation of TRP channels
TTDI01824;hsa00230;Purine metabolism
TTDI01824;hsa04740;Olfactory transduction
TTDI01824;hsa04744;Phototransduction
TTDI01825;hsa04024;cAMP signaling pathway
TTDI01825;hsa04066;HIF-1 signaling pathway
TTDI01825;hsa04068;FoxO signaling pathway
TTDI01825;hsa04110;Cell cycle
TTDI01825;hsa04310;Wnt signaling pathway
TTDI01825;hsa04330;Notch signaling pathway
TTDI01825;hsa04350;TGF-beta signaling pathway
TTDI01825;hsa04520;Adherens junction
TTDI01825;hsa04630;Jak-STAT signaling pathway
TTDI01825;hsa04720;Long-term potentiation
TTDI01825;hsa04916;Melanogenesis
TTDI01825;hsa04919;Thyroid hormone signaling pathway
TTDI01825;hsa04922;Glucagon signaling pathway
TTDI01825;hsa05016;Huntington's disease
TTDI01825;hsa05152;Tuberculosis
TTDI01825;hsa05161;Hepatitis B
TTDI01825;hsa05164;Influenza A
TTDI01825;hsa05166;HTLV-I infection
TTDI01825;hsa05168;Herpes simplex infection
TTDI01825;hsa05169;Epstein-Barr virus infection
TTDI01825;hsa05200;Pathways in cancer
TTDI01825;hsa05203;Viral carcinogenesis
TTDI01825;hsa05206;MicroRNAs in cancer
TTDI01825;hsa05211;Renal cell carcinoma
TTDI01825;hsa05215;Prostate cancer
TTDI01826;hsa00790;Folate biosynthesis
TTDI01826;hsa01100;Metabolic pathways
TTDI01827;hsa04060;Cytokine-cytokine receptor interaction
TTDI01827;hsa04210;Apoptosis
TTDI01827;hsa04650;Natural killer cell mediated cytotoxicity
TTDI01827;hsa05162;Measles
TTDI01827;hsa05164;Influenza A
TTDI01869;hsa04014;Ras signaling pathway
TTDI01869;hsa04015;Rap1 signaling pathway
TTDI01869;hsa04060;Cytokine-cytokine receptor interaction
TTDI01869;hsa04151;PI3K-Akt signaling pathway
TTDI01869;hsa04380;Osteoclast differentiation
TTDI01869;hsa04640;Hematopoietic cell lineage
TTDI01869;hsa04668;TNF signaling pathway
TTDI01869;hsa05323;Rheumatoid arthritis
TTDI01904;hsa04514;Cell adhesion molecules (CAMs)
TTDI01904;hsa04620;Toll-like receptor signaling pathway
TTDI01904;hsa04672;Intestinal immune network for IgA production
TTDI01904;hsa04940;Type I diabetes mellitus
TTDI01904;hsa05320;Autoimmune thyroid disease
TTDI01904;hsa05322;Systemic lupus erythematosus
TTDI01904;hsa05323;Rheumatoid arthritis
TTDI01904;hsa05330;Allograft rejection
TTDI01904;hsa05332;Graft-versus-host disease
TTDI01904;hsa05416;Viral myocarditis
TTDI01905;hsa04022;cGMP-PKG signaling pathway
TTDI01905;hsa04071;Sphingolipid signaling pathway
TTDI01905;hsa04270;Vascular smooth muscle contraction
TTDI01905;hsa04530;Tight junction
TTDI01905;hsa04664;Fc epsilon RI signaling pathway
TTDI01905;hsa04666;Fc gamma R-mediated phagocytosis
TTDI01905;hsa04750;Inflammatory mediator regulation of TRP channels
TTDI01905;hsa04930;Type II diabetes mellitus
TTDI01905;hsa05206;MicroRNAs in cancer
TTDI01906;hsa04080;Neuroactive ligand-receptor interaction
TTDI01907;hsa04114;Oocyte meiosis
TTDI01907;hsa05200;Pathways in cancer
TTDI01907;hsa05215;Prostate cancer
TTDI01908;hsa04060;Cytokine-cytokine receptor interaction
TTDI01908;hsa04151;PI3K-Akt signaling pathway
TTDI01908;hsa04630;Jak-STAT signaling pathway
TTDI01908;hsa04640;Hematopoietic cell lineage
TTDI01908;hsa05200;Pathways in cancer
TTDI01909;hsa04080;Neuroactive ligand-receptor interaction
TTDI01909;hsa04723;Retrograde endocannabinoid signaling
TTDI01909;hsa04727;GABAergic synapse
TTDI01909;hsa05032;Morphine addiction
TTDI01909;hsa05033;Nicotine addiction
TTDI01916;hsa04020;Calcium signaling pathway
TTDI01916;hsa04080;Neuroactive ligand-receptor interaction
TTDI01917;hsa04060;Cytokine-cytokine receptor interaction
TTDI01917;hsa04066;HIF-1 signaling pathway
TTDI01917;hsa04151;PI3K-Akt signaling pathway
TTDI01917;hsa04630;Jak-STAT signaling pathway
TTDI01917;hsa04640;Hematopoietic cell lineage
TTDI01918;hsa04144;Endocytosis
TTDI01921;hsa04060;Cytokine-cytokine receptor interaction
TTDI01921;hsa04140;Regulation of autophagy
TTDI01921;hsa04151;PI3K-Akt signaling pathway
TTDI01921;hsa04620;Toll-like receptor signaling pathway
TTDI01921;hsa04622;RIG-I-like receptor signaling pathway
TTDI01921;hsa04623;Cytosolic DNA-sensing pathway
TTDI01921;hsa04630;Jak-STAT signaling pathway
TTDI01921;hsa04650;Natural killer cell mediated cytotoxicity
TTDI01921;hsa05152;Tuberculosis
TTDI01921;hsa05160;Hepatitis C
TTDI01921;hsa05161;Hepatitis B
TTDI01921;hsa05162;Measles
TTDI01921;hsa05164;Influenza A
TTDI01921;hsa05168;Herpes simplex infection
TTDI01921;hsa05320;Autoimmune thyroid disease
TTDI01922;hsa04060;Cytokine-cytokine receptor interaction
TTDI01922;hsa04151;PI3K-Akt signaling pathway
TTDI01922;hsa04380;Osteoclast differentiation
TTDI01922;hsa04620;Toll-like receptor signaling pathway
TTDI01922;hsa04622;RIG-I-like receptor signaling pathway
TTDI01922;hsa04623;Cytosolic DNA-sensing pathway
TTDI01922;hsa04630;Jak-STAT signaling pathway
TTDI01922;hsa04650;Natural killer cell mediated cytotoxicity
TTDI01922;hsa05142;Chagas disease (American trypanosomiasis)
TTDI01922;hsa05152;Tuberculosis
TTDI01922;hsa05160;Hepatitis C
TTDI01922;hsa05161;Hepatitis B
TTDI01922;hsa05162;Measles
TTDI01922;hsa05164;Influenza A
TTDI01922;hsa05168;Herpes simplex infection
TTDI01923;hsa04145;Phagosome
TTDI01923;hsa04540;Gap junction
TTDI01923;hsa05130;Pathogenic Escherichia coli infection
TTDI01931;hsa04010;MAPK signaling pathway
TTDI01931;hsa04012;ErbB signaling pathway
TTDI01931;hsa04024;cAMP signaling pathway
TTDI01931;hsa04310;Wnt signaling pathway
TTDI01931;hsa04380;Osteoclast differentiation
TTDI01931;hsa04510;Focal adhesion
TTDI01931;hsa04620;Toll-like receptor signaling pathway
TTDI01931;hsa04660;T cell receptor signaling pathway
TTDI01931;hsa04662;B cell receptor signaling pathway
TTDI01931;hsa04668;TNF signaling pathway
TTDI01931;hsa04722;Neurotrophin signaling pathway
TTDI01931;hsa04912;GnRH signaling pathway
TTDI01931;hsa04915;Estrogen signaling pathway
TTDI01931;hsa04921;Oxytocin signaling pathway
TTDI01931;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDI01931;hsa05030;Cocaine addiction
TTDI01931;hsa05031;Amphetamine addiction
TTDI01931;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDI01931;hsa05132;Salmonella infection
TTDI01931;hsa05133;Pertussis
TTDI01931;hsa05140;Leishmaniasis
TTDI01931;hsa05142;Chagas disease (American trypanosomiasis)
TTDI01931;hsa05161;Hepatitis B
TTDI01931;hsa05164;Influenza A
TTDI01931;hsa05166;HTLV-I infection
TTDI01931;hsa05168;Herpes simplex infection
TTDI01931;hsa05169;Epstein-Barr virus infection
TTDI01931;hsa05200;Pathways in cancer
TTDI01931;hsa05203;Viral carcinogenesis
TTDI01931;hsa05210;Colorectal cancer
TTDI01931;hsa05211;Renal cell carcinoma
TTDI01931;hsa05231;Choline metabolism in cancer
TTDI01931;hsa05321;Inflammatory bowel disease (IBD)
TTDI01931;hsa05323;Rheumatoid arthritis
TTDI01932;hsa04514;Cell adhesion molecules (CAMs)
TTDI01932;hsa04620;Toll-like receptor signaling pathway
TTDI01932;hsa04672;Intestinal immune network for IgA production
TTDI01932;hsa04940;Type I diabetes mellitus
TTDI01932;hsa05202;Transcriptional misregulation in cancer
TTDI01932;hsa05320;Autoimmune thyroid disease
TTDI01932;hsa05322;Systemic lupus erythematosus
TTDI01932;hsa05323;Rheumatoid arthritis
TTDI01932;hsa05330;Allograft rejection
TTDI01932;hsa05332;Graft-versus-host disease
TTDI01932;hsa05416;Viral myocarditis
TTDI01933;hsa04064;NF-kappa B signaling pathway
TTDI01933;hsa04514;Cell adhesion molecules (CAMs)
TTDI01933;hsa04650;Natural killer cell mediated cytotoxicity
TTDI01933;hsa04668;TNF signaling pathway
TTDI01933;hsa04670;Leukocyte transendothelial migration
TTDI01933;hsa05143;African trypanosomiasis
TTDI01933;hsa05144;Malaria
TTDI01933;hsa05150;Staphylococcus aureus infection
TTDI01933;hsa05164;Influenza A
TTDI01933;hsa05166;HTLV-I infection
TTDI01933;hsa05169;Epstein-Barr virus infection
TTDI01933;hsa05323;Rheumatoid arthritis
TTDI01933;hsa05416;Viral myocarditis
TTDI01934;hsa04520;Adherens junction
TTDI01934;hsa04910;Insulin signaling pathway
TTDI01935;hsa04010;MAPK signaling pathway
TTDI01935;hsa04060;Cytokine-cytokine receptor interaction
TTDI01935;hsa04210;Apoptosis
TTDI01935;hsa04380;Osteoclast differentiation
TTDI01935;hsa04640;Hematopoietic cell lineage
TTDI01935;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDI01935;hsa04940;Type I diabetes mellitus
TTDI01935;hsa05020;Prion diseases
TTDI01935;hsa05132;Salmonella infection
TTDI01935;hsa05133;Pertussis
TTDI01935;hsa05140;Leishmaniasis
TTDI01935;hsa05152;Tuberculosis
TTDI01935;hsa05162;Measles
TTDI01935;hsa05164;Influenza A
TTDI01935;hsa05321;Inflammatory bowel disease (IBD)
TTDI01935;hsa05323;Rheumatoid arthritis
TTDI01935;hsa05332;Graft-versus-host disease
TTDI01936;hsa00071;Fatty acid degradation
TTDI01936;hsa01212;Fatty acid metabolism
TTDI01936;hsa03320;PPAR signaling pathway
TTDI01936;hsa04152;AMPK signaling pathway
TTDI01936;hsa04920;Adipocytokine signaling pathway
TTDI01936;hsa04922;Glucagon signaling pathway
TTDI01937;hsa00230;Purine metabolism
TTDI01937;hsa04020;Calcium signaling pathway
TTDI01937;hsa04742;Taste transduction
TTDI01937;hsa05032;Morphine addiction
TTDI01938;hsa04145;Phagosome
TTDI01938;hsa04380;Osteoclast differentiation
TTDI01938;hsa04650;Natural killer cell mediated cytotoxicity
TTDI01938;hsa04666;Fc gamma R-mediated phagocytosis
TTDI01938;hsa05140;Leishmaniasis
TTDI01938;hsa05150;Staphylococcus aureus infection
TTDI01938;hsa05152;Tuberculosis
TTDI01938;hsa05322;Systemic lupus erythematosus
TTDI01939;hsa04610;Complement and coagulation cascades
TTDI01940;hsa04974;Protein digestion and absorption
TTDI01941;hsa00561;Glycerolipid metabolism
TTDI01941;hsa00830;Retinol metabolism
TTDI01941;hsa01100;Metabolic pathways
TTDI01941;hsa04975;Fat digestion and absorption
TTDI01942;sce00500;Starch and sucrose metabolism
TTDI01942;sce04011;MAPK signaling pathway - yeast
TTDI01945;hsa04010;MAPK signaling pathway
TTDI01945;hsa05010;Alzheimer's disease
TTDI01947;hsa04270;Vascular smooth muscle contraction
TTDI01948;hsa00230;Purine metabolism
TTDI01948;hsa00240;Pyrimidine metabolism
TTDI01948;hsa01100;Metabolic pathways
TTDI01949;hsa04015;Rap1 signaling pathway
TTDI01949;hsa04144;Endocytosis
TTDI01949;hsa04390;Hippo signaling pathway
TTDI01949;hsa04530;Tight junction
TTDI01949;hsa04611;Platelet activation
TTDI01949;hsa04910;Insulin signaling pathway
TTDI01950;hsa04064;NF-kappa B signaling pathway
TTDI01950;hsa04270;Vascular smooth muscle contraction
TTDI01950;hsa04530;Tight junction
TTDI01950;hsa04660;T cell receptor signaling pathway
TTDI01950;hsa04750;Inflammatory mediator regulation of TRP channels
TTDI01950;hsa04920;Adipocytokine signaling pathway
TTDI01950;hsa05162;Measles
TTDI01951;hsa00230;Purine metabolism
TTDI01951;hsa05032;Morphine addiction
TTDI01952;hsa00230;Purine metabolism
TTDI01952;hsa05032;Morphine addiction
TTDI01954;hsa04115;p53 signaling pathway
TTDI01954;hsa04120;Ubiquitin mediated proteolysis
TTDI01956;hsa04919;Thyroid hormone signaling pathway
TTDI01956;hsa05034;Alcoholism
TTDI01956;hsa05203;Viral carcinogenesis
TTDI01957;hsa04514;Cell adhesion molecules (CAMs)
TTDI01957;hsa04612;Antigen processing and presentation
TTDI01957;hsa04640;Hematopoietic cell lineage
TTDI01957;hsa04660;T cell receptor signaling pathway
TTDI01957;hsa05340;Primary immunodeficiency
TTDI01960;hsa04151;PI3K-Akt signaling pathway
TTDI01960;hsa04510;Focal adhesion
TTDI01960;hsa04512;ECM-receptor interaction
TTDI01960;hsa04611;Platelet activation
TTDI01960;hsa04974;Protein digestion and absorption
TTDI01960;hsa05146;Amoebiasis
TTDI01961;hsa04010;MAPK signaling pathway
TTDI01961;hsa04014;Ras signaling pathway
TTDI01961;hsa04015;Rap1 signaling pathway
TTDI01961;hsa04151;PI3K-Akt signaling pathway
TTDI01961;hsa04810;Regulation of actin cytoskeleton
TTDI01961;hsa05200;Pathways in cancer
TTDI01961;hsa05218;Melanoma
TTDI01963;hsa00360;Phenylalanine metabolism
TTDI01963;hsa00400;Phenylalanine, tyrosine and tryptophan biosynthesis
TTDI01963;hsa01100;Metabolic pathways
TTDI01963;hsa01230;Biosynthesis of amino acids
TTDI01964;hsa04610;Complement and coagulation cascades
TTDI01965;hsa04024;cAMP signaling pathway
TTDI01965;hsa04080;Neuroactive ligand-receptor interaction
TTDI01965;hsa04727;GABAergic synapse
TTDI01965;hsa04915;Estrogen signaling pathway
TTDI01965;hsa05032;Morphine addiction
TTDI01966;hsa04010;MAPK signaling pathway
TTDI01966;hsa04014;Ras signaling pathway
TTDI01966;hsa04024;cAMP signaling pathway
TTDI01966;hsa04062;Chemokine signaling pathway
TTDI01966;hsa04064;NF-kappa B signaling pathway
TTDI01966;hsa04066;HIF-1 signaling pathway
TTDI01966;hsa04071;Sphingolipid signaling pathway
TTDI01966;hsa04151;PI3K-Akt signaling pathway
TTDI01966;hsa04210;Apoptosis
TTDI01966;hsa04380;Osteoclast differentiation
TTDI01966;hsa04620;Toll-like receptor signaling pathway
TTDI01966;hsa04621;NOD-like receptor signaling pathway
TTDI01966;hsa04622;RIG-I-like receptor signaling pathway
TTDI01966;hsa04623;Cytosolic DNA-sensing pathway
TTDI01966;hsa04660;T cell receptor signaling pathway
TTDI01966;hsa04662;B cell receptor signaling pathway
TTDI01966;hsa04668;TNF signaling pathway
TTDI01966;hsa04722;Neurotrophin signaling pathway
TTDI01966;hsa04917;Prolactin signaling pathway
TTDI01966;hsa04920;Adipocytokine signaling pathway
TTDI01966;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDI01966;hsa05030;Cocaine addiction
TTDI01966;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDI01966;hsa05131;Shigellosis
TTDI01966;hsa05132;Salmonella infection
TTDI01966;hsa05133;Pertussis
TTDI01966;hsa05134;Legionellosis
TTDI01966;hsa05140;Leishmaniasis
TTDI01966;hsa05142;Chagas disease (American trypanosomiasis)
TTDI01966;hsa05145;Toxoplasmosis
TTDI01966;hsa05146;Amoebiasis
TTDI01966;hsa05152;Tuberculosis
TTDI01966;hsa05160;Hepatitis C
TTDI01966;hsa05161;Hepatitis B
TTDI01966;hsa05162;Measles
TTDI01966;hsa05164;Influenza A
TTDI01966;hsa05166;HTLV-I infection
TTDI01966;hsa05168;Herpes simplex infection
TTDI01966;hsa05169;Epstein-Barr virus infection
TTDI01966;hsa05200;Pathways in cancer
TTDI01966;hsa05202;Transcriptional misregulation in cancer
TTDI01966;hsa05203;Viral carcinogenesis
TTDI01966;hsa05206;MicroRNAs in cancer
TTDI01966;hsa05212;Pancreatic cancer
TTDI01966;hsa05215;Prostate cancer
TTDI01966;hsa05220;Chronic myeloid leukemia
TTDI01966;hsa05221;Acute myeloid leukemia
TTDI01966;hsa05222;Small cell lung cancer
TTDI01966;hsa05321;Inflammatory bowel disease (IBD)
TTDI01967;hsa04512;ECM-receptor interaction
TTDI01967;hsa05161;Hepatitis B
TTDI01967;hsa05205;Proteoglycans in cancer
TTDI01969;hsa00380;Tryptophan metabolism
TTDI01969;hsa01100;Metabolic pathways
TTDI01969;hsa04726;Serotonergic synapse
TTDI01971;hsa04022;cGMP-PKG signaling pathway
TTDI01971;hsa04270;Vascular smooth muscle contraction
TTDI01971;hsa04911;Insulin secretion
TTDI01971;hsa04970;Salivary secretion
TTDI01971;hsa04972;Pancreatic secretion
TTDI01973;hsa04060;Cytokine-cytokine receptor interaction
TTDI01973;hsa04630;Jak-STAT signaling pathway
TTDI01973;hsa05145;Toxoplasmosis
TTDI01973;hsa05152;Tuberculosis
TTDI01973;hsa05169;Epstein-Barr virus infection
TTDI01975;hsa04024;cAMP signaling pathway
TTDI01975;hsa04080;Neuroactive ligand-receptor interaction
TTDI01975;hsa04713;Circadian entrainment
TTDI01975;hsa04723;Retrograde endocannabinoid signaling
TTDI01975;hsa04724;Glutamatergic synapse
TTDI01975;hsa04728;Dopaminergic synapse
TTDI01975;hsa05031;Amphetamine addiction
TTDI01975;hsa05033;Nicotine addiction
TTDI01980;hsa04022;cGMP-PKG signaling pathway
TTDI01980;hsa04270;Vascular smooth muscle contraction
TTDI01980;hsa04911;Insulin secretion
TTDI01980;hsa04970;Salivary secretion
TTDI01980;hsa04972;Pancreatic secretion
TTDI01981;hsa04022;cGMP-PKG signaling pathway
TTDI01981;hsa04270;Vascular smooth muscle contraction
TTDI01981;hsa04911;Insulin secretion
TTDI01983;hsa04060;Cytokine-cytokine receptor interaction
TTDI01983;hsa04340;Hedgehog signaling pathway
TTDI01983;hsa04350;TGF-beta signaling pathway
TTDI01983;hsa04390;Hippo signaling pathway
TTDI01983;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDI01983;hsa05200;Pathways in cancer
TTDI01983;hsa05217;Basal cell carcinoma
TTDI01985;hsa05144;Malaria
TTDI01986;hsa04010;MAPK signaling pathway
TTDI01986;hsa04012;ErbB signaling pathway
TTDI01986;hsa04014;Ras signaling pathway
TTDI01986;hsa04015;Rap1 signaling pathway
TTDI01986;hsa04060;Cytokine-cytokine receptor interaction
TTDI01986;hsa04066;HIF-1 signaling pathway
TTDI01986;hsa04068;FoxO signaling pathway
TTDI01986;hsa04144;Endocytosis
TTDI01986;hsa04151;PI3K-Akt signaling pathway
TTDI01986;hsa04510;Focal adhesion
TTDI01986;hsa04540;Gap junction
TTDI01986;hsa04810;Regulation of actin cytoskeleton
TTDI01986;hsa05160;Hepatitis C
TTDI01986;hsa05200;Pathways in cancer
TTDI01986;hsa05212;Pancreatic cancer
TTDI01986;hsa05213;Endometrial cancer
TTDI01986;hsa05214;Glioma
TTDI01986;hsa05215;Prostate cancer
TTDI01986;hsa05218;Melanoma
TTDI01986;hsa05219;Bladder cancer
TTDI01986;hsa05223;Non-small cell lung cancer
TTDI01986;hsa05231;Choline metabolism in cancer
TTDI01987;hsa04141;Protein processing in endoplasmic reticulum
TTDI01987;hsa04151;PI3K-Akt signaling pathway
TTDI01987;hsa04621;NOD-like receptor signaling pathway
TTDI01987;hsa04915;Estrogen signaling pathway
TTDI01987;hsa04918;Thyroid hormone synthesis
TTDI01987;hsa05200;Pathways in cancer
TTDI01987;hsa05215;Prostate cancer
TTDI01990;hsa04621;NOD-like receptor signaling pathway
TTDI01990;hsa04668;TNF signaling pathway
TTDI01990;hsa05131;Shigellosis
TTDI01990;hsa05152;Tuberculosis
TTDI01990;hsa05321;Inflammatory bowel disease (IBD)
TTDI01991;hsa00330;Arginine and proline metabolism
TTDI01991;hsa01100;Metabolic pathways
TTDI01993;hsa04014;Ras signaling pathway
TTDI01993;hsa04015;Rap1 signaling pathway
TTDI01993;hsa04060;Cytokine-cytokine receptor interaction
TTDI01993;hsa04151;PI3K-Akt signaling pathway
TTDI01993;hsa04640;Hematopoietic cell lineage
TTDI01993;hsa04916;Melanogenesis
TTDI01993;hsa05200;Pathways in cancer
TTDI01994;hsa00860;Porphyrin and chlorophyll metabolism
TTDI01994;hsa00970;Aminoacyl-tRNA biosynthesis
TTDI01994;hsa01100;Metabolic pathways
TTDI02000;hsa04066;HIF-1 signaling pathway
TTDI02000;hsa04120;Ubiquitin mediated proteolysis
TTDI02000;hsa05200;Pathways in cancer
TTDI02000;hsa05211;Renal cell carcinoma
TTDI02002;hsa00250;Alanine, aspartate and glutamate metabolism
TTDI02002;hsa00330;Arginine and proline metabolism
TTDI02002;hsa00471;D-Glutamine and D-glutamate metabolism
TTDI02002;hsa01100;Metabolic pathways
TTDI02002;hsa04724;Glutamatergic synapse
TTDI02002;hsa04727;GABAergic synapse
TTDI02002;hsa04964;Proximal tubule bicarbonate reclamation
TTDI02002;hsa05206;MicroRNAs in cancer
TTDI02002;hsa05230;Central carbon metabolism in cancer
TTDI02005;hsa04514;Cell adhesion molecules (CAMs)
TTDI02005;hsa05020;Prion diseases
TTDI02006;hsa00600;Sphingolipid metabolism
TTDI02006;hsa01100;Metabolic pathways
TTDI02006;hsa04071;Sphingolipid signaling pathway
TTDI02007;hsa00240;Pyrimidine metabolism
TTDI02007;hsa00983;Drug metabolism - other enzymes
TTDI02007;hsa01100;Metabolic pathways
TTDI02008;hsa04012;ErbB signaling pathway
TTDI02008;hsa04020;Calcium signaling pathway
TTDI02008;hsa04024;cAMP signaling pathway
TTDI02008;hsa04066;HIF-1 signaling pathway
TTDI02008;hsa04114;Oocyte meiosis
TTDI02008;hsa04261;Adrenergic signaling in cardiomyocytes
TTDI02008;hsa04310;Wnt signaling pathway
TTDI02008;hsa04713;Circadian entrainment
TTDI02008;hsa04720;Long-term potentiation
TTDI02008;hsa04722;Neurotrophin signaling pathway
TTDI02008;hsa04725;Cholinergic synapse
TTDI02008;hsa04728;Dopaminergic synapse
TTDI02008;hsa04740;Olfactory transduction
TTDI02008;hsa04750;Inflammatory mediator regulation of TRP channels
TTDI02008;hsa04911;Insulin secretion
TTDI02008;hsa04912;GnRH signaling pathway
TTDI02008;hsa04916;Melanogenesis
TTDI02008;hsa04921;Oxytocin signaling pathway
TTDI02008;hsa04922;Glucagon signaling pathway
TTDI02008;hsa04971;Gastric acid secretion
TTDI02008;hsa05031;Amphetamine addiction
TTDI02008;hsa05152;Tuberculosis
TTDI02008;hsa05205;Proteoglycans in cancer
TTDI02008;hsa05214;Glioma
TTDI02011;hsa04974;Protein digestion and absorption
TTDI02014;hsa04672;Intestinal immune network for IgA production
TTDI02014;hsa05340;Primary immunodeficiency
TTDI02015;hsa04010;MAPK signaling pathway
TTDI02015;hsa04012;ErbB signaling pathway
TTDI02015;hsa04014;Ras signaling pathway
TTDI02015;hsa04015;Rap1 signaling pathway
TTDI02015;hsa04022;cGMP-PKG signaling pathway
TTDI02015;hsa04024;cAMP signaling pathway
TTDI02015;hsa04062;Chemokine signaling pathway
TTDI02015;hsa04066;HIF-1 signaling pathway
TTDI02015;hsa04068;FoxO signaling pathway
TTDI02015;hsa04071;Sphingolipid signaling pathway
TTDI02015;hsa04150;mTOR signaling pathway
TTDI02015;hsa04151;PI3K-Akt signaling pathway
TTDI02015;hsa04152;AMPK signaling pathway
TTDI02015;hsa04210;Apoptosis
TTDI02015;hsa04261;Adrenergic signaling in cardiomyocytes
TTDI02015;hsa04370;VEGF signaling pathway
TTDI02015;hsa04380;Osteoclast differentiation
TTDI02015;hsa04510;Focal adhesion
TTDI02015;hsa04530;Tight junction
TTDI02015;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDI02015;hsa04611;Platelet activation
TTDI02015;hsa04620;Toll-like receptor signaling pathway
TTDI02015;hsa04630;Jak-STAT signaling pathway
TTDI02015;hsa04660;T cell receptor signaling pathway
TTDI02015;hsa04662;B cell receptor signaling pathway
TTDI02015;hsa04664;Fc epsilon RI signaling pathway
TTDI02015;hsa04666;Fc gamma R-mediated phagocytosis
TTDI02015;hsa04668;TNF signaling pathway
TTDI02015;hsa04722;Neurotrophin signaling pathway
TTDI02015;hsa04725;Cholinergic synapse
TTDI02015;hsa04728;Dopaminergic synapse
TTDI02015;hsa04910;Insulin signaling pathway
TTDI02015;hsa04914;Progesterone-mediated oocyte maturation
TTDI02015;hsa04915;Estrogen signaling pathway
TTDI02015;hsa04917;Prolactin signaling pathway
TTDI02015;hsa04919;Thyroid hormone signaling pathway
TTDI02015;hsa04920;Adipocytokine signaling pathway
TTDI02015;hsa04922;Glucagon signaling pathway
TTDI02015;hsa04923;Regulation of lipolysis in adipocytes
TTDI02015;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDI02015;hsa04973;Carbohydrate digestion and absorption
TTDI02015;hsa05142;Chagas disease (American trypanosomiasis)
TTDI02015;hsa05145;Toxoplasmosis
TTDI02015;hsa05152;Tuberculosis
TTDI02015;hsa05160;Hepatitis C
TTDI02015;hsa05161;Hepatitis B
TTDI02015;hsa05162;Measles
TTDI02015;hsa05164;Influenza A
TTDI02015;hsa05166;HTLV-I infection
TTDI02015;hsa05169;Epstein-Barr virus infection
TTDI02015;hsa05200;Pathways in cancer
TTDI02015;hsa05205;Proteoglycans in cancer
TTDI02015;hsa05210;Colorectal cancer
TTDI02015;hsa05211;Renal cell carcinoma
TTDI02015;hsa05212;Pancreatic cancer
TTDI02015;hsa05213;Endometrial cancer
TTDI02015;hsa05214;Glioma
TTDI02015;hsa05215;Prostate cancer
TTDI02015;hsa05218;Melanoma
TTDI02015;hsa05220;Chronic myeloid leukemia
TTDI02015;hsa05221;Acute myeloid leukemia
TTDI02015;hsa05222;Small cell lung cancer
TTDI02015;hsa05223;Non-small cell lung cancer
TTDI02015;hsa05230;Central carbon metabolism in cancer
TTDI02015;hsa05231;Choline metabolism in cancer
TTDI02016;hsa04010;MAPK signaling pathway
TTDI02016;hsa04012;ErbB signaling pathway
TTDI02016;hsa04014;Ras signaling pathway
TTDI02016;hsa04015;Rap1 signaling pathway
TTDI02016;hsa04022;cGMP-PKG signaling pathway
TTDI02016;hsa04024;cAMP signaling pathway
TTDI02016;hsa04062;Chemokine signaling pathway
TTDI02016;hsa04066;HIF-1 signaling pathway
TTDI02016;hsa04068;FoxO signaling pathway
TTDI02016;hsa04071;Sphingolipid signaling pathway
TTDI02016;hsa04150;mTOR signaling pathway
TTDI02016;hsa04151;PI3K-Akt signaling pathway
TTDI02016;hsa04152;AMPK signaling pathway
TTDI02016;hsa04210;Apoptosis
TTDI02016;hsa04261;Adrenergic signaling in cardiomyocytes
TTDI02016;hsa04370;VEGF signaling pathway
TTDI02016;hsa04380;Osteoclast differentiation
TTDI02016;hsa04510;Focal adhesion
TTDI02016;hsa04530;Tight junction
TTDI02016;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDI02016;hsa04611;Platelet activation
TTDI02016;hsa04620;Toll-like receptor signaling pathway
TTDI02016;hsa04630;Jak-STAT signaling pathway
TTDI02016;hsa04660;T cell receptor signaling pathway
TTDI02016;hsa04662;B cell receptor signaling pathway
TTDI02016;hsa04664;Fc epsilon RI signaling pathway
TTDI02016;hsa04666;Fc gamma R-mediated phagocytosis
TTDI02016;hsa04668;TNF signaling pathway
TTDI02016;hsa04722;Neurotrophin signaling pathway
TTDI02016;hsa04725;Cholinergic synapse
TTDI02016;hsa04728;Dopaminergic synapse
TTDI02016;hsa04910;Insulin signaling pathway
TTDI02016;hsa04914;Progesterone-mediated oocyte maturation
TTDI02016;hsa04915;Estrogen signaling pathway
TTDI02016;hsa04917;Prolactin signaling pathway
TTDI02016;hsa04919;Thyroid hormone signaling pathway
TTDI02016;hsa04920;Adipocytokine signaling pathway
TTDI02016;hsa04922;Glucagon signaling pathway
TTDI02016;hsa04923;Regulation of lipolysis in adipocytes
TTDI02016;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDI02016;hsa04973;Carbohydrate digestion and absorption
TTDI02016;hsa05142;Chagas disease (American trypanosomiasis)
TTDI02016;hsa05145;Toxoplasmosis
TTDI02016;hsa05152;Tuberculosis
TTDI02016;hsa05160;Hepatitis C
TTDI02016;hsa05161;Hepatitis B
TTDI02016;hsa05162;Measles
TTDI02016;hsa05164;Influenza A
TTDI02016;hsa05166;HTLV-I infection
TTDI02016;hsa05169;Epstein-Barr virus infection
TTDI02016;hsa05200;Pathways in cancer
TTDI02016;hsa05205;Proteoglycans in cancer
TTDI02016;hsa05210;Colorectal cancer
TTDI02016;hsa05211;Renal cell carcinoma
TTDI02016;hsa05212;Pancreatic cancer
TTDI02016;hsa05213;Endometrial cancer
TTDI02016;hsa05214;Glioma
TTDI02016;hsa05215;Prostate cancer
TTDI02016;hsa05218;Melanoma
TTDI02016;hsa05220;Chronic myeloid leukemia
TTDI02016;hsa05221;Acute myeloid leukemia
TTDI02016;hsa05222;Small cell lung cancer
TTDI02016;hsa05223;Non-small cell lung cancer
TTDI02016;hsa05230;Central carbon metabolism in cancer
TTDI02016;hsa05231;Choline metabolism in cancer
TTDI02020;hsa03320;PPAR signaling pathway
TTDI02020;hsa04975;Fat digestion and absorption
TTDI02020;hsa04977;Vitamin digestion and absorption
TTDI02020;hsa05143;African trypanosomiasis
TTDI02021;hsa00600;Sphingolipid metabolism
TTDI02021;hsa04142;Lysosome
TTDI02023;hsa03460;Fanconi anemia pathway
TTDI02023;hsa04110;Cell cycle
TTDI02023;hsa04115;p53 signaling pathway
TTDI02023;hsa05166;HTLV-I infection
TTDI02024;hsa04014;Ras signaling pathway
TTDI02024;hsa04064;NF-kappa B signaling pathway
TTDI02024;hsa04151;PI3K-Akt signaling pathway
TTDI02024;hsa04210;Apoptosis
TTDI02024;hsa04630;Jak-STAT signaling pathway
TTDI02024;hsa05014;Amyotrophic lateral sclerosis (ALS)
TTDI02024;hsa05145;Toxoplasmosis
TTDI02024;hsa05166;HTLV-I infection
TTDI02024;hsa05200;Pathways in cancer
TTDI02024;hsa05202;Transcriptional misregulation in cancer
TTDI02024;hsa05212;Pancreatic cancer
TTDI02024;hsa05220;Chronic myeloid leukemia
TTDI02024;hsa05222;Small cell lung cancer
TTDI02025;hsa04064;NF-kappa B signaling pathway
TTDI02025;hsa04120;Ubiquitin mediated proteolysis
TTDI02025;hsa04210;Apoptosis
TTDI02025;hsa04390;Hippo signaling pathway
TTDI02025;hsa04510;Focal adhesion
TTDI02025;hsa04621;NOD-like receptor signaling pathway
TTDI02025;hsa04668;TNF signaling pathway
TTDI02025;hsa05145;Toxoplasmosis
TTDI02025;hsa05200;Pathways in cancer
TTDI02025;hsa05222;Small cell lung cancer
TTDI02026;hsa04064;NF-kappa B signaling pathway
TTDI02026;hsa04120;Ubiquitin mediated proteolysis
TTDI02026;hsa04210;Apoptosis
TTDI02026;hsa04510;Focal adhesion
TTDI02026;hsa04621;NOD-like receptor signaling pathway
TTDI02026;hsa04668;TNF signaling pathway
TTDI02026;hsa05145;Toxoplasmosis
TTDI02026;hsa05200;Pathways in cancer
TTDI02026;hsa05202;Transcriptional misregulation in cancer
TTDI02026;hsa05222;Small cell lung cancer
TTDI02034;hsa04514;Cell adhesion molecules (CAMs)
TTDI02035;hsa00380;Tryptophan metabolism
TTDI02035;hsa00630;Glyoxylate and dicarboxylate metabolism
TTDI02035;hsa01130;Biosynthesis of antibiotics
TTDI02035;hsa04068;FoxO signaling pathway
TTDI02035;hsa04146;Peroxisome
TTDI02035;hsa05014;Amyotrophic lateral sclerosis (ALS)
TTDI02036;hsa04060;Cytokine-cytokine receptor interaction
TTDI02036;hsa04062;Chemokine signaling pathway
TTDI02036;hsa05310;Asthma
TTDI02037;hsa04060;Cytokine-cytokine receptor interaction
TTDI02037;hsa04062;Chemokine signaling pathway
TTDI02037;hsa04620;Toll-like receptor signaling pathway
TTDI02037;hsa04621;NOD-like receptor signaling pathway
TTDI02037;hsa04623;Cytosolic DNA-sensing pathway
TTDI02037;hsa04668;TNF signaling pathway
TTDI02037;hsa05020;Prion diseases
TTDI02037;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDI02037;hsa05142;Chagas disease (American trypanosomiasis)
TTDI02037;hsa05164;Influenza A
TTDI02037;hsa05168;Herpes simplex infection
TTDI02037;hsa05323;Rheumatoid arthritis
TTDI02038;hsa04514;Cell adhesion molecules (CAMs)
TTDI02038;hsa04640;Hematopoietic cell lineage
TTDI02040;hsa00240;Pyrimidine metabolism
TTDI02040;hsa00983;Drug metabolism - other enzymes
TTDI02040;hsa01100;Metabolic pathways
TTDI02042;hsa04610;Complement and coagulation cascades
TTDI02042;hsa05150;Staphylococcus aureus infection
TTDI02045;hsa04514;Cell adhesion molecules (CAMs)
TTDI02045;hsa04530;Tight junction
TTDI02045;hsa04670;Leukocyte transendothelial migration
TTDI02045;hsa05160;Hepatitis C
TTDI02046;hsa00100;Steroid biosynthesis
TTDI02046;hsa01100;Metabolic pathways
TTDI02046;hsa05206;MicroRNAs in cancer
TTDI02047;hsa00120;Primary bile acid biosynthesis
TTDI02048;hsa04060;Cytokine-cytokine receptor interaction
TTDI02048;hsa04630;Jak-STAT signaling pathway
TTDI02049;hsa04390;Hippo signaling pathway
TTDI02050;hsa04610;Complement and coagulation cascades
TTDI02050;hsa04640;Hematopoietic cell lineage
TTDI02050;hsa05416;Viral myocarditis
TTDI02051;hsa04064;NF-kappa B signaling pathway
TTDI02051;hsa04622;RIG-I-like receptor signaling pathway
TTDI02051;hsa04623;Cytosolic DNA-sensing pathway
TTDI02051;hsa05160;Hepatitis C
TTDI02051;hsa05161;Hepatitis B
TTDI02051;hsa05162;Measles
TTDI02051;hsa05164;Influenza A
TTDI02051;hsa05168;Herpes simplex infection
TTDI02051;hsa05169;Epstein-Barr virus infection
TTDI02053;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDI02053;hsa05412;Arrhythmogenic right ventricular cardiomyopathy (ARVC)
TTDI02053;hsa05414;Dilated cardiomyopathy
TTDI02053;hsa05416;Viral myocarditis
TTDI02054;hsa00350;Tyrosine metabolism
TTDI02054;hsa01100;Metabolic pathways
TTDI02055;hsa04145;Phagosome
TTDI02055;hsa04514;Cell adhesion molecules (CAMs)
TTDI02055;hsa04612;Antigen processing and presentation
TTDI02055;hsa04672;Intestinal immune network for IgA production
TTDI02055;hsa04940;Type I diabetes mellitus
TTDI02055;hsa05140;Leishmaniasis
TTDI02055;hsa05145;Toxoplasmosis
TTDI02055;hsa05150;Staphylococcus aureus infection
TTDI02055;hsa05152;Tuberculosis
TTDI02055;hsa05164;Influenza A
TTDI02055;hsa05166;HTLV-I infection
TTDI02055;hsa05168;Herpes simplex infection
TTDI02055;hsa05169;Epstein-Barr virus infection
TTDI02055;hsa05310;Asthma
TTDI02055;hsa05320;Autoimmune thyroid disease
TTDI02055;hsa05321;Inflammatory bowel disease (IBD)
TTDI02055;hsa05322;Systemic lupus erythematosus
TTDI02055;hsa05323;Rheumatoid arthritis
TTDI02055;hsa05330;Allograft rejection
TTDI02055;hsa05332;Graft-versus-host disease
TTDI02055;hsa05416;Viral myocarditis
TTDI02056;hsa04110;Cell cycle
TTDI02056;hsa05161;Hepatitis B
TTDI02056;hsa05166;HTLV-I infection
TTDI02056;hsa05200;Pathways in cancer
TTDI02056;hsa05206;MicroRNAs in cancer
TTDI02056;hsa05212;Pancreatic cancer
TTDI02056;hsa05214;Glioma
TTDI02056;hsa05215;Prostate cancer
TTDI02056;hsa05218;Melanoma
TTDI02056;hsa05219;Bladder cancer
TTDI02056;hsa05220;Chronic myeloid leukemia
TTDI02056;hsa05222;Small cell lung cancer
TTDI02056;hsa05223;Non-small cell lung cancer
TTDI02057;hsa00100;Steroid biosynthesis
TTDI02057;hsa01100;Metabolic pathways
TTDI02059;hsa05020;Prion diseases
TTDI02059;hsa05166;HTLV-I infection
TTDI02061;hsa04360;Axon guidance
TTDI02062;hsa04012;ErbB signaling pathway
TTDI02063;hsa05206;MicroRNAs in cancer
TTDI02065;hsa00051;Fructose and mannose metabolism
TTDI02065;hsa04066;HIF-1 signaling pathway
TTDI02065;hsa04152;AMPK signaling pathway
TTDI02067;sao00061;Fatty acid biosynthesis
TTDI02067;sao00780;Biotin metabolism
TTDI02067;sao01100;Metabolic pathways
TTDI02067;sao01212;Fatty acid metabolism
TTDI02068;hsa04640;Hematopoietic cell lineage
TTDI02068;hsa05169;Epstein-Barr virus infection
TTDI02069;hsa04024;cAMP signaling pathway
TTDI02070;hsa04010;MAPK signaling pathway
TTDI02070;hsa04014;Ras signaling pathway
TTDI02070;hsa04015;Rap1 signaling pathway
TTDI02070;hsa04151;PI3K-Akt signaling pathway
TTDI02070;hsa04810;Regulation of actin cytoskeleton
TTDI02070;hsa05200;Pathways in cancer
TTDI02070;hsa05218;Melanoma
TTDI02071;hsa04010;MAPK signaling pathway
TTDI02071;hsa04014;Ras signaling pathway
TTDI02071;hsa04015;Rap1 signaling pathway
TTDI02071;hsa04151;PI3K-Akt signaling pathway
TTDI02071;hsa04810;Regulation of actin cytoskeleton
TTDI02071;hsa05200;Pathways in cancer
TTDI02071;hsa05218;Melanoma
TTDI02074;hsa00601;Glycosphingolipid biosynthesis - lacto and neolacto series
TTDI02074;hsa01100;Metabolic pathways
TTDI02075;hsa04310;Wnt signaling pathway
TTDI02075;hsa04390;Hippo signaling pathway
TTDI02075;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDI02075;hsa04916;Melanogenesis
TTDI02075;hsa05166;HTLV-I infection
TTDI02075;hsa05200;Pathways in cancer
TTDI02075;hsa05205;Proteoglycans in cancer
TTDI02075;hsa05217;Basal cell carcinoma
TTDI02076;hsa04971;Gastric acid secretion
TTDI02078;hsa04060;Cytokine-cytokine receptor interaction
TTDI02078;hsa04350;TGF-beta signaling pathway
TTDI02078;hsa04390;Hippo signaling pathway
TTDI02079;hsa04666;Fc gamma R-mediated phagocytosis
TTDI02079;hsa04810;Regulation of actin cytoskeleton
TTDI02079;hsa05203;Viral carcinogenesis
TTDI02080;hsa00520;Amino sugar and nucleotide sugar metabolism
TTDI02080;hsa01100;Metabolic pathways
TTDI02082;hsa00250;Alanine, aspartate and glutamate metabolism
TTDI02082;hsa00330;Arginine and proline metabolism
TTDI02082;hsa00630;Glyoxylate and dicarboxylate metabolism
TTDI02082;hsa00910;Nitrogen metabolism
TTDI02082;hsa01100;Metabolic pathways
TTDI02082;hsa01230;Biosynthesis of amino acids
TTDI02082;hsa04724;Glutamatergic synapse
TTDI02082;hsa04727;GABAergic synapse
TTDI02083;hsa04512;ECM-receptor interaction
TTDI02083;hsa04611;Platelet activation
TTDI02083;hsa04640;Hematopoietic cell lineage
TTDI02084;hsa05205;Proteoglycans in cancer
TTDI02085;hsa04512;ECM-receptor interaction
TTDI02085;hsa04611;Platelet activation
TTDI02086;hsa03018;RNA degradation
TTDI02086;hsa05152;Tuberculosis
TTDI02087;hsa03060;Protein export
TTDI02087;hsa04141;Protein processing in endoplasmic reticulum
TTDI02087;hsa04612;Antigen processing and presentation
TTDI02087;hsa04918;Thyroid hormone synthesis
TTDI02087;hsa05020;Prion diseases
TTDI02088;hsa00480;Glutathione metabolism
TTDI02088;hsa00980;Metabolism of xenobiotics by cytochrome P450
TTDI02088;hsa00982;Drug metabolism - cytochrome P450
TTDI02088;hsa05200;Pathways in cancer
TTDI02088;hsa05204;Chemical carcinogenesis
TTDI02088;hsa05215;Prostate cancer
TTDI02091;hsa04612;Antigen processing and presentation
TTDI02091;hsa05152;Tuberculosis
TTDI02091;hsa05168;Herpes simplex infection
TTDI02093;hsa04060;Cytokine-cytokine receptor interaction
TTDI02093;hsa04630;Jak-STAT signaling pathway
TTDI02093;hsa04672;Intestinal immune network for IgA production
TTDI02093;hsa05166;HTLV-I infection
TTDI02094;hsa00020;Citrate cycle (TCA cycle)
TTDI02094;hsa00480;Glutathione metabolism
TTDI02094;hsa01100;Metabolic pathways
TTDI02094;hsa01130;Biosynthesis of antibiotics
TTDI02094;hsa01200;Carbon metabolism
TTDI02094;hsa01210;2-Oxocarboxylic acid metabolism
TTDI02094;hsa01230;Biosynthesis of amino acids
TTDI02094;hsa04146;Peroxisome
TTDI02094;hsa05230;Central carbon metabolism in cancer
TTDI02095;hsa00020;Citrate cycle (TCA cycle)
TTDI02095;hsa00480;Glutathione metabolism
TTDI02095;hsa01100;Metabolic pathways
TTDI02095;hsa01130;Biosynthesis of antibiotics
TTDI02095;hsa01200;Carbon metabolism
TTDI02095;hsa01210;2-Oxocarboxylic acid metabolism
TTDI02095;hsa01230;Biosynthesis of amino acids
TTDI02095;hsa04146;Peroxisome
TTDI02096;hsa04060;Cytokine-cytokine receptor interaction
TTDI02096;hsa04140;Regulation of autophagy
TTDI02096;hsa04151;PI3K-Akt signaling pathway
TTDI02096;hsa04620;Toll-like receptor signaling pathway
TTDI02096;hsa04622;RIG-I-like receptor signaling pathway
TTDI02096;hsa04623;Cytosolic DNA-sensing pathway
TTDI02096;hsa04630;Jak-STAT signaling pathway
TTDI02096;hsa04650;Natural killer cell mediated cytotoxicity
TTDI02096;hsa05152;Tuberculosis
TTDI02096;hsa05160;Hepatitis C
TTDI02096;hsa05161;Hepatitis B
TTDI02096;hsa05162;Measles
TTDI02096;hsa05164;Influenza A
TTDI02096;hsa05168;Herpes simplex infection
TTDI02096;hsa05320;Autoimmune thyroid disease
TTDI02097;hsa04060;Cytokine-cytokine receptor interaction
TTDI02097;hsa04622;RIG-I-like receptor signaling pathway
TTDI02097;hsa04630;Jak-STAT signaling pathway
TTDI02099;hsa04060;Cytokine-cytokine receptor interaction
TTDI02099;hsa04630;Jak-STAT signaling pathway
TTDI02099;hsa05321;Inflammatory bowel disease (IBD)
TTDI02101;hsa04623;Cytosolic DNA-sensing pathway
TTDI02101;hsa05164;Influenza A
TTDI02105;hsa04612;Antigen processing and presentation
TTDI02105;hsa04650;Natural killer cell mediated cytotoxicity
TTDI02105;hsa05332;Graft-versus-host disease
TTDI02106;hsa04612;Antigen processing and presentation
TTDI02106;hsa04650;Natural killer cell mediated cytotoxicity
TTDI02106;hsa05332;Graft-versus-host disease
TTDI02107;hsa04612;Antigen processing and presentation
TTDI02107;hsa04650;Natural killer cell mediated cytotoxicity
TTDI02107;hsa05332;Graft-versus-host disease
TTDI02109;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDI02110;hsa00010;Glycolysis / Gluconeogenesis
TTDI02110;hsa00230;Purine metabolism
TTDI02110;hsa00620;Pyruvate metabolism
TTDI02110;hsa01100;Metabolic pathways
TTDI02110;hsa01130;Biosynthesis of antibiotics
TTDI02110;hsa01200;Carbon metabolism
TTDI02110;hsa01230;Biosynthesis of amino acids
TTDI02110;hsa04922;Glucagon signaling pathway
TTDI02110;hsa04930;Type II diabetes mellitus
TTDI02110;hsa05203;Viral carcinogenesis
TTDI02110;hsa05230;Central carbon metabolism in cancer
TTDI02111;hsa00564;Glycerophospholipid metabolism
TTDI02116;hsa04015;Rap1 signaling pathway
TTDI02116;hsa04080;Neuroactive ligand-receptor interaction
TTDI02116;hsa04151;PI3K-Akt signaling pathway
TTDI02116;hsa05200;Pathways in cancer
TTDI02118;hsa04970;Salivary secretion
TTDI02119;hsa04010;MAPK signaling pathway
TTDI02119;hsa04370;VEGF signaling pathway
TTDI02119;hsa04722;Neurotrophin signaling pathway
TTDI02119;hsa05203;Viral carcinogenesis
TTDI02122;hsa04145;Phagosome
TTDI02122;hsa04610;Complement and coagulation cascades
TTDI02122;hsa05150;Staphylococcus aureus infection
TTDI02123;hsa04080;Neuroactive ligand-receptor interaction
TTDI02126;hsa04142;Lysosome
TTDI02131;hsa04022;cGMP-PKG signaling pathway
TTDI02131;hsa04260;Cardiac muscle contraction
TTDI02131;hsa04261;Adrenergic signaling in cardiomyocytes
TTDI02131;hsa04530;Tight junction
TTDI02131;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDI02131;hsa05414;Dilated cardiomyopathy
TTDI02131;hsa05416;Viral myocarditis
TTDI02132;hsa00760;Nicotinate and nicotinamide metabolism
TTDI02132;hsa01100;Metabolic pathways
TTDI02134;hsa04320;Dorso-ventral axis formation
TTDI02134;hsa04330;Notch signaling pathway
TTDI02134;hsa04919;Thyroid hormone signaling pathway
TTDI02134;hsa05206;MicroRNAs in cancer
TTDI02135;hsa04320;Dorso-ventral axis formation
TTDI02135;hsa04330;Notch signaling pathway
TTDI02135;hsa04919;Thyroid hormone signaling pathway
TTDI02135;hsa05206;MicroRNAs in cancer
TTDI02140;hsa04722;Neurotrophin signaling pathway
TTDI02140;hsa05230;Central carbon metabolism in cancer
TTDI02141;hsa05130;Pathogenic Escherichia coli infection
TTDI02145;hsa04012;ErbB signaling pathway
TTDI02145;hsa04014;Ras signaling pathway
TTDI02145;hsa04360;Axon guidance
TTDI02145;hsa04510;Focal adhesion
TTDI02145;hsa04660;T cell receptor signaling pathway
TTDI02145;hsa04810;Regulation of actin cytoskeleton
TTDI02145;hsa05206;MicroRNAs in cancer
TTDI02145;hsa05211;Renal cell carcinoma
TTDI02148;hsa00230;Purine metabolism
TTDI02149;hsa04014;Ras signaling pathway
TTDI02149;hsa04015;Rap1 signaling pathway
TTDI02149;hsa04151;PI3K-Akt signaling pathway
TTDI02149;hsa04510;Focal adhesion
TTDI02149;hsa04540;Gap junction
TTDI02149;hsa04810;Regulation of actin cytoskeleton
TTDI02149;hsa05215;Prostate cancer
TTDI02149;hsa05218;Melanoma
TTDI02149;hsa05231;Choline metabolism in cancer
TTDI02154;hsa05202;Transcriptional misregulation in cancer
TTDI02159;hsa04014;Ras signaling pathway
TTDI02159;hsa04015;Rap1 signaling pathway
TTDI02159;hsa04022;cGMP-PKG signaling pathway
TTDI02159;hsa04024;cAMP signaling pathway
TTDI02159;hsa04062;Chemokine signaling pathway
TTDI02159;hsa04071;Sphingolipid signaling pathway
TTDI02159;hsa04144;Endocytosis
TTDI02159;hsa04270;Vascular smooth muscle contraction
TTDI02159;hsa04310;Wnt signaling pathway
TTDI02159;hsa04350;TGF-beta signaling pathway
TTDI02159;hsa04360;Axon guidance
TTDI02159;hsa04510;Focal adhesion
TTDI02159;hsa04520;Adherens junction
TTDI02159;hsa04530;Tight junction
TTDI02159;hsa04611;Platelet activation
TTDI02159;hsa04660;T cell receptor signaling pathway
TTDI02159;hsa04670;Leukocyte transendothelial migration
TTDI02159;hsa04722;Neurotrophin signaling pathway
TTDI02159;hsa04810;Regulation of actin cytoskeleton
TTDI02159;hsa04921;Oxytocin signaling pathway
TTDI02159;hsa04972;Pancreatic secretion
TTDI02159;hsa05100;Bacterial invasion of epithelial cells
TTDI02159;hsa05130;Pathogenic Escherichia coli infection
TTDI02159;hsa05133;Pertussis
TTDI02159;hsa05152;Tuberculosis
TTDI02159;hsa05200;Pathways in cancer
TTDI02159;hsa05203;Viral carcinogenesis
TTDI02159;hsa05205;Proteoglycans in cancer
TTDI02159;hsa05206;MicroRNAs in cancer
TTDI02159;hsa05210;Colorectal cancer
TTDI02162;hsa04022;cGMP-PKG signaling pathway
TTDI02162;hsa04024;cAMP signaling pathway
TTDI02162;hsa04062;Chemokine signaling pathway
TTDI02162;hsa04071;Sphingolipid signaling pathway
TTDI02162;hsa04270;Vascular smooth muscle contraction
TTDI02162;hsa04310;Wnt signaling pathway
TTDI02162;hsa04360;Axon guidance
TTDI02162;hsa04510;Focal adhesion
TTDI02162;hsa04611;Platelet activation
TTDI02162;hsa04670;Leukocyte transendothelial migration
TTDI02162;hsa04810;Regulation of actin cytoskeleton
TTDI02162;hsa04921;Oxytocin signaling pathway
TTDI02162;hsa05130;Pathogenic Escherichia coli infection
TTDI02162;hsa05131;Shigellosis
TTDI02162;hsa05132;Salmonella infection
TTDI02162;hsa05200;Pathways in cancer
TTDI02162;hsa05205;Proteoglycans in cancer
TTDI02167;hsa04071;Sphingolipid signaling pathway
TTDI02167;hsa04080;Neuroactive ligand-receptor interaction
TTDI02171;hsa04360;Axon guidance
TTDI02172;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDI02172;hsa05412;Arrhythmogenic right ventricular cardiomyopathy (ARVC)
TTDI02172;hsa05414;Dilated cardiomyopathy
TTDI02172;hsa05416;Viral myocarditis
TTDI02173;hsa00600;Sphingolipid metabolism
TTDI02173;hsa01100;Metabolic pathways
TTDI02173;hsa04071;Sphingolipid signaling pathway
TTDI02174;hsa00562;Inositol phosphate metabolism
TTDI02174;hsa04070;Phosphatidylinositol signaling system
TTDI02174;hsa04662;B cell receptor signaling pathway
TTDI02174;hsa04664;Fc epsilon RI signaling pathway
TTDI02174;hsa04666;Fc gamma R-mediated phagocytosis
TTDI02176;hsa03013;RNA transport
TTDI02177;hsa04068;FoxO signaling pathway
TTDI02177;hsa04146;Peroxisome
TTDI02177;hsa05016;Huntington's disease
TTDI02179;hsa00600;Sphingolipid metabolism
TTDI02179;hsa01100;Metabolic pathways
TTDI02179;hsa04020;Calcium signaling pathway
TTDI02179;hsa04071;Sphingolipid signaling pathway
TTDI02179;hsa04370;VEGF signaling pathway
TTDI02179;hsa04666;Fc gamma R-mediated phagocytosis
TTDI02179;hsa05152;Tuberculosis
TTDI02180;hsa00531;Glycosaminoglycan degradation
TTDI02180;hsa01100;Metabolic pathways
TTDI02180;hsa04142;Lysosome
TTDI02182;hsa04380;Osteoclast differentiation
TTDI02184;hsa04062;Chemokine signaling pathway
TTDI02184;hsa04066;HIF-1 signaling pathway
TTDI02184;hsa04068;FoxO signaling pathway
TTDI02184;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDI02184;hsa04630;Jak-STAT signaling pathway
TTDI02184;hsa04917;Prolactin signaling pathway
TTDI02184;hsa04920;Adipocytokine signaling pathway
TTDI02184;hsa05145;Toxoplasmosis
TTDI02184;hsa05160;Hepatitis C
TTDI02184;hsa05161;Hepatitis B
TTDI02184;hsa05162;Measles
TTDI02184;hsa05169;Epstein-Barr virus infection
TTDI02184;hsa05200;Pathways in cancer
TTDI02184;hsa05203;Viral carcinogenesis
TTDI02184;hsa05205;Proteoglycans in cancer
TTDI02184;hsa05206;MicroRNAs in cancer
TTDI02184;hsa05212;Pancreatic cancer
TTDI02184;hsa05221;Acute myeloid leukemia
TTDI02184;hsa05321;Inflammatory bowel disease (IBD)
TTDI02186;hsa05010;Alzheimer's disease
TTDI02186;hsa05012;Parkinson's disease
TTDI02187;hsa04141;Protein processing in endoplasmic reticulum
TTDI02187;hsa05134;Legionellosis
TTDI02190;hsa04010;MAPK signaling pathway
TTDI02190;hsa04060;Cytokine-cytokine receptor interaction
TTDI02190;hsa04068;FoxO signaling pathway
TTDI02190;hsa04144;Endocytosis
TTDI02190;hsa04350;TGF-beta signaling pathway
TTDI02190;hsa04380;Osteoclast differentiation
TTDI02190;hsa04390;Hippo signaling pathway
TTDI02190;hsa04520;Adherens junction
TTDI02190;hsa05142;Chagas disease (American trypanosomiasis)
TTDI02190;hsa05166;HTLV-I infection
TTDI02190;hsa05200;Pathways in cancer
TTDI02190;hsa05202;Transcriptional misregulation in cancer
TTDI02190;hsa05210;Colorectal cancer
TTDI02190;hsa05212;Pancreatic cancer
TTDI02190;hsa05220;Chronic myeloid leukemia
TTDI02191;hsa04620;Toll-like receptor signaling pathway
TTDI02191;hsa05130;Pathogenic Escherichia coli infection
TTDI02191;hsa05132;Salmonella infection
TTDI02191;hsa05134;Legionellosis
TTDI02191;hsa05321;Inflammatory bowel disease (IBD)
TTDI02192;hsa04145;Phagosome
TTDI02192;hsa04620;Toll-like receptor signaling pathway
TTDI02192;hsa05142;Chagas disease (American trypanosomiasis)
TTDI02192;hsa05152;Tuberculosis
TTDI02193;hsa04060;Cytokine-cytokine receptor interaction
TTDI02193;hsa04068;FoxO signaling pathway
TTDI02193;hsa04210;Apoptosis
TTDI02193;hsa04650;Natural killer cell mediated cytotoxicity
TTDI02193;hsa05162;Measles
TTDI02193;hsa05164;Influenza A
TTDI02194;hsa04060;Cytokine-cytokine receptor interaction
TTDI02196;hsa04060;Cytokine-cytokine receptor interaction
TTDI02197;hsa04060;Cytokine-cytokine receptor interaction
TTDI02198;hsa04060;Cytokine-cytokine receptor interaction
TTDI02198;hsa04064;NF-kappa B signaling pathway
TTDI02198;hsa04066;HIF-1 signaling pathway
TTDI02198;hsa04672;Intestinal immune network for IgA production
TTDI02198;hsa05166;HTLV-I infection
TTDI02198;hsa05203;Viral carcinogenesis
TTDI02199;hsa04010;MAPK signaling pathway
TTDI02199;hsa04060;Cytokine-cytokine receptor interaction
TTDI02199;hsa04115;p53 signaling pathway
TTDI02199;hsa04210;Apoptosis
TTDI02199;hsa04650;Natural killer cell mediated cytotoxicity
TTDI02199;hsa04668;TNF signaling pathway
TTDI02199;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDI02199;hsa04940;Type I diabetes mellitus
TTDI02199;hsa05010;Alzheimer's disease
TTDI02199;hsa05142;Chagas disease (American trypanosomiasis)
TTDI02199;hsa05143;African trypanosomiasis
TTDI02199;hsa05161;Hepatitis B
TTDI02199;hsa05162;Measles
TTDI02199;hsa05164;Influenza A
TTDI02199;hsa05168;Herpes simplex infection
TTDI02199;hsa05200;Pathways in cancer
TTDI02199;hsa05205;Proteoglycans in cancer
TTDI02199;hsa05320;Autoimmune thyroid disease
TTDI02199;hsa05330;Allograft rejection
TTDI02199;hsa05332;Graft-versus-host disease
TTDI02200;hsa04144;Endocytosis
TTDI02201;hsa04015;Rap1 signaling pathway
TTDI02201;hsa04115;p53 signaling pathway
TTDI02201;hsa04145;Phagosome
TTDI02201;hsa04151;PI3K-Akt signaling pathway
TTDI02201;hsa04350;TGF-beta signaling pathway
TTDI02201;hsa04510;Focal adhesion
TTDI02201;hsa04512;ECM-receptor interaction
TTDI02201;hsa05144;Malaria
TTDI02201;hsa05205;Proteoglycans in cancer
TTDI02201;hsa05206;MicroRNAs in cancer
TTDI02201;hsa05219;Bladder cancer
TTDI02203;hsa00350;Tyrosine metabolism
TTDI02203;hsa01100;Metabolic pathways
TTDI02203;hsa04916;Melanogenesis
TTDI02208;hsa04024;cAMP signaling pathway
TTDI02208;hsa04080;Neuroactive ligand-receptor interaction
TTDI02210;hsa04911;Insulin secretion
TTDI02219;hsa04010;MAPK signaling pathway
TTDI02219;hsa04014;Ras signaling pathway
TTDI02219;hsa04015;Rap1 signaling pathway
TTDI02219;hsa04151;PI3K-Akt signaling pathway
TTDI02219;hsa04210;Apoptosis
TTDI02219;hsa04722;Neurotrophin signaling pathway
TTDI02219;hsa04750;Inflammatory mediator regulation of TRP channels
TTDI02220;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDI02220;hsa05412;Arrhythmogenic right ventricular cardiomyopathy (ARVC)
TTDI02220;hsa05414;Dilated cardiomyopathy
TTDI02220;hsa05416;Viral myocarditis
TTDI02221;hsa04062;Chemokine signaling pathway
TTDI02221;hsa04520;Adherens junction
TTDI02221;hsa04666;Fc gamma R-mediated phagocytosis
TTDI02221;hsa04810;Regulation of actin cytoskeleton
TTDI02221;hsa05100;Bacterial invasion of epithelial cells
TTDI02221;hsa05130;Pathogenic Escherichia coli infection
TTDI02221;hsa05131;Shigellosis
TTDI02221;hsa05132;Salmonella infection
TTDI02221;hsa05231;Choline metabolism in cancer
TTDI02222;hsa02010;ABC transporters
TTDI02226;hsa04340;Hedgehog signaling pathway
TTDI02226;hsa05200;Pathways in cancer
TTDI02226;hsa05217;Basal cell carcinoma
TTDI02228;hsa04014;Ras signaling pathway
TTDI02228;hsa04015;Rap1 signaling pathway
TTDI02228;hsa04066;HIF-1 signaling pathway
TTDI02228;hsa04068;FoxO signaling pathway
TTDI02228;hsa04114;Oocyte meiosis
TTDI02228;hsa04115;p53 signaling pathway
TTDI02228;hsa04150;mTOR signaling pathway
TTDI02228;hsa04151;PI3K-Akt signaling pathway
TTDI02228;hsa04152;AMPK signaling pathway
TTDI02228;hsa04510;Focal adhesion
TTDI02228;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDI02228;hsa04730;Long-term depression
TTDI02228;hsa04750;Inflammatory mediator regulation of TRP channels
TTDI02228;hsa04913;Ovarian steroidogenesis
TTDI02228;hsa04914;Progesterone-mediated oocyte maturation
TTDI02228;hsa04960;Aldosterone-regulated sodium reabsorption
TTDI02228;hsa05200;Pathways in cancer
TTDI02228;hsa05202;Transcriptional misregulation in cancer
TTDI02228;hsa05205;Proteoglycans in cancer
TTDI02228;hsa05214;Glioma
TTDI02228;hsa05215;Prostate cancer
TTDI02228;hsa05218;Melanoma
TTDI02228;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDI02228;hsa05414;Dilated cardiomyopathy
TTDI02230;mtu00561;Glycerolipid metabolism
TTDI02230;mtu01100;Metabolic pathways
TTDI02235;hsa04014;Ras signaling pathway
TTDI02235;hsa04015;Rap1 signaling pathway
TTDI02235;hsa04060;Cytokine-cytokine receptor interaction
TTDI02235;hsa04066;HIF-1 signaling pathway
TTDI02235;hsa04150;mTOR signaling pathway
TTDI02235;hsa04151;PI3K-Akt signaling pathway
TTDI02235;hsa04370;VEGF signaling pathway
TTDI02235;hsa04510;Focal adhesion
TTDI02235;hsa05200;Pathways in cancer
TTDI02235;hsa05205;Proteoglycans in cancer
TTDI02235;hsa05206;MicroRNAs in cancer
TTDI02235;hsa05211;Renal cell carcinoma
TTDI02235;hsa05212;Pancreatic cancer
TTDI02235;hsa05219;Bladder cancer
TTDI02235;hsa05323;Rheumatoid arthritis
TTDI02236;hsa04060;Cytokine-cytokine receptor interaction
TTDI02236;hsa04062;Chemokine signaling pathway
TTDI02236;hsa04144;Endocytosis
TTDI02236;hsa05145;Toxoplasmosis
TTDI02236;hsa05203;Viral carcinogenesis
TTDI02237;hsa04064;NF-kappa B signaling pathway
TTDI02237;hsa04151;PI3K-Akt signaling pathway
TTDI02237;hsa04380;Osteoclast differentiation
TTDI02237;hsa04611;Platelet activation
TTDI02237;hsa04650;Natural killer cell mediated cytotoxicity
TTDI02237;hsa04662;B cell receptor signaling pathway
TTDI02237;hsa04664;Fc epsilon RI signaling pathway
TTDI02237;hsa04666;Fc gamma R-mediated phagocytosis
TTDI02237;hsa05152;Tuberculosis
TTDI02237;hsa05169;Epstein-Barr virus infection
TTDI02237;hsa05203;Viral carcinogenesis
TTDI02239;hsa04068;FoxO signaling pathway
TTDI02239;hsa04110;Cell cycle
TTDI02239;hsa04114;Oocyte meiosis
TTDI02239;hsa04914;Progesterone-mediated oocyte maturation
TTDI02245;hsa04014;Ras signaling pathway
TTDI02245;hsa04015;Rap1 signaling pathway
TTDI02245;hsa04066;HIF-1 signaling pathway
TTDI02245;hsa04068;FoxO signaling pathway
TTDI02245;hsa04114;Oocyte meiosis
TTDI02245;hsa04144;Endocytosis
TTDI02245;hsa04151;PI3K-Akt signaling pathway
TTDI02245;hsa04152;AMPK signaling pathway
TTDI02245;hsa04510;Focal adhesion
TTDI02245;hsa04520;Adherens junction
TTDI02245;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDI02245;hsa04730;Long-term depression
TTDI02245;hsa04913;Ovarian steroidogenesis
TTDI02245;hsa04914;Progesterone-mediated oocyte maturation
TTDI02245;hsa05200;Pathways in cancer
TTDI02245;hsa05202;Transcriptional misregulation in cancer
TTDI02245;hsa05205;Proteoglycans in cancer
TTDI02245;hsa05214;Glioma
TTDI02245;hsa05215;Prostate cancer
TTDI02245;hsa05218;Melanoma
TTDI02248;hsa04066;HIF-1 signaling pathway
TTDI02248;hsa04978;Mineral absorption
TTDI02249;hsa04010;MAPK signaling pathway
TTDI02249;hsa04012;ErbB signaling pathway
TTDI02249;hsa04014;Ras signaling pathway
TTDI02249;hsa04015;Rap1 signaling pathway
TTDI02249;hsa04020;Calcium signaling pathway
TTDI02249;hsa04060;Cytokine-cytokine receptor interaction
TTDI02249;hsa04066;HIF-1 signaling pathway
TTDI02249;hsa04068;FoxO signaling pathway
TTDI02249;hsa04144;Endocytosis
TTDI02249;hsa04151;PI3K-Akt signaling pathway
TTDI02249;hsa04320;Dorso-ventral axis formation
TTDI02249;hsa04510;Focal adhesion
TTDI02249;hsa04520;Adherens junction
TTDI02249;hsa04540;Gap junction
TTDI02249;hsa04810;Regulation of actin cytoskeleton
TTDI02249;hsa04912;GnRH signaling pathway
TTDI02249;hsa04915;Estrogen signaling pathway
TTDI02249;hsa04921;Oxytocin signaling pathway
TTDI02249;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDI02249;hsa05160;Hepatitis C
TTDI02249;hsa05200;Pathways in cancer
TTDI02249;hsa05205;Proteoglycans in cancer
TTDI02249;hsa05206;MicroRNAs in cancer
TTDI02249;hsa05212;Pancreatic cancer
TTDI02249;hsa05213;Endometrial cancer
TTDI02249;hsa05214;Glioma
TTDI02249;hsa05215;Prostate cancer
TTDI02249;hsa05218;Melanoma
TTDI02249;hsa05219;Bladder cancer
TTDI02249;hsa05223;Non-small cell lung cancer
TTDI02249;hsa05230;Central carbon metabolism in cancer
TTDI02249;hsa05231;Choline metabolism in cancer
TTDI02256;hsa04020;Calcium signaling pathway
TTDI02256;hsa04022;cGMP-PKG signaling pathway
TTDI02256;hsa04024;cAMP signaling pathway
TTDI02256;hsa04080;Neuroactive ligand-receptor interaction
TTDI02256;hsa04144;Endocytosis
TTDI02256;hsa04261;Adrenergic signaling in cardiomyocytes
TTDI02256;hsa04970;Salivary secretion
TTDI02258;hsa04010;MAPK signaling pathway
TTDI02258;hsa04014;Ras signaling pathway
TTDI02258;hsa04024;cAMP signaling pathway
TTDI02258;hsa04062;Chemokine signaling pathway
TTDI02258;hsa04064;NF-kappa B signaling pathway
TTDI02258;hsa04066;HIF-1 signaling pathway
TTDI02258;hsa04071;Sphingolipid signaling pathway
TTDI02258;hsa04151;PI3K-Akt signaling pathway
TTDI02258;hsa04210;Apoptosis
TTDI02258;hsa04380;Osteoclast differentiation
TTDI02258;hsa04620;Toll-like receptor signaling pathway
TTDI02258;hsa04621;NOD-like receptor signaling pathway
TTDI02258;hsa04622;RIG-I-like receptor signaling pathway
TTDI02258;hsa04623;Cytosolic DNA-sensing pathway
TTDI02258;hsa04660;T cell receptor signaling pathway
TTDI02258;hsa04662;B cell receptor signaling pathway
TTDI02258;hsa04668;TNF signaling pathway
TTDI02258;hsa04722;Neurotrophin signaling pathway
TTDI02258;hsa04917;Prolactin signaling pathway
TTDI02258;hsa04920;Adipocytokine signaling pathway
TTDI02258;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDI02258;hsa05030;Cocaine addiction
TTDI02258;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDI02258;hsa05131;Shigellosis
TTDI02258;hsa05132;Salmonella infection
TTDI02258;hsa05133;Pertussis
TTDI02258;hsa05134;Legionellosis
TTDI02258;hsa05140;Leishmaniasis
TTDI02258;hsa05142;Chagas disease (American trypanosomiasis)
TTDI02258;hsa05145;Toxoplasmosis
TTDI02258;hsa05146;Amoebiasis
TTDI02258;hsa05152;Tuberculosis
TTDI02258;hsa05160;Hepatitis C
TTDI02258;hsa05161;Hepatitis B
TTDI02258;hsa05162;Measles
TTDI02258;hsa05164;Influenza A
TTDI02258;hsa05166;HTLV-I infection
TTDI02258;hsa05168;Herpes simplex infection
TTDI02258;hsa05169;Epstein-Barr virus infection
TTDI02258;hsa05200;Pathways in cancer
TTDI02258;hsa05202;Transcriptional misregulation in cancer
TTDI02258;hsa05203;Viral carcinogenesis
TTDI02258;hsa05206;MicroRNAs in cancer
TTDI02258;hsa05212;Pancreatic cancer
TTDI02258;hsa05215;Prostate cancer
TTDI02258;hsa05220;Chronic myeloid leukemia
TTDI02258;hsa05221;Acute myeloid leukemia
TTDI02258;hsa05222;Small cell lung cancer
TTDI02258;hsa05321;Inflammatory bowel disease (IBD)
TTDI02259;hsa00230;Purine metabolism
TTDI02259;hsa00240;Pyrimidine metabolism
TTDI02259;hsa00480;Glutathione metabolism
TTDI02259;hsa01100;Metabolic pathways
TTDI02259;hsa04115;p53 signaling pathway
TTDI02260;hsa04064;NF-kappa B signaling pathway
TTDI02260;hsa04066;HIF-1 signaling pathway
TTDI02260;hsa04071;Sphingolipid signaling pathway
TTDI02260;hsa04141;Protein processing in endoplasmic reticulum
TTDI02260;hsa04151;PI3K-Akt signaling pathway
TTDI02260;hsa04210;Apoptosis
TTDI02260;hsa04261;Adrenergic signaling in cardiomyocytes
TTDI02260;hsa04510;Focal adhesion
TTDI02260;hsa04722;Neurotrophin signaling pathway
TTDI02260;hsa04725;Cholinergic synapse
TTDI02260;hsa05014;Amyotrophic lateral sclerosis (ALS)
TTDI02260;hsa05145;Toxoplasmosis
TTDI02260;hsa05152;Tuberculosis
TTDI02260;hsa05161;Hepatitis B
TTDI02260;hsa05169;Epstein-Barr virus infection
TTDI02260;hsa05200;Pathways in cancer
TTDI02260;hsa05206;MicroRNAs in cancer
TTDI02260;hsa05210;Colorectal cancer
TTDI02260;hsa05215;Prostate cancer
TTDI02260;hsa05222;Small cell lung cancer
TTDI02261;hsa04610;Complement and coagulation cascades
TTDI02262;hsa00140;Steroid hormone biosynthesis
TTDI02262;hsa00591;Linoleic acid metabolism
TTDI02262;hsa00830;Retinol metabolism
TTDI02262;hsa00980;Metabolism of xenobiotics by cytochrome P450
TTDI02262;hsa00982;Drug metabolism - cytochrome P450
TTDI02262;hsa00983;Drug metabolism - other enzymes
TTDI02262;hsa01100;Metabolic pathways
TTDI02262;hsa04976;Bile secretion
TTDI02262;hsa05204;Chemical carcinogenesis
TTDI02268;hsa04010;MAPK signaling pathway
TTDI02268;hsa04012;ErbB signaling pathway
TTDI02268;hsa04110;Cell cycle
TTDI02268;hsa04151;PI3K-Akt signaling pathway
TTDI02268;hsa04310;Wnt signaling pathway
TTDI02268;hsa04350;TGF-beta signaling pathway
TTDI02268;hsa04390;Hippo signaling pathway
TTDI02268;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDI02268;hsa04630;Jak-STAT signaling pathway
TTDI02268;hsa04919;Thyroid hormone signaling pathway
TTDI02268;hsa05161;Hepatitis B
TTDI02268;hsa05166;HTLV-I infection
TTDI02268;hsa05169;Epstein-Barr virus infection
TTDI02268;hsa05200;Pathways in cancer
TTDI02268;hsa05202;Transcriptional misregulation in cancer
TTDI02268;hsa05205;Proteoglycans in cancer
TTDI02268;hsa05206;MicroRNAs in cancer
TTDI02268;hsa05210;Colorectal cancer
TTDI02268;hsa05213;Endometrial cancer
TTDI02268;hsa05216;Thyroid cancer
TTDI02268;hsa05219;Bladder cancer
TTDI02268;hsa05220;Chronic myeloid leukemia
TTDI02268;hsa05221;Acute myeloid leukemia
TTDI02268;hsa05222;Small cell lung cancer
TTDI02268;hsa05230;Central carbon metabolism in cancer
TTDI02269;hsa04010;MAPK signaling pathway
TTDI02269;hsa05206;MicroRNAs in cancer
TTDI02271;hsa05223;Non-small cell lung cancer
TTDI02272;hsa00531;Glycosaminoglycan degradation
TTDI02272;hsa01100;Metabolic pathways
TTDI02272;hsa04142;Lysosome
TTDI02273;hsa04062;Chemokine signaling pathway
TTDI02273;hsa04064;NF-kappa B signaling pathway
TTDI02273;hsa04611;Platelet activation
TTDI02273;hsa04662;B cell receptor signaling pathway
TTDI02273;hsa04664;Fc epsilon RI signaling pathway
TTDI02273;hsa04666;Fc gamma R-mediated phagocytosis
TTDI02273;hsa04730;Long-term depression
TTDI02273;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDI02273;hsa05169;Epstein-Barr virus infection
TTDI02273;hsa05203;Viral carcinogenesis
TTDI02274;hsa04010;MAPK signaling pathway
TTDI02274;hsa04012;ErbB signaling pathway
TTDI02274;hsa04014;Ras signaling pathway
TTDI02274;hsa04015;Rap1 signaling pathway
TTDI02274;hsa04022;cGMP-PKG signaling pathway
TTDI02274;hsa04024;cAMP signaling pathway
TTDI02274;hsa04066;HIF-1 signaling pathway
TTDI02274;hsa04068;FoxO signaling pathway
TTDI02274;hsa04071;Sphingolipid signaling pathway
TTDI02274;hsa04151;PI3K-Akt signaling pathway
TTDI02274;hsa04270;Vascular smooth muscle contraction
TTDI02274;hsa04370;VEGF signaling pathway
TTDI02274;hsa04540;Gap junction
TTDI02274;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDI02274;hsa04620;Toll-like receptor signaling pathway
TTDI02274;hsa04650;Natural killer cell mediated cytotoxicity
TTDI02274;hsa04660;T cell receptor signaling pathway
TTDI02274;hsa04662;B cell receptor signaling pathway
TTDI02274;hsa04664;Fc epsilon RI signaling pathway
TTDI02274;hsa04720;Long-term potentiation
TTDI02274;hsa04722;Neurotrophin signaling pathway
TTDI02274;hsa04730;Long-term depression
TTDI02274;hsa04810;Regulation of actin cytoskeleton
TTDI02274;hsa04910;Insulin signaling pathway
TTDI02274;hsa04912;GnRH signaling pathway
TTDI02274;hsa04915;Estrogen signaling pathway
TTDI02274;hsa04916;Melanogenesis
TTDI02274;hsa04917;Prolactin signaling pathway
TTDI02274;hsa04919;Thyroid hormone signaling pathway
TTDI02274;hsa04921;Oxytocin signaling pathway
TTDI02274;hsa05020;Prion diseases
TTDI02274;hsa05161;Hepatitis B
TTDI02274;hsa05164;Influenza A
TTDI02274;hsa05200;Pathways in cancer
TTDI02274;hsa05205;Proteoglycans in cancer
TTDI02274;hsa05206;MicroRNAs in cancer
TTDI02274;hsa05211;Renal cell carcinoma
TTDI02274;hsa05213;Endometrial cancer
TTDI02274;hsa05214;Glioma
TTDI02274;hsa05215;Prostate cancer
TTDI02274;hsa05216;Thyroid cancer
TTDI02274;hsa05218;Melanoma
TTDI02274;hsa05219;Bladder cancer
TTDI02274;hsa05220;Chronic myeloid leukemia
TTDI02274;hsa05221;Acute myeloid leukemia
TTDI02274;hsa05223;Non-small cell lung cancer
TTDI02274;hsa05230;Central carbon metabolism in cancer
TTDI02274;hsa05231;Choline metabolism in cancer
TTDI02275;hsa00531;Glycosaminoglycan degradation
TTDI02275;hsa01100;Metabolic pathways
TTDI02275;hsa04142;Lysosome
TTDI02276;hsa04012;ErbB signaling pathway
TTDI02276;hsa04015;Rap1 signaling pathway
TTDI02276;hsa04062;Chemokine signaling pathway
TTDI02276;hsa04144;Endocytosis
TTDI02276;hsa04370;VEGF signaling pathway
TTDI02276;hsa04510;Focal adhesion
TTDI02276;hsa04520;Adherens junction
TTDI02276;hsa04530;Tight junction
TTDI02276;hsa04540;Gap junction
TTDI02276;hsa04611;Platelet activation
TTDI02276;hsa04727;GABAergic synapse
TTDI02276;hsa04750;Inflammatory mediator regulation of TRP channels
TTDI02276;hsa04810;Regulation of actin cytoskeleton
TTDI02276;hsa04912;GnRH signaling pathway
TTDI02276;hsa04915;Estrogen signaling pathway
TTDI02276;hsa04917;Prolactin signaling pathway
TTDI02276;hsa04919;Thyroid hormone signaling pathway
TTDI02276;hsa04921;Oxytocin signaling pathway
TTDI02276;hsa05100;Bacterial invasion of epithelial cells
TTDI02276;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDI02276;hsa05131;Shigellosis
TTDI02276;hsa05152;Tuberculosis
TTDI02276;hsa05161;Hepatitis B
TTDI02276;hsa05203;Viral carcinogenesis
TTDI02276;hsa05205;Proteoglycans in cancer
TTDI02277;hsa04071;Sphingolipid signaling pathway
TTDI02277;hsa04360;Axon guidance
TTDI02277;hsa04380;Osteoclast differentiation
TTDI02277;hsa04510;Focal adhesion
TTDI02277;hsa04520;Adherens junction
TTDI02277;hsa04611;Platelet activation
TTDI02277;hsa04650;Natural killer cell mediated cytotoxicity
TTDI02277;hsa04660;T cell receptor signaling pathway
TTDI02277;hsa04664;Fc epsilon RI signaling pathway
TTDI02277;hsa04725;Cholinergic synapse
TTDI02277;hsa05020;Prion diseases
TTDI02277;hsa05130;Pathogenic Escherichia coli infection
TTDI02277;hsa05162;Measles
TTDI02277;hsa05416;Viral myocarditis
TTDI02278;hsa04064;NF-kappa B signaling pathway
TTDI02278;hsa04380;Osteoclast differentiation
TTDI02278;hsa04650;Natural killer cell mediated cytotoxicity
TTDI02278;hsa04660;T cell receptor signaling pathway
TTDI02278;hsa05166;HTLV-I infection
TTDI02278;hsa05340;Primary immunodeficiency
TTDI02280;hsa04014;Ras signaling pathway
TTDI02280;hsa04015;Rap1 signaling pathway
TTDI02280;hsa04060;Cytokine-cytokine receptor interaction
TTDI02280;hsa04144;Endocytosis
TTDI02280;hsa04151;PI3K-Akt signaling pathway
TTDI02280;hsa04360;Axon guidance
TTDI02280;hsa04510;Focal adhesion
TTDI02280;hsa04520;Adherens junction
TTDI02280;hsa05100;Bacterial invasion of epithelial cells
TTDI02280;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDI02280;hsa05144;Malaria
TTDI02280;hsa05200;Pathways in cancer
TTDI02280;hsa05202;Transcriptional misregulation in cancer
TTDI02280;hsa05205;Proteoglycans in cancer
TTDI02280;hsa05206;MicroRNAs in cancer
TTDI02280;hsa05211;Renal cell carcinoma
TTDI02280;hsa05218;Melanoma
TTDI02280;hsa05230;Central carbon metabolism in cancer
TTDI02281;hsa04062;Chemokine signaling pathway
TTDI02281;hsa04151;PI3K-Akt signaling pathway
TTDI02281;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDI02281;hsa04630;Jak-STAT signaling pathway
TTDI02281;hsa05162;Measles
TTDI02281;hsa05166;HTLV-I infection
TTDI02281;hsa05169;Epstein-Barr virus infection
TTDI02281;hsa05203;Viral carcinogenesis
TTDI02281;hsa05340;Primary immunodeficiency
TTDI02282;hsa04014;Ras signaling pathway
TTDI02282;hsa04015;Rap1 signaling pathway
TTDI02282;hsa04060;Cytokine-cytokine receptor interaction
TTDI02282;hsa04144;Endocytosis
TTDI02282;hsa04151;PI3K-Akt signaling pathway
TTDI02282;hsa04370;VEGF signaling pathway
TTDI02282;hsa04510;Focal adhesion
TTDI02282;hsa05205;Proteoglycans in cancer
TTDI02283;hsa04012;ErbB signaling pathway
TTDI02283;hsa04020;Calcium signaling pathway
TTDI02283;hsa04066;HIF-1 signaling pathway
TTDI02283;hsa04510;Focal adhesion
TTDI02283;hsa04520;Adherens junction
TTDI02283;hsa05200;Pathways in cancer
TTDI02283;hsa05205;Proteoglycans in cancer
TTDI02283;hsa05206;MicroRNAs in cancer
TTDI02283;hsa05212;Pancreatic cancer
TTDI02283;hsa05213;Endometrial cancer
TTDI02283;hsa05215;Prostate cancer
TTDI02283;hsa05219;Bladder cancer
TTDI02283;hsa05223;Non-small cell lung cancer
TTDI02283;hsa05230;Central carbon metabolism in cancer
TTDI02284;hsa04010;MAPK signaling pathway
TTDI02284;hsa04012;ErbB signaling pathway
TTDI02284;hsa04015;Rap1 signaling pathway
TTDI02284;hsa04024;cAMP signaling pathway
TTDI02284;hsa04062;Chemokine signaling pathway
TTDI02284;hsa04068;FoxO signaling pathway
TTDI02284;hsa04150;mTOR signaling pathway
TTDI02284;hsa04270;Vascular smooth muscle contraction
TTDI02284;hsa04510;Focal adhesion
TTDI02284;hsa04650;Natural killer cell mediated cytotoxicity
TTDI02284;hsa04720;Long-term potentiation
TTDI02284;hsa04722;Neurotrophin signaling pathway
TTDI02284;hsa04726;Serotonergic synapse
TTDI02284;hsa04730;Long-term depression
TTDI02284;hsa04810;Regulation of actin cytoskeleton
TTDI02284;hsa04910;Insulin signaling pathway
TTDI02284;hsa04914;Progesterone-mediated oocyte maturation
TTDI02284;hsa05034;Alcoholism
TTDI02284;hsa05160;Hepatitis C
TTDI02284;hsa05200;Pathways in cancer
TTDI02284;hsa05205;Proteoglycans in cancer
TTDI02284;hsa05210;Colorectal cancer
TTDI02284;hsa05211;Renal cell carcinoma
TTDI02284;hsa05212;Pancreatic cancer
TTDI02284;hsa05213;Endometrial cancer
TTDI02284;hsa05214;Glioma
TTDI02284;hsa05215;Prostate cancer
TTDI02284;hsa05216;Thyroid cancer
TTDI02284;hsa05218;Melanoma
TTDI02284;hsa05219;Bladder cancer
TTDI02284;hsa05220;Chronic myeloid leukemia
TTDI02284;hsa05221;Acute myeloid leukemia
TTDI02284;hsa05223;Non-small cell lung cancer
TTDI02285;hsa04060;Cytokine-cytokine receptor interaction
TTDI02285;hsa04640;Hematopoietic cell lineage
TTDI02285;hsa05200;Pathways in cancer
TTDI02285;hsa05202;Transcriptional misregulation in cancer
TTDI02285;hsa05221;Acute myeloid leukemia
TTDI02285;hsa05230;Central carbon metabolism in cancer
TTDI02286;hsa00531;Glycosaminoglycan degradation
TTDI02286;hsa01100;Metabolic pathways
TTDI02286;hsa04142;Lysosome
TTDI02287;hsa04010;MAPK signaling pathway
TTDI02287;hsa04012;ErbB signaling pathway
TTDI02287;hsa04014;Ras signaling pathway
TTDI02287;hsa04015;Rap1 signaling pathway
TTDI02287;hsa04022;cGMP-PKG signaling pathway
TTDI02287;hsa04024;cAMP signaling pathway
TTDI02287;hsa04062;Chemokine signaling pathway
TTDI02287;hsa04068;FoxO signaling pathway
TTDI02287;hsa04071;Sphingolipid signaling pathway
TTDI02287;hsa04151;PI3K-Akt signaling pathway
TTDI02287;hsa04270;Vascular smooth muscle contraction
TTDI02287;hsa04370;VEGF signaling pathway
TTDI02287;hsa04510;Focal adhesion
TTDI02287;hsa04540;Gap junction
TTDI02287;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDI02287;hsa04650;Natural killer cell mediated cytotoxicity
TTDI02287;hsa04660;T cell receptor signaling pathway
TTDI02287;hsa04662;B cell receptor signaling pathway
TTDI02287;hsa04664;Fc epsilon RI signaling pathway
TTDI02287;hsa04666;Fc gamma R-mediated phagocytosis
TTDI02287;hsa04720;Long-term potentiation
TTDI02287;hsa04722;Neurotrophin signaling pathway
TTDI02287;hsa04726;Serotonergic synapse
TTDI02287;hsa04730;Long-term depression
TTDI02287;hsa04810;Regulation of actin cytoskeleton
TTDI02287;hsa04910;Insulin signaling pathway
TTDI02287;hsa04912;GnRH signaling pathway
TTDI02287;hsa04914;Progesterone-mediated oocyte maturation
TTDI02287;hsa04915;Estrogen signaling pathway
TTDI02287;hsa04916;Melanogenesis
TTDI02287;hsa04917;Prolactin signaling pathway
TTDI02287;hsa04919;Thyroid hormone signaling pathway
TTDI02287;hsa04921;Oxytocin signaling pathway
TTDI02287;hsa05034;Alcoholism
TTDI02287;hsa05152;Tuberculosis
TTDI02287;hsa05160;Hepatitis C
TTDI02287;hsa05161;Hepatitis B
TTDI02287;hsa05164;Influenza A
TTDI02287;hsa05200;Pathways in cancer
TTDI02287;hsa05205;Proteoglycans in cancer
TTDI02287;hsa05206;MicroRNAs in cancer
TTDI02287;hsa05210;Colorectal cancer
TTDI02287;hsa05211;Renal cell carcinoma
TTDI02287;hsa05212;Pancreatic cancer
TTDI02287;hsa05213;Endometrial cancer
TTDI02287;hsa05214;Glioma
TTDI02287;hsa05215;Prostate cancer
TTDI02287;hsa05218;Melanoma
TTDI02287;hsa05219;Bladder cancer
TTDI02287;hsa05220;Chronic myeloid leukemia
TTDI02287;hsa05221;Acute myeloid leukemia
TTDI02287;hsa05223;Non-small cell lung cancer
TTDI02287;hsa05230;Central carbon metabolism in cancer
TTDI02287;hsa05231;Choline metabolism in cancer
TTDI02290;hsa04144;Endocytosis
TTDI02290;hsa05200;Pathways in cancer
TTDI02290;hsa05216;Thyroid cancer
TTDI02290;hsa05230;Central carbon metabolism in cancer
TTDI02293;hsa00511;Other glycan degradation
TTDI02293;hsa04142;Lysosome
TTDI02294;hsa03013;RNA transport
TTDI02295;hsa00830;Retinol metabolism
TTDI02296;hsa04060;Cytokine-cytokine receptor interaction
TTDI02296;hsa04630;Jak-STAT signaling pathway
TTDI02297;hsa00562;Inositol phosphate metabolism
TTDI02297;hsa04012;ErbB signaling pathway
TTDI02297;hsa04014;Ras signaling pathway
TTDI02297;hsa04015;Rap1 signaling pathway
TTDI02297;hsa04022;cGMP-PKG signaling pathway
TTDI02297;hsa04024;cAMP signaling pathway
TTDI02297;hsa04062;Chemokine signaling pathway
TTDI02297;hsa04066;HIF-1 signaling pathway
TTDI02297;hsa04068;FoxO signaling pathway
TTDI02297;hsa04070;Phosphatidylinositol signaling system
TTDI02297;hsa04071;Sphingolipid signaling pathway
TTDI02297;hsa04150;mTOR signaling pathway
TTDI02297;hsa04151;PI3K-Akt signaling pathway
TTDI02297;hsa04152;AMPK signaling pathway
TTDI02297;hsa04210;Apoptosis
TTDI02297;hsa04261;Adrenergic signaling in cardiomyocytes
TTDI02297;hsa04370;VEGF signaling pathway
TTDI02297;hsa04380;Osteoclast differentiation
TTDI02297;hsa04510;Focal adhesion
TTDI02297;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDI02297;hsa04611;Platelet activation
TTDI02297;hsa04620;Toll-like receptor signaling pathway
TTDI02297;hsa04630;Jak-STAT signaling pathway
TTDI02297;hsa04650;Natural killer cell mediated cytotoxicity
TTDI02297;hsa04660;T cell receptor signaling pathway
TTDI02297;hsa04662;B cell receptor signaling pathway
TTDI02297;hsa04664;Fc epsilon RI signaling pathway
TTDI02297;hsa04666;Fc gamma R-mediated phagocytosis
TTDI02297;hsa04668;TNF signaling pathway
TTDI02297;hsa04670;Leukocyte transendothelial migration
TTDI02297;hsa04722;Neurotrophin signaling pathway
TTDI02297;hsa04725;Cholinergic synapse
TTDI02297;hsa04750;Inflammatory mediator regulation of TRP channels
TTDI02297;hsa04810;Regulation of actin cytoskeleton
TTDI02297;hsa04910;Insulin signaling pathway
TTDI02297;hsa04914;Progesterone-mediated oocyte maturation
TTDI02297;hsa04915;Estrogen signaling pathway
TTDI02297;hsa04917;Prolactin signaling pathway
TTDI02297;hsa04919;Thyroid hormone signaling pathway
TTDI02297;hsa04921;Oxytocin signaling pathway
TTDI02297;hsa04923;Regulation of lipolysis in adipocytes
TTDI02297;hsa04930;Type II diabetes mellitus
TTDI02297;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDI02297;hsa04960;Aldosterone-regulated sodium reabsorption
TTDI02297;hsa04973;Carbohydrate digestion and absorption
TTDI02297;hsa05100;Bacterial invasion of epithelial cells
TTDI02297;hsa05142;Chagas disease (American trypanosomiasis)
TTDI02297;hsa05145;Toxoplasmosis
TTDI02297;hsa05146;Amoebiasis
TTDI02297;hsa05160;Hepatitis C
TTDI02297;hsa05161;Hepatitis B
TTDI02297;hsa05162;Measles
TTDI02297;hsa05164;Influenza A
TTDI02297;hsa05166;HTLV-I infection
TTDI02297;hsa05169;Epstein-Barr virus infection
TTDI02297;hsa05200;Pathways in cancer
TTDI02297;hsa05203;Viral carcinogenesis
TTDI02297;hsa05205;Proteoglycans in cancer
TTDI02297;hsa05210;Colorectal cancer
TTDI02297;hsa05211;Renal cell carcinoma
TTDI02297;hsa05212;Pancreatic cancer
TTDI02297;hsa05213;Endometrial cancer
TTDI02297;hsa05214;Glioma
TTDI02297;hsa05215;Prostate cancer
TTDI02297;hsa05218;Melanoma
TTDI02297;hsa05220;Chronic myeloid leukemia
TTDI02297;hsa05221;Acute myeloid leukemia
TTDI02297;hsa05222;Small cell lung cancer
TTDI02297;hsa05223;Non-small cell lung cancer
TTDI02297;hsa05230;Central carbon metabolism in cancer
TTDI02297;hsa05231;Choline metabolism in cancer
TTDI02298;hsa04010;MAPK signaling pathway
TTDI02298;hsa04064;NF-kappa B signaling pathway
TTDI02298;hsa04380;Osteoclast differentiation
TTDI02298;hsa05134;Legionellosis
TTDI02298;hsa05166;HTLV-I infection
TTDI02298;hsa05169;Epstein-Barr virus infection
TTDI02298;hsa05200;Pathways in cancer
TTDI02298;hsa05203;Viral carcinogenesis
TTDI02299;hsa04022;cGMP-PKG signaling pathway
TTDI02299;hsa04068;FoxO signaling pathway
TTDI02299;hsa04150;mTOR signaling pathway
TTDI02299;hsa04151;PI3K-Akt signaling pathway
TTDI02299;hsa04152;AMPK signaling pathway
TTDI02299;hsa04722;Neurotrophin signaling pathway
TTDI02299;hsa04910;Insulin signaling pathway
TTDI02299;hsa04920;Adipocytokine signaling pathway
TTDI02299;hsa04930;Type II diabetes mellitus
TTDI02299;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDI02299;hsa04960;Aldosterone-regulated sodium reabsorption
TTDI02299;hsa05206;MicroRNAs in cancer
TTDI02300;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDI02300;hsa05412;Arrhythmogenic right ventricular cardiomyopathy (ARVC)
TTDI02300;hsa05414;Dilated cardiomyopathy
TTDI02300;hsa05416;Viral myocarditis
TTDI02301;hsa00190;Oxidative phosphorylation
TTDI02301;hsa01100;Metabolic pathways
TTDI02301;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDI02301;hsa05010;Alzheimer's disease
TTDI02301;hsa05012;Parkinson's disease
TTDI02301;hsa05016;Huntington's disease
TTDI02302;hsa04514;Cell adhesion molecules (CAMs)
TTDI02303;hsa00100;Steroid biosynthesis
TTDI02303;hsa04142;Lysosome
TTDI02304;sao00230;Purine metabolism
TTDI02304;sao00240;Pyrimidine metabolism
TTDI02304;sao01100;Metabolic pathways
TTDI02304;sao03020;RNA polymerase
TTDI02306;hsa04010;MAPK signaling pathway
TTDI02306;hsa04060;Cytokine-cytokine receptor interaction
TTDI02306;hsa04068;FoxO signaling pathway
TTDI02306;hsa04110;Cell cycle
TTDI02306;hsa04144;Endocytosis
TTDI02306;hsa04350;TGF-beta signaling pathway
TTDI02306;hsa04380;Osteoclast differentiation
TTDI02306;hsa04390;Hippo signaling pathway
TTDI02306;hsa05140;Leishmaniasis
TTDI02306;hsa05142;Chagas disease (American trypanosomiasis)
TTDI02306;hsa05144;Malaria
TTDI02306;hsa05145;Toxoplasmosis
TTDI02306;hsa05146;Amoebiasis
TTDI02306;hsa05152;Tuberculosis
TTDI02306;hsa05161;Hepatitis B
TTDI02306;hsa05166;HTLV-I infection
TTDI02306;hsa05200;Pathways in cancer
TTDI02306;hsa05205;Proteoglycans in cancer
TTDI02306;hsa05206;MicroRNAs in cancer
TTDI02306;hsa05210;Colorectal cancer
TTDI02306;hsa05211;Renal cell carcinoma
TTDI02306;hsa05212;Pancreatic cancer
TTDI02306;hsa05220;Chronic myeloid leukemia
TTDI02306;hsa05321;Inflammatory bowel disease (IBD)
TTDI02306;hsa05323;Rheumatoid arthritis
TTDI02306;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDI02306;hsa05414;Dilated cardiomyopathy
TTDI02308;hsa04390;Hippo signaling pathway
TTDI02308;hsa05161;Hepatitis B
TTDI02308;hsa05200;Pathways in cancer
TTDI02308;hsa05210;Colorectal cancer
TTDI02311;hsa04010;MAPK signaling pathway
TTDI02311;hsa04012;ErbB signaling pathway
TTDI02311;hsa04014;Ras signaling pathway
TTDI02311;hsa04015;Rap1 signaling pathway
TTDI02311;hsa04022;cGMP-PKG signaling pathway
TTDI02311;hsa04024;cAMP signaling pathway
TTDI02311;hsa04062;Chemokine signaling pathway
TTDI02311;hsa04066;HIF-1 signaling pathway
TTDI02311;hsa04068;FoxO signaling pathway
TTDI02311;hsa04071;Sphingolipid signaling pathway
TTDI02311;hsa04150;mTOR signaling pathway
TTDI02311;hsa04151;PI3K-Akt signaling pathway
TTDI02311;hsa04152;AMPK signaling pathway
TTDI02311;hsa04210;Apoptosis
TTDI02311;hsa04261;Adrenergic signaling in cardiomyocytes
TTDI02311;hsa04370;VEGF signaling pathway
TTDI02311;hsa04380;Osteoclast differentiation
TTDI02311;hsa04510;Focal adhesion
TTDI02311;hsa04530;Tight junction
TTDI02311;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDI02311;hsa04611;Platelet activation
TTDI02311;hsa04620;Toll-like receptor signaling pathway
TTDI02311;hsa04630;Jak-STAT signaling pathway
TTDI02311;hsa04660;T cell receptor signaling pathway
TTDI02311;hsa04662;B cell receptor signaling pathway
TTDI02311;hsa04664;Fc epsilon RI signaling pathway
TTDI02311;hsa04666;Fc gamma R-mediated phagocytosis
TTDI02311;hsa04668;TNF signaling pathway
TTDI02311;hsa04722;Neurotrophin signaling pathway
TTDI02311;hsa04725;Cholinergic synapse
TTDI02311;hsa04728;Dopaminergic synapse
TTDI02311;hsa04910;Insulin signaling pathway
TTDI02311;hsa04914;Progesterone-mediated oocyte maturation
TTDI02311;hsa04915;Estrogen signaling pathway
TTDI02311;hsa04917;Prolactin signaling pathway
TTDI02311;hsa04919;Thyroid hormone signaling pathway
TTDI02311;hsa04920;Adipocytokine signaling pathway
TTDI02311;hsa04922;Glucagon signaling pathway
TTDI02311;hsa04923;Regulation of lipolysis in adipocytes
TTDI02311;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDI02311;hsa04973;Carbohydrate digestion and absorption
TTDI02311;hsa05142;Chagas disease (American trypanosomiasis)
TTDI02311;hsa05145;Toxoplasmosis
TTDI02311;hsa05152;Tuberculosis
TTDI02311;hsa05160;Hepatitis C
TTDI02311;hsa05161;Hepatitis B
TTDI02311;hsa05162;Measles
TTDI02311;hsa05164;Influenza A
TTDI02311;hsa05166;HTLV-I infection
TTDI02311;hsa05169;Epstein-Barr virus infection
TTDI02311;hsa05200;Pathways in cancer
TTDI02311;hsa05205;Proteoglycans in cancer
TTDI02311;hsa05210;Colorectal cancer
TTDI02311;hsa05211;Renal cell carcinoma
TTDI02311;hsa05212;Pancreatic cancer
TTDI02311;hsa05213;Endometrial cancer
TTDI02311;hsa05214;Glioma
TTDI02311;hsa05215;Prostate cancer
TTDI02311;hsa05218;Melanoma
TTDI02311;hsa05220;Chronic myeloid leukemia
TTDI02311;hsa05221;Acute myeloid leukemia
TTDI02311;hsa05222;Small cell lung cancer
TTDI02311;hsa05223;Non-small cell lung cancer
TTDI02311;hsa05230;Central carbon metabolism in cancer
TTDI02311;hsa05231;Choline metabolism in cancer
TTDI02313;hsa04080;Neuroactive ligand-receptor interaction
TTDI02313;hsa04614;Renin-angiotensin system
TTDI02315;hsa04110;Cell cycle
TTDI02315;hsa04115;p53 signaling pathway
TTDI02315;hsa04151;PI3K-Akt signaling pathway
TTDI02315;hsa04530;Tight junction
TTDI02315;hsa04660;T cell receptor signaling pathway
TTDI02315;hsa05161;Hepatitis B
TTDI02315;hsa05162;Measles
TTDI02315;hsa05166;HTLV-I infection
TTDI02315;hsa05200;Pathways in cancer
TTDI02315;hsa05203;Viral carcinogenesis
TTDI02315;hsa05212;Pancreatic cancer
TTDI02315;hsa05214;Glioma
TTDI02315;hsa05218;Melanoma
TTDI02315;hsa05219;Bladder cancer
TTDI02315;hsa05220;Chronic myeloid leukemia
TTDI02315;hsa05222;Small cell lung cancer
TTDI02315;hsa05223;Non-small cell lung cancer
TTDI02316;hsa04110;Cell cycle
TTDI02316;hsa04115;p53 signaling pathway
TTDI02316;hsa04151;PI3K-Akt signaling pathway
TTDI02316;hsa05161;Hepatitis B
TTDI02316;hsa05162;Measles
TTDI02316;hsa05200;Pathways in cancer
TTDI02316;hsa05203;Viral carcinogenesis
TTDI02316;hsa05206;MicroRNAs in cancer
TTDI02316;hsa05212;Pancreatic cancer
TTDI02316;hsa05214;Glioma
TTDI02316;hsa05218;Melanoma
TTDI02316;hsa05220;Chronic myeloid leukemia
TTDI02316;hsa05222;Small cell lung cancer
TTDI02316;hsa05223;Non-small cell lung cancer
TTDI02317;hsa04010;MAPK signaling pathway
TTDI02317;hsa04014;Ras signaling pathway
TTDI02317;hsa04015;Rap1 signaling pathway
TTDI02317;hsa04060;Cytokine-cytokine receptor interaction
TTDI02317;hsa04151;PI3K-Akt signaling pathway
TTDI02317;hsa04510;Focal adhesion
TTDI02317;hsa04540;Gap junction
TTDI02317;hsa04810;Regulation of actin cytoskeleton
TTDI02317;hsa05166;HTLV-I infection
TTDI02317;hsa05200;Pathways in cancer
TTDI02317;hsa05206;MicroRNAs in cancer
TTDI02317;hsa05211;Renal cell carcinoma
TTDI02317;hsa05214;Glioma
TTDI02317;hsa05215;Prostate cancer
TTDI02317;hsa05218;Melanoma
TTDI02317;hsa05231;Choline metabolism in cancer
TTDI02318;hsa04060;Cytokine-cytokine receptor interaction
TTDI02318;hsa04630;Jak-STAT signaling pathway
TTDI02318;hsa04640;Hematopoietic cell lineage
TTDI02318;hsa04660;T cell receptor signaling pathway
TTDI02318;hsa04664;Fc epsilon RI signaling pathway
TTDI02318;hsa04672;Intestinal immune network for IgA production
TTDI02318;hsa05310;Asthma
TTDI02318;hsa05320;Autoimmune thyroid disease
TTDI02318;hsa05321;Inflammatory bowel disease (IBD)
TTDI02318;hsa05330;Allograft rejection
TTDI02320;hsa00250;Alanine, aspartate and glutamate metabolism
TTDI02320;hsa00410;beta-Alanine metabolism
TTDI02320;hsa00430;Taurine and hypotaurine metabolism
TTDI02320;hsa00650;Butanoate metabolism
TTDI02320;hsa01100;Metabolic pathways
TTDI02320;hsa04727;GABAergic synapse
TTDI02320;hsa04940;Type I diabetes mellitus
TTDI02321;hsa05166;HTLV-I infection
TTDI02323;hsa04010;MAPK signaling pathway
TTDI02323;hsa04014;Ras signaling pathway
TTDI02323;hsa04015;Rap1 signaling pathway
TTDI02323;hsa04151;PI3K-Akt signaling pathway
TTDI02323;hsa04810;Regulation of actin cytoskeleton
TTDI02323;hsa05200;Pathways in cancer
TTDI02323;hsa05218;Melanoma
TTDI02325;hsa04010;MAPK signaling pathway
TTDI02325;hsa04071;Sphingolipid signaling pathway
TTDI02325;hsa04110;Cell cycle
TTDI02325;hsa04115;p53 signaling pathway
TTDI02325;hsa04151;PI3K-Akt signaling pathway
TTDI02325;hsa04210;Apoptosis
TTDI02325;hsa04310;Wnt signaling pathway
TTDI02325;hsa04722;Neurotrophin signaling pathway
TTDI02325;hsa04919;Thyroid hormone signaling pathway
TTDI02325;hsa05014;Amyotrophic lateral sclerosis (ALS)
TTDI02325;hsa05016;Huntington's disease
TTDI02325;hsa05160;Hepatitis C
TTDI02325;hsa05161;Hepatitis B
TTDI02325;hsa05162;Measles
TTDI02325;hsa05166;HTLV-I infection
TTDI02325;hsa05168;Herpes simplex infection
TTDI02325;hsa05169;Epstein-Barr virus infection
TTDI02325;hsa05200;Pathways in cancer
TTDI02325;hsa05202;Transcriptional misregulation in cancer
TTDI02325;hsa05203;Viral carcinogenesis
TTDI02325;hsa05205;Proteoglycans in cancer
TTDI02325;hsa05206;MicroRNAs in cancer
TTDI02325;hsa05210;Colorectal cancer
TTDI02325;hsa05212;Pancreatic cancer
TTDI02325;hsa05213;Endometrial cancer
TTDI02325;hsa05214;Glioma
TTDI02325;hsa05215;Prostate cancer
TTDI02325;hsa05216;Thyroid cancer
TTDI02325;hsa05217;Basal cell carcinoma
TTDI02325;hsa05218;Melanoma
TTDI02325;hsa05219;Bladder cancer
TTDI02325;hsa05220;Chronic myeloid leukemia
TTDI02325;hsa05222;Small cell lung cancer
TTDI02325;hsa05223;Non-small cell lung cancer
TTDI02325;hsa05230;Central carbon metabolism in cancer
TTDI02326;hsa04060;Cytokine-cytokine receptor interaction
TTDI02327;hsa05010;Alzheimer's disease
TTDI02327;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDI02328;hsa04066;HIF-1 signaling pathway
TTDI02328;hsa04150;mTOR signaling pathway
TTDI02328;hsa04919;Thyroid hormone signaling pathway
TTDI02328;hsa05200;Pathways in cancer
TTDI02328;hsa05205;Proteoglycans in cancer
TTDI02328;hsa05211;Renal cell carcinoma
TTDI02328;hsa05230;Central carbon metabolism in cancer
TTDI02328;hsa05231;Choline metabolism in cancer
TTDI02330;hsa04610;Complement and coagulation cascades
TTDI02333;hsa04064;NF-kappa B signaling pathway
TTDI02333;hsa04120;Ubiquitin mediated proteolysis
TTDI02333;hsa04210;Apoptosis
TTDI02333;hsa04510;Focal adhesion
TTDI02333;hsa05145;Toxoplasmosis
TTDI02333;hsa05166;HTLV-I infection
TTDI02333;hsa05200;Pathways in cancer
TTDI02333;hsa05222;Small cell lung cancer
TTDI02334;hsa04146;Peroxisome
TTDI02334;hsa05014;Amyotrophic lateral sclerosis (ALS)
TTDI02334;hsa05016;Huntington's disease
TTDI02334;hsa05020;Prion diseases
TTDI02335;hsa04060;Cytokine-cytokine receptor interaction
TTDI02335;hsa04630;Jak-STAT signaling pathway
TTDI02336;hsa04060;Cytokine-cytokine receptor interaction
TTDI02336;hsa04630;Jak-STAT signaling pathway
TTDI02336;hsa05321;Inflammatory bowel disease (IBD)
TTDI02339;hsa04145;Phagosome
TTDI02339;hsa04514;Cell adhesion molecules (CAMs)
TTDI02339;hsa04612;Antigen processing and presentation
TTDI02339;hsa04640;Hematopoietic cell lineage
TTDI02339;hsa04672;Intestinal immune network for IgA production
TTDI02339;hsa04940;Type I diabetes mellitus
TTDI02339;hsa05140;Leishmaniasis
TTDI02339;hsa05145;Toxoplasmosis
TTDI02339;hsa05150;Staphylococcus aureus infection
TTDI02339;hsa05152;Tuberculosis
TTDI02339;hsa05164;Influenza A
TTDI02339;hsa05166;HTLV-I infection
TTDI02339;hsa05168;Herpes simplex infection
TTDI02339;hsa05169;Epstein-Barr virus infection
TTDI02339;hsa05310;Asthma
TTDI02339;hsa05320;Autoimmune thyroid disease
TTDI02339;hsa05321;Inflammatory bowel disease (IBD)
TTDI02339;hsa05322;Systemic lupus erythematosus
TTDI02339;hsa05323;Rheumatoid arthritis
TTDI02339;hsa05330;Allograft rejection
TTDI02339;hsa05332;Graft-versus-host disease
TTDI02339;hsa05416;Viral myocarditis
TTDI02342;hsa04024;cAMP signaling pathway
TTDI02342;hsa04080;Neuroactive ligand-receptor interaction
TTDI02344;hsa00230;Purine metabolism
TTDI02344;hsa00240;Pyrimidine metabolism
TTDI02344;hsa00480;Glutathione metabolism
TTDI02344;hsa01100;Metabolic pathways
TTDI02346;hsa05130;Pathogenic Escherichia coli infection
TTDI02348;hsa04610;Complement and coagulation cascades
TTDI02348;hsa05020;Prion diseases
TTDI02348;hsa05133;Pertussis
TTDI02348;hsa05142;Chagas disease (American trypanosomiasis)
TTDI02348;hsa05150;Staphylococcus aureus infection
TTDI02348;hsa05322;Systemic lupus erythematosus
TTDI02349;hsa00600;Sphingolipid metabolism
TTDI02349;hsa01100;Metabolic pathways
TTDI02349;hsa04071;Sphingolipid signaling pathway
TTDI02350;hsa00250;Alanine, aspartate and glutamate metabolism
TTDI02350;hsa00270;Cysteine and methionine metabolism
TTDI02350;hsa00330;Arginine and proline metabolism
TTDI02350;hsa00350;Tyrosine metabolism
TTDI02350;hsa00360;Phenylalanine metabolism
TTDI02350;hsa00400;Phenylalanine, tyrosine and tryptophan biosynthesis
TTDI02350;hsa01100;Metabolic pathways
TTDI02350;hsa01130;Biosynthesis of antibiotics
TTDI02350;hsa01200;Carbon metabolism
TTDI02350;hsa01210;2-Oxocarboxylic acid metabolism
TTDI02350;hsa01230;Biosynthesis of amino acids
TTDI02350;hsa04975;Fat digestion and absorption
TTDI02353;hsa04142;Lysosome
TTDI02354;hsa04610;Complement and coagulation cascades
TTDI02354;hsa05150;Staphylococcus aureus infection
TTDI02355;hsa04610;Complement and coagulation cascades
TTDI02355;hsa05150;Staphylococcus aureus infection
TTDI02356;hsa00520;Amino sugar and nucleotide sugar metabolism
TTDI02358;hsa04062;Chemokine signaling pathway
TTDI02358;hsa04728;Dopaminergic synapse
TTDI02358;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDI02359;hsa00860;Porphyrin and chlorophyll metabolism
TTDI02359;hsa01100;Metabolic pathways
TTDI02360;hsa04151;PI3K-Akt signaling pathway
TTDI02360;hsa04510;Focal adhesion
TTDI02360;hsa04512;ECM-receptor interaction
TTDI02360;hsa05145;Toxoplasmosis
TTDI02360;hsa05146;Amoebiasis
TTDI02360;hsa05200;Pathways in cancer
TTDI02360;hsa05222;Small cell lung cancer
TTDI02361;hsa04060;Cytokine-cytokine receptor interaction
TTDI02361;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDI02361;hsa04630;Jak-STAT signaling pathway
TTDI02362;hsa04610;Complement and coagulation cascades
TTDI02362;hsa05162;Measles
TTDI02363;hsa04010;MAPK signaling pathway
TTDI02363;hsa04722;Neurotrophin signaling pathway
TTDI02364;hsa00260;Glycine, serine and threonine metabolism
TTDI02364;hsa00330;Arginine and proline metabolism
TTDI02364;hsa00472;D-Arginine and D-ornithine metabolism
TTDI02364;hsa01100;Metabolic pathways
TTDI02364;hsa01130;Biosynthesis of antibiotics
TTDI02364;hsa04146;Peroxisome
TTDI02365;hsa04010;MAPK signaling pathway
TTDI02365;hsa04014;Ras signaling pathway
TTDI02365;hsa04015;Rap1 signaling pathway
TTDI02365;hsa04024;cAMP signaling pathway
TTDI02365;hsa04062;Chemokine signaling pathway
TTDI02365;hsa04071;Sphingolipid signaling pathway
TTDI02365;hsa04145;Phagosome
TTDI02365;hsa04151;PI3K-Akt signaling pathway
TTDI02365;hsa04310;Wnt signaling pathway
TTDI02365;hsa04360;Axon guidance
TTDI02365;hsa04370;VEGF signaling pathway
TTDI02365;hsa04380;Osteoclast differentiation
TTDI02365;hsa04510;Focal adhesion
TTDI02365;hsa04520;Adherens junction
TTDI02365;hsa04620;Toll-like receptor signaling pathway
TTDI02365;hsa04650;Natural killer cell mediated cytotoxicity
TTDI02365;hsa04662;B cell receptor signaling pathway
TTDI02365;hsa04664;Fc epsilon RI signaling pathway
TTDI02365;hsa04666;Fc gamma R-mediated phagocytosis
TTDI02365;hsa04670;Leukocyte transendothelial migration
TTDI02365;hsa04722;Neurotrophin signaling pathway
TTDI02365;hsa04810;Regulation of actin cytoskeleton
TTDI02365;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDI02365;hsa04972;Pancreatic secretion
TTDI02365;hsa05014;Amyotrophic lateral sclerosis (ALS)
TTDI02365;hsa05100;Bacterial invasion of epithelial cells
TTDI02365;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDI02365;hsa05131;Shigellosis
TTDI02365;hsa05132;Salmonella infection
TTDI02365;hsa05200;Pathways in cancer
TTDI02365;hsa05203;Viral carcinogenesis
TTDI02365;hsa05205;Proteoglycans in cancer
TTDI02365;hsa05210;Colorectal cancer
TTDI02365;hsa05211;Renal cell carcinoma
TTDI02365;hsa05212;Pancreatic cancer
TTDI02365;hsa05231;Choline metabolism in cancer
TTDI02365;hsa05416;Viral myocarditis
TTDI02368;hsa00250;Alanine, aspartate and glutamate metabolism
TTDI02368;hsa00260;Glycine, serine and threonine metabolism
TTDI02368;hsa00630;Glyoxylate and dicarboxylate metabolism
TTDI02368;hsa01100;Metabolic pathways
TTDI02368;hsa01130;Biosynthesis of antibiotics
TTDI02368;hsa01200;Carbon metabolism
TTDI02368;hsa04146;Peroxisome
TTDI02371;hsa04014;Ras signaling pathway
TTDI02371;hsa04064;NF-kappa B signaling pathway
TTDI02371;hsa04650;Natural killer cell mediated cytotoxicity
TTDI02371;hsa04660;T cell receptor signaling pathway
TTDI02371;hsa05340;Primary immunodeficiency
TTDI02372;hsa04141;Protein processing in endoplasmic reticulum
TTDI02372;hsa05203;Viral carcinogenesis
TTDI02372;hsa05206;MicroRNAs in cancer
TTDI02373;hsa04066;HIF-1 signaling pathway
TTDI02373;hsa04978;Mineral absorption
TTDI02374;hsa00510;N-Glycan biosynthesis
TTDI02374;hsa01100;Metabolic pathways
TTDI02375;hsa05168;Herpes simplex infection
TTDI02377;hsa04360;Axon guidance
TTDI02380;hsa04010;MAPK signaling pathway
TTDI02380;hsa04060;Cytokine-cytokine receptor interaction
TTDI02380;hsa04064;NF-kappa B signaling pathway
TTDI02380;hsa04071;Sphingolipid signaling pathway
TTDI02380;hsa04150;mTOR signaling pathway
TTDI02380;hsa04210;Apoptosis
TTDI02380;hsa04350;TGF-beta signaling pathway
TTDI02380;hsa04380;Osteoclast differentiation
TTDI02380;hsa04612;Antigen processing and presentation
TTDI02380;hsa04620;Toll-like receptor signaling pathway
TTDI02380;hsa04621;NOD-like receptor signaling pathway
TTDI02380;hsa04622;RIG-I-like receptor signaling pathway
TTDI02380;hsa04640;Hematopoietic cell lineage
TTDI02380;hsa04650;Natural killer cell mediated cytotoxicity
TTDI02380;hsa04660;T cell receptor signaling pathway
TTDI02380;hsa04664;Fc epsilon RI signaling pathway
TTDI02380;hsa04668;TNF signaling pathway
TTDI02380;hsa04920;Adipocytokine signaling pathway
TTDI02380;hsa04930;Type II diabetes mellitus
TTDI02380;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDI02380;hsa04940;Type I diabetes mellitus
TTDI02380;hsa05010;Alzheimer's disease
TTDI02380;hsa05014;Amyotrophic lateral sclerosis (ALS)
TTDI02380;hsa05133;Pertussis
TTDI02380;hsa05134;Legionellosis
TTDI02380;hsa05140;Leishmaniasis
TTDI02380;hsa05142;Chagas disease (American trypanosomiasis)
TTDI02380;hsa05143;African trypanosomiasis
TTDI02380;hsa05144;Malaria
TTDI02380;hsa05145;Toxoplasmosis
TTDI02380;hsa05146;Amoebiasis
TTDI02380;hsa05152;Tuberculosis
TTDI02380;hsa05160;Hepatitis C
TTDI02380;hsa05161;Hepatitis B
TTDI02380;hsa05164;Influenza A
TTDI02380;hsa05166;HTLV-I infection
TTDI02380;hsa05168;Herpes simplex infection
TTDI02380;hsa05205;Proteoglycans in cancer
TTDI02380;hsa05310;Asthma
TTDI02380;hsa05321;Inflammatory bowel disease (IBD)
TTDI02380;hsa05322;Systemic lupus erythematosus
TTDI02380;hsa05323;Rheumatoid arthritis
TTDI02380;hsa05330;Allograft rejection
TTDI02380;hsa05332;Graft-versus-host disease
TTDI02380;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDI02380;hsa05414;Dilated cardiomyopathy
TTDI02382;hsa04012;ErbB signaling pathway
TTDI02382;hsa04020;Calcium signaling pathway
TTDI02382;hsa04066;HIF-1 signaling pathway
TTDI02382;hsa04510;Focal adhesion
TTDI02382;hsa04520;Adherens junction
TTDI02382;hsa05200;Pathways in cancer
TTDI02382;hsa05205;Proteoglycans in cancer
TTDI02382;hsa05206;MicroRNAs in cancer
TTDI02382;hsa05212;Pancreatic cancer
TTDI02382;hsa05213;Endometrial cancer
TTDI02382;hsa05215;Prostate cancer
TTDI02382;hsa05219;Bladder cancer
TTDI02382;hsa05223;Non-small cell lung cancer
TTDI02382;hsa05230;Central carbon metabolism in cancer
TTDI02383;hsa04010;MAPK signaling pathway
TTDI02383;hsa04012;ErbB signaling pathway
TTDI02383;hsa04014;Ras signaling pathway
TTDI02383;hsa04015;Rap1 signaling pathway
TTDI02383;hsa04020;Calcium signaling pathway
TTDI02383;hsa04066;HIF-1 signaling pathway
TTDI02383;hsa04070;Phosphatidylinositol signaling system
TTDI02383;hsa04071;Sphingolipid signaling pathway
TTDI02383;hsa04150;mTOR signaling pathway
TTDI02383;hsa04151;PI3K-Akt signaling pathway
TTDI02383;hsa04261;Adrenergic signaling in cardiomyocytes
TTDI02383;hsa04270;Vascular smooth muscle contraction
TTDI02383;hsa04310;Wnt signaling pathway
TTDI02383;hsa04370;VEGF signaling pathway
TTDI02383;hsa04510;Focal adhesion
TTDI02383;hsa04530;Tight junction
TTDI02383;hsa04540;Gap junction
TTDI02383;hsa04650;Natural killer cell mediated cytotoxicity
TTDI02383;hsa04664;Fc epsilon RI signaling pathway
TTDI02383;hsa04666;Fc gamma R-mediated phagocytosis
TTDI02383;hsa04670;Leukocyte transendothelial migration
TTDI02383;hsa04713;Circadian entrainment
TTDI02383;hsa04720;Long-term potentiation
TTDI02383;hsa04723;Retrograde endocannabinoid signaling
TTDI02383;hsa04724;Glutamatergic synapse
TTDI02383;hsa04725;Cholinergic synapse
TTDI02383;hsa04726;Serotonergic synapse
TTDI02383;hsa04727;GABAergic synapse
TTDI02383;hsa04728;Dopaminergic synapse
TTDI02383;hsa04730;Long-term depression
TTDI02383;hsa04750;Inflammatory mediator regulation of TRP channels
TTDI02383;hsa04911;Insulin secretion
TTDI02383;hsa04912;GnRH signaling pathway
TTDI02383;hsa04916;Melanogenesis
TTDI02383;hsa04918;Thyroid hormone synthesis
TTDI02383;hsa04919;Thyroid hormone signaling pathway
TTDI02383;hsa04921;Oxytocin signaling pathway
TTDI02383;hsa04960;Aldosterone-regulated sodium reabsorption
TTDI02383;hsa04961;Endocrine and other factor-regulated calcium reabsorption
TTDI02383;hsa04970;Salivary secretion
TTDI02383;hsa04971;Gastric acid secretion
TTDI02383;hsa04972;Pancreatic secretion
TTDI02383;hsa05031;Amphetamine addiction
TTDI02383;hsa05032;Morphine addiction
TTDI02383;hsa05110;Vibrio cholerae infection
TTDI02383;hsa05130;Pathogenic Escherichia coli infection
TTDI02383;hsa05143;African trypanosomiasis
TTDI02383;hsa05146;Amoebiasis
TTDI02383;hsa05161;Hepatitis B
TTDI02383;hsa05164;Influenza A
TTDI02383;hsa05200;Pathways in cancer
TTDI02383;hsa05205;Proteoglycans in cancer
TTDI02383;hsa05206;MicroRNAs in cancer
TTDI02383;hsa05214;Glioma
TTDI02383;hsa05223;Non-small cell lung cancer
TTDI02383;hsa05231;Choline metabolism in cancer
TTDI02385;hsa04012;ErbB signaling pathway
TTDI02385;hsa04014;Ras signaling pathway
TTDI02385;hsa04110;Cell cycle
TTDI02385;hsa04360;Axon guidance
TTDI02385;hsa04722;Neurotrophin signaling pathway
TTDI02385;hsa05130;Pathogenic Escherichia coli infection
TTDI02385;hsa05131;Shigellosis
TTDI02385;hsa05200;Pathways in cancer
TTDI02385;hsa05206;MicroRNAs in cancer
TTDI02385;hsa05220;Chronic myeloid leukemia
TTDI02385;hsa05416;Viral myocarditis
TTDI02392;hsa04115;p53 signaling pathway
TTDI02392;hsa04390;Hippo signaling pathway
TTDI02392;hsa05016;Huntington's disease
TTDI02392;hsa05162;Measles
TTDI02393;hsa04012;ErbB signaling pathway
TTDI02393;hsa04390;Hippo signaling pathway
TTDI02394;hsa04514;Cell adhesion molecules (CAMs)
TTDI02394;hsa04670;Leukocyte transendothelial migration
TTDI02394;hsa05144;Malaria
TTDI02395;hsa04010;MAPK signaling pathway
TTDI02395;hsa04014;Ras signaling pathway
TTDI02395;hsa04015;Rap1 signaling pathway
TTDI02395;hsa04151;PI3K-Akt signaling pathway
TTDI02395;hsa04810;Regulation of actin cytoskeleton
TTDI02395;hsa05200;Pathways in cancer
TTDI02395;hsa05218;Melanoma
TTDI02397;hsa04612;Antigen processing and presentation
TTDI02397;hsa04650;Natural killer cell mediated cytotoxicity
TTDI02397;hsa05332;Graft-versus-host disease
TTDI02398;hsa04514;Cell adhesion molecules (CAMs)
TTDI02398;hsa05169;Epstein-Barr virus infection
TTDI02402;hsa04742;Taste transduction
TTDI02405;hsa04530;Tight junction
TTDI02406;hsa04145;Phagosome
TTDI02406;hsa04540;Gap junction
TTDI02406;hsa05130;Pathogenic Escherichia coli infection
TTDI02409;hsa00240;Pyrimidine metabolism
TTDI02409;hsa00983;Drug metabolism - other enzymes
TTDI02409;hsa01100;Metabolic pathways
TTDI02410;hsa05020;Prion diseases
TTDI02411;hsa05134;Legionellosis
TTDI02412;hsa00240;Pyrimidine metabolism
TTDI02412;hsa00450;Selenocompound metabolism
TTDI02413;hsa05202;Transcriptional misregulation in cancer
TTDI02415;hsa05016;Huntington's disease
TTDI02416;hsa04310;Wnt signaling pathway
TTDI02419;hsa04012;ErbB signaling pathway
TTDI02419;hsa04120;Ubiquitin mediated proteolysis
TTDI02419;hsa04144;Endocytosis
TTDI02419;hsa04630;Jak-STAT signaling pathway
TTDI02419;hsa04660;T cell receptor signaling pathway
TTDI02419;hsa04910;Insulin signaling pathway
TTDI02419;hsa05100;Bacterial invasion of epithelial cells
TTDI02419;hsa05162;Measles
TTDI02419;hsa05200;Pathways in cancer
TTDI02419;hsa05205;Proteoglycans in cancer
TTDI02419;hsa05220;Chronic myeloid leukemia
TTDI02420;hsa00562;Inositol phosphate metabolism
TTDI02420;hsa01100;Metabolic pathways
TTDI02420;hsa04070;Phosphatidylinositol signaling system
TTDI02421;hsa04020;Calcium signaling pathway
TTDI02421;hsa04022;cGMP-PKG signaling pathway
TTDI02421;hsa04260;Cardiac muscle contraction
TTDI02421;hsa04261;Adrenergic signaling in cardiomyocytes
TTDI02421;hsa04961;Endocrine and other factor-regulated calcium reabsorption
TTDI02421;hsa04974;Protein digestion and absorption
TTDI02421;hsa04978;Mineral absorption
TTDI02421;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDI02421;hsa05412;Arrhythmogenic right ventricular cardiomyopathy (ARVC)
TTDI02421;hsa05414;Dilated cardiomyopathy
TTDI02422;hsa00561;Glycerolipid metabolism
TTDI02422;hsa01100;Metabolic pathways
TTDI02422;hsa04975;Fat digestion and absorption
TTDI02423;hsa04512;ECM-receptor interaction
TTDI02425;hsa04060;Cytokine-cytokine receptor interaction
TTDI02427;hsa04015;Rap1 signaling pathway
TTDI02427;hsa04145;Phagosome
TTDI02427;hsa04151;PI3K-Akt signaling pathway
TTDI02427;hsa04380;Osteoclast differentiation
TTDI02427;hsa04510;Focal adhesion
TTDI02427;hsa04512;ECM-receptor interaction
TTDI02427;hsa04611;Platelet activation
TTDI02427;hsa04640;Hematopoietic cell lineage
TTDI02427;hsa04810;Regulation of actin cytoskeleton
TTDI02427;hsa04919;Thyroid hormone signaling pathway
TTDI02427;hsa05205;Proteoglycans in cancer
TTDI02427;hsa05206;MicroRNAs in cancer
TTDI02427;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDI02427;hsa05412;Arrhythmogenic right ventricular cardiomyopathy (ARVC)
TTDI02427;hsa05414;Dilated cardiomyopathy
TTDI02429;hsa04350;TGF-beta signaling pathway
TTDI02432;hsa04970;Salivary secretion
TTDI02432;hsa05152;Tuberculosis
TTDI02433;hsa04066;HIF-1 signaling pathway
TTDI02433;hsa05200;Pathways in cancer
TTDI02433;hsa05211;Renal cell carcinoma
TTDI02434;hsa04145;Phagosome
TTDI02434;hsa05152;Tuberculosis
TTDI02435;hsa04012;ErbB signaling pathway
TTDI02435;hsa04120;Ubiquitin mediated proteolysis
TTDI02435;hsa04144;Endocytosis
TTDI02435;hsa04630;Jak-STAT signaling pathway
TTDI02435;hsa04660;T cell receptor signaling pathway
TTDI02435;hsa04910;Insulin signaling pathway
TTDI02435;hsa05100;Bacterial invasion of epithelial cells
TTDI02435;hsa05200;Pathways in cancer
TTDI02435;hsa05205;Proteoglycans in cancer
TTDI02435;hsa05220;Chronic myeloid leukemia
TTDI02436;hsa00350;Tyrosine metabolism
TTDI02436;hsa01100;Metabolic pathways
TTDI02436;hsa04918;Thyroid hormone synthesis
TTDI02436;hsa05320;Autoimmune thyroid disease
TTDI02437;hsa04020;Calcium signaling pathway
TTDI02437;hsa04022;cGMP-PKG signaling pathway
TTDI02437;hsa05012;Parkinson's disease
TTDI02437;hsa05016;Huntington's disease
TTDI02437;hsa05145;Toxoplasmosis
TTDI02438;hsa04022;cGMP-PKG signaling pathway
TTDI02439;hsa04152;AMPK signaling pathway
TTDI02439;hsa04920;Adipocytokine signaling pathway
TTDI02439;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDI02440;hsa04744;Phototransduction
TTDI02443;hsa04340;Hedgehog signaling pathway
TTDI02443;hsa04918;Thyroid hormone synthesis
TTDI02444;hsa04144;Endocytosis
TTDI02444;hsa04913;Ovarian steroidogenesis
TTDI02444;hsa04976;Bile secretion
TTDI02444;hsa05145;Toxoplasmosis
TTDI02444;hsa05160;Hepatitis C
TTDI02445;hsa04060;Cytokine-cytokine receptor interaction
TTDI02445;hsa04350;TGF-beta signaling pathway
TTDI02445;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDI02446;hsa05160;Hepatitis C
TTDI02446;hsa05164;Influenza A
TTDI02446;hsa05168;Herpes simplex infection
TTDI02447;hsa04010;MAPK signaling pathway
TTDI02447;hsa04014;Ras signaling pathway
TTDI02447;hsa04068;FoxO signaling pathway
TTDI02447;hsa05200;Pathways in cancer
TTDI02447;hsa05223;Non-small cell lung cancer
TTDI02450;hsa04810;Regulation of actin cytoskeleton
TTDI02453;hsa04022;cGMP-PKG signaling pathway
TTDI02453;hsa04068;FoxO signaling pathway
TTDI02453;hsa04150;mTOR signaling pathway
TTDI02453;hsa04151;PI3K-Akt signaling pathway
TTDI02453;hsa04152;AMPK signaling pathway
TTDI02453;hsa04722;Neurotrophin signaling pathway
TTDI02453;hsa04910;Insulin signaling pathway
TTDI02453;hsa04920;Adipocytokine signaling pathway
TTDI02453;hsa04930;Type II diabetes mellitus
TTDI02453;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDI02453;hsa04960;Aldosterone-regulated sodium reabsorption
TTDI02453;hsa05206;MicroRNAs in cancer
TTDI02454;hsa00230;Purine metabolism
TTDI02454;hsa04020;Calcium signaling pathway
TTDI02454;hsa05032;Morphine addiction
TTDI02455;hsa04970;Salivary secretion
TTDI02455;hsa04972;Pancreatic secretion
TTDI02455;hsa05110;Vibrio cholerae infection
TTDI02456;hsa04068;FoxO signaling pathway
TTDI02456;hsa05168;Herpes simplex infection
TTDI02456;hsa05169;Epstein-Barr virus infection
TTDI02456;hsa05203;Viral carcinogenesis
TTDI02457;hsa04144;Endocytosis
TTDI02458;hsa04750;Inflammatory mediator regulation of TRP channels
TTDI02463;hsa04115;p53 signaling pathway
TTDI02463;hsa04210;Apoptosis
TTDI02463;hsa04620;Toll-like receptor signaling pathway
TTDI02463;hsa04621;NOD-like receptor signaling pathway
TTDI02463;hsa04622;RIG-I-like receptor signaling pathway
TTDI02463;hsa04668;TNF signaling pathway
TTDI02463;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDI02463;hsa05010;Alzheimer's disease
TTDI02463;hsa05016;Huntington's disease
TTDI02463;hsa05134;Legionellosis
TTDI02463;hsa05142;Chagas disease (American trypanosomiasis)
TTDI02463;hsa05145;Toxoplasmosis
TTDI02463;hsa05152;Tuberculosis
TTDI02463;hsa05161;Hepatitis B
TTDI02463;hsa05168;Herpes simplex infection
TTDI02463;hsa05200;Pathways in cancer
TTDI02463;hsa05203;Viral carcinogenesis
TTDI02463;hsa05416;Viral myocarditis
TTDI02464;hsa04064;NF-kappa B signaling pathway
TTDI02464;hsa04210;Apoptosis
TTDI02464;hsa04668;TNF signaling pathway
TTDI02464;hsa05142;Chagas disease (American trypanosomiasis)
TTDI02465;hsa05034;Alcoholism
TTDI02465;hsa05169;Epstein-Barr virus infection
TTDI02465;hsa05203;Viral carcinogenesis
TTDI02465;hsa05206;MicroRNAs in cancer
TTDI02468;hsa04975;Fat digestion and absorption
TTDI02468;hsa04977;Vitamin digestion and absorption
TTDI02469;hsa04066;HIF-1 signaling pathway
TTDI02469;hsa04145;Phagosome
TTDI02469;hsa04380;Osteoclast differentiation
TTDI02469;hsa04670;Leukocyte transendothelial migration
TTDI02472;hsa04020;Calcium signaling pathway
TTDI02472;hsa04062;Chemokine signaling pathway
TTDI02472;hsa04650;Natural killer cell mediated cytotoxicity
TTDI02472;hsa04670;Leukocyte transendothelial migration
TTDI02472;hsa04912;GnRH signaling pathway
TTDI02472;hsa05161;Hepatitis B
TTDI02473;hsa00010;Glycolysis / Gluconeogenesis
TTDI02473;hsa00071;Fatty acid degradation
TTDI02473;hsa00350;Tyrosine metabolism
TTDI02473;hsa00830;Retinol metabolism
TTDI02473;hsa00980;Metabolism of xenobiotics by cytochrome P450
TTDI02473;hsa00982;Drug metabolism - cytochrome P450
TTDI02473;hsa01100;Metabolic pathways
TTDI02473;hsa05204;Chemical carcinogenesis
TTDI02475;hsa04080;Neuroactive ligand-receptor interaction
TTDI02476;hsa04010;MAPK signaling pathway
TTDI02476;hsa04014;Ras signaling pathway
TTDI02476;hsa04360;Axon guidance
TTDI02477;hsa04340;Hedgehog signaling pathway
TTDI02477;hsa04350;TGF-beta signaling pathway
TTDI02477;hsa04390;Hippo signaling pathway
TTDI02477;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDI02477;hsa04919;Thyroid hormone signaling pathway
TTDI02477;hsa05200;Pathways in cancer
TTDI02477;hsa05217;Basal cell carcinoma
TTDI02478;hsa04350;TGF-beta signaling pathway
TTDI02478;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDI02479;hsa04974;Protein digestion and absorption
TTDI02481;hsa04015;Rap1 signaling pathway
TTDI02482;hsa04068;FoxO signaling pathway
TTDI02484;hsa04610;Complement and coagulation cascades
TTDI02484;hsa05150;Staphylococcus aureus infection
TTDI02487;hsa04110;Cell cycle
TTDI02487;hsa04152;AMPK signaling pathway
TTDI02487;hsa04914;Progesterone-mediated oocyte maturation
TTDI02487;hsa05161;Hepatitis B
TTDI02487;hsa05169;Epstein-Barr virus infection
TTDI02487;hsa05203;Viral carcinogenesis
TTDI02489;hsa04024;cAMP signaling pathway
TTDI02489;hsa04066;HIF-1 signaling pathway
TTDI02489;hsa04068;FoxO signaling pathway
TTDI02489;hsa04110;Cell cycle
TTDI02489;hsa04310;Wnt signaling pathway
TTDI02489;hsa04330;Notch signaling pathway
TTDI02489;hsa04350;TGF-beta signaling pathway
TTDI02489;hsa04520;Adherens junction
TTDI02489;hsa04630;Jak-STAT signaling pathway
TTDI02489;hsa04720;Long-term potentiation
TTDI02489;hsa04916;Melanogenesis
TTDI02489;hsa04919;Thyroid hormone signaling pathway
TTDI02489;hsa04922;Glucagon signaling pathway
TTDI02489;hsa05016;Huntington's disease
TTDI02489;hsa05152;Tuberculosis
TTDI02489;hsa05161;Hepatitis B
TTDI02489;hsa05164;Influenza A
TTDI02489;hsa05166;HTLV-I infection
TTDI02489;hsa05168;Herpes simplex infection
TTDI02489;hsa05169;Epstein-Barr virus infection
TTDI02489;hsa05200;Pathways in cancer
TTDI02489;hsa05203;Viral carcinogenesis
TTDI02489;hsa05206;MicroRNAs in cancer
TTDI02489;hsa05211;Renal cell carcinoma
TTDI02489;hsa05215;Prostate cancer
TTDI02493;hsa04115;p53 signaling pathway
TTDI02493;hsa04151;PI3K-Akt signaling pathway
TTDI02493;hsa04210;Apoptosis
TTDI02493;hsa04370;VEGF signaling pathway
TTDI02493;hsa04919;Thyroid hormone signaling pathway
TTDI02493;hsa05010;Alzheimer's disease
TTDI02493;hsa05012;Parkinson's disease
TTDI02493;hsa05014;Amyotrophic lateral sclerosis (ALS)
TTDI02493;hsa05016;Huntington's disease
TTDI02493;hsa05134;Legionellosis
TTDI02493;hsa05145;Toxoplasmosis
TTDI02493;hsa05152;Tuberculosis
TTDI02493;hsa05161;Hepatitis B
TTDI02493;hsa05164;Influenza A
TTDI02493;hsa05200;Pathways in cancer
TTDI02493;hsa05210;Colorectal cancer
TTDI02493;hsa05212;Pancreatic cancer
TTDI02493;hsa05213;Endometrial cancer
TTDI02493;hsa05215;Prostate cancer
TTDI02493;hsa05222;Small cell lung cancer
TTDI02493;hsa05223;Non-small cell lung cancer
TTDI02493;hsa05416;Viral myocarditis
TTDI02495;hsa04080;Neuroactive ligand-receptor interaction
TTDI02495;hsa04724;Glutamatergic synapse
TTDI02495;hsa04742;Taste transduction
TTDI02496;hsa04080;Neuroactive ligand-receptor interaction
TTDI02496;hsa04724;Glutamatergic synapse
TTDI02497;hsa04014;Ras signaling pathway
TTDI02497;hsa04015;Rap1 signaling pathway
TTDI02497;hsa04020;Calcium signaling pathway
TTDI02497;hsa04024;cAMP signaling pathway
TTDI02497;hsa04080;Neuroactive ligand-receptor interaction
TTDI02497;hsa04713;Circadian entrainment
TTDI02497;hsa04720;Long-term potentiation
TTDI02497;hsa04724;Glutamatergic synapse
TTDI02497;hsa05010;Alzheimer's disease
TTDI02497;hsa05014;Amyotrophic lateral sclerosis (ALS)
TTDI02497;hsa05016;Huntington's disease
TTDI02497;hsa05030;Cocaine addiction
TTDI02497;hsa05031;Amphetamine addiction
TTDI02497;hsa05033;Nicotine addiction
TTDI02497;hsa05034;Alcoholism
TTDI02498;hsa04151;PI3K-Akt signaling pathway
TTDI02498;hsa04510;Focal adhesion
TTDI02498;hsa04512;ECM-receptor interaction
TTDI02498;hsa04810;Regulation of actin cytoskeleton
TTDI02498;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDI02498;hsa05412;Arrhythmogenic right ventricular cardiomyopathy (ARVC)
TTDI02498;hsa05414;Dilated cardiomyopathy
TTDI02500;hsa04514;Cell adhesion molecules (CAMs)
TTDI02501;hsa03320;PPAR signaling pathway
TTDI02501;hsa04510;Focal adhesion
TTDI02501;hsa05100;Bacterial invasion of epithelial cells
TTDI02501;hsa05213;Endometrial cancer
TTDI02503;hsa04060;Cytokine-cytokine receptor interaction
TTDI02503;hsa04144;Endocytosis
TTDI02503;hsa04151;PI3K-Akt signaling pathway
TTDI02503;hsa04630;Jak-STAT signaling pathway
TTDI02503;hsa05162;Measles
TTDI02503;hsa05166;HTLV-I infection
TTDI02503;hsa05321;Inflammatory bowel disease (IBD)
TTDI02503;hsa05340;Primary immunodeficiency
TTDI02505;hsa04350;TGF-beta signaling pathway
TTDI02505;hsa05205;Proteoglycans in cancer
TTDI02506;hsa04060;Cytokine-cytokine receptor interaction
TTDI02506;hsa04062;Chemokine signaling pathway
TTDI02506;hsa05202;Transcriptional misregulation in cancer
TTDI02507;hsa04060;Cytokine-cytokine receptor interaction
TTDI02507;hsa04062;Chemokine signaling pathway
TTDI02508;hsa04060;Cytokine-cytokine receptor interaction
TTDI02510;hsa04015;Rap1 signaling pathway
TTDI02510;hsa04080;Neuroactive ligand-receptor interaction
TTDI02510;hsa05150;Staphylococcus aureus infection
TTDI02516;hsa04024;cAMP signaling pathway
TTDI02518;hsa04015;Rap1 signaling pathway
TTDI02518;hsa04080;Neuroactive ligand-receptor interaction
TTDI02518;hsa04611;Platelet activation
TTDI02519;hsa04080;Neuroactive ligand-receptor interaction
TTDI02520;hsa04080;Neuroactive ligand-receptor interaction
TTDI02520;hsa04750;Inflammatory mediator regulation of TRP channels
TTDI02520;hsa05143;African trypanosomiasis
TTDI02522;hsa04071;Sphingolipid signaling pathway
TTDI02522;hsa04080;Neuroactive ligand-receptor interaction
TTDI02523;hsa04071;Sphingolipid signaling pathway
TTDI02523;hsa04080;Neuroactive ligand-receptor interaction
TTDI02524;hsa04024;cAMP signaling pathway
TTDI02524;hsa04080;Neuroactive ligand-receptor interaction
TTDI02528;hsa04060;Cytokine-cytokine receptor interaction
TTDI02528;hsa04064;NF-kappa B signaling pathway
TTDI02528;hsa04380;Osteoclast differentiation
TTDI02528;hsa04917;Prolactin signaling pathway
TTDI02528;hsa05323;Rheumatoid arthritis
TTDI02529;hsa04610;Complement and coagulation cascades
TTDI02529;hsa04640;Hematopoietic cell lineage
TTDI02530;hsa04024;cAMP signaling pathway
TTDI02533;hsa05200;Pathways in cancer
TTDI02533;hsa05215;Prostate cancer
TTDI02535;hsa04145;Phagosome
TTDI02535;hsa05152;Tuberculosis
TTDI02535;hsa05162;Measles
TTDI02539;hsa00590;Arachidonic acid metabolism
TTDI02539;hsa01100;Metabolic pathways
TTDI02541;hsa04620;Toll-like receptor signaling pathway
TTDI02541;hsa04622;RIG-I-like receptor signaling pathway
TTDI02541;hsa04623;Cytosolic DNA-sensing pathway
TTDI02541;hsa05160;Hepatitis C
TTDI02541;hsa05161;Hepatitis B
TTDI02541;hsa05162;Measles
TTDI02541;hsa05164;Influenza A
TTDI02541;hsa05168;Herpes simplex infection
TTDI02543;hsa04010;MAPK signaling pathway
TTDI02543;hsa04012;ErbB signaling pathway
TTDI02543;hsa04014;Ras signaling pathway
TTDI02543;hsa04024;cAMP signaling pathway
TTDI02543;hsa04068;FoxO signaling pathway
TTDI02543;hsa04071;Sphingolipid signaling pathway
TTDI02543;hsa04141;Protein processing in endoplasmic reticulum
TTDI02543;hsa04310;Wnt signaling pathway
TTDI02543;hsa04380;Osteoclast differentiation
TTDI02543;hsa04510;Focal adhesion
TTDI02543;hsa04620;Toll-like receptor signaling pathway
TTDI02543;hsa04621;NOD-like receptor signaling pathway
TTDI02543;hsa04622;RIG-I-like receptor signaling pathway
TTDI02543;hsa04664;Fc epsilon RI signaling pathway
TTDI02543;hsa04668;TNF signaling pathway
TTDI02543;hsa04722;Neurotrophin signaling pathway
TTDI02543;hsa04723;Retrograde endocannabinoid signaling
TTDI02543;hsa04728;Dopaminergic synapse
TTDI02543;hsa04750;Inflammatory mediator regulation of TRP channels
TTDI02543;hsa04910;Insulin signaling pathway
TTDI02543;hsa04912;GnRH signaling pathway
TTDI02543;hsa04914;Progesterone-mediated oocyte maturation
TTDI02543;hsa04917;Prolactin signaling pathway
TTDI02543;hsa04920;Adipocytokine signaling pathway
TTDI02543;hsa04930;Type II diabetes mellitus
TTDI02543;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDI02543;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDI02543;hsa05131;Shigellosis
TTDI02543;hsa05132;Salmonella infection
TTDI02543;hsa05133;Pertussis
TTDI02543;hsa05142;Chagas disease (American trypanosomiasis)
TTDI02543;hsa05145;Toxoplasmosis
TTDI02543;hsa05152;Tuberculosis
TTDI02543;hsa05160;Hepatitis C
TTDI02543;hsa05161;Hepatitis B
TTDI02543;hsa05164;Influenza A
TTDI02543;hsa05168;Herpes simplex infection
TTDI02543;hsa05169;Epstein-Barr virus infection
TTDI02543;hsa05200;Pathways in cancer
TTDI02543;hsa05210;Colorectal cancer
TTDI02543;hsa05212;Pancreatic cancer
TTDI02543;hsa05231;Choline metabolism in cancer
TTDI02544;hsa04064;NF-kappa B signaling pathway
TTDI02544;hsa04210;Apoptosis
TTDI02544;hsa04620;Toll-like receptor signaling pathway
TTDI02544;hsa04722;Neurotrophin signaling pathway
TTDI02544;hsa05133;Pertussis
TTDI02544;hsa05140;Leishmaniasis
TTDI02544;hsa05142;Chagas disease (American trypanosomiasis)
TTDI02544;hsa05145;Toxoplasmosis
TTDI02544;hsa05152;Tuberculosis
TTDI02544;hsa05162;Measles
TTDI02544;hsa05164;Influenza A
TTDI02546;hsa04010;MAPK signaling pathway
TTDI02546;hsa04014;Ras signaling pathway
TTDI02546;hsa04062;Chemokine signaling pathway
TTDI02546;hsa04064;NF-kappa B signaling pathway
TTDI02546;hsa04068;FoxO signaling pathway
TTDI02546;hsa04151;PI3K-Akt signaling pathway
TTDI02546;hsa04210;Apoptosis
TTDI02546;hsa04380;Osteoclast differentiation
TTDI02546;hsa04620;Toll-like receptor signaling pathway
TTDI02546;hsa04621;NOD-like receptor signaling pathway
TTDI02546;hsa04622;RIG-I-like receptor signaling pathway
TTDI02546;hsa04623;Cytosolic DNA-sensing pathway
TTDI02546;hsa04660;T cell receptor signaling pathway
TTDI02546;hsa04662;B cell receptor signaling pathway
TTDI02546;hsa04668;TNF signaling pathway
TTDI02546;hsa04920;Adipocytokine signaling pathway
TTDI02546;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDI02546;hsa05131;Shigellosis
TTDI02546;hsa05142;Chagas disease (American trypanosomiasis)
TTDI02546;hsa05145;Toxoplasmosis
TTDI02546;hsa05160;Hepatitis C
TTDI02546;hsa05161;Hepatitis B
TTDI02546;hsa05162;Measles
TTDI02546;hsa05166;HTLV-I infection
TTDI02546;hsa05168;Herpes simplex infection
TTDI02546;hsa05169;Epstein-Barr virus infection
TTDI02546;hsa05200;Pathways in cancer
TTDI02546;hsa05212;Pancreatic cancer
TTDI02546;hsa05215;Prostate cancer
TTDI02546;hsa05220;Chronic myeloid leukemia
TTDI02546;hsa05221;Acute myeloid leukemia
TTDI02546;hsa05222;Small cell lung cancer
TTDI02547;hsa04010;MAPK signaling pathway
TTDI02547;hsa04012;ErbB signaling pathway
TTDI02547;hsa04014;Ras signaling pathway
TTDI02547;hsa04015;Rap1 signaling pathway
TTDI02547;hsa04062;Chemokine signaling pathway
TTDI02547;hsa04068;FoxO signaling pathway
TTDI02547;hsa04071;Sphingolipid signaling pathway
TTDI02547;hsa04144;Endocytosis
TTDI02547;hsa04151;PI3K-Akt signaling pathway
TTDI02547;hsa04360;Axon guidance
TTDI02547;hsa04370;VEGF signaling pathway
TTDI02547;hsa04510;Focal adhesion
TTDI02547;hsa04530;Tight junction
TTDI02547;hsa04540;Gap junction
TTDI02547;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDI02547;hsa04650;Natural killer cell mediated cytotoxicity
TTDI02547;hsa04660;T cell receptor signaling pathway
TTDI02547;hsa04662;B cell receptor signaling pathway
TTDI02547;hsa04664;Fc epsilon RI signaling pathway
TTDI02547;hsa04720;Long-term potentiation
TTDI02547;hsa04722;Neurotrophin signaling pathway
TTDI02547;hsa04725;Cholinergic synapse
TTDI02547;hsa04726;Serotonergic synapse
TTDI02547;hsa04730;Long-term depression
TTDI02547;hsa04810;Regulation of actin cytoskeleton
TTDI02547;hsa04910;Insulin signaling pathway
TTDI02547;hsa04912;GnRH signaling pathway
TTDI02547;hsa04915;Estrogen signaling pathway
TTDI02547;hsa04916;Melanogenesis
TTDI02547;hsa04917;Prolactin signaling pathway
TTDI02547;hsa04919;Thyroid hormone signaling pathway
TTDI02547;hsa04921;Oxytocin signaling pathway
TTDI02547;hsa05034;Alcoholism
TTDI02547;hsa05160;Hepatitis C
TTDI02547;hsa05161;Hepatitis B
TTDI02547;hsa05166;HTLV-I infection
TTDI02547;hsa05200;Pathways in cancer
TTDI02547;hsa05203;Viral carcinogenesis
TTDI02547;hsa05205;Proteoglycans in cancer
TTDI02547;hsa05206;MicroRNAs in cancer
TTDI02547;hsa05211;Renal cell carcinoma
TTDI02547;hsa05213;Endometrial cancer
TTDI02547;hsa05214;Glioma
TTDI02547;hsa05215;Prostate cancer
TTDI02547;hsa05216;Thyroid cancer
TTDI02547;hsa05218;Melanoma
TTDI02547;hsa05219;Bladder cancer
TTDI02547;hsa05220;Chronic myeloid leukemia
TTDI02547;hsa05221;Acute myeloid leukemia
TTDI02547;hsa05223;Non-small cell lung cancer
TTDI02547;hsa05230;Central carbon metabolism in cancer
TTDI02547;hsa05231;Choline metabolism in cancer
TTDI02550;hsa04650;Natural killer cell mediated cytotoxicity
TTDI02550;hsa04940;Type I diabetes mellitus
TTDI02550;hsa05202;Transcriptional misregulation in cancer
TTDI02550;hsa05320;Autoimmune thyroid disease
TTDI02550;hsa05330;Allograft rejection
TTDI02550;hsa05332;Graft-versus-host disease
TTDI02551;hsa04961;Endocrine and other factor-regulated calcium reabsorption
TTDI02552;hsa04961;Endocrine and other factor-regulated calcium reabsorption
TTDI02553;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDI02553;hsa05202;Transcriptional misregulation in cancer
TTDI02553;hsa05206;MicroRNAs in cancer
TTDI02555;hsa00140;Steroid hormone biosynthesis
TTDI02555;hsa01100;Metabolic pathways
TTDI02555;hsa04913;Ovarian steroidogenesis
TTDI02556;hsa04310;Wnt signaling pathway
TTDI02556;hsa04340;Hedgehog signaling pathway
TTDI02556;hsa04390;Hippo signaling pathway
TTDI02556;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDI02556;hsa04916;Melanogenesis
TTDI02556;hsa05166;HTLV-I infection
TTDI02556;hsa05200;Pathways in cancer
TTDI02556;hsa05205;Proteoglycans in cancer
TTDI02556;hsa05217;Basal cell carcinoma
TTDI02557;hsa04310;Wnt signaling pathway
TTDI02557;hsa04340;Hedgehog signaling pathway
TTDI02557;hsa04390;Hippo signaling pathway
TTDI02557;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDI02557;hsa04916;Melanogenesis
TTDI02557;hsa05166;HTLV-I infection
TTDI02557;hsa05200;Pathways in cancer
TTDI02557;hsa05205;Proteoglycans in cancer
TTDI02557;hsa05217;Basal cell carcinoma
TTDI02559;hsa00300;Lysine biosynthesis
TTDI02559;hsa00310;Lysine degradation
TTDI02559;hsa00380;Tryptophan metabolism
TTDI02559;hsa01100;Metabolic pathways
TTDI02559;hsa01130;Biosynthesis of antibiotics
TTDI02559;hsa01210;2-Oxocarboxylic acid metabolism
TTDI02559;hsa01230;Biosynthesis of amino acids
TTDI02561;hsa04120;Ubiquitin mediated proteolysis
TTDI02561;hsa04141;Protein processing in endoplasmic reticulum
TTDI02562;hsa00910;Nitrogen metabolism
TTDI02562;hsa04964;Proximal tubule bicarbonate reclamation
TTDI02563;hsa00340;Histidine metabolism
TTDI02563;hsa01100;Metabolic pathways
TTDI02564;hsa04060;Cytokine-cytokine receptor interaction
TTDI02564;hsa04064;NF-kappa B signaling pathway
TTDI02564;hsa05168;Herpes simplex infection
TTDI02565;hsa04060;Cytokine-cytokine receptor interaction
TTDI02566;hsa04110;Cell cycle
TTDI02566;hsa04114;Oocyte meiosis
TTDI02566;hsa04151;PI3K-Akt signaling pathway
TTDI02566;hsa04390;Hippo signaling pathway
TTDI02566;hsa05169;Epstein-Barr virus infection
TTDI02566;hsa05203;Viral carcinogenesis
TTDI02567;hsa04068;FoxO signaling pathway
TTDI02567;hsa04152;AMPK signaling pathway
TTDI02567;hsa04910;Insulin signaling pathway
TTDI02567;hsa04919;Thyroid hormone signaling pathway
TTDI02567;hsa04922;Glucagon signaling pathway
TTDI02567;hsa05200;Pathways in cancer
TTDI02567;hsa05202;Transcriptional misregulation in cancer
TTDI02567;hsa05215;Prostate cancer
TTDI02568;hsa00350;Tyrosine metabolism
TTDI02568;hsa01100;Metabolic pathways
TTDI02568;hsa04916;Melanogenesis
TTDI02569;hsa00330;Arginine and proline metabolism
TTDI02569;hsa00480;Glutathione metabolism
TTDI02569;hsa01100;Metabolic pathways
TTDI02569;hsa01130;Biosynthesis of antibiotics
TTDI02570;hsa00051;Fructose and mannose metabolism
TTDI02570;hsa01100;Metabolic pathways
TTDI02571;hsa04727;GABAergic synapse
TTDI02572;hsa04640;Hematopoietic cell lineage
TTDI02575;hsa00900;Terpenoid backbone biosynthesis
TTDI02575;hsa01100;Metabolic pathways
TTDI02575;hsa01130;Biosynthesis of antibiotics
TTDI02578;hsa04115;p53 signaling pathway
TTDI02579;hsa04921;Oxytocin signaling pathway
TTDI02580;hsa04750;Inflammatory mediator regulation of TRP channels
TTDI02582;hsa04640;Hematopoietic cell lineage
TTDI02583;hsa04014;Ras signaling pathway
TTDI02583;hsa05200;Pathways in cancer
TTDI02583;hsa05212;Pancreatic cancer
TTDI02585;hsa02010;ABC transporters
TTDI02585;hsa04911;Insulin secretion
TTDI02585;hsa04930;Type II diabetes mellitus
TTDI02586;hsa05010;Alzheimer's disease
TTDI02587;hsa00240;Pyrimidine metabolism
TTDI02587;hsa01100;Metabolic pathways
TTDI02589;hsa04514;Cell adhesion molecules (CAMs)
TTDI02589;hsa04530;Tight junction
TTDI02589;hsa04670;Leukocyte transendothelial migration
TTDI02589;hsa05160;Hepatitis C
TTDI02590;hsa05034;Alcoholism
TTDI02590;hsa05203;Viral carcinogenesis
TTDI02591;hsa04742;Taste transduction
TTDI02591;hsa04750;Inflammatory mediator regulation of TRP channels
TTDI02592;hsa04750;Inflammatory mediator regulation of TRP channels
TTDI02593;hsa04713;Circadian entrainment
TTDI02593;hsa04723;Retrograde endocannabinoid signaling
TTDI02593;hsa04724;Glutamatergic synapse
TTDI02593;hsa04725;Cholinergic synapse
TTDI02593;hsa04726;Serotonergic synapse
TTDI02593;hsa04728;Dopaminergic synapse
TTDI02593;hsa04915;Estrogen signaling pathway
TTDI02593;hsa04921;Oxytocin signaling pathway
TTDI02593;hsa05032;Morphine addiction
TTDI02594;hsa04713;Circadian entrainment
TTDI02594;hsa04723;Retrograde endocannabinoid signaling
TTDI02594;hsa04726;Serotonergic synapse
TTDI02594;hsa04728;Dopaminergic synapse
TTDI02594;hsa04915;Estrogen signaling pathway
TTDI02594;hsa04921;Oxytocin signaling pathway
TTDI02594;hsa05032;Morphine addiction
TTDI02595;hsa00270;Cysteine and methionine metabolism
TTDI02595;hsa01100;Metabolic pathways
TTDI02598;hsa03430;Mismatch repair
TTDI02598;hsa03460;Fanconi anemia pathway
TTDI02598;hsa05200;Pathways in cancer
TTDI02598;hsa05210;Colorectal cancer
TTDI02598;hsa05213;Endometrial cancer
TTDI02599;hsa00590;Arachidonic acid metabolism
TTDI02599;hsa01100;Metabolic pathways
TTDI02600;hsa00860;Porphyrin and chlorophyll metabolism
TTDI02600;hsa04066;HIF-1 signaling pathway
TTDI02600;hsa04978;Mineral absorption
TTDI02600;hsa05206;MicroRNAs in cancer
TTDI02602;hsa04144;Endocytosis
TTDI02602;hsa04510;Focal adhesion
TTDI02602;hsa05100;Bacterial invasion of epithelial cells
TTDI02602;hsa05205;Proteoglycans in cancer
TTDI02602;hsa05416;Viral myocarditis
TTDI02604;hsa04142;Lysosome
TTDI02604;hsa04145;Phagosome
TTDI02604;hsa05152;Tuberculosis
TTDI02605;hsa00380;Tryptophan metabolism
TTDI02605;hsa01100;Metabolic pathways
TTDI02607;hsa04142;Lysosome
TTDI02607;hsa04978;Mineral absorption
TTDI02608;hsa00600;Sphingolipid metabolism
TTDI02608;hsa04071;Sphingolipid signaling pathway
TTDI02609;hsa04060;Cytokine-cytokine receptor interaction
TTDI02609;hsa04210;Apoptosis
TTDI02609;hsa04750;Inflammatory mediator regulation of TRP channels
TTDI02610;hsa04060;Cytokine-cytokine receptor interaction
TTDI02610;hsa05321;Inflammatory bowel disease (IBD)
TTDI02611;hsa04146;Peroxisome
TTDI02612;hsa04142;Lysosome
TTDI02612;hsa04612;Antigen processing and presentation
TTDI02613;hsa04066;HIF-1 signaling pathway
TTDI02613;hsa04120;Ubiquitin mediated proteolysis
TTDI02613;hsa05200;Pathways in cancer
TTDI02613;hsa05211;Renal cell carcinoma
TTDI02614;hsa00600;Sphingolipid metabolism
TTDI02614;hsa01100;Metabolic pathways
TTDI02614;hsa04142;Lysosome
TTDI02616;hsa04012;ErbB signaling pathway
TTDI02616;hsa04066;HIF-1 signaling pathway
TTDI02616;hsa04068;FoxO signaling pathway
TTDI02616;hsa04110;Cell cycle
TTDI02616;hsa04151;PI3K-Akt signaling pathway
TTDI02616;hsa05161;Hepatitis B
TTDI02616;hsa05162;Measles
TTDI02616;hsa05169;Epstein-Barr virus infection
TTDI02616;hsa05200;Pathways in cancer
TTDI02616;hsa05202;Transcriptional misregulation in cancer
TTDI02616;hsa05203;Viral carcinogenesis
TTDI02616;hsa05206;MicroRNAs in cancer
TTDI02616;hsa05215;Prostate cancer
TTDI02616;hsa05220;Chronic myeloid leukemia
TTDI02616;hsa05222;Small cell lung cancer
TTDI02617;hsa04975;Fat digestion and absorption
TTDI02620;hsa04971;Gastric acid secretion
TTDI02622;hsa05010;Alzheimer's disease
TTDI02622;hsa05030;Cocaine addiction
TTDI02623;hsa03015;mRNA surveillance pathway
TTDI02626;hsa04014;Ras signaling pathway
TTDI02626;hsa04015;Rap1 signaling pathway
TTDI02626;hsa04060;Cytokine-cytokine receptor interaction
TTDI02626;hsa04151;PI3K-Akt signaling pathway
TTDI02626;hsa04380;Osteoclast differentiation
TTDI02626;hsa04640;Hematopoietic cell lineage
TTDI02626;hsa04668;TNF signaling pathway
TTDI02626;hsa05323;Rheumatoid arthritis
TTDI02627;hsa00532;Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate
TTDI02627;hsa01100;Metabolic pathways
TTDI02630;hsa05206;MicroRNAs in cancer
TTDI02632;hsa04060;Cytokine-cytokine receptor interaction
TTDI02632;hsa04630;Jak-STAT signaling pathway
TTDI02635;hsa04514;Cell adhesion molecules (CAMs)
TTDI02635;hsa04530;Tight junction
TTDI02635;hsa04670;Leukocyte transendothelial migration
TTDI02635;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDI02638;hsa04514;Cell adhesion molecules (CAMs)
TTDI02639;hsa04010;MAPK signaling pathway
TTDI02639;hsa04064;NF-kappa B signaling pathway
TTDI02639;hsa04152;AMPK signaling pathway
TTDI02639;hsa04310;Wnt signaling pathway
TTDI02639;hsa04380;Osteoclast differentiation
TTDI02639;hsa04520;Adherens junction
TTDI02639;hsa04620;Toll-like receptor signaling pathway
TTDI02639;hsa04621;NOD-like receptor signaling pathway
TTDI02639;hsa04622;RIG-I-like receptor signaling pathway
TTDI02639;hsa04660;T cell receptor signaling pathway
TTDI02639;hsa04668;TNF signaling pathway
TTDI02639;hsa05140;Leishmaniasis
TTDI02639;hsa05145;Toxoplasmosis
TTDI02639;hsa05162;Measles
TTDI02639;hsa05168;Herpes simplex infection
TTDI02639;hsa05169;Epstein-Barr virus infection
TTDI02640;hsa04010;MAPK signaling pathway
TTDI02640;hsa04014;Ras signaling pathway
TTDI02640;hsa04015;Rap1 signaling pathway
TTDI02640;hsa04144;Endocytosis
TTDI02640;hsa04151;PI3K-Akt signaling pathway
TTDI02640;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDI02640;hsa04810;Regulation of actin cytoskeleton
TTDI02641;hsa03018;RNA degradation
TTDI02644;hsa04390;Hippo signaling pathway
TTDI02645;hsa05016;Huntington's disease
TTDI02646;hsa00561;Glycerolipid metabolism
TTDI02646;hsa01100;Metabolic pathways
TTDI02646;hsa04723;Retrograde endocannabinoid signaling
TTDI02647;hsa00531;Glycosaminoglycan degradation
TTDI02647;hsa01100;Metabolic pathways
TTDI02647;hsa04142;Lysosome
TTDI02648;hsa04640;Hematopoietic cell lineage
TTDI02649;hsa04060;Cytokine-cytokine receptor interaction
TTDI02649;hsa04630;Jak-STAT signaling pathway
TTDI02652;hsa04340;Hedgehog signaling pathway
TTDI02652;hsa04390;Hippo signaling pathway
TTDI02652;hsa05200;Pathways in cancer
TTDI02652;hsa05217;Basal cell carcinoma
TTDI02654;hsa04015;Rap1 signaling pathway
TTDI02654;hsa04350;TGF-beta signaling pathway
TTDI02654;hsa04390;Hippo signaling pathway
TTDI02654;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDI02655;hsa04622;RIG-I-like receptor signaling pathway
TTDI02657;hsa05016;Huntington's disease
TTDI02658;hsa04612;Antigen processing and presentation
TTDI02658;hsa05152;Tuberculosis
TTDI02658;hsa05168;Herpes simplex infection
TTDI02659;hsa04670;Leukocyte transendothelial migration
TTDI02659;hsa04912;GnRH signaling pathway
TTDI02659;hsa04915;Estrogen signaling pathway
TTDI02659;hsa05200;Pathways in cancer
TTDI02659;hsa05205;Proteoglycans in cancer
TTDI02659;hsa05219;Bladder cancer
TTDI02660;hsa04668;TNF signaling pathway
TTDI02660;hsa04670;Leukocyte transendothelial migration
TTDI02660;hsa04915;Estrogen signaling pathway
TTDI02660;hsa05161;Hepatitis B
TTDI02660;hsa05200;Pathways in cancer
TTDI02660;hsa05202;Transcriptional misregulation in cancer
TTDI02660;hsa05205;Proteoglycans in cancer
TTDI02660;hsa05206;MicroRNAs in cancer
TTDI02660;hsa05219;Bladder cancer
TTDI02661;hsa04115;p53 signaling pathway
TTDI02661;hsa04120;Ubiquitin mediated proteolysis
TTDI02662;hsa04146;Peroxisome
TTDI02662;hsa05014;Amyotrophic lateral sclerosis (ALS)
TTDI02662;hsa05016;Huntington's disease
TTDI02662;hsa05020;Prion diseases
TTDI02663;hsa05010;Alzheimer's disease
TTDI02663;hsa05012;Parkinson's disease
TTDI02664;hsa04080;Neuroactive ligand-receptor interaction
TTDI02664;hsa04750;Inflammatory mediator regulation of TRP channels
TTDI02665;hsa04014;Ras signaling pathway
TTDI02665;hsa04015;Rap1 signaling pathway
TTDI02665;hsa04060;Cytokine-cytokine receptor interaction
TTDI02665;hsa04066;HIF-1 signaling pathway
TTDI02665;hsa04144;Endocytosis
TTDI02665;hsa04151;PI3K-Akt signaling pathway
TTDI02665;hsa04510;Focal adhesion
TTDI02665;hsa05202;Transcriptional misregulation in cancer
TTDI02665;hsa05323;Rheumatoid arthritis
TTDI02666;hsa04110;Cell cycle
TTDI02677;hsa04610;Complement and coagulation cascades
TTDI02678;hsa04010;MAPK signaling pathway
TTDI02678;hsa04060;Cytokine-cytokine receptor interaction
TTDI02678;hsa04068;FoxO signaling pathway
TTDI02678;hsa04110;Cell cycle
TTDI02678;hsa04144;Endocytosis
TTDI02678;hsa04350;TGF-beta signaling pathway
TTDI02678;hsa04380;Osteoclast differentiation
TTDI02678;hsa04390;Hippo signaling pathway
TTDI02678;hsa04672;Intestinal immune network for IgA production
TTDI02678;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDI02678;hsa05140;Leishmaniasis
TTDI02678;hsa05142;Chagas disease (American trypanosomiasis)
TTDI02678;hsa05144;Malaria
TTDI02678;hsa05145;Toxoplasmosis
TTDI02678;hsa05146;Amoebiasis
TTDI02678;hsa05152;Tuberculosis
TTDI02678;hsa05161;Hepatitis B
TTDI02678;hsa05166;HTLV-I infection
TTDI02678;hsa05200;Pathways in cancer
TTDI02678;hsa05205;Proteoglycans in cancer
TTDI02678;hsa05210;Colorectal cancer
TTDI02678;hsa05211;Renal cell carcinoma
TTDI02678;hsa05212;Pancreatic cancer
TTDI02678;hsa05220;Chronic myeloid leukemia
TTDI02678;hsa05321;Inflammatory bowel disease (IBD)
TTDI02678;hsa05323;Rheumatoid arthritis
TTDI02678;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDI02678;hsa05414;Dilated cardiomyopathy
TTDI02680;hsa00670;One carbon pool by folate
TTDI02680;hsa01100;Metabolic pathways
TTDI02680;hsa01200;Carbon metabolism
TTDI02681;hsa04060;Cytokine-cytokine receptor interaction
TTDI02681;hsa04064;NF-kappa B signaling pathway
TTDI02681;hsa04514;Cell adhesion molecules (CAMs)
TTDI02681;hsa04660;T cell receptor signaling pathway
TTDI02681;hsa04672;Intestinal immune network for IgA production
TTDI02681;hsa05144;Malaria
TTDI02681;hsa05145;Toxoplasmosis
TTDI02681;hsa05310;Asthma
TTDI02681;hsa05320;Autoimmune thyroid disease
TTDI02681;hsa05322;Systemic lupus erythematosus
TTDI02681;hsa05330;Allograft rejection
TTDI02681;hsa05340;Primary immunodeficiency
TTDI02681;hsa05416;Viral myocarditis
TTDI02682;hsa04728;Dopaminergic synapse
TTDI02683;hsa00230;Purine metabolism
TTDI02683;hsa04022;cGMP-PKG signaling pathway
TTDI02683;hsa04024;cAMP signaling pathway
TTDI02683;hsa04270;Vascular smooth muscle contraction
TTDI02683;hsa04921;Oxytocin signaling pathway
TTDI02684;hsa04010;MAPK signaling pathway
TTDI02684;hsa04012;ErbB signaling pathway
TTDI02684;hsa04014;Ras signaling pathway
TTDI02684;hsa04015;Rap1 signaling pathway
TTDI02684;hsa04062;Chemokine signaling pathway
TTDI02684;hsa04068;FoxO signaling pathway
TTDI02684;hsa04071;Sphingolipid signaling pathway
TTDI02684;hsa04151;PI3K-Akt signaling pathway
TTDI02684;hsa04320;Dorso-ventral axis formation
TTDI02684;hsa04360;Axon guidance
TTDI02684;hsa04370;VEGF signaling pathway
TTDI02684;hsa04530;Tight junction
TTDI02684;hsa04540;Gap junction
TTDI02684;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDI02684;hsa04650;Natural killer cell mediated cytotoxicity
TTDI02684;hsa04660;T cell receptor signaling pathway
TTDI02684;hsa04662;B cell receptor signaling pathway
TTDI02684;hsa04664;Fc epsilon RI signaling pathway
TTDI02684;hsa04720;Long-term potentiation
TTDI02684;hsa04722;Neurotrophin signaling pathway
TTDI02684;hsa04725;Cholinergic synapse
TTDI02684;hsa04726;Serotonergic synapse
TTDI02684;hsa04730;Long-term depression
TTDI02684;hsa04810;Regulation of actin cytoskeleton
TTDI02684;hsa04910;Insulin signaling pathway
TTDI02684;hsa04912;GnRH signaling pathway
TTDI02684;hsa04914;Progesterone-mediated oocyte maturation
TTDI02684;hsa04915;Estrogen signaling pathway
TTDI02684;hsa04916;Melanogenesis
TTDI02684;hsa04917;Prolactin signaling pathway
TTDI02684;hsa04919;Thyroid hormone signaling pathway
TTDI02684;hsa04921;Oxytocin signaling pathway
TTDI02684;hsa04960;Aldosterone-regulated sodium reabsorption
TTDI02684;hsa05034;Alcoholism
TTDI02684;hsa05160;Hepatitis C
TTDI02684;hsa05161;Hepatitis B
TTDI02684;hsa05166;HTLV-I infection
TTDI02684;hsa05200;Pathways in cancer
TTDI02684;hsa05203;Viral carcinogenesis
TTDI02684;hsa05205;Proteoglycans in cancer
TTDI02684;hsa05206;MicroRNAs in cancer
TTDI02684;hsa05210;Colorectal cancer
TTDI02684;hsa05211;Renal cell carcinoma
TTDI02684;hsa05212;Pancreatic cancer
TTDI02684;hsa05213;Endometrial cancer
TTDI02684;hsa05214;Glioma
TTDI02684;hsa05215;Prostate cancer
TTDI02684;hsa05216;Thyroid cancer
TTDI02684;hsa05218;Melanoma
TTDI02684;hsa05219;Bladder cancer
TTDI02684;hsa05220;Chronic myeloid leukemia
TTDI02684;hsa05221;Acute myeloid leukemia
TTDI02684;hsa05223;Non-small cell lung cancer
TTDI02684;hsa05230;Central carbon metabolism in cancer
TTDI02684;hsa05231;Choline metabolism in cancer
TTDI02685;hsa04012;ErbB signaling pathway
TTDI02685;hsa04020;Calcium signaling pathway
TTDI02685;hsa04144;Endocytosis
TTDI02685;hsa05205;Proteoglycans in cancer
TTDI02685;hsa05206;MicroRNAs in cancer
TTDI02686;hsa04060;Cytokine-cytokine receptor interaction
TTDI02686;hsa04151;PI3K-Akt signaling pathway
TTDI02686;hsa04630;Jak-STAT signaling pathway
TTDI02686;hsa04640;Hematopoietic cell lineage
TTDI02686;hsa05321;Inflammatory bowel disease (IBD)
TTDNC00348;hsa04010;MAPK signaling pathway
TTDNC00348;hsa04120;Ubiquitin mediated proteolysis
TTDNC00348;hsa04622;RIG-I-like receptor signaling pathway
TTDNC00348;hsa04722;Neurotrophin signaling pathway
TTDNC00348;hsa04912;GnRH signaling pathway
TTDNC00348;hsa05161;Hepatitis B
TTDNC00348;hsa05166;HTLV-I infection
TTDNC00370;hsa04310;Wnt signaling pathway
TTDNC00371;hsa04060;Cytokine-cytokine receptor interaction
TTDNC00371;hsa04630;Jak-STAT signaling pathway
TTDNC00371;hsa05321;Inflammatory bowel disease (IBD)
TTDNC00372;hsa04151;PI3K-Akt signaling pathway
TTDNC00372;hsa04510;Focal adhesion
TTDNC00372;hsa04512;ECM-receptor interaction
TTDNC00372;hsa04640;Hematopoietic cell lineage
TTDNC00372;hsa04810;Regulation of actin cytoskeleton
TTDNC00372;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDNC00372;hsa05412;Arrhythmogenic right ventricular cardiomyopathy (ARVC)
TTDNC00372;hsa05414;Dilated cardiomyopathy
TTDNC00373;hsa04060;Cytokine-cytokine receptor interaction
TTDNC00373;hsa04151;PI3K-Akt signaling pathway
TTDNC00373;hsa04380;Osteoclast differentiation
TTDNC00373;hsa04620;Toll-like receptor signaling pathway
TTDNC00373;hsa04630;Jak-STAT signaling pathway
TTDNC00373;hsa04650;Natural killer cell mediated cytotoxicity
TTDNC00373;hsa05160;Hepatitis C
TTDNC00373;hsa05161;Hepatitis B
TTDNC00373;hsa05162;Measles
TTDNC00373;hsa05164;Influenza A
TTDNC00373;hsa05168;Herpes simplex infection
TTDNC00376;hsa04020;Calcium signaling pathway
TTDNC00376;hsa04080;Neuroactive ligand-receptor interaction
TTDNC00376;hsa04725;Cholinergic synapse
TTDNC00376;hsa05033;Nicotine addiction
TTDNC00376;hsa05204;Chemical carcinogenesis
TTDNC00380;hsa04130;SNARE interactions in vesicular transport
TTDNC00381;hsa04080;Neuroactive ligand-receptor interaction
TTDNC00381;hsa04725;Cholinergic synapse
TTDNC00381;hsa05033;Nicotine addiction
TTDNC00385;hsa04014;Ras signaling pathway
TTDNC00385;hsa04015;Rap1 signaling pathway
TTDNC00385;hsa04060;Cytokine-cytokine receptor interaction
TTDNC00385;hsa04151;PI3K-Akt signaling pathway
TTDNC00385;hsa04510;Focal adhesion
TTDNC00385;hsa04668;TNF signaling pathway
TTDNC00385;hsa05200;Pathways in cancer
TTDNC00387;hsa04024;cAMP signaling pathway
TTDNC00387;hsa04066;HIF-1 signaling pathway
TTDNC00387;hsa04068;FoxO signaling pathway
TTDNC00387;hsa04110;Cell cycle
TTDNC00387;hsa04310;Wnt signaling pathway
TTDNC00387;hsa04330;Notch signaling pathway
TTDNC00387;hsa04350;TGF-beta signaling pathway
TTDNC00387;hsa04520;Adherens junction
TTDNC00387;hsa04630;Jak-STAT signaling pathway
TTDNC00387;hsa04720;Long-term potentiation
TTDNC00387;hsa04916;Melanogenesis
TTDNC00387;hsa04919;Thyroid hormone signaling pathway
TTDNC00387;hsa04922;Glucagon signaling pathway
TTDNC00387;hsa05016;Huntington's disease
TTDNC00387;hsa05152;Tuberculosis
TTDNC00387;hsa05161;Hepatitis B
TTDNC00387;hsa05164;Influenza A
TTDNC00387;hsa05166;HTLV-I infection
TTDNC00387;hsa05168;Herpes simplex infection
TTDNC00387;hsa05169;Epstein-Barr virus infection
TTDNC00387;hsa05200;Pathways in cancer
TTDNC00387;hsa05203;Viral carcinogenesis
TTDNC00387;hsa05206;MicroRNAs in cancer
TTDNC00387;hsa05211;Renal cell carcinoma
TTDNC00387;hsa05215;Prostate cancer
TTDNC00388;hsa00562;Inositol phosphate metabolism
TTDNC00388;hsa04012;ErbB signaling pathway
TTDNC00388;hsa04014;Ras signaling pathway
TTDNC00388;hsa04015;Rap1 signaling pathway
TTDNC00388;hsa04022;cGMP-PKG signaling pathway
TTDNC00388;hsa04024;cAMP signaling pathway
TTDNC00388;hsa04062;Chemokine signaling pathway
TTDNC00388;hsa04066;HIF-1 signaling pathway
TTDNC00388;hsa04068;FoxO signaling pathway
TTDNC00388;hsa04070;Phosphatidylinositol signaling system
TTDNC00388;hsa04071;Sphingolipid signaling pathway
TTDNC00388;hsa04150;mTOR signaling pathway
TTDNC00388;hsa04151;PI3K-Akt signaling pathway
TTDNC00388;hsa04152;AMPK signaling pathway
TTDNC00388;hsa04210;Apoptosis
TTDNC00388;hsa04261;Adrenergic signaling in cardiomyocytes
TTDNC00388;hsa04370;VEGF signaling pathway
TTDNC00388;hsa04380;Osteoclast differentiation
TTDNC00388;hsa04510;Focal adhesion
TTDNC00388;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDNC00388;hsa04611;Platelet activation
TTDNC00388;hsa04620;Toll-like receptor signaling pathway
TTDNC00388;hsa04630;Jak-STAT signaling pathway
TTDNC00388;hsa04650;Natural killer cell mediated cytotoxicity
TTDNC00388;hsa04660;T cell receptor signaling pathway
TTDNC00388;hsa04662;B cell receptor signaling pathway
TTDNC00388;hsa04664;Fc epsilon RI signaling pathway
TTDNC00388;hsa04666;Fc gamma R-mediated phagocytosis
TTDNC00388;hsa04668;TNF signaling pathway
TTDNC00388;hsa04670;Leukocyte transendothelial migration
TTDNC00388;hsa04722;Neurotrophin signaling pathway
TTDNC00388;hsa04725;Cholinergic synapse
TTDNC00388;hsa04750;Inflammatory mediator regulation of TRP channels
TTDNC00388;hsa04810;Regulation of actin cytoskeleton
TTDNC00388;hsa04910;Insulin signaling pathway
TTDNC00388;hsa04914;Progesterone-mediated oocyte maturation
TTDNC00388;hsa04915;Estrogen signaling pathway
TTDNC00388;hsa04917;Prolactin signaling pathway
TTDNC00388;hsa04919;Thyroid hormone signaling pathway
TTDNC00388;hsa04921;Oxytocin signaling pathway
TTDNC00388;hsa04923;Regulation of lipolysis in adipocytes
TTDNC00388;hsa04930;Type II diabetes mellitus
TTDNC00388;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDNC00388;hsa04960;Aldosterone-regulated sodium reabsorption
TTDNC00388;hsa04973;Carbohydrate digestion and absorption
TTDNC00388;hsa05100;Bacterial invasion of epithelial cells
TTDNC00388;hsa05142;Chagas disease (American trypanosomiasis)
TTDNC00388;hsa05145;Toxoplasmosis
TTDNC00388;hsa05146;Amoebiasis
TTDNC00388;hsa05160;Hepatitis C
TTDNC00388;hsa05161;Hepatitis B
TTDNC00388;hsa05162;Measles
TTDNC00388;hsa05164;Influenza A
TTDNC00388;hsa05166;HTLV-I infection
TTDNC00388;hsa05169;Epstein-Barr virus infection
TTDNC00388;hsa05200;Pathways in cancer
TTDNC00388;hsa05203;Viral carcinogenesis
TTDNC00388;hsa05205;Proteoglycans in cancer
TTDNC00388;hsa05206;MicroRNAs in cancer
TTDNC00388;hsa05210;Colorectal cancer
TTDNC00388;hsa05211;Renal cell carcinoma
TTDNC00388;hsa05212;Pancreatic cancer
TTDNC00388;hsa05213;Endometrial cancer
TTDNC00388;hsa05214;Glioma
TTDNC00388;hsa05215;Prostate cancer
TTDNC00388;hsa05218;Melanoma
TTDNC00388;hsa05220;Chronic myeloid leukemia
TTDNC00388;hsa05221;Acute myeloid leukemia
TTDNC00388;hsa05222;Small cell lung cancer
TTDNC00388;hsa05223;Non-small cell lung cancer
TTDNC00388;hsa05230;Central carbon metabolism in cancer
TTDNC00388;hsa05231;Choline metabolism in cancer
TTDNC00389;hsa04010;MAPK signaling pathway
TTDNC00389;hsa04020;Calcium signaling pathway
TTDNC00389;hsa04713;Circadian entrainment
TTDNC00392;hsa05166;HTLV-I infection
TTDNC00393;hsa04151;PI3K-Akt signaling pathway
TTDNC00393;hsa04152;AMPK signaling pathway
TTDNC00393;hsa04922;Glucagon signaling pathway
TTDNC00393;hsa05166;HTLV-I infection
TTDNC00395;hsa04066;HIF-1 signaling pathway
TTDNC00395;hsa04145;Phagosome
TTDNC00395;hsa04380;Osteoclast differentiation
TTDNC00395;hsa04670;Leukocyte transendothelial migration
TTDNC00397;hsa04330;Notch signaling pathway
TTDNC00398;hsa04514;Cell adhesion molecules (CAMs)
TTDNC00400;sce00562;Inositol phosphate metabolism
TTDNC00400;sce01100;Metabolic pathways
TTDNC00400;sce04070;Phosphatidylinositol signaling system
TTDNC00406;hsa04060;Cytokine-cytokine receptor interaction
TTDNC00407;hsa04010;MAPK signaling pathway
TTDNC00407;hsa05206;MicroRNAs in cancer
TTDNC00410;hsa04060;Cytokine-cytokine receptor interaction
TTDNC00410;hsa04640;Hematopoietic cell lineage
TTDNC00410;hsa05200;Pathways in cancer
TTDNC00410;hsa05202;Transcriptional misregulation in cancer
TTDNC00410;hsa05221;Acute myeloid leukemia
TTDNC00410;hsa05230;Central carbon metabolism in cancer
TTDNC00411;hsa04110;Cell cycle
TTDNC00411;hsa05161;Hepatitis B
TTDNC00411;hsa05166;HTLV-I infection
TTDNC00411;hsa05200;Pathways in cancer
TTDNC00411;hsa05206;MicroRNAs in cancer
TTDNC00411;hsa05212;Pancreatic cancer
TTDNC00411;hsa05214;Glioma
TTDNC00411;hsa05215;Prostate cancer
TTDNC00411;hsa05218;Melanoma
TTDNC00411;hsa05219;Bladder cancer
TTDNC00411;hsa05220;Chronic myeloid leukemia
TTDNC00411;hsa05222;Small cell lung cancer
TTDNC00411;hsa05223;Non-small cell lung cancer
TTDNC00412;hsa04380;Osteoclast differentiation
TTDNC00412;hsa04630;Jak-STAT signaling pathway
TTDNC00412;hsa05145;Toxoplasmosis
TTDNC00412;hsa05160;Hepatitis C
TTDNC00412;hsa05162;Measles
TTDNC00412;hsa05164;Influenza A
TTDNC00412;hsa05168;Herpes simplex infection
TTDNC00412;hsa05169;Epstein-Barr virus infection
TTDNC00415;hsa04320;Dorso-ventral axis formation
TTDNC00415;hsa04330;Notch signaling pathway
TTDNC00415;hsa04919;Thyroid hormone signaling pathway
TTDNC00415;hsa05020;Prion diseases
TTDNC00415;hsa05206;MicroRNAs in cancer
TTDNC00419;hsa04014;Ras signaling pathway
TTDNC00419;hsa04015;Rap1 signaling pathway
TTDNC00419;hsa04066;HIF-1 signaling pathway
TTDNC00419;hsa04151;PI3K-Akt signaling pathway
TTDNC00419;hsa05323;Rheumatoid arthritis
TTDNC00420;hsa04012;ErbB signaling pathway
TTDNC00420;hsa04912;GnRH signaling pathway
TTDNC00420;hsa04915;Estrogen signaling pathway
TTDNC00420;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDNC00420;hsa05205;Proteoglycans in cancer
TTDNC00421;hsa04060;Cytokine-cytokine receptor interaction
TTDNC00424;hsa00760;Nicotinate and nicotinamide metabolism
TTDNC00424;hsa01100;Metabolic pathways
TTDNC00424;hsa04020;Calcium signaling pathway
TTDNC00424;hsa04640;Hematopoietic cell lineage
TTDNC00424;hsa04921;Oxytocin signaling pathway
TTDNC00424;hsa04970;Salivary secretion
TTDNC00424;hsa04972;Pancreatic secretion
TTDNC00424;hsa05169;Epstein-Barr virus infection
TTDNC00425;hsa03008;Ribosome biogenesis in eukaryotes
TTDNC00425;hsa04064;NF-kappa B signaling pathway
TTDNC00425;hsa04310;Wnt signaling pathway
TTDNC00425;hsa04520;Adherens junction
TTDNC00425;hsa04530;Tight junction
TTDNC00425;hsa05162;Measles
TTDNC00425;hsa05168;Herpes simplex infection
TTDNC00425;hsa05169;Epstein-Barr virus infection
TTDNC00426;hsa04145;Phagosome
TTDNC00426;hsa04151;PI3K-Akt signaling pathway
TTDNC00426;hsa04510;Focal adhesion
TTDNC00426;hsa04512;ECM-receptor interaction
TTDNC00426;hsa04640;Hematopoietic cell lineage
TTDNC00426;hsa04810;Regulation of actin cytoskeleton
TTDNC00426;hsa05100;Bacterial invasion of epithelial cells
TTDNC00426;hsa05131;Shigellosis
TTDNC00426;hsa05133;Pertussis
TTDNC00426;hsa05205;Proteoglycans in cancer
TTDNC00426;hsa05206;MicroRNAs in cancer
TTDNC00426;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDNC00426;hsa05412;Arrhythmogenic right ventricular cardiomyopathy (ARVC)
TTDNC00426;hsa05414;Dilated cardiomyopathy
TTDNC00427;hsa04750;Inflammatory mediator regulation of TRP channels
TTDNC00433;hsa00562;Inositol phosphate metabolism
TTDNC00433;hsa01100;Metabolic pathways
TTDNC00433;hsa04070;Phosphatidylinositol signaling system
TTDNC00437;hsa03022;Basal transcription factors
TTDNC00441;hsa04973;Carbohydrate digestion and absorption
TTDNC00441;hsa04976;Bile secretion
TTDNC00441;hsa04978;Mineral absorption
TTDNC00442;hsa04976;Bile secretion
TTDNC00444;hsa00561;Glycerolipid metabolism
TTDNC00444;hsa00564;Glycerophospholipid metabolism
TTDNC00444;hsa01100;Metabolic pathways
TTDNC00444;hsa04975;Fat digestion and absorption
TTDNC00446;hsa04520;Adherens junction
TTDNC00447;hsa04014;Ras signaling pathway
TTDNC00447;hsa04015;Rap1 signaling pathway
TTDNC00447;hsa04066;HIF-1 signaling pathway
TTDNC00447;hsa04151;PI3K-Akt signaling pathway
TTDNC00447;hsa05323;Rheumatoid arthritis
TTDNC00448;hsa04142;Lysosome
TTDNC00448;hsa04614;Renin-angiotensin system
TTDNC00454;hsa04024;cAMP signaling pathway
TTDNC00454;hsa04080;Neuroactive ligand-receptor interaction
TTDNC00454;hsa04726;Serotonergic synapse
TTDNC00456;hsa00230;Purine metabolism
TTDNC00456;hsa05032;Morphine addiction
TTDNC00460;hsa04060;Cytokine-cytokine receptor interaction
TTDNC00460;hsa04630;Jak-STAT signaling pathway
TTDNC00461;hsa04310;Wnt signaling pathway
TTDNC00462;hsa04080;Neuroactive ligand-receptor interaction
TTDNC00462;hsa04270;Vascular smooth muscle contraction
TTDNC00463;hsa04514;Cell adhesion molecules (CAMs)
TTDNC00463;hsa04672;Intestinal immune network for IgA production
TTDNC00464;hsa04145;Phagosome
TTDNC00464;hsa04380;Osteoclast differentiation
TTDNC00464;hsa04662;B cell receptor signaling pathway
TTDNC00464;hsa04666;Fc gamma R-mediated phagocytosis
TTDNC00464;hsa05150;Staphylococcus aureus infection
TTDNC00464;hsa05152;Tuberculosis
TTDNC00464;hsa05162;Measles
TTDNC00468;hsa04514;Cell adhesion molecules (CAMs)
TTDNC00474;hsa04610;Complement and coagulation cascades
TTDNC00474;hsa05020;Prion diseases
TTDNC00474;hsa05133;Pertussis
TTDNC00474;hsa05150;Staphylococcus aureus infection
TTDNC00474;hsa05168;Herpes simplex infection
TTDNC00474;hsa05322;Systemic lupus erythematosus
TTDNC00475;hsa04060;Cytokine-cytokine receptor interaction
TTDNC00475;hsa04630;Jak-STAT signaling pathway
TTDNC00484;hsa04060;Cytokine-cytokine receptor interaction
TTDNC00485;hsa04024;cAMP signaling pathway
TTDNC00485;hsa04911;Insulin secretion
TTDNC00486;hsa04610;Complement and coagulation cascades
TTDNC00486;hsa04972;Pancreatic secretion
TTDNC00486;hsa04974;Protein digestion and absorption
TTDNC00489;hsa04514;Cell adhesion molecules (CAMs)
TTDNC00489;hsa04660;T cell receptor signaling pathway
TTDNC00490;hsa04012;ErbB signaling pathway
TTDNC00490;hsa04020;Calcium signaling pathway
TTDNC00490;hsa04144;Endocytosis
TTDNC00490;hsa05205;Proteoglycans in cancer
TTDNC00492;hsa00310;Lysine degradation
TTDNC00492;hsa05202;Transcriptional misregulation in cancer
TTDNC00497;hsa04310;Wnt signaling pathway
TTDNC00498;hsa04630;Jak-STAT signaling pathway
TTDNC00498;hsa05206;MicroRNAs in cancer
TTDNC00498;hsa05221;Acute myeloid leukemia
TTDNC00499;hsa04978;Mineral absorption
TTDNC00502;hsa04010;MAPK signaling pathway
TTDNC00502;hsa04060;Cytokine-cytokine receptor interaction
TTDNC00502;hsa04064;NF-kappa B signaling pathway
TTDNC00502;hsa04071;Sphingolipid signaling pathway
TTDNC00502;hsa04210;Apoptosis
TTDNC00502;hsa04380;Osteoclast differentiation
TTDNC00502;hsa04668;TNF signaling pathway
TTDNC00502;hsa04920;Adipocytokine signaling pathway
TTDNC00502;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDNC00502;hsa05010;Alzheimer's disease
TTDNC00502;hsa05014;Amyotrophic lateral sclerosis (ALS)
TTDNC00502;hsa05142;Chagas disease (American trypanosomiasis)
TTDNC00502;hsa05145;Toxoplasmosis
TTDNC00502;hsa05152;Tuberculosis
TTDNC00502;hsa05160;Hepatitis C
TTDNC00502;hsa05164;Influenza A
TTDNC00502;hsa05166;HTLV-I infection
TTDNC00502;hsa05168;Herpes simplex infection
TTDNC00504;hsa04640;Hematopoietic cell lineage
TTDNC00504;hsa04660;T cell receptor signaling pathway
TTDNC00504;hsa05142;Chagas disease (American trypanosomiasis)
TTDNC00504;hsa05162;Measles
TTDNC00504;hsa05166;HTLV-I infection
TTDNC00506;hsa04973;Carbohydrate digestion and absorption
TTDNC00506;hsa04976;Bile secretion
TTDNC00506;hsa04978;Mineral absorption
TTDNC00511;hsa00230;Purine metabolism
TTDNC00511;hsa04024;cAMP signaling pathway
TTDNC00511;hsa05032;Morphine addiction
TTDNC00512;hsa00565;Ether lipid metabolism
TTDNC00512;hsa01100;Metabolic pathways
TTDNC00512;hsa01130;Biosynthesis of antibiotics
TTDNC00515;hsa04080;Neuroactive ligand-receptor interaction
TTDNC00518;hsa04080;Neuroactive ligand-receptor interaction
TTDNC00518;hsa04610;Complement and coagulation cascades
TTDNC00518;hsa05150;Staphylococcus aureus infection
TTDNC00520;hsa04612;Antigen processing and presentation
TTDNC00520;hsa04650;Natural killer cell mediated cytotoxicity
TTDNC00520;hsa05332;Graft-versus-host disease
TTDNC00527;hsa04060;Cytokine-cytokine receptor interaction
TTDNC00527;hsa04062;Chemokine signaling pathway
TTDNC00527;hsa04144;Endocytosis
TTDNC00527;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDNC00532;hsa04978;Mineral absorption
TTDNC00539;hsa04010;MAPK signaling pathway
TTDNC00539;hsa04014;Ras signaling pathway
TTDNC00539;hsa04015;Rap1 signaling pathway
TTDNC00539;hsa04144;Endocytosis
TTDNC00539;hsa04151;PI3K-Akt signaling pathway
TTDNC00539;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDNC00539;hsa04810;Regulation of actin cytoskeleton
TTDNC00539;hsa05200;Pathways in cancer
TTDNC00539;hsa05206;MicroRNAs in cancer
TTDNC00539;hsa05219;Bladder cancer
TTDNC00539;hsa05230;Central carbon metabolism in cancer
TTDNC00540;hsa04640;Hematopoietic cell lineage
TTDNC00542;hsa05034;Alcoholism
TTDNC00542;hsa05203;Viral carcinogenesis
TTDNC00553;hsa04062;Chemokine signaling pathway
TTDNC00553;hsa04270;Vascular smooth muscle contraction
TTDNC00553;hsa04530;Tight junction
TTDNC00553;hsa04664;Fc epsilon RI signaling pathway
TTDNC00553;hsa04666;Fc gamma R-mediated phagocytosis
TTDNC00553;hsa04722;Neurotrophin signaling pathway
TTDNC00553;hsa04750;Inflammatory mediator regulation of TRP channels
TTDNC00553;hsa04912;GnRH signaling pathway
TTDNC00553;hsa04915;Estrogen signaling pathway
TTDNC00553;hsa04930;Type II diabetes mellitus
TTDNC00569;hsa00250;Alanine, aspartate and glutamate metabolism
TTDNC00569;hsa01100;Metabolic pathways
TTDNC00569;hsa04977;Vitamin digestion and absorption
TTDNC00572;hsa00140;Steroid hormone biosynthesis
TTDNC00572;hsa01100;Metabolic pathways
TTDNC00574;hsa04060;Cytokine-cytokine receptor interaction
TTDNC00574;hsa04062;Chemokine signaling pathway
TTDNC00576;hsa04014;Ras signaling pathway
TTDNC00576;hsa04015;Rap1 signaling pathway
TTDNC00576;hsa04022;cGMP-PKG signaling pathway
TTDNC00576;hsa04066;HIF-1 signaling pathway
TTDNC00576;hsa04068;FoxO signaling pathway
TTDNC00576;hsa04114;Oocyte meiosis
TTDNC00576;hsa04140;Regulation of autophagy
TTDNC00576;hsa04150;mTOR signaling pathway
TTDNC00576;hsa04151;PI3K-Akt signaling pathway
TTDNC00576;hsa04152;AMPK signaling pathway
TTDNC00576;hsa04810;Regulation of actin cytoskeleton
TTDNC00576;hsa04910;Insulin signaling pathway
TTDNC00576;hsa04911;Insulin secretion
TTDNC00576;hsa04913;Ovarian steroidogenesis
TTDNC00576;hsa04914;Progesterone-mediated oocyte maturation
TTDNC00576;hsa04917;Prolactin signaling pathway
TTDNC00576;hsa04930;Type II diabetes mellitus
TTDNC00576;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDNC00576;hsa04940;Type I diabetes mellitus
TTDNC00576;hsa04950;Maturity onset diabetes of the young
TTDNC00576;hsa04960;Aldosterone-regulated sodium reabsorption
TTDNC00576;hsa05215;Prostate cancer
TTDNC00577;hsa04974;Protein digestion and absorption
TTDNC00578;hsa04973;Carbohydrate digestion and absorption
TTDNC00578;hsa04976;Bile secretion
TTDNC00578;hsa04978;Mineral absorption
TTDNC00581;hsa04975;Fat digestion and absorption
TTDNC00584;hsa04060;Cytokine-cytokine receptor interaction
TTDNC00584;hsa04151;PI3K-Akt signaling pathway
TTDNC00584;hsa04630;Jak-STAT signaling pathway
TTDNC00584;hsa04640;Hematopoietic cell lineage
TTDNC00585;hsa04060;Cytokine-cytokine receptor interaction
TTDNC00586;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDNC00586;hsa05414;Dilated cardiomyopathy
TTDNC00589;hsa04151;PI3K-Akt signaling pathway
TTDNC00589;hsa04510;Focal adhesion
TTDNC00589;hsa04512;ECM-receptor interaction
TTDNC00589;hsa04514;Cell adhesion molecules (CAMs)
TTDNC00589;hsa04640;Hematopoietic cell lineage
TTDNC00589;hsa04670;Leukocyte transendothelial migration
TTDNC00589;hsa04672;Intestinal immune network for IgA production
TTDNC00589;hsa04810;Regulation of actin cytoskeleton
TTDNC00589;hsa05140;Leishmaniasis
TTDNC00589;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDNC00589;hsa05412;Arrhythmogenic right ventricular cardiomyopathy (ARVC)
TTDNC00589;hsa05414;Dilated cardiomyopathy
TTDNC00597;hsa00270;Cysteine and methionine metabolism
TTDNC00597;hsa01100;Metabolic pathways
TTDNC00597;hsa05206;MicroRNAs in cancer
TTDNC00602;hsa04614;Renin-angiotensin system
TTDNC00602;hsa04974;Protein digestion and absorption
TTDNC00604;hsa04060;Cytokine-cytokine receptor interaction
TTDNC00604;hsa04210;Apoptosis
TTDNC00604;hsa04650;Natural killer cell mediated cytotoxicity
TTDNC00604;hsa05162;Measles
TTDNC00604;hsa05164;Influenza A
TTDNC00608;hsa04060;Cytokine-cytokine receptor interaction
TTDNC00608;hsa04062;Chemokine signaling pathway
TTDNC00613;hsa04010;MAPK signaling pathway
TTDNC00613;hsa04012;ErbB signaling pathway
TTDNC00613;hsa04014;Ras signaling pathway
TTDNC00613;hsa04015;Rap1 signaling pathway
TTDNC00613;hsa04022;cGMP-PKG signaling pathway
TTDNC00613;hsa04024;cAMP signaling pathway
TTDNC00613;hsa04066;HIF-1 signaling pathway
TTDNC00613;hsa04068;FoxO signaling pathway
TTDNC00613;hsa04071;Sphingolipid signaling pathway
TTDNC00613;hsa04151;PI3K-Akt signaling pathway
TTDNC00613;hsa04270;Vascular smooth muscle contraction
TTDNC00613;hsa04370;VEGF signaling pathway
TTDNC00613;hsa04540;Gap junction
TTDNC00613;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDNC00613;hsa04620;Toll-like receptor signaling pathway
TTDNC00613;hsa04650;Natural killer cell mediated cytotoxicity
TTDNC00613;hsa04660;T cell receptor signaling pathway
TTDNC00613;hsa04662;B cell receptor signaling pathway
TTDNC00613;hsa04664;Fc epsilon RI signaling pathway
TTDNC00613;hsa04720;Long-term potentiation
TTDNC00613;hsa04722;Neurotrophin signaling pathway
TTDNC00613;hsa04730;Long-term depression
TTDNC00613;hsa04810;Regulation of actin cytoskeleton
TTDNC00613;hsa04910;Insulin signaling pathway
TTDNC00613;hsa04912;GnRH signaling pathway
TTDNC00613;hsa04915;Estrogen signaling pathway
TTDNC00613;hsa04916;Melanogenesis
TTDNC00613;hsa04917;Prolactin signaling pathway
TTDNC00613;hsa04919;Thyroid hormone signaling pathway
TTDNC00613;hsa04921;Oxytocin signaling pathway
TTDNC00613;hsa05020;Prion diseases
TTDNC00613;hsa05161;Hepatitis B
TTDNC00613;hsa05164;Influenza A
TTDNC00613;hsa05200;Pathways in cancer
TTDNC00613;hsa05205;Proteoglycans in cancer
TTDNC00613;hsa05206;MicroRNAs in cancer
TTDNC00613;hsa05211;Renal cell carcinoma
TTDNC00613;hsa05213;Endometrial cancer
TTDNC00613;hsa05214;Glioma
TTDNC00613;hsa05215;Prostate cancer
TTDNC00613;hsa05216;Thyroid cancer
TTDNC00613;hsa05218;Melanoma
TTDNC00613;hsa05219;Bladder cancer
TTDNC00613;hsa05220;Chronic myeloid leukemia
TTDNC00613;hsa05221;Acute myeloid leukemia
TTDNC00613;hsa05223;Non-small cell lung cancer
TTDNC00613;hsa05230;Central carbon metabolism in cancer
TTDNC00613;hsa05231;Choline metabolism in cancer
TTDNC00616;hsa03320;PPAR signaling pathway
TTDNC00621;hsa04010;MAPK signaling pathway
TTDNC00621;hsa04014;Ras signaling pathway
TTDNC00621;hsa04015;Rap1 signaling pathway
TTDNC00621;hsa04144;Endocytosis
TTDNC00621;hsa04151;PI3K-Akt signaling pathway
TTDNC00621;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDNC00621;hsa04810;Regulation of actin cytoskeleton
TTDNC00625;hsa04060;Cytokine-cytokine receptor interaction
TTDNC00625;hsa04350;TGF-beta signaling pathway
TTDNC00625;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDNC00630;hsa04010;MAPK signaling pathway
TTDNC00630;hsa04144;Endocytosis
TTDNC00630;hsa04210;Apoptosis
TTDNC00630;hsa04722;Neurotrophin signaling pathway
TTDNC00630;hsa04750;Inflammatory mediator regulation of TRP channels
TTDNC00630;hsa05200;Pathways in cancer
TTDNC00630;hsa05202;Transcriptional misregulation in cancer
TTDNC00630;hsa05216;Thyroid cancer
TTDNC00630;hsa05230;Central carbon metabolism in cancer
TTDNC00634;hsa04662;B cell receptor signaling pathway
TTDNC00645;hsa04010;MAPK signaling pathway
TTDNC00645;hsa04024;cAMP signaling pathway
TTDNC00645;hsa04722;Neurotrophin signaling pathway
TTDNC00645;hsa05016;Huntington's disease
TTDNC00645;hsa05030;Cocaine addiction
TTDNC00645;hsa05034;Alcoholism
TTDNC00650;hsa04060;Cytokine-cytokine receptor interaction
TTDNC00650;hsa04672;Intestinal immune network for IgA production
TTDNC00650;hsa05323;Rheumatoid arthritis
TTDNC00651;hsa04080;Neuroactive ligand-receptor interaction
TTDNC00653;hsa04911;Insulin secretion
TTDNC00658;hsa04080;Neuroactive ligand-receptor interaction
TTDNC00658;hsa04915;Estrogen signaling pathway
TTDNC00658;hsa05032;Morphine addiction
TTDNC00667;hsa04060;Cytokine-cytokine receptor interaction
TTDNC00667;hsa04062;Chemokine signaling pathway
TTDNC00667;hsa04672;Intestinal immune network for IgA production
TTDNC00676;hsa04610;Complement and coagulation cascades
TTDNC00676;hsa04640;Hematopoietic cell lineage
TTDNC00676;hsa04662;B cell receptor signaling pathway
TTDNC00676;hsa05169;Epstein-Barr virus infection
TTDNC00677;hsa00600;Sphingolipid metabolism
TTDNC00677;hsa01100;Metabolic pathways
TTDNR00643;hsa04614;Renin-angiotensin system
TTDNR00649;hsa04010;MAPK signaling pathway
TTDNR00649;hsa04722;Neurotrophin signaling pathway
TTDNR00649;hsa05034;Alcoholism
TTDNR00652;hsa04060;Cytokine-cytokine receptor interaction
TTDNR00652;hsa04630;Jak-STAT signaling pathway
TTDNR00671;hsa03008;Ribosome biogenesis in eukaryotes
TTDNR00671;hsa03013;RNA transport
TTDNR00671;hsa05164;Influenza A
TTDNR00671;hsa05166;HTLV-I infection
TTDNR00671;hsa05169;Epstein-Barr virus infection
TTDNR00702;hsa04310;Wnt signaling pathway
TTDNR00709;hsa04360;Axon guidance
TTDNR00714;hsa04141;Protein processing in endoplasmic reticulum
TTDNR00726;hsa03320;PPAR signaling pathway
TTDNR00726;hsa04145;Phagosome
TTDNR00726;hsa04152;AMPK signaling pathway
TTDNR00726;hsa04512;ECM-receptor interaction
TTDNR00726;hsa04640;Hematopoietic cell lineage
TTDNR00726;hsa04920;Adipocytokine signaling pathway
TTDNR00726;hsa04975;Fat digestion and absorption
TTDNR00726;hsa05144;Malaria
TTDNR00746;hsa05221;Acute myeloid leukemia
TTDNS00536;hsa04340;Hedgehog signaling pathway
TTDNS00536;hsa05200;Pathways in cancer
TTDNS00536;hsa05205;Proteoglycans in cancer
TTDNS00536;hsa05217;Basal cell carcinoma
TTDNS00537;hsa04020;Calcium signaling pathway
TTDNS00537;hsa04080;Neuroactive ligand-receptor interaction
TTDNS00541;hsa00563;Glycosylphosphatidylinositol(GPI)-anchor biosynthesis
TTDNS00541;hsa01100;Metabolic pathways
TTDNS00542;hsa04014;Ras signaling pathway
TTDNS00542;hsa04015;Rap1 signaling pathway
TTDNS00542;hsa04060;Cytokine-cytokine receptor interaction
TTDNS00542;hsa04066;HIF-1 signaling pathway
TTDNS00542;hsa04150;mTOR signaling pathway
TTDNS00542;hsa04151;PI3K-Akt signaling pathway
TTDNS00542;hsa04370;VEGF signaling pathway
TTDNS00542;hsa04510;Focal adhesion
TTDNS00542;hsa05200;Pathways in cancer
TTDNS00542;hsa05205;Proteoglycans in cancer
TTDNS00542;hsa05206;MicroRNAs in cancer
TTDNS00542;hsa05211;Renal cell carcinoma
TTDNS00542;hsa05212;Pancreatic cancer
TTDNS00542;hsa05219;Bladder cancer
TTDNS00542;hsa05323;Rheumatoid arthritis
TTDNS00544;hsa04080;Neuroactive ligand-receptor interaction
TTDNS00564;hsa04970;Salivary secretion
TTDNS00564;hsa05152;Tuberculosis
TTDNS00582;hsa04020;Calcium signaling pathway
TTDNS00582;hsa04024;cAMP signaling pathway
TTDNS00582;hsa04080;Neuroactive ligand-receptor interaction
TTDNS00582;hsa04151;PI3K-Akt signaling pathway
TTDNS00582;hsa04725;Cholinergic synapse
TTDNS00582;hsa04810;Regulation of actin cytoskeleton
TTDNS00592;hsa04012;ErbB signaling pathway
TTDNS00592;hsa04014;Ras signaling pathway
TTDNS00592;hsa04110;Cell cycle
TTDNS00592;hsa04360;Axon guidance
TTDNS00592;hsa04722;Neurotrophin signaling pathway
TTDNS00592;hsa05130;Pathogenic Escherichia coli infection
TTDNS00592;hsa05131;Shigellosis
TTDNS00592;hsa05200;Pathways in cancer
TTDNS00592;hsa05206;MicroRNAs in cancer
TTDNS00592;hsa05220;Chronic myeloid leukemia
TTDNS00592;hsa05416;Viral myocarditis
TTDNS00593;hsa04144;Endocytosis
TTDNS00593;hsa05200;Pathways in cancer
TTDNS00593;hsa05216;Thyroid cancer
TTDNS00593;hsa05230;Central carbon metabolism in cancer
TTDNS00605;hsa02010;ABC transporters
TTDNS00605;hsa04024;cAMP signaling pathway
TTDNS00605;hsa04152;AMPK signaling pathway
TTDNS00605;hsa04971;Gastric acid secretion
TTDNS00605;hsa04972;Pancreatic secretion
TTDNS00605;hsa04976;Bile secretion
TTDNS00605;hsa05110;Vibrio cholerae infection
TTDNS00611;hsa04151;PI3K-Akt signaling pathway
TTDNS00611;hsa04380;Osteoclast differentiation
TTDNS00611;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDNS00611;hsa04630;Jak-STAT signaling pathway
TTDNS00611;hsa05140;Leishmaniasis
TTDNS00611;hsa05145;Toxoplasmosis
TTDNS00611;hsa05152;Tuberculosis
TTDNS00611;hsa05160;Hepatitis C
TTDNS00611;hsa05161;Hepatitis B
TTDNS00611;hsa05162;Measles
TTDNS00611;hsa05164;Influenza A
TTDNS00611;hsa05166;HTLV-I infection
TTDNS00611;hsa05168;Herpes simplex infection
TTDNS00611;hsa05169;Epstein-Barr virus infection
TTDNS00611;hsa05200;Pathways in cancer
TTDNS00611;hsa05203;Viral carcinogenesis
TTDNS00611;hsa05212;Pancreatic cancer
TTDNS00615;hsa00230;Purine metabolism
TTDNS00615;hsa04022;cGMP-PKG signaling pathway
TTDR00006;hsa04080;Neuroactive ligand-receptor interaction
TTDR00006;hsa04912;GnRH signaling pathway
TTDR00006;hsa04913;Ovarian steroidogenesis
TTDR00006;hsa04917;Prolactin signaling pathway
TTDR00006;hsa04918;Thyroid hormone synthesis
TTDR00006;hsa05320;Autoimmune thyroid disease
TTDR00007;hsa02010;ABC transporters
TTDR00007;hsa04976;Bile secretion
TTDR00007;hsa05206;MicroRNAs in cancer
TTDR00008;hsa00030;Pentose phosphate pathway
TTDR00008;hsa00480;Glutathione metabolism
TTDR00008;hsa01100;Metabolic pathways
TTDR00008;hsa01130;Biosynthesis of antibiotics
TTDR00008;hsa01200;Carbon metabolism
TTDR00008;hsa05230;Central carbon metabolism in cancer
TTDR00010;hsa00330;Arginine and proline metabolism
TTDR00010;hsa00340;Histidine metabolism
TTDR00010;hsa00380;Tryptophan metabolism
TTDR00011;hsa04015;Rap1 signaling pathway
TTDR00011;hsa04080;Neuroactive ligand-receptor interaction
TTDR00011;hsa05150;Staphylococcus aureus infection
TTDR00012;hsa04060;Cytokine-cytokine receptor interaction
TTDR00012;hsa04151;PI3K-Akt signaling pathway
TTDR00012;hsa04210;Apoptosis
TTDR00012;hsa04630;Jak-STAT signaling pathway
TTDR00012;hsa04640;Hematopoietic cell lineage
TTDR00015;hsa04614;Renin-angiotensin system
TTDR00018;hsa00100;Steroid biosynthesis
TTDR00018;hsa01100;Metabolic pathways
TTDR00020;hsa02010;ABC transporters
TTDR00020;hsa04976;Bile secretion
TTDR00029;hsa04310;Wnt signaling pathway
TTDR00032;hsa04060;Cytokine-cytokine receptor interaction
TTDR00032;hsa04630;Jak-STAT signaling pathway
TTDR00033;hsa00140;Steroid hormone biosynthesis
TTDR00033;hsa00590;Arachidonic acid metabolism
TTDR00033;hsa01100;Metabolic pathways
TTDR00033;hsa04913;Ovarian steroidogenesis
TTDR00035;hsa04964;Proximal tubule bicarbonate reclamation
TTDR00035;hsa04974;Protein digestion and absorption
TTDR00035;hsa04976;Bile secretion
TTDR00035;hsa04978;Mineral absorption
TTDR00036;hsa05162;Measles
TTDR00042;pfa00061;Fatty acid biosynthesis
TTDR00042;pfa00780;Biotin metabolism
TTDR00042;pfa01100;Metabolic pathways
TTDR00042;pfa01212;Fatty acid metabolism
TTDR00048;rno04010;MAPK signaling pathway
TTDR00048;rno04020;Calcium signaling pathway
TTDR00048;rno04713;Circadian entrainment
TTDR00081;hsa04015;Rap1 signaling pathway
TTDR00081;hsa04080;Neuroactive ligand-receptor interaction
TTDR00081;hsa04611;Platelet activation
TTDR00082;hsa03320;PPAR signaling pathway
TTDR00082;hsa05016;Huntington's disease
TTDR00085;hsa04010;MAPK signaling pathway
TTDR00085;hsa04726;Serotonergic synapse
TTDR00086;hsa04060;Cytokine-cytokine receptor interaction
TTDR00086;hsa04151;PI3K-Akt signaling pathway
TTDR00086;hsa04630;Jak-STAT signaling pathway
TTDR00086;hsa04640;Hematopoietic cell lineage
TTDR00086;hsa04660;T cell receptor signaling pathway
TTDR00086;hsa04664;Fc epsilon RI signaling pathway
TTDR00086;hsa04672;Intestinal immune network for IgA production
TTDR00086;hsa05140;Leishmaniasis
TTDR00086;hsa05162;Measles
TTDR00086;hsa05310;Asthma
TTDR00086;hsa05320;Autoimmune thyroid disease
TTDR00086;hsa05321;Inflammatory bowel disease (IBD)
TTDR00086;hsa05330;Allograft rejection
TTDR00088;hsa04060;Cytokine-cytokine receptor interaction
TTDR00088;hsa04630;Jak-STAT signaling pathway
TTDR00088;hsa04640;Hematopoietic cell lineage
TTDR00088;hsa04660;T cell receptor signaling pathway
TTDR00088;hsa04664;Fc epsilon RI signaling pathway
TTDR00088;hsa04672;Intestinal immune network for IgA production
TTDR00088;hsa05310;Asthma
TTDR00088;hsa05320;Autoimmune thyroid disease
TTDR00088;hsa05321;Inflammatory bowel disease (IBD)
TTDR00088;hsa05330;Allograft rejection
TTDR00094;hsa00030;Pentose phosphate pathway
TTDR00094;hsa01100;Metabolic pathways
TTDR00094;hsa01130;Biosynthesis of antibiotics
TTDR00094;hsa01200;Carbon metabolism
TTDR00094;hsa01230;Biosynthesis of amino acids
TTDR00096;hsa04920;Adipocytokine signaling pathway
TTDR00109;hsa04080;Neuroactive ligand-receptor interaction
TTDR00109;hsa04750;Inflammatory mediator regulation of TRP channels
TTDR00109;hsa05143;African trypanosomiasis
TTDR00111;hsa04015;Rap1 signaling pathway
TTDR00111;hsa04080;Neuroactive ligand-receptor interaction
TTDR00111;hsa04611;Platelet activation
TTDR00111;hsa05200;Pathways in cancer
TTDR00116;hsa04010;MAPK signaling pathway
TTDR00116;hsa04110;Cell cycle
TTDR00116;hsa04914;Progesterone-mediated oocyte maturation
TTDR00116;hsa05206;MicroRNAs in cancer
TTDR00117;hsa04010;MAPK signaling pathway
TTDR00117;hsa04120;Ubiquitin mediated proteolysis
TTDR00117;hsa04622;RIG-I-like receptor signaling pathway
TTDR00117;hsa04722;Neurotrophin signaling pathway
TTDR00117;hsa04912;GnRH signaling pathway
TTDR00117;hsa05161;Hepatitis B
TTDR00117;hsa05166;HTLV-I infection
TTDR00118;hsa04080;Neuroactive ligand-receptor interaction
TTDR00138;hsa04060;Cytokine-cytokine receptor interaction
TTDR00138;hsa04068;FoxO signaling pathway
TTDR00138;hsa04630;Jak-STAT signaling pathway
TTDR00138;hsa04660;T cell receptor signaling pathway
TTDR00138;hsa04672;Intestinal immune network for IgA production
TTDR00138;hsa05133;Pertussis
TTDR00138;hsa05140;Leishmaniasis
TTDR00138;hsa05142;Chagas disease (American trypanosomiasis)
TTDR00138;hsa05143;African trypanosomiasis
TTDR00138;hsa05144;Malaria
TTDR00138;hsa05145;Toxoplasmosis
TTDR00138;hsa05146;Amoebiasis
TTDR00138;hsa05150;Staphylococcus aureus infection
TTDR00138;hsa05152;Tuberculosis
TTDR00138;hsa05169;Epstein-Barr virus infection
TTDR00138;hsa05310;Asthma
TTDR00138;hsa05320;Autoimmune thyroid disease
TTDR00138;hsa05321;Inflammatory bowel disease (IBD)
TTDR00138;hsa05322;Systemic lupus erythematosus
TTDR00138;hsa05330;Allograft rejection
TTDR00141;hsa04060;Cytokine-cytokine receptor interaction
TTDR00141;hsa04151;PI3K-Akt signaling pathway
TTDR00141;hsa04630;Jak-STAT signaling pathway
TTDR00141;hsa04660;T cell receptor signaling pathway
TTDR00141;hsa04672;Intestinal immune network for IgA production
TTDR00141;hsa04940;Type I diabetes mellitus
TTDR00141;hsa05142;Chagas disease (American trypanosomiasis)
TTDR00141;hsa05162;Measles
TTDR00141;hsa05166;HTLV-I infection
TTDR00141;hsa05320;Autoimmune thyroid disease
TTDR00141;hsa05321;Inflammatory bowel disease (IBD)
TTDR00141;hsa05330;Allograft rejection
TTDR00141;hsa05332;Graft-versus-host disease
TTDR00147;hsa04010;MAPK signaling pathway
TTDR00147;hsa04012;ErbB signaling pathway
TTDR00147;hsa04141;Protein processing in endoplasmic reticulum
TTDR00147;hsa04380;Osteoclast differentiation
TTDR00147;hsa04620;Toll-like receptor signaling pathway
TTDR00147;hsa04660;T cell receptor signaling pathway
TTDR00147;hsa04664;Fc epsilon RI signaling pathway
TTDR00147;hsa04668;TNF signaling pathway
TTDR00147;hsa04722;Neurotrophin signaling pathway
TTDR00147;hsa04912;GnRH signaling pathway
TTDR00147;hsa05164;Influenza A
TTDR00147;hsa05169;Epstein-Barr virus infection
TTDR00148;hsa04010;MAPK signaling pathway
TTDR00148;hsa04012;ErbB signaling pathway
TTDR00148;hsa04014;Ras signaling pathway
TTDR00148;hsa04015;Rap1 signaling pathway
TTDR00148;hsa04022;cGMP-PKG signaling pathway
TTDR00148;hsa04024;cAMP signaling pathway
TTDR00148;hsa04062;Chemokine signaling pathway
TTDR00148;hsa04066;HIF-1 signaling pathway
TTDR00148;hsa04068;FoxO signaling pathway
TTDR00148;hsa04071;Sphingolipid signaling pathway
TTDR00148;hsa04114;Oocyte meiosis
TTDR00148;hsa04151;PI3K-Akt signaling pathway
TTDR00148;hsa04270;Vascular smooth muscle contraction
TTDR00148;hsa04320;Dorso-ventral axis formation
TTDR00148;hsa04370;VEGF signaling pathway
TTDR00148;hsa04380;Osteoclast differentiation
TTDR00148;hsa04510;Focal adhesion
TTDR00148;hsa04540;Gap junction
TTDR00148;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDR00148;hsa04620;Toll-like receptor signaling pathway
TTDR00148;hsa04650;Natural killer cell mediated cytotoxicity
TTDR00148;hsa04660;T cell receptor signaling pathway
TTDR00148;hsa04662;B cell receptor signaling pathway
TTDR00148;hsa04664;Fc epsilon RI signaling pathway
TTDR00148;hsa04666;Fc gamma R-mediated phagocytosis
TTDR00148;hsa04668;TNF signaling pathway
TTDR00148;hsa04720;Long-term potentiation
TTDR00148;hsa04722;Neurotrophin signaling pathway
TTDR00148;hsa04725;Cholinergic synapse
TTDR00148;hsa04726;Serotonergic synapse
TTDR00148;hsa04730;Long-term depression
TTDR00148;hsa04810;Regulation of actin cytoskeleton
TTDR00148;hsa04910;Insulin signaling pathway
TTDR00148;hsa04912;GnRH signaling pathway
TTDR00148;hsa04914;Progesterone-mediated oocyte maturation
TTDR00148;hsa04915;Estrogen signaling pathway
TTDR00148;hsa04916;Melanogenesis
TTDR00148;hsa04917;Prolactin signaling pathway
TTDR00148;hsa04919;Thyroid hormone signaling pathway
TTDR00148;hsa04921;Oxytocin signaling pathway
TTDR00148;hsa05020;Prion diseases
TTDR00148;hsa05034;Alcoholism
TTDR00148;hsa05161;Hepatitis B
TTDR00148;hsa05164;Influenza A
TTDR00148;hsa05200;Pathways in cancer
TTDR00148;hsa05205;Proteoglycans in cancer
TTDR00148;hsa05206;MicroRNAs in cancer
TTDR00148;hsa05210;Colorectal cancer
TTDR00148;hsa05211;Renal cell carcinoma
TTDR00148;hsa05212;Pancreatic cancer
TTDR00148;hsa05213;Endometrial cancer
TTDR00148;hsa05214;Glioma
TTDR00148;hsa05215;Prostate cancer
TTDR00148;hsa05216;Thyroid cancer
TTDR00148;hsa05218;Melanoma
TTDR00148;hsa05219;Bladder cancer
TTDR00148;hsa05220;Chronic myeloid leukemia
TTDR00148;hsa05221;Acute myeloid leukemia
TTDR00148;hsa05223;Non-small cell lung cancer
TTDR00148;hsa05230;Central carbon metabolism in cancer
TTDR00148;hsa05231;Choline metabolism in cancer
TTDR00151;hsa04610;Complement and coagulation cascades
TTDR00152;hsa04068;FoxO signaling pathway
TTDR00152;hsa04110;Cell cycle
TTDR00152;hsa04114;Oocyte meiosis
TTDR00152;hsa04115;p53 signaling pathway
TTDR00152;hsa04914;Progesterone-mediated oocyte maturation
TTDR00154;hsa00052;Galactose metabolism
TTDR00154;hsa01100;Metabolic pathways
TTDR00154;hsa04973;Carbohydrate digestion and absorption
TTDR00157;hsa04014;Ras signaling pathway
TTDR00157;hsa04020;Calcium signaling pathway
TTDR00157;hsa04080;Neuroactive ligand-receptor interaction
TTDR00157;hsa04726;Serotonergic synapse
TTDR00159;hsa00970;Aminoacyl-tRNA biosynthesis
TTDR00164;hsa04080;Neuroactive ligand-receptor interaction
TTDR00164;hsa04725;Cholinergic synapse
TTDR00165;mtc00473;D-Alanine metabolism
TTDR00165;mtc00550;Peptidoglycan biosynthesis
TTDR00165;mtc01100;Metabolic pathways
TTDR00165;mtc01502;Vancomycin resistance
TTDR00171;hsa00240;Pyrimidine metabolism
TTDR00171;hsa00250;Alanine, aspartate and glutamate metabolism
TTDR00171;hsa01100;Metabolic pathways
TTDR00172;hsa00564;Glycerophospholipid metabolism
TTDR00172;hsa01100;Metabolic pathways
TTDR00172;hsa05231;Choline metabolism in cancer
TTDR00173;hsa00230;Purine metabolism
TTDR00173;hsa04015;Rap1 signaling pathway
TTDR00173;hsa04020;Calcium signaling pathway
TTDR00173;hsa04022;cGMP-PKG signaling pathway
TTDR00173;hsa04024;cAMP signaling pathway
TTDR00173;hsa04062;Chemokine signaling pathway
TTDR00173;hsa04114;Oocyte meiosis
TTDR00173;hsa04261;Adrenergic signaling in cardiomyocytes
TTDR00173;hsa04270;Vascular smooth muscle contraction
TTDR00173;hsa04540;Gap junction
TTDR00173;hsa04611;Platelet activation
TTDR00173;hsa04713;Circadian entrainment
TTDR00173;hsa04723;Retrograde endocannabinoid signaling
TTDR00173;hsa04724;Glutamatergic synapse
TTDR00173;hsa04725;Cholinergic synapse
TTDR00173;hsa04727;GABAergic synapse
TTDR00173;hsa04750;Inflammatory mediator regulation of TRP channels
TTDR00173;hsa04911;Insulin secretion
TTDR00173;hsa04912;GnRH signaling pathway
TTDR00173;hsa04913;Ovarian steroidogenesis
TTDR00173;hsa04914;Progesterone-mediated oocyte maturation
TTDR00173;hsa04915;Estrogen signaling pathway
TTDR00173;hsa04916;Melanogenesis
TTDR00173;hsa04918;Thyroid hormone synthesis
TTDR00173;hsa04921;Oxytocin signaling pathway
TTDR00173;hsa04922;Glucagon signaling pathway
TTDR00173;hsa04923;Regulation of lipolysis in adipocytes
TTDR00173;hsa04970;Salivary secretion
TTDR00173;hsa04971;Gastric acid secretion
TTDR00173;hsa04972;Pancreatic secretion
TTDR00173;hsa04976;Bile secretion
TTDR00173;hsa05032;Morphine addiction
TTDR00173;hsa05166;HTLV-I infection
TTDR00173;hsa05200;Pathways in cancer
TTDR00173;hsa05414;Dilated cardiomyopathy
TTDR00184;hsa04080;Neuroactive ligand-receptor interaction
TTDR00192;hsa04060;Cytokine-cytokine receptor interaction
TTDR00197;hsa04614;Renin-angiotensin system
TTDR00199;hsa04010;MAPK signaling pathway
TTDR00199;hsa04020;Calcium signaling pathway
TTDR00199;hsa04721;Synaptic vesicle cycle
TTDR00199;hsa04723;Retrograde endocannabinoid signaling
TTDR00199;hsa04724;Glutamatergic synapse
TTDR00199;hsa04725;Cholinergic synapse
TTDR00199;hsa04726;Serotonergic synapse
TTDR00199;hsa04727;GABAergic synapse
TTDR00199;hsa04728;Dopaminergic synapse
TTDR00199;hsa04730;Long-term depression
TTDR00199;hsa04742;Taste transduction
TTDR00199;hsa04930;Type II diabetes mellitus
TTDR00199;hsa05032;Morphine addiction
TTDR00199;hsa05033;Nicotine addiction
TTDR00200;hsa04010;MAPK signaling pathway
TTDR00200;hsa04020;Calcium signaling pathway
TTDR00200;hsa04930;Type II diabetes mellitus
TTDR00202;hsa04110;Cell cycle
TTDR00202;hsa04914;Progesterone-mediated oocyte maturation
TTDR00202;hsa05206;MicroRNAs in cancer
TTDR00205;hsa04060;Cytokine-cytokine receptor interaction
TTDR00205;hsa04062;Chemokine signaling pathway
TTDR00205;hsa04064;NF-kappa B signaling pathway
TTDR00205;hsa04620;Toll-like receptor signaling pathway
TTDR00205;hsa04621;NOD-like receptor signaling pathway
TTDR00205;hsa04622;RIG-I-like receptor signaling pathway
TTDR00205;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDR00205;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDR00205;hsa05131;Shigellosis
TTDR00205;hsa05132;Salmonella infection
TTDR00205;hsa05133;Pertussis
TTDR00205;hsa05134;Legionellosis
TTDR00205;hsa05142;Chagas disease (American trypanosomiasis)
TTDR00205;hsa05144;Malaria
TTDR00205;hsa05146;Amoebiasis
TTDR00205;hsa05160;Hepatitis C
TTDR00205;hsa05161;Hepatitis B
TTDR00205;hsa05164;Influenza A
TTDR00205;hsa05200;Pathways in cancer
TTDR00205;hsa05202;Transcriptional misregulation in cancer
TTDR00205;hsa05219;Bladder cancer
TTDR00205;hsa05323;Rheumatoid arthritis
TTDR00208;hsa04110;Cell cycle
TTDR00208;hsa04114;Oocyte meiosis
TTDR00208;hsa04914;Progesterone-mediated oocyte maturation
TTDR00208;hsa05206;MicroRNAs in cancer
TTDR00209;hsa00910;Nitrogen metabolism
TTDR00209;hsa04964;Proximal tubule bicarbonate reclamation
TTDR00210;hsa00910;Nitrogen metabolism
TTDR00211;hsa00910;Nitrogen metabolism
TTDR00212;hsa00910;Nitrogen metabolism
TTDR00213;hsa00910;Nitrogen metabolism
TTDR00217;hsa04151;PI3K-Akt signaling pathway
TTDR00217;hsa04510;Focal adhesion
TTDR00217;hsa04512;ECM-receptor interaction
TTDR00217;hsa04514;Cell adhesion molecules (CAMs)
TTDR00217;hsa04640;Hematopoietic cell lineage
TTDR00217;hsa04670;Leukocyte transendothelial migration
TTDR00217;hsa04672;Intestinal immune network for IgA production
TTDR00217;hsa04810;Regulation of actin cytoskeleton
TTDR00217;hsa05140;Leishmaniasis
TTDR00217;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDR00217;hsa05412;Arrhythmogenic right ventricular cardiomyopathy (ARVC)
TTDR00217;hsa05414;Dilated cardiomyopathy
TTDR00219;hsa00230;Purine metabolism
TTDR00219;hsa00983;Drug metabolism - other enzymes
TTDR00219;hsa01100;Metabolic pathways
TTDR00221;hsa04744;Phototransduction
TTDR00222;hsa00250;Alanine, aspartate and glutamate metabolism
TTDR00222;hsa00270;Cysteine and methionine metabolism
TTDR00222;hsa00330;Arginine and proline metabolism
TTDR00222;hsa00350;Tyrosine metabolism
TTDR00222;hsa00360;Phenylalanine metabolism
TTDR00222;hsa00400;Phenylalanine, tyrosine and tryptophan biosynthesis
TTDR00222;hsa01100;Metabolic pathways
TTDR00222;hsa01130;Biosynthesis of antibiotics
TTDR00222;hsa01200;Carbon metabolism
TTDR00222;hsa01210;2-Oxocarboxylic acid metabolism
TTDR00222;hsa01230;Biosynthesis of amino acids
TTDR00224;hsa03030;DNA replication
TTDR00224;hsa03410;Base excision repair
TTDR00224;hsa03420;Nucleotide excision repair
TTDR00224;hsa03430;Mismatch repair
TTDR00224;hsa04110;Cell cycle
TTDR00224;hsa05161;Hepatitis B
TTDR00224;hsa05166;HTLV-I infection
TTDR00225;hsa04144;Endocytosis
TTDR00225;hsa04913;Ovarian steroidogenesis
TTDR00225;hsa04976;Bile secretion
TTDR00225;hsa05145;Toxoplasmosis
TTDR00225;hsa05160;Hepatitis C
TTDR00226;hsa00260;Glycine, serine and threonine metabolism
TTDR00226;hsa00460;Cyanoamino acid metabolism
TTDR00226;hsa00630;Glyoxylate and dicarboxylate metabolism
TTDR00226;hsa00670;One carbon pool by folate
TTDR00226;hsa01100;Metabolic pathways
TTDR00226;hsa01130;Biosynthesis of antibiotics
TTDR00226;hsa01200;Carbon metabolism
TTDR00226;hsa01230;Biosynthesis of amino acids
TTDR00231;hsa00240;Pyrimidine metabolism
TTDR00231;hsa00983;Drug metabolism - other enzymes
TTDR00231;hsa01100;Metabolic pathways
TTDR00233;hsa04064;NF-kappa B signaling pathway
TTDR00233;hsa04380;Osteoclast differentiation
TTDR00233;hsa04611;Platelet activation
TTDR00233;hsa04662;B cell receptor signaling pathway
TTDR00233;hsa04664;Fc epsilon RI signaling pathway
TTDR00233;hsa05340;Primary immunodeficiency
TTDR00234;hsa00590;Arachidonic acid metabolism
TTDR00234;hsa00591;Linoleic acid metabolism
TTDR00234;hsa01100;Metabolic pathways
TTDR00234;hsa04726;Serotonergic synapse
TTDR00238;hsa04060;Cytokine-cytokine receptor interaction
TTDR00238;hsa04080;Neuroactive ligand-receptor interaction
TTDR00238;hsa04152;AMPK signaling pathway
TTDR00238;hsa04630;Jak-STAT signaling pathway
TTDR00238;hsa04920;Adipocytokine signaling pathway
TTDR00238;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDR00239;hsa00590;Arachidonic acid metabolism
TTDR00239;hsa01100;Metabolic pathways
TTDR00239;hsa04726;Serotonergic synapse
TTDR00239;hsa04750;Inflammatory mediator regulation of TRP channels
TTDR00242;hsa00140;Steroid hormone biosynthesis
TTDR00242;hsa00380;Tryptophan metabolism
TTDR00242;hsa00980;Metabolism of xenobiotics by cytochrome P450
TTDR00242;hsa04913;Ovarian steroidogenesis
TTDR00242;hsa05204;Chemical carcinogenesis
TTDR00242;hsa05206;MicroRNAs in cancer
TTDR00249;hsa00330;Arginine and proline metabolism
TTDR00249;hsa01100;Metabolic pathways
TTDR00249;hsa01130;Biosynthesis of antibiotics
TTDR00251;hsa00240;Pyrimidine metabolism
TTDR00251;hsa00983;Drug metabolism - other enzymes
TTDR00251;hsa01100;Metabolic pathways
TTDR00251;hsa05219;Bladder cancer
TTDR00252;hsa05205;Proteoglycans in cancer
TTDR00256;hsa00230;Purine metabolism
TTDR00256;hsa04022;cGMP-PKG signaling pathway
TTDR00256;hsa05032;Morphine addiction
TTDR00261;hsa04916;Melanogenesis
TTDR00261;hsa04920;Adipocytokine signaling pathway
TTDR00262;hsa04962;Vasopressin-regulated water reabsorption
TTDR00265;hsa04146;Peroxisome
TTDR00265;hsa05014;Amyotrophic lateral sclerosis (ALS)
TTDR00265;hsa05016;Huntington's disease
TTDR00265;hsa05020;Prion diseases
TTDR00266;hsa04080;Neuroactive ligand-receptor interaction
TTDR00266;hsa04750;Inflammatory mediator regulation of TRP channels
TTDR00268;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDR00268;hsa04950;Maturity onset diabetes of the young
TTDR00269;hsa04152;AMPK signaling pathway
TTDR00269;hsa04950;Maturity onset diabetes of the young
TTDR00273;hsa03320;PPAR signaling pathway
TTDR00273;hsa04068;FoxO signaling pathway
TTDR00273;hsa04071;Sphingolipid signaling pathway
TTDR00273;hsa04150;mTOR signaling pathway
TTDR00273;hsa04151;PI3K-Akt signaling pathway
TTDR00273;hsa04152;AMPK signaling pathway
TTDR00273;hsa04510;Focal adhesion
TTDR00273;hsa04660;T cell receptor signaling pathway
TTDR00273;hsa04664;Fc epsilon RI signaling pathway
TTDR00273;hsa04722;Neurotrophin signaling pathway
TTDR00273;hsa04910;Insulin signaling pathway
TTDR00273;hsa04919;Thyroid hormone signaling pathway
TTDR00273;hsa04960;Aldosterone-regulated sodium reabsorption
TTDR00273;hsa05145;Toxoplasmosis
TTDR00273;hsa05160;Hepatitis C
TTDR00273;hsa05205;Proteoglycans in cancer
TTDR00273;hsa05213;Endometrial cancer
TTDR00273;hsa05215;Prostate cancer
TTDR00273;hsa05223;Non-small cell lung cancer
TTDR00273;hsa05231;Choline metabolism in cancer
TTDR00274;hsa00983;Drug metabolism - other enzymes
TTDR00274;hsa01100;Metabolic pathways
TTDR00275;hsa00061;Fatty acid biosynthesis
TTDR00275;hsa00620;Pyruvate metabolism
TTDR00275;hsa00640;Propanoate metabolism
TTDR00275;hsa01100;Metabolic pathways
TTDR00275;hsa01212;Fatty acid metabolism
TTDR00275;hsa04152;AMPK signaling pathway
TTDR00275;hsa04910;Insulin signaling pathway
TTDR00275;hsa04922;Glucagon signaling pathway
TTDR00276;hsa04145;Phagosome
TTDR00276;hsa04151;PI3K-Akt signaling pathway
TTDR00276;hsa04510;Focal adhesion
TTDR00276;hsa04512;ECM-receptor interaction
TTDR00276;hsa04611;Platelet activation
TTDR00276;hsa04640;Hematopoietic cell lineage
TTDR00276;hsa04810;Regulation of actin cytoskeleton
TTDR00276;hsa05200;Pathways in cancer
TTDR00276;hsa05205;Proteoglycans in cancer
TTDR00276;hsa05222;Small cell lung cancer
TTDR00276;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDR00276;hsa05412;Arrhythmogenic right ventricular cardiomyopathy (ARVC)
TTDR00276;hsa05414;Dilated cardiomyopathy
TTDR00278;hsa04020;Calcium signaling pathway
TTDR00278;hsa04080;Neuroactive ligand-receptor interaction
TTDR00280;hsa04062;Chemokine signaling pathway
TTDR00280;hsa04144;Endocytosis
TTDR00280;hsa04724;Glutamatergic synapse
TTDR00280;hsa05032;Morphine addiction
TTDR00283;hsa04010;MAPK signaling pathway
TTDR00283;hsa04064;NF-kappa B signaling pathway
TTDR00283;hsa04145;Phagosome
TTDR00283;hsa04620;Toll-like receptor signaling pathway
TTDR00283;hsa04640;Hematopoietic cell lineage
TTDR00283;hsa04810;Regulation of actin cytoskeleton
TTDR00283;hsa05130;Pathogenic Escherichia coli infection
TTDR00283;hsa05132;Salmonella infection
TTDR00283;hsa05133;Pertussis
TTDR00283;hsa05134;Legionellosis
TTDR00283;hsa05146;Amoebiasis
TTDR00283;hsa05152;Tuberculosis
TTDR00283;hsa05202;Transcriptional misregulation in cancer
TTDR00284;hsa04060;Cytokine-cytokine receptor interaction
TTDR00284;hsa04064;NF-kappa B signaling pathway
TTDR00284;hsa04514;Cell adhesion molecules (CAMs)
TTDR00284;hsa04660;T cell receptor signaling pathway
TTDR00284;hsa04672;Intestinal immune network for IgA production
TTDR00284;hsa05144;Malaria
TTDR00284;hsa05145;Toxoplasmosis
TTDR00284;hsa05310;Asthma
TTDR00284;hsa05320;Autoimmune thyroid disease
TTDR00284;hsa05322;Systemic lupus erythematosus
TTDR00284;hsa05330;Allograft rejection
TTDR00284;hsa05340;Primary immunodeficiency
TTDR00284;hsa05416;Viral myocarditis
TTDR00288;hsa02010;ABC transporters
TTDR00288;hsa04975;Fat digestion and absorption
TTDR00293;hsa04540;Gap junction
TTDR00293;hsa05412;Arrhythmogenic right ventricular cardiomyopathy (ARVC)
TTDR00296;hsa04360;Axon guidance
TTDR00296;hsa05010;Alzheimer's disease
TTDR00296;hsa05030;Cocaine addiction
TTDR00303;sme00061;Fatty acid biosynthesis
TTDR00303;sme00780;Biotin metabolism
TTDR00303;sme01100;Metabolic pathways
TTDR00303;sme01212;Fatty acid metabolism
TTDR00304;sme00061;Fatty acid biosynthesis
TTDR00304;sme00780;Biotin metabolism
TTDR00304;sme01100;Metabolic pathways
TTDR00304;sme01212;Fatty acid metabolism
TTDR00309;hsa03320;PPAR signaling pathway
TTDR00310;hsa04145;Phagosome
TTDR00310;hsa05150;Staphylococcus aureus infection
TTDR00311;hsa04145;Phagosome
TTDR00311;hsa04380;Osteoclast differentiation
TTDR00311;hsa04640;Hematopoietic cell lineage
TTDR00311;hsa04666;Fc gamma R-mediated phagocytosis
TTDR00311;hsa05140;Leishmaniasis
TTDR00311;hsa05150;Staphylococcus aureus infection
TTDR00311;hsa05152;Tuberculosis
TTDR00311;hsa05202;Transcriptional misregulation in cancer
TTDR00311;hsa05322;Systemic lupus erythematosus
TTDR00321;hsa04080;Neuroactive ligand-receptor interaction
TTDR00321;hsa04724;Glutamatergic synapse
TTDR00321;hsa05030;Cocaine addiction
TTDR00322;hsa04060;Cytokine-cytokine receptor interaction
TTDR00322;hsa04630;Jak-STAT signaling pathway
TTDR00322;hsa04640;Hematopoietic cell lineage
TTDR00322;hsa04650;Natural killer cell mediated cytotoxicity
TTDR00322;hsa04660;T cell receptor signaling pathway
TTDR00322;hsa04664;Fc epsilon RI signaling pathway
TTDR00322;hsa04668;TNF signaling pathway
TTDR00322;hsa05132;Salmonella infection
TTDR00322;hsa05146;Amoebiasis
TTDR00322;hsa05166;HTLV-I infection
TTDR00322;hsa05202;Transcriptional misregulation in cancer
TTDR00322;hsa05323;Rheumatoid arthritis
TTDR00334;hsa04010;MAPK signaling pathway
TTDR00334;hsa04012;ErbB signaling pathway
TTDR00334;hsa04014;Ras signaling pathway
TTDR00334;hsa04024;cAMP signaling pathway
TTDR00334;hsa04068;FoxO signaling pathway
TTDR00334;hsa04071;Sphingolipid signaling pathway
TTDR00334;hsa04141;Protein processing in endoplasmic reticulum
TTDR00334;hsa04310;Wnt signaling pathway
TTDR00334;hsa04380;Osteoclast differentiation
TTDR00334;hsa04510;Focal adhesion
TTDR00334;hsa04620;Toll-like receptor signaling pathway
TTDR00334;hsa04621;NOD-like receptor signaling pathway
TTDR00334;hsa04622;RIG-I-like receptor signaling pathway
TTDR00334;hsa04660;T cell receptor signaling pathway
TTDR00334;hsa04664;Fc epsilon RI signaling pathway
TTDR00334;hsa04668;TNF signaling pathway
TTDR00334;hsa04722;Neurotrophin signaling pathway
TTDR00334;hsa04723;Retrograde endocannabinoid signaling
TTDR00334;hsa04728;Dopaminergic synapse
TTDR00334;hsa04750;Inflammatory mediator regulation of TRP channels
TTDR00334;hsa04910;Insulin signaling pathway
TTDR00334;hsa04912;GnRH signaling pathway
TTDR00334;hsa04914;Progesterone-mediated oocyte maturation
TTDR00334;hsa04917;Prolactin signaling pathway
TTDR00334;hsa04920;Adipocytokine signaling pathway
TTDR00334;hsa04930;Type II diabetes mellitus
TTDR00334;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDR00334;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDR00334;hsa05131;Shigellosis
TTDR00334;hsa05132;Salmonella infection
TTDR00334;hsa05133;Pertussis
TTDR00334;hsa05142;Chagas disease (American trypanosomiasis)
TTDR00334;hsa05145;Toxoplasmosis
TTDR00334;hsa05152;Tuberculosis
TTDR00334;hsa05160;Hepatitis C
TTDR00334;hsa05161;Hepatitis B
TTDR00334;hsa05164;Influenza A
TTDR00334;hsa05168;Herpes simplex infection
TTDR00334;hsa05169;Epstein-Barr virus infection
TTDR00334;hsa05200;Pathways in cancer
TTDR00334;hsa05210;Colorectal cancer
TTDR00334;hsa05212;Pancreatic cancer
TTDR00334;hsa05231;Choline metabolism in cancer
TTDR00337;hsa04010;MAPK signaling pathway
TTDR00337;hsa04540;Gap junction
TTDR00337;hsa04912;GnRH signaling pathway
TTDR00341;mmu04010;MAPK signaling pathway
TTDR00341;mmu04932;Non-alcoholic fatty liver disease (NAFLD)
TTDR00347;hsa04024;cAMP signaling pathway
TTDR00347;hsa04260;Cardiac muscle contraction
TTDR00347;hsa04261;Adrenergic signaling in cardiomyocytes
TTDR00347;hsa04810;Regulation of actin cytoskeleton
TTDR00347;hsa04919;Thyroid hormone signaling pathway
TTDR00347;hsa04970;Salivary secretion
TTDR00347;hsa04971;Gastric acid secretion
TTDR00347;hsa04972;Pancreatic secretion
TTDR00347;hsa04976;Bile secretion
TTDR00347;hsa05205;Proteoglycans in cancer
TTDR00350;hsa04970;Salivary secretion
TTDR00350;hsa04978;Mineral absorption
TTDR00352;hsa04010;MAPK signaling pathway
TTDR00352;hsa04015;Rap1 signaling pathway
TTDR00352;hsa04068;FoxO signaling pathway
TTDR00352;hsa04071;Sphingolipid signaling pathway
TTDR00352;hsa04261;Adrenergic signaling in cardiomyocytes
TTDR00352;hsa04370;VEGF signaling pathway
TTDR00352;hsa04380;Osteoclast differentiation
TTDR00352;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDR00352;hsa04611;Platelet activation
TTDR00352;hsa04620;Toll-like receptor signaling pathway
TTDR00352;hsa04621;NOD-like receptor signaling pathway
TTDR00352;hsa04622;RIG-I-like receptor signaling pathway
TTDR00352;hsa04660;T cell receptor signaling pathway
TTDR00352;hsa04664;Fc epsilon RI signaling pathway
TTDR00352;hsa04668;TNF signaling pathway
TTDR00352;hsa04670;Leukocyte transendothelial migration
TTDR00352;hsa04722;Neurotrophin signaling pathway
TTDR00352;hsa04723;Retrograde endocannabinoid signaling
TTDR00352;hsa04728;Dopaminergic synapse
TTDR00352;hsa04750;Inflammatory mediator regulation of TRP channels
TTDR00352;hsa04912;GnRH signaling pathway
TTDR00352;hsa04914;Progesterone-mediated oocyte maturation
TTDR00352;hsa04917;Prolactin signaling pathway
TTDR00352;hsa05014;Amyotrophic lateral sclerosis (ALS)
TTDR00352;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDR00352;hsa05131;Shigellosis
TTDR00352;hsa05132;Salmonella infection
TTDR00352;hsa05133;Pertussis
TTDR00352;hsa05140;Leishmaniasis
TTDR00352;hsa05142;Chagas disease (American trypanosomiasis)
TTDR00352;hsa05145;Toxoplasmosis
TTDR00352;hsa05152;Tuberculosis
TTDR00352;hsa05160;Hepatitis C
TTDR00352;hsa05164;Influenza A
TTDR00352;hsa05169;Epstein-Barr virus infection
TTDR00352;hsa05205;Proteoglycans in cancer
TTDR00355;hsa04622;RIG-I-like receptor signaling pathway
TTDR00356;hsa00562;Inositol phosphate metabolism
TTDR00356;hsa04012;ErbB signaling pathway
TTDR00356;hsa04014;Ras signaling pathway
TTDR00356;hsa04015;Rap1 signaling pathway
TTDR00356;hsa04022;cGMP-PKG signaling pathway
TTDR00356;hsa04024;cAMP signaling pathway
TTDR00356;hsa04062;Chemokine signaling pathway
TTDR00356;hsa04066;HIF-1 signaling pathway
TTDR00356;hsa04068;FoxO signaling pathway
TTDR00356;hsa04070;Phosphatidylinositol signaling system
TTDR00356;hsa04071;Sphingolipid signaling pathway
TTDR00356;hsa04150;mTOR signaling pathway
TTDR00356;hsa04151;PI3K-Akt signaling pathway
TTDR00356;hsa04152;AMPK signaling pathway
TTDR00356;hsa04210;Apoptosis
TTDR00356;hsa04261;Adrenergic signaling in cardiomyocytes
TTDR00356;hsa04370;VEGF signaling pathway
TTDR00356;hsa04380;Osteoclast differentiation
TTDR00356;hsa04510;Focal adhesion
TTDR00356;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDR00356;hsa04611;Platelet activation
TTDR00356;hsa04620;Toll-like receptor signaling pathway
TTDR00356;hsa04630;Jak-STAT signaling pathway
TTDR00356;hsa04650;Natural killer cell mediated cytotoxicity
TTDR00356;hsa04660;T cell receptor signaling pathway
TTDR00356;hsa04662;B cell receptor signaling pathway
TTDR00356;hsa04664;Fc epsilon RI signaling pathway
TTDR00356;hsa04666;Fc gamma R-mediated phagocytosis
TTDR00356;hsa04668;TNF signaling pathway
TTDR00356;hsa04670;Leukocyte transendothelial migration
TTDR00356;hsa04722;Neurotrophin signaling pathway
TTDR00356;hsa04725;Cholinergic synapse
TTDR00356;hsa04750;Inflammatory mediator regulation of TRP channels
TTDR00356;hsa04810;Regulation of actin cytoskeleton
TTDR00356;hsa04910;Insulin signaling pathway
TTDR00356;hsa04914;Progesterone-mediated oocyte maturation
TTDR00356;hsa04915;Estrogen signaling pathway
TTDR00356;hsa04917;Prolactin signaling pathway
TTDR00356;hsa04919;Thyroid hormone signaling pathway
TTDR00356;hsa04921;Oxytocin signaling pathway
TTDR00356;hsa04923;Regulation of lipolysis in adipocytes
TTDR00356;hsa04930;Type II diabetes mellitus
TTDR00356;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDR00356;hsa04960;Aldosterone-regulated sodium reabsorption
TTDR00356;hsa04973;Carbohydrate digestion and absorption
TTDR00356;hsa05100;Bacterial invasion of epithelial cells
TTDR00356;hsa05142;Chagas disease (American trypanosomiasis)
TTDR00356;hsa05145;Toxoplasmosis
TTDR00356;hsa05146;Amoebiasis
TTDR00356;hsa05160;Hepatitis C
TTDR00356;hsa05161;Hepatitis B
TTDR00356;hsa05162;Measles
TTDR00356;hsa05164;Influenza A
TTDR00356;hsa05166;HTLV-I infection
TTDR00356;hsa05169;Epstein-Barr virus infection
TTDR00356;hsa05200;Pathways in cancer
TTDR00356;hsa05203;Viral carcinogenesis
TTDR00356;hsa05205;Proteoglycans in cancer
TTDR00356;hsa05206;MicroRNAs in cancer
TTDR00356;hsa05210;Colorectal cancer
TTDR00356;hsa05211;Renal cell carcinoma
TTDR00356;hsa05212;Pancreatic cancer
TTDR00356;hsa05213;Endometrial cancer
TTDR00356;hsa05214;Glioma
TTDR00356;hsa05215;Prostate cancer
TTDR00356;hsa05218;Melanoma
TTDR00356;hsa05220;Chronic myeloid leukemia
TTDR00356;hsa05221;Acute myeloid leukemia
TTDR00356;hsa05222;Small cell lung cancer
TTDR00356;hsa05223;Non-small cell lung cancer
TTDR00356;hsa05230;Central carbon metabolism in cancer
TTDR00356;hsa05231;Choline metabolism in cancer
TTDR00360;ape00400;Phenylalanine, tyrosine and tryptophan biosynthesis
TTDR00360;ape01100;Metabolic pathways
TTDR00360;ape01110;Biosynthesis of secondary metabolites
TTDR00360;ape01130;Biosynthesis of antibiotics
TTDR00360;ape01230;Biosynthesis of amino acids
TTDR00363;hsa03015;mRNA surveillance pathway
TTDR00363;hsa04071;Sphingolipid signaling pathway
TTDR00363;hsa04114;Oocyte meiosis
TTDR00363;hsa04151;PI3K-Akt signaling pathway
TTDR00363;hsa04152;AMPK signaling pathway
TTDR00363;hsa04261;Adrenergic signaling in cardiomyocytes
TTDR00363;hsa04728;Dopaminergic synapse
TTDR00372;hsa04010;MAPK signaling pathway
TTDR00372;hsa04012;ErbB signaling pathway
TTDR00372;hsa04014;Ras signaling pathway
TTDR00372;hsa04015;Rap1 signaling pathway
TTDR00372;hsa04022;cGMP-PKG signaling pathway
TTDR00372;hsa04024;cAMP signaling pathway
TTDR00372;hsa04062;Chemokine signaling pathway
TTDR00372;hsa04066;HIF-1 signaling pathway
TTDR00372;hsa04068;FoxO signaling pathway
TTDR00372;hsa04071;Sphingolipid signaling pathway
TTDR00372;hsa04114;Oocyte meiosis
TTDR00372;hsa04150;mTOR signaling pathway
TTDR00372;hsa04151;PI3K-Akt signaling pathway
TTDR00372;hsa04261;Adrenergic signaling in cardiomyocytes
TTDR00372;hsa04270;Vascular smooth muscle contraction
TTDR00372;hsa04320;Dorso-ventral axis formation
TTDR00372;hsa04350;TGF-beta signaling pathway
TTDR00372;hsa04360;Axon guidance
TTDR00372;hsa04370;VEGF signaling pathway
TTDR00372;hsa04380;Osteoclast differentiation
TTDR00372;hsa04510;Focal adhesion
TTDR00372;hsa04520;Adherens junction
TTDR00372;hsa04540;Gap junction
TTDR00372;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDR00372;hsa04611;Platelet activation
TTDR00372;hsa04620;Toll-like receptor signaling pathway
TTDR00372;hsa04621;NOD-like receptor signaling pathway
TTDR00372;hsa04650;Natural killer cell mediated cytotoxicity
TTDR00372;hsa04660;T cell receptor signaling pathway
TTDR00372;hsa04662;B cell receptor signaling pathway
TTDR00372;hsa04664;Fc epsilon RI signaling pathway
TTDR00372;hsa04666;Fc gamma R-mediated phagocytosis
TTDR00372;hsa04668;TNF signaling pathway
TTDR00372;hsa04713;Circadian entrainment
TTDR00372;hsa04720;Long-term potentiation
TTDR00372;hsa04722;Neurotrophin signaling pathway
TTDR00372;hsa04723;Retrograde endocannabinoid signaling
TTDR00372;hsa04724;Glutamatergic synapse
TTDR00372;hsa04725;Cholinergic synapse
TTDR00372;hsa04726;Serotonergic synapse
TTDR00372;hsa04730;Long-term depression
TTDR00372;hsa04810;Regulation of actin cytoskeleton
TTDR00372;hsa04910;Insulin signaling pathway
TTDR00372;hsa04912;GnRH signaling pathway
TTDR00372;hsa04914;Progesterone-mediated oocyte maturation
TTDR00372;hsa04915;Estrogen signaling pathway
TTDR00372;hsa04916;Melanogenesis
TTDR00372;hsa04917;Prolactin signaling pathway
TTDR00372;hsa04919;Thyroid hormone signaling pathway
TTDR00372;hsa04921;Oxytocin signaling pathway
TTDR00372;hsa04930;Type II diabetes mellitus
TTDR00372;hsa04960;Aldosterone-regulated sodium reabsorption
TTDR00372;hsa05010;Alzheimer's disease
TTDR00372;hsa05020;Prion diseases
TTDR00372;hsa05034;Alcoholism
TTDR00372;hsa05131;Shigellosis
TTDR00372;hsa05132;Salmonella infection
TTDR00372;hsa05133;Pertussis
TTDR00372;hsa05140;Leishmaniasis
TTDR00372;hsa05142;Chagas disease (American trypanosomiasis)
TTDR00372;hsa05145;Toxoplasmosis
TTDR00372;hsa05152;Tuberculosis
TTDR00372;hsa05160;Hepatitis C
TTDR00372;hsa05161;Hepatitis B
TTDR00372;hsa05164;Influenza A
TTDR00372;hsa05200;Pathways in cancer
TTDR00372;hsa05203;Viral carcinogenesis
TTDR00372;hsa05205;Proteoglycans in cancer
TTDR00372;hsa05206;MicroRNAs in cancer
TTDR00372;hsa05210;Colorectal cancer
TTDR00372;hsa05211;Renal cell carcinoma
TTDR00372;hsa05212;Pancreatic cancer
TTDR00372;hsa05213;Endometrial cancer
TTDR00372;hsa05214;Glioma
TTDR00372;hsa05215;Prostate cancer
TTDR00372;hsa05216;Thyroid cancer
TTDR00372;hsa05218;Melanoma
TTDR00372;hsa05219;Bladder cancer
TTDR00372;hsa05220;Chronic myeloid leukemia
TTDR00372;hsa05221;Acute myeloid leukemia
TTDR00372;hsa05223;Non-small cell lung cancer
TTDR00372;hsa05230;Central carbon metabolism in cancer
TTDR00372;hsa05231;Choline metabolism in cancer
TTDR00373;hsa04010;MAPK signaling pathway
TTDR00373;hsa04012;ErbB signaling pathway
TTDR00373;hsa04014;Ras signaling pathway
TTDR00373;hsa04015;Rap1 signaling pathway
TTDR00373;hsa04022;cGMP-PKG signaling pathway
TTDR00373;hsa04024;cAMP signaling pathway
TTDR00373;hsa04062;Chemokine signaling pathway
TTDR00373;hsa04066;HIF-1 signaling pathway
TTDR00373;hsa04068;FoxO signaling pathway
TTDR00373;hsa04071;Sphingolipid signaling pathway
TTDR00373;hsa04114;Oocyte meiosis
TTDR00373;hsa04150;mTOR signaling pathway
TTDR00373;hsa04151;PI3K-Akt signaling pathway
TTDR00373;hsa04261;Adrenergic signaling in cardiomyocytes
TTDR00373;hsa04270;Vascular smooth muscle contraction
TTDR00373;hsa04320;Dorso-ventral axis formation
TTDR00373;hsa04350;TGF-beta signaling pathway
TTDR00373;hsa04360;Axon guidance
TTDR00373;hsa04370;VEGF signaling pathway
TTDR00373;hsa04380;Osteoclast differentiation
TTDR00373;hsa04510;Focal adhesion
TTDR00373;hsa04520;Adherens junction
TTDR00373;hsa04540;Gap junction
TTDR00373;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDR00373;hsa04611;Platelet activation
TTDR00373;hsa04620;Toll-like receptor signaling pathway
TTDR00373;hsa04621;NOD-like receptor signaling pathway
TTDR00373;hsa04650;Natural killer cell mediated cytotoxicity
TTDR00373;hsa04660;T cell receptor signaling pathway
TTDR00373;hsa04662;B cell receptor signaling pathway
TTDR00373;hsa04664;Fc epsilon RI signaling pathway
TTDR00373;hsa04666;Fc gamma R-mediated phagocytosis
TTDR00373;hsa04668;TNF signaling pathway
TTDR00373;hsa04713;Circadian entrainment
TTDR00373;hsa04720;Long-term potentiation
TTDR00373;hsa04722;Neurotrophin signaling pathway
TTDR00373;hsa04723;Retrograde endocannabinoid signaling
TTDR00373;hsa04724;Glutamatergic synapse
TTDR00373;hsa04725;Cholinergic synapse
TTDR00373;hsa04726;Serotonergic synapse
TTDR00373;hsa04730;Long-term depression
TTDR00373;hsa04810;Regulation of actin cytoskeleton
TTDR00373;hsa04910;Insulin signaling pathway
TTDR00373;hsa04912;GnRH signaling pathway
TTDR00373;hsa04914;Progesterone-mediated oocyte maturation
TTDR00373;hsa04915;Estrogen signaling pathway
TTDR00373;hsa04916;Melanogenesis
TTDR00373;hsa04917;Prolactin signaling pathway
TTDR00373;hsa04919;Thyroid hormone signaling pathway
TTDR00373;hsa04921;Oxytocin signaling pathway
TTDR00373;hsa04930;Type II diabetes mellitus
TTDR00373;hsa04960;Aldosterone-regulated sodium reabsorption
TTDR00373;hsa05010;Alzheimer's disease
TTDR00373;hsa05020;Prion diseases
TTDR00373;hsa05034;Alcoholism
TTDR00373;hsa05131;Shigellosis
TTDR00373;hsa05132;Salmonella infection
TTDR00373;hsa05133;Pertussis
TTDR00373;hsa05140;Leishmaniasis
TTDR00373;hsa05142;Chagas disease (American trypanosomiasis)
TTDR00373;hsa05145;Toxoplasmosis
TTDR00373;hsa05152;Tuberculosis
TTDR00373;hsa05160;Hepatitis C
TTDR00373;hsa05161;Hepatitis B
TTDR00373;hsa05164;Influenza A
TTDR00373;hsa05200;Pathways in cancer
TTDR00373;hsa05203;Viral carcinogenesis
TTDR00373;hsa05205;Proteoglycans in cancer
TTDR00373;hsa05210;Colorectal cancer
TTDR00373;hsa05211;Renal cell carcinoma
TTDR00373;hsa05212;Pancreatic cancer
TTDR00373;hsa05213;Endometrial cancer
TTDR00373;hsa05214;Glioma
TTDR00373;hsa05215;Prostate cancer
TTDR00373;hsa05216;Thyroid cancer
TTDR00373;hsa05218;Melanoma
TTDR00373;hsa05219;Bladder cancer
TTDR00373;hsa05220;Chronic myeloid leukemia
TTDR00373;hsa05221;Acute myeloid leukemia
TTDR00373;hsa05223;Non-small cell lung cancer
TTDR00373;hsa05230;Central carbon metabolism in cancer
TTDR00373;hsa05231;Choline metabolism in cancer
TTDR00374;hsa00564;Glycerophospholipid metabolism
TTDR00374;hsa00565;Ether lipid metabolism
TTDR00374;hsa01100;Metabolic pathways
TTDR00374;hsa04014;Ras signaling pathway
TTDR00374;hsa04024;cAMP signaling pathway
TTDR00374;hsa04071;Sphingolipid signaling pathway
TTDR00374;hsa04144;Endocytosis
TTDR00374;hsa04666;Fc gamma R-mediated phagocytosis
TTDR00374;hsa04724;Glutamatergic synapse
TTDR00374;hsa04912;GnRH signaling pathway
TTDR00374;hsa05200;Pathways in cancer
TTDR00374;hsa05212;Pancreatic cancer
TTDR00374;hsa05231;Choline metabolism in cancer
TTDR00375;hsa04080;Neuroactive ligand-receptor interaction
TTDR00381;hsa00072;Synthesis and degradation of ketone bodies
TTDR00381;hsa00280;Valine, leucine and isoleucine degradation
TTDR00381;hsa00650;Butanoate metabolism
TTDR00381;hsa00900;Terpenoid backbone biosynthesis
TTDR00381;hsa01100;Metabolic pathways
TTDR00381;hsa01130;Biosynthesis of antibiotics
TTDR00381;hsa03320;PPAR signaling pathway
TTDR00387;hsa04730;Long-term depression
TTDR00387;hsa05034;Alcoholism
TTDR00389;hsa04080;Neuroactive ligand-receptor interaction
TTDR00389;hsa04912;GnRH signaling pathway
TTDR00389;hsa04913;Ovarian steroidogenesis
TTDR00389;hsa04917;Prolactin signaling pathway
TTDR00389;hsa04918;Thyroid hormone synthesis
TTDR00389;hsa05320;Autoimmune thyroid disease
TTDR00395;hsa04610;Complement and coagulation cascades
TTDR00396;hsa04610;Complement and coagulation cascades
TTDR00397;hsa04068;FoxO signaling pathway
TTDR00397;hsa04110;Cell cycle
TTDR00397;hsa04115;p53 signaling pathway
TTDR00397;hsa04151;PI3K-Akt signaling pathway
TTDR00397;hsa04152;AMPK signaling pathway
TTDR00397;hsa04310;Wnt signaling pathway
TTDR00397;hsa04390;Hippo signaling pathway
TTDR00397;hsa04510;Focal adhesion
TTDR00397;hsa04630;Jak-STAT signaling pathway
TTDR00397;hsa04917;Prolactin signaling pathway
TTDR00397;hsa04919;Thyroid hormone signaling pathway
TTDR00397;hsa04921;Oxytocin signaling pathway
TTDR00397;hsa05161;Hepatitis B
TTDR00397;hsa05162;Measles
TTDR00397;hsa05166;HTLV-I infection
TTDR00397;hsa05200;Pathways in cancer
TTDR00397;hsa05203;Viral carcinogenesis
TTDR00397;hsa05205;Proteoglycans in cancer
TTDR00397;hsa05206;MicroRNAs in cancer
TTDR00397;hsa05210;Colorectal cancer
TTDR00397;hsa05212;Pancreatic cancer
TTDR00397;hsa05213;Endometrial cancer
TTDR00397;hsa05214;Glioma
TTDR00397;hsa05215;Prostate cancer
TTDR00397;hsa05216;Thyroid cancer
TTDR00397;hsa05218;Melanoma
TTDR00397;hsa05219;Bladder cancer
TTDR00397;hsa05220;Chronic myeloid leukemia
TTDR00397;hsa05221;Acute myeloid leukemia
TTDR00397;hsa05222;Small cell lung cancer
TTDR00397;hsa05223;Non-small cell lung cancer
TTDR00397;hsa05416;Viral myocarditis
TTDR00405;hsa04020;Calcium signaling pathway
TTDR00405;hsa04080;Neuroactive ligand-receptor interaction
TTDR00405;hsa04610;Complement and coagulation cascades
TTDR00405;hsa04750;Inflammatory mediator regulation of TRP channels
TTDR00405;hsa04810;Regulation of actin cytoskeleton
TTDR00405;hsa05200;Pathways in cancer
TTDR00406;hsa04610;Complement and coagulation cascades
TTDR00407;rno04020;Calcium signaling pathway
TTDR00407;rno04080;Neuroactive ligand-receptor interaction
TTDR00407;rno04610;Complement and coagulation cascades
TTDR00407;rno04750;Inflammatory mediator regulation of TRP channels
TTDR00407;rno04810;Regulation of actin cytoskeleton
TTDR00407;rno05200;Pathways in cancer
TTDR00411;hsa05010;Alzheimer's disease
TTDR00414;hsa00270;Cysteine and methionine metabolism
TTDR00414;hsa00330;Arginine and proline metabolism
TTDR00414;hsa01100;Metabolic pathways
TTDR00415;hsa00604;Glycosphingolipid biosynthesis - ganglio series
TTDR00415;hsa01100;Metabolic pathways
TTDR00418;hsa04060;Cytokine-cytokine receptor interaction
TTDR00418;hsa04080;Neuroactive ligand-receptor interaction
TTDR00418;hsa04151;PI3K-Akt signaling pathway
TTDR00418;hsa04630;Jak-STAT signaling pathway
TTDR00418;hsa04917;Prolactin signaling pathway
TTDR00420;hsa03320;PPAR signaling pathway
TTDR00420;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDR00420;hsa05160;Hepatitis C
TTDR00430;hsa04512;ECM-receptor interaction
TTDR00432;hsa04911;Insulin secretion
TTDR00433;hsa04115;p53 signaling pathway
TTDR00433;hsa04210;Apoptosis
TTDR00433;hsa04620;Toll-like receptor signaling pathway
TTDR00433;hsa04621;NOD-like receptor signaling pathway
TTDR00433;hsa04622;RIG-I-like receptor signaling pathway
TTDR00433;hsa04668;TNF signaling pathway
TTDR00433;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDR00433;hsa05010;Alzheimer's disease
TTDR00433;hsa05016;Huntington's disease
TTDR00433;hsa05134;Legionellosis
TTDR00433;hsa05142;Chagas disease (American trypanosomiasis)
TTDR00433;hsa05145;Toxoplasmosis
TTDR00433;hsa05152;Tuberculosis
TTDR00433;hsa05161;Hepatitis B
TTDR00433;hsa05168;Herpes simplex infection
TTDR00433;hsa05200;Pathways in cancer
TTDR00433;hsa05203;Viral carcinogenesis
TTDR00433;hsa05416;Viral myocarditis
TTDR00434;hsa04621;NOD-like receptor signaling pathway
TTDR00434;hsa04623;Cytosolic DNA-sensing pathway
TTDR00434;hsa05014;Amyotrophic lateral sclerosis (ALS)
TTDR00434;hsa05132;Salmonella infection
TTDR00434;hsa05133;Pertussis
TTDR00434;hsa05134;Legionellosis
TTDR00434;hsa05164;Influenza A
TTDR00440;hsa04010;MAPK signaling pathway
TTDR00440;hsa04115;p53 signaling pathway
TTDR00440;hsa04210;Apoptosis
TTDR00440;hsa04650;Natural killer cell mediated cytotoxicity
TTDR00440;hsa04668;TNF signaling pathway
TTDR00440;hsa04726;Serotonergic synapse
TTDR00440;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDR00440;hsa05010;Alzheimer's disease
TTDR00440;hsa05012;Parkinson's disease
TTDR00440;hsa05014;Amyotrophic lateral sclerosis (ALS)
TTDR00440;hsa05016;Huntington's disease
TTDR00440;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDR00440;hsa05133;Pertussis
TTDR00440;hsa05134;Legionellosis
TTDR00440;hsa05145;Toxoplasmosis
TTDR00440;hsa05146;Amoebiasis
TTDR00440;hsa05152;Tuberculosis
TTDR00440;hsa05161;Hepatitis B
TTDR00440;hsa05168;Herpes simplex infection
TTDR00440;hsa05200;Pathways in cancer
TTDR00440;hsa05203;Viral carcinogenesis
TTDR00440;hsa05205;Proteoglycans in cancer
TTDR00440;hsa05206;MicroRNAs in cancer
TTDR00440;hsa05210;Colorectal cancer
TTDR00440;hsa05416;Viral myocarditis
TTDR00441;hsa03320;PPAR signaling pathway
TTDR00443;hsa00564;Glycerophospholipid metabolism
TTDR00443;hsa00565;Ether lipid metabolism
TTDR00443;hsa00590;Arachidonic acid metabolism
TTDR00443;hsa00591;Linoleic acid metabolism
TTDR00443;hsa00592;alpha-Linolenic acid metabolism
TTDR00443;hsa01100;Metabolic pathways
TTDR00443;hsa04010;MAPK signaling pathway
TTDR00443;hsa04014;Ras signaling pathway
TTDR00443;hsa04270;Vascular smooth muscle contraction
TTDR00443;hsa04370;VEGF signaling pathway
TTDR00443;hsa04611;Platelet activation
TTDR00443;hsa04664;Fc epsilon RI signaling pathway
TTDR00443;hsa04666;Fc gamma R-mediated phagocytosis
TTDR00443;hsa04724;Glutamatergic synapse
TTDR00443;hsa04726;Serotonergic synapse
TTDR00443;hsa04730;Long-term depression
TTDR00443;hsa04750;Inflammatory mediator regulation of TRP channels
TTDR00443;hsa04912;GnRH signaling pathway
TTDR00443;hsa04913;Ovarian steroidogenesis
TTDR00443;hsa04921;Oxytocin signaling pathway
TTDR00443;hsa05231;Choline metabolism in cancer
TTDR00444;hsa04310;Wnt signaling pathway
TTDR00444;hsa04330;Notch signaling pathway
TTDR00444;hsa04722;Neurotrophin signaling pathway
TTDR00444;hsa05010;Alzheimer's disease
TTDR00445;hsa04330;Notch signaling pathway
TTDR00445;hsa04722;Neurotrophin signaling pathway
TTDR00445;hsa05010;Alzheimer's disease
TTDR00447;hsa04071;Sphingolipid signaling pathway
TTDR00447;hsa04142;Lysosome
TTDR00447;hsa05152;Tuberculosis
TTDR00451;hsa04060;Cytokine-cytokine receptor interaction
TTDR00451;hsa04062;Chemokine signaling pathway
TTDR00451;hsa04621;NOD-like receptor signaling pathway
TTDR00451;hsa04668;TNF signaling pathway
TTDR00451;hsa05142;Chagas disease (American trypanosomiasis)
TTDR00451;hsa05144;Malaria
TTDR00451;hsa05164;Influenza A
TTDR00451;hsa05168;Herpes simplex infection
TTDR00451;hsa05323;Rheumatoid arthritis
TTDR00458;hsa04060;Cytokine-cytokine receptor interaction
TTDR00458;hsa04151;PI3K-Akt signaling pathway
TTDR00458;hsa04630;Jak-STAT signaling pathway
TTDR00459;hsa05166;HTLV-I infection
TTDR00466;hsa00230;Purine metabolism
TTDR00466;hsa04024;cAMP signaling pathway
TTDR00466;hsa05032;Morphine addiction
TTDR00470;hsa04010;MAPK signaling pathway
TTDR00470;hsa04012;ErbB signaling pathway
TTDR00470;hsa04015;Rap1 signaling pathway
TTDR00470;hsa04062;Chemokine signaling pathway
TTDR00470;hsa04510;Focal adhesion
TTDR00470;hsa04666;Fc gamma R-mediated phagocytosis
TTDR00470;hsa04722;Neurotrophin signaling pathway
TTDR00470;hsa04810;Regulation of actin cytoskeleton
TTDR00470;hsa04910;Insulin signaling pathway
TTDR00470;hsa05100;Bacterial invasion of epithelial cells
TTDR00470;hsa05131;Shigellosis
TTDR00470;hsa05200;Pathways in cancer
TTDR00470;hsa05206;MicroRNAs in cancer
TTDR00470;hsa05211;Renal cell carcinoma
TTDR00470;hsa05220;Chronic myeloid leukemia
TTDR00473;hsa04145;Phagosome
TTDR00473;hsa04151;PI3K-Akt signaling pathway
TTDR00473;hsa04510;Focal adhesion
TTDR00473;hsa04512;ECM-receptor interaction
TTDR00473;hsa04514;Cell adhesion molecules (CAMs)
TTDR00473;hsa04810;Regulation of actin cytoskeleton
TTDR00473;hsa04919;Thyroid hormone signaling pathway
TTDR00473;hsa05200;Pathways in cancer
TTDR00473;hsa05205;Proteoglycans in cancer
TTDR00473;hsa05222;Small cell lung cancer
TTDR00473;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDR00473;hsa05412;Arrhythmogenic right ventricular cardiomyopathy (ARVC)
TTDR00473;hsa05414;Dilated cardiomyopathy
TTDR00476;hsa03320;PPAR signaling pathway
TTDR00478;hsa04010;MAPK signaling pathway
TTDR00478;hsa04722;Neurotrophin signaling pathway
TTDR00484;hsa04151;PI3K-Akt signaling pathway
TTDR00484;hsa04510;Focal adhesion
TTDR00484;hsa04512;ECM-receptor interaction
TTDR00484;hsa04620;Toll-like receptor signaling pathway
TTDR00489;hsa04919;Thyroid hormone signaling pathway
TTDR00498;hsa04060;Cytokine-cytokine receptor interaction
TTDR00498;hsa04062;Chemokine signaling pathway
TTDR00498;hsa04620;Toll-like receptor signaling pathway
TTDR00498;hsa04622;RIG-I-like receptor signaling pathway
TTDR00498;hsa04623;Cytosolic DNA-sensing pathway
TTDR00498;hsa04668;TNF signaling pathway
TTDR00498;hsa05164;Influenza A
TTDR00500;ecj00240;Pyrimidine metabolism
TTDR00500;ecj01100;Metabolic pathways
TTDR00503;hsa05200;Pathways in cancer
TTDR00503;hsa05215;Prostate cancer
TTDR00505;hsa04141;Protein processing in endoplasmic reticulum
TTDR00505;hsa04210;Apoptosis
TTDR00505;hsa05010;Alzheimer's disease
TTDR00510;hsa05203;Viral carcinogenesis
TTDR00511;hsa04010;MAPK signaling pathway
TTDR00511;hsa04060;Cytokine-cytokine receptor interaction
TTDR00511;hsa04068;FoxO signaling pathway
TTDR00511;hsa04110;Cell cycle
TTDR00511;hsa04144;Endocytosis
TTDR00511;hsa04350;TGF-beta signaling pathway
TTDR00511;hsa04380;Osteoclast differentiation
TTDR00511;hsa04390;Hippo signaling pathway
TTDR00511;hsa04672;Intestinal immune network for IgA production
TTDR00511;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDR00511;hsa05140;Leishmaniasis
TTDR00511;hsa05142;Chagas disease (American trypanosomiasis)
TTDR00511;hsa05144;Malaria
TTDR00511;hsa05145;Toxoplasmosis
TTDR00511;hsa05146;Amoebiasis
TTDR00511;hsa05152;Tuberculosis
TTDR00511;hsa05161;Hepatitis B
TTDR00511;hsa05166;HTLV-I infection
TTDR00511;hsa05200;Pathways in cancer
TTDR00511;hsa05205;Proteoglycans in cancer
TTDR00511;hsa05210;Colorectal cancer
TTDR00511;hsa05211;Renal cell carcinoma
TTDR00511;hsa05212;Pancreatic cancer
TTDR00511;hsa05220;Chronic myeloid leukemia
TTDR00511;hsa05321;Inflammatory bowel disease (IBD)
TTDR00511;hsa05323;Rheumatoid arthritis
TTDR00511;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDR00511;hsa05414;Dilated cardiomyopathy
TTDR00513;hsa04020;Calcium signaling pathway
TTDR00513;hsa04022;cGMP-PKG signaling pathway
TTDR00513;hsa04024;cAMP signaling pathway
TTDR00513;hsa04260;Cardiac muscle contraction
TTDR00513;hsa04261;Adrenergic signaling in cardiomyocytes
TTDR00513;hsa04919;Thyroid hormone signaling pathway
TTDR00513;hsa04972;Pancreatic secretion
TTDR00513;hsa05010;Alzheimer's disease
TTDR00513;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDR00513;hsa05412;Arrhythmogenic right ventricular cardiomyopathy (ARVC)
TTDR00513;hsa05414;Dilated cardiomyopathy
TTDR00518;hsa03410;Base excision repair
TTDR00519;hsa04060;Cytokine-cytokine receptor interaction
TTDR00519;hsa04630;Jak-STAT signaling pathway
TTDR00519;hsa04640;Hematopoietic cell lineage
TTDR00519;hsa05323;Rheumatoid arthritis
TTDR00525;hsa04512;ECM-receptor interaction
TTDR00525;hsa04640;Hematopoietic cell lineage
TTDR00525;hsa05131;Shigellosis
TTDR00525;hsa05169;Epstein-Barr virus infection
TTDR00525;hsa05205;Proteoglycans in cancer
TTDR00525;hsa05206;MicroRNAs in cancer
TTDR00526;hsa00260;Glycine, serine and threonine metabolism
TTDR00526;hsa00270;Cysteine and methionine metabolism
TTDR00526;hsa01100;Metabolic pathways
TTDR00526;hsa01130;Biosynthesis of antibiotics
TTDR00526;hsa01230;Biosynthesis of amino acids
TTDR00529;hsa00230;Purine metabolism
TTDR00529;hsa01100;Metabolic pathways
TTDR00530;hsa04080;Neuroactive ligand-receptor interaction
TTDR00530;hsa04916;Melanogenesis
TTDR00531;hsa04614;Renin-angiotensin system
TTDR00534;hsa04060;Cytokine-cytokine receptor interaction
TTDR00534;hsa04062;Chemokine signaling pathway
TTDR00537;hsa00230;Purine metabolism
TTDR00537;hsa00240;Pyrimidine metabolism
TTDR00537;hsa05169;Epstein-Barr virus infection
TTDR00542;hsa04060;Cytokine-cytokine receptor interaction
TTDR00542;hsa04630;Jak-STAT signaling pathway
TTDR00544;hsa04725;Cholinergic synapse
TTDR00545;hsa04020;Calcium signaling pathway
TTDR00545;hsa04080;Neuroactive ligand-receptor interaction
TTDR00556;hsa04066;HIF-1 signaling pathway
TTDR00556;hsa04115;p53 signaling pathway
TTDR00556;hsa04390;Hippo signaling pathway
TTDR00556;hsa04610;Complement and coagulation cascades
TTDR00556;hsa05142;Chagas disease (American trypanosomiasis)
TTDR00557;hsa04015;Rap1 signaling pathway
TTDR00557;hsa04062;Chemokine signaling pathway
TTDR00557;hsa04071;Sphingolipid signaling pathway
TTDR00557;hsa04144;Endocytosis
TTDR00557;hsa04151;PI3K-Akt signaling pathway
TTDR00557;hsa04390;Hippo signaling pathway
TTDR00557;hsa04530;Tight junction
TTDR00557;hsa04611;Platelet activation
TTDR00557;hsa04910;Insulin signaling pathway
TTDR00557;hsa04930;Type II diabetes mellitus
TTDR00562;hsa04080;Neuroactive ligand-receptor interaction
TTDR00564;hsa04024;cAMP signaling pathway
TTDR00564;hsa04080;Neuroactive ligand-receptor interaction
TTDR00564;hsa04726;Serotonergic synapse
TTDR00565;hsa04020;Calcium signaling pathway
TTDR00565;hsa04080;Neuroactive ligand-receptor interaction
TTDR00565;hsa04726;Serotonergic synapse
TTDR00567;hsa04010;MAPK signaling pathway
TTDR00567;hsa04014;Ras signaling pathway
TTDR00567;hsa04015;Rap1 signaling pathway
TTDR00567;hsa04151;PI3K-Akt signaling pathway
TTDR00567;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDR00567;hsa04810;Regulation of actin cytoskeleton
TTDR00567;hsa05200;Pathways in cancer
TTDR00567;hsa05205;Proteoglycans in cancer
TTDR00567;hsa05218;Melanoma
TTDR00568;ath00562;Inositol phosphate metabolism
TTDR00568;ath01100;Metabolic pathways
TTDR00568;ath04070;Phosphatidylinositol signaling system
TTDR00568;ath04140;Regulation of autophagy
TTDR00568;ath04145;Phagosome
TTDR00571;hsa04142;Lysosome
TTDR00580;hsa04015;Rap1 signaling pathway
TTDR00580;hsa04080;Neuroactive ligand-receptor interaction
TTDR00580;hsa04151;PI3K-Akt signaling pathway
TTDR00580;hsa04540;Gap junction
TTDR00580;hsa05200;Pathways in cancer
TTDR00583;hsa04024;cAMP signaling pathway
TTDR00587;hsa00140;Steroid hormone biosynthesis
TTDR00587;hsa01100;Metabolic pathways
TTDR00587;hsa04913;Ovarian steroidogenesis
TTDR00593;hsa04710;Circadian rhythm
TTDR00593;hsa05321;Inflammatory bowel disease (IBD)
TTDR00602;hin00760;Nicotinate and nicotinamide metabolism
TTDR00602;hin01100;Metabolic pathways
TTDR00611;hsa04514;Cell adhesion molecules (CAMs)
TTDR00611;hsa04660;T cell receptor signaling pathway
TTDR00611;hsa04666;Fc gamma R-mediated phagocytosis
TTDR00611;hsa05340;Primary immunodeficiency
TTDR00615;hsa00480;Glutathione metabolism
TTDR00615;hsa01100;Metabolic pathways
TTDR00619;mtu00630;Glyoxylate and dicarboxylate metabolism
TTDR00619;mtu01100;Metabolic pathways
TTDR00619;mtu01110;Biosynthesis of secondary metabolites
TTDR00619;mtu01120;Microbial metabolism in diverse environments
TTDR00619;mtu01200;Carbon metabolism
TTDR00620;hsa04010;MAPK signaling pathway
TTDR00620;hsa04020;Calcium signaling pathway
TTDR00620;hsa04022;cGMP-PKG signaling pathway
TTDR00620;hsa04024;cAMP signaling pathway
TTDR00620;hsa04260;Cardiac muscle contraction
TTDR00620;hsa04261;Adrenergic signaling in cardiomyocytes
TTDR00620;hsa04270;Vascular smooth muscle contraction
TTDR00620;hsa04713;Circadian entrainment
TTDR00620;hsa04723;Retrograde endocannabinoid signaling
TTDR00620;hsa04724;Glutamatergic synapse
TTDR00620;hsa04725;Cholinergic synapse
TTDR00620;hsa04726;Serotonergic synapse
TTDR00620;hsa04727;GABAergic synapse
TTDR00620;hsa04728;Dopaminergic synapse
TTDR00620;hsa04911;Insulin secretion
TTDR00620;hsa04912;GnRH signaling pathway
TTDR00620;hsa04921;Oxytocin signaling pathway
TTDR00620;hsa04930;Type II diabetes mellitus
TTDR00620;hsa04973;Carbohydrate digestion and absorption
TTDR00620;hsa05010;Alzheimer's disease
TTDR00620;hsa05031;Amphetamine addiction
TTDR00620;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDR00620;hsa05412;Arrhythmogenic right ventricular cardiomyopathy (ARVC)
TTDR00620;hsa05414;Dilated cardiomyopathy
TTDR00626;hsa05230;Central carbon metabolism in cancer
TTDR00630;hsa00590;Arachidonic acid metabolism
TTDR00630;hsa01100;Metabolic pathways
TTDR00633;mtu00760;Nicotinate and nicotinamide metabolism
TTDR00633;mtu01100;Metabolic pathways
TTDR00634;hsa03320;PPAR signaling pathway
TTDR00634;hsa04975;Fat digestion and absorption
TTDR00644;hsa05206;MicroRNAs in cancer
TTDR00650;hsa04151;PI3K-Akt signaling pathway
TTDR00650;hsa04510;Focal adhesion
TTDR00650;hsa04512;ECM-receptor interaction
TTDR00650;hsa04514;Cell adhesion molecules (CAMs)
TTDR00650;hsa04640;Hematopoietic cell lineage
TTDR00650;hsa04670;Leukocyte transendothelial migration
TTDR00650;hsa04672;Intestinal immune network for IgA production
TTDR00650;hsa04810;Regulation of actin cytoskeleton
TTDR00650;hsa05140;Leishmaniasis
TTDR00650;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDR00650;hsa05412;Arrhythmogenic right ventricular cardiomyopathy (ARVC)
TTDR00650;hsa05414;Dilated cardiomyopathy
TTDR00659;hsa00230;Purine metabolism
TTDR00659;hsa05222;Small cell lung cancer
TTDR00659;hsa05223;Non-small cell lung cancer
TTDR00661;hsa00020;Citrate cycle (TCA cycle)
TTDR00661;hsa00630;Glyoxylate and dicarboxylate metabolism
TTDR00661;hsa01100;Metabolic pathways
TTDR00661;hsa01130;Biosynthesis of antibiotics
TTDR00661;hsa01200;Carbon metabolism
TTDR00661;hsa01210;2-Oxocarboxylic acid metabolism
TTDR00661;hsa01230;Biosynthesis of amino acids
TTDR00662;hsa00052;Galactose metabolism
TTDR00662;hsa00520;Amino sugar and nucleotide sugar metabolism
TTDR00662;hsa01100;Metabolic pathways
TTDR00663;hsa03018;RNA degradation
TTDR00663;hsa04940;Type I diabetes mellitus
TTDR00663;hsa05134;Legionellosis
TTDR00663;hsa05152;Tuberculosis
TTDR00668;hsa04012;ErbB signaling pathway
TTDR00669;hsa04012;ErbB signaling pathway
TTDR00669;hsa04062;Chemokine signaling pathway
TTDR00669;hsa04151;PI3K-Akt signaling pathway
TTDR00669;hsa04360;Axon guidance
TTDR00669;hsa04370;VEGF signaling pathway
TTDR00669;hsa04510;Focal adhesion
TTDR00669;hsa04670;Leukocyte transendothelial migration
TTDR00669;hsa04810;Regulation of actin cytoskeleton
TTDR00669;hsa05100;Bacterial invasion of epithelial cells
TTDR00669;hsa05146;Amoebiasis
TTDR00669;hsa05200;Pathways in cancer
TTDR00669;hsa05202;Transcriptional misregulation in cancer
TTDR00669;hsa05205;Proteoglycans in cancer
TTDR00669;hsa05222;Small cell lung cancer
TTDR00673;hsa04020;Calcium signaling pathway
TTDR00673;hsa04080;Neuroactive ligand-receptor interaction
TTDR00673;hsa05200;Pathways in cancer
TTDR00677;hsa04630;Jak-STAT signaling pathway
TTDR00679;hsa04390;Hippo signaling pathway
TTDR00683;hsa04151;PI3K-Akt signaling pathway
TTDR00683;hsa04510;Focal adhesion
TTDR00683;hsa04512;ECM-receptor interaction
TTDR00683;hsa05206;MicroRNAs in cancer
TTDR00688;hsa05202;Transcriptional misregulation in cancer
TTDR00712;hsa04141;Protein processing in endoplasmic reticulum
TTDR00713;hsa04015;Rap1 signaling pathway
TTDR00713;hsa04310;Wnt signaling pathway
TTDR00713;hsa04390;Hippo signaling pathway
TTDR00713;hsa04510;Focal adhesion
TTDR00713;hsa04520;Adherens junction
TTDR00713;hsa04530;Tight junction
TTDR00713;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDR00713;hsa04670;Leukocyte transendothelial migration
TTDR00713;hsa04916;Melanogenesis
TTDR00713;hsa04919;Thyroid hormone signaling pathway
TTDR00713;hsa05100;Bacterial invasion of epithelial cells
TTDR00713;hsa05130;Pathogenic Escherichia coli infection
TTDR00713;hsa05166;HTLV-I infection
TTDR00713;hsa05200;Pathways in cancer
TTDR00713;hsa05205;Proteoglycans in cancer
TTDR00713;hsa05210;Colorectal cancer
TTDR00713;hsa05213;Endometrial cancer
TTDR00713;hsa05215;Prostate cancer
TTDR00713;hsa05216;Thyroid cancer
TTDR00713;hsa05217;Basal cell carcinoma
TTDR00713;hsa05412;Arrhythmogenic right ventricular cardiomyopathy (ARVC)
TTDR00716;hsa00900;Terpenoid backbone biosynthesis
TTDR00716;hsa01130;Biosynthesis of antibiotics
TTDR00722;hsa04514;Cell adhesion molecules (CAMs)
TTDR00731;hsa04080;Neuroactive ligand-receptor interaction
TTDR00732;hsa00330;Arginine and proline metabolism
TTDR00732;hsa01100;Metabolic pathways
TTDR00732;hsa01130;Biosynthesis of antibiotics
TTDR00732;hsa01230;Biosynthesis of amino acids
TTDR00732;hsa05146;Amoebiasis
TTDR00734;hsa04610;Complement and coagulation cascades
TTDR00734;hsa04640;Hematopoietic cell lineage
TTDR00734;hsa05134;Legionellosis
TTDR00734;hsa05140;Leishmaniasis
TTDR00734;hsa05144;Malaria
TTDR00734;hsa05152;Tuberculosis
TTDR00742;hsa00260;Glycine, serine and threonine metabolism
TTDR00742;hsa00350;Tyrosine metabolism
TTDR00742;hsa00360;Phenylalanine metabolism
TTDR00742;hsa00410;beta-Alanine metabolism
TTDR00742;hsa01100;Metabolic pathways
TTDR00748;eco00790;Folate biosynthesis
TTDR00748;eco01100;Metabolic pathways
TTDR00755;hsa04080;Neuroactive ligand-receptor interaction
TTDR00755;hsa04724;Glutamatergic synapse
TTDR00763;hsa04060;Cytokine-cytokine receptor interaction
TTDR00763;hsa04062;Chemokine signaling pathway
TTDR00763;hsa05203;Viral carcinogenesis
TTDR00771;hsa04080;Neuroactive ligand-receptor interaction
TTDR00774;hsa00230;Purine metabolism
TTDR00774;hsa00983;Drug metabolism - other enzymes
TTDR00774;hsa01100;Metabolic pathways
TTDR00776;hsa04068;FoxO signaling pathway
TTDR00776;hsa04152;AMPK signaling pathway
TTDR00776;hsa04910;Insulin signaling pathway
TTDR00776;hsa04920;Adipocytokine signaling pathway
TTDR00776;hsa04930;Type II diabetes mellitus
TTDR00777;hsa04024;cAMP signaling pathway
TTDR00777;hsa04920;Adipocytokine signaling pathway
TTDR00777;hsa05034;Alcoholism
TTDR00784;hsa00480;Glutathione metabolism
TTDR00784;hsa01100;Metabolic pathways
TTDR00784;hsa04614;Renin-angiotensin system
TTDR00784;hsa04640;Hematopoietic cell lineage
TTDR00786;hsa04110;Cell cycle
TTDR00786;hsa04114;Oocyte meiosis
TTDR00786;hsa04115;p53 signaling pathway
TTDR00786;hsa04151;PI3K-Akt signaling pathway
TTDR00786;hsa05161;Hepatitis B
TTDR00786;hsa05162;Measles
TTDR00786;hsa05200;Pathways in cancer
TTDR00786;hsa05203;Viral carcinogenesis
TTDR00786;hsa05206;MicroRNAs in cancer
TTDR00786;hsa05215;Prostate cancer
TTDR00786;hsa05222;Small cell lung cancer
TTDR00794;hsa04020;Calcium signaling pathway
TTDR00794;hsa04022;cGMP-PKG signaling pathway
TTDR00794;hsa04270;Vascular smooth muscle contraction
TTDR00794;hsa04510;Focal adhesion
TTDR00794;hsa04611;Platelet activation
TTDR00794;hsa04810;Regulation of actin cytoskeleton
TTDR00794;hsa04921;Oxytocin signaling pathway
TTDR00794;hsa04971;Gastric acid secretion
TTDR00795;hsa03320;PPAR signaling pathway
TTDR00801;hsa04080;Neuroactive ligand-receptor interaction
TTDR00802;hsa04080;Neuroactive ligand-receptor interaction
TTDR00805;hsa00564;Glycerophospholipid metabolism
TTDR00805;hsa01100;Metabolic pathways
TTDR00805;hsa05231;Choline metabolism in cancer
TTDR00806;hsa04390;Hippo signaling pathway
TTDR00806;hsa04724;Glutamatergic synapse
TTDR00806;hsa05016;Huntington's disease
TTDR00806;hsa05030;Cocaine addiction
TTDR00808;hsa04060;Cytokine-cytokine receptor interaction
TTDR00808;hsa04062;Chemokine signaling pathway
TTDR00808;hsa04064;NF-kappa B signaling pathway
TTDR00808;hsa04360;Axon guidance
TTDR00808;hsa04670;Leukocyte transendothelial migration
TTDR00808;hsa04672;Intestinal immune network for IgA production
TTDR00808;hsa05200;Pathways in cancer
TTDR00808;hsa05323;Rheumatoid arthritis
TTDR00811;hsa00120;Primary bile acid biosynthesis
TTDR00811;hsa01100;Metabolic pathways
TTDR00811;hsa04146;Peroxisome
TTDR00813;hsa04145;Phagosome
TTDR00813;hsa04151;PI3K-Akt signaling pathway
TTDR00813;hsa04620;Toll-like receptor signaling pathway
TTDR00813;hsa05134;Legionellosis
TTDR00813;hsa05140;Leishmaniasis
TTDR00813;hsa05142;Chagas disease (American trypanosomiasis)
TTDR00813;hsa05144;Malaria
TTDR00813;hsa05145;Toxoplasmosis
TTDR00813;hsa05146;Amoebiasis
TTDR00813;hsa05152;Tuberculosis
TTDR00813;hsa05161;Hepatitis B
TTDR00813;hsa05162;Measles
TTDR00813;hsa05168;Herpes simplex infection
TTDR00813;hsa05205;Proteoglycans in cancer
TTDR00813;hsa05321;Inflammatory bowel disease (IBD)
TTDR00813;hsa05323;Rheumatoid arthritis
TTDR00821;hsa04080;Neuroactive ligand-receptor interaction
TTDR00821;hsa04724;Glutamatergic synapse
TTDR00830;hsa04514;Cell adhesion molecules (CAMs)
TTDR00830;hsa04670;Leukocyte transendothelial migration
TTDR00847;hsa04330;Notch signaling pathway
TTDR00847;hsa05010;Alzheimer's disease
TTDR00847;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDR00849;eco00520;Amino sugar and nucleotide sugar metabolism
TTDR00849;eco01100;Metabolic pathways
TTDR00849;eco01130;Biosynthesis of antibiotics
TTDR00854;hsa04145;Phagosome
TTDR00854;hsa05152;Tuberculosis
TTDR00854;hsa05162;Measles
TTDR00855;hsa04060;Cytokine-cytokine receptor interaction
TTDR00855;hsa04630;Jak-STAT signaling pathway
TTDR00858;hsa04062;Chemokine signaling pathway
TTDR00858;hsa04660;T cell receptor signaling pathway
TTDR00858;hsa04670;Leukocyte transendothelial migration
TTDR00865;pae00540;Lipopolysaccharide biosynthesis
TTDR00865;pae01100;Metabolic pathways
TTDR00866;hsa00100;Steroid biosynthesis
TTDR00866;hsa01100;Metabolic pathways
TTDR00866;hsa01130;Biosynthesis of antibiotics
TTDR00868;hsa04320;Dorso-ventral axis formation
TTDR00868;hsa04330;Notch signaling pathway
TTDR00868;hsa04919;Thyroid hormone signaling pathway
TTDR00868;hsa05020;Prion diseases
TTDR00868;hsa05206;MicroRNAs in cancer
TTDR00879;hsa00040;Pentose and glucuronate interconversions
TTDR00879;hsa00051;Fructose and mannose metabolism
TTDR00879;hsa01100;Metabolic pathways
TTDR00886;hsa04142;Lysosome
TTDR00886;hsa04612;Antigen processing and presentation
TTDR00910;hsa00030;Pentose phosphate pathway
TTDR00910;hsa00480;Glutathione metabolism
TTDR00910;hsa01100;Metabolic pathways
TTDR00910;hsa01130;Biosynthesis of antibiotics
TTDR00910;hsa01200;Carbon metabolism
TTDR00917;hsa04024;cAMP signaling pathway
TTDR00917;hsa04152;AMPK signaling pathway
TTDR00917;hsa04910;Insulin signaling pathway
TTDR00921;hsa04060;Cytokine-cytokine receptor interaction
TTDR00921;hsa04062;Chemokine signaling pathway
TTDR00921;hsa04620;Toll-like receptor signaling pathway
TTDR00921;hsa05132;Salmonella infection
TTDR00921;hsa05142;Chagas disease (American trypanosomiasis)
TTDR00921;hsa05323;Rheumatoid arthritis
TTDR00922;hsa03440;Homologous recombination
TTDR00922;hsa03460;Fanconi anemia pathway
TTDR00922;hsa05200;Pathways in cancer
TTDR00922;hsa05212;Pancreatic cancer
TTDR00925;hsa04010;MAPK signaling pathway
TTDR00925;hsa04014;Ras signaling pathway
TTDR00925;hsa04015;Rap1 signaling pathway
TTDR00925;hsa04151;PI3K-Akt signaling pathway
TTDR00925;hsa04390;Hippo signaling pathway
TTDR00925;hsa04810;Regulation of actin cytoskeleton
TTDR00925;hsa05200;Pathways in cancer
TTDR00925;hsa05218;Melanoma
TTDR00926;hsa04014;Ras signaling pathway
TTDR00926;hsa04015;Rap1 signaling pathway
TTDR00926;hsa04060;Cytokine-cytokine receptor interaction
TTDR00926;hsa04151;PI3K-Akt signaling pathway
TTDR00926;hsa04510;Focal adhesion
TTDR00926;hsa05200;Pathways in cancer
TTDR00927;hsa04064;NF-kappa B signaling pathway
TTDR00927;hsa04620;Toll-like receptor signaling pathway
TTDR00927;hsa05130;Pathogenic Escherichia coli infection
TTDR00927;hsa05133;Pertussis
TTDR00927;hsa05145;Toxoplasmosis
TTDR00928;hsa04010;MAPK signaling pathway
TTDR00928;hsa04012;ErbB signaling pathway
TTDR00928;hsa04014;Ras signaling pathway
TTDR00928;hsa04024;cAMP signaling pathway
TTDR00928;hsa04068;FoxO signaling pathway
TTDR00928;hsa04071;Sphingolipid signaling pathway
TTDR00928;hsa04141;Protein processing in endoplasmic reticulum
TTDR00928;hsa04310;Wnt signaling pathway
TTDR00928;hsa04380;Osteoclast differentiation
TTDR00928;hsa04510;Focal adhesion
TTDR00928;hsa04620;Toll-like receptor signaling pathway
TTDR00928;hsa04621;NOD-like receptor signaling pathway
TTDR00928;hsa04622;RIG-I-like receptor signaling pathway
TTDR00928;hsa04664;Fc epsilon RI signaling pathway
TTDR00928;hsa04668;TNF signaling pathway
TTDR00928;hsa04722;Neurotrophin signaling pathway
TTDR00928;hsa04723;Retrograde endocannabinoid signaling
TTDR00928;hsa04728;Dopaminergic synapse
TTDR00928;hsa04750;Inflammatory mediator regulation of TRP channels
TTDR00928;hsa04910;Insulin signaling pathway
TTDR00928;hsa04912;GnRH signaling pathway
TTDR00928;hsa04914;Progesterone-mediated oocyte maturation
TTDR00928;hsa04917;Prolactin signaling pathway
TTDR00928;hsa04920;Adipocytokine signaling pathway
TTDR00928;hsa04930;Type II diabetes mellitus
TTDR00928;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDR00928;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDR00928;hsa05131;Shigellosis
TTDR00928;hsa05132;Salmonella infection
TTDR00928;hsa05133;Pertussis
TTDR00928;hsa05142;Chagas disease (American trypanosomiasis)
TTDR00928;hsa05145;Toxoplasmosis
TTDR00928;hsa05152;Tuberculosis
TTDR00928;hsa05160;Hepatitis C
TTDR00928;hsa05161;Hepatitis B
TTDR00928;hsa05164;Influenza A
TTDR00928;hsa05168;Herpes simplex infection
TTDR00928;hsa05169;Epstein-Barr virus infection
TTDR00928;hsa05200;Pathways in cancer
TTDR00928;hsa05210;Colorectal cancer
TTDR00928;hsa05212;Pancreatic cancer
TTDR00928;hsa05231;Choline metabolism in cancer
TTDR00929;mtu00240;Pyrimidine metabolism
TTDR00929;mtu01100;Metabolic pathways
TTDR00930;hsa00562;Inositol phosphate metabolism
TTDR00930;hsa04012;ErbB signaling pathway
TTDR00930;hsa04014;Ras signaling pathway
TTDR00930;hsa04015;Rap1 signaling pathway
TTDR00930;hsa04022;cGMP-PKG signaling pathway
TTDR00930;hsa04024;cAMP signaling pathway
TTDR00930;hsa04062;Chemokine signaling pathway
TTDR00930;hsa04066;HIF-1 signaling pathway
TTDR00930;hsa04068;FoxO signaling pathway
TTDR00930;hsa04070;Phosphatidylinositol signaling system
TTDR00930;hsa04071;Sphingolipid signaling pathway
TTDR00930;hsa04150;mTOR signaling pathway
TTDR00930;hsa04151;PI3K-Akt signaling pathway
TTDR00930;hsa04152;AMPK signaling pathway
TTDR00930;hsa04210;Apoptosis
TTDR00930;hsa04261;Adrenergic signaling in cardiomyocytes
TTDR00930;hsa04370;VEGF signaling pathway
TTDR00930;hsa04380;Osteoclast differentiation
TTDR00930;hsa04510;Focal adhesion
TTDR00930;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDR00930;hsa04611;Platelet activation
TTDR00930;hsa04620;Toll-like receptor signaling pathway
TTDR00930;hsa04630;Jak-STAT signaling pathway
TTDR00930;hsa04650;Natural killer cell mediated cytotoxicity
TTDR00930;hsa04660;T cell receptor signaling pathway
TTDR00930;hsa04662;B cell receptor signaling pathway
TTDR00930;hsa04664;Fc epsilon RI signaling pathway
TTDR00930;hsa04666;Fc gamma R-mediated phagocytosis
TTDR00930;hsa04668;TNF signaling pathway
TTDR00930;hsa04670;Leukocyte transendothelial migration
TTDR00930;hsa04722;Neurotrophin signaling pathway
TTDR00930;hsa04725;Cholinergic synapse
TTDR00930;hsa04750;Inflammatory mediator regulation of TRP channels
TTDR00930;hsa04810;Regulation of actin cytoskeleton
TTDR00930;hsa04910;Insulin signaling pathway
TTDR00930;hsa04914;Progesterone-mediated oocyte maturation
TTDR00930;hsa04915;Estrogen signaling pathway
TTDR00930;hsa04917;Prolactin signaling pathway
TTDR00930;hsa04919;Thyroid hormone signaling pathway
TTDR00930;hsa04921;Oxytocin signaling pathway
TTDR00930;hsa04923;Regulation of lipolysis in adipocytes
TTDR00930;hsa04930;Type II diabetes mellitus
TTDR00930;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDR00930;hsa04960;Aldosterone-regulated sodium reabsorption
TTDR00930;hsa04973;Carbohydrate digestion and absorption
TTDR00930;hsa05100;Bacterial invasion of epithelial cells
TTDR00930;hsa05142;Chagas disease (American trypanosomiasis)
TTDR00930;hsa05145;Toxoplasmosis
TTDR00930;hsa05146;Amoebiasis
TTDR00930;hsa05160;Hepatitis C
TTDR00930;hsa05161;Hepatitis B
TTDR00930;hsa05162;Measles
TTDR00930;hsa05164;Influenza A
TTDR00930;hsa05166;HTLV-I infection
TTDR00930;hsa05169;Epstein-Barr virus infection
TTDR00930;hsa05200;Pathways in cancer
TTDR00930;hsa05203;Viral carcinogenesis
TTDR00930;hsa05205;Proteoglycans in cancer
TTDR00930;hsa05210;Colorectal cancer
TTDR00930;hsa05211;Renal cell carcinoma
TTDR00930;hsa05212;Pancreatic cancer
TTDR00930;hsa05213;Endometrial cancer
TTDR00930;hsa05214;Glioma
TTDR00930;hsa05215;Prostate cancer
TTDR00930;hsa05218;Melanoma
TTDR00930;hsa05220;Chronic myeloid leukemia
TTDR00930;hsa05221;Acute myeloid leukemia
TTDR00930;hsa05222;Small cell lung cancer
TTDR00930;hsa05223;Non-small cell lung cancer
TTDR00930;hsa05230;Central carbon metabolism in cancer
TTDR00930;hsa05231;Choline metabolism in cancer
TTDR00947;hsa04610;Complement and coagulation cascades
TTDR00950;hsa00380;Tryptophan metabolism
TTDR00950;hsa01100;Metabolic pathways
TTDR00956;hsa00240;Pyrimidine metabolism
TTDR00956;hsa01100;Metabolic pathways
TTDR00957;hsa00270;Cysteine and methionine metabolism
TTDR00957;hsa01100;Metabolic pathways
TTDR00959;hsa00270;Cysteine and methionine metabolism
TTDR00959;hsa01100;Metabolic pathways
TTDR00965;hsa04080;Neuroactive ligand-receptor interaction
TTDR00965;hsa04724;Glutamatergic synapse
TTDR00965;hsa04742;Taste transduction
TTDR00967;hsa03410;Base excision repair
TTDR00968;hsa04010;MAPK signaling pathway
TTDR00968;hsa04071;Sphingolipid signaling pathway
TTDR00968;hsa04141;Protein processing in endoplasmic reticulum
TTDR00968;hsa04668;TNF signaling pathway
TTDR00968;hsa04722;Neurotrophin signaling pathway
TTDR00968;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDR00968;hsa05014;Amyotrophic lateral sclerosis (ALS)
TTDR00972;spn00240;Pyrimidine metabolism
TTDR00972;spn01100;Metabolic pathways
TTDR00977;hsa04210;Apoptosis
TTDR00977;hsa04910;Insulin signaling pathway
TTDR00978;hsa04210;Apoptosis
TTDR00978;hsa04910;Insulin signaling pathway
TTDR00983;hsa04115;p53 signaling pathway
TTDR00983;hsa05206;MicroRNAs in cancer
TTDR00984;bps00562;Inositol phosphate metabolism
TTDR00984;bps00564;Glycerophospholipid metabolism
TTDR00984;bps01100;Metabolic pathways
TTDR00984;bps01110;Biosynthesis of secondary metabolites
TTDR00989;hsa00670;One carbon pool by folate
TTDR00989;hsa01100;Metabolic pathways
TTDR00989;hsa01200;Carbon metabolism
TTDR00995;hsa00010;Glycolysis / Gluconeogenesis
TTDR00995;hsa01100;Metabolic pathways
TTDR00995;hsa01130;Biosynthesis of antibiotics
TTDR00995;hsa01200;Carbon metabolism
TTDR00995;hsa01230;Biosynthesis of amino acids
TTDR00995;hsa04066;HIF-1 signaling pathway
TTDR00995;hsa05010;Alzheimer's disease
TTDR00998;hsa04010;MAPK signaling pathway
TTDR00998;hsa04060;Cytokine-cytokine receptor interaction
TTDR00998;hsa04068;FoxO signaling pathway
TTDR00998;hsa04144;Endocytosis
TTDR00998;hsa04350;TGF-beta signaling pathway
TTDR00998;hsa04380;Osteoclast differentiation
TTDR00998;hsa04390;Hippo signaling pathway
TTDR00998;hsa04520;Adherens junction
TTDR00998;hsa05142;Chagas disease (American trypanosomiasis)
TTDR00998;hsa05161;Hepatitis B
TTDR00998;hsa05166;HTLV-I infection
TTDR00998;hsa05200;Pathways in cancer
TTDR00998;hsa05210;Colorectal cancer
TTDR00998;hsa05212;Pancreatic cancer
TTDR00998;hsa05220;Chronic myeloid leukemia
TTDR01001;hsa04918;Thyroid hormone synthesis
TTDR01004;hsa00020;Citrate cycle (TCA cycle)
TTDR01004;hsa01100;Metabolic pathways
TTDR01004;hsa01130;Biosynthesis of antibiotics
TTDR01006;hsa04115;p53 signaling pathway
TTDR01006;hsa04151;PI3K-Akt signaling pathway
TTDR01006;hsa04210;Apoptosis
TTDR01006;hsa04370;VEGF signaling pathway
TTDR01006;hsa04919;Thyroid hormone signaling pathway
TTDR01006;hsa05010;Alzheimer's disease
TTDR01006;hsa05012;Parkinson's disease
TTDR01006;hsa05014;Amyotrophic lateral sclerosis (ALS)
TTDR01006;hsa05016;Huntington's disease
TTDR01006;hsa05134;Legionellosis
TTDR01006;hsa05145;Toxoplasmosis
TTDR01006;hsa05152;Tuberculosis
TTDR01006;hsa05161;Hepatitis B
TTDR01006;hsa05164;Influenza A
TTDR01006;hsa05200;Pathways in cancer
TTDR01006;hsa05210;Colorectal cancer
TTDR01006;hsa05212;Pancreatic cancer
TTDR01006;hsa05213;Endometrial cancer
TTDR01006;hsa05215;Prostate cancer
TTDR01006;hsa05222;Small cell lung cancer
TTDR01006;hsa05223;Non-small cell lung cancer
TTDR01006;hsa05416;Viral myocarditis
TTDR01018;hsa00770;Pantothenate and CoA biosynthesis
TTDR01018;hsa01100;Metabolic pathways
TTDR01028;hsa00280;Valine, leucine and isoleucine degradation
TTDR01028;hsa00290;Valine, leucine and isoleucine biosynthesis
TTDR01028;hsa00770;Pantothenate and CoA biosynthesis
TTDR01028;hsa01100;Metabolic pathways
TTDR01028;hsa01130;Biosynthesis of antibiotics
TTDR01028;hsa01210;2-Oxocarboxylic acid metabolism
TTDR01028;hsa01230;Biosynthesis of amino acids
TTDR01031;hsa04142;Lysosome
TTDR01031;hsa04145;Phagosome
TTDR01031;hsa04612;Antigen processing and presentation
TTDR01031;hsa05205;Proteoglycans in cancer
TTDR01031;hsa05323;Rheumatoid arthritis
TTDR01032;hsa04142;Lysosome
TTDR01042;hsa04080;Neuroactive ligand-receptor interaction
TTDR01042;hsa04723;Retrograde endocannabinoid signaling
TTDR01042;hsa04727;GABAergic synapse
TTDR01042;hsa05032;Morphine addiction
TTDR01042;hsa05033;Nicotine addiction
TTDR01044;hsa04080;Neuroactive ligand-receptor interaction
TTDR01045;hsa04080;Neuroactive ligand-receptor interaction
TTDR01048;hsa04060;Cytokine-cytokine receptor interaction
TTDR01048;hsa04080;Neuroactive ligand-receptor interaction
TTDR01048;hsa04151;PI3K-Akt signaling pathway
TTDR01048;hsa04630;Jak-STAT signaling pathway
TTDR01056;hsa04080;Neuroactive ligand-receptor interaction
TTDR01057;hsa04151;PI3K-Akt signaling pathway
TTDR01057;hsa04510;Focal adhesion
TTDR01057;hsa04512;ECM-receptor interaction
TTDR01057;hsa05145;Toxoplasmosis
TTDR01057;hsa05146;Amoebiasis
TTDR01057;hsa05200;Pathways in cancer
TTDR01057;hsa05222;Small cell lung cancer
TTDR01059;hsa04145;Phagosome
TTDR01063;spy00450;Selenocompound metabolism
TTDR01063;spy00970;Aminoacyl-tRNA biosynthesis
TTDR01066;hsa04514;Cell adhesion molecules (CAMs)
TTDR01073;hsa03320;PPAR signaling pathway
TTDR01073;hsa04151;PI3K-Akt signaling pathway
TTDR01073;hsa04919;Thyroid hormone signaling pathway
TTDR01073;hsa04920;Adipocytokine signaling pathway
TTDR01073;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDR01073;hsa04976;Bile secretion
TTDR01073;hsa05160;Hepatitis C
TTDR01073;hsa05200;Pathways in cancer
TTDR01073;hsa05202;Transcriptional misregulation in cancer
TTDR01073;hsa05216;Thyroid cancer
TTDR01073;hsa05222;Small cell lung cancer
TTDR01073;hsa05223;Non-small cell lung cancer
TTDR01075;hsa03320;PPAR signaling pathway
TTDR01075;hsa04919;Thyroid hormone signaling pathway
TTDR01075;hsa04920;Adipocytokine signaling pathway
TTDR01075;hsa05200;Pathways in cancer
TTDR01075;hsa05202;Transcriptional misregulation in cancer
TTDR01075;hsa05216;Thyroid cancer
TTDR01075;hsa05222;Small cell lung cancer
TTDR01075;hsa05223;Non-small cell lung cancer
TTDR01076;hsa00900;Terpenoid backbone biosynthesis
TTDR01076;hsa01130;Biosynthesis of antibiotics
TTDR01085;mge00010;Glycolysis / Gluconeogenesis
TTDR01085;mge00260;Glycine, serine and threonine metabolism
TTDR01085;mge00680;Methane metabolism
TTDR01085;mge01100;Metabolic pathways
TTDR01085;mge01110;Biosynthesis of secondary metabolites
TTDR01085;mge01120;Microbial metabolism in diverse environments
TTDR01085;mge01130;Biosynthesis of antibiotics
TTDR01085;mge01200;Carbon metabolism
TTDR01085;mge01230;Biosynthesis of amino acids
TTDR01100;hsa00270;Cysteine and methionine metabolism
TTDR01100;hsa01100;Metabolic pathways
TTDR01100;hsa05206;MicroRNAs in cancer
TTDR01101;hsa04060;Cytokine-cytokine receptor interaction
TTDR01101;hsa04144;Endocytosis
TTDR01101;hsa04151;PI3K-Akt signaling pathway
TTDR01101;hsa04630;Jak-STAT signaling pathway
TTDR01101;hsa04640;Hematopoietic cell lineage
TTDR01101;hsa05162;Measles
TTDR01101;hsa05166;HTLV-I infection
TTDR01104;hsa04060;Cytokine-cytokine receptor interaction
TTDR01104;hsa04630;Jak-STAT signaling pathway
TTDR01104;hsa05321;Inflammatory bowel disease (IBD)
TTDR01110;hsa04110;Cell cycle
TTDR01112;hsa04514;Cell adhesion molecules (CAMs)
TTDR01112;hsa05150;Staphylococcus aureus infection
TTDR01123;hsa04514;Cell adhesion molecules (CAMs)
TTDR01123;hsa04660;T cell receptor signaling pathway
TTDR01123;hsa04672;Intestinal immune network for IgA production
TTDR01123;hsa05340;Primary immunodeficiency
TTDR01132;hsa04973;Carbohydrate digestion and absorption
TTDR01133;hsa04360;Axon guidance
TTDR01134;hsa04620;Toll-like receptor signaling pathway
TTDR01134;hsa04622;RIG-I-like receptor signaling pathway
TTDR01134;hsa04623;Cytosolic DNA-sensing pathway
TTDR01134;hsa05133;Pertussis
TTDR01134;hsa05160;Hepatitis C
TTDR01134;hsa05161;Hepatitis B
TTDR01134;hsa05162;Measles
TTDR01134;hsa05164;Influenza A
TTDR01134;hsa05168;Herpes simplex infection
TTDR01134;hsa05169;Epstein-Barr virus infection
TTDR01134;hsa05203;Viral carcinogenesis
TTDR01138;hsa04744;Phototransduction
TTDR01142;hsa03450;Non-homologous end-joining
TTDR01142;hsa04110;Cell cycle
TTDR01143;eco00900;Terpenoid backbone biosynthesis
TTDR01143;eco01110;Biosynthesis of secondary metabolites
TTDR01153;hsa04145;Phagosome
TTDR01153;hsa04610;Complement and coagulation cascades
TTDR01153;hsa05133;Pertussis
TTDR01153;hsa05134;Legionellosis
TTDR01153;hsa05140;Leishmaniasis
TTDR01153;hsa05142;Chagas disease (American trypanosomiasis)
TTDR01153;hsa05150;Staphylococcus aureus infection
TTDR01153;hsa05152;Tuberculosis
TTDR01153;hsa05168;Herpes simplex infection
TTDR01153;hsa05203;Viral carcinogenesis
TTDR01153;hsa05322;Systemic lupus erythematosus
TTDR01156;hsa04110;Cell cycle
TTDR01156;hsa04330;Notch signaling pathway
TTDR01156;hsa04919;Thyroid hormone signaling pathway
TTDR01156;hsa05016;Huntington's disease
TTDR01156;hsa05034;Alcoholism
TTDR01156;hsa05169;Epstein-Barr virus infection
TTDR01156;hsa05200;Pathways in cancer
TTDR01156;hsa05202;Transcriptional misregulation in cancer
TTDR01156;hsa05203;Viral carcinogenesis
TTDR01156;hsa05220;Chronic myeloid leukemia
TTDR01157;pae00760;Nicotinate and nicotinamide metabolism
TTDR01157;pae01100;Metabolic pathways
TTDR01160;hsa04750;Inflammatory mediator regulation of TRP channels
TTDR01165;hsa04020;Calcium signaling pathway
TTDR01165;hsa04080;Neuroactive ligand-receptor interaction
TTDR01165;hsa05150;Staphylococcus aureus infection
TTDR01167;hsa05034;Alcoholism
TTDR01167;hsa05203;Viral carcinogenesis
TTDR01168;spn00400;Phenylalanine, tyrosine and tryptophan biosynthesis
TTDR01168;spn01100;Metabolic pathways
TTDR01168;spn01110;Biosynthesis of secondary metabolites
TTDR01168;spn01130;Biosynthesis of antibiotics
TTDR01168;spn01230;Biosynthesis of amino acids
TTDR01170;hsa04015;Rap1 signaling pathway
TTDR01170;hsa04145;Phagosome
TTDR01170;hsa04390;Hippo signaling pathway
TTDR01170;hsa04514;Cell adhesion molecules (CAMs)
TTDR01170;hsa04650;Natural killer cell mediated cytotoxicity
TTDR01170;hsa04670;Leukocyte transendothelial migration
TTDR01170;hsa04810;Regulation of actin cytoskeleton
TTDR01170;hsa05133;Pertussis
TTDR01170;hsa05134;Legionellosis
TTDR01170;hsa05140;Leishmaniasis
TTDR01170;hsa05144;Malaria
TTDR01170;hsa05146;Amoebiasis
TTDR01170;hsa05150;Staphylococcus aureus infection
TTDR01170;hsa05152;Tuberculosis
TTDR01170;hsa05166;HTLV-I infection
TTDR01170;hsa05323;Rheumatoid arthritis
TTDR01170;hsa05416;Viral myocarditis
TTDR01177;hsa04080;Neuroactive ligand-receptor interaction
TTDR01177;hsa04723;Retrograde endocannabinoid signaling
TTDR01177;hsa04727;GABAergic synapse
TTDR01177;hsa05032;Morphine addiction
TTDR01177;hsa05033;Nicotine addiction
TTDR01178;hsa04080;Neuroactive ligand-receptor interaction
TTDR01178;hsa04723;Retrograde endocannabinoid signaling
TTDR01178;hsa04727;GABAergic synapse
TTDR01178;hsa05032;Morphine addiction
TTDR01178;hsa05033;Nicotine addiction
TTDR01179;hsa04727;GABAergic synapse
TTDR01180;hsa04022;cGMP-PKG signaling pathway
TTDR01180;hsa04080;Neuroactive ligand-receptor interaction
TTDR01182;hsa00140;Steroid hormone biosynthesis
TTDR01183;hsa00140;Steroid hormone biosynthesis
TTDR01183;hsa05215;Prostate cancer
TTDR01184;eco00360;Phenylalanine metabolism
TTDR01184;eco00362;Benzoate degradation
TTDR01184;eco00620;Pyruvate metabolism
TTDR01184;eco00621;Dioxin degradation
TTDR01184;eco00622;Xylene degradation
TTDR01184;eco00650;Butanoate metabolism
TTDR01184;eco01100;Metabolic pathways
TTDR01184;eco01120;Microbial metabolism in diverse environments
TTDR01184;eco01220;Degradation of aromatic compounds
TTDR01185;hsa00010;Glycolysis / Gluconeogenesis
TTDR01185;hsa00040;Pentose and glucuronate interconversions
TTDR01185;hsa00053;Ascorbate and aldarate metabolism
TTDR01185;hsa00071;Fatty acid degradation
TTDR01185;hsa00280;Valine, leucine and isoleucine degradation
TTDR01185;hsa00310;Lysine degradation
TTDR01185;hsa00330;Arginine and proline metabolism
TTDR01185;hsa00340;Histidine metabolism
TTDR01185;hsa00380;Tryptophan metabolism
TTDR01185;hsa00410;beta-Alanine metabolism
TTDR01185;hsa00561;Glycerolipid metabolism
TTDR01185;hsa00620;Pyruvate metabolism
TTDR01185;hsa01100;Metabolic pathways
TTDR01185;hsa01130;Biosynthesis of antibiotics
TTDR01187;hsa00240;Pyrimidine metabolism
TTDR01187;hsa00410;beta-Alanine metabolism
TTDR01187;hsa00770;Pantothenate and CoA biosynthesis
TTDR01187;hsa00983;Drug metabolism - other enzymes
TTDR01187;hsa01100;Metabolic pathways
TTDR01191;hsa05200;Pathways in cancer
TTDR01191;hsa05222;Small cell lung cancer
TTDR01191;hsa05223;Non-small cell lung cancer
TTDR01193;hsa04080;Neuroactive ligand-receptor interaction
TTDR01194;hsa04024;cAMP signaling pathway
TTDR01194;hsa04080;Neuroactive ligand-receptor interaction
TTDR01194;hsa04726;Serotonergic synapse
TTDR01197;hsa04020;Calcium signaling pathway
TTDR01197;hsa04080;Neuroactive ligand-receptor interaction
TTDR01201;hsa00750;Vitamin B6 metabolism
TTDR01201;hsa01100;Metabolic pathways
TTDR01202;hsa00562;Inositol phosphate metabolism
TTDR01202;hsa01100;Metabolic pathways
TTDR01202;hsa04070;Phosphatidylinositol signaling system
TTDR01203;hsa00590;Arachidonic acid metabolism
TTDR01203;hsa01100;Metabolic pathways
TTDR01203;hsa04146;Peroxisome
TTDR01206;hsa04010;MAPK signaling pathway
TTDR01206;hsa04014;Ras signaling pathway
TTDR01206;hsa04062;Chemokine signaling pathway
TTDR01206;hsa04064;NF-kappa B signaling pathway
TTDR01206;hsa04068;FoxO signaling pathway
TTDR01206;hsa04150;mTOR signaling pathway
TTDR01206;hsa04151;PI3K-Akt signaling pathway
TTDR01206;hsa04210;Apoptosis
TTDR01206;hsa04380;Osteoclast differentiation
TTDR01206;hsa04620;Toll-like receptor signaling pathway
TTDR01206;hsa04621;NOD-like receptor signaling pathway
TTDR01206;hsa04622;RIG-I-like receptor signaling pathway
TTDR01206;hsa04623;Cytosolic DNA-sensing pathway
TTDR01206;hsa04660;T cell receptor signaling pathway
TTDR01206;hsa04662;B cell receptor signaling pathway
TTDR01206;hsa04668;TNF signaling pathway
TTDR01206;hsa04722;Neurotrophin signaling pathway
TTDR01206;hsa04910;Insulin signaling pathway
TTDR01206;hsa04920;Adipocytokine signaling pathway
TTDR01206;hsa04930;Type II diabetes mellitus
TTDR01206;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDR01206;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDR01206;hsa05131;Shigellosis
TTDR01206;hsa05142;Chagas disease (American trypanosomiasis)
TTDR01206;hsa05145;Toxoplasmosis
TTDR01206;hsa05160;Hepatitis C
TTDR01206;hsa05161;Hepatitis B
TTDR01206;hsa05164;Influenza A
TTDR01206;hsa05166;HTLV-I infection
TTDR01206;hsa05168;Herpes simplex infection
TTDR01206;hsa05169;Epstein-Barr virus infection
TTDR01206;hsa05200;Pathways in cancer
TTDR01206;hsa05206;MicroRNAs in cancer
TTDR01206;hsa05212;Pancreatic cancer
TTDR01206;hsa05215;Prostate cancer
TTDR01206;hsa05220;Chronic myeloid leukemia
TTDR01206;hsa05221;Acute myeloid leukemia
TTDR01206;hsa05222;Small cell lung cancer
TTDR01214;hsa04014;Ras signaling pathway
TTDR01214;hsa04015;Rap1 signaling pathway
TTDR01214;hsa04151;PI3K-Akt signaling pathway
TTDR01214;hsa04360;Axon guidance
TTDR01217;hsa04010;MAPK signaling pathway
TTDR01217;hsa04014;Ras signaling pathway
TTDR01217;hsa04015;Rap1 signaling pathway
TTDR01217;hsa04020;Calcium signaling pathway
TTDR01217;hsa04060;Cytokine-cytokine receptor interaction
TTDR01217;hsa04151;PI3K-Akt signaling pathway
TTDR01217;hsa04510;Focal adhesion
TTDR01217;hsa04540;Gap junction
TTDR01217;hsa04810;Regulation of actin cytoskeleton
TTDR01217;hsa05166;HTLV-I infection
TTDR01217;hsa05200;Pathways in cancer
TTDR01217;hsa05206;MicroRNAs in cancer
TTDR01217;hsa05214;Glioma
TTDR01217;hsa05215;Prostate cancer
TTDR01217;hsa05218;Melanoma
TTDR01217;hsa05230;Central carbon metabolism in cancer
TTDR01217;hsa05231;Choline metabolism in cancer
TTDR01220;hsa04728;Dopaminergic synapse
TTDR01222;hsa00310;Lysine degradation
TTDR01224;hsa00910;Nitrogen metabolism
TTDR01227;hsa04080;Neuroactive ligand-receptor interaction
TTDR01227;hsa04919;Thyroid hormone signaling pathway
TTDR01229;hsa00230;Purine metabolism
TTDR01229;hsa00240;Pyrimidine metabolism
TTDR01229;hsa00760;Nicotinate and nicotinamide metabolism
TTDR01229;hsa01100;Metabolic pathways
TTDR01230;pfa00190;Oxidative phosphorylation
TTDR01230;pfa01100;Metabolic pathways
TTDR01233;hsa04610;Complement and coagulation cascades
TTDR01233;hsa05202;Transcriptional misregulation in cancer
TTDR01234;hsa04060;Cytokine-cytokine receptor interaction
TTDR01234;hsa04151;PI3K-Akt signaling pathway
TTDR01234;hsa04630;Jak-STAT signaling pathway
TTDR01234;hsa04640;Hematopoietic cell lineage
TTDR01234;hsa05144;Malaria
TTDR01236;hsa02010;ABC transporters
TTDR01236;hsa04911;Insulin secretion
TTDR01236;hsa04930;Type II diabetes mellitus
TTDR01237;hsa05020;Prion diseases
TTDR01240;hsa00230;Purine metabolism
TTDR01240;hsa00670;One carbon pool by folate
TTDR01240;hsa01100;Metabolic pathways
TTDR01240;hsa01130;Biosynthesis of antibiotics
TTDR01246;hsa00620;Pyruvate metabolism
TTDR01247;hsa04080;Neuroactive ligand-receptor interaction
TTDR01250;hsa04068;FoxO signaling pathway
TTDR01250;hsa04151;PI3K-Akt signaling pathway
TTDR01250;hsa04960;Aldosterone-regulated sodium reabsorption
TTDR01251;hsa04014;Ras signaling pathway
TTDR01251;hsa04015;Rap1 signaling pathway
TTDR01251;hsa04060;Cytokine-cytokine receptor interaction
TTDR01251;hsa04151;PI3K-Akt signaling pathway
TTDR01251;hsa04510;Focal adhesion
TTDR01251;hsa05200;Pathways in cancer
TTDR01253;hsa04010;MAPK signaling pathway
TTDR01253;hsa04260;Cardiac muscle contraction
TTDR01253;hsa04261;Adrenergic signaling in cardiomyocytes
TTDR01253;hsa04921;Oxytocin signaling pathway
TTDR01253;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDR01253;hsa05412;Arrhythmogenic right ventricular cardiomyopathy (ARVC)
TTDR01253;hsa05414;Dilated cardiomyopathy
TTDR01256;hsa04750;Inflammatory mediator regulation of TRP channels
TTDR01257;hsa04750;Inflammatory mediator regulation of TRP channels
TTDR01258;hsa04750;Inflammatory mediator regulation of TRP channels
TTDR01259;hsa04014;Ras signaling pathway
TTDR01259;hsa04015;Rap1 signaling pathway
TTDR01259;hsa04020;Calcium signaling pathway
TTDR01259;hsa04024;cAMP signaling pathway
TTDR01259;hsa04080;Neuroactive ligand-receptor interaction
TTDR01259;hsa04713;Circadian entrainment
TTDR01259;hsa04720;Long-term potentiation
TTDR01259;hsa04724;Glutamatergic synapse
TTDR01259;hsa05010;Alzheimer's disease
TTDR01259;hsa05014;Amyotrophic lateral sclerosis (ALS)
TTDR01259;hsa05016;Huntington's disease
TTDR01259;hsa05030;Cocaine addiction
TTDR01259;hsa05031;Amphetamine addiction
TTDR01259;hsa05033;Nicotine addiction
TTDR01259;hsa05034;Alcoholism
TTDR01261;hsa04020;Calcium signaling pathway
TTDR01261;hsa04080;Neuroactive ligand-receptor interaction
TTDR01263;hsa04014;Ras signaling pathway
TTDR01263;hsa04630;Jak-STAT signaling pathway
TTDR01263;hsa04650;Natural killer cell mediated cytotoxicity
TTDR01263;hsa04670;Leukocyte transendothelial migration
TTDR01263;hsa04722;Neurotrophin signaling pathway
TTDR01263;hsa04920;Adipocytokine signaling pathway
TTDR01263;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDR01263;hsa05168;Herpes simplex infection
TTDR01263;hsa05205;Proteoglycans in cancer
TTDR01263;hsa05211;Renal cell carcinoma
TTDR01263;hsa05220;Chronic myeloid leukemia
TTDR01264;hsa04060;Cytokine-cytokine receptor interaction
TTDR01264;hsa04630;Jak-STAT signaling pathway
TTDR01265;hsa04012;ErbB signaling pathway
TTDR01265;hsa04020;Calcium signaling pathway
TTDR01265;hsa04144;Endocytosis
TTDR01265;hsa05205;Proteoglycans in cancer
TTDR01265;hsa05206;MicroRNAs in cancer
TTDR01269;hsa00140;Steroid hormone biosynthesis
TTDR01269;hsa04960;Aldosterone-regulated sodium reabsorption
TTDR01270;hsa04911;Insulin secretion
TTDR01270;hsa04930;Type II diabetes mellitus
TTDR01293;hsa04978;Mineral absorption
TTDR01298;hsa04024;cAMP signaling pathway
TTDR01298;hsa04340;Hedgehog signaling pathway
TTDR01298;hsa05200;Pathways in cancer
TTDR01298;hsa05217;Basal cell carcinoma
TTDR01340;hsa04120;Ubiquitin mediated proteolysis
TTDR01341;hsa04110;Cell cycle
TTDR01341;hsa05161;Hepatitis B
TTDR01341;hsa05166;HTLV-I infection
TTDR01341;hsa05200;Pathways in cancer
TTDR01341;hsa05206;MicroRNAs in cancer
TTDR01341;hsa05212;Pancreatic cancer
TTDR01341;hsa05214;Glioma
TTDR01341;hsa05215;Prostate cancer
TTDR01341;hsa05218;Melanoma
TTDR01341;hsa05219;Bladder cancer
TTDR01341;hsa05220;Chronic myeloid leukemia
TTDR01341;hsa05222;Small cell lung cancer
TTDR01341;hsa05223;Non-small cell lung cancer
TTDR01342;hsa05010;Alzheimer's disease
TTDR01342;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDR01343;hsa04144;Endocytosis
TTDR01343;hsa04350;TGF-beta signaling pathway
TTDR01343;hsa04390;Hippo signaling pathway
TTDR01344;hsa04010;MAPK signaling pathway
TTDR01344;hsa04014;Ras signaling pathway
TTDR01344;hsa04062;Chemokine signaling pathway
TTDR01344;hsa04064;NF-kappa B signaling pathway
TTDR01344;hsa04068;FoxO signaling pathway
TTDR01344;hsa04151;PI3K-Akt signaling pathway
TTDR01344;hsa04210;Apoptosis
TTDR01344;hsa04380;Osteoclast differentiation
TTDR01344;hsa04620;Toll-like receptor signaling pathway
TTDR01344;hsa04621;NOD-like receptor signaling pathway
TTDR01344;hsa04622;RIG-I-like receptor signaling pathway
TTDR01344;hsa04623;Cytosolic DNA-sensing pathway
TTDR01344;hsa04660;T cell receptor signaling pathway
TTDR01344;hsa04662;B cell receptor signaling pathway
TTDR01344;hsa04668;TNF signaling pathway
TTDR01344;hsa04920;Adipocytokine signaling pathway
TTDR01344;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDR01344;hsa05131;Shigellosis
TTDR01344;hsa05142;Chagas disease (American trypanosomiasis)
TTDR01344;hsa05145;Toxoplasmosis
TTDR01344;hsa05160;Hepatitis C
TTDR01344;hsa05161;Hepatitis B
TTDR01344;hsa05162;Measles
TTDR01344;hsa05166;HTLV-I infection
TTDR01344;hsa05168;Herpes simplex infection
TTDR01344;hsa05169;Epstein-Barr virus infection
TTDR01344;hsa05200;Pathways in cancer
TTDR01344;hsa05212;Pancreatic cancer
TTDR01344;hsa05215;Prostate cancer
TTDR01344;hsa05220;Chronic myeloid leukemia
TTDR01344;hsa05221;Acute myeloid leukemia
TTDR01344;hsa05222;Small cell lung cancer
TTDR01345;hsa03320;PPAR signaling pathway
TTDR01345;hsa04068;FoxO signaling pathway
TTDR01345;hsa04071;Sphingolipid signaling pathway
TTDR01345;hsa04150;mTOR signaling pathway
TTDR01345;hsa04151;PI3K-Akt signaling pathway
TTDR01345;hsa04152;AMPK signaling pathway
TTDR01345;hsa04510;Focal adhesion
TTDR01345;hsa04660;T cell receptor signaling pathway
TTDR01345;hsa04664;Fc epsilon RI signaling pathway
TTDR01345;hsa04722;Neurotrophin signaling pathway
TTDR01345;hsa04910;Insulin signaling pathway
TTDR01345;hsa04919;Thyroid hormone signaling pathway
TTDR01345;hsa04960;Aldosterone-regulated sodium reabsorption
TTDR01345;hsa05145;Toxoplasmosis
TTDR01345;hsa05160;Hepatitis C
TTDR01345;hsa05205;Proteoglycans in cancer
TTDR01345;hsa05213;Endometrial cancer
TTDR01345;hsa05215;Prostate cancer
TTDR01345;hsa05223;Non-small cell lung cancer
TTDR01345;hsa05231;Choline metabolism in cancer
TTDR01346;hsa04621;NOD-like receptor signaling pathway
TTDR01346;hsa04722;Neurotrophin signaling pathway
TTDR01346;hsa05131;Shigellosis
TTDR01346;hsa05152;Tuberculosis
TTDR01347;hsa04144;Endocytosis
TTDR01347;hsa04350;TGF-beta signaling pathway
TTDR01352;hsa00561;Glycerolipid metabolism
TTDR01352;hsa00830;Retinol metabolism
TTDR01352;hsa01100;Metabolic pathways
TTDR01352;hsa04975;Fat digestion and absorption
TTDR01353;hsa00100;Steroid biosynthesis
TTDR01355;hsa04146;Peroxisome
TTDR01355;hsa05014;Amyotrophic lateral sclerosis (ALS)
TTDR01355;hsa05016;Huntington's disease
TTDR01355;hsa05020;Prion diseases
TTDR01356;hsa04010;MAPK signaling pathway
TTDR01356;hsa04012;ErbB signaling pathway
TTDR01356;hsa04014;Ras signaling pathway
TTDR01356;hsa04015;Rap1 signaling pathway
TTDR01356;hsa04062;Chemokine signaling pathway
TTDR01356;hsa04068;FoxO signaling pathway
TTDR01356;hsa04071;Sphingolipid signaling pathway
TTDR01356;hsa04144;Endocytosis
TTDR01356;hsa04151;PI3K-Akt signaling pathway
TTDR01356;hsa04360;Axon guidance
TTDR01356;hsa04370;VEGF signaling pathway
TTDR01356;hsa04510;Focal adhesion
TTDR01356;hsa04530;Tight junction
TTDR01356;hsa04540;Gap junction
TTDR01356;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDR01356;hsa04650;Natural killer cell mediated cytotoxicity
TTDR01356;hsa04660;T cell receptor signaling pathway
TTDR01356;hsa04662;B cell receptor signaling pathway
TTDR01356;hsa04664;Fc epsilon RI signaling pathway
TTDR01356;hsa04720;Long-term potentiation
TTDR01356;hsa04722;Neurotrophin signaling pathway
TTDR01356;hsa04725;Cholinergic synapse
TTDR01356;hsa04726;Serotonergic synapse
TTDR01356;hsa04730;Long-term depression
TTDR01356;hsa04810;Regulation of actin cytoskeleton
TTDR01356;hsa04910;Insulin signaling pathway
TTDR01356;hsa04912;GnRH signaling pathway
TTDR01356;hsa04915;Estrogen signaling pathway
TTDR01356;hsa04916;Melanogenesis
TTDR01356;hsa04917;Prolactin signaling pathway
TTDR01356;hsa04919;Thyroid hormone signaling pathway
TTDR01356;hsa04921;Oxytocin signaling pathway
TTDR01356;hsa05034;Alcoholism
TTDR01356;hsa05160;Hepatitis C
TTDR01356;hsa05161;Hepatitis B
TTDR01356;hsa05166;HTLV-I infection
TTDR01356;hsa05200;Pathways in cancer
TTDR01356;hsa05203;Viral carcinogenesis
TTDR01356;hsa05205;Proteoglycans in cancer
TTDR01356;hsa05206;MicroRNAs in cancer
TTDR01356;hsa05211;Renal cell carcinoma
TTDR01356;hsa05213;Endometrial cancer
TTDR01356;hsa05214;Glioma
TTDR01356;hsa05215;Prostate cancer
TTDR01356;hsa05216;Thyroid cancer
TTDR01356;hsa05218;Melanoma
TTDR01356;hsa05219;Bladder cancer
TTDR01356;hsa05220;Chronic myeloid leukemia
TTDR01356;hsa05221;Acute myeloid leukemia
TTDR01356;hsa05223;Non-small cell lung cancer
TTDR01356;hsa05230;Central carbon metabolism in cancer
TTDR01356;hsa05231;Choline metabolism in cancer
TTDR01357;hsa03320;PPAR signaling pathway
TTDR01357;hsa04975;Fat digestion and absorption
TTDR01357;hsa04977;Vitamin digestion and absorption
TTDR01357;hsa05143;African trypanosomiasis
TTDR01360;hsa04975;Fat digestion and absorption
TTDR01360;hsa04977;Vitamin digestion and absorption
TTDR01361;hsa04012;ErbB signaling pathway
TTDR01361;hsa04020;Calcium signaling pathway
TTDR01361;hsa04066;HIF-1 signaling pathway
TTDR01361;hsa04510;Focal adhesion
TTDR01361;hsa04520;Adherens junction
TTDR01361;hsa05200;Pathways in cancer
TTDR01361;hsa05205;Proteoglycans in cancer
TTDR01361;hsa05206;MicroRNAs in cancer
TTDR01361;hsa05212;Pancreatic cancer
TTDR01361;hsa05213;Endometrial cancer
TTDR01361;hsa05215;Prostate cancer
TTDR01361;hsa05219;Bladder cancer
TTDR01361;hsa05223;Non-small cell lung cancer
TTDR01361;hsa05230;Central carbon metabolism in cancer
TTDR01362;hsa04015;Rap1 signaling pathway
TTDR01362;hsa04145;Phagosome
TTDR01362;hsa04151;PI3K-Akt signaling pathway
TTDR01362;hsa04380;Osteoclast differentiation
TTDR01362;hsa04510;Focal adhesion
TTDR01362;hsa04512;ECM-receptor interaction
TTDR01362;hsa04611;Platelet activation
TTDR01362;hsa04640;Hematopoietic cell lineage
TTDR01362;hsa04810;Regulation of actin cytoskeleton
TTDR01362;hsa04919;Thyroid hormone signaling pathway
TTDR01362;hsa05205;Proteoglycans in cancer
TTDR01362;hsa05206;MicroRNAs in cancer
TTDR01362;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDR01362;hsa05412;Arrhythmogenic right ventricular cardiomyopathy (ARVC)
TTDR01362;hsa05414;Dilated cardiomyopathy
TTDR01363;hsa04010;MAPK signaling pathway
TTDR01363;hsa04012;ErbB signaling pathway
TTDR01363;hsa04024;cAMP signaling pathway
TTDR01363;hsa04310;Wnt signaling pathway
TTDR01363;hsa04380;Osteoclast differentiation
TTDR01363;hsa04510;Focal adhesion
TTDR01363;hsa04620;Toll-like receptor signaling pathway
TTDR01363;hsa04660;T cell receptor signaling pathway
TTDR01363;hsa04662;B cell receptor signaling pathway
TTDR01363;hsa04668;TNF signaling pathway
TTDR01363;hsa04722;Neurotrophin signaling pathway
TTDR01363;hsa04912;GnRH signaling pathway
TTDR01363;hsa04915;Estrogen signaling pathway
TTDR01363;hsa04921;Oxytocin signaling pathway
TTDR01363;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDR01363;hsa05030;Cocaine addiction
TTDR01363;hsa05031;Amphetamine addiction
TTDR01363;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDR01363;hsa05132;Salmonella infection
TTDR01363;hsa05133;Pertussis
TTDR01363;hsa05140;Leishmaniasis
TTDR01363;hsa05142;Chagas disease (American trypanosomiasis)
TTDR01363;hsa05161;Hepatitis B
TTDR01363;hsa05164;Influenza A
TTDR01363;hsa05166;HTLV-I infection
TTDR01363;hsa05168;Herpes simplex infection
TTDR01363;hsa05169;Epstein-Barr virus infection
TTDR01363;hsa05200;Pathways in cancer
TTDR01363;hsa05203;Viral carcinogenesis
TTDR01363;hsa05210;Colorectal cancer
TTDR01363;hsa05211;Renal cell carcinoma
TTDR01363;hsa05231;Choline metabolism in cancer
TTDR01363;hsa05321;Inflammatory bowel disease (IBD)
TTDR01363;hsa05323;Rheumatoid arthritis
TTDR01368;hsa03040;Spliceosome
TTDR01369;hsa00590;Arachidonic acid metabolism
TTDR01369;hsa01100;Metabolic pathways
TTDR01369;hsa04726;Serotonergic synapse
TTDR01369;hsa04913;Ovarian steroidogenesis
TTDR01369;hsa05145;Toxoplasmosis
TTDR01370;hsa04012;ErbB signaling pathway
TTDR01370;hsa04068;FoxO signaling pathway
TTDR01370;hsa04270;Vascular smooth muscle contraction
TTDR01370;hsa04650;Natural killer cell mediated cytotoxicity
TTDR01370;hsa04720;Long-term potentiation
TTDR01370;hsa04726;Serotonergic synapse
TTDR01370;hsa04730;Long-term depression
TTDR01370;hsa04810;Regulation of actin cytoskeleton
TTDR01370;hsa04910;Insulin signaling pathway
TTDR01370;hsa04914;Progesterone-mediated oocyte maturation
TTDR01370;hsa05034;Alcoholism
TTDR01370;hsa05160;Hepatitis C
TTDR01370;hsa05200;Pathways in cancer
TTDR01370;hsa05205;Proteoglycans in cancer
TTDR01370;hsa05210;Colorectal cancer
TTDR01370;hsa05211;Renal cell carcinoma
TTDR01370;hsa05212;Pancreatic cancer
TTDR01370;hsa05213;Endometrial cancer
TTDR01370;hsa05214;Glioma
TTDR01370;hsa05215;Prostate cancer
TTDR01370;hsa05218;Melanoma
TTDR01370;hsa05219;Bladder cancer
TTDR01370;hsa05220;Chronic myeloid leukemia
TTDR01370;hsa05221;Acute myeloid leukemia
TTDR01370;hsa05223;Non-small cell lung cancer
TTDR01371;hsa04151;PI3K-Akt signaling pathway
TTDR01371;hsa04510;Focal adhesion
TTDR01371;hsa04512;ECM-receptor interaction
TTDR01371;hsa04514;Cell adhesion molecules (CAMs)
TTDR01371;hsa04640;Hematopoietic cell lineage
TTDR01371;hsa04670;Leukocyte transendothelial migration
TTDR01371;hsa04672;Intestinal immune network for IgA production
TTDR01371;hsa04810;Regulation of actin cytoskeleton
TTDR01371;hsa05140;Leishmaniasis
TTDR01371;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDR01371;hsa05412;Arrhythmogenic right ventricular cardiomyopathy (ARVC)
TTDR01371;hsa05414;Dilated cardiomyopathy
TTDR01372;hsa00350;Tyrosine metabolism
TTDR01372;hsa00360;Phenylalanine metabolism
TTDR01373;hsa04010;MAPK signaling pathway
TTDR01373;hsa04012;ErbB signaling pathway
TTDR01373;hsa04015;Rap1 signaling pathway
TTDR01373;hsa04024;cAMP signaling pathway
TTDR01373;hsa04062;Chemokine signaling pathway
TTDR01373;hsa04068;FoxO signaling pathway
TTDR01373;hsa04150;mTOR signaling pathway
TTDR01373;hsa04270;Vascular smooth muscle contraction
TTDR01373;hsa04510;Focal adhesion
TTDR01373;hsa04650;Natural killer cell mediated cytotoxicity
TTDR01373;hsa04720;Long-term potentiation
TTDR01373;hsa04722;Neurotrophin signaling pathway
TTDR01373;hsa04726;Serotonergic synapse
TTDR01373;hsa04730;Long-term depression
TTDR01373;hsa04810;Regulation of actin cytoskeleton
TTDR01373;hsa04910;Insulin signaling pathway
TTDR01373;hsa04914;Progesterone-mediated oocyte maturation
TTDR01373;hsa05034;Alcoholism
TTDR01373;hsa05160;Hepatitis C
TTDR01373;hsa05200;Pathways in cancer
TTDR01373;hsa05205;Proteoglycans in cancer
TTDR01373;hsa05210;Colorectal cancer
TTDR01373;hsa05211;Renal cell carcinoma
TTDR01373;hsa05212;Pancreatic cancer
TTDR01373;hsa05213;Endometrial cancer
TTDR01373;hsa05214;Glioma
TTDR01373;hsa05215;Prostate cancer
TTDR01373;hsa05216;Thyroid cancer
TTDR01373;hsa05218;Melanoma
TTDR01373;hsa05219;Bladder cancer
TTDR01373;hsa05220;Chronic myeloid leukemia
TTDR01373;hsa05221;Acute myeloid leukemia
TTDR01373;hsa05223;Non-small cell lung cancer
TTDR01374;hsa04514;Cell adhesion molecules (CAMs)
TTDR01374;hsa04668;TNF signaling pathway
TTDR01374;hsa05143;African trypanosomiasis
TTDR01374;hsa05144;Malaria
TTDR01375;hsa04010;MAPK signaling pathway
TTDR01375;hsa04014;Ras signaling pathway
TTDR01375;hsa04020;Calcium signaling pathway
TTDR01375;hsa04024;cAMP signaling pathway
TTDR01375;hsa04062;Chemokine signaling pathway
TTDR01375;hsa04114;Oocyte meiosis
TTDR01375;hsa04210;Apoptosis
TTDR01375;hsa04261;Adrenergic signaling in cardiomyocytes
TTDR01375;hsa04270;Vascular smooth muscle contraction
TTDR01375;hsa04310;Wnt signaling pathway
TTDR01375;hsa04340;Hedgehog signaling pathway
TTDR01375;hsa04540;Gap junction
TTDR01375;hsa04611;Platelet activation
TTDR01375;hsa04713;Circadian entrainment
TTDR01375;hsa04720;Long-term potentiation
TTDR01375;hsa04723;Retrograde endocannabinoid signaling
TTDR01375;hsa04724;Glutamatergic synapse
TTDR01375;hsa04725;Cholinergic synapse
TTDR01375;hsa04726;Serotonergic synapse
TTDR01375;hsa04727;GABAergic synapse
TTDR01375;hsa04728;Dopaminergic synapse
TTDR01375;hsa04740;Olfactory transduction
TTDR01375;hsa04742;Taste transduction
TTDR01375;hsa04750;Inflammatory mediator regulation of TRP channels
TTDR01375;hsa04910;Insulin signaling pathway
TTDR01375;hsa04911;Insulin secretion
TTDR01375;hsa04912;GnRH signaling pathway
TTDR01375;hsa04913;Ovarian steroidogenesis
TTDR01375;hsa04914;Progesterone-mediated oocyte maturation
TTDR01375;hsa04915;Estrogen signaling pathway
TTDR01375;hsa04916;Melanogenesis
TTDR01375;hsa04918;Thyroid hormone synthesis
TTDR01375;hsa04919;Thyroid hormone signaling pathway
TTDR01375;hsa04921;Oxytocin signaling pathway
TTDR01375;hsa04922;Glucagon signaling pathway
TTDR01375;hsa04923;Regulation of lipolysis in adipocytes
TTDR01375;hsa04924;Renin secretion
TTDR01375;hsa04961;Endocrine and other factor-regulated calcium reabsorption
TTDR01375;hsa04962;Vasopressin-regulated water reabsorption
TTDR01375;hsa04970;Salivary secretion
TTDR01375;hsa04971;Gastric acid secretion
TTDR01375;hsa04976;Bile secretion
TTDR01375;hsa05012;Parkinson's disease
TTDR01375;hsa05020;Prion diseases
TTDR01375;hsa05030;Cocaine addiction
TTDR01375;hsa05031;Amphetamine addiction
TTDR01375;hsa05032;Morphine addiction
TTDR01375;hsa05034;Alcoholism
TTDR01375;hsa05110;Vibrio cholerae infection
TTDR01375;hsa05146;Amoebiasis
TTDR01375;hsa05166;HTLV-I infection
TTDR01375;hsa05169;Epstein-Barr virus infection
TTDR01375;hsa05200;Pathways in cancer
TTDR01375;hsa05203;Viral carcinogenesis
TTDR01375;hsa05205;Proteoglycans in cancer
TTDR01375;hsa05414;Dilated cardiomyopathy
TTDR01376;hsa04668;TNF signaling pathway
TTDR01376;hsa05152;Tuberculosis
TTDR01376;hsa05202;Transcriptional misregulation in cancer
TTDR01377;hsa04064;NF-kappa B signaling pathway
TTDR01377;hsa04514;Cell adhesion molecules (CAMs)
TTDR01377;hsa04668;TNF signaling pathway
TTDR01377;hsa04670;Leukocyte transendothelial migration
TTDR01377;hsa05143;African trypanosomiasis
TTDR01377;hsa05144;Malaria
TTDR01377;hsa05166;HTLV-I infection
TTDR01378;hsa05130;Pathogenic Escherichia coli infection
TTDR01379;hsa04270;Vascular smooth muscle contraction
TTDR01379;hsa04530;Tight junction
TTDR01379;hsa04750;Inflammatory mediator regulation of TRP channels
TTDR01380;hsa04010;MAPK signaling pathway
TTDR01380;hsa04060;Cytokine-cytokine receptor interaction
TTDR01380;hsa04115;p53 signaling pathway
TTDR01380;hsa04210;Apoptosis
TTDR01380;hsa04650;Natural killer cell mediated cytotoxicity
TTDR01380;hsa04668;TNF signaling pathway
TTDR01380;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDR01380;hsa04940;Type I diabetes mellitus
TTDR01380;hsa05010;Alzheimer's disease
TTDR01380;hsa05142;Chagas disease (American trypanosomiasis)
TTDR01380;hsa05143;African trypanosomiasis
TTDR01380;hsa05161;Hepatitis B
TTDR01380;hsa05162;Measles
TTDR01380;hsa05164;Influenza A
TTDR01380;hsa05168;Herpes simplex infection
TTDR01380;hsa05200;Pathways in cancer
TTDR01380;hsa05205;Proteoglycans in cancer
TTDR01380;hsa05320;Autoimmune thyroid disease
TTDR01380;hsa05330;Allograft rejection
TTDR01380;hsa05332;Graft-versus-host disease
TTDR01381;hsa04060;Cytokine-cytokine receptor interaction
TTDR01381;hsa04064;NF-kappa B signaling pathway
TTDR01381;hsa04514;Cell adhesion molecules (CAMs)
TTDR01381;hsa04620;Toll-like receptor signaling pathway
TTDR01381;hsa04672;Intestinal immune network for IgA production
TTDR01381;hsa05144;Malaria
TTDR01381;hsa05145;Toxoplasmosis
TTDR01381;hsa05166;HTLV-I infection
TTDR01381;hsa05169;Epstein-Barr virus infection
TTDR01381;hsa05202;Transcriptional misregulation in cancer
TTDR01381;hsa05310;Asthma
TTDR01381;hsa05320;Autoimmune thyroid disease
TTDR01381;hsa05322;Systemic lupus erythematosus
TTDR01381;hsa05330;Allograft rejection
TTDR01381;hsa05340;Primary immunodeficiency
TTDR01381;hsa05416;Viral myocarditis
TTDR01383;hsa04020;Calcium signaling pathway
TTDR01383;hsa04022;cGMP-PKG signaling pathway
TTDR01383;hsa04270;Vascular smooth muscle contraction
TTDR01383;hsa04540;Gap junction
TTDR01383;hsa04725;Cholinergic synapse
TTDR01383;hsa04730;Long-term depression
TTDR01383;hsa04911;Insulin secretion
TTDR01383;hsa04912;GnRH signaling pathway
TTDR01383;hsa05142;Chagas disease (American trypanosomiasis)
TTDR01383;hsa05146;Amoebiasis
TTDR01383;hsa05200;Pathways in cancer
TTDR01384;hsa04514;Cell adhesion molecules (CAMs)
TTDR01384;hsa04620;Toll-like receptor signaling pathway
TTDR01384;hsa04672;Intestinal immune network for IgA production
TTDR01384;hsa04940;Type I diabetes mellitus
TTDR01384;hsa05320;Autoimmune thyroid disease
TTDR01384;hsa05322;Systemic lupus erythematosus
TTDR01384;hsa05323;Rheumatoid arthritis
TTDR01384;hsa05330;Allograft rejection
TTDR01384;hsa05332;Graft-versus-host disease
TTDR01384;hsa05416;Viral myocarditis
TTDR01385;hsa04010;MAPK signaling pathway
TTDR01385;hsa04012;ErbB signaling pathway
TTDR01385;hsa04014;Ras signaling pathway
TTDR01385;hsa04015;Rap1 signaling pathway
TTDR01385;hsa04022;cGMP-PKG signaling pathway
TTDR01385;hsa04024;cAMP signaling pathway
TTDR01385;hsa04066;HIF-1 signaling pathway
TTDR01385;hsa04068;FoxO signaling pathway
TTDR01385;hsa04071;Sphingolipid signaling pathway
TTDR01385;hsa04151;PI3K-Akt signaling pathway
TTDR01385;hsa04270;Vascular smooth muscle contraction
TTDR01385;hsa04370;VEGF signaling pathway
TTDR01385;hsa04540;Gap junction
TTDR01385;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDR01385;hsa04620;Toll-like receptor signaling pathway
TTDR01385;hsa04650;Natural killer cell mediated cytotoxicity
TTDR01385;hsa04660;T cell receptor signaling pathway
TTDR01385;hsa04662;B cell receptor signaling pathway
TTDR01385;hsa04664;Fc epsilon RI signaling pathway
TTDR01385;hsa04720;Long-term potentiation
TTDR01385;hsa04722;Neurotrophin signaling pathway
TTDR01385;hsa04730;Long-term depression
TTDR01385;hsa04810;Regulation of actin cytoskeleton
TTDR01385;hsa04910;Insulin signaling pathway
TTDR01385;hsa04912;GnRH signaling pathway
TTDR01385;hsa04915;Estrogen signaling pathway
TTDR01385;hsa04916;Melanogenesis
TTDR01385;hsa04917;Prolactin signaling pathway
TTDR01385;hsa04919;Thyroid hormone signaling pathway
TTDR01385;hsa04921;Oxytocin signaling pathway
TTDR01385;hsa05020;Prion diseases
TTDR01385;hsa05161;Hepatitis B
TTDR01385;hsa05164;Influenza A
TTDR01385;hsa05200;Pathways in cancer
TTDR01385;hsa05205;Proteoglycans in cancer
TTDR01385;hsa05206;MicroRNAs in cancer
TTDR01385;hsa05211;Renal cell carcinoma
TTDR01385;hsa05213;Endometrial cancer
TTDR01385;hsa05214;Glioma
TTDR01385;hsa05215;Prostate cancer
TTDR01385;hsa05216;Thyroid cancer
TTDR01385;hsa05218;Melanoma
TTDR01385;hsa05219;Bladder cancer
TTDR01385;hsa05220;Chronic myeloid leukemia
TTDR01385;hsa05221;Acute myeloid leukemia
TTDR01385;hsa05223;Non-small cell lung cancer
TTDR01385;hsa05230;Central carbon metabolism in cancer
TTDR01385;hsa05231;Choline metabolism in cancer
TTDR01386;hsa03320;PPAR signaling pathway
TTDR01386;hsa04152;AMPK signaling pathway
TTDR01386;hsa04380;Osteoclast differentiation
TTDR01386;hsa05016;Huntington's disease
TTDR01386;hsa05200;Pathways in cancer
TTDR01386;hsa05202;Transcriptional misregulation in cancer
TTDR01386;hsa05216;Thyroid cancer
TTDR01387;hsa04062;Chemokine signaling pathway
TTDR01387;hsa04066;HIF-1 signaling pathway
TTDR01387;hsa04068;FoxO signaling pathway
TTDR01387;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDR01387;hsa04630;Jak-STAT signaling pathway
TTDR01387;hsa04917;Prolactin signaling pathway
TTDR01387;hsa04920;Adipocytokine signaling pathway
TTDR01387;hsa05145;Toxoplasmosis
TTDR01387;hsa05160;Hepatitis C
TTDR01387;hsa05161;Hepatitis B
TTDR01387;hsa05162;Measles
TTDR01387;hsa05169;Epstein-Barr virus infection
TTDR01387;hsa05200;Pathways in cancer
TTDR01387;hsa05203;Viral carcinogenesis
TTDR01387;hsa05205;Proteoglycans in cancer
TTDR01387;hsa05206;MicroRNAs in cancer
TTDR01387;hsa05212;Pancreatic cancer
TTDR01387;hsa05221;Acute myeloid leukemia
TTDR01387;hsa05321;Inflammatory bowel disease (IBD)
TTDR01388;hsa04010;MAPK signaling pathway
TTDR01388;hsa04620;Toll-like receptor signaling pathway
TTDR01388;hsa04660;T cell receptor signaling pathway
TTDR01388;hsa04668;TNF signaling pathway
TTDR01389;hsa04514;Cell adhesion molecules (CAMs)
TTDR01389;hsa04620;Toll-like receptor signaling pathway
TTDR01389;hsa04672;Intestinal immune network for IgA production
TTDR01389;hsa04940;Type I diabetes mellitus
TTDR01389;hsa05202;Transcriptional misregulation in cancer
TTDR01389;hsa05320;Autoimmune thyroid disease
TTDR01389;hsa05322;Systemic lupus erythematosus
TTDR01389;hsa05323;Rheumatoid arthritis
TTDR01389;hsa05330;Allograft rejection
TTDR01389;hsa05332;Graft-versus-host disease
TTDR01389;hsa05416;Viral myocarditis
TTDR01390;hsa00562;Inositol phosphate metabolism
TTDR01390;hsa04012;ErbB signaling pathway
TTDR01390;hsa04014;Ras signaling pathway
TTDR01390;hsa04015;Rap1 signaling pathway
TTDR01390;hsa04022;cGMP-PKG signaling pathway
TTDR01390;hsa04024;cAMP signaling pathway
TTDR01390;hsa04062;Chemokine signaling pathway
TTDR01390;hsa04066;HIF-1 signaling pathway
TTDR01390;hsa04068;FoxO signaling pathway
TTDR01390;hsa04070;Phosphatidylinositol signaling system
TTDR01390;hsa04071;Sphingolipid signaling pathway
TTDR01390;hsa04150;mTOR signaling pathway
TTDR01390;hsa04151;PI3K-Akt signaling pathway
TTDR01390;hsa04152;AMPK signaling pathway
TTDR01390;hsa04210;Apoptosis
TTDR01390;hsa04261;Adrenergic signaling in cardiomyocytes
TTDR01390;hsa04370;VEGF signaling pathway
TTDR01390;hsa04380;Osteoclast differentiation
TTDR01390;hsa04510;Focal adhesion
TTDR01390;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDR01390;hsa04611;Platelet activation
TTDR01390;hsa04620;Toll-like receptor signaling pathway
TTDR01390;hsa04630;Jak-STAT signaling pathway
TTDR01390;hsa04650;Natural killer cell mediated cytotoxicity
TTDR01390;hsa04660;T cell receptor signaling pathway
TTDR01390;hsa04662;B cell receptor signaling pathway
TTDR01390;hsa04664;Fc epsilon RI signaling pathway
TTDR01390;hsa04666;Fc gamma R-mediated phagocytosis
TTDR01390;hsa04668;TNF signaling pathway
TTDR01390;hsa04670;Leukocyte transendothelial migration
TTDR01390;hsa04722;Neurotrophin signaling pathway
TTDR01390;hsa04725;Cholinergic synapse
TTDR01390;hsa04750;Inflammatory mediator regulation of TRP channels
TTDR01390;hsa04810;Regulation of actin cytoskeleton
TTDR01390;hsa04910;Insulin signaling pathway
TTDR01390;hsa04914;Progesterone-mediated oocyte maturation
TTDR01390;hsa04915;Estrogen signaling pathway
TTDR01390;hsa04917;Prolactin signaling pathway
TTDR01390;hsa04919;Thyroid hormone signaling pathway
TTDR01390;hsa04921;Oxytocin signaling pathway
TTDR01390;hsa04923;Regulation of lipolysis in adipocytes
TTDR01390;hsa04930;Type II diabetes mellitus
TTDR01390;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDR01390;hsa04960;Aldosterone-regulated sodium reabsorption
TTDR01390;hsa04973;Carbohydrate digestion and absorption
TTDR01390;hsa05100;Bacterial invasion of epithelial cells
TTDR01390;hsa05142;Chagas disease (American trypanosomiasis)
TTDR01390;hsa05145;Toxoplasmosis
TTDR01390;hsa05146;Amoebiasis
TTDR01390;hsa05160;Hepatitis C
TTDR01390;hsa05161;Hepatitis B
TTDR01390;hsa05162;Measles
TTDR01390;hsa05164;Influenza A
TTDR01390;hsa05166;HTLV-I infection
TTDR01390;hsa05169;Epstein-Barr virus infection
TTDR01390;hsa05200;Pathways in cancer
TTDR01390;hsa05203;Viral carcinogenesis
TTDR01390;hsa05205;Proteoglycans in cancer
TTDR01390;hsa05210;Colorectal cancer
TTDR01390;hsa05211;Renal cell carcinoma
TTDR01390;hsa05212;Pancreatic cancer
TTDR01390;hsa05213;Endometrial cancer
TTDR01390;hsa05214;Glioma
TTDR01390;hsa05215;Prostate cancer
TTDR01390;hsa05218;Melanoma
TTDR01390;hsa05220;Chronic myeloid leukemia
TTDR01390;hsa05221;Acute myeloid leukemia
TTDR01390;hsa05222;Small cell lung cancer
TTDR01390;hsa05223;Non-small cell lung cancer
TTDR01390;hsa05230;Central carbon metabolism in cancer
TTDR01390;hsa05231;Choline metabolism in cancer
TTDR01391;hsa04010;MAPK signaling pathway
TTDR01391;hsa04012;ErbB signaling pathway
TTDR01391;hsa04014;Ras signaling pathway
TTDR01391;hsa04024;cAMP signaling pathway
TTDR01391;hsa04068;FoxO signaling pathway
TTDR01391;hsa04071;Sphingolipid signaling pathway
TTDR01391;hsa04141;Protein processing in endoplasmic reticulum
TTDR01391;hsa04310;Wnt signaling pathway
TTDR01391;hsa04380;Osteoclast differentiation
TTDR01391;hsa04510;Focal adhesion
TTDR01391;hsa04620;Toll-like receptor signaling pathway
TTDR01391;hsa04621;NOD-like receptor signaling pathway
TTDR01391;hsa04622;RIG-I-like receptor signaling pathway
TTDR01391;hsa04660;T cell receptor signaling pathway
TTDR01391;hsa04664;Fc epsilon RI signaling pathway
TTDR01391;hsa04668;TNF signaling pathway
TTDR01391;hsa04722;Neurotrophin signaling pathway
TTDR01391;hsa04723;Retrograde endocannabinoid signaling
TTDR01391;hsa04728;Dopaminergic synapse
TTDR01391;hsa04750;Inflammatory mediator regulation of TRP channels
TTDR01391;hsa04910;Insulin signaling pathway
TTDR01391;hsa04912;GnRH signaling pathway
TTDR01391;hsa04914;Progesterone-mediated oocyte maturation
TTDR01391;hsa04917;Prolactin signaling pathway
TTDR01391;hsa04920;Adipocytokine signaling pathway
TTDR01391;hsa04930;Type II diabetes mellitus
TTDR01391;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDR01391;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDR01391;hsa05131;Shigellosis
TTDR01391;hsa05132;Salmonella infection
TTDR01391;hsa05133;Pertussis
TTDR01391;hsa05142;Chagas disease (American trypanosomiasis)
TTDR01391;hsa05145;Toxoplasmosis
TTDR01391;hsa05152;Tuberculosis
TTDR01391;hsa05160;Hepatitis C
TTDR01391;hsa05161;Hepatitis B
TTDR01391;hsa05164;Influenza A
TTDR01391;hsa05168;Herpes simplex infection
TTDR01391;hsa05169;Epstein-Barr virus infection
TTDR01391;hsa05200;Pathways in cancer
TTDR01391;hsa05210;Colorectal cancer
TTDR01391;hsa05212;Pancreatic cancer
TTDR01391;hsa05231;Choline metabolism in cancer
TTDR01393;hsa04010;MAPK signaling pathway
TTDR01393;hsa04014;Ras signaling pathway
TTDR01393;hsa04060;Cytokine-cytokine receptor interaction
TTDR01393;hsa04068;FoxO signaling pathway
TTDR01393;hsa04151;PI3K-Akt signaling pathway
TTDR01393;hsa04210;Apoptosis
TTDR01393;hsa04650;Natural killer cell mediated cytotoxicity
TTDR01393;hsa04722;Neurotrophin signaling pathway
TTDR01393;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDR01393;hsa04940;Type I diabetes mellitus
TTDR01393;hsa05142;Chagas disease (American trypanosomiasis)
TTDR01393;hsa05143;African trypanosomiasis
TTDR01393;hsa05161;Hepatitis B
TTDR01393;hsa05162;Measles
TTDR01393;hsa05164;Influenza A
TTDR01393;hsa05168;Herpes simplex infection
TTDR01393;hsa05200;Pathways in cancer
TTDR01393;hsa05205;Proteoglycans in cancer
TTDR01393;hsa05320;Autoimmune thyroid disease
TTDR01393;hsa05330;Allograft rejection
TTDR01393;hsa05332;Graft-versus-host disease
TTDR01394;hsa04062;Chemokine signaling pathway
TTDR01394;hsa04728;Dopaminergic synapse
TTDR01394;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDR01396;hsa04210;Apoptosis
TTDR01397;hsa00562;Inositol phosphate metabolism
TTDR01397;hsa04068;FoxO signaling pathway
TTDR01397;hsa04070;Phosphatidylinositol signaling system
TTDR01397;hsa04071;Sphingolipid signaling pathway
TTDR01397;hsa04115;p53 signaling pathway
TTDR01397;hsa04150;mTOR signaling pathway
TTDR01397;hsa04151;PI3K-Akt signaling pathway
TTDR01397;hsa04510;Focal adhesion
TTDR01397;hsa04530;Tight junction
TTDR01397;hsa05161;Hepatitis B
TTDR01397;hsa05200;Pathways in cancer
TTDR01397;hsa05206;MicroRNAs in cancer
TTDR01397;hsa05213;Endometrial cancer
TTDR01397;hsa05214;Glioma
TTDR01397;hsa05215;Prostate cancer
TTDR01397;hsa05218;Melanoma
TTDR01397;hsa05222;Small cell lung cancer
TTDR01397;hsa05230;Central carbon metabolism in cancer
TTDR01398;hsa04014;Ras signaling pathway
TTDR01398;hsa04015;Rap1 signaling pathway
TTDR01398;hsa04022;cGMP-PKG signaling pathway
TTDR01398;hsa04024;cAMP signaling pathway
TTDR01398;hsa04062;Chemokine signaling pathway
TTDR01398;hsa04071;Sphingolipid signaling pathway
TTDR01398;hsa04144;Endocytosis
TTDR01398;hsa04270;Vascular smooth muscle contraction
TTDR01398;hsa04310;Wnt signaling pathway
TTDR01398;hsa04350;TGF-beta signaling pathway
TTDR01398;hsa04360;Axon guidance
TTDR01398;hsa04510;Focal adhesion
TTDR01398;hsa04520;Adherens junction
TTDR01398;hsa04530;Tight junction
TTDR01398;hsa04611;Platelet activation
TTDR01398;hsa04660;T cell receptor signaling pathway
TTDR01398;hsa04670;Leukocyte transendothelial migration
TTDR01398;hsa04722;Neurotrophin signaling pathway
TTDR01398;hsa04810;Regulation of actin cytoskeleton
TTDR01398;hsa04921;Oxytocin signaling pathway
TTDR01398;hsa04972;Pancreatic secretion
TTDR01398;hsa05100;Bacterial invasion of epithelial cells
TTDR01398;hsa05130;Pathogenic Escherichia coli infection
TTDR01398;hsa05133;Pertussis
TTDR01398;hsa05152;Tuberculosis
TTDR01398;hsa05200;Pathways in cancer
TTDR01398;hsa05203;Viral carcinogenesis
TTDR01398;hsa05205;Proteoglycans in cancer
TTDR01398;hsa05206;MicroRNAs in cancer
TTDR01398;hsa05210;Colorectal cancer
TTDR01399;hsa04068;FoxO signaling pathway
TTDR01399;hsa04110;Cell cycle
TTDR01399;hsa04115;p53 signaling pathway
TTDR01399;hsa04120;Ubiquitin mediated proteolysis
TTDR01399;hsa04144;Endocytosis
TTDR01399;hsa04151;PI3K-Akt signaling pathway
TTDR01399;hsa04919;Thyroid hormone signaling pathway
TTDR01399;hsa05169;Epstein-Barr virus infection
TTDR01399;hsa05200;Pathways in cancer
TTDR01399;hsa05202;Transcriptional misregulation in cancer
TTDR01399;hsa05203;Viral carcinogenesis
TTDR01399;hsa05205;Proteoglycans in cancer
TTDR01399;hsa05206;MicroRNAs in cancer
TTDR01399;hsa05214;Glioma
TTDR01399;hsa05215;Prostate cancer
TTDR01399;hsa05218;Melanoma
TTDR01399;hsa05219;Bladder cancer
TTDR01399;hsa05220;Chronic myeloid leukemia
TTDR01400;hsa04110;Cell cycle
TTDR01400;hsa05161;Hepatitis B
TTDR01400;hsa05166;HTLV-I infection
TTDR01400;hsa05200;Pathways in cancer
TTDR01400;hsa05206;MicroRNAs in cancer
TTDR01400;hsa05212;Pancreatic cancer
TTDR01400;hsa05214;Glioma
TTDR01400;hsa05215;Prostate cancer
TTDR01400;hsa05218;Melanoma
TTDR01400;hsa05219;Bladder cancer
TTDR01400;hsa05220;Chronic myeloid leukemia
TTDR01400;hsa05222;Small cell lung cancer
TTDR01400;hsa05223;Non-small cell lung cancer
TTDR01401;hsa04022;cGMP-PKG signaling pathway
TTDR01401;hsa04071;Sphingolipid signaling pathway
TTDR01401;hsa04270;Vascular smooth muscle contraction
TTDR01401;hsa04530;Tight junction
TTDR01401;hsa04664;Fc epsilon RI signaling pathway
TTDR01401;hsa04666;Fc gamma R-mediated phagocytosis
TTDR01401;hsa04750;Inflammatory mediator regulation of TRP channels
TTDR01401;hsa04930;Type II diabetes mellitus
TTDR01401;hsa05206;MicroRNAs in cancer
TTDR01402;hsa04064;NF-kappa B signaling pathway
TTDR01402;hsa04270;Vascular smooth muscle contraction
TTDR01402;hsa04530;Tight junction
TTDR01402;hsa04660;T cell receptor signaling pathway
TTDR01402;hsa04750;Inflammatory mediator regulation of TRP channels
TTDR01402;hsa04920;Adipocytokine signaling pathway
TTDR01402;hsa05162;Measles
TTDR01403;hsa04015;Rap1 signaling pathway
TTDR01403;hsa04062;Chemokine signaling pathway
TTDR01403;hsa04071;Sphingolipid signaling pathway
TTDR01403;hsa04144;Endocytosis
TTDR01403;hsa04151;PI3K-Akt signaling pathway
TTDR01403;hsa04390;Hippo signaling pathway
TTDR01403;hsa04530;Tight junction
TTDR01403;hsa04611;Platelet activation
TTDR01403;hsa04910;Insulin signaling pathway
TTDR01403;hsa04930;Type II diabetes mellitus
TTDR01404;hsa04062;Chemokine signaling pathway
TTDR01404;hsa04270;Vascular smooth muscle contraction
TTDR01404;hsa04530;Tight junction
TTDR01404;hsa04664;Fc epsilon RI signaling pathway
TTDR01404;hsa04666;Fc gamma R-mediated phagocytosis
TTDR01404;hsa04722;Neurotrophin signaling pathway
TTDR01404;hsa04750;Inflammatory mediator regulation of TRP channels
TTDR01404;hsa04912;GnRH signaling pathway
TTDR01404;hsa04915;Estrogen signaling pathway
TTDR01404;hsa04930;Type II diabetes mellitus
TTDR01405;hsa04014;Ras signaling pathway
TTDR01405;hsa04064;NF-kappa B signaling pathway
TTDR01405;hsa04151;PI3K-Akt signaling pathway
TTDR01405;hsa04210;Apoptosis
TTDR01405;hsa04630;Jak-STAT signaling pathway
TTDR01405;hsa05014;Amyotrophic lateral sclerosis (ALS)
TTDR01405;hsa05145;Toxoplasmosis
TTDR01405;hsa05166;HTLV-I infection
TTDR01405;hsa05200;Pathways in cancer
TTDR01405;hsa05202;Transcriptional misregulation in cancer
TTDR01405;hsa05212;Pancreatic cancer
TTDR01405;hsa05220;Chronic myeloid leukemia
TTDR01405;hsa05222;Small cell lung cancer
TTDR01406;hsa04068;FoxO signaling pathway
TTDR01406;hsa04152;AMPK signaling pathway
TTDR01406;hsa04910;Insulin signaling pathway
TTDR01406;hsa04919;Thyroid hormone signaling pathway
TTDR01406;hsa04922;Glucagon signaling pathway
TTDR01406;hsa05200;Pathways in cancer
TTDR01406;hsa05202;Transcriptional misregulation in cancer
TTDR01406;hsa05215;Prostate cancer
TTDR01408;hsa04010;MAPK signaling pathway
TTDR01409;hsa04010;MAPK signaling pathway
TTDR01409;hsa04120;Ubiquitin mediated proteolysis
TTDR01409;hsa04622;RIG-I-like receptor signaling pathway
TTDR01409;hsa04722;Neurotrophin signaling pathway
TTDR01409;hsa04912;GnRH signaling pathway
TTDR01409;hsa05161;Hepatitis B
TTDR01409;hsa05166;HTLV-I infection
TTDR01410;hsa04064;NF-kappa B signaling pathway
TTDR01410;hsa04120;Ubiquitin mediated proteolysis
TTDR01410;hsa04210;Apoptosis
TTDR01410;hsa04510;Focal adhesion
TTDR01410;hsa04621;NOD-like receptor signaling pathway
TTDR01410;hsa04668;TNF signaling pathway
TTDR01410;hsa05145;Toxoplasmosis
TTDR01410;hsa05200;Pathways in cancer
TTDR01410;hsa05202;Transcriptional misregulation in cancer
TTDR01410;hsa05222;Small cell lung cancer
TTDR01411;hsa03013;RNA transport
TTDR01412;hsa05200;Pathways in cancer
TTDR01412;hsa05216;Thyroid cancer
TTDR01413;hsa04115;p53 signaling pathway
TTDR01413;hsa04210;Apoptosis
TTDR01413;hsa04620;Toll-like receptor signaling pathway
TTDR01413;hsa04621;NOD-like receptor signaling pathway
TTDR01413;hsa04622;RIG-I-like receptor signaling pathway
TTDR01413;hsa04668;TNF signaling pathway
TTDR01413;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDR01413;hsa05010;Alzheimer's disease
TTDR01413;hsa05016;Huntington's disease
TTDR01413;hsa05134;Legionellosis
TTDR01413;hsa05142;Chagas disease (American trypanosomiasis)
TTDR01413;hsa05145;Toxoplasmosis
TTDR01413;hsa05152;Tuberculosis
TTDR01413;hsa05161;Hepatitis B
TTDR01413;hsa05168;Herpes simplex infection
TTDR01413;hsa05200;Pathways in cancer
TTDR01413;hsa05203;Viral carcinogenesis
TTDR01413;hsa05416;Viral myocarditis
TTDR01414;hsa04012;ErbB signaling pathway
TTDR01414;hsa04020;Calcium signaling pathway
TTDR01414;hsa04144;Endocytosis
TTDR01414;hsa05205;Proteoglycans in cancer
TTDR01415;hsa04350;TGF-beta signaling pathway
TTDR01415;hsa04390;Hippo signaling pathway
TTDR01415;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDR01415;hsa05202;Transcriptional misregulation in cancer
TTDR01416;hsa04066;HIF-1 signaling pathway
TTDR01416;hsa04150;mTOR signaling pathway
TTDR01416;hsa04919;Thyroid hormone signaling pathway
TTDR01416;hsa05200;Pathways in cancer
TTDR01416;hsa05205;Proteoglycans in cancer
TTDR01416;hsa05211;Renal cell carcinoma
TTDR01416;hsa05230;Central carbon metabolism in cancer
TTDR01416;hsa05231;Choline metabolism in cancer
TTDR01417;hsa04010;MAPK signaling pathway
TTDR01421;hsa04144;Endocytosis
TTDR01422;hsa04010;MAPK signaling pathway
TTDR01422;hsa04722;Neurotrophin signaling pathway
TTDR01422;hsa04912;GnRH signaling pathway
TTDR01422;hsa05166;HTLV-I infection
TTDR01423;hsa05200;Pathways in cancer
TTDR01423;hsa05211;Renal cell carcinoma
TTDR01424;hsa04010;MAPK signaling pathway
TTDR01424;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDR01425;hsa04120;Ubiquitin mediated proteolysis
TTDR01425;hsa04144;Endocytosis
TTDR01426;hsa04064;NF-kappa B signaling pathway
TTDR01426;hsa04210;Apoptosis
TTDR01426;hsa04620;Toll-like receptor signaling pathway
TTDR01426;hsa04722;Neurotrophin signaling pathway
TTDR01426;hsa05133;Pertussis
TTDR01426;hsa05140;Leishmaniasis
TTDR01426;hsa05142;Chagas disease (American trypanosomiasis)
TTDR01426;hsa05145;Toxoplasmosis
TTDR01426;hsa05152;Tuberculosis
TTDR01426;hsa05162;Measles
TTDR01426;hsa05164;Influenza A
TTDR01427;hsa05206;MicroRNAs in cancer
TTDR01430;hsa04330;Notch signaling pathway
TTDR01431;hsa04010;MAPK signaling pathway
TTDR01431;hsa04012;ErbB signaling pathway
TTDR01431;hsa04014;Ras signaling pathway
TTDR01431;hsa04015;Rap1 signaling pathway
TTDR01431;hsa04022;cGMP-PKG signaling pathway
TTDR01431;hsa04024;cAMP signaling pathway
TTDR01431;hsa04062;Chemokine signaling pathway
TTDR01431;hsa04066;HIF-1 signaling pathway
TTDR01431;hsa04068;FoxO signaling pathway
TTDR01431;hsa04071;Sphingolipid signaling pathway
TTDR01431;hsa04150;mTOR signaling pathway
TTDR01431;hsa04151;PI3K-Akt signaling pathway
TTDR01431;hsa04152;AMPK signaling pathway
TTDR01431;hsa04210;Apoptosis
TTDR01431;hsa04261;Adrenergic signaling in cardiomyocytes
TTDR01431;hsa04370;VEGF signaling pathway
TTDR01431;hsa04380;Osteoclast differentiation
TTDR01431;hsa04510;Focal adhesion
TTDR01431;hsa04530;Tight junction
TTDR01431;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDR01431;hsa04611;Platelet activation
TTDR01431;hsa04620;Toll-like receptor signaling pathway
TTDR01431;hsa04630;Jak-STAT signaling pathway
TTDR01431;hsa04660;T cell receptor signaling pathway
TTDR01431;hsa04662;B cell receptor signaling pathway
TTDR01431;hsa04664;Fc epsilon RI signaling pathway
TTDR01431;hsa04666;Fc gamma R-mediated phagocytosis
TTDR01431;hsa04668;TNF signaling pathway
TTDR01431;hsa04722;Neurotrophin signaling pathway
TTDR01431;hsa04725;Cholinergic synapse
TTDR01431;hsa04728;Dopaminergic synapse
TTDR01431;hsa04910;Insulin signaling pathway
TTDR01431;hsa04914;Progesterone-mediated oocyte maturation
TTDR01431;hsa04915;Estrogen signaling pathway
TTDR01431;hsa04917;Prolactin signaling pathway
TTDR01431;hsa04919;Thyroid hormone signaling pathway
TTDR01431;hsa04920;Adipocytokine signaling pathway
TTDR01431;hsa04922;Glucagon signaling pathway
TTDR01431;hsa04923;Regulation of lipolysis in adipocytes
TTDR01431;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDR01431;hsa04973;Carbohydrate digestion and absorption
TTDR01431;hsa05142;Chagas disease (American trypanosomiasis)
TTDR01431;hsa05145;Toxoplasmosis
TTDR01431;hsa05152;Tuberculosis
TTDR01431;hsa05160;Hepatitis C
TTDR01431;hsa05161;Hepatitis B
TTDR01431;hsa05162;Measles
TTDR01431;hsa05164;Influenza A
TTDR01431;hsa05166;HTLV-I infection
TTDR01431;hsa05169;Epstein-Barr virus infection
TTDR01431;hsa05200;Pathways in cancer
TTDR01431;hsa05205;Proteoglycans in cancer
TTDR01431;hsa05210;Colorectal cancer
TTDR01431;hsa05211;Renal cell carcinoma
TTDR01431;hsa05212;Pancreatic cancer
TTDR01431;hsa05213;Endometrial cancer
TTDR01431;hsa05214;Glioma
TTDR01431;hsa05215;Prostate cancer
TTDR01431;hsa05218;Melanoma
TTDR01431;hsa05220;Chronic myeloid leukemia
TTDR01431;hsa05221;Acute myeloid leukemia
TTDR01431;hsa05222;Small cell lung cancer
TTDR01431;hsa05223;Non-small cell lung cancer
TTDR01431;hsa05230;Central carbon metabolism in cancer
TTDR01431;hsa05231;Choline metabolism in cancer
TTDR01432;hsa04010;MAPK signaling pathway
TTDR01432;hsa04540;Gap junction
TTDR01432;hsa04912;GnRH signaling pathway
TTDR01433;hsa04015;Rap1 signaling pathway
TTDR01433;hsa04510;Focal adhesion
TTDR01433;hsa04611;Platelet activation
TTDR01433;hsa05166;HTLV-I infection
TTDR01434;hsa04060;Cytokine-cytokine receptor interaction
TTDR01434;hsa04064;NF-kappa B signaling pathway
TTDR01434;hsa04380;Osteoclast differentiation
TTDR01434;hsa04917;Prolactin signaling pathway
TTDR01434;hsa05323;Rheumatoid arthritis
TTDR01436;hsa04080;Neuroactive ligand-receptor interaction
TTDR01437;hsa04520;Adherens junction
TTDR01437;hsa04910;Insulin signaling pathway
TTDR01438;hsa04010;MAPK signaling pathway
TTDR01438;hsa04014;Ras signaling pathway
TTDR01438;hsa04015;Rap1 signaling pathway
TTDR01438;hsa04144;Endocytosis
TTDR01438;hsa04151;PI3K-Akt signaling pathway
TTDR01438;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDR01438;hsa04810;Regulation of actin cytoskeleton
TTDS00002;hsa04020;Calcium signaling pathway
TTDS00002;hsa04024;cAMP signaling pathway
TTDS00002;hsa04080;Neuroactive ligand-receptor interaction
TTDS00002;hsa04151;PI3K-Akt signaling pathway
TTDS00002;hsa04725;Cholinergic synapse
TTDS00002;hsa04810;Regulation of actin cytoskeleton
TTDS00003;hsa04020;Calcium signaling pathway
TTDS00003;hsa04024;cAMP signaling pathway
TTDS00003;hsa04080;Neuroactive ligand-receptor interaction
TTDS00003;hsa04151;PI3K-Akt signaling pathway
TTDS00003;hsa04725;Cholinergic synapse
TTDS00003;hsa04810;Regulation of actin cytoskeleton
TTDS00004;hsa04020;Calcium signaling pathway
TTDS00004;hsa04080;Neuroactive ligand-receptor interaction
TTDS00004;hsa04725;Cholinergic synapse
TTDS00004;hsa04810;Regulation of actin cytoskeleton
TTDS00004;hsa04911;Insulin secretion
TTDS00004;hsa04970;Salivary secretion
TTDS00004;hsa04971;Gastric acid secretion
TTDS00004;hsa04972;Pancreatic secretion
TTDS00005;hsa04080;Neuroactive ligand-receptor interaction
TTDS00005;hsa04725;Cholinergic synapse
TTDS00005;hsa04810;Regulation of actin cytoskeleton
TTDS00006;hsa04020;Calcium signaling pathway
TTDS00006;hsa04080;Neuroactive ligand-receptor interaction
TTDS00006;hsa04725;Cholinergic synapse
TTDS00006;hsa04810;Regulation of actin cytoskeleton
TTDS00007;hsa04014;Ras signaling pathway
TTDS00007;hsa04015;Rap1 signaling pathway
TTDS00007;hsa04060;Cytokine-cytokine receptor interaction
TTDS00007;hsa04066;HIF-1 signaling pathway
TTDS00007;hsa04144;Endocytosis
TTDS00007;hsa04151;PI3K-Akt signaling pathway
TTDS00007;hsa04510;Focal adhesion
TTDS00007;hsa05202;Transcriptional misregulation in cancer
TTDS00007;hsa05323;Rheumatoid arthritis
TTDS00008;hsa04014;Ras signaling pathway
TTDS00008;hsa04015;Rap1 signaling pathway
TTDS00008;hsa04060;Cytokine-cytokine receptor interaction
TTDS00008;hsa04144;Endocytosis
TTDS00008;hsa04151;PI3K-Akt signaling pathway
TTDS00008;hsa04370;VEGF signaling pathway
TTDS00008;hsa04510;Focal adhesion
TTDS00008;hsa05205;Proteoglycans in cancer
TTDS00011;hsa04020;Calcium signaling pathway
TTDS00011;hsa04024;cAMP signaling pathway
TTDS00011;hsa04080;Neuroactive ligand-receptor interaction
TTDS00011;hsa04540;Gap junction
TTDS00011;hsa04728;Dopaminergic synapse
TTDS00011;hsa05012;Parkinson's disease
TTDS00011;hsa05030;Cocaine addiction
TTDS00011;hsa05031;Amphetamine addiction
TTDS00011;hsa05032;Morphine addiction
TTDS00011;hsa05034;Alcoholism
TTDS00012;hsa04015;Rap1 signaling pathway
TTDS00012;hsa04024;cAMP signaling pathway
TTDS00012;hsa04080;Neuroactive ligand-receptor interaction
TTDS00012;hsa04540;Gap junction
TTDS00012;hsa04728;Dopaminergic synapse
TTDS00012;hsa05012;Parkinson's disease
TTDS00012;hsa05030;Cocaine addiction
TTDS00012;hsa05034;Alcoholism
TTDS00013;hsa04080;Neuroactive ligand-receptor interaction
TTDS00013;hsa04728;Dopaminergic synapse
TTDS00015;hsa04020;Calcium signaling pathway
TTDS00015;hsa04024;cAMP signaling pathway
TTDS00015;hsa04080;Neuroactive ligand-receptor interaction
TTDS00015;hsa04728;Dopaminergic synapse
TTDS00017;hsa04728;Dopaminergic synapse
TTDS00017;hsa05012;Parkinson's disease
TTDS00017;hsa05030;Cocaine addiction
TTDS00017;hsa05031;Amphetamine addiction
TTDS00017;hsa05034;Alcoholism
TTDS00022;hsa04024;cAMP signaling pathway
TTDS00022;hsa04080;Neuroactive ligand-receptor interaction
TTDS00022;hsa04727;GABAergic synapse
TTDS00022;hsa04915;Estrogen signaling pathway
TTDS00022;hsa05032;Morphine addiction
TTDS00024;hsa00250;Alanine, aspartate and glutamate metabolism
TTDS00024;hsa00280;Valine, leucine and isoleucine degradation
TTDS00024;hsa00410;beta-Alanine metabolism
TTDS00024;hsa00640;Propanoate metabolism
TTDS00024;hsa00650;Butanoate metabolism
TTDS00024;hsa01100;Metabolic pathways
TTDS00024;hsa04727;GABAergic synapse
TTDS00029;hsa04020;Calcium signaling pathway
TTDS00029;hsa04022;cGMP-PKG signaling pathway
TTDS00029;hsa04080;Neuroactive ligand-receptor interaction
TTDS00029;hsa04261;Adrenergic signaling in cardiomyocytes
TTDS00029;hsa04270;Vascular smooth muscle contraction
TTDS00029;hsa04970;Salivary secretion
TTDS00030;hsa04020;Calcium signaling pathway
TTDS00030;hsa04022;cGMP-PKG signaling pathway
TTDS00030;hsa04080;Neuroactive ligand-receptor interaction
TTDS00030;hsa04261;Adrenergic signaling in cardiomyocytes
TTDS00030;hsa04270;Vascular smooth muscle contraction
TTDS00030;hsa04970;Salivary secretion
TTDS00032;hsa04022;cGMP-PKG signaling pathway
TTDS00032;hsa04080;Neuroactive ligand-receptor interaction
TTDS00036;hsa04020;Calcium signaling pathway
TTDS00036;hsa04022;cGMP-PKG signaling pathway
TTDS00036;hsa04024;cAMP signaling pathway
TTDS00036;hsa04080;Neuroactive ligand-receptor interaction
TTDS00036;hsa04144;Endocytosis
TTDS00036;hsa04261;Adrenergic signaling in cardiomyocytes
TTDS00036;hsa04540;Gap junction
TTDS00036;hsa04970;Salivary secretion
TTDS00036;hsa05414;Dilated cardiomyopathy
TTDS00037;hsa04020;Calcium signaling pathway
TTDS00037;hsa04022;cGMP-PKG signaling pathway
TTDS00037;hsa04024;cAMP signaling pathway
TTDS00037;hsa04080;Neuroactive ligand-receptor interaction
TTDS00037;hsa04144;Endocytosis
TTDS00037;hsa04261;Adrenergic signaling in cardiomyocytes
TTDS00037;hsa04970;Salivary secretion
TTDS00040;hsa00590;Arachidonic acid metabolism
TTDS00040;hsa01100;Metabolic pathways
TTDS00040;hsa04611;Platelet activation
TTDS00040;hsa04726;Serotonergic synapse
TTDS00041;hsa00590;Arachidonic acid metabolism
TTDS00041;hsa01100;Metabolic pathways
TTDS00041;hsa04064;NF-kappa B signaling pathway
TTDS00041;hsa04370;VEGF signaling pathway
TTDS00041;hsa04668;TNF signaling pathway
TTDS00041;hsa04723;Retrograde endocannabinoid signaling
TTDS00041;hsa04726;Serotonergic synapse
TTDS00041;hsa04913;Ovarian steroidogenesis
TTDS00041;hsa04921;Oxytocin signaling pathway
TTDS00041;hsa04923;Regulation of lipolysis in adipocytes
TTDS00041;hsa05140;Leishmaniasis
TTDS00041;hsa05200;Pathways in cancer
TTDS00041;hsa05204;Chemical carcinogenesis
TTDS00041;hsa05206;MicroRNAs in cancer
TTDS00041;hsa05222;Small cell lung cancer
TTDS00043;hsa04020;Calcium signaling pathway
TTDS00043;hsa04080;Neuroactive ligand-receptor interaction
TTDS00043;hsa04971;Gastric acid secretion
TTDS00044;hsa00190;Oxidative phosphorylation
TTDS00044;hsa04966;Collecting duct acid secretion
TTDS00044;hsa04971;Gastric acid secretion
TTDS00045;hsa04022;cGMP-PKG signaling pathway
TTDS00045;hsa04024;cAMP signaling pathway
TTDS00045;hsa04260;Cardiac muscle contraction
TTDS00045;hsa04261;Adrenergic signaling in cardiomyocytes
TTDS00045;hsa04911;Insulin secretion
TTDS00045;hsa04918;Thyroid hormone synthesis
TTDS00045;hsa04919;Thyroid hormone signaling pathway
TTDS00045;hsa04960;Aldosterone-regulated sodium reabsorption
TTDS00045;hsa04961;Endocrine and other factor-regulated calcium reabsorption
TTDS00045;hsa04964;Proximal tubule bicarbonate reclamation
TTDS00045;hsa04970;Salivary secretion
TTDS00045;hsa04971;Gastric acid secretion
TTDS00045;hsa04972;Pancreatic secretion
TTDS00045;hsa04973;Carbohydrate digestion and absorption
TTDS00045;hsa04974;Protein digestion and absorption
TTDS00045;hsa04976;Bile secretion
TTDS00045;hsa04978;Mineral absorption
TTDS00054;hsa00250;Alanine, aspartate and glutamate metabolism
TTDS00054;hsa00650;Butanoate metabolism
TTDS00054;hsa01100;Metabolic pathways
TTDS00056;hsa00230;Purine metabolism
TTDS00056;hsa00232;Caffeine metabolism
TTDS00056;hsa00983;Drug metabolism - other enzymes
TTDS00056;hsa01100;Metabolic pathways
TTDS00056;hsa04146;Peroxisome
TTDS00059;hsa00240;Pyrimidine metabolism
TTDS00059;hsa01100;Metabolic pathways
TTDS00060;hsa00010;Glycolysis / Gluconeogenesis
TTDS00060;hsa00040;Pentose and glucuronate interconversions
TTDS00060;hsa00561;Glycerolipid metabolism
TTDS00060;hsa01100;Metabolic pathways
TTDS00060;hsa01130;Biosynthesis of antibiotics
TTDS00060;hsa01220;Degradation of aromatic compounds
TTDS00062;bbu00230;Purine metabolism
TTDS00062;bbu01100;Metabolic pathways
TTDS00062;bbu01110;Biosynthesis of secondary metabolites
TTDS00063;hsa00230;Purine metabolism
TTDS00063;hsa00983;Drug metabolism - other enzymes
TTDS00063;hsa01100;Metabolic pathways
TTDS00065;hsa00564;Glycerophospholipid metabolism
TTDS00065;hsa00565;Ether lipid metabolism
TTDS00065;hsa00590;Arachidonic acid metabolism
TTDS00065;hsa00591;Linoleic acid metabolism
TTDS00065;hsa00592;alpha-Linolenic acid metabolism
TTDS00065;hsa01100;Metabolic pathways
TTDS00065;hsa04014;Ras signaling pathway
TTDS00065;hsa04270;Vascular smooth muscle contraction
TTDS00065;hsa04972;Pancreatic secretion
TTDS00065;hsa04975;Fat digestion and absorption
TTDS00066;hsa00561;Glycerolipid metabolism
TTDS00066;hsa03320;PPAR signaling pathway
TTDS00066;hsa05010;Alzheimer's disease
TTDS00073;hsa05200;Pathways in cancer
TTDS00073;hsa05202;Transcriptional misregulation in cancer
TTDS00073;hsa05221;Acute myeloid leukemia
TTDS00076;hsa04060;Cytokine-cytokine receptor interaction
TTDS00076;hsa04080;Neuroactive ligand-receptor interaction
TTDS00076;hsa04151;PI3K-Akt signaling pathway
TTDS00076;hsa04630;Jak-STAT signaling pathway
TTDS00078;hsa00280;Valine, leucine and isoleucine degradation
TTDS00078;hsa00350;Tyrosine metabolism
TTDS00078;hsa00380;Tryptophan metabolism
TTDS00078;hsa00750;Vitamin B6 metabolism
TTDS00078;hsa00760;Nicotinate and nicotinamide metabolism
TTDS00078;hsa00830;Retinol metabolism
TTDS00078;hsa00982;Drug metabolism - cytochrome P450
TTDS00078;hsa01100;Metabolic pathways
TTDS00086;hsa04020;Calcium signaling pathway
TTDS00086;hsa04080;Neuroactive ligand-receptor interaction
TTDS00086;hsa04750;Inflammatory mediator regulation of TRP channels
TTDS00087;hsa04020;Calcium signaling pathway
TTDS00087;hsa04080;Neuroactive ligand-receptor interaction
TTDS00087;hsa04971;Gastric acid secretion
TTDS00089;hsa00340;Histidine metabolism
TTDS00090;hsa04060;Cytokine-cytokine receptor interaction
TTDS00090;hsa04640;Hematopoietic cell lineage
TTDS00090;hsa05200;Pathways in cancer
TTDS00090;hsa05202;Transcriptional misregulation in cancer
TTDS00090;hsa05221;Acute myeloid leukemia
TTDS00090;hsa05230;Central carbon metabolism in cancer
TTDS00091;hsa04640;Hematopoietic cell lineage
TTDS00092;hsa00230;Purine metabolism
TTDS00092;hsa01100;Metabolic pathways
TTDS00092;hsa05340;Primary immunodeficiency
TTDS00093;hsa04974;Protein digestion and absorption
TTDS00095;hsa04110;Cell cycle
TTDS00095;hsa04330;Notch signaling pathway
TTDS00095;hsa04919;Thyroid hormone signaling pathway
TTDS00095;hsa05016;Huntington's disease
TTDS00095;hsa05031;Amphetamine addiction
TTDS00095;hsa05034;Alcoholism
TTDS00095;hsa05169;Epstein-Barr virus infection
TTDS00095;hsa05200;Pathways in cancer
TTDS00095;hsa05202;Transcriptional misregulation in cancer
TTDS00095;hsa05203;Viral carcinogenesis
TTDS00095;hsa05206;MicroRNAs in cancer
TTDS00095;hsa05220;Chronic myeloid leukemia
TTDS00098;hsa04024;cAMP signaling pathway
TTDS00098;hsa04080;Neuroactive ligand-receptor interaction
TTDS00098;hsa04726;Serotonergic synapse
TTDS00099;hsa04024;cAMP signaling pathway
TTDS00099;hsa04080;Neuroactive ligand-receptor interaction
TTDS00099;hsa04726;Serotonergic synapse
TTDS00100;hsa04024;cAMP signaling pathway
TTDS00100;hsa04080;Neuroactive ligand-receptor interaction
TTDS00100;hsa04726;Serotonergic synapse
TTDS00103;hsa04020;Calcium signaling pathway
TTDS00103;hsa04080;Neuroactive ligand-receptor interaction
TTDS00103;hsa04540;Gap junction
TTDS00103;hsa04726;Serotonergic synapse
TTDS00103;hsa04750;Inflammatory mediator regulation of TRP channels
TTDS00104;hsa04020;Calcium signaling pathway
TTDS00104;hsa04080;Neuroactive ligand-receptor interaction
TTDS00104;hsa04540;Gap junction
TTDS00104;hsa04726;Serotonergic synapse
TTDS00104;hsa04750;Inflammatory mediator regulation of TRP channels
TTDS00105;hsa04020;Calcium signaling pathway
TTDS00105;hsa04080;Neuroactive ligand-receptor interaction
TTDS00105;hsa04540;Gap junction
TTDS00105;hsa04726;Serotonergic synapse
TTDS00105;hsa04750;Inflammatory mediator regulation of TRP channels
TTDS00107;hsa04020;Calcium signaling pathway
TTDS00107;hsa04024;cAMP signaling pathway
TTDS00107;hsa04080;Neuroactive ligand-receptor interaction
TTDS00107;hsa04726;Serotonergic synapse
TTDS00109;hsa04020;Calcium signaling pathway
TTDS00109;hsa04080;Neuroactive ligand-receptor interaction
TTDS00109;hsa04270;Vascular smooth muscle contraction
TTDS00111;hsa04080;Neuroactive ligand-receptor interaction
TTDS00111;hsa04962;Vasopressin-regulated water reabsorption
TTDS00112;hsa00590;Arachidonic acid metabolism
TTDS00112;hsa01100;Metabolic pathways
TTDS00112;hsa04726;Serotonergic synapse
TTDS00112;hsa04913;Ovarian steroidogenesis
TTDS00112;hsa05145;Toxoplasmosis
TTDS00113;hsa04611;Platelet activation
TTDS00115;hsa00040;Pentose and glucuronate interconversions
TTDS00115;hsa00051;Fructose and mannose metabolism
TTDS00115;hsa00052;Galactose metabolism
TTDS00115;hsa00561;Glycerolipid metabolism
TTDS00115;hsa01100;Metabolic pathways
TTDS00118;hsa04721;Synaptic vesicle cycle
TTDS00118;hsa04726;Serotonergic synapse
TTDS00118;hsa04728;Dopaminergic synapse
TTDS00118;hsa05012;Parkinson's disease
TTDS00118;hsa05030;Cocaine addiction
TTDS00118;hsa05031;Amphetamine addiction
TTDS00118;hsa05034;Alcoholism
TTDS00122;hsa04080;Neuroactive ligand-receptor interaction
TTDS00122;hsa04724;Glutamatergic synapse
TTDS00123;hsa04014;Ras signaling pathway
TTDS00123;hsa04015;Rap1 signaling pathway
TTDS00123;hsa04020;Calcium signaling pathway
TTDS00123;hsa04024;cAMP signaling pathway
TTDS00123;hsa04080;Neuroactive ligand-receptor interaction
TTDS00123;hsa04713;Circadian entrainment
TTDS00123;hsa04720;Long-term potentiation
TTDS00123;hsa04724;Glutamatergic synapse
TTDS00123;hsa04728;Dopaminergic synapse
TTDS00123;hsa05010;Alzheimer's disease
TTDS00123;hsa05014;Amyotrophic lateral sclerosis (ALS)
TTDS00123;hsa05030;Cocaine addiction
TTDS00123;hsa05031;Amphetamine addiction
TTDS00123;hsa05033;Nicotine addiction
TTDS00123;hsa05034;Alcoholism
TTDS00123;hsa05322;Systemic lupus erythematosus
TTDS00126;hsa04080;Neuroactive ligand-receptor interaction
TTDS00126;hsa04915;Estrogen signaling pathway
TTDS00126;hsa05032;Morphine addiction
TTDS00127;hsa04080;Neuroactive ligand-receptor interaction
TTDS00128;hsa04022;cGMP-PKG signaling pathway
TTDS00128;hsa04071;Sphingolipid signaling pathway
TTDS00128;hsa04080;Neuroactive ligand-receptor interaction
TTDS00131;hsa04010;MAPK signaling pathway
TTDS00131;hsa04060;Cytokine-cytokine receptor interaction
TTDS00131;hsa04064;NF-kappa B signaling pathway
TTDS00131;hsa04071;Sphingolipid signaling pathway
TTDS00131;hsa04150;mTOR signaling pathway
TTDS00131;hsa04210;Apoptosis
TTDS00131;hsa04350;TGF-beta signaling pathway
TTDS00131;hsa04380;Osteoclast differentiation
TTDS00131;hsa04612;Antigen processing and presentation
TTDS00131;hsa04620;Toll-like receptor signaling pathway
TTDS00131;hsa04621;NOD-like receptor signaling pathway
TTDS00131;hsa04622;RIG-I-like receptor signaling pathway
TTDS00131;hsa04640;Hematopoietic cell lineage
TTDS00131;hsa04650;Natural killer cell mediated cytotoxicity
TTDS00131;hsa04660;T cell receptor signaling pathway
TTDS00131;hsa04664;Fc epsilon RI signaling pathway
TTDS00131;hsa04668;TNF signaling pathway
TTDS00131;hsa04920;Adipocytokine signaling pathway
TTDS00131;hsa04930;Type II diabetes mellitus
TTDS00131;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDS00131;hsa04940;Type I diabetes mellitus
TTDS00131;hsa05010;Alzheimer's disease
TTDS00131;hsa05014;Amyotrophic lateral sclerosis (ALS)
TTDS00131;hsa05133;Pertussis
TTDS00131;hsa05134;Legionellosis
TTDS00131;hsa05140;Leishmaniasis
TTDS00131;hsa05142;Chagas disease (American trypanosomiasis)
TTDS00131;hsa05143;African trypanosomiasis
TTDS00131;hsa05144;Malaria
TTDS00131;hsa05145;Toxoplasmosis
TTDS00131;hsa05146;Amoebiasis
TTDS00131;hsa05152;Tuberculosis
TTDS00131;hsa05160;Hepatitis C
TTDS00131;hsa05161;Hepatitis B
TTDS00131;hsa05164;Influenza A
TTDS00131;hsa05166;HTLV-I infection
TTDS00131;hsa05168;Herpes simplex infection
TTDS00131;hsa05205;Proteoglycans in cancer
TTDS00131;hsa05310;Asthma
TTDS00131;hsa05321;Inflammatory bowel disease (IBD)
TTDS00131;hsa05322;Systemic lupus erythematosus
TTDS00131;hsa05323;Rheumatoid arthritis
TTDS00131;hsa05330;Allograft rejection
TTDS00131;hsa05332;Graft-versus-host disease
TTDS00131;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDS00131;hsa05414;Dilated cardiomyopathy
TTDS00134;hsa05010;Alzheimer's disease
TTDS00138;hsa04010;MAPK signaling pathway
TTDS00138;hsa04060;Cytokine-cytokine receptor interaction
TTDS00138;hsa04064;NF-kappa B signaling pathway
TTDS00138;hsa04210;Apoptosis
TTDS00138;hsa04380;Osteoclast differentiation
TTDS00138;hsa04640;Hematopoietic cell lineage
TTDS00138;hsa04750;Inflammatory mediator regulation of TRP channels
TTDS00138;hsa05146;Amoebiasis
TTDS00138;hsa05166;HTLV-I infection
TTDS00139;hsa04060;Cytokine-cytokine receptor interaction
TTDS00139;hsa04144;Endocytosis
TTDS00139;hsa04151;PI3K-Akt signaling pathway
TTDS00139;hsa04630;Jak-STAT signaling pathway
TTDS00139;hsa04640;Hematopoietic cell lineage
TTDS00139;hsa05162;Measles
TTDS00139;hsa05166;HTLV-I infection
TTDS00140;hsa00564;Glycerophospholipid metabolism
TTDS00140;hsa04725;Cholinergic synapse
TTDS00141;hsa04080;Neuroactive ligand-receptor interaction
TTDS00141;hsa04725;Cholinergic synapse
TTDS00141;hsa05033;Nicotine addiction
TTDS00144;hsa04060;Cytokine-cytokine receptor interaction
TTDS00144;hsa04151;PI3K-Akt signaling pathway
TTDS00144;hsa04630;Jak-STAT signaling pathway
TTDS00144;hsa04640;Hematopoietic cell lineage
TTDS00148;hsa04261;Adrenergic signaling in cardiomyocytes
TTDS00148;hsa04725;Cholinergic synapse
TTDS00148;hsa04971;Gastric acid secretion
TTDS00148;hsa04972;Pancreatic secretion
TTDS00148;hsa04974;Protein digestion and absorption
TTDS00148;hsa05110;Vibrio cholerae infection
TTDS00149;hsa04725;Cholinergic synapse
TTDS00150;hsa04713;Circadian entrainment
TTDS00150;hsa04723;Retrograde endocannabinoid signaling
TTDS00150;hsa04726;Serotonergic synapse
TTDS00150;hsa04728;Dopaminergic synapse
TTDS00150;hsa04915;Estrogen signaling pathway
TTDS00150;hsa04921;Oxytocin signaling pathway
TTDS00150;hsa05032;Morphine addiction
TTDS00153;hsa04970;Salivary secretion
TTDS00153;hsa04972;Pancreatic secretion
TTDS00153;hsa05110;Vibrio cholerae infection
TTDS00158;hsa04742;Taste transduction
TTDS00158;hsa04960;Aldosterone-regulated sodium reabsorption
TTDS00161;hsa04010;MAPK signaling pathway
TTDS00161;hsa04020;Calcium signaling pathway
TTDS00161;hsa04713;Circadian entrainment
TTDS00161;hsa04930;Type II diabetes mellitus
TTDS00168;hsa04024;cAMP signaling pathway
TTDS00168;hsa04080;Neuroactive ligand-receptor interaction
TTDS00168;hsa04750;Inflammatory mediator regulation of TRP channels
TTDS00168;hsa04924;Renin secretion
TTDS00168;hsa05200;Pathways in cancer
TTDS00169;hsa04020;Calcium signaling pathway
TTDS00169;hsa04080;Neuroactive ligand-receptor interaction
TTDS00170;hsa04080;Neuroactive ligand-receptor interaction
TTDS00170;hsa04270;Vascular smooth muscle contraction
TTDS00170;hsa04611;Platelet activation
TTDS00171;hsa04010;MAPK signaling pathway
TTDS00171;hsa04014;Ras signaling pathway
TTDS00171;hsa04015;Rap1 signaling pathway
TTDS00171;hsa04144;Endocytosis
TTDS00171;hsa04151;PI3K-Akt signaling pathway
TTDS00171;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDS00171;hsa04810;Regulation of actin cytoskeleton
TTDS00171;hsa05200;Pathways in cancer
TTDS00171;hsa05215;Prostate cancer
TTDS00171;hsa05230;Central carbon metabolism in cancer
TTDS00174;stm00511;Other glycan degradation
TTDS00177;hsa04723;Retrograde endocannabinoid signaling
TTDS00181;hsa04614;Renin-angiotensin system
TTDS00181;hsa05142;Chagas disease (American trypanosomiasis)
TTDS00181;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDS00182;efa00550;Peptidoglycan biosynthesis
TTDS00182;efa01502;Vancomycin resistance
TTDS00182;efa02020;Two-component system
TTDS00183;hsa04020;Calcium signaling pathway
TTDS00183;hsa04080;Neuroactive ligand-receptor interaction
TTDS00186;hsa04022;cGMP-PKG signaling pathway
TTDS00186;hsa04024;cAMP signaling pathway
TTDS00186;hsa04071;Sphingolipid signaling pathway
TTDS00186;hsa04080;Neuroactive ligand-receptor interaction
TTDS00186;hsa05032;Morphine addiction
TTDS00187;hsa04015;Rap1 signaling pathway
TTDS00187;hsa04020;Calcium signaling pathway
TTDS00187;hsa04024;cAMP signaling pathway
TTDS00187;hsa04080;Neuroactive ligand-receptor interaction
TTDS00187;hsa04270;Vascular smooth muscle contraction
TTDS00187;hsa05012;Parkinson's disease
TTDS00187;hsa05034;Alcoholism
TTDS00188;hsa04015;Rap1 signaling pathway
TTDS00188;hsa04020;Calcium signaling pathway
TTDS00188;hsa04080;Neuroactive ligand-receptor interaction
TTDS00188;hsa04270;Vascular smooth muscle contraction
TTDS00188;hsa05034;Alcoholism
TTDS00191;hsa03410;Base excision repair
TTDS00191;hsa04064;NF-kappa B signaling pathway
TTDS00192;hsa00590;Arachidonic acid metabolism
TTDS00192;hsa01100;Metabolic pathways
TTDS00194;hsa04020;Calcium signaling pathway
TTDS00194;hsa04080;Neuroactive ligand-receptor interaction
TTDS00194;hsa05162;Measles
TTDS00195;hsa00900;Terpenoid backbone biosynthesis
TTDS00195;hsa01100;Metabolic pathways
TTDS00195;hsa01130;Biosynthesis of antibiotics
TTDS00195;hsa04152;AMPK signaling pathway
TTDS00195;hsa04976;Bile secretion
TTDS00198;hsa04020;Calcium signaling pathway
TTDS00198;hsa04022;cGMP-PKG signaling pathway
TTDS00198;hsa04024;cAMP signaling pathway
TTDS00198;hsa04080;Neuroactive ligand-receptor interaction
TTDS00198;hsa04270;Vascular smooth muscle contraction
TTDS00198;hsa04924;Renin secretion
TTDS00198;hsa05200;Pathways in cancer
TTDS00199;hsa04020;Calcium signaling pathway
TTDS00199;hsa04022;cGMP-PKG signaling pathway
TTDS00199;hsa04080;Neuroactive ligand-receptor interaction
TTDS00199;hsa04916;Melanogenesis
TTDS00199;hsa05200;Pathways in cancer
TTDS00202;hsa04080;Neuroactive ligand-receptor interaction
TTDS00202;hsa04610;Complement and coagulation cascades
TTDS00202;hsa04810;Regulation of actin cytoskeleton
TTDS00203;hsa04610;Complement and coagulation cascades
TTDS00204;hsa04610;Complement and coagulation cascades
TTDS00205;hsa04610;Complement and coagulation cascades
TTDS00206;hsa04960;Aldosterone-regulated sodium reabsorption
TTDS00209;hsa04068;FoxO signaling pathway
TTDS00209;hsa04140;Regulation of autophagy
TTDS00209;hsa04150;mTOR signaling pathway
TTDS00209;hsa04151;PI3K-Akt signaling pathway
TTDS00209;hsa04152;AMPK signaling pathway
TTDS00209;hsa04710;Circadian rhythm
TTDS00209;hsa04910;Insulin signaling pathway
TTDS00209;hsa04920;Adipocytokine signaling pathway
TTDS00209;hsa04921;Oxytocin signaling pathway
TTDS00209;hsa04922;Glucagon signaling pathway
TTDS00209;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDS00209;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDS00226;sao00230;Purine metabolism
TTDS00226;sao00240;Pyrimidine metabolism
TTDS00226;sao01100;Metabolic pathways
TTDS00226;sao03020;RNA polymerase
TTDS00234;hsa03040;Spliceosome
TTDS00234;hsa04010;MAPK signaling pathway
TTDS00234;hsa04141;Protein processing in endoplasmic reticulum
TTDS00234;hsa04144;Endocytosis
TTDS00234;hsa04612;Antigen processing and presentation
TTDS00234;hsa04915;Estrogen signaling pathway
TTDS00234;hsa05134;Legionellosis
TTDS00234;hsa05145;Toxoplasmosis
TTDS00234;hsa05162;Measles
TTDS00234;hsa05164;Influenza A
TTDS00234;hsa05169;Epstein-Barr virus infection
TTDS00241;hsa00140;Steroid hormone biosynthesis
TTDS00241;hsa01100;Metabolic pathways
TTDS00241;hsa04913;Ovarian steroidogenesis
TTDS00241;hsa04917;Prolactin signaling pathway
TTDS00242;hsa04915;Estrogen signaling pathway
TTDS00242;hsa04917;Prolactin signaling pathway
TTDS00242;hsa04919;Thyroid hormone signaling pathway
TTDS00242;hsa04961;Endocrine and other factor-regulated calcium reabsorption
TTDS00242;hsa05205;Proteoglycans in cancer
TTDS00245;hsa04114;Oocyte meiosis
TTDS00245;hsa04914;Progesterone-mediated oocyte maturation
TTDS00247;hsa04012;ErbB signaling pathway
TTDS00247;hsa04015;Rap1 signaling pathway
TTDS00247;hsa04062;Chemokine signaling pathway
TTDS00247;hsa04144;Endocytosis
TTDS00247;hsa04370;VEGF signaling pathway
TTDS00247;hsa04510;Focal adhesion
TTDS00247;hsa04520;Adherens junction
TTDS00247;hsa04530;Tight junction
TTDS00247;hsa04540;Gap junction
TTDS00247;hsa04611;Platelet activation
TTDS00247;hsa04727;GABAergic synapse
TTDS00247;hsa04750;Inflammatory mediator regulation of TRP channels
TTDS00247;hsa04810;Regulation of actin cytoskeleton
TTDS00247;hsa04912;GnRH signaling pathway
TTDS00247;hsa04915;Estrogen signaling pathway
TTDS00247;hsa04917;Prolactin signaling pathway
TTDS00247;hsa04919;Thyroid hormone signaling pathway
TTDS00247;hsa04921;Oxytocin signaling pathway
TTDS00247;hsa05100;Bacterial invasion of epithelial cells
TTDS00247;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDS00247;hsa05131;Shigellosis
TTDS00247;hsa05152;Tuberculosis
TTDS00247;hsa05161;Hepatitis B
TTDS00247;hsa05203;Viral carcinogenesis
TTDS00247;hsa05205;Proteoglycans in cancer
TTDS00249;hsa04012;ErbB signaling pathway
TTDS00249;hsa04020;Calcium signaling pathway
TTDS00249;hsa04066;HIF-1 signaling pathway
TTDS00249;hsa04510;Focal adhesion
TTDS00249;hsa04520;Adherens junction
TTDS00249;hsa05200;Pathways in cancer
TTDS00249;hsa05205;Proteoglycans in cancer
TTDS00249;hsa05206;MicroRNAs in cancer
TTDS00249;hsa05212;Pancreatic cancer
TTDS00249;hsa05213;Endometrial cancer
TTDS00249;hsa05215;Prostate cancer
TTDS00249;hsa05219;Bladder cancer
TTDS00249;hsa05223;Non-small cell lung cancer
TTDS00249;hsa05230;Central carbon metabolism in cancer
TTDS00250;hsa04915;Estrogen signaling pathway
TTDS00250;hsa04917;Prolactin signaling pathway
TTDS00251;hsa04961;Endocrine and other factor-regulated calcium reabsorption
TTDS00251;hsa04978;Mineral absorption
TTDS00251;hsa05152;Tuberculosis
TTDS00252;hsa00140;Steroid hormone biosynthesis
TTDS00252;hsa01100;Metabolic pathways
TTDS00252;hsa04913;Ovarian steroidogenesis
TTDS00253;hsa04912;GnRH signaling pathway
TTDS00254;hsa04020;Calcium signaling pathway
TTDS00254;hsa04080;Neuroactive ligand-receptor interaction
TTDS00254;hsa04913;Ovarian steroidogenesis
TTDS00254;hsa04917;Prolactin signaling pathway
TTDS00256;hsa00790;Folate biosynthesis
TTDS00256;hsa01100;Metabolic pathways
TTDS00258;hsa04080;Neuroactive ligand-receptor interaction
TTDS00258;hsa04961;Endocrine and other factor-regulated calcium reabsorption
TTDS00264;hsa04020;Calcium signaling pathway
TTDS00264;hsa04024;cAMP signaling pathway
TTDS00264;hsa04080;Neuroactive ligand-receptor interaction
TTDS00264;hsa04921;Oxytocin signaling pathway
TTDS00265;hsa04012;ErbB signaling pathway
TTDS00265;hsa04066;HIF-1 signaling pathway
TTDS00265;hsa04150;mTOR signaling pathway
TTDS00265;hsa04151;PI3K-Akt signaling pathway
TTDS00265;hsa04152;AMPK signaling pathway
TTDS00265;hsa04910;Insulin signaling pathway
TTDS00265;hsa04919;Thyroid hormone signaling pathway
TTDS00265;hsa04920;Adipocytokine signaling pathway
TTDS00265;hsa04930;Type II diabetes mellitus
TTDS00265;hsa05200;Pathways in cancer
TTDS00265;hsa05205;Proteoglycans in cancer
TTDS00265;hsa05206;MicroRNAs in cancer
TTDS00265;hsa05214;Glioma
TTDS00265;hsa05215;Prostate cancer
TTDS00265;hsa05221;Acute myeloid leukemia
TTDS00265;hsa05230;Central carbon metabolism in cancer
TTDS00265;hsa05231;Choline metabolism in cancer
TTDS00267;hsa04020;Calcium signaling pathway
TTDS00267;hsa04022;cGMP-PKG signaling pathway
TTDS00267;hsa04080;Neuroactive ligand-receptor interaction
TTDS00267;hsa04261;Adrenergic signaling in cardiomyocytes
TTDS00267;hsa04270;Vascular smooth muscle contraction
TTDS00267;hsa04614;Renin-angiotensin system
TTDS00267;hsa04924;Renin secretion
TTDS00267;hsa05200;Pathways in cancer
TTDS00268;hsa04640;Hematopoietic cell lineage
TTDS00269;hsa04014;Ras signaling pathway
TTDS00269;hsa04015;Rap1 signaling pathway
TTDS00269;hsa04066;HIF-1 signaling pathway
TTDS00269;hsa04068;FoxO signaling pathway
TTDS00269;hsa04114;Oocyte meiosis
TTDS00269;hsa04144;Endocytosis
TTDS00269;hsa04151;PI3K-Akt signaling pathway
TTDS00269;hsa04152;AMPK signaling pathway
TTDS00269;hsa04510;Focal adhesion
TTDS00269;hsa04520;Adherens junction
TTDS00269;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDS00269;hsa04730;Long-term depression
TTDS00269;hsa04913;Ovarian steroidogenesis
TTDS00269;hsa04914;Progesterone-mediated oocyte maturation
TTDS00269;hsa05200;Pathways in cancer
TTDS00269;hsa05202;Transcriptional misregulation in cancer
TTDS00269;hsa05205;Proteoglycans in cancer
TTDS00269;hsa05214;Glioma
TTDS00269;hsa05215;Prostate cancer
TTDS00269;hsa05218;Melanoma
TTDS00270;hsa04014;Ras signaling pathway
TTDS00270;hsa04015;Rap1 signaling pathway
TTDS00270;hsa04060;Cytokine-cytokine receptor interaction
TTDS00270;hsa04144;Endocytosis
TTDS00270;hsa04151;PI3K-Akt signaling pathway
TTDS00270;hsa04640;Hematopoietic cell lineage
TTDS00270;hsa04916;Melanogenesis
TTDS00270;hsa05200;Pathways in cancer
TTDS00270;hsa05221;Acute myeloid leukemia
TTDS00270;hsa05230;Central carbon metabolism in cancer
TTDS00272;hsa04976;Bile secretion
TTDS00273;hsa04080;Neuroactive ligand-receptor interaction
TTDS00273;hsa04912;GnRH signaling pathway
TTDS00275;hsa04062;Chemokine signaling pathway
TTDS00275;hsa04066;HIF-1 signaling pathway
TTDS00275;hsa04068;FoxO signaling pathway
TTDS00275;hsa04550;Signaling pathways regulating pluripotency of stem cells
TTDS00275;hsa04630;Jak-STAT signaling pathway
TTDS00275;hsa04917;Prolactin signaling pathway
TTDS00275;hsa04920;Adipocytokine signaling pathway
TTDS00275;hsa05145;Toxoplasmosis
TTDS00275;hsa05160;Hepatitis C
TTDS00275;hsa05161;Hepatitis B
TTDS00275;hsa05162;Measles
TTDS00275;hsa05169;Epstein-Barr virus infection
TTDS00275;hsa05200;Pathways in cancer
TTDS00275;hsa05203;Viral carcinogenesis
TTDS00275;hsa05205;Proteoglycans in cancer
TTDS00275;hsa05206;MicroRNAs in cancer
TTDS00275;hsa05212;Pancreatic cancer
TTDS00275;hsa05221;Acute myeloid leukemia
TTDS00275;hsa05321;Inflammatory bowel disease (IBD)
TTDS00278;hsa02010;ABC transporters
TTDS00278;hsa04976;Bile secretion
TTDS00280;hsa00230;Purine metabolism
TTDS00280;hsa04024;cAMP signaling pathway
TTDS00280;hsa05032;Morphine addiction
TTDS00282;hsa04080;Neuroactive ligand-receptor interaction
TTDS00282;hsa04972;Pancreatic secretion
TTDS00282;hsa04974;Protein digestion and absorption
TTDS00282;hsa05164;Influenza A
TTDS00283;hsa04080;Neuroactive ligand-receptor interaction
TTDS00285;hsa04610;Complement and coagulation cascades
TTDS00286;hsa04024;cAMP signaling pathway
TTDS00286;hsa04080;Neuroactive ligand-receptor interaction
TTDS00287;hsa04978;Mineral absorption
TTDS00288;hsa02010;ABC transporters
TTDS00288;hsa04071;Sphingolipid signaling pathway
TTDS00288;hsa04977;Vitamin digestion and absorption
TTDS00288;hsa05206;MicroRNAs in cancer
TTDS00289;hsa00260;Glycine, serine and threonine metabolism
TTDS00289;hsa00330;Arginine and proline metabolism
TTDS00289;hsa00340;Histidine metabolism
TTDS00289;hsa00350;Tyrosine metabolism
TTDS00289;hsa00360;Phenylalanine metabolism
TTDS00289;hsa00380;Tryptophan metabolism
TTDS00289;hsa00982;Drug metabolism - cytochrome P450
TTDS00289;hsa01100;Metabolic pathways
TTDS00289;hsa04726;Serotonergic synapse
TTDS00289;hsa04728;Dopaminergic synapse
TTDS00289;hsa05030;Cocaine addiction
TTDS00289;hsa05031;Amphetamine addiction
TTDS00289;hsa05034;Alcoholism
TTDS00291;hsa00052;Galactose metabolism
TTDS00291;hsa00500;Starch and sucrose metabolism
TTDS00291;hsa01100;Metabolic pathways
TTDS00291;hsa04973;Carbohydrate digestion and absorption
TTDS00292;hsa04014;Ras signaling pathway
TTDS00292;hsa04015;Rap1 signaling pathway
TTDS00292;hsa04022;cGMP-PKG signaling pathway
TTDS00292;hsa04066;HIF-1 signaling pathway
TTDS00292;hsa04068;FoxO signaling pathway
TTDS00292;hsa04151;PI3K-Akt signaling pathway
TTDS00292;hsa04152;AMPK signaling pathway
TTDS00292;hsa04520;Adherens junction
TTDS00292;hsa04910;Insulin signaling pathway
TTDS00292;hsa04913;Ovarian steroidogenesis
TTDS00292;hsa04930;Type II diabetes mellitus
TTDS00292;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDS00292;hsa04960;Aldosterone-regulated sodium reabsorption
TTDS00295;hsa00061;Fatty acid biosynthesis
TTDS00295;hsa01100;Metabolic pathways
TTDS00295;hsa01212;Fatty acid metabolism
TTDS00295;hsa04152;AMPK signaling pathway
TTDS00295;hsa04910;Insulin signaling pathway
TTDS00296;hsa00230;Purine metabolism
TTDS00296;hsa04022;cGMP-PKG signaling pathway
TTDS00299;sce00500;Starch and sucrose metabolism
TTDS00299;sce04011;MAPK signaling pathway - yeast
TTDS00301;hsa00240;Pyrimidine metabolism
TTDS00301;hsa00670;One carbon pool by folate
TTDS00301;hsa01100;Metabolic pathways
TTDS00302;sce00100;Steroid biosynthesis
TTDS00302;sce00909;Sesquiterpenoid and triterpenoid biosynthesis
TTDS00302;sce01100;Metabolic pathways
TTDS00302;sce01110;Biosynthesis of secondary metabolites
TTDS00302;sce01130;Biosynthesis of antibiotics
TTDS00306;hsa00910;Nitrogen metabolism
TTDS00306;hsa04964;Proximal tubule bicarbonate reclamation
TTDS00306;hsa04966;Collecting duct acid secretion
TTDS00306;hsa04971;Gastric acid secretion
TTDS00306;hsa04972;Pancreatic secretion
TTDS00306;hsa04976;Bile secretion
TTDS00308;hsa04145;Phagosome
TTDS00308;hsa04540;Gap junction
TTDS00308;hsa05130;Pathogenic Escherichia coli infection
TTDS00311;hsa04620;Toll-like receptor signaling pathway
TTDS00311;hsa05162;Measles
TTDS00311;hsa05164;Influenza A
TTDS00314;mmu00130;Ubiquinone and other terpenoid-quinone biosynthesis
TTDS00314;mmu00350;Tyrosine metabolism
TTDS00314;mmu00360;Phenylalanine metabolism
TTDS00314;mmu01100;Metabolic pathways
TTDS00326;hsa04060;Cytokine-cytokine receptor interaction
TTDS00326;hsa04062;Chemokine signaling pathway
TTDS00326;hsa04144;Endocytosis
TTDS00326;hsa05145;Toxoplasmosis
TTDS00326;hsa05203;Viral carcinogenesis
TTDS00328;hsa04975;Fat digestion and absorption
TTDS00334;hsa04015;Rap1 signaling pathway
TTDS00334;hsa04080;Neuroactive ligand-receptor interaction
TTDS00334;hsa04723;Retrograde endocannabinoid signaling
TTDS00337;hsa00220;Arginine biosynthesis
TTDS00337;hsa00330;Arginine and proline metabolism
TTDS00337;hsa01100;Metabolic pathways
TTDS00337;hsa04020;Calcium signaling pathway
TTDS00337;hsa04066;HIF-1 signaling pathway
TTDS00337;hsa04146;Peroxisome
TTDS00337;hsa05132;Salmonella infection
TTDS00337;hsa05133;Pertussis
TTDS00337;hsa05140;Leishmaniasis
TTDS00337;hsa05142;Chagas disease (American trypanosomiasis)
TTDS00337;hsa05145;Toxoplasmosis
TTDS00337;hsa05146;Amoebiasis
TTDS00337;hsa05152;Tuberculosis
TTDS00337;hsa05200;Pathways in cancer
TTDS00337;hsa05222;Small cell lung cancer
TTDS00338;hsa03320;PPAR signaling pathway
TTDS00338;hsa04152;AMPK signaling pathway
TTDS00338;hsa04380;Osteoclast differentiation
TTDS00338;hsa05016;Huntington's disease
TTDS00338;hsa05200;Pathways in cancer
TTDS00338;hsa05202;Transcriptional misregulation in cancer
TTDS00338;hsa05216;Thyroid cancer
TTDS00340;hsa03320;PPAR signaling pathway
TTDS00340;hsa04024;cAMP signaling pathway
TTDS00340;hsa04920;Adipocytokine signaling pathway
TTDS00340;hsa04922;Glucagon signaling pathway
TTDS00340;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDS00340;hsa05160;Hepatitis C
TTDS00341;hsa00260;Glycine, serine and threonine metabolism
TTDS00341;hsa00330;Arginine and proline metabolism
TTDS00341;hsa00340;Histidine metabolism
TTDS00341;hsa00350;Tyrosine metabolism
TTDS00341;hsa00360;Phenylalanine metabolism
TTDS00341;hsa00380;Tryptophan metabolism
TTDS00341;hsa00982;Drug metabolism - cytochrome P450
TTDS00341;hsa01100;Metabolic pathways
TTDS00341;hsa04726;Serotonergic synapse
TTDS00341;hsa04728;Dopaminergic synapse
TTDS00341;hsa05030;Cocaine addiction
TTDS00341;hsa05031;Amphetamine addiction
TTDS00341;hsa05034;Alcoholism
TTDS00342;hsa00860;Porphyrin and chlorophyll metabolism
TTDS00342;hsa01100;Metabolic pathways
TTDS00346;hsa04010;MAPK signaling pathway
TTDS00346;hsa04012;ErbB signaling pathway
TTDS00346;hsa04015;Rap1 signaling pathway
TTDS00346;hsa04024;cAMP signaling pathway
TTDS00346;hsa04062;Chemokine signaling pathway
TTDS00346;hsa04068;FoxO signaling pathway
TTDS00346;hsa04150;mTOR signaling pathway
TTDS00346;hsa04270;Vascular smooth muscle contraction
TTDS00346;hsa04510;Focal adhesion
TTDS00346;hsa04650;Natural killer cell mediated cytotoxicity
TTDS00346;hsa04720;Long-term potentiation
TTDS00346;hsa04722;Neurotrophin signaling pathway
TTDS00346;hsa04726;Serotonergic synapse
TTDS00346;hsa04730;Long-term depression
TTDS00346;hsa04810;Regulation of actin cytoskeleton
TTDS00346;hsa04910;Insulin signaling pathway
TTDS00346;hsa04914;Progesterone-mediated oocyte maturation
TTDS00346;hsa05034;Alcoholism
TTDS00346;hsa05160;Hepatitis C
TTDS00346;hsa05200;Pathways in cancer
TTDS00346;hsa05205;Proteoglycans in cancer
TTDS00346;hsa05210;Colorectal cancer
TTDS00346;hsa05211;Renal cell carcinoma
TTDS00346;hsa05212;Pancreatic cancer
TTDS00346;hsa05213;Endometrial cancer
TTDS00346;hsa05214;Glioma
TTDS00346;hsa05215;Prostate cancer
TTDS00346;hsa05216;Thyroid cancer
TTDS00346;hsa05218;Melanoma
TTDS00346;hsa05219;Bladder cancer
TTDS00346;hsa05220;Chronic myeloid leukemia
TTDS00346;hsa05221;Acute myeloid leukemia
TTDS00346;hsa05223;Non-small cell lung cancer
TTDS00348;hsa04144;Endocytosis
TTDS00348;hsa05200;Pathways in cancer
TTDS00348;hsa05216;Thyroid cancer
TTDS00348;hsa05230;Central carbon metabolism in cancer
TTDS00350;hsa04012;ErbB signaling pathway
TTDS00350;hsa04014;Ras signaling pathway
TTDS00350;hsa04110;Cell cycle
TTDS00350;hsa04360;Axon guidance
TTDS00350;hsa04722;Neurotrophin signaling pathway
TTDS00350;hsa05130;Pathogenic Escherichia coli infection
TTDS00350;hsa05131;Shigellosis
TTDS00350;hsa05200;Pathways in cancer
TTDS00350;hsa05206;MicroRNAs in cancer
TTDS00350;hsa05220;Chronic myeloid leukemia
TTDS00350;hsa05416;Viral myocarditis
TTDS00355;hsa04010;MAPK signaling pathway
TTDS00355;hsa04012;ErbB signaling pathway
TTDS00355;hsa04014;Ras signaling pathway
TTDS00355;hsa04015;Rap1 signaling pathway
TTDS00355;hsa04020;Calcium signaling pathway
TTDS00355;hsa04060;Cytokine-cytokine receptor interaction
TTDS00355;hsa04066;HIF-1 signaling pathway
TTDS00355;hsa04068;FoxO signaling pathway
TTDS00355;hsa04144;Endocytosis
TTDS00355;hsa04151;PI3K-Akt signaling pathway
TTDS00355;hsa04320;Dorso-ventral axis formation
TTDS00355;hsa04510;Focal adhesion
TTDS00355;hsa04520;Adherens junction
TTDS00355;hsa04540;Gap junction
TTDS00355;hsa04810;Regulation of actin cytoskeleton
TTDS00355;hsa04912;GnRH signaling pathway
TTDS00355;hsa04915;Estrogen signaling pathway
TTDS00355;hsa04921;Oxytocin signaling pathway
TTDS00355;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDS00355;hsa05160;Hepatitis C
TTDS00355;hsa05200;Pathways in cancer
TTDS00355;hsa05205;Proteoglycans in cancer
TTDS00355;hsa05206;MicroRNAs in cancer
TTDS00355;hsa05212;Pancreatic cancer
TTDS00355;hsa05213;Endometrial cancer
TTDS00355;hsa05214;Glioma
TTDS00355;hsa05215;Prostate cancer
TTDS00355;hsa05218;Melanoma
TTDS00355;hsa05219;Bladder cancer
TTDS00355;hsa05223;Non-small cell lung cancer
TTDS00355;hsa05230;Central carbon metabolism in cancer
TTDS00355;hsa05231;Choline metabolism in cancer
TTDS00357;hsa00061;Fatty acid biosynthesis
TTDS00357;hsa00620;Pyruvate metabolism
TTDS00357;hsa00640;Propanoate metabolism
TTDS00357;hsa01100;Metabolic pathways
TTDS00357;hsa01212;Fatty acid metabolism
TTDS00357;hsa04152;AMPK signaling pathway
TTDS00357;hsa04910;Insulin signaling pathway
TTDS00357;hsa04920;Adipocytokine signaling pathway
TTDS00357;hsa04922;Glucagon signaling pathway
TTDS00361;hsa00340;Histidine metabolism
TTDS00361;hsa00350;Tyrosine metabolism
TTDS00361;hsa00360;Phenylalanine metabolism
TTDS00361;hsa00380;Tryptophan metabolism
TTDS00361;hsa01100;Metabolic pathways
TTDS00361;hsa04726;Serotonergic synapse
TTDS00361;hsa04728;Dopaminergic synapse
TTDS00361;hsa05030;Cocaine addiction
TTDS00361;hsa05031;Amphetamine addiction
TTDS00361;hsa05034;Alcoholism
TTDS00362;hsa00140;Steroid hormone biosynthesis
TTDS00362;hsa00350;Tyrosine metabolism
TTDS00362;hsa01100;Metabolic pathways
TTDS00362;hsa04728;Dopaminergic synapse
TTDS00363;hsa04010;MAPK signaling pathway
TTDS00363;hsa04020;Calcium signaling pathway
TTDS00363;hsa04022;cGMP-PKG signaling pathway
TTDS00363;hsa04114;Oocyte meiosis
TTDS00363;hsa04210;Apoptosis
TTDS00363;hsa04310;Wnt signaling pathway
TTDS00363;hsa04360;Axon guidance
TTDS00363;hsa04370;VEGF signaling pathway
TTDS00363;hsa04380;Osteoclast differentiation
TTDS00363;hsa04650;Natural killer cell mediated cytotoxicity
TTDS00363;hsa04660;T cell receptor signaling pathway
TTDS00363;hsa04662;B cell receptor signaling pathway
TTDS00363;hsa04720;Long-term potentiation
TTDS00363;hsa04724;Glutamatergic synapse
TTDS00363;hsa04728;Dopaminergic synapse
TTDS00363;hsa04921;Oxytocin signaling pathway
TTDS00363;hsa04922;Glucagon signaling pathway
TTDS00363;hsa05010;Alzheimer's disease
TTDS00363;hsa05014;Amyotrophic lateral sclerosis (ALS)
TTDS00363;hsa05031;Amphetamine addiction
TTDS00363;hsa05152;Tuberculosis
TTDS00363;hsa05166;HTLV-I infection
TTDS00365;hsa00350;Tyrosine metabolism
TTDS00365;hsa01100;Metabolic pathways
TTDS00365;hsa04728;Dopaminergic synapse
TTDS00365;hsa04917;Prolactin signaling pathway
TTDS00365;hsa05012;Parkinson's disease
TTDS00365;hsa05030;Cocaine addiction
TTDS00365;hsa05031;Amphetamine addiction
TTDS00365;hsa05034;Alcoholism
TTDS00367;hsa04114;Oocyte meiosis
TTDS00367;hsa05200;Pathways in cancer
TTDS00367;hsa05215;Prostate cancer
TTDS00368;hsa04514;Cell adhesion molecules (CAMs)
TTDS00368;hsa04640;Hematopoietic cell lineage
TTDS00372;hsa00900;Terpenoid backbone biosynthesis
TTDS00372;hsa01100;Metabolic pathways
TTDS00372;hsa01130;Biosynthesis of antibiotics
TTDS00372;hsa05164;Influenza A
TTDS00372;hsa05166;HTLV-I infection
TTDS00373;hsa00350;Tyrosine metabolism
TTDS00373;hsa00740;Riboflavin metabolism
TTDS00373;hsa01100;Metabolic pathways
TTDS00373;hsa04916;Melanogenesis
TTDS00377;hsa00600;Sphingolipid metabolism
TTDS00377;hsa01100;Metabolic pathways
TTDS00378;hsa04610;Complement and coagulation cascades
TTDS00380;hsa00350;Tyrosine metabolism
TTDS00380;hsa01100;Metabolic pathways
TTDS00380;hsa04918;Thyroid hormone synthesis
TTDS00380;hsa05320;Autoimmune thyroid disease
TTDS00381;hsa04080;Neuroactive ligand-receptor interaction
TTDS00381;hsa04919;Thyroid hormone signaling pathway
TTDS00390;hsa00230;Purine metabolism
TTDS00390;hsa04022;cGMP-PKG signaling pathway
TTDS00390;hsa04024;cAMP signaling pathway
TTDS00390;hsa05032;Morphine addiction
TTDS00392;hsa04080;Neuroactive ligand-receptor interaction
TTDS00392;hsa04610;Complement and coagulation cascades
TTDS00392;hsa05150;Staphylococcus aureus infection
TTDS00392;hsa05164;Influenza A
TTDS00393;hsa04080;Neuroactive ligand-receptor interaction
TTDS00393;hsa04713;Circadian entrainment
TTDS00394;hsa04024;cAMP signaling pathway
TTDS00394;hsa04080;Neuroactive ligand-receptor interaction
TTDS00394;hsa04971;Gastric acid secretion
TTDS00395;hsa04020;Calcium signaling pathway
TTDS00395;hsa04080;Neuroactive ligand-receptor interaction
TTDS00395;hsa04611;Platelet activation
TTDS00397;hsa00500;Starch and sucrose metabolism
TTDS00397;hsa01100;Metabolic pathways
TTDS00397;hsa04972;Pancreatic secretion
TTDS00397;hsa04973;Carbohydrate digestion and absorption
TTDS00398;hsa00130;Ubiquinone and other terpenoid-quinone biosynthesis
TTDS00399;hsa04726;Serotonergic synapse
TTDS00400;hsa04080;Neuroactive ligand-receptor interaction
TTDS00401;hsa00230;Purine metabolism
TTDS00401;hsa00983;Drug metabolism - other enzymes
TTDS00401;hsa01100;Metabolic pathways
TTDS00402;hsa04261;Adrenergic signaling in cardiomyocytes
TTDS00403;hsa04080;Neuroactive ligand-receptor interaction
TTDS00403;hsa04723;Retrograde endocannabinoid signaling
TTDS00403;hsa04727;GABAergic synapse
TTDS00403;hsa05032;Morphine addiction
TTDS00403;hsa05033;Nicotine addiction
TTDS00404;hsa04728;Dopaminergic synapse
TTDS00405;hsa04020;Calcium signaling pathway
TTDS00405;hsa04022;cGMP-PKG signaling pathway
TTDS00405;hsa05012;Parkinson's disease
TTDS00405;hsa05016;Huntington's disease
TTDS00405;hsa05166;HTLV-I infection
TTDS00406;hsa04071;Sphingolipid signaling pathway
TTDS00406;hsa04360;Axon guidance
TTDS00406;hsa04380;Osteoclast differentiation
TTDS00406;hsa04510;Focal adhesion
TTDS00406;hsa04520;Adherens junction
TTDS00406;hsa04611;Platelet activation
TTDS00406;hsa04650;Natural killer cell mediated cytotoxicity
TTDS00406;hsa04660;T cell receptor signaling pathway
TTDS00406;hsa04664;Fc epsilon RI signaling pathway
TTDS00406;hsa04725;Cholinergic synapse
TTDS00406;hsa05020;Prion diseases
TTDS00406;hsa05130;Pathogenic Escherichia coli infection
TTDS00406;hsa05162;Measles
TTDS00406;hsa05416;Viral myocarditis
TTDS00407;hsa04064;NF-kappa B signaling pathway
TTDS00407;hsa04380;Osteoclast differentiation
TTDS00407;hsa04650;Natural killer cell mediated cytotoxicity
TTDS00407;hsa04660;T cell receptor signaling pathway
TTDS00407;hsa05166;HTLV-I infection
TTDS00407;hsa05340;Primary immunodeficiency
TTDS00408;hsa04520;Adherens junction
TTDS00408;hsa04530;Tight junction
TTDS00409;hsa04020;Calcium signaling pathway
TTDS00409;hsa04260;Cardiac muscle contraction
TTDS00409;hsa04261;Adrenergic signaling in cardiomyocytes
TTDS00409;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDS00409;hsa05414;Dilated cardiomyopathy
TTDS00410;hsa04080;Neuroactive ligand-receptor interaction
TTDS00410;hsa04723;Retrograde endocannabinoid signaling
TTDS00410;hsa04726;Serotonergic synapse
TTDS00410;hsa04727;GABAergic synapse
TTDS00410;hsa05032;Morphine addiction
TTDS00410;hsa05033;Nicotine addiction
TTDS00411;hsa04060;Cytokine-cytokine receptor interaction
TTDS00411;hsa04151;PI3K-Akt signaling pathway
TTDS00411;hsa04630;Jak-STAT signaling pathway
TTDS00411;hsa04640;Hematopoietic cell lineage
TTDS00411;hsa05200;Pathways in cancer
TTDS00413;hsa04010;MAPK signaling pathway
TTDS00413;hsa04020;Calcium signaling pathway
TTDS00413;hsa04713;Circadian entrainment
TTDS00414;hsa04010;MAPK signaling pathway
TTDS00414;hsa04020;Calcium signaling pathway
TTDS00414;hsa04022;cGMP-PKG signaling pathway
TTDS00414;hsa04024;cAMP signaling pathway
TTDS00414;hsa04260;Cardiac muscle contraction
TTDS00414;hsa04261;Adrenergic signaling in cardiomyocytes
TTDS00414;hsa04270;Vascular smooth muscle contraction
TTDS00414;hsa04713;Circadian entrainment
TTDS00414;hsa04720;Long-term potentiation
TTDS00414;hsa04723;Retrograde endocannabinoid signaling
TTDS00414;hsa04724;Glutamatergic synapse
TTDS00414;hsa04725;Cholinergic synapse
TTDS00414;hsa04726;Serotonergic synapse
TTDS00414;hsa04727;GABAergic synapse
TTDS00414;hsa04728;Dopaminergic synapse
TTDS00414;hsa04911;Insulin secretion
TTDS00414;hsa04912;GnRH signaling pathway
TTDS00414;hsa04921;Oxytocin signaling pathway
TTDS00414;hsa04930;Type II diabetes mellitus
TTDS00414;hsa05010;Alzheimer's disease
TTDS00414;hsa05031;Amphetamine addiction
TTDS00414;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDS00414;hsa05412;Arrhythmogenic right ventricular cardiomyopathy (ARVC)
TTDS00414;hsa05414;Dilated cardiomyopathy
TTDS00415;hsa04010;MAPK signaling pathway
TTDS00415;hsa04260;Cardiac muscle contraction
TTDS00415;hsa04261;Adrenergic signaling in cardiomyocytes
TTDS00415;hsa04921;Oxytocin signaling pathway
TTDS00415;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDS00415;hsa05412;Arrhythmogenic right ventricular cardiomyopathy (ARVC)
TTDS00415;hsa05414;Dilated cardiomyopathy
TTDS00418;hsa00140;Steroid hormone biosynthesis
TTDS00418;hsa00591;Linoleic acid metabolism
TTDS00418;hsa00830;Retinol metabolism
TTDS00418;hsa00980;Metabolism of xenobiotics by cytochrome P450
TTDS00418;hsa00982;Drug metabolism - cytochrome P450
TTDS00418;hsa00983;Drug metabolism - other enzymes
TTDS00418;hsa01100;Metabolic pathways
TTDS00418;hsa04976;Bile secretion
TTDS00418;hsa05204;Chemical carcinogenesis
TTDS00419;hsa00140;Steroid hormone biosynthesis
TTDS00419;hsa01100;Metabolic pathways
TTDS00419;hsa04913;Ovarian steroidogenesis
TTDS00420;hsa00140;Steroid hormone biosynthesis
TTDS00420;hsa01100;Metabolic pathways
TTDS00421;hsa00230;Purine metabolism
TTDS00421;hsa00240;Pyrimidine metabolism
TTDS00421;hsa00480;Glutathione metabolism
TTDS00421;hsa01100;Metabolic pathways
TTDS00421;hsa04115;p53 signaling pathway
TTDS00422;hsa04080;Neuroactive ligand-receptor interaction
TTDS00422;hsa04713;Circadian entrainment
TTDS00424;hsa00230;Purine metabolism
TTDS00424;hsa04022;cGMP-PKG signaling pathway
TTDS00424;hsa04270;Vascular smooth muscle contraction
TTDS00424;hsa04540;Gap junction
TTDS00424;hsa04611;Platelet activation
TTDS00424;hsa04713;Circadian entrainment
TTDS00424;hsa04730;Long-term depression
TTDS00424;hsa04921;Oxytocin signaling pathway
TTDS00424;hsa04970;Salivary secretion
TTDS00426;hsa04919;Thyroid hormone signaling pathway
TTDS00427;hsa00190;Oxidative phosphorylation
TTDS00427;hsa01100;Metabolic pathways
TTDS00427;hsa04145;Phagosome
TTDS00427;hsa04721;Synaptic vesicle cycle
TTDS00427;hsa04966;Collecting duct acid secretion
TTDS00427;hsa05110;Vibrio cholerae infection
TTDS00427;hsa05120;Epithelial cell signaling in Helicobacter pylori infection
TTDS00427;hsa05323;Rheumatoid arthritis
TTDS00428;hsa04080;Neuroactive ligand-receptor interaction
TTDS00428;hsa04723;Retrograde endocannabinoid signaling
TTDS00428;hsa04727;GABAergic synapse
TTDS00428;hsa05032;Morphine addiction
TTDS00428;hsa05033;Nicotine addiction
TTDS00429;hsa00561;Glycerolipid metabolism
TTDS00429;hsa01100;Metabolic pathways
TTDS00429;hsa04975;Fat digestion and absorption
TTDS00431;hsa04971;Gastric acid secretion
TTDS00432;hsa04014;Ras signaling pathway
TTDS00432;hsa04015;Rap1 signaling pathway
TTDS00432;hsa04020;Calcium signaling pathway
TTDS00432;hsa04022;cGMP-PKG signaling pathway
TTDS00432;hsa04024;cAMP signaling pathway
TTDS00432;hsa04070;Phosphatidylinositol signaling system
TTDS00432;hsa04114;Oocyte meiosis
TTDS00432;hsa04261;Adrenergic signaling in cardiomyocytes
TTDS00432;hsa04270;Vascular smooth muscle contraction
TTDS00432;hsa04713;Circadian entrainment
TTDS00432;hsa04720;Long-term potentiation
TTDS00432;hsa04722;Neurotrophin signaling pathway
TTDS00432;hsa04728;Dopaminergic synapse
TTDS00432;hsa04740;Olfactory transduction
TTDS00432;hsa04744;Phototransduction
TTDS00432;hsa04750;Inflammatory mediator regulation of TRP channels
TTDS00432;hsa04910;Insulin signaling pathway
TTDS00432;hsa04912;GnRH signaling pathway
TTDS00432;hsa04915;Estrogen signaling pathway
TTDS00432;hsa04916;Melanogenesis
TTDS00432;hsa04921;Oxytocin signaling pathway
TTDS00432;hsa04922;Glucagon signaling pathway
TTDS00432;hsa04970;Salivary secretion
TTDS00432;hsa04971;Gastric acid secretion
TTDS00432;hsa05010;Alzheimer's disease
TTDS00432;hsa05031;Amphetamine addiction
TTDS00432;hsa05034;Alcoholism
TTDS00432;hsa05133;Pertussis
TTDS00432;hsa05152;Tuberculosis
TTDS00432;hsa05214;Glioma
TTDS00433;hsa00071;Fatty acid degradation
TTDS00433;hsa01212;Fatty acid metabolism
TTDS00433;hsa03320;PPAR signaling pathway
TTDS00433;hsa04152;AMPK signaling pathway
TTDS00433;hsa04920;Adipocytokine signaling pathway
TTDS00433;hsa04922;Glucagon signaling pathway
TTDS00435;hsa04610;Complement and coagulation cascades
TTDS00435;hsa05020;Prion diseases
TTDS00435;hsa05133;Pertussis
TTDS00435;hsa05150;Staphylococcus aureus infection
TTDS00435;hsa05168;Herpes simplex infection
TTDS00435;hsa05322;Systemic lupus erythematosus
TTDS00437;hsa00860;Porphyrin and chlorophyll metabolism
TTDS00437;hsa01100;Metabolic pathways
TTDS00438;hsa04024;cAMP signaling pathway
TTDS00438;hsa04080;Neuroactive ligand-receptor interaction
TTDS00438;hsa04913;Ovarian steroidogenesis
TTDS00439;hsa04080;Neuroactive ligand-receptor interaction
TTDS00439;hsa04922;Glucagon signaling pathway
TTDS00440;hsa04024;cAMP signaling pathway
TTDS00440;hsa04080;Neuroactive ligand-receptor interaction
TTDS00440;hsa04911;Insulin secretion
TTDS00441;hsa00250;Alanine, aspartate and glutamate metabolism
TTDS00441;hsa01100;Metabolic pathways
TTDS00441;hsa04977;Vitamin digestion and absorption
TTDS00442;hsa04060;Cytokine-cytokine receptor interaction
TTDS00442;hsa04630;Jak-STAT signaling pathway
TTDS00442;hsa04640;Hematopoietic cell lineage
TTDS00442;hsa05200;Pathways in cancer
TTDS00444;hsa04015;Rap1 signaling pathway
TTDS00444;hsa04514;Cell adhesion molecules (CAMs)
TTDS00444;hsa04650;Natural killer cell mediated cytotoxicity
TTDS00444;hsa04670;Leukocyte transendothelial migration
TTDS00444;hsa04810;Regulation of actin cytoskeleton
TTDS00444;hsa05144;Malaria
TTDS00444;hsa05150;Staphylococcus aureus infection
TTDS00444;hsa05166;HTLV-I infection
TTDS00444;hsa05169;Epstein-Barr virus infection
TTDS00444;hsa05323;Rheumatoid arthritis
TTDS00444;hsa05416;Viral myocarditis
TTDS00445;hsa04151;PI3K-Akt signaling pathway
TTDS00445;hsa04510;Focal adhesion
TTDS00445;hsa04512;ECM-receptor interaction
TTDS00445;hsa04514;Cell adhesion molecules (CAMs)
TTDS00445;hsa04640;Hematopoietic cell lineage
TTDS00445;hsa04670;Leukocyte transendothelial migration
TTDS00445;hsa04672;Intestinal immune network for IgA production
TTDS00445;hsa04810;Regulation of actin cytoskeleton
TTDS00445;hsa05140;Leishmaniasis
TTDS00445;hsa05410;Hypertrophic cardiomyopathy (HCM)
TTDS00445;hsa05412;Arrhythmogenic right ventricular cardiomyopathy (ARVC)
TTDS00445;hsa05414;Dilated cardiomyopathy
TTDS00446;hsa04080;Neuroactive ligand-receptor interaction
TTDS00447;hsa04010;MAPK signaling pathway
TTDS00447;hsa04060;Cytokine-cytokine receptor interaction
TTDS00447;hsa04064;NF-kappa B signaling pathway
TTDS00447;hsa04210;Apoptosis
TTDS00447;hsa04380;Osteoclast differentiation
TTDS00447;hsa04620;Toll-like receptor signaling pathway
TTDS00447;hsa04621;NOD-like receptor signaling pathway
TTDS00447;hsa04623;Cytosolic DNA-sensing pathway
TTDS00447;hsa04640;Hematopoietic cell lineage
TTDS00447;hsa04668;TNF signaling pathway
TTDS00447;hsa04750;Inflammatory mediator regulation of TRP channels
TTDS00447;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDS00447;hsa04940;Type I diabetes mellitus
TTDS00447;hsa05010;Alzheimer's disease
TTDS00447;hsa05020;Prion diseases
TTDS00447;hsa05132;Salmonella infection
TTDS00447;hsa05133;Pertussis
TTDS00447;hsa05134;Legionellosis
TTDS00447;hsa05140;Leishmaniasis
TTDS00447;hsa05142;Chagas disease (American trypanosomiasis)
TTDS00447;hsa05143;African trypanosomiasis
TTDS00447;hsa05144;Malaria
TTDS00447;hsa05146;Amoebiasis
TTDS00447;hsa05152;Tuberculosis
TTDS00447;hsa05162;Measles
TTDS00447;hsa05164;Influenza A
TTDS00447;hsa05168;Herpes simplex infection
TTDS00447;hsa05321;Inflammatory bowel disease (IBD)
TTDS00447;hsa05323;Rheumatoid arthritis
TTDS00447;hsa05332;Graft-versus-host disease
TTDS00448;hsa05202;Transcriptional misregulation in cancer
TTDS00448;hsa05322;Systemic lupus erythematosus
TTDS00449;hsa04614;Renin-angiotensin system
TTDS00449;hsa04640;Hematopoietic cell lineage
TTDS00449;hsa04974;Protein digestion and absorption
TTDS00449;hsa05010;Alzheimer's disease
TTDS00450;cal00051;Fructose and mannose metabolism
TTDS00450;cal00520;Amino sugar and nucleotide sugar metabolism
TTDS00450;cal01100;Metabolic pathways
TTDS00450;cal01110;Biosynthesis of secondary metabolites
TTDS00451;hsa04614;Renin-angiotensin system
TTDS00452;hsa04024;cAMP signaling pathway
TTDS00452;hsa04080;Neuroactive ligand-receptor interaction
TTDS00452;hsa04918;Thyroid hormone synthesis
TTDS00452;hsa05320;Autoimmune thyroid disease
TTDS00453;hsa04514;Cell adhesion molecules (CAMs)
TTDS00453;hsa04620;Toll-like receptor signaling pathway
TTDS00453;hsa04672;Intestinal immune network for IgA production
TTDS00453;hsa04940;Type I diabetes mellitus
TTDS00453;hsa05320;Autoimmune thyroid disease
TTDS00453;hsa05322;Systemic lupus erythematosus
TTDS00453;hsa05323;Rheumatoid arthritis
TTDS00453;hsa05330;Allograft rejection
TTDS00453;hsa05332;Graft-versus-host disease
TTDS00453;hsa05416;Viral myocarditis
TTDS00454;hsa04080;Neuroactive ligand-receptor interaction
TTDS00454;hsa05166;HTLV-I infection
TTDS00465;hsa04750;Inflammatory mediator regulation of TRP channels
TTDS00466;hsa00561;Glycerolipid metabolism
TTDS00466;hsa00830;Retinol metabolism
TTDS00466;hsa01100;Metabolic pathways
TTDS00466;hsa04975;Fat digestion and absorption
TTDS00467;hsa04610;Complement and coagulation cascades
TTDS00469;hsa00190;Oxidative phosphorylation
TTDS00469;hsa01100;Metabolic pathways
TTDS00469;hsa05012;Parkinson's disease
TTDS00470;hsa04610;Complement and coagulation cascades
TTDS00472;hsa04640;Hematopoietic cell lineage
TTDS00473;hsa04640;Hematopoietic cell lineage
TTDS00473;hsa04660;T cell receptor signaling pathway
TTDS00473;hsa05142;Chagas disease (American trypanosomiasis)
TTDS00473;hsa05162;Measles
TTDS00473;hsa05166;HTLV-I infection
TTDS00473;hsa05340;Primary immunodeficiency
TTDS00474;mtu00473;D-Alanine metabolism
TTDS00474;mtu00550;Peptidoglycan biosynthesis
TTDS00474;mtu01100;Metabolic pathways
TTDS00474;mtu01502;Vancomycin resistance
TTDS00475;hsa00980;Metabolism of xenobiotics by cytochrome P450
TTDS00475;hsa00982;Drug metabolism - cytochrome P450
TTDS00475;hsa04726;Serotonergic synapse
TTDS00476;hsa00380;Tryptophan metabolism
TTDS00476;hsa01100;Metabolic pathways
TTDS00476;hsa05143;African trypanosomiasis
TTDS00477;hsa04060;Cytokine-cytokine receptor interaction
TTDS00477;hsa04066;HIF-1 signaling pathway
TTDS00477;hsa04380;Osteoclast differentiation
TTDS00477;hsa04630;Jak-STAT signaling pathway
TTDS00477;hsa04650;Natural killer cell mediated cytotoxicity
TTDS00477;hsa05132;Salmonella infection
TTDS00477;hsa05140;Leishmaniasis
TTDS00477;hsa05142;Chagas disease (American trypanosomiasis)
TTDS00477;hsa05145;Toxoplasmosis
TTDS00477;hsa05152;Tuberculosis
TTDS00477;hsa05162;Measles
TTDS00477;hsa05164;Influenza A
TTDS00477;hsa05168;Herpes simplex infection
TTDS00477;hsa05321;Inflammatory bowel disease (IBD)
TTDS00478;hsa00230;Purine metabolism
TTDS00478;hsa04022;cGMP-PKG signaling pathway
TTDS00478;hsa04024;cAMP signaling pathway
TTDS00478;hsa04270;Vascular smooth muscle contraction
TTDS00478;hsa04921;Oxytocin signaling pathway
TTDS00480;hsa04514;Cell adhesion molecules (CAMs)
TTDS00480;hsa04640;Hematopoietic cell lineage
TTDS00480;hsa04662;B cell receptor signaling pathway
TTDS00481;hsa04142;Lysosome
TTDS00481;hsa04145;Phagosome
TTDS00482;hsa00280;Valine, leucine and isoleucine degradation
TTDS00482;hsa00630;Glyoxylate and dicarboxylate metabolism
TTDS00482;hsa00640;Propanoate metabolism
TTDS00482;hsa01100;Metabolic pathways
TTDS00482;hsa01200;Carbon metabolism
TTDS00484;hsa04071;Sphingolipid signaling pathway
TTDS00484;hsa04664;Fc epsilon RI signaling pathway
TTDS00484;hsa05310;Asthma
TTDS00485;hsa04080;Neuroactive ligand-receptor interaction
TTDS00485;hsa04380;Osteoclast differentiation
TTDS00486;hsa00130;Ubiquinone and other terpenoid-quinone biosynthesis
TTDS00490;hsa04514;Cell adhesion molecules (CAMs)
TTDS00490;hsa04620;Toll-like receptor signaling pathway
TTDS00490;hsa04672;Intestinal immune network for IgA production
TTDS00490;hsa04940;Type I diabetes mellitus
TTDS00490;hsa05202;Transcriptional misregulation in cancer
TTDS00490;hsa05320;Autoimmune thyroid disease
TTDS00490;hsa05322;Systemic lupus erythematosus
TTDS00490;hsa05323;Rheumatoid arthritis
TTDS00490;hsa05330;Allograft rejection
TTDS00490;hsa05332;Graft-versus-host disease
TTDS00490;hsa05416;Viral myocarditis
TTDS00491;hsa04080;Neuroactive ligand-receptor interaction
TTDS00491;hsa04972;Pancreatic secretion
TTDS00491;hsa04976;Bile secretion
TTDS00492;hsa04060;Cytokine-cytokine receptor interaction
TTDS00492;hsa04151;PI3K-Akt signaling pathway
TTDS00492;hsa04380;Osteoclast differentiation
TTDS00492;hsa04620;Toll-like receptor signaling pathway
TTDS00492;hsa04630;Jak-STAT signaling pathway
TTDS00492;hsa04650;Natural killer cell mediated cytotoxicity
TTDS00492;hsa05160;Hepatitis C
TTDS00492;hsa05161;Hepatitis B
TTDS00492;hsa05162;Measles
TTDS00492;hsa05164;Influenza A
TTDS00492;hsa05168;Herpes simplex infection
TTDS00494;hsa00860;Porphyrin and chlorophyll metabolism
TTDS00495;hsa00531;Glycosaminoglycan degradation
TTDS00495;hsa01100;Metabolic pathways
TTDS00495;hsa04142;Lysosome
TTDS00496;hsa04721;Synaptic vesicle cycle
TTDS00496;hsa04911;Insulin secretion
TTDS00497;hsa04971;Gastric acid secretion
TTDS00498;hsa05143;African trypanosomiasis
TTDS00498;hsa05144;Malaria
TTDS00499;hsa00230;Purine metabolism
TTDS00499;hsa04024;cAMP signaling pathway
TTDS00499;hsa05032;Morphine addiction
TTDS00500;hsa00230;Purine metabolism
TTDS00500;hsa04015;Rap1 signaling pathway
TTDS00500;hsa04020;Calcium signaling pathway
TTDS00500;hsa04022;cGMP-PKG signaling pathway
TTDS00500;hsa04024;cAMP signaling pathway
TTDS00500;hsa04062;Chemokine signaling pathway
TTDS00500;hsa04114;Oocyte meiosis
TTDS00500;hsa04261;Adrenergic signaling in cardiomyocytes
TTDS00500;hsa04270;Vascular smooth muscle contraction
TTDS00500;hsa04540;Gap junction
TTDS00500;hsa04611;Platelet activation
TTDS00500;hsa04713;Circadian entrainment
TTDS00500;hsa04720;Long-term potentiation
TTDS00500;hsa04723;Retrograde endocannabinoid signaling
TTDS00500;hsa04724;Glutamatergic synapse
TTDS00500;hsa04725;Cholinergic synapse
TTDS00500;hsa04727;GABAergic synapse
TTDS00500;hsa04750;Inflammatory mediator regulation of TRP channels
TTDS00500;hsa04911;Insulin secretion
TTDS00500;hsa04912;GnRH signaling pathway
TTDS00500;hsa04913;Ovarian steroidogenesis
TTDS00500;hsa04914;Progesterone-mediated oocyte maturation
TTDS00500;hsa04915;Estrogen signaling pathway
TTDS00500;hsa04916;Melanogenesis
TTDS00500;hsa04918;Thyroid hormone synthesis
TTDS00500;hsa04921;Oxytocin signaling pathway
TTDS00500;hsa04923;Regulation of lipolysis in adipocytes
TTDS00500;hsa04970;Salivary secretion
TTDS00500;hsa04971;Gastric acid secretion
TTDS00500;hsa04972;Pancreatic secretion
TTDS00500;hsa04976;Bile secretion
TTDS00500;hsa05032;Morphine addiction
TTDS00500;hsa05142;Chagas disease (American trypanosomiasis)
TTDS00500;hsa05146;Amoebiasis
TTDS00500;hsa05166;HTLV-I infection
TTDS00500;hsa05200;Pathways in cancer
TTDS00500;hsa05414;Dilated cardiomyopathy
TTDS00501;hsa04060;Cytokine-cytokine receptor interaction
TTDS00501;hsa04630;Jak-STAT signaling pathway
TTDS00501;hsa04640;Hematopoietic cell lineage
TTDS00505;afm00051;Fructose and mannose metabolism
TTDS00506;afm00051;Fructose and mannose metabolism
TTDS00507;hsa04750;Inflammatory mediator regulation of TRP channels
TTDS00515;hsa04145;Phagosome
TTDS00515;hsa04380;Osteoclast differentiation
TTDS00515;hsa04611;Platelet activation
TTDS00515;hsa04666;Fc gamma R-mediated phagocytosis
TTDS00515;hsa05140;Leishmaniasis
TTDS00515;hsa05150;Staphylococcus aureus infection
TTDS00515;hsa05152;Tuberculosis
TTDS00515;hsa05322;Systemic lupus erythematosus
TTDS00516;mtc01100;Metabolic pathways
TTDS00520;hsa04020;Calcium signaling pathway
TTDS00520;hsa04080;Neuroactive ligand-receptor interaction
TTDS00520;hsa04725;Cholinergic synapse
TTDS00520;hsa05033;Nicotine addiction
TTDS00520;hsa05204;Chemical carcinogenesis
TTDS00521;hsa04060;Cytokine-cytokine receptor interaction
TTDS00521;hsa04066;HIF-1 signaling pathway
TTDS00521;hsa04151;PI3K-Akt signaling pathway
TTDS00521;hsa04630;Jak-STAT signaling pathway
TTDS00521;hsa04640;Hematopoietic cell lineage
TTDS00521;hsa04932;Non-alcoholic fatty liver disease (NAFLD)
TTDS00524;hsa04060;Cytokine-cytokine receptor interaction
TTDS00524;hsa04630;Jak-STAT signaling pathway
TTDS00525;hsa04080;Neuroactive ligand-receptor interaction
TTDS00525;hsa04261;Adrenergic signaling in cardiomyocytes
TTDS00525;hsa04614;Renin-angiotensin system
TTDS00529;hsa04010;MAPK signaling pathway
TTDS00529;hsa04020;Calcium signaling pathway
TTDS00529;hsa04721;Synaptic vesicle cycle
TTDS00529;hsa04723;Retrograde endocannabinoid signaling
TTDS00529;hsa04725;Cholinergic synapse
TTDS00529;hsa04726;Serotonergic synapse
TTDS00529;hsa04727;GABAergic synapse
TTDS00529;hsa04728;Dopaminergic synapse
TTDS00529;hsa04742;Taste transduction
TTDS00529;hsa04930;Type II diabetes mellitus
TTDS00529;hsa05032;Morphine addiction
TTDS00529;hsa05033;Nicotine addiction
TTDS00531;hsa00561;Glycerolipid metabolism
TTDS00531;hsa01100;Metabolic pathways
TTDS00531;hsa04975;Fat digestion and absorption
TTDS00533;hsa00250;Alanine, aspartate and glutamate metabolism
TTDS00533;hsa00330;Arginine and proline metabolism
TTDS00533;hsa00910;Nitrogen metabolism
TTDS00533;hsa01100;Metabolic pathways
TTDS00533;hsa01200;Carbon metabolism
TTDS00533;hsa01230;Biosynthesis of amino acids
TTDC00005;WP1530;miRNA Regulation of DNA Damage Response
TTDC00005;WP1775;Cell Cycle Checkpoints
TTDC00005;WP179;Cell Cycle
TTDC00005;WP1971;Integrated Cancer pathway
TTDC00005;WP1984;Integrated Breast Cancer Pathway
TTDC00005;WP2263;Prostate Cancer
TTDC00005;WP2377;Integrated Pancreatic Cancer Pathway
TTDC00005;WP2446;Retinoblastoma (RB) in Cancer
TTDC00005;WP2516;ATM Signaling Pathway
TTDC00005;WP2713;Signaling by SCF-KIT
TTDC00005;WP707;DNA Damage Response
TTDC00006;WP1782;APC/C-mediated degradation of cell cycle proteins
TTDC00006;WP1984;Integrated Breast Cancer Pathway
TTDC00006;WP2361;Gastric Cancer Network 1
TTDC00006;WP2593;JAK/STAT
TTDC00006;WP437;EGF/EGFR Signaling Pathway
TTDC00007;WP1449;Regulation of toll-like receptor signaling pathway
TTDC00007;WP2709;Trafficking and processing of endosomal TLR
TTDC00007;WP2752;MyD88-independent cascade
TTDC00007;WP2775;Toll-Like Receptors Cascades
TTDC00007;WP2794;Cytosolic sensors of pathogen-associated DNA
TTDC00007;WP75;Toll-like receptor signaling pathway
TTDC00009;WP2670;Iron uptake and transport
TTDC00010;WP1530;miRNA Regulation of DNA Damage Response
TTDC00010;WP179;Cell Cycle
TTDC00010;WP1971;Integrated Cancer pathway
TTDC00010;WP1984;Integrated Breast Cancer Pathway
TTDC00010;WP2263;Prostate Cancer
TTDC00010;WP2377;Integrated Pancreatic Cancer Pathway
TTDC00010;WP2516;ATM Signaling Pathway
TTDC00010;WP707;DNA Damage Response
TTDC00012;WP1794;Cell surface interactions at the vascular wall
TTDC00012;WP1832;Integrin alphaIIb beta3 signaling
TTDC00012;WP1833;Integrin cell surface interactions
TTDC00012;WP2643;Nanoparticle-mediated activation of receptor signaling
TTDC00012;WP2703;Extracellular matrix organization
TTDC00012;WP2911;miRNA targets in ECM and membrane receptors
TTDC00012;WP306;Focal Adhesion
TTDC00012;WP366;TGF beta Signaling Pathway
TTDC00012;WP453;Inflammatory Response Pathway
TTDC00012;WP51;Regulation of Actin Cytoskeleton
TTDC00012;WP615;Senescence and Autophagy in Cancer
TTDC00013;WP1818;Formation of Fibrin Clot (Clotting Cascade)
TTDC00013;WP272;Blood Clotting Cascade
TTDC00013;WP2806;Human Complement System
TTDC00013;WP558;Complement and Coagulation Cascades
TTDC00014;WP2788;Sphingolipid metabolism
TTDC00015;WP1903;Response to elevated platelet cytosolic Ca2+
TTDC00015;WP1978;Opioid Signalling
TTDC00015;WP2012;miRs in Muscle Cell Differentiation
TTDC00015;WP2261;Signaling Pathways in Glioblastoma
TTDC00015;WP2688;DAG and IP3 signaling
TTDC00015;WP289;Myometrial Relaxation and Contraction Pathways
TTDC00015;WP35;G Protein Signaling Pathways
TTDC00015;WP363;Wnt Signaling Pathway Netpath
TTDC00015;WP382;MAPK Signaling Pathway
TTDC00015;WP399;Wnt Signaling Pathway and Pluripotency
TTDC00015;WP428;Wnt Signaling Pathway
TTDC00015;WP536;Calcium Regulation in the Cardiac Cell
TTDC00016;WP2788;Sphingolipid metabolism
TTDC00017;WP1824;GPCR downstream signaling
TTDC00017;WP1825;GPCR ligand binding
TTDC00017;WP2197;Endothelin Pathways
TTDC00017;WP289;Myometrial Relaxation and Contraction Pathways
TTDC00018;WP1433;NOD pathway
TTDC00018;WP1850;Metabolism of nitric oxide
TTDC00018;WP1859;Mitotic G2-G2/M phases
TTDC00018;WP1907;Semaphorin interactions
TTDC00018;WP1910;Signaling by EGFR
TTDC00018;WP2100;Arylhydrocarbon receptor (AhR) signaling pathway
TTDC00018;WP231;TNF alpha Signaling Pathway
TTDC00018;WP2355;Corticotropin-releasing hormone
TTDC00018;WP2586;Aryl Hydrocarbon Receptor
TTDC00018;WP262;EBV LMP1 signaling
TTDC00018;WP2683;Influenza Life Cycle
TTDC00018;WP2719;Fcgamma receptor (FCGR) dependent phagocytosis
TTDC00018;WP2780;Signaling by ERBB2
TTDC00018;WP2784;Binding and Uptake of Ligands by Scavenger Receptors
TTDC00018;WP2873;Aryl Hydrocarbon Receptor Pathway
TTDC00018;WP2875;Constitutive Androstane Receptor Pathway
TTDC00018;WP2876;Pregnane X Receptor pathway
TTDC00018;WP2882;Nuclear Receptors Meta-Pathway
TTDC00018;WP2884;NRF2 pathway
TTDC00019;WP2799;Regulation of Insulin-like Growth Factor (IGF) Transport and Uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
TTDC00019;WP554;ACE Inhibitor Pathway
TTDC00020;WP1794;Cell surface interactions at the vascular wall
TTDC00020;WP1833;Integrin cell surface interactions
TTDC00020;WP1843;L1CAM interactions
TTDC00020;WP185;Integrin-mediated Cell Adhesion
TTDC00020;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDC00020;WP2666;Elastic fibre formation
TTDC00020;WP2703;Extracellular matrix organization
TTDC00020;WP306;Focal Adhesion
TTDC00022;WP1815;Factors involved in megakaryocyte development and platelet production
TTDC00022;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDC00022;WP2064;Neural Crest Differentiation
TTDC00022;WP2849;Hematopoietic Stem Cell Differentiation
TTDC00022;WP3297;EV release from cardiac cells and their functional effects
TTDC00022;WP706;SIDS Susceptibility Pathways
TTDC00024;WP1911;Signaling by FGFR
TTDC00024;WP2064;Neural Crest Differentiation
TTDC00024;WP2261;Signaling Pathways in Glioblastoma
TTDC00024;WP2377;Integrated Pancreatic Cancer Pathway
TTDC00024;WP2804;Hair Follicle Development: Induction (Part 1 of 3)
TTDC00024;WP2857;Mesodermal Commitment Pathway
TTDC00024;WP382;MAPK Signaling Pathway
TTDC00024;WP474;Endochondral Ossification
TTDC00024;WP51;Regulation of Actin Cytoskeleton
TTDC00025;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDC00025;WP167;Eicosanoid Synthesis
TTDC00025;WP2431;Spinal Cord Injury
TTDC00025;WP2533;Glycerophospholipid Biosynthetic Pathway
TTDC00025;WP2740;Glycerophospholipid biosynthesis
TTDC00025;WP2795;Cardiac Hypertrophic Response
TTDC00026;WP1840;Interleukin-3, 5 and GM-CSF signaling
TTDC00026;WP2732;Interleukin-2 signaling
TTDC00026;WP453;Inflammatory Response Pathway
TTDC00026;WP49;IL-2 Signaling Pathway
TTDC00027;WP2693;Metabolism of amino acids and derivatives
TTDC00027;WP550;Biogenic Amine Synthesis
TTDC00028;WP2263;Prostate Cancer
TTDC00030;WP2797;Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
TTDC00030;WP2879;Farnesoid X Receptor Pathway
TTDC00030;WP2882;Nuclear Receptors Meta-Pathway
TTDC00030;WP299;Nuclear Receptors in Lipid Metabolism and Toxicity
TTDC00031;WP1829;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
TTDC00031;WP1833;Integrin cell surface interactions
TTDC00031;WP185;Integrin-mediated Cell Adhesion
TTDC00031;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDC00031;WP306;Focal Adhesion
TTDC00032;WP1449;Regulation of toll-like receptor signaling pathway
TTDC00032;WP1794;Cell surface interactions at the vascular wall
TTDC00032;WP1799;Costimulation by the CD28 family
TTDC00032;WP1835;Interferon alpha/beta signaling
TTDC00032;WP1836;Interferon gamma signaling
TTDC00032;WP1840;Interleukin-3, 5 and GM-CSF signaling
TTDC00032;WP1885;Platelet homeostasis
TTDC00032;WP1909;Signal regulatory protein (SIRP) family interactions
TTDC00032;WP23;B Cell Receptor Signaling Pathway
TTDC00032;WP2583;T-Cell Receptor and Co-stimulatory Signaling
TTDC00032;WP2657;Growth hormone receptor signaling
TTDC00032;WP2713;Signaling by SCF-KIT
TTDC00032;WP2732;Interleukin-2 signaling
TTDC00032;WP286;IL-3 Signaling Pathway
TTDC00032;WP304;Kit receptor signaling pathway
TTDC00032;WP395;IL-4 Signaling Pathway
TTDC00032;WP585;Interferon type I signaling pathways
TTDC00033;WP1449;Regulation of toll-like receptor signaling pathway
TTDC00033;WP2328;Allograft Rejection
TTDC00033;WP2873;Aryl Hydrocarbon Receptor Pathway
TTDC00033;WP2877;Vitamin D Receptor Pathway
TTDC00033;WP2882;Nuclear Receptors Meta-Pathway
TTDC00033;WP75;Toll-like receptor signaling pathway
TTDC00034;WP1824;GPCR downstream signaling
TTDC00034;WP1825;GPCR ligand binding
TTDC00034;WP24;Peptide GPCRs
TTDC00034;WP455;GPCRs, Class A Rhodopsin-like
TTDC00037;WP1824;GPCR downstream signaling
TTDC00037;WP1825;GPCR ligand binding
TTDC00037;WP247;Small Ligand GPCRs
TTDC00037;WP455;GPCRs, Class A Rhodopsin-like
TTDC00037;WP98;Prostaglandin Synthesis and Regulation
TTDC00039;WP2670;Iron uptake and transport
TTDC00040;WP1824;GPCR downstream signaling
TTDC00040;WP1825;GPCR ligand binding
TTDC00040;WP24;Peptide GPCRs
TTDC00040;WP455;GPCRs, Class A Rhodopsin-like
TTDC00041;WP1824;GPCR downstream signaling
TTDC00041;WP1825;GPCR ligand binding
TTDC00041;WP334;GPCRs, Class B Secretin-like
TTDC00042;WP129;Matrix Metalloproteinases
TTDC00042;WP2324;AGE/RAGE pathway
TTDC00042;WP2708;Degradation of collagen
TTDC00042;WP2769;Activation of Matrix Metalloproteinases
TTDC00042;WP615;Senescence and Autophagy in Cancer
TTDC00043;WP1824;GPCR downstream signaling
TTDC00043;WP1825;GPCR ligand binding
TTDC00043;WP24;Peptide GPCRs
TTDC00043;WP455;GPCRs, Class A Rhodopsin-like
TTDC00044;WP1449;Regulation of toll-like receptor signaling pathway
TTDC00044;WP1808;DSCAM interactions
TTDC00044;WP185;Integrin-mediated Cell Adhesion
TTDC00044;WP1865;Myogenesis
TTDC00044;WP1873;NGF signalling via TRKA from the plasma membrane
TTDC00044;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDC00044;WP2005;miR-targeted genes in muscle cell - TarBase
TTDC00044;WP2371;Parkinsons Disease Pathway
TTDC00044;WP2643;Nanoparticle-mediated activation of receptor signaling
TTDC00044;WP26;Signal Transduction of S1P Receptor
TTDC00044;WP306;Focal Adhesion
TTDC00044;WP382;MAPK Signaling Pathway
TTDC00044;WP422;MAPK Cascade
TTDC00044;WP481;Insulin Signaling
TTDC00044;WP75;Toll-like receptor signaling pathway
TTDC00045;WP2877;Vitamin D Receptor Pathway
TTDC00046;WP1449;Regulation of toll-like receptor signaling pathway
TTDC00046;WP1533;Vitamin B12 Metabolism
TTDC00046;WP15;Selenium Micronutrient Network
TTDC00046;WP176;Folate Metabolism
TTDC00046;WP1838;Interleukin-1 processing
TTDC00046;WP1904;RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
TTDC00046;WP2018;RANKL/RANK Signaling Pathway
TTDC00046;WP2036;TWEAK Signaling Pathway
TTDC00046;WP2064;Neural Crest Differentiation
TTDC00046;WP2203;TSLP Signaling Pathway
TTDC00046;WP231;TNF alpha Signaling Pathway
TTDC00046;WP262;EBV LMP1 signaling
TTDC00046;WP2656;TAK1 activates NFkB by phosphorylation and activation of IKKs complex
TTDC00046;WP2794;Cytosolic sensors of pathogen-associated DNA
TTDC00046;WP2882;Nuclear Receptors Meta-Pathway
TTDC00046;WP706;SIDS Susceptibility Pathways
TTDC00046;WP710;DNA Damage Response (only ATM dependent)
TTDC00046;WP75;Toll-like receptor signaling pathway
TTDC00048;WP1772;Apoptosis Modulation and Signaling
TTDC00048;WP2003;miR-targeted genes in leukocytes - TarBase
TTDC00048;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDC00048;WP2005;miR-targeted genes in muscle cell - TarBase
TTDC00048;WP254;Apoptosis
TTDC00050;WP2728;Incretin Synthesis, Secretion, and Inactivation
TTDC00051;WP1976;Signalling by NGF
TTDC00051;WP268;Notch Signaling Pathway
TTDC00051;WP2718;Signaling by NOTCH2
TTDC00051;WP2720;Signaling by NOTCH1
TTDC00051;WP2721;Signaling by NOTCH4
TTDC00051;WP2722;Signaling by NOTCH3
TTDC00051;WP2781;Signaling by ERBB4
TTDC00051;WP61;Notch Signaling Pathway
TTDC00052;WP138;Androgen receptor signaling pathway
TTDC00052;WP1982;SREBP signalling
TTDC00052;WP1984;Integrated Breast Cancer Pathway
TTDC00052;WP2011;SREBF and miR33 in cholesterol and lipid homeostasis
TTDC00052;WP2377;Integrated Pancreatic Cancer Pathway
TTDC00053;WP558;Complement and Coagulation Cascades
TTDC00056;WP1449;Regulation of toll-like receptor signaling pathway
TTDC00056;WP2709;Trafficking and processing of endosomal TLR
TTDC00056;WP2768;MyD88 dependent cascade initiated on endosome
TTDC00056;WP2775;Toll-Like Receptors Cascades
TTDC00056;WP75;Toll-like receptor signaling pathway
TTDC00057;WP2788;Sphingolipid metabolism
TTDC00058;WP1422;Sphingolipid Metabolism
TTDC00058;WP26;Signal Transduction of S1P Receptor
TTDC00060;WP2743;Glycosaminoglycan metabolism
TTDC00062;WP15;Selenium Micronutrient Network
TTDC00062;WP167;Eicosanoid Synthesis
TTDC00062;WP2650;Arachidonic acid metabolism
TTDC00062;WP2882;Nuclear Receptors Meta-Pathway
TTDC00063;WP1455;Serotonin Transporter Activity
TTDC00063;WP1995;Effects of Nitric Oxide
TTDC00063;WP2059;Alzheimers Disease
TTDC00063;WP2431;Spinal Cord Injury
TTDC00063;WP2435;Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis
TTDC00063;WP2447;Amyotrophic lateral sclerosis (ALS)
TTDC00063;WP289;Myometrial Relaxation and Contraction Pathways
TTDC00063;WP727;Monoamine Transport
TTDC00064;WP1842;Kinesins
TTDC00064;WP2652;Mitotic Prometaphase
TTDC00064;WP2679;MHC class II antigen presentation
TTDC00064;WP2757;Mitotic Metaphase and Anaphase
TTDC00065;WP1784;Apoptotic execution phase
TTDC00065;WP2776;Visual phototransduction
TTDC00066;WP1528;Physiological and Pathological Hypertrophy of the Heart
TTDC00066;WP1809;Effects of PIP2 hydrolysis
TTDC00066;WP1824;GPCR downstream signaling
TTDC00066;WP2012;miRs in Muscle Cell Differentiation
TTDC00066;WP2374;Oncostatin M Signaling Pathway
TTDC00066;WP289;Myometrial Relaxation and Contraction Pathways
TTDC00066;WP35;G Protein Signaling Pathways
TTDC00066;WP399;Wnt Signaling Pathway and Pluripotency
TTDC00066;WP428;Wnt Signaling Pathway
TTDC00066;WP536;Calcium Regulation in the Cardiac Cell
TTDC00066;WP666;Hypothetical Network for Drug Addiction
TTDC00067;WP2709;Trafficking and processing of endosomal TLR
TTDC00067;WP2796;Class I MHC mediated antigen processing & presentation
TTDC00068;WP12;Osteoclast Signaling
TTDC00068;WP2018;RANKL/RANK Signaling Pathway
TTDC00069;WP170;Nuclear Receptors
TTDC00069;WP236;Adipogenesis
TTDC00069;WP2858;Ectoderm Differentiation
TTDC00069;WP2877;Vitamin D Receptor Pathway
TTDC00069;WP2882;Nuclear Receptors Meta-Pathway
TTDC00069;WP2884;NRF2 pathway
TTDC00069;WP299;Nuclear Receptors in Lipid Metabolism and Toxicity
TTDC00069;WP399;Wnt Signaling Pathway and Pluripotency
TTDC00070;WP237;Glucocorticoid & Mineralcorticoid Metabolism
TTDC00070;WP2749;Metabolism of steroid hormones and vitamin D
TTDC00070;WP98;Prostaglandin Synthesis and Regulation
TTDC00071;WP117;GPCRs, Other
TTDC00071;WP1824;GPCR downstream signaling
TTDC00071;WP1825;GPCR ligand binding
TTDC00071;WP1929;Thrombin signalling through proteinase activated receptors (PARs)
TTDC00071;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDC00071;WP2849;Hematopoietic Stem Cell Differentiation
TTDC00071;WP2864;Apoptosis-related network due to altered Notch3 in ovarian cancer
TTDC00071;WP2865;IL1 and megakaryotyces in obesity
TTDC00071;WP455;GPCRs, Class A Rhodopsin-like
TTDC00071;WP51;Regulation of Actin Cytoskeleton
TTDC00071;WP558;Complement and Coagulation Cascades
TTDC00072;WP1824;GPCR downstream signaling
TTDC00072;WP1825;GPCR ligand binding
TTDC00072;WP24;Peptide GPCRs
TTDC00072;WP455;GPCRs, Class A Rhodopsin-like
TTDC00073;WP1824;GPCR downstream signaling
TTDC00073;WP1825;GPCR ligand binding
TTDC00073;WP2355;Corticotropin-releasing hormone
TTDC00073;WP289;Myometrial Relaxation and Contraction Pathways
TTDC00073;WP334;GPCRs, Class B Secretin-like
TTDC00074;WP1824;GPCR downstream signaling
TTDC00074;WP1825;GPCR ligand binding
TTDC00074;WP2355;Corticotropin-releasing hormone
TTDC00074;WP334;GPCRs, Class B Secretin-like
TTDC00075;WP15;Selenium Micronutrient Network
TTDC00075;WP1851;Metabolism of nucleotides
TTDC00075;WP231;TNF alpha Signaling Pathway
TTDC00075;WP2763;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
TTDC00075;WP2806;Human Complement System
TTDC00075;WP2824;Detoxification of Reactive Oxygen Species
TTDC00075;WP2882;Nuclear Receptors Meta-Pathway
TTDC00075;WP2884;NRF2 pathway
TTDC00076;WP129;Matrix Metalloproteinases
TTDC00076;WP1434;Osteopontin Signaling
TTDC00076;WP1539;Angiogenesis
TTDC00076;WP2036;TWEAK Signaling Pathway
TTDC00076;WP2324;AGE/RAGE pathway
TTDC00076;WP2431;Spinal Cord Injury
TTDC00076;WP2708;Degradation of collagen
TTDC00076;WP2769;Activation of Matrix Metalloproteinases
TTDC00076;WP2815;Mammary gland development pathway - Involution (Stage 4 of 4)
TTDC00076;WP2865;IL1 and megakaryotyces in obesity
TTDC00076;WP474;Endochondral Ossification
TTDC00077;WP1584;Type II diabetes mellitus
TTDC00077;WP1784;Apoptotic execution phase
TTDC00077;WP1809;Effects of PIP2 hydrolysis
TTDC00077;WP1824;GPCR downstream signaling
TTDC00077;WP1978;Opioid Signalling
TTDC00077;WP2012;miRs in Muscle Cell Differentiation
TTDC00077;WP2261;Signaling Pathways in Glioblastoma
TTDC00077;WP2324;AGE/RAGE pathway
TTDC00077;WP2355;Corticotropin-releasing hormone
TTDC00077;WP2374;Oncostatin M Signaling Pathway
TTDC00077;WP2380;BDNF signaling pathway
TTDC00077;WP23;B Cell Receptor Signaling Pathway
TTDC00077;WP244;Alpha 6 Beta 4 signaling pathway
TTDC00077;WP2688;DAG and IP3 signaling
TTDC00077;WP2733;Regulation of mRNA Stability by Proteins that Bind AU-rich Elements
TTDC00077;WP289;Myometrial Relaxation and Contraction Pathways
TTDC00077;WP35;G Protein Signaling Pathways
TTDC00077;WP364;IL-6 signaling pathway
TTDC00077;WP382;MAPK Signaling Pathway
TTDC00077;WP399;Wnt Signaling Pathway and Pluripotency
TTDC00077;WP428;Wnt Signaling Pathway
TTDC00077;WP437;EGF/EGFR Signaling Pathway
TTDC00077;WP481;Insulin Signaling
TTDC00077;WP536;Calcium Regulation in the Cardiac Cell
TTDC00077;WP619;Type II interferon signaling (IFNG)
TTDC00077;WP69;TCR Signaling Pathway
TTDC00078;WP1818;Formation of Fibrin Clot (Clotting Cascade)
TTDC00078;WP272;Blood Clotting Cascade
TTDC00078;WP2762;PTM: gamma carboxylation, hypusine formation and arylsulfatase activation
TTDC00078;WP558;Complement and Coagulation Cascades
TTDC00079;WP1824;GPCR downstream signaling
TTDC00079;WP1825;GPCR ligand binding
TTDC00079;WP455;GPCRs, Class A Rhodopsin-like
TTDC00079;WP727;Monoamine Transport
TTDC00080;WP1449;Regulation of toll-like receptor signaling pathway
TTDC00080;WP1533;Vitamin B12 Metabolism
TTDC00080;WP15;Selenium Micronutrient Network
TTDC00080;WP176;Folate Metabolism
TTDC00080;WP2036;TWEAK Signaling Pathway
TTDC00080;WP2203;TSLP Signaling Pathway
TTDC00080;WP231;TNF alpha Signaling Pathway
TTDC00080;WP236;Adipogenesis
TTDC00080;WP2431;Spinal Cord Injury
TTDC00080;WP2704;Interleukin-6 signaling
TTDC00080;WP2848;Differentiation Pathway
TTDC00080;WP2849;Hematopoietic Stem Cell Differentiation
TTDC00080;WP289;Myometrial Relaxation and Contraction Pathways
TTDC00080;WP364;IL-6 signaling pathway
TTDC00080;WP530;Cytokines and Inflammatory Response
TTDC00080;WP615;Senescence and Autophagy in Cancer
TTDC00080;WP69;TCR Signaling Pathway
TTDC00080;WP706;SIDS Susceptibility Pathways
TTDC00080;WP75;Toll-like receptor signaling pathway
TTDC00081;WP395;IL-4 Signaling Pathway
TTDC00081;WP453;Inflammatory Response Pathway
TTDC00082;WP1824;GPCR downstream signaling
TTDC00082;WP1825;GPCR ligand binding
TTDC00082;WP24;Peptide GPCRs
TTDC00082;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDC00082;WP455;GPCRs, Class A Rhodopsin-like
TTDC00084;WP1840;Interleukin-3, 5 and GM-CSF signaling
TTDC00084;WP205;IL-7 Signaling Pathway
TTDC00084;WP22;IL-9 Signaling Pathway
TTDC00084;WP2374;Oncostatin M Signaling Pathway
TTDC00084;WP2673;Interleukin-7 signaling
TTDC00084;WP2732;Interleukin-2 signaling
TTDC00084;WP395;IL-4 Signaling Pathway
TTDC00084;WP49;IL-2 Signaling Pathway
TTDC00085;WP1798;Complement cascade
TTDC00085;WP2806;Human Complement System
TTDC00085;WP545;Complement Activation, Classical Pathway
TTDC00085;WP558;Complement and Coagulation Cascades
TTDC00086;WP167;Eicosanoid Synthesis
TTDC00086;WP1879;Phase 1 - Functionalization of compounds
TTDC00086;WP2650;Arachidonic acid metabolism
TTDC00086;WP98;Prostaglandin Synthesis and Regulation
TTDC00087;WP117;GPCRs, Other
TTDC00087;WP1824;GPCR downstream signaling
TTDC00087;WP1825;GPCR ligand binding
TTDC00087;WP24;Peptide GPCRs
TTDC00087;WP455;GPCRs, Class A Rhodopsin-like
TTDC00088;WP1530;miRNA Regulation of DNA Damage Response
TTDC00088;WP1775;Cell Cycle Checkpoints
TTDC00088;WP1782;APC/C-mediated degradation of cell cycle proteins
TTDC00088;WP179;Cell Cycle
TTDC00088;WP1815;Factors involved in megakaryocyte development and platelet production
TTDC00088;WP1858;Mitotic G1-G1/S phases
TTDC00088;WP1859;Mitotic G2-G2/M phases
TTDC00088;WP1898;Regulation of DNA replication
TTDC00088;WP1925;Synthesis of DNA
TTDC00088;WP1971;Integrated Cancer pathway
TTDC00088;WP1984;Integrated Breast Cancer Pathway
TTDC00088;WP2032;TSH signaling pathway
TTDC00088;WP2261;Signaling Pathways in Glioblastoma
TTDC00088;WP2263;Prostate Cancer
TTDC00088;WP2374;Oncostatin M Signaling Pathway
TTDC00088;WP2377;Integrated Pancreatic Cancer Pathway
TTDC00088;WP2431;Spinal Cord Injury
TTDC00088;WP2446;Retinoblastoma (RB) in Cancer
TTDC00088;WP2516;ATM Signaling Pathway
TTDC00088;WP2586;Aryl Hydrocarbon Receptor
TTDC00088;WP2698;Meiotic Recombination
TTDC00088;WP2772;S Phase
TTDC00088;WP2785;M/G1 Transition
TTDC00088;WP2877;Vitamin D Receptor Pathway
TTDC00088;WP45;G1 to S cell cycle control
TTDC00088;WP466;DNA Replication
TTDC00088;WP53;ID signaling pathway
TTDC00088;WP707;DNA Damage Response
TTDC00089;WP1824;GPCR downstream signaling
TTDC00089;WP1825;GPCR ligand binding
TTDC00089;WP24;Peptide GPCRs
TTDC00089;WP455;GPCRs, Class A Rhodopsin-like
TTDC00090;WP1824;GPCR downstream signaling
TTDC00090;WP1825;GPCR ligand binding
TTDC00090;WP24;Peptide GPCRs
TTDC00090;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDC00091;WP1851;Metabolism of nucleotides
TTDC00091;WP2002;miR-targeted genes in epithelium - TarBase
TTDC00091;WP2003;miR-targeted genes in leukocytes - TarBase
TTDC00091;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDC00091;WP2006;miR-targeted genes in squamous cell - TarBase
TTDC00093;WP1824;GPCR downstream signaling
TTDC00093;WP1825;GPCR ligand binding
TTDC00093;WP2197;Endothelin Pathways
TTDC00093;WP334;GPCRs, Class B Secretin-like
TTDC00094;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDC00094;WP1858;Mitotic G1-G1/S phases
TTDC00094;WP1859;Mitotic G2-G2/M phases
TTDC00094;WP1861;mRNA Capping
TTDC00094;WP1905;RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription
TTDC00094;WP1906;RNA Polymerase II Transcription
TTDC00094;WP1980;Nucleotide Excision Repair
TTDC00094;WP1984;Integrated Breast Cancer Pathway
TTDC00094;WP2658;HIV Life Cycle
TTDC00094;WP2772;S Phase
TTDC00094;WP2795;Cardiac Hypertrophic Response
TTDC00094;WP405;Eukaryotic Transcription Initiation
TTDC00094;WP45;G1 to S cell cycle control
TTDC00095;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDC00095;WP1906;RNA Polymerase II Transcription
TTDC00095;WP22;IL-9 Signaling Pathway
TTDC00095;WP2658;HIV Life Cycle
TTDC00095;WP2684;Host Interactions of HIV factors
TTDC00095;WP2755;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
TTDC00095;WP2795;Cardiac Hypertrophic Response
TTDC00096;WP1533;Vitamin B12 Metabolism
TTDC00096;WP15;Selenium Micronutrient Network
TTDC00096;WP176;Folate Metabolism
TTDC00096;WP1836;Interferon gamma signaling
TTDC00096;WP183;Proteasome Degradation
TTDC00096;WP2328;Allograft Rejection
TTDC00096;WP2431;Spinal Cord Injury
TTDC00096;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDC00096;WP2865;IL1 and megakaryotyces in obesity
TTDC00096;WP2873;Aryl Hydrocarbon Receptor Pathway
TTDC00096;WP2882;Nuclear Receptors Meta-Pathway
TTDC00096;WP453;Inflammatory Response Pathway
TTDC00096;WP516;Hypertrophy Model
TTDC00096;WP530;Cytokines and Inflammatory Response
TTDC00096;WP560;TGF Beta Signaling Pathway
TTDC00096;WP615;Senescence and Autophagy in Cancer
TTDC00096;WP619;Type II interferon signaling (IFNG)
TTDC00097;WP1539;Angiogenesis
TTDC00097;WP1850;Metabolism of nitric oxide
TTDC00097;WP1995;Effects of Nitric Oxide
TTDC00097;WP2034;Leptin signaling pathway
TTDC00097;WP2197;Endothelin Pathways
TTDC00097;WP2324;AGE/RAGE pathway
TTDC00097;WP2355;Corticotropin-releasing hormone
TTDC00097;WP2593;JAK/STAT
TTDC00097;WP289;Myometrial Relaxation and Contraction Pathways
TTDC00097;WP437;EGF/EGFR Signaling Pathway
TTDC00097;WP554;ACE Inhibitor Pathway
TTDC00098;WP1794;Cell surface interactions at the vascular wall
TTDC00098;WP231;TNF alpha Signaling Pathway
TTDC00098;WP2806;Human Complement System
TTDC00099;WP1848;Metabolism of carbohydrates
TTDC00099;WP500;Glycogen Metabolism
TTDC00100;WP1824;GPCR downstream signaling
TTDC00100;WP1825;GPCR ligand binding
TTDC00100;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDC00100;WP501;GPCRs, Class C Metabotropic glutamate, pheromone
TTDC00100;WP666;Hypothetical Network for Drug Addiction
TTDC00101;WP1539;Angiogenesis
TTDC00101;WP1797;Circadian Clock
TTDC00101;WP2324;AGE/RAGE pathway
TTDC00101;WP236;Adipogenesis
TTDC00101;WP2374;Oncostatin M Signaling Pathway
TTDC00101;WP2720;Signaling by NOTCH1
TTDC00101;WP2727;Regulation of Hypoxia-inducible Factor (HIF) by Oxygen
TTDC00101;WP2877;Vitamin D Receptor Pathway
TTDC00101;WP61;Notch Signaling Pathway
TTDC00101;WP706;SIDS Susceptibility Pathways
TTDC00102;WP12;Osteoclast Signaling
TTDC00102;WP1449;Regulation of toll-like receptor signaling pathway
TTDC00102;WP1528;Physiological and Pathological Hypertrophy of the Heart
TTDC00102;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDC00102;WP1584;Type II diabetes mellitus
TTDC00102;WP1772;Apoptosis Modulation and Signaling
TTDC00102;WP1808;DSCAM interactions
TTDC00102;WP1841;Intrinsic Pathway for Apoptosis
TTDC00102;WP195;IL-1 signaling pathway
TTDC00102;WP1976;Signalling by NGF
TTDC00102;WP2018;RANKL/RANK Signaling Pathway
TTDC00102;WP2034;Leptin signaling pathway
TTDC00102;WP2036;TWEAK Signaling Pathway
TTDC00102;WP2203;TSLP Signaling Pathway
TTDC00102;WP2263;Prostate Cancer
TTDC00102;WP231;TNF alpha Signaling Pathway
TTDC00102;WP2324;AGE/RAGE pathway
TTDC00102;WP2355;Corticotropin-releasing hormone
TTDC00102;WP2374;Oncostatin M Signaling Pathway
TTDC00102;WP2377;Integrated Pancreatic Cancer Pathway
TTDC00102;WP2380;BDNF signaling pathway
TTDC00102;WP23;B Cell Receptor Signaling Pathway
TTDC00102;WP2513;Nanoparticle triggered regulated necrosis
TTDC00102;WP2526;PDGF Pathway
TTDC00102;WP2593;JAK/STAT
TTDC00102;WP262;EBV LMP1 signaling
TTDC00102;WP2637;Structural Pathway of Interleukin 1 (IL-1)
TTDC00102;WP2643;Nanoparticle-mediated activation of receptor signaling
TTDC00102;WP2795;Cardiac Hypertrophic Response
TTDC00102;WP286;IL-3 Signaling Pathway
TTDC00102;WP288;NLR Proteins
TTDC00102;WP304;Kit receptor signaling pathway
TTDC00102;WP306;Focal Adhesion
TTDC00102;WP313;Signaling of Hepatocyte Growth Factor Receptor
TTDC00102;WP314;FAS pathway and Stress induction of HSP regulation
TTDC00102;WP363;Wnt Signaling Pathway Netpath
TTDC00102;WP366;TGF beta Signaling Pathway
TTDC00102;WP382;MAPK Signaling Pathway
TTDC00102;WP3;Transcriptional activation by NRF2
TTDC00102;WP437;EGF/EGFR Signaling Pathway
TTDC00102;WP481;Insulin Signaling
TTDC00102;WP673;ErbB Signaling Pathway
TTDC00102;WP69;TCR Signaling Pathway
TTDC00102;WP710;DNA Damage Response (only ATM dependent)
TTDC00102;WP75;Toll-like receptor signaling pathway
TTDC00103;WP236;Adipogenesis
TTDC00103;WP2431;Spinal Cord Injury
TTDC00104;WP129;Matrix Metalloproteinases
TTDC00104;WP2324;AGE/RAGE pathway
TTDC00104;WP2769;Activation of Matrix Metalloproteinases
TTDC00105;WP129;Matrix Metalloproteinases
TTDC00105;WP2374;Oncostatin M Signaling Pathway
TTDC00105;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDC00105;WP2769;Activation of Matrix Metalloproteinases
TTDC00106;WP1795;Cholesterol biosynthesis
TTDC00106;WP197;Cholesterol Biosynthesis
TTDC00106;WP1982;SREBP signalling
TTDC00106;WP2706;Activation of Gene Expression by SREBP (SREBF)
TTDC00106;WP2797;Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
TTDC00106;WP430;Statin Pathway
TTDC00107;WP1449;Regulation of toll-like receptor signaling pathway
TTDC00107;WP2677;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
TTDC00107;WP2709;Trafficking and processing of endosomal TLR
TTDC00107;WP2768;MyD88 dependent cascade initiated on endosome
TTDC00107;WP2775;Toll-Like Receptors Cascades
TTDC00107;WP75;Toll-like receptor signaling pathway
TTDC00108;WP1818;Formation of Fibrin Clot (Clotting Cascade)
TTDC00108;WP1823;GP1b-IX-V activation signalling
TTDC00108;WP1832;Integrin alphaIIb beta3 signaling
TTDC00108;WP1883;Platelet Adhesion to exposed collagen
TTDC00108;WP272;Blood Clotting Cascade
TTDC00108;WP306;Focal Adhesion
TTDC00108;WP558;Complement and Coagulation Cascades
TTDC00110;WP1907;Semaphorin interactions
TTDC00110;WP2002;miR-targeted genes in epithelium - TarBase
TTDC00110;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDC00110;WP2005;miR-targeted genes in muscle cell - TarBase
TTDC00110;WP2006;miR-targeted genes in squamous cell - TarBase
TTDC00110;WP2261;Signaling Pathways in Glioblastoma
TTDC00110;WP2870;Extracellular vesicle-mediated signaling in recipient cells
TTDC00110;WP306;Focal Adhesion
TTDC00110;WP313;Signaling of Hepatocyte Growth Factor Receptor
TTDC00110;WP366;TGF beta Signaling Pathway
TTDC00111;WP1824;GPCR downstream signaling
TTDC00111;WP1825;GPCR ligand binding
TTDC00111;WP24;Peptide GPCRs
TTDC00111;WP259;Nifedipine Activity
TTDC00111;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDC00111;WP455;GPCRs, Class A Rhodopsin-like
TTDC00111;WP51;Regulation of Actin Cytoskeleton
TTDC00111;WP554;ACE Inhibitor Pathway
TTDC00112;WP1824;GPCR downstream signaling
TTDC00112;WP1825;GPCR ligand binding
TTDC00112;WP24;Peptide GPCRs
TTDC00112;WP455;GPCRs, Class A Rhodopsin-like
TTDC00112;WP706;SIDS Susceptibility Pathways
TTDC00113;WP127;IL-5 Signaling Pathway
TTDC00113;WP1449;Regulation of toll-like receptor signaling pathway
TTDC00113;WP1916;Signaling by PDGF
TTDC00113;WP1971;Integrated Cancer pathway
TTDC00113;WP1984;Integrated Breast Cancer Pathway
TTDC00113;WP2018;RANKL/RANK Signaling Pathway
TTDC00113;WP2032;TSH signaling pathway
TTDC00113;WP2034;Leptin signaling pathway
TTDC00113;WP205;IL-7 Signaling Pathway
TTDC00113;WP2113;Type III interferon signaling
TTDC00113;WP2203;TSLP Signaling Pathway
TTDC00113;WP2263;Prostate Cancer
TTDC00113;WP22;IL-9 Signaling Pathway
TTDC00113;WP2324;AGE/RAGE pathway
TTDC00113;WP2328;Allograft Rejection
TTDC00113;WP2332;Interleukin-11 Signaling Pathway
TTDC00113;WP236;Adipogenesis
TTDC00113;WP2374;Oncostatin M Signaling Pathway
TTDC00113;WP2377;Integrated Pancreatic Cancer Pathway
TTDC00113;WP2380;BDNF signaling pathway
TTDC00113;WP2526;PDGF Pathway
TTDC00113;WP2593;JAK/STAT
TTDC00113;WP2713;Signaling by SCF-KIT
TTDC00113;WP2853;Endoderm Differentiation
TTDC00113;WP304;Kit receptor signaling pathway
TTDC00113;WP364;IL-6 signaling pathway
TTDC00113;WP395;IL-4 Signaling Pathway
TTDC00113;WP400;p38 MAPK Signaling Pathway
TTDC00113;WP437;EGF/EGFR Signaling Pathway
TTDC00113;WP474;Endochondral Ossification
TTDC00113;WP49;IL-2 Signaling Pathway
TTDC00113;WP560;TGF Beta Signaling Pathway
TTDC00113;WP581;EPO Receptor Signaling
TTDC00113;WP585;Interferon type I signaling pathways
TTDC00113;WP619;Type II interferon signaling (IFNG)
TTDC00113;WP75;Toll-like receptor signaling pathway
TTDC00114;WP3297;EV release from cardiac cells and their functional effects
TTDC00114;WP673;ErbB Signaling Pathway
TTDC00116;WP1926;Synthesis, Secretion, and Deacylation of Ghrelin
TTDC00116;WP2865;IL1 and megakaryotyces in obesity
TTDC00117;WP1824;GPCR downstream signaling
TTDC00117;WP1825;GPCR ligand binding
TTDC00117;WP24;Peptide GPCRs
TTDC00117;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDC00118;WP1403;AMPK Signaling
TTDC00118;WP1530;miRNA Regulation of DNA Damage Response
TTDC00118;WP1545;miRNAs involved in DNA damage response
TTDC00118;WP1601;Fluoropyrimidine Activity
TTDC00118;WP1742;TP53 Network
TTDC00118;WP176;Folate Metabolism
TTDC00118;WP1772;Apoptosis Modulation and Signaling
TTDC00118;WP1775;Cell Cycle Checkpoints
TTDC00118;WP179;Cell Cycle
TTDC00118;WP1815;Factors involved in megakaryocyte development and platelet production
TTDC00118;WP1841;Intrinsic Pathway for Apoptosis
TTDC00118;WP1971;Integrated Cancer pathway
TTDC00118;WP1984;Integrated Breast Cancer Pathway
TTDC00118;WP2059;Alzheimers Disease
TTDC00118;WP2249;Metastatic brain tumor
TTDC00118;WP2261;Signaling Pathways in Glioblastoma
TTDC00118;WP2263;Prostate Cancer
TTDC00118;WP2363;Gastric cancer network 2
TTDC00118;WP2374;Oncostatin M Signaling Pathway
TTDC00118;WP2377;Integrated Pancreatic Cancer Pathway
TTDC00118;WP2431;Spinal Cord Injury
TTDC00118;WP2446;Retinoblastoma (RB) in Cancer
TTDC00118;WP2447;Amyotrophic lateral sclerosis (ALS)
TTDC00118;WP2516;ATM Signaling Pathway
TTDC00118;WP254;Apoptosis
TTDC00118;WP2786;Pre-NOTCH Expression and Processing
TTDC00118;WP2815;Mammary gland development pathway - Involution (Stage 4 of 4)
TTDC00118;WP2828;Bladder Cancer
TTDC00118;WP3286;Copper homeostasis
TTDC00118;WP366;TGF beta Signaling Pathway
TTDC00118;WP382;MAPK Signaling Pathway
TTDC00118;WP399;Wnt Signaling Pathway and Pluripotency
TTDC00118;WP45;G1 to S cell cycle control
TTDC00118;WP4;Sandbox Pathway
TTDC00118;WP615;Senescence and Autophagy in Cancer
TTDC00118;WP673;ErbB Signaling Pathway
TTDC00118;WP707;DNA Damage Response
TTDC00118;WP710;DNA Damage Response (only ATM dependent)
TTDC00119;WP127;IL-5 Signaling Pathway
TTDC00119;WP138;Androgen receptor signaling pathway
TTDC00119;WP1449;Regulation of toll-like receptor signaling pathway
TTDC00119;WP1528;Physiological and Pathological Hypertrophy of the Heart
TTDC00119;WP1772;Apoptosis Modulation and Signaling
TTDC00119;WP1845;MAPK targets/ Nuclear events mediated by MAP kinases
TTDC00119;WP195;IL-1 signaling pathway
TTDC00119;WP1984;Integrated Breast Cancer Pathway
TTDC00119;WP2018;RANKL/RANK Signaling Pathway
TTDC00119;WP2032;TSH signaling pathway
TTDC00119;WP2036;TWEAK Signaling Pathway
TTDC00119;WP2100;Arylhydrocarbon receptor (AhR) signaling pathway
TTDC00119;WP2263;Prostate Cancer
TTDC00119;WP231;TNF alpha Signaling Pathway
TTDC00119;WP2324;AGE/RAGE pathway
TTDC00119;WP2377;Integrated Pancreatic Cancer Pathway
TTDC00119;WP2380;BDNF signaling pathway
TTDC00119;WP23;B Cell Receptor Signaling Pathway
TTDC00119;WP2435;Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis
TTDC00119;WP2516;ATM Signaling Pathway
TTDC00119;WP2526;PDGF Pathway
TTDC00119;WP254;Apoptosis
TTDC00119;WP2571;Polycystic Kidney Disease Pathway
TTDC00119;WP2759;Fc epsilon receptor (FCERI) signaling
TTDC00119;WP2786;Pre-NOTCH Expression and Processing
TTDC00119;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDC00119;WP286;IL-3 Signaling Pathway
TTDC00119;WP2873;Aryl Hydrocarbon Receptor Pathway
TTDC00119;WP2881;Estrogen Receptor Pathway
TTDC00119;WP2882;Nuclear Receptors Meta-Pathway
TTDC00119;WP289;Myometrial Relaxation and Contraction Pathways
TTDC00119;WP28;Selenium Metabolism and Selenoproteins
TTDC00119;WP306;Focal Adhesion
TTDC00119;WP313;Signaling of Hepatocyte Growth Factor Receptor
TTDC00119;WP314;FAS pathway and Stress induction of HSP regulation
TTDC00119;WP3286;Copper homeostasis
TTDC00119;WP366;TGF beta Signaling Pathway
TTDC00119;WP382;MAPK Signaling Pathway
TTDC00119;WP399;Wnt Signaling Pathway and Pluripotency
TTDC00119;WP422;MAPK Cascade
TTDC00119;WP428;Wnt Signaling Pathway
TTDC00119;WP437;EGF/EGFR Signaling Pathway
TTDC00119;WP481;Insulin Signaling
TTDC00119;WP49;IL-2 Signaling Pathway
TTDC00119;WP560;TGF Beta Signaling Pathway
TTDC00119;WP615;Senescence and Autophagy in Cancer
TTDC00119;WP673;ErbB Signaling Pathway
TTDC00119;WP69;TCR Signaling Pathway
TTDC00119;WP706;SIDS Susceptibility Pathways
TTDC00119;WP710;DNA Damage Response (only ATM dependent)
TTDC00119;WP712;Estrogen signaling pathway
TTDC00119;WP75;Toll-like receptor signaling pathway
TTDC00121;WP1824;GPCR downstream signaling
TTDC00121;WP1825;GPCR ligand binding
TTDC00121;WP2406;Cardiac Progenitor Differentiation
TTDC00121;WP24;Peptide GPCRs
TTDC00121;WP2658;HIV Life Cycle
TTDC00121;WP2849;Hematopoietic Stem Cell Differentiation
TTDC00121;WP455;GPCRs, Class A Rhodopsin-like
TTDC00122;WP1824;GPCR downstream signaling
TTDC00122;WP1825;GPCR ligand binding
TTDC00122;WP2431;Spinal Cord Injury
TTDC00122;WP24;Peptide GPCRs
TTDC00122;WP2671;Defensins
TTDC00122;WP455;GPCRs, Class A Rhodopsin-like
TTDC00123;WP2764;Lipid digestion, mobilization, and transport
TTDC00123;WP430;Statin Pathway
TTDC00124;WP2764;Lipid digestion, mobilization, and transport
TTDC00124;WP430;Statin Pathway
TTDC00125;WP117;GPCRs, Other
TTDC00125;WP1824;GPCR downstream signaling
TTDC00125;WP1825;GPCR ligand binding
TTDC00125;WP24;Peptide GPCRs
TTDC00125;WP455;GPCRs, Class A Rhodopsin-like
TTDC00126;WP1824;GPCR downstream signaling
TTDC00126;WP1825;GPCR ligand binding
TTDC00126;WP501;GPCRs, Class C Metabotropic glutamate, pheromone
TTDC00127;WP1824;GPCR downstream signaling
TTDC00127;WP1825;GPCR ligand binding
TTDC00127;WP24;Peptide GPCRs
TTDC00127;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDC00127;WP455;GPCRs, Class A Rhodopsin-like
TTDC00128;WP1843;L1CAM interactions
TTDC00128;WP2669;Potassium Channels
TTDC00129;WP1824;GPCR downstream signaling
TTDC00129;WP1825;GPCR ligand binding
TTDC00129;WP2431;Spinal Cord Injury
TTDC00129;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDC00129;WP455;GPCRs, Class A Rhodopsin-like
TTDC00129;WP80;Nucleotide GPCRs
TTDC00130;WP167;Eicosanoid Synthesis
TTDC00130;WP2650;Arachidonic acid metabolism
TTDC00131;WP1911;Signaling by FGFR
TTDC00131;WP2064;Neural Crest Differentiation
TTDC00131;WP2828;Bladder Cancer
TTDC00131;WP474;Endochondral Ossification
TTDC00131;WP51;Regulation of Actin Cytoskeleton
TTDC00132;WP127;IL-5 Signaling Pathway
TTDC00132;WP138;Androgen receptor signaling pathway
TTDC00132;WP1403;AMPK Signaling
TTDC00132;WP1449;Regulation of toll-like receptor signaling pathway
TTDC00132;WP1471;TOR Signaling
TTDC00132;WP1539;Angiogenesis
TTDC00132;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDC00132;WP1559;TFs Regulate miRNAs related to cardiac hypertrophy
TTDC00132;WP1850;Metabolism of nitric oxide
TTDC00132;WP185;Integrin-mediated Cell Adhesion
TTDC00132;WP195;IL-1 signaling pathway
TTDC00132;WP1971;Integrated Cancer pathway
TTDC00132;WP1982;SREBP signalling
TTDC00132;WP1984;Integrated Breast Cancer Pathway
TTDC00132;WP2018;RANKL/RANK Signaling Pathway
TTDC00132;WP2032;TSH signaling pathway
TTDC00132;WP2034;Leptin signaling pathway
TTDC00132;WP2035;FSH signaling pathway
TTDC00132;WP2036;TWEAK Signaling Pathway
TTDC00132;WP2038;Regulation of Microtubule Cytoskeleton
TTDC00132;WP205;IL-7 Signaling Pathway
TTDC00132;WP2112;IL17 signaling pathway
TTDC00132;WP2203;TSLP Signaling Pathway
TTDC00132;WP2261;Signaling Pathways in Glioblastoma
TTDC00132;WP2263;Prostate Cancer
TTDC00132;WP231;TNF alpha Signaling Pathway
TTDC00132;WP2324;AGE/RAGE pathway
TTDC00132;WP2332;Interleukin-11 Signaling Pathway
TTDC00132;WP2355;Corticotropin-releasing hormone
TTDC00132;WP2374;Oncostatin M Signaling Pathway
TTDC00132;WP2377;Integrated Pancreatic Cancer Pathway
TTDC00132;WP2380;BDNF signaling pathway
TTDC00132;WP23;B Cell Receptor Signaling Pathway
TTDC00132;WP244;Alpha 6 Beta 4 signaling pathway
TTDC00132;WP254;Apoptosis
TTDC00132;WP2572;Primary Focal Segmental Glomerulosclerosis FSGS
TTDC00132;WP2583;T-Cell Receptor and Co-stimulatory Signaling
TTDC00132;WP2653;PIP3 activates AKT signaling
TTDC00132;WP26;Signal Transduction of S1P Receptor
TTDC00132;WP2733;Regulation of mRNA Stability by Proteins that Bind AU-rich Elements
TTDC00132;WP2777;Translocation of GLUT4 to the Plasma Membrane
TTDC00132;WP2795;Cardiac Hypertrophic Response
TTDC00132;WP2864;Apoptosis-related network due to altered Notch3 in ovarian cancer
TTDC00132;WP286;IL-3 Signaling Pathway
TTDC00132;WP2870;Extracellular vesicle-mediated signaling in recipient cells
TTDC00132;WP304;Kit receptor signaling pathway
TTDC00132;WP306;Focal Adhesion
TTDC00132;WP3286;Copper homeostasis
TTDC00132;WP363;Wnt Signaling Pathway Netpath
TTDC00132;WP364;IL-6 signaling pathway
TTDC00132;WP366;TGF beta Signaling Pathway
TTDC00132;WP382;MAPK Signaling Pathway
TTDC00132;WP395;IL-4 Signaling Pathway
TTDC00132;WP437;EGF/EGFR Signaling Pathway
TTDC00132;WP474;Endochondral Ossification
TTDC00132;WP481;Insulin Signaling
TTDC00132;WP49;IL-2 Signaling Pathway
TTDC00132;WP581;EPO Receptor Signaling
TTDC00132;WP61;Notch Signaling Pathway
TTDC00132;WP69;TCR Signaling Pathway
TTDC00132;WP710;DNA Damage Response (only ATM dependent)
TTDC00132;WP712;Estrogen signaling pathway
TTDC00132;WP75;Toll-like receptor signaling pathway
TTDC00133;WP1824;GPCR downstream signaling
TTDC00133;WP1825;GPCR ligand binding
TTDC00133;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDC00133;WP455;GPCRs, Class A Rhodopsin-like
TTDC00134;WP2002;miR-targeted genes in epithelium - TarBase
TTDC00134;WP2003;miR-targeted genes in leukocytes - TarBase
TTDC00134;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDC00134;WP2005;miR-targeted genes in muscle cell - TarBase
TTDC00134;WP2006;miR-targeted genes in squamous cell - TarBase
TTDC00134;WP2882;Nuclear Receptors Meta-Pathway
TTDC00134;WP2884;NRF2 pathway
TTDC00134;WP3;Transcriptional activation by NRF2
TTDC00134;WP408;Oxidative Stress
TTDC00135;WP1829;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
TTDC00135;WP23;B Cell Receptor Signaling Pathway
TTDC00135;WP2653;PIP3 activates AKT signaling
TTDC00135;WP2746;Signaling by the B Cell Receptor (BCR)
TTDC00135;WP2806;Human Complement System
TTDC00136;WP205;IL-7 Signaling Pathway
TTDC00136;WP2203;TSLP Signaling Pathway
TTDC00136;WP2673;Interleukin-7 signaling
TTDC00136;WP2864;Apoptosis-related network due to altered Notch3 in ovarian cancer
TTDC00137;WP1793;Cell junction organization
TTDC00137;WP2064;Neural Crest Differentiation
TTDC00137;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDC00137;WP2380;BDNF signaling pathway
TTDC00137;WP2572;Primary Focal Segmental Glomerulosclerosis FSGS
TTDC00139;WP1782;APC/C-mediated degradation of cell cycle proteins
TTDC00139;WP2002;miR-targeted genes in epithelium - TarBase
TTDC00139;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDC00139;WP2038;Regulation of Microtubule Cytoskeleton
TTDC00139;WP2652;Mitotic Prometaphase
TTDC00139;WP2757;Mitotic Metaphase and Anaphase
TTDC00140;WP127;IL-5 Signaling Pathway
TTDC00140;WP1403;AMPK Signaling
TTDC00140;WP1449;Regulation of toll-like receptor signaling pathway
TTDC00140;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDC00140;WP1824;GPCR downstream signaling
TTDC00140;WP1826;GPVI-mediated activation cascade
TTDC00140;WP2261;Signaling Pathways in Glioblastoma
TTDC00140;WP23;B Cell Receptor Signaling Pathway
TTDC00140;WP2747;PI Metabolism
TTDC00140;WP306;Focal Adhesion
TTDC00140;WP481;Insulin Signaling
TTDC00140;WP51;Regulation of Actin Cytoskeleton
TTDC00140;WP581;EPO Receptor Signaling
TTDC00140;WP710;DNA Damage Response (only ATM dependent)
TTDC00140;WP75;Toll-like receptor signaling pathway
TTDC00141;WP1828;Hexose transport
TTDC00141;WP1848;Metabolism of carbohydrates
TTDC00141;WP1897;Regulation of beta-cell development
TTDC00141;WP382;MAPK Signaling Pathway
TTDC00141;WP534;Glycolysis and Gluconeogenesis
TTDC00141;WP706;SIDS Susceptibility Pathways
TTDC00142;WP558;Complement and Coagulation Cascades
TTDC00143;WP1842;Kinesins
TTDC00143;WP2679;MHC class II antigen presentation
TTDC00144;WP117;GPCRs, Other
TTDC00144;WP1824;GPCR downstream signaling
TTDC00144;WP1825;GPCR ligand binding
TTDC00144;WP24;Peptide GPCRs
TTDC00144;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDC00144;WP455;GPCRs, Class A Rhodopsin-like
TTDC00145;WP127;IL-5 Signaling Pathway
TTDC00145;WP1403;AMPK Signaling
TTDC00145;WP1471;TOR Signaling
TTDC00145;WP1913;Signaling by Insulin receptor
TTDC00145;WP2032;TSH signaling pathway
TTDC00145;WP2034;Leptin signaling pathway
TTDC00145;WP2035;FSH signaling pathway
TTDC00145;WP2332;Interleukin-11 Signaling Pathway
TTDC00145;WP2380;BDNF signaling pathway
TTDC00145;WP2677;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
TTDC00145;WP2864;Apoptosis-related network due to altered Notch3 in ovarian cancer
TTDC00145;WP304;Kit receptor signaling pathway
TTDC00145;WP364;IL-6 signaling pathway
TTDC00145;WP395;IL-4 Signaling Pathway
TTDC00145;WP437;EGF/EGFR Signaling Pathway
TTDC00145;WP477;Cytoplasmic Ribosomal Proteins
TTDC00145;WP481;Insulin Signaling
TTDC00145;WP49;IL-2 Signaling Pathway
TTDC00145;WP524;G13 Signaling Pathway
TTDC00145;WP585;Interferon type I signaling pathways
TTDC00145;WP673;ErbB Signaling Pathway
TTDC00147;WP129;Matrix Metalloproteinases
TTDC00147;WP1794;Cell surface interactions at the vascular wall
TTDC00147;WP1971;Integrated Cancer pathway
TTDC00147;WP1984;Integrated Breast Cancer Pathway
TTDC00147;WP2263;Prostate Cancer
TTDC00147;WP2374;Oncostatin M Signaling Pathway
TTDC00147;WP2435;Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis
TTDC00147;WP2708;Degradation of collagen
TTDC00147;WP2769;Activation of Matrix Metalloproteinases
TTDC00147;WP2828;Bladder Cancer
TTDC00147;WP366;TGF beta Signaling Pathway
TTDC00148;WP1793;Cell junction organization
TTDC00148;WP1794;Cell surface interactions at the vascular wall
TTDC00148;WP1829;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
TTDC00148;WP1833;Integrin cell surface interactions
TTDC00148;WP1843;L1CAM interactions
TTDC00148;WP185;Integrin-mediated Cell Adhesion
TTDC00148;WP1883;Platelet Adhesion to exposed collagen
TTDC00148;WP1907;Semaphorin interactions
TTDC00148;WP2064;Neural Crest Differentiation
TTDC00148;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDC00148;WP2272;Pathogenic Escherichia coli infection
TTDC00148;WP2572;Primary Focal Segmental Glomerulosclerosis FSGS
TTDC00148;WP2593;JAK/STAT
TTDC00148;WP2643;Nanoparticle-mediated activation of receptor signaling
TTDC00148;WP2666;Elastic fibre formation
TTDC00148;WP2703;Extracellular matrix organization
TTDC00148;WP2839;Hair Follicle Development: Organogenesis (Part 2 of 3)
TTDC00148;WP306;Focal Adhesion
TTDC00148;WP313;Signaling of Hepatocyte Growth Factor Receptor
TTDC00148;WP366;TGF beta Signaling Pathway
TTDC00149;WP2788;Sphingolipid metabolism
TTDC00149;WP2877;Vitamin D Receptor Pathway
TTDC00149;WP697;Estrogen metabolism
TTDC00150;WP129;Matrix Metalloproteinases
TTDC00150;WP2324;AGE/RAGE pathway
TTDC00150;WP2374;Oncostatin M Signaling Pathway
TTDC00150;WP2769;Activation of Matrix Metalloproteinases
TTDC00150;WP474;Endochondral Ossification
TTDC00151;WP1824;GPCR downstream signaling
TTDC00151;WP1825;GPCR ligand binding
TTDC00151;WP247;Small Ligand GPCRs
TTDC00151;WP2877;Vitamin D Receptor Pathway
TTDC00151;WP455;GPCRs, Class A Rhodopsin-like
TTDC00151;WP98;Prostaglandin Synthesis and Regulation
TTDC00152;WP534;Glycolysis and Gluconeogenesis
TTDC00153;WP1824;GPCR downstream signaling
TTDC00153;WP1825;GPCR ligand binding
TTDC00153;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDC00153;WP455;GPCRs, Class A Rhodopsin-like
TTDC00155;WP1824;GPCR downstream signaling
TTDC00155;WP1825;GPCR ligand binding
TTDC00155;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDC00155;WP455;GPCRs, Class A Rhodopsin-like
TTDC00156;WP127;IL-5 Signaling Pathway
TTDC00156;WP1449;Regulation of toll-like receptor signaling pathway
TTDC00156;WP1826;GPVI-mediated activation cascade
TTDC00156;WP1832;Integrin alphaIIb beta3 signaling
TTDC00156;WP2018;RANKL/RANK Signaling Pathway
TTDC00156;WP23;B Cell Receptor Signaling Pathway
TTDC00156;WP2694;DAP12 interactions
TTDC00156;WP2719;Fcgamma receptor (FCGR) dependent phagocytosis
TTDC00156;WP2732;Interleukin-2 signaling
TTDC00156;WP2746;Signaling by the B Cell Receptor (BCR)
TTDC00156;WP2759;Fc epsilon receptor (FCERI) signaling
TTDC00156;WP286;IL-3 Signaling Pathway
TTDC00156;WP49;IL-2 Signaling Pathway
TTDC00157;WP129;Matrix Metalloproteinases
TTDC00157;WP2708;Degradation of collagen
TTDC00157;WP366;TGF beta Signaling Pathway
TTDC00158;WP2882;Nuclear Receptors Meta-Pathway
TTDC00158;WP2884;NRF2 pathway
TTDC00159;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDC00159;WP179;Cell Cycle
TTDC00159;WP1992;TarBasePathway
TTDC00159;WP2002;miR-targeted genes in epithelium - TarBase
TTDC00159;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDC00159;WP2005;miR-targeted genes in muscle cell - TarBase
TTDC00159;WP2064;Neural Crest Differentiation
TTDC00159;WP2795;Cardiac Hypertrophic Response
TTDC00159;WP474;Endochondral Ossification
TTDC00160;WP1449;Regulation of toll-like receptor signaling pathway
TTDC00160;WP1782;APC/C-mediated degradation of cell cycle proteins
TTDC00160;WP179;Cell Cycle
TTDC00160;WP1859;Mitotic G2-G2/M phases
TTDC00160;WP1971;Integrated Cancer pathway
TTDC00160;WP1984;Integrated Breast Cancer Pathway
TTDC00160;WP2002;miR-targeted genes in epithelium - TarBase
TTDC00160;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDC00160;WP2005;miR-targeted genes in muscle cell - TarBase
TTDC00160;WP2263;Prostate Cancer
TTDC00160;WP231;TNF alpha Signaling Pathway
TTDC00160;WP2377;Integrated Pancreatic Cancer Pathway
TTDC00160;WP2652;Mitotic Prometaphase
TTDC00160;WP2654;Mitotic Prophase
TTDC00160;WP2757;Mitotic Metaphase and Anaphase
TTDC00160;WP2765;Mitotic Telophase/Cytokinesis
TTDC00161;WP1539;Angiogenesis
TTDC00161;WP1794;Cell surface interactions at the vascular wall
TTDC00161;WP363;Wnt Signaling Pathway Netpath
TTDC00162;WP127;IL-5 Signaling Pathway
TTDC00162;WP138;Androgen receptor signaling pathway
TTDC00162;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDC00162;WP179;Cell Cycle
TTDC00162;WP1907;Semaphorin interactions
TTDC00162;WP2034;Leptin signaling pathway
TTDC00162;WP2036;TWEAK Signaling Pathway
TTDC00162;WP2038;Regulation of Microtubule Cytoskeleton
TTDC00162;WP2059;Alzheimers Disease
TTDC00162;WP205;IL-7 Signaling Pathway
TTDC00162;WP2064;Neural Crest Differentiation
TTDC00162;WP2112;IL17 signaling pathway
TTDC00162;WP2355;Corticotropin-releasing hormone
TTDC00162;WP2380;BDNF signaling pathway
TTDC00162;WP23;B Cell Receptor Signaling Pathway
TTDC00162;WP2406;Cardiac Progenitor Differentiation
TTDC00162;WP2583;T-Cell Receptor and Co-stimulatory Signaling
TTDC00162;WP2773;Degradation of beta-catenin by the destruction complex
TTDC00162;WP2795;Cardiac Hypertrophic Response
TTDC00162;WP2804;Hair Follicle Development: Induction (Part 1 of 3)
TTDC00162;WP306;Focal Adhesion
TTDC00162;WP3286;Copper homeostasis
TTDC00162;WP363;Wnt Signaling Pathway Netpath
TTDC00162;WP364;IL-6 signaling pathway
TTDC00162;WP399;Wnt Signaling Pathway and Pluripotency
TTDC00162;WP428;Wnt Signaling Pathway
TTDC00162;WP481;Insulin Signaling
TTDC00162;WP500;Glycogen Metabolism
TTDC00162;WP615;Senescence and Autophagy in Cancer
TTDC00162;WP61;Notch Signaling Pathway
TTDC00162;WP673;ErbB Signaling Pathway
TTDC00162;WP710;DNA Damage Response (only ATM dependent)
TTDC00163;WP1528;Physiological and Pathological Hypertrophy of the Heart
TTDC00163;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDC00163;WP1903;Response to elevated platelet cytosolic Ca2+
TTDC00163;WP2012;miRs in Muscle Cell Differentiation
TTDC00163;WP2261;Signaling Pathways in Glioblastoma
TTDC00163;WP2324;AGE/RAGE pathway
TTDC00163;WP2355;Corticotropin-releasing hormone
TTDC00163;WP2374;Oncostatin M Signaling Pathway
TTDC00163;WP23;B Cell Receptor Signaling Pathway
TTDC00163;WP2746;Signaling by the B Cell Receptor (BCR)
TTDC00163;WP289;Myometrial Relaxation and Contraction Pathways
TTDC00163;WP304;Kit receptor signaling pathway
TTDC00163;WP35;G Protein Signaling Pathways
TTDC00163;WP363;Wnt Signaling Pathway Netpath
TTDC00163;WP382;MAPK Signaling Pathway
TTDC00163;WP399;Wnt Signaling Pathway and Pluripotency
TTDC00163;WP428;Wnt Signaling Pathway
TTDC00163;WP437;EGF/EGFR Signaling Pathway
TTDC00163;WP481;Insulin Signaling
TTDC00163;WP536;Calcium Regulation in the Cardiac Cell
TTDC00165;WP1530;miRNA Regulation of DNA Damage Response
TTDC00165;WP179;Cell Cycle
TTDC00165;WP1858;Mitotic G1-G1/S phases
TTDC00165;WP1971;Integrated Cancer pathway
TTDC00165;WP1984;Integrated Breast Cancer Pathway
TTDC00165;WP2032;TSH signaling pathway
TTDC00165;WP2261;Signaling Pathways in Glioblastoma
TTDC00165;WP2263;Prostate Cancer
TTDC00165;WP2377;Integrated Pancreatic Cancer Pathway
TTDC00165;WP2431;Spinal Cord Injury
TTDC00165;WP2446;Retinoblastoma (RB) in Cancer
TTDC00165;WP2698;Meiotic Recombination
TTDC00165;WP2751;Transcriptional Regulation of White Adipocyte Differentiation
TTDC00165;WP2772;S Phase
TTDC00165;WP2828;Bladder Cancer
TTDC00165;WP2878;PPAR Alpha Pathway
TTDC00165;WP2882;Nuclear Receptors Meta-Pathway
TTDC00165;WP34;Ovarian Infertility Genes
TTDC00165;WP45;G1 to S cell cycle control
TTDC00165;WP707;DNA Damage Response
TTDC00166;WP1530;miRNA Regulation of DNA Damage Response
TTDC00166;WP1775;Cell Cycle Checkpoints
TTDC00166;WP1782;APC/C-mediated degradation of cell cycle proteins
TTDC00166;WP179;Cell Cycle
TTDC00166;WP1858;Mitotic G1-G1/S phases
TTDC00166;WP1859;Mitotic G2-G2/M phases
TTDC00166;WP1971;Integrated Cancer pathway
TTDC00166;WP2038;Regulation of Microtubule Cytoskeleton
TTDC00166;WP2263;Prostate Cancer
TTDC00166;WP2431;Spinal Cord Injury
TTDC00166;WP2446;Retinoblastoma (RB) in Cancer
TTDC00166;WP2516;ATM Signaling Pathway
TTDC00166;WP2612;BMI1
TTDC00166;WP2652;Mitotic Prometaphase
TTDC00166;WP2654;Mitotic Prophase
TTDC00166;WP2735;RAF/MAP kinase cascade
TTDC00166;WP2792;MAP kinase activation in TLR cascade
TTDC00166;WP2878;PPAR Alpha Pathway
TTDC00166;WP2882;Nuclear Receptors Meta-Pathway
TTDC00166;WP366;TGF beta Signaling Pathway
TTDC00166;WP45;G1 to S cell cycle control
TTDC00166;WP707;DNA Damage Response
TTDC00168;WP1772;Apoptosis Modulation and Signaling
TTDC00168;WP1841;Intrinsic Pathway for Apoptosis
TTDC00168;WP2034;Leptin signaling pathway
TTDC00168;WP205;IL-7 Signaling Pathway
TTDC00168;WP231;TNF alpha Signaling Pathway
TTDC00168;WP2447;Amyotrophic lateral sclerosis (ALS)
TTDC00168;WP254;Apoptosis
TTDC00168;WP2763;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
TTDC00168;WP286;IL-3 Signaling Pathway
TTDC00168;WP364;IL-6 signaling pathway
TTDC00169;WP1530;miRNA Regulation of DNA Damage Response
TTDC00169;WP1545;miRNAs involved in DNA damage response
TTDC00169;WP179;Cell Cycle
TTDC00169;WP1858;Mitotic G1-G1/S phases
TTDC00169;WP2002;miR-targeted genes in epithelium - TarBase
TTDC00169;WP2003;miR-targeted genes in leukocytes - TarBase
TTDC00169;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDC00169;WP2005;miR-targeted genes in muscle cell - TarBase
TTDC00169;WP2249;Metastatic brain tumor
TTDC00169;WP2261;Signaling Pathways in Glioblastoma
TTDC00169;WP2446;Retinoblastoma (RB) in Cancer
TTDC00169;WP363;Wnt Signaling Pathway Netpath
TTDC00169;WP45;G1 to S cell cycle control
TTDC00169;WP707;DNA Damage Response
TTDC00176;WP1919;Signaling by VEGF
TTDC00176;WP306;Focal Adhesion
TTDC00177;WP2328;Allograft Rejection
TTDC00177;WP530;Cytokines and Inflammatory Response
TTDC00177;WP706;SIDS Susceptibility Pathways
TTDC00178;WP1784;Apoptotic execution phase
TTDC00178;WP1809;Effects of PIP2 hydrolysis
TTDC00178;WP1824;GPCR downstream signaling
TTDC00178;WP1868;Netrin-1 signaling
TTDC00178;WP1927;TCR signaling
TTDC00178;WP2012;miRs in Muscle Cell Differentiation
TTDC00178;WP2261;Signaling Pathways in Glioblastoma
TTDC00178;WP2355;Corticotropin-releasing hormone
TTDC00178;WP2759;Fc epsilon receptor (FCERI) signaling
TTDC00178;WP2877;Vitamin D Receptor Pathway
TTDC00178;WP289;Myometrial Relaxation and Contraction Pathways
TTDC00178;WP35;G Protein Signaling Pathways
TTDC00178;WP399;Wnt Signaling Pathway and Pluripotency
TTDC00178;WP428;Wnt Signaling Pathway
TTDC00178;WP481;Insulin Signaling
TTDC00178;WP536;Calcium Regulation in the Cardiac Cell
TTDC00178;WP69;TCR Signaling Pathway
TTDC00179;WP1824;GPCR downstream signaling
TTDC00179;WP1825;GPCR ligand binding
TTDC00179;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDC00179;WP455;GPCRs, Class A Rhodopsin-like
TTDC00179;WP80;Nucleotide GPCRs
TTDC00180;WP1976;Signalling by NGF
TTDC00180;WP2059;Alzheimers Disease
TTDC00180;WP268;Notch Signaling Pathway
TTDC00180;WP2718;Signaling by NOTCH2
TTDC00180;WP2720;Signaling by NOTCH1
TTDC00180;WP2721;Signaling by NOTCH4
TTDC00180;WP2722;Signaling by NOTCH3
TTDC00180;WP2781;Signaling by ERBB4
TTDC00180;WP61;Notch Signaling Pathway
TTDC00182;WP1471;TOR Signaling
TTDC00182;WP1831;Integration of energy metabolism
TTDC00182;WP1903;Response to elevated platelet cytosolic Ca2+
TTDC00182;WP1978;Opioid Signalling
TTDC00182;WP2012;miRs in Muscle Cell Differentiation
TTDC00182;WP2035;FSH signaling pathway
TTDC00182;WP2038;Regulation of Microtubule Cytoskeleton
TTDC00182;WP2197;Endothelin Pathways
TTDC00182;WP2261;Signaling Pathways in Glioblastoma
TTDC00182;WP2272;Pathogenic Escherichia coli infection
TTDC00182;WP2324;AGE/RAGE pathway
TTDC00182;WP2355;Corticotropin-releasing hormone
TTDC00182;WP2374;Oncostatin M Signaling Pathway
TTDC00182;WP2377;Integrated Pancreatic Cancer Pathway
TTDC00182;WP2431;Spinal Cord Injury
TTDC00182;WP244;Alpha 6 Beta 4 signaling pathway
TTDC00182;WP2583;T-Cell Receptor and Co-stimulatory Signaling
TTDC00182;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDC00182;WP2688;DAG and IP3 signaling
TTDC00182;WP2713;Signaling by SCF-KIT
TTDC00182;WP2733;Regulation of mRNA Stability by Proteins that Bind AU-rich Elements
TTDC00182;WP2787;Syndecan interactions
TTDC00182;WP2795;Cardiac Hypertrophic Response
TTDC00182;WP2806;Human Complement System
TTDC00182;WP289;Myometrial Relaxation and Contraction Pathways
TTDC00182;WP304;Kit receptor signaling pathway
TTDC00182;WP35;G Protein Signaling Pathways
TTDC00182;WP363;Wnt Signaling Pathway Netpath
TTDC00182;WP399;Wnt Signaling Pathway and Pluripotency
TTDC00182;WP3;Transcriptional activation by NRF2
TTDC00182;WP428;Wnt Signaling Pathway
TTDC00182;WP437;EGF/EGFR Signaling Pathway
TTDC00182;WP481;Insulin Signaling
TTDC00182;WP536;Calcium Regulation in the Cardiac Cell
TTDC00182;WP673;ErbB Signaling Pathway
TTDC00183;WP1843;L1CAM interactions
TTDC00183;WP1907;Semaphorin interactions
TTDC00183;WP1919;Signaling by VEGF
TTDC00183;WP2002;miR-targeted genes in epithelium - TarBase
TTDC00183;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDC00183;WP2005;miR-targeted genes in muscle cell - TarBase
TTDC00183;WP2006;miR-targeted genes in squamous cell - TarBase
TTDC00184;WP1824;GPCR downstream signaling
TTDC00184;WP1825;GPCR ligand binding
TTDC00184;WP455;GPCRs, Class A Rhodopsin-like
TTDC00184;WP536;Calcium Regulation in the Cardiac Cell
TTDC00184;WP58;Monoamine GPCRs
TTDC00185;WP1824;GPCR downstream signaling
TTDC00185;WP1825;GPCR ligand binding
TTDC00185;WP455;GPCRs, Class A Rhodopsin-like
TTDC00185;WP58;Monoamine GPCRs
TTDC00185;WP734;Serotonin Receptor 4/6/7 and NR3C Signaling
TTDC00186;WP22;IL-9 Signaling Pathway
TTDC00186;WP69;TCR Signaling Pathway
TTDC00187;WP127;IL-5 Signaling Pathway
TTDC00187;WP1815;Factors involved in megakaryocyte development and platelet production
TTDC00187;WP1836;Interferon gamma signaling
TTDC00187;WP1840;Interleukin-3, 5 and GM-CSF signaling
TTDC00187;WP2032;TSH signaling pathway
TTDC00187;WP2034;Leptin signaling pathway
TTDC00187;WP2112;IL17 signaling pathway
TTDC00187;WP2203;TSLP Signaling Pathway
TTDC00187;WP2324;AGE/RAGE pathway
TTDC00187;WP2332;Interleukin-11 Signaling Pathway
TTDC00187;WP2374;Oncostatin M Signaling Pathway
TTDC00187;WP2380;BDNF signaling pathway
TTDC00187;WP2593;JAK/STAT
TTDC00187;WP2657;Growth hormone receptor signaling
TTDC00187;WP2678;Prolactin receptor signaling
TTDC00187;WP2713;Signaling by SCF-KIT
TTDC00187;WP2732;Interleukin-2 signaling
TTDC00187;WP2857;Mesodermal Commitment Pathway
TTDC00187;WP286;IL-3 Signaling Pathway
TTDC00187;WP304;Kit receptor signaling pathway
TTDC00187;WP364;IL-6 signaling pathway
TTDC00187;WP395;IL-4 Signaling Pathway
TTDC00187;WP437;EGF/EGFR Signaling Pathway
TTDC00187;WP581;EPO Receptor Signaling
TTDC00187;WP619;Type II interferon signaling (IFNG)
TTDC00187;WP61;Notch Signaling Pathway
TTDC00187;WP733;Serotonin Receptor 2 and STAT3 Signaling
TTDC00188;WP1449;Regulation of toll-like receptor signaling pathway
TTDC00188;WP2328;Allograft Rejection
TTDC00188;WP2806;Human Complement System
TTDC00188;WP2877;Vitamin D Receptor Pathway
TTDC00188;WP288;NLR Proteins
TTDC00188;WP453;Inflammatory Response Pathway
TTDC00188;WP75;Toll-like receptor signaling pathway
TTDC00189;WP1976;Signalling by NGF
TTDC00189;WP2380;BDNF signaling pathway
TTDC00189;WP2431;Spinal Cord Injury
TTDC00190;WP117;GPCRs, Other
TTDC00190;WP1824;GPCR downstream signaling
TTDC00190;WP1825;GPCR ligand binding
TTDC00190;WP24;Peptide GPCRs
TTDC00190;WP2848;Differentiation Pathway
TTDC00190;WP455;GPCRs, Class A Rhodopsin-like
TTDC00191;WP1832;Integrin alphaIIb beta3 signaling
TTDC00191;WP1835;Interferon alpha/beta signaling
TTDC00191;WP1836;Interferon gamma signaling
TTDC00191;WP2034;Leptin signaling pathway
TTDC00191;WP2657;Growth hormone receptor signaling
TTDC00191;WP481;Insulin Signaling
TTDC00192;WP1533;Vitamin B12 Metabolism
TTDC00192;WP15;Selenium Micronutrient Network
TTDC00192;WP176;Folate Metabolism
TTDC00192;WP1829;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
TTDC00192;WP1833;Integrin cell surface interactions
TTDC00192;WP2018;RANKL/RANK Signaling Pathway
TTDC00192;WP2332;Interleukin-11 Signaling Pathway
TTDC00192;WP2431;Spinal Cord Injury
TTDC00192;WP2806;Human Complement System
TTDC00192;WP2865;IL1 and megakaryotyces in obesity
TTDC00192;WP619;Type II interferon signaling (IFNG)
TTDC00193;WP1824;GPCR downstream signaling
TTDC00193;WP1825;GPCR ligand binding
TTDC00193;WP2197;Endothelin Pathways
TTDC00193;WP24;Peptide GPCRs
TTDC00193;WP455;GPCRs, Class A Rhodopsin-like
TTDC00194;WP2263;Prostate Cancer
TTDC00194;WP2673;Interleukin-7 signaling
TTDC00194;WP2848;Differentiation Pathway
TTDC00194;WP2870;Extracellular vesicle-mediated signaling in recipient cells
TTDC00194;WP2882;Nuclear Receptors Meta-Pathway
TTDC00194;WP2884;NRF2 pathway
TTDC00194;WP306;Focal Adhesion
TTDC00194;WP313;Signaling of Hepatocyte Growth Factor Receptor
TTDC00196;WP2431;Spinal Cord Injury
TTDC00197;WP1794;Cell surface interactions at the vascular wall
TTDC00197;WP2431;Spinal Cord Injury
TTDC00197;WP2806;Human Complement System
TTDC00199;WP1533;Vitamin B12 Metabolism
TTDC00199;WP15;Selenium Micronutrient Network
TTDC00199;WP176;Folate Metabolism
TTDC00200;WP2100;Arylhydrocarbon receptor (AhR) signaling pathway
TTDC00200;WP2436;Dopamine metabolism
TTDC00200;WP2586;Aryl Hydrocarbon Receptor
TTDC00200;WP2693;Metabolism of amino acids and derivatives
TTDC00200;WP2864;Apoptosis-related network due to altered Notch3 in ovarian cancer
TTDC00200;WP2873;Aryl Hydrocarbon Receptor Pathway
TTDC00200;WP2882;Nuclear Receptors Meta-Pathway
TTDC00200;WP2884;NRF2 pathway
TTDC00200;WP3;Transcriptional activation by NRF2
TTDC00200;WP408;Oxidative Stress
TTDC00200;WP697;Estrogen metabolism
TTDC00201;WP1449;Regulation of toll-like receptor signaling pathway
TTDC00201;WP1528;Physiological and Pathological Hypertrophy of the Heart
TTDC00201;WP1539;Angiogenesis
TTDC00201;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDC00201;WP1808;DSCAM interactions
TTDC00201;WP1865;Myogenesis
TTDC00201;WP1873;NGF signalling via TRKA from the plasma membrane
TTDC00201;WP1885;Platelet homeostasis
TTDC00201;WP1908;Signal amplification
TTDC00201;WP195;IL-1 signaling pathway
TTDC00201;WP2002;miR-targeted genes in epithelium - TarBase
TTDC00201;WP2003;miR-targeted genes in leukocytes - TarBase
TTDC00201;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDC00201;WP2005;miR-targeted genes in muscle cell - TarBase
TTDC00201;WP2018;RANKL/RANK Signaling Pathway
TTDC00201;WP2032;TSH signaling pathway
TTDC00201;WP2034;Leptin signaling pathway
TTDC00201;WP2035;FSH signaling pathway
TTDC00201;WP2036;TWEAK Signaling Pathway
TTDC00201;WP2203;TSLP Signaling Pathway
TTDC00201;WP2263;Prostate Cancer
TTDC00201;WP2324;AGE/RAGE pathway
TTDC00201;WP2355;Corticotropin-releasing hormone
TTDC00201;WP2371;Parkinsons Disease Pathway
TTDC00201;WP2374;Oncostatin M Signaling Pathway
TTDC00201;WP2377;Integrated Pancreatic Cancer Pathway
TTDC00201;WP2380;BDNF signaling pathway
TTDC00201;WP23;B Cell Receptor Signaling Pathway
TTDC00201;WP2406;Cardiac Progenitor Differentiation
TTDC00201;WP2447;Amyotrophic lateral sclerosis (ALS)
TTDC00201;WP244;Alpha 6 Beta 4 signaling pathway
TTDC00201;WP2593;JAK/STAT
TTDC00201;WP2637;Structural Pathway of Interleukin 1 (IL-1)
TTDC00201;WP2643;Nanoparticle-mediated activation of receptor signaling
TTDC00201;WP2733;Regulation of mRNA Stability by Proteins that Bind AU-rich Elements
TTDC00201;WP2792;MAP kinase activation in TLR cascade
TTDC00201;WP2795;Cardiac Hypertrophic Response
TTDC00201;WP304;Kit receptor signaling pathway
TTDC00201;WP366;TGF beta Signaling Pathway
TTDC00201;WP382;MAPK Signaling Pathway
TTDC00201;WP395;IL-4 Signaling Pathway
TTDC00201;WP400;p38 MAPK Signaling Pathway
TTDC00201;WP408;Oxidative Stress
TTDC00201;WP422;MAPK Cascade
TTDC00201;WP437;EGF/EGFR Signaling Pathway
TTDC00201;WP481;Insulin Signaling
TTDC00201;WP585;Interferon type I signaling pathways
TTDC00201;WP615;Senescence and Autophagy in Cancer
TTDC00201;WP69;TCR Signaling Pathway
TTDC00201;WP712;Estrogen signaling pathway
TTDC00201;WP722;Serotonin HTR1 Group and FOS Pathway
TTDC00201;WP727;Monoamine Transport
TTDC00201;WP75;Toll-like receptor signaling pathway
TTDC00202;WP138;Androgen receptor signaling pathway
TTDC00202;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDC00202;WP1784;Apoptotic execution phase
TTDC00202;WP1824;GPCR downstream signaling
TTDC00202;WP185;Integrin-mediated Cell Adhesion
TTDC00202;WP1907;Semaphorin interactions
TTDC00202;WP2034;Leptin signaling pathway
TTDC00202;WP2038;Regulation of Microtubule Cytoskeleton
TTDC00202;WP2272;Pathogenic Escherichia coli infection
TTDC00202;WP2324;AGE/RAGE pathway
TTDC00202;WP2593;JAK/STAT
TTDC00202;WP306;Focal Adhesion
TTDC00202;WP366;TGF beta Signaling Pathway
TTDC00202;WP437;EGF/EGFR Signaling Pathway
TTDC00202;WP51;Regulation of Actin Cytoskeleton
TTDC00202;WP524;G13 Signaling Pathway
TTDC00204;WP1824;GPCR downstream signaling
TTDC00204;WP1825;GPCR ligand binding
TTDC00204;WP334;GPCRs, Class B Secretin-like
TTDC00204;WP706;SIDS Susceptibility Pathways
TTDC00205;WP1824;GPCR downstream signaling
TTDC00205;WP1825;GPCR ligand binding
TTDC00205;WP1831;Integration of energy metabolism
TTDC00205;WP1926;Synthesis, Secretion, and Deacylation of Ghrelin
TTDC00205;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDC00205;WP2728;Incretin Synthesis, Secretion, and Inactivation
TTDC00206;WP138;Androgen receptor signaling pathway
TTDC00206;WP1530;miRNA Regulation of DNA Damage Response
TTDC00206;WP1742;TP53 Network
TTDC00206;WP1775;Cell Cycle Checkpoints
TTDC00206;WP179;Cell Cycle
TTDC00206;WP1971;Integrated Cancer pathway
TTDC00206;WP1984;Integrated Breast Cancer Pathway
TTDC00206;WP2261;Signaling Pathways in Glioblastoma
TTDC00206;WP2263;Prostate Cancer
TTDC00206;WP2377;Integrated Pancreatic Cancer Pathway
TTDC00206;WP2446;Retinoblastoma (RB) in Cancer
TTDC00206;WP2516;ATM Signaling Pathway
TTDC00206;WP254;Apoptosis
TTDC00206;WP2653;PIP3 activates AKT signaling
TTDC00206;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDC00206;WP2828;Bladder Cancer
TTDC00206;WP3286;Copper homeostasis
TTDC00206;WP45;G1 to S cell cycle control
TTDC00206;WP465;Tryptophan metabolism
TTDC00206;WP615;Senescence and Autophagy in Cancer
TTDC00206;WP673;ErbB Signaling Pathway
TTDC00206;WP707;DNA Damage Response
TTDC00206;WP710;DNA Damage Response (only ATM dependent)
TTDC00207;WP1824;GPCR downstream signaling
TTDC00207;WP1825;GPCR ligand binding
TTDC00207;WP24;Peptide GPCRs
TTDC00207;WP2865;IL1 and megakaryotyces in obesity
TTDC00207;WP286;IL-3 Signaling Pathway
TTDC00207;WP455;GPCRs, Class A Rhodopsin-like
TTDC00208;WP1799;Costimulation by the CD28 family
TTDC00208;WP2328;Allograft Rejection
TTDC00208;WP2583;T-Cell Receptor and Co-stimulatory Signaling
TTDC00208;WP2653;PIP3 activates AKT signaling
TTDC00208;WP2684;Host Interactions of HIV factors
TTDC00208;WP453;Inflammatory Response Pathway
TTDC00208;WP69;TCR Signaling Pathway
TTDC00209;WP1449;Regulation of toll-like receptor signaling pathway
TTDC00209;WP2272;Pathogenic Escherichia coli infection
TTDC00209;WP2355;Corticotropin-releasing hormone
TTDC00209;WP2431;Spinal Cord Injury
TTDC00209;WP2572;Primary Focal Segmental Glomerulosclerosis FSGS
TTDC00209;WP2752;MyD88-independent cascade
TTDC00209;WP2761;MyD88:Mal cascade initiated on plasma membrane
TTDC00209;WP2775;Toll-Like Receptors Cascades
TTDC00209;WP75;Toll-like receptor signaling pathway
TTDC00210;WP1794;Cell surface interactions at the vascular wall
TTDC00213;WP2738;YAP1- and WWTR1 (TAZ)-stimulated gene expression
TTDC00213;WP2797;Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
TTDC00213;WP2804;Hair Follicle Development: Induction (Part 1 of 3)
TTDC00213;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDC00214;WP2112;IL17 signaling pathway
TTDC00214;WP2328;Allograft Rejection
TTDC00214;WP69;TCR Signaling Pathway
TTDC00215;WP1824;GPCR downstream signaling
TTDC00215;WP1825;GPCR ligand binding
TTDC00215;WP24;Peptide GPCRs
TTDC00215;WP455;GPCRs, Class A Rhodopsin-like
TTDC00216;WP1533;Vitamin B12 Metabolism
TTDC00216;WP15;Selenium Micronutrient Network
TTDC00216;WP176;Folate Metabolism
TTDC00216;WP1798;Complement cascade
TTDC00216;WP2806;Human Complement System
TTDC00216;WP364;IL-6 signaling pathway
TTDC00218;WP2763;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
TTDC00220;WP117;GPCRs, Other
TTDC00220;WP1824;GPCR downstream signaling
TTDC00220;WP1825;GPCR ligand binding
TTDC00220;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDC00220;WP501;GPCRs, Class C Metabotropic glutamate, pheromone
TTDC00220;WP666;Hypothetical Network for Drug Addiction
TTDC00221;WP1433;NOD pathway
TTDC00221;WP2355;Corticotropin-releasing hormone
TTDC00221;WP2865;IL1 and megakaryotyces in obesity
TTDC00221;WP516;Hypertrophy Model
TTDC00222;WP1433;NOD pathway
TTDC00222;WP1434;Osteopontin Signaling
TTDC00222;WP1449;Regulation of toll-like receptor signaling pathway
TTDC00222;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDC00222;WP1584;Type II diabetes mellitus
TTDC00222;WP1772;Apoptosis Modulation and Signaling
TTDC00222;WP1839;Interleukin-1 signaling
TTDC00222;WP1904;RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
TTDC00222;WP1927;TCR signaling
TTDC00222;WP195;IL-1 signaling pathway
TTDC00222;WP1976;Signalling by NGF
TTDC00222;WP2018;RANKL/RANK Signaling Pathway
TTDC00222;WP2034;Leptin signaling pathway
TTDC00222;WP2036;TWEAK Signaling Pathway
TTDC00222;WP2112;IL17 signaling pathway
TTDC00222;WP231;TNF alpha Signaling Pathway
TTDC00222;WP2324;AGE/RAGE pathway
TTDC00222;WP2332;Interleukin-11 Signaling Pathway
TTDC00222;WP2380;BDNF signaling pathway
TTDC00222;WP23;B Cell Receptor Signaling Pathway
TTDC00222;WP2435;Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis
TTDC00222;WP254;Apoptosis
TTDC00222;WP2571;Polycystic Kidney Disease Pathway
TTDC00222;WP262;EBV LMP1 signaling
TTDC00222;WP2637;Structural Pathway of Interleukin 1 (IL-1)
TTDC00222;WP2656;TAK1 activates NFkB by phosphorylation and activation of IKKs complex
TTDC00222;WP2746;Signaling by the B Cell Receptor (BCR)
TTDC00222;WP2752;MyD88-independent cascade
TTDC00222;WP2759;Fc epsilon receptor (FCERI) signaling
TTDC00222;WP2761;MyD88:Mal cascade initiated on plasma membrane
TTDC00222;WP2763;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
TTDC00222;WP2768;MyD88 dependent cascade initiated on endosome
TTDC00222;WP2794;Cytosolic sensors of pathogen-associated DNA
TTDC00222;WP2795;Cardiac Hypertrophic Response
TTDC00222;WP2801;MyD88 cascade initiated on plasma membrane
TTDC00222;WP2804;Hair Follicle Development: Induction (Part 1 of 3)
TTDC00222;WP288;NLR Proteins
TTDC00222;WP382;MAPK Signaling Pathway
TTDC00222;WP395;IL-4 Signaling Pathway
TTDC00222;WP481;Insulin Signaling
TTDC00222;WP69;TCR Signaling Pathway
TTDC00222;WP712;Estrogen signaling pathway
TTDC00222;WP75;Toll-like receptor signaling pathway
TTDC00224;WP12;Osteoclast Signaling
TTDC00224;WP2018;RANKL/RANK Signaling Pathway
TTDC00224;WP2848;Differentiation Pathway
TTDC00224;WP2877;Vitamin D Receptor Pathway
TTDC00224;WP322;Osteoblast Signaling
TTDC00225;WP1824;GPCR downstream signaling
TTDC00225;WP1825;GPCR ligand binding
TTDC00225;WP2431;Spinal Cord Injury
TTDC00225;WP530;Cytokines and Inflammatory Response
TTDC00226;WP1824;GPCR downstream signaling
TTDC00226;WP1825;GPCR ligand binding
TTDC00226;WP24;Peptide GPCRs
TTDC00226;WP455;GPCRs, Class A Rhodopsin-like
TTDC00227;WP2882;Nuclear Receptors Meta-Pathway
TTDC00227;WP2884;NRF2 pathway
TTDC00228;WP107;Translation Factors
TTDC00228;WP1812;Eukaryotic Translation Initiation
TTDC00228;WP1889;Processing of Capped Intron-Containing Pre-mRNA
TTDC00228;WP1913;Signaling by Insulin receptor
TTDC00228;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDC00228;WP2005;miR-targeted genes in muscle cell - TarBase
TTDC00228;WP2034;Leptin signaling pathway
TTDC00228;WP2380;BDNF signaling pathway
TTDC00228;WP2637;Structural Pathway of Interleukin 1 (IL-1)
TTDC00228;WP2659;Deadenylation-dependent mRNA decay
TTDC00228;WP2672;ISG15 antiviral mechanism
TTDC00228;WP2677;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
TTDC00228;WP481;Insulin Signaling
TTDC00228;WP516;Hypertrophy Model
TTDC00228;WP585;Interferon type I signaling pathways
TTDC00230;WP117;GPCRs, Other
TTDC00230;WP24;Peptide GPCRs
TTDC00230;WP455;GPCRs, Class A Rhodopsin-like
TTDC00231;WP1824;GPCR downstream signaling
TTDC00231;WP1825;GPCR ligand binding
TTDC00231;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDC00232;WP1879;Phase 1 - Functionalization of compounds
TTDC00232;WP236;Adipogenesis
TTDC00232;WP299;Nuclear Receptors in Lipid Metabolism and Toxicity
TTDC00232;WP43;Oxidation by Cytochrome P450
TTDC00232;WP702;Metapathway biotransformation
TTDC00232;WP716;Vitamin A and Carotenoid Metabolism
TTDC00234;WP1772;Apoptosis Modulation and Signaling
TTDC00234;WP1839;Interleukin-1 signaling
TTDC00234;WP382;MAPK Signaling Pathway
TTDC00237;WP1824;GPCR downstream signaling
TTDC00237;WP1825;GPCR ligand binding
TTDC00237;WP455;GPCRs, Class A Rhodopsin-like
TTDC00239;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDC00240;WP1831;Integration of energy metabolism
TTDC00240;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDC00241;WP1471;TOR Signaling
TTDC00243;WP1935;Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds
TTDC00244;WP1772;Apoptosis Modulation and Signaling
TTDC00244;WP254;Apoptosis
TTDC00247;WP1539;Angiogenesis
TTDC00247;WP1794;Cell surface interactions at the vascular wall
TTDC00250;WP2380;BDNF signaling pathway
TTDC00250;WP2447;Amyotrophic lateral sclerosis (ALS)
TTDC00250;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDC00250;WP666;Hypothetical Network for Drug Addiction
TTDC00251;WP530;Cytokines and Inflammatory Response
TTDC00253;WP1824;GPCR downstream signaling
TTDC00253;WP1825;GPCR ligand binding
TTDC00253;WP24;Peptide GPCRs
TTDC00253;WP455;GPCRs, Class A Rhodopsin-like
TTDC00254;WP1824;GPCR downstream signaling
TTDC00254;WP1825;GPCR ligand binding
TTDC00254;WP24;Peptide GPCRs
TTDC00254;WP455;GPCRs, Class A Rhodopsin-like
TTDC00255;WP1455;Serotonin Transporter Activity
TTDC00255;WP2267;Synaptic Vesicle Pathway
TTDC00255;WP2882;Nuclear Receptors Meta-Pathway
TTDC00255;WP2884;NRF2 pathway
TTDC00255;WP706;SIDS Susceptibility Pathways
TTDC00255;WP727;Monoamine Transport
TTDC00256;WP1775;Cell Cycle Checkpoints
TTDC00256;WP179;Cell Cycle
TTDC00256;WP1815;Factors involved in megakaryocyte development and platelet production
TTDC00256;WP1858;Mitotic G1-G1/S phases
TTDC00256;WP1859;Mitotic G2-G2/M phases
TTDC00256;WP1984;Integrated Breast Cancer Pathway
TTDC00256;WP2446;Retinoblastoma (RB) in Cancer
TTDC00256;WP2772;S Phase
TTDC00256;WP45;G1 to S cell cycle control
TTDC00257;WP236;Adipogenesis
TTDC00258;WP117;GPCRs, Other
TTDC00258;WP1824;GPCR downstream signaling
TTDC00258;WP1825;GPCR ligand binding
TTDC00258;WP247;Small Ligand GPCRs
TTDC00258;WP26;Signal Transduction of S1P Receptor
TTDC00259;WP1799;Costimulation by the CD28 family
TTDC00259;WP2328;Allograft Rejection
TTDC00259;WP2583;T-Cell Receptor and Co-stimulatory Signaling
TTDC00259;WP2877;Vitamin D Receptor Pathway
TTDC00260;WP1848;Metabolism of carbohydrates
TTDC00260;WP1935;Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds
TTDC00260;WP2882;Nuclear Receptors Meta-Pathway
TTDC00260;WP2884;NRF2 pathway
TTDC00263;WP176;Folate Metabolism
TTDC00263;WP2005;miR-targeted genes in muscle cell - TarBase
TTDC00263;WP2848;Differentiation Pathway
TTDC00263;WP2849;Hematopoietic Stem Cell Differentiation
TTDC00263;WP530;Cytokines and Inflammatory Response
TTDC00265;WP1799;Costimulation by the CD28 family
TTDC00265;WP1927;TCR signaling
TTDC00265;WP2658;HIV Life Cycle
TTDC00265;WP2671;Defensins
TTDC00265;WP2684;Host Interactions of HIV factors
TTDC00265;WP530;Cytokines and Inflammatory Response
TTDC00265;WP69;TCR Signaling Pathway
TTDC00266;WP1530;miRNA Regulation of DNA Damage Response
TTDC00266;WP1772;Apoptosis Modulation and Signaling
TTDC00266;WP1814;Extrinsic Pathway for Apoptosis
TTDC00266;WP2002;miR-targeted genes in epithelium - TarBase
TTDC00266;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDC00266;WP2005;miR-targeted genes in muscle cell - TarBase
TTDC00266;WP2006;miR-targeted genes in squamous cell - TarBase
TTDC00266;WP254;Apoptosis
TTDC00266;WP2864;Apoptosis-related network due to altered Notch3 in ovarian cancer
TTDC00266;WP707;DNA Damage Response
TTDC00267;WP1772;Apoptosis Modulation and Signaling
TTDC00267;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDC00269;WP2733;Regulation of mRNA Stability by Proteins that Bind AU-rich Elements
TTDC00269;WP2864;Apoptosis-related network due to altered Notch3 in ovarian cancer
TTDC00269;WP314;FAS pathway and Stress induction of HSP regulation
TTDC00269;WP382;MAPK Signaling Pathway
TTDC00269;WP400;p38 MAPK Signaling Pathway
TTDC00271;WP127;IL-5 Signaling Pathway
TTDC00271;WP1530;miRNA Regulation of DNA Damage Response
TTDC00271;WP1545;miRNAs involved in DNA damage response
TTDC00271;WP1742;TP53 Network
TTDC00271;WP1858;Mitotic G1-G1/S phases
TTDC00271;WP1971;Integrated Cancer pathway
TTDC00271;WP1984;Integrated Breast Cancer Pathway
TTDC00271;WP2032;TSH signaling pathway
TTDC00271;WP205;IL-7 Signaling Pathway
TTDC00271;WP2064;Neural Crest Differentiation
TTDC00271;WP2203;TSLP Signaling Pathway
TTDC00271;WP2249;Metastatic brain tumor
TTDC00271;WP2263;Prostate Cancer
TTDC00271;WP2363;Gastric cancer network 2
TTDC00271;WP2377;Integrated Pancreatic Cancer Pathway
TTDC00271;WP23;B Cell Receptor Signaling Pathway
TTDC00271;WP2431;Spinal Cord Injury
TTDC00271;WP2446;Retinoblastoma (RB) in Cancer
TTDC00271;WP254;Apoptosis
TTDC00271;WP2571;Polycystic Kidney Disease Pathway
TTDC00271;WP2586;Aryl Hydrocarbon Receptor
TTDC00271;WP2637;Structural Pathway of Interleukin 1 (IL-1)
TTDC00271;WP2720;Signaling by NOTCH1
TTDC00271;WP2755;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
TTDC00271;WP2772;S Phase
TTDC00271;WP2804;Hair Follicle Development: Induction (Part 1 of 3)
TTDC00271;WP2815;Mammary gland development pathway - Involution (Stage 4 of 4)
TTDC00271;WP2828;Bladder Cancer
TTDC00271;WP2839;Hair Follicle Development: Organogenesis (Part 2 of 3)
TTDC00271;WP2858;Ectoderm Differentiation
TTDC00271;WP2877;Vitamin D Receptor Pathway
TTDC00271;WP2878;PPAR Alpha Pathway
TTDC00271;WP2882;Nuclear Receptors Meta-Pathway
TTDC00271;WP363;Wnt Signaling Pathway Netpath
TTDC00271;WP366;TGF beta Signaling Pathway
TTDC00271;WP382;MAPK Signaling Pathway
TTDC00271;WP399;Wnt Signaling Pathway and Pluripotency
TTDC00271;WP400;p38 MAPK Signaling Pathway
TTDC00271;WP428;Wnt Signaling Pathway
TTDC00271;WP45;G1 to S cell cycle control
TTDC00271;WP49;IL-2 Signaling Pathway
TTDC00271;WP61;Notch Signaling Pathway
TTDC00271;WP673;ErbB Signaling Pathway
TTDC00271;WP707;DNA Damage Response
TTDC00271;WP710;DNA Damage Response (only ATM dependent)
TTDC00272;WP2666;Elastic fibre formation
TTDC00272;WP2703;Extracellular matrix organization
TTDC00272;WP2870;Extracellular vesicle-mediated signaling in recipient cells
TTDC00272;WP2877;Vitamin D Receptor Pathway
TTDC00272;WP2882;Nuclear Receptors Meta-Pathway
TTDC00272;WP2884;NRF2 pathway
TTDC00272;WP382;MAPK Signaling Pathway
TTDC00272;WP400;p38 MAPK Signaling Pathway
TTDC00272;WP474;Endochondral Ossification
TTDC00273;WP1772;Apoptosis Modulation and Signaling
TTDC00273;WP2332;Interleukin-11 Signaling Pathway
TTDC00273;WP254;Apoptosis
TTDC00273;WP2652;Mitotic Prometaphase
TTDC00273;WP2757;Mitotic Metaphase and Anaphase
TTDC00273;WP2864;Apoptosis-related network due to altered Notch3 in ovarian cancer
TTDC00273;WP395;IL-4 Signaling Pathway
TTDC00280;WP1433;NOD pathway
TTDC00280;WP1772;Apoptosis Modulation and Signaling
TTDC00280;WP1841;Intrinsic Pathway for Apoptosis
TTDC00280;WP254;Apoptosis
TTDC00280;WP306;Focal Adhesion
TTDC00280;WP3286;Copper homeostasis
TTDC00290;WP1919;Signaling by VEGF
TTDC00291;WP117;GPCRs, Other
TTDC00291;WP1602;Nicotine Activity on Dopaminergic Neurons
TTDC00291;WP1824;GPCR downstream signaling
TTDC00291;WP1825;GPCR ligand binding
TTDC00291;WP2636;Genes and (Common) Pathways Underlying Drug Addiction
TTDC00291;WP455;GPCRs, Class A Rhodopsin-like
TTDC00291;WP58;Monoamine GPCRs
TTDC00291;WP666;Hypothetical Network for Drug Addiction
TTDC00292;WP1403;AMPK Signaling
TTDC00292;WP1824;GPCR downstream signaling
TTDC00292;WP1825;GPCR ligand binding
TTDC00292;WP2197;Endothelin Pathways
TTDC00292;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDC00292;WP455;GPCRs, Class A Rhodopsin-like
TTDC00292;WP536;Calcium Regulation in the Cardiac Cell
TTDC00292;WP58;Monoamine GPCRs
TTDC00293;WP1824;GPCR downstream signaling
TTDC00293;WP1825;GPCR ligand binding
TTDC00293;WP1884;Platelet Aggregation (Plug Formation)
TTDC00293;WP455;GPCRs, Class A Rhodopsin-like
TTDC00293;WP58;Monoamine GPCRs
TTDC00295;WP2764;Lipid digestion, mobilization, and transport
TTDC00295;WP2776;Visual phototransduction
TTDC00298;WP1824;GPCR downstream signaling
TTDC00298;WP1825;GPCR ligand binding
TTDC00298;WP24;Peptide GPCRs
TTDC00298;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDC00298;WP455;GPCRs, Class A Rhodopsin-like
TTDC00299;WP2380;BDNF signaling pathway
TTDC00299;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDC00299;WP666;Hypothetical Network for Drug Addiction
TTDC00301;WP1602;Nicotine Activity on Dopaminergic Neurons
TTDC00301;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDC00301;WP706;SIDS Susceptibility Pathways
TTDC00303;WP2669;Potassium Channels
TTDC00304;WP1935;Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds
TTDC00304;WP2882;Nuclear Receptors Meta-Pathway
TTDC00304;WP2884;NRF2 pathway
TTDC00304;WP727;Monoamine Transport
TTDC00310;WP127;IL-5 Signaling Pathway
TTDC00310;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDC00310;WP1823;GP1b-IX-V activation signalling
TTDC00310;WP185;Integrin-mediated Cell Adhesion
TTDC00310;WP1895;Rap1 signalling
TTDC00310;WP2032;TSH signaling pathway
TTDC00310;WP2034;Leptin signaling pathway
TTDC00310;WP2035;FSH signaling pathway
TTDC00310;WP2036;TWEAK Signaling Pathway
TTDC00310;WP2197;Endothelin Pathways
TTDC00310;WP2261;Signaling Pathways in Glioblastoma
TTDC00310;WP2263;Prostate Cancer
TTDC00310;WP231;TNF alpha Signaling Pathway
TTDC00310;WP2324;AGE/RAGE pathway
TTDC00310;WP2332;Interleukin-11 Signaling Pathway
TTDC00310;WP2355;Corticotropin-releasing hormone
TTDC00310;WP2374;Oncostatin M Signaling Pathway
TTDC00310;WP2377;Integrated Pancreatic Cancer Pathway
TTDC00310;WP2380;BDNF signaling pathway
TTDC00310;WP23;B Cell Receptor Signaling Pathway
TTDC00310;WP2446;Retinoblastoma (RB) in Cancer
TTDC00310;WP2526;PDGF Pathway
TTDC00310;WP2586;Aryl Hydrocarbon Receptor
TTDC00310;WP2643;Nanoparticle-mediated activation of receptor signaling
TTDC00310;WP2670;Iron uptake and transport
TTDC00310;WP2735;RAF/MAP kinase cascade
TTDC00310;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDC00310;WP2795;Cardiac Hypertrophic Response
TTDC00310;WP286;IL-3 Signaling Pathway
TTDC00310;WP2870;Extracellular vesicle-mediated signaling in recipient cells
TTDC00310;WP304;Kit receptor signaling pathway
TTDC00310;WP306;Focal Adhesion
TTDC00310;WP313;Signaling of Hepatocyte Growth Factor Receptor
TTDC00310;WP366;TGF beta Signaling Pathway
TTDC00310;WP382;MAPK Signaling Pathway
TTDC00310;WP422;MAPK Cascade
TTDC00310;WP437;EGF/EGFR Signaling Pathway
TTDC00310;WP481;Insulin Signaling
TTDC00310;WP49;IL-2 Signaling Pathway
TTDC00310;WP51;Regulation of Actin Cytoskeleton
TTDC00310;WP581;EPO Receptor Signaling
TTDC00310;WP615;Senescence and Autophagy in Cancer
TTDC00310;WP69;TCR Signaling Pathway
TTDC00310;WP732;Serotonin Receptor 2 and ELK-SRF/GATA4 signaling
TTDC00311;WP1539;Angiogenesis
TTDC00311;WP1916;Signaling by PDGF
TTDC00311;WP2261;Signaling Pathways in Glioblastoma
TTDC00311;WP2328;Allograft Rejection
TTDC00311;WP2377;Integrated Pancreatic Cancer Pathway
TTDC00311;WP2406;Cardiac Progenitor Differentiation
TTDC00311;WP2653;PIP3 activates AKT signaling
TTDC00311;WP2839;Hair Follicle Development: Organogenesis (Part 2 of 3)
TTDC00311;WP306;Focal Adhesion
TTDC00311;WP322;Osteoblast Signaling
TTDC00311;WP51;Regulation of Actin Cytoskeleton
TTDC00312;WP1434;Osteopontin Signaling
TTDC00312;WP1802;Dissolution of Fibrin Clot
TTDC00312;WP272;Blood Clotting Cascade
TTDC00312;WP399;Wnt Signaling Pathway and Pluripotency
TTDC00312;WP428;Wnt Signaling Pathway
TTDC00312;WP474;Endochondral Ossification
TTDC00312;WP558;Complement and Coagulation Cascades
TTDC00312;WP615;Senescence and Autophagy in Cancer
TTDC00312;WP710;DNA Damage Response (only ATM dependent)
TTDC00313;WP143;Fatty Acid Beta Oxidation
TTDC00313;WP1817;Fatty acid, triacylglycerol, and ketone body metabolism
TTDC00313;WP2693;Metabolism of amino acids and derivatives
TTDC00313;WP311;Synthesis and Degradation of Ketone Bodies
TTDC00313;WP465;Tryptophan metabolism
TTDC00314;WP1824;GPCR downstream signaling
TTDC00314;WP1825;GPCR ligand binding
TTDC00314;WP247;Small Ligand GPCRs
TTDC00314;WP455;GPCRs, Class A Rhodopsin-like
TTDC00318;WP1873;NGF signalling via TRKA from the plasma membrane
TTDC00318;WP2377;Integrated Pancreatic Cancer Pathway
TTDC00318;WP2380;BDNF signaling pathway
TTDC00318;WP382;MAPK Signaling Pathway
TTDC00319;WP127;IL-5 Signaling Pathway
TTDC00319;WP1438;Influenza A virus infection
TTDC00319;WP1742;TP53 Network
TTDC00319;WP1772;Apoptosis Modulation and Signaling
TTDC00319;WP1841;Intrinsic Pathway for Apoptosis
TTDC00319;WP1971;Integrated Cancer pathway
TTDC00319;WP1984;Integrated Breast Cancer Pathway
TTDC00319;WP2003;miR-targeted genes in leukocytes - TarBase
TTDC00319;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDC00319;WP2005;miR-targeted genes in muscle cell - TarBase
TTDC00319;WP2263;Prostate Cancer
TTDC00319;WP2332;Interleukin-11 Signaling Pathway
TTDC00319;WP2355;Corticotropin-releasing hormone
TTDC00319;WP2377;Integrated Pancreatic Cancer Pathway
TTDC00319;WP2447;Amyotrophic lateral sclerosis (ALS)
TTDC00319;WP2509;Nanoparticle triggered autophagic cell death
TTDC00319;WP254;Apoptosis
TTDC00319;WP2763;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
TTDC00319;WP286;IL-3 Signaling Pathway
TTDC00319;WP304;Kit receptor signaling pathway
TTDC00319;WP306;Focal Adhesion
TTDC00319;WP314;FAS pathway and Stress induction of HSP regulation
TTDC00319;WP49;IL-2 Signaling Pathway
TTDC00319;WP615;Senescence and Autophagy in Cancer
TTDC00319;WP710;DNA Damage Response (only ATM dependent)
TTDC00319;WP712;Estrogen signaling pathway
TTDC00325;WP1533;Vitamin B12 Metabolism
TTDC00325;WP15;Selenium Micronutrient Network
TTDC00325;WP176;Folate Metabolism
TTDC00325;WP2324;AGE/RAGE pathway
TTDC00325;WP2436;Dopamine metabolism
TTDC00325;WP2447;Amyotrophic lateral sclerosis (ALS)
TTDC00325;WP259;Nifedipine Activity
TTDC00325;WP2824;Detoxification of Reactive Oxygen Species
TTDC00325;WP3286;Copper homeostasis
TTDC00325;WP408;Oxidative Stress
TTDC00326;WP1798;Complement cascade
TTDC00326;WP236;Adipogenesis
TTDC00326;WP2806;Human Complement System
TTDC00326;WP558;Complement and Coagulation Cascades
TTDC00327;WP254;Apoptosis
TTDC00328;WP2764;Lipid digestion, mobilization, and transport
TTDC00328;WP2776;Visual phototransduction
TTDC00328;WP2878;PPAR Alpha Pathway
TTDC00328;WP2882;Nuclear Receptors Meta-Pathway
TTDC00328;WP430;Statin Pathway
TTDC00329;WP2703;Extracellular matrix organization
TTDC00329;WP2776;Visual phototransduction
TTDC00330;WP1818;Formation of Fibrin Clot (Clotting Cascade)
TTDC00330;WP272;Blood Clotting Cascade
TTDC00330;WP2806;Human Complement System
TTDC00331;WP1533;Vitamin B12 Metabolism
TTDC00331;WP15;Selenium Micronutrient Network
TTDC00331;WP176;Folate Metabolism
TTDC00331;WP1794;Cell surface interactions at the vascular wall
TTDC00331;WP1885;Platelet homeostasis
TTDC00331;WP2764;Lipid digestion, mobilization, and transport
TTDC00331;WP2776;Visual phototransduction
TTDC00331;WP2784;Binding and Uptake of Ligands by Scavenger Receptors
TTDC00331;WP430;Statin Pathway
TTDC00332;WP138;Androgen receptor signaling pathway
TTDC00332;WP170;Nuclear Receptors
TTDC00332;WP1984;Integrated Breast Cancer Pathway
TTDC00332;WP2263;Prostate Cancer
TTDC00332;WP2377;Integrated Pancreatic Cancer Pathway
TTDC00332;WP706;SIDS Susceptibility Pathways
TTDC00333;WP236;Adipogenesis
TTDC00333;WP2657;Growth hormone receptor signaling
TTDC00333;WP2678;Prolactin receptor signaling
TTDC00333;WP34;Ovarian Infertility Genes
TTDC00334;WP1539;Angiogenesis
TTDC00334;WP1919;Signaling by VEGF
TTDC00334;WP306;Focal Adhesion
TTDC00335;WP2738;YAP1- and WWTR1 (TAZ)-stimulated gene expression
TTDC00335;WP2797;Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
TTDC00335;WP2804;Hair Follicle Development: Induction (Part 1 of 3)
TTDC00335;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDC00336;WP1935;Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds
TTDC00336;WP2882;Nuclear Receptors Meta-Pathway
TTDC00336;WP2884;NRF2 pathway
TTDC00339;WP1842;Kinesins
TTDC00339;WP2679;MHC class II antigen presentation
TTDC00341;WP2659;Deadenylation-dependent mRNA decay
TTDC00342;WP1885;Platelet homeostasis
TTDC00342;WP2746;Signaling by the B Cell Receptor (BCR)
TTDC00343;WP1793;Cell junction organization
TTDC00344;WP117;GPCRs, Other
TTDC00344;WP1825;GPCR ligand binding
TTDC00344;WP2377;Integrated Pancreatic Cancer Pathway
TTDC00344;WP2804;Hair Follicle Development: Induction (Part 1 of 3)
TTDC00344;WP2839;Hair Follicle Development: Organogenesis (Part 2 of 3)
TTDC00344;WP47;Hedgehog Signaling Pathway
TTDC00345;WP2657;Growth hormone receptor signaling
TTDC00345;WP2678;Prolactin receptor signaling
TTDC00345;WP474;Endochondral Ossification
TTDI00319;WP1851;Metabolism of nucleotides
TTDI00319;WP2002;miR-targeted genes in epithelium - TarBase
TTDI00319;WP2003;miR-targeted genes in leukocytes - TarBase
TTDI00319;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDI00319;WP2006;miR-targeted genes in squamous cell - TarBase
TTDI00342;WP1824;GPCR downstream signaling
TTDI00342;WP1825;GPCR ligand binding
TTDI00342;WP2406;Cardiac Progenitor Differentiation
TTDI00342;WP24;Peptide GPCRs
TTDI00342;WP2658;HIV Life Cycle
TTDI00342;WP2849;Hematopoietic Stem Cell Differentiation
TTDI00342;WP455;GPCRs, Class A Rhodopsin-like
TTDI00350;WP127;IL-5 Signaling Pathway
TTDI00350;WP138;Androgen receptor signaling pathway
TTDI00350;WP1403;AMPK Signaling
TTDI00350;WP1449;Regulation of toll-like receptor signaling pathway
TTDI00350;WP1471;TOR Signaling
TTDI00350;WP1539;Angiogenesis
TTDI00350;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDI00350;WP1559;TFs Regulate miRNAs related to cardiac hypertrophy
TTDI00350;WP1850;Metabolism of nitric oxide
TTDI00350;WP185;Integrin-mediated Cell Adhesion
TTDI00350;WP195;IL-1 signaling pathway
TTDI00350;WP1971;Integrated Cancer pathway
TTDI00350;WP1982;SREBP signalling
TTDI00350;WP1984;Integrated Breast Cancer Pathway
TTDI00350;WP2018;RANKL/RANK Signaling Pathway
TTDI00350;WP2032;TSH signaling pathway
TTDI00350;WP2034;Leptin signaling pathway
TTDI00350;WP2035;FSH signaling pathway
TTDI00350;WP2036;TWEAK Signaling Pathway
TTDI00350;WP2038;Regulation of Microtubule Cytoskeleton
TTDI00350;WP205;IL-7 Signaling Pathway
TTDI00350;WP2112;IL17 signaling pathway
TTDI00350;WP2203;TSLP Signaling Pathway
TTDI00350;WP2261;Signaling Pathways in Glioblastoma
TTDI00350;WP2263;Prostate Cancer
TTDI00350;WP231;TNF alpha Signaling Pathway
TTDI00350;WP2324;AGE/RAGE pathway
TTDI00350;WP2332;Interleukin-11 Signaling Pathway
TTDI00350;WP2355;Corticotropin-releasing hormone
TTDI00350;WP2374;Oncostatin M Signaling Pathway
TTDI00350;WP2377;Integrated Pancreatic Cancer Pathway
TTDI00350;WP2380;BDNF signaling pathway
TTDI00350;WP23;B Cell Receptor Signaling Pathway
TTDI00350;WP244;Alpha 6 Beta 4 signaling pathway
TTDI00350;WP254;Apoptosis
TTDI00350;WP2572;Primary Focal Segmental Glomerulosclerosis FSGS
TTDI00350;WP2583;T-Cell Receptor and Co-stimulatory Signaling
TTDI00350;WP2653;PIP3 activates AKT signaling
TTDI00350;WP26;Signal Transduction of S1P Receptor
TTDI00350;WP2733;Regulation of mRNA Stability by Proteins that Bind AU-rich Elements
TTDI00350;WP2777;Translocation of GLUT4 to the Plasma Membrane
TTDI00350;WP2795;Cardiac Hypertrophic Response
TTDI00350;WP2864;Apoptosis-related network due to altered Notch3 in ovarian cancer
TTDI00350;WP286;IL-3 Signaling Pathway
TTDI00350;WP2870;Extracellular vesicle-mediated signaling in recipient cells
TTDI00350;WP304;Kit receptor signaling pathway
TTDI00350;WP306;Focal Adhesion
TTDI00350;WP3286;Copper homeostasis
TTDI00350;WP363;Wnt Signaling Pathway Netpath
TTDI00350;WP364;IL-6 signaling pathway
TTDI00350;WP366;TGF beta Signaling Pathway
TTDI00350;WP382;MAPK Signaling Pathway
TTDI00350;WP395;IL-4 Signaling Pathway
TTDI00350;WP437;EGF/EGFR Signaling Pathway
TTDI00350;WP474;Endochondral Ossification
TTDI00350;WP481;Insulin Signaling
TTDI00350;WP49;IL-2 Signaling Pathway
TTDI00350;WP581;EPO Receptor Signaling
TTDI00350;WP61;Notch Signaling Pathway
TTDI00350;WP69;TCR Signaling Pathway
TTDI00350;WP710;DNA Damage Response (only ATM dependent)
TTDI00350;WP712;Estrogen signaling pathway
TTDI00350;WP75;Toll-like receptor signaling pathway
TTDI00462;WP1824;GPCR downstream signaling
TTDI00462;WP1825;GPCR ligand binding
TTDI00587;WP1850;Metabolism of nitric oxide
TTDI00605;WP1787;Base Excision Repair
TTDI00605;WP179;Cell Cycle
TTDI00605;WP1858;Mitotic G1-G1/S phases
TTDI00605;WP1925;Synthesis of DNA
TTDI00605;WP1928;Telomere Maintenance
TTDI00605;WP1980;Nucleotide Excision Repair
TTDI00605;WP2377;Integrated Pancreatic Cancer Pathway
TTDI00605;WP2446;Retinoblastoma (RB) in Cancer
TTDI00605;WP2572;Primary Focal Segmental Glomerulosclerosis FSGS
TTDI00605;WP259;Nifedipine Activity
TTDI00605;WP2772;S Phase
TTDI00605;WP437;EGF/EGFR Signaling Pathway
TTDI00605;WP45;G1 to S cell cycle control
TTDI00605;WP466;DNA Replication
TTDI00605;WP531;Mismatch repair
TTDI00605;WP615;Senescence and Autophagy in Cancer
TTDI00607;WP167;Eicosanoid Synthesis
TTDI00607;WP2650;Arachidonic acid metabolism
TTDI00641;WP1911;Signaling by FGFR
TTDI00641;WP231;TNF alpha Signaling Pathway
TTDI00641;WP2380;BDNF signaling pathway
TTDI00641;WP2436;Dopamine metabolism
TTDI00641;WP2710;Nonsense-Mediated Decay
TTDI00641;WP2757;Mitotic Metaphase and Anaphase
TTDI00641;WP2857;Mesodermal Commitment Pathway
TTDI00641;WP399;Wnt Signaling Pathway and Pluripotency
TTDI00641;WP500;Glycogen Metabolism
TTDI00711;WP2776;Visual phototransduction
TTDI00747;WP1982;SREBP signalling
TTDI00747;WP2011;SREBF and miR33 in cholesterol and lipid homeostasis
TTDI00747;WP236;Adipogenesis
TTDI00747;WP2874;Liver X Receptor Pathway
TTDI00747;WP2882;Nuclear Receptors Meta-Pathway
TTDI00747;WP357;Fatty Acid Biosynthesis
TTDI00816;WP100;Glutathione metabolism
TTDI00816;WP15;Selenium Micronutrient Network
TTDI00816;WP2882;Nuclear Receptors Meta-Pathway
TTDI00816;WP2884;NRF2 pathway
TTDI00816;WP408;Oxidative Stress
TTDI00816;WP692;Sulfation Biotransformation Reaction
TTDI00816;WP702;Metapathway biotransformation
TTDI00862;WP1851;Metabolism of nucleotides
TTDI00909;WP2670;Iron uptake and transport
TTDI00909;WP289;Myometrial Relaxation and Contraction Pathways
TTDI00909;WP536;Calcium Regulation in the Cardiac Cell
TTDI00915;WP2729;Metabolism of Angiotensinogen to Angiotensins
TTDI00915;WP554;ACE Inhibitor Pathway
TTDI00931;WP1601;Fluoropyrimidine Activity
TTDI00931;WP176;Folate Metabolism
TTDI00931;WP1850;Metabolism of nitric oxide
TTDI00931;WP1857;Metabolism of water-soluble vitamins and cofactors
TTDI00931;WP241;One Carbon Metabolism
TTDI00931;WP2446;Retinoblastoma (RB) in Cancer
TTDI00931;WP2525;Trans-sulfuration and one carbon metabolism
TTDI00931;WP404;Nucleotide Metabolism
TTDI00939;WP170;Nuclear Receptors
TTDI00939;WP1984;Integrated Breast Cancer Pathway
TTDI00939;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI00939;WP2034;Leptin signaling pathway
TTDI00939;WP2377;Integrated Pancreatic Cancer Pathway
TTDI00939;WP2586;Aryl Hydrocarbon Receptor
TTDI00939;WP2593;JAK/STAT
TTDI00939;WP2781;Signaling by ERBB4
TTDI00939;WP2881;Estrogen Receptor Pathway
TTDI00939;WP2882;Nuclear Receptors Meta-Pathway
TTDI00939;WP712;Estrogen signaling pathway
TTDI00956;WP15;Selenium Micronutrient Network
TTDI00964;WP1601;Fluoropyrimidine Activity
TTDI00964;WP1851;Metabolism of nucleotides
TTDI00964;WP2002;miR-targeted genes in epithelium - TarBase
TTDI00964;WP2003;miR-targeted genes in leukocytes - TarBase
TTDI00964;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDI00964;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI00964;WP2377;Integrated Pancreatic Cancer Pathway
TTDI00964;WP241;One Carbon Metabolism
TTDI00964;WP2446;Retinoblastoma (RB) in Cancer
TTDI00964;WP2525;Trans-sulfuration and one carbon metabolism
TTDI00965;WP1795;Cholesterol biosynthesis
TTDI00965;WP197;Cholesterol Biosynthesis
TTDI00965;WP1982;SREBP signalling
TTDI00965;WP2706;Activation of Gene Expression by SREBP (SREBF)
TTDI00965;WP430;Statin Pathway
TTDI00967;WP1892;Protein folding
TTDI00967;WP2272;Pathogenic Escherichia coli infection
TTDI00967;WP2359;Parkin-Ubiquitin Proteasomal System pathway
TTDI00990;WP197;Cholesterol Biosynthesis
TTDI00990;WP1982;SREBP signalling
TTDI00990;WP2706;Activation of Gene Expression by SREBP (SREBF)
TTDI01008;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDI01008;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI01008;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDI01014;WP1403;AMPK Signaling
TTDI01014;WP143;Fatty Acid Beta Oxidation
TTDI01022;WP1794;Cell surface interactions at the vascular wall
TTDI01022;WP1829;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
TTDI01022;WP1833;Integrin cell surface interactions
TTDI01022;WP185;Integrin-mediated Cell Adhesion
TTDI01022;WP306;Focal Adhesion
TTDI01040;WP1533;Vitamin B12 Metabolism
TTDI01040;WP15;Selenium Micronutrient Network
TTDI01040;WP176;Folate Metabolism
TTDI01040;WP1995;Effects of Nitric Oxide
TTDI01040;WP2681;Uptake of Oxygen and Release of Carbon Dioxide by Erythrocytes
TTDI01040;WP2744;Uptake of Carbon Dioxide and Release of Oxygen by Erythrocytes
TTDI01040;WP2784;Binding and Uptake of Ligands by Scavenger Receptors
TTDI01041;WP1533;Vitamin B12 Metabolism
TTDI01041;WP15;Selenium Micronutrient Network
TTDI01041;WP176;Folate Metabolism
TTDI01041;WP1815;Factors involved in megakaryocyte development and platelet production
TTDI01041;WP2681;Uptake of Oxygen and Release of Carbon Dioxide by Erythrocytes
TTDI01041;WP2744;Uptake of Carbon Dioxide and Release of Oxygen by Erythrocytes
TTDI01041;WP2784;Binding and Uptake of Ligands by Scavenger Receptors
TTDI01746;WP1449;Regulation of toll-like receptor signaling pathway
TTDI01746;WP2328;Allograft Rejection
TTDI01746;WP2873;Aryl Hydrocarbon Receptor Pathway
TTDI01746;WP2877;Vitamin D Receptor Pathway
TTDI01746;WP2882;Nuclear Receptors Meta-Pathway
TTDI01746;WP75;Toll-like receptor signaling pathway
TTDI01749;WP1824;GPCR downstream signaling
TTDI01749;WP1825;GPCR ligand binding
TTDI01749;WP2597;Secretion of Hydrochloric Acid in Parietal Cells
TTDI01749;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDI01749;WP455;GPCRs, Class A Rhodopsin-like
TTDI01749;WP51;Regulation of Actin Cytoskeleton
TTDI01749;WP536;Calcium Regulation in the Cardiac Cell
TTDI01749;WP58;Monoamine GPCRs
TTDI01750;WP1824;GPCR downstream signaling
TTDI01750;WP1825;GPCR ligand binding
TTDI01750;WP1831;Integration of energy metabolism
TTDI01750;WP1884;Platelet Aggregation (Plug Formation)
TTDI01750;WP455;GPCRs, Class A Rhodopsin-like
TTDI01750;WP58;Monoamine GPCRs
TTDI01752;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDI01753;WP1403;AMPK Signaling
TTDI01753;WP1817;Fatty acid, triacylglycerol, and ketone body metabolism
TTDI01753;WP1982;SREBP signalling
TTDI01753;WP2034;Leptin signaling pathway
TTDI01753;WP2355;Corticotropin-releasing hormone
TTDI01753;WP2593;JAK/STAT
TTDI01753;WP2706;Activation of Gene Expression by SREBP (SREBF)
TTDI01753;WP2853;Endoderm Differentiation
TTDI01753;WP2857;Mesodermal Commitment Pathway
TTDI01753;WP357;Fatty Acid Biosynthesis
TTDI01755;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDI01756;WP1824;GPCR downstream signaling
TTDI01756;WP1825;GPCR ligand binding
TTDI01756;WP2197;Endothelin Pathways
TTDI01756;WP455;GPCRs, Class A Rhodopsin-like
TTDI01756;WP536;Calcium Regulation in the Cardiac Cell
TTDI01756;WP58;Monoamine GPCRs
TTDI01760;WP129;Matrix Metalloproteinases
TTDI01760;WP2324;AGE/RAGE pathway
TTDI01760;WP2769;Activation of Matrix Metalloproteinases
TTDI01762;WP1403;AMPK Signaling
TTDI01762;WP1824;GPCR downstream signaling
TTDI01762;WP1825;GPCR ligand binding
TTDI01762;WP2197;Endothelin Pathways
TTDI01762;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDI01762;WP455;GPCRs, Class A Rhodopsin-like
TTDI01762;WP536;Calcium Regulation in the Cardiac Cell
TTDI01762;WP58;Monoamine GPCRs
TTDI01763;WP1824;GPCR downstream signaling
TTDI01763;WP1825;GPCR ligand binding
TTDI01763;WP2355;Corticotropin-releasing hormone
TTDI01763;WP289;Myometrial Relaxation and Contraction Pathways
TTDI01763;WP334;GPCRs, Class B Secretin-like
TTDI01764;WP1403;AMPK Signaling
TTDI01764;WP1824;GPCR downstream signaling
TTDI01764;WP1825;GPCR ligand binding
TTDI01764;WP2197;Endothelin Pathways
TTDI01764;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDI01764;WP455;GPCRs, Class A Rhodopsin-like
TTDI01764;WP536;Calcium Regulation in the Cardiac Cell
TTDI01764;WP58;Monoamine GPCRs
TTDI01765;WP1818;Formation of Fibrin Clot (Clotting Cascade)
TTDI01765;WP1832;Integrin alphaIIb beta3 signaling
TTDI01765;WP1833;Integrin cell surface interactions
TTDI01765;WP272;Blood Clotting Cascade
TTDI01765;WP2806;Human Complement System
TTDI01766;WP1824;GPCR downstream signaling
TTDI01766;WP1825;GPCR ligand binding
TTDI01766;WP247;Small Ligand GPCRs
TTDI01766;WP455;GPCRs, Class A Rhodopsin-like
TTDI01767;WP1794;Cell surface interactions at the vascular wall
TTDI01767;WP1840;Interleukin-3, 5 and GM-CSF signaling
TTDI01767;WP185;Integrin-mediated Cell Adhesion
TTDI01767;WP1866;NCAM signaling for neurite out-growth
TTDI01767;WP1873;NGF signalling via TRKA from the plasma membrane
TTDI01767;WP1910;Signaling by EGFR
TTDI01767;WP1911;Signaling by FGFR
TTDI01767;WP1913;Signaling by Insulin receptor
TTDI01767;WP1916;Signaling by PDGF
TTDI01767;WP2032;TSH signaling pathway
TTDI01767;WP2034;Leptin signaling pathway
TTDI01767;WP2261;Signaling Pathways in Glioblastoma
TTDI01767;WP2263;Prostate Cancer
TTDI01767;WP2290;RalA downstream regulated genes
TTDI01767;WP231;TNF alpha Signaling Pathway
TTDI01767;WP2332;Interleukin-11 Signaling Pathway
TTDI01767;WP2374;Oncostatin M Signaling Pathway
TTDI01767;WP2380;BDNF signaling pathway
TTDI01767;WP23;B Cell Receptor Signaling Pathway
TTDI01767;WP244;Alpha 6 Beta 4 signaling pathway
TTDI01767;WP2526;PDGF Pathway
TTDI01767;WP2586;Aryl Hydrocarbon Receptor
TTDI01767;WP2593;JAK/STAT
TTDI01767;WP2643;Nanoparticle-mediated activation of receptor signaling
TTDI01767;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDI01767;WP2677;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
TTDI01767;WP2694;DAP12 interactions
TTDI01767;WP2713;Signaling by SCF-KIT
TTDI01767;WP2732;Interleukin-2 signaling
TTDI01767;WP2735;RAF/MAP kinase cascade
TTDI01767;WP2746;Signaling by the B Cell Receptor (BCR)
TTDI01767;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDI01767;WP2759;Fc epsilon receptor (FCERI) signaling
TTDI01767;WP2780;Signaling by ERBB2
TTDI01767;WP2781;Signaling by ERBB4
TTDI01767;WP2828;Bladder Cancer
TTDI01767;WP286;IL-3 Signaling Pathway
TTDI01767;WP2870;Extracellular vesicle-mediated signaling in recipient cells
TTDI01767;WP304;Kit receptor signaling pathway
TTDI01767;WP306;Focal Adhesion
TTDI01767;WP313;Signaling of Hepatocyte Growth Factor Receptor
TTDI01767;WP35;G Protein Signaling Pathways
TTDI01767;WP400;p38 MAPK Signaling Pathway
TTDI01767;WP422;MAPK Cascade
TTDI01767;WP437;EGF/EGFR Signaling Pathway
TTDI01767;WP481;Insulin Signaling
TTDI01767;WP49;IL-2 Signaling Pathway
TTDI01767;WP560;TGF Beta Signaling Pathway
TTDI01767;WP615;Senescence and Autophagy in Cancer
TTDI01767;WP673;ErbB Signaling Pathway
TTDI01767;WP69;TCR Signaling Pathway
TTDI01767;WP710;DNA Damage Response (only ATM dependent)
TTDI01767;WP732;Serotonin Receptor 2 and ELK-SRF/GATA4 signaling
TTDI01768;WP1794;Cell surface interactions at the vascular wall
TTDI01768;WP1833;Integrin cell surface interactions
TTDI01768;WP1843;L1CAM interactions
TTDI01768;WP185;Integrin-mediated Cell Adhesion
TTDI01768;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDI01768;WP2666;Elastic fibre formation
TTDI01768;WP2703;Extracellular matrix organization
TTDI01768;WP306;Focal Adhesion
TTDI01769;WP1824;GPCR downstream signaling
TTDI01769;WP1825;GPCR ligand binding
TTDI01769;WP24;Peptide GPCRs
TTDI01769;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDI01769;WP2877;Vitamin D Receptor Pathway
TTDI01769;WP455;GPCRs, Class A Rhodopsin-like
TTDI01769;WP51;Regulation of Actin Cytoskeleton
TTDI01769;WP554;ACE Inhibitor Pathway
TTDI01769;WP558;Complement and Coagulation Cascades
TTDI01771;WP404;Nucleotide Metabolism
TTDI01772;WP1824;GPCR downstream signaling
TTDI01772;WP1825;GPCR ligand binding
TTDI01772;WP24;Peptide GPCRs
TTDI01772;WP455;GPCRs, Class A Rhodopsin-like
TTDI01773;WP1794;Cell surface interactions at the vascular wall
TTDI01773;WP231;TNF alpha Signaling Pathway
TTDI01773;WP2806;Human Complement System
TTDI01774;WP2670;Iron uptake and transport
TTDI01774;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDI01774;WP706;SIDS Susceptibility Pathways
TTDI01775;WP127;IL-5 Signaling Pathway
TTDI01775;WP1434;Osteopontin Signaling
TTDI01775;WP1449;Regulation of toll-like receptor signaling pathway
TTDI01775;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDI01775;WP1843;L1CAM interactions
TTDI01775;WP185;Integrin-mediated Cell Adhesion
TTDI01775;WP1911;Signaling by FGFR
TTDI01775;WP195;IL-1 signaling pathway
TTDI01775;WP2018;RANKL/RANK Signaling Pathway
TTDI01775;WP2032;TSH signaling pathway
TTDI01775;WP2034;Leptin signaling pathway
TTDI01775;WP205;IL-7 Signaling Pathway
TTDI01775;WP2197;Endothelin Pathways
TTDI01775;WP2203;TSLP Signaling Pathway
TTDI01775;WP2261;Signaling Pathways in Glioblastoma
TTDI01775;WP2263;Prostate Cancer
TTDI01775;WP22;IL-9 Signaling Pathway
TTDI01775;WP2324;AGE/RAGE pathway
TTDI01775;WP2332;Interleukin-11 Signaling Pathway
TTDI01775;WP2355;Corticotropin-releasing hormone
TTDI01775;WP2374;Oncostatin M Signaling Pathway
TTDI01775;WP2377;Integrated Pancreatic Cancer Pathway
TTDI01775;WP2380;BDNF signaling pathway
TTDI01775;WP23;B Cell Receptor Signaling Pathway
TTDI01775;WP2526;PDGF Pathway
TTDI01775;WP2586;Aryl Hydrocarbon Receptor
TTDI01775;WP259;Nifedipine Activity
TTDI01775;WP2636;Genes and (Common) Pathways Underlying Drug Addiction
TTDI01775;WP2637;Structural Pathway of Interleukin 1 (IL-1)
TTDI01775;WP2643;Nanoparticle-mediated activation of receptor signaling
TTDI01775;WP2735;RAF/MAP kinase cascade
TTDI01775;WP2792;MAP kinase activation in TLR cascade
TTDI01775;WP2795;Cardiac Hypertrophic Response
TTDI01775;WP2828;Bladder Cancer
TTDI01775;WP286;IL-3 Signaling Pathway
TTDI01775;WP304;Kit receptor signaling pathway
TTDI01775;WP306;Focal Adhesion
TTDI01775;WP313;Signaling of Hepatocyte Growth Factor Receptor
TTDI01775;WP364;IL-6 signaling pathway
TTDI01775;WP366;TGF beta Signaling Pathway
TTDI01775;WP382;MAPK Signaling Pathway
TTDI01775;WP422;MAPK Cascade
TTDI01775;WP437;EGF/EGFR Signaling Pathway
TTDI01775;WP481;Insulin Signaling
TTDI01775;WP49;IL-2 Signaling Pathway
TTDI01775;WP51;Regulation of Actin Cytoskeleton
TTDI01775;WP581;EPO Receptor Signaling
TTDI01775;WP615;Senescence and Autophagy in Cancer
TTDI01775;WP666;Hypothetical Network for Drug Addiction
TTDI01775;WP673;ErbB Signaling Pathway
TTDI01775;WP69;TCR Signaling Pathway
TTDI01775;WP712;Estrogen signaling pathway
TTDI01775;WP722;Serotonin HTR1 Group and FOS Pathway
TTDI01775;WP732;Serotonin Receptor 2 and ELK-SRF/GATA4 signaling
TTDI01775;WP734;Serotonin Receptor 4/6/7 and NR3C Signaling
TTDI01775;WP75;Toll-like receptor signaling pathway
TTDI01776;WP2858;Ectoderm Differentiation
TTDI01776;WP35;G Protein Signaling Pathways
TTDI01777;WP1782;APC/C-mediated degradation of cell cycle proteins
TTDI01777;WP1984;Integrated Breast Cancer Pathway
TTDI01777;WP2361;Gastric Cancer Network 1
TTDI01777;WP2593;JAK/STAT
TTDI01777;WP437;EGF/EGFR Signaling Pathway
TTDI01778;WP24;Peptide GPCRs
TTDI01778;WP455;GPCRs, Class A Rhodopsin-like
TTDI01779;WP1591;Heart Development
TTDI01779;WP1822;Generic Transcription Pathway
TTDI01779;WP1897;Regulation of beta-cell development
TTDI01779;WP2002;miR-targeted genes in epithelium - TarBase
TTDI01779;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDI01779;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI01779;WP2064;Neural Crest Differentiation
TTDI01779;WP2361;Gastric Cancer Network 1
TTDI01779;WP2406;Cardiac Progenitor Differentiation
TTDI01779;WP2572;Primary Focal Segmental Glomerulosclerosis FSGS
TTDI01779;WP268;Notch Signaling Pathway
TTDI01779;WP2720;Signaling by NOTCH1
TTDI01779;WP2786;Pre-NOTCH Expression and Processing
TTDI01779;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDI01779;WP2848;Differentiation Pathway
TTDI01779;WP2849;Hematopoietic Stem Cell Differentiation
TTDI01779;WP2853;Endoderm Differentiation
TTDI01779;WP2854;Gene regulatory network modelling somitogenesis
TTDI01779;WP61;Notch Signaling Pathway
TTDI01781;WP1434;Osteopontin Signaling
TTDI01781;WP1794;Cell surface interactions at the vascular wall
TTDI01781;WP1833;Integrin cell surface interactions
TTDI01781;WP1843;L1CAM interactions
TTDI01781;WP185;Integrin-mediated Cell Adhesion
TTDI01781;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDI01781;WP2572;Primary Focal Segmental Glomerulosclerosis FSGS
TTDI01781;WP2666;Elastic fibre formation
TTDI01781;WP2703;Extracellular matrix organization
TTDI01781;WP2787;Syndecan interactions
TTDI01781;WP2796;Class I MHC mediated antigen processing & presentation
TTDI01781;WP306;Focal Adhesion
TTDI01781;WP322;Osteoblast Signaling
TTDI01784;WP117;GPCRs, Other
TTDI01784;WP1824;GPCR downstream signaling
TTDI01784;WP1825;GPCR ligand binding
TTDI01784;WP1873;NGF signalling via TRKA from the plasma membrane
TTDI01784;WP455;GPCRs, Class A Rhodopsin-like
TTDI01784;WP727;Monoamine Transport
TTDI01784;WP80;Nucleotide GPCRs
TTDI01785;WP1824;GPCR downstream signaling
TTDI01785;WP1825;GPCR ligand binding
TTDI01785;WP2431;Spinal Cord Injury
TTDI01785;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDI01785;WP455;GPCRs, Class A Rhodopsin-like
TTDI01785;WP80;Nucleotide GPCRs
TTDI01786;WP1833;Integrin cell surface interactions
TTDI01786;WP1843;L1CAM interactions
TTDI01786;WP185;Integrin-mediated Cell Adhesion
TTDI01786;WP1883;Platelet Adhesion to exposed collagen
TTDI01786;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDI01786;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI01786;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDI01786;WP2332;Interleukin-11 Signaling Pathway
TTDI01786;WP2703;Extracellular matrix organization
TTDI01786;WP2806;Human Complement System
TTDI01786;WP306;Focal Adhesion
TTDI01786;WP366;TGF beta Signaling Pathway
TTDI01789;WP1794;Cell surface interactions at the vascular wall
TTDI01789;WP1833;Integrin cell surface interactions
TTDI01789;WP1843;L1CAM interactions
TTDI01789;WP185;Integrin-mediated Cell Adhesion
TTDI01789;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDI01789;WP2666;Elastic fibre formation
TTDI01789;WP2703;Extracellular matrix organization
TTDI01789;WP306;Focal Adhesion
TTDI01790;WP1434;Osteopontin Signaling
TTDI01790;WP1794;Cell surface interactions at the vascular wall
TTDI01790;WP1833;Integrin cell surface interactions
TTDI01790;WP1843;L1CAM interactions
TTDI01790;WP185;Integrin-mediated Cell Adhesion
TTDI01790;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDI01790;WP2572;Primary Focal Segmental Glomerulosclerosis FSGS
TTDI01790;WP2666;Elastic fibre formation
TTDI01790;WP2703;Extracellular matrix organization
TTDI01790;WP2787;Syndecan interactions
TTDI01790;WP2796;Class I MHC mediated antigen processing & presentation
TTDI01790;WP306;Focal Adhesion
TTDI01790;WP322;Osteoblast Signaling
TTDI01793;WP2002;miR-targeted genes in epithelium - TarBase
TTDI01793;WP2003;miR-targeted genes in leukocytes - TarBase
TTDI01793;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDI01793;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI01793;WP2006;miR-targeted genes in squamous cell - TarBase
TTDI01793;WP2882;Nuclear Receptors Meta-Pathway
TTDI01793;WP2884;NRF2 pathway
TTDI01793;WP3;Transcriptional activation by NRF2
TTDI01793;WP408;Oxidative Stress
TTDI01795;WP1794;Cell surface interactions at the vascular wall
TTDI01795;WP1833;Integrin cell surface interactions
TTDI01795;WP1843;L1CAM interactions
TTDI01795;WP185;Integrin-mediated Cell Adhesion
TTDI01795;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDI01795;WP2666;Elastic fibre formation
TTDI01795;WP2703;Extracellular matrix organization
TTDI01795;WP306;Focal Adhesion
TTDI01796;WP2112;IL17 signaling pathway
TTDI01796;WP2328;Allograft Rejection
TTDI01796;WP69;TCR Signaling Pathway
TTDI01797;WP1794;Cell surface interactions at the vascular wall
TTDI01797;WP1829;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
TTDI01797;WP1833;Integrin cell surface interactions
TTDI01797;WP185;Integrin-mediated Cell Adhesion
TTDI01797;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDI01797;WP306;Focal Adhesion
TTDI01799;WP1449;Regulation of toll-like receptor signaling pathway
TTDI01799;WP1835;Interferon alpha/beta signaling
TTDI01799;WP75;Toll-like receptor signaling pathway
TTDI01800;WP1840;Interleukin-3, 5 and GM-CSF signaling
TTDI01800;WP2732;Interleukin-2 signaling
TTDI01800;WP286;IL-3 Signaling Pathway
TTDI01801;WP138;Androgen receptor signaling pathway
TTDI01801;WP1530;miRNA Regulation of DNA Damage Response
TTDI01801;WP1545;miRNAs involved in DNA damage response
TTDI01801;WP1984;Integrated Breast Cancer Pathway
TTDI01801;WP2002;miR-targeted genes in epithelium - TarBase
TTDI01801;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDI01801;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI01801;WP2034;Leptin signaling pathway
TTDI01801;WP205;IL-7 Signaling Pathway
TTDI01801;WP2261;Signaling Pathways in Glioblastoma
TTDI01801;WP2263;Prostate Cancer
TTDI01801;WP2377;Integrated Pancreatic Cancer Pathway
TTDI01801;WP2431;Spinal Cord Injury
TTDI01801;WP2446;Retinoblastoma (RB) in Cancer
TTDI01801;WP2571;Polycystic Kidney Disease Pathway
TTDI01801;WP2772;S Phase
TTDI01801;WP2786;Pre-NOTCH Expression and Processing
TTDI01801;WP2828;Bladder Cancer
TTDI01801;WP2839;Hair Follicle Development: Organogenesis (Part 2 of 3)
TTDI01801;WP2857;Mesodermal Commitment Pathway
TTDI01801;WP2877;Vitamin D Receptor Pathway
TTDI01801;WP2878;PPAR Alpha Pathway
TTDI01801;WP2882;Nuclear Receptors Meta-Pathway
TTDI01801;WP306;Focal Adhesion
TTDI01801;WP3286;Copper homeostasis
TTDI01801;WP363;Wnt Signaling Pathway Netpath
TTDI01801;WP366;TGF beta Signaling Pathway
TTDI01801;WP399;Wnt Signaling Pathway and Pluripotency
TTDI01801;WP428;Wnt Signaling Pathway
TTDI01801;WP45;G1 to S cell cycle control
TTDI01801;WP61;Notch Signaling Pathway
TTDI01801;WP673;ErbB Signaling Pathway
TTDI01801;WP707;DNA Damage Response
TTDI01801;WP710;DNA Damage Response (only ATM dependent)
TTDI01803;WP1824;GPCR downstream signaling
TTDI01803;WP1825;GPCR ligand binding
TTDI01803;WP24;Peptide GPCRs
TTDI01803;WP455;GPCRs, Class A Rhodopsin-like
TTDI01804;WP117;GPCRs, Other
TTDI01804;WP1824;GPCR downstream signaling
TTDI01804;WP1825;GPCR ligand binding
TTDI01804;WP24;Peptide GPCRs
TTDI01804;WP2848;Differentiation Pathway
TTDI01804;WP455;GPCRs, Class A Rhodopsin-like
TTDI01805;WP1833;Integrin cell surface interactions
TTDI01805;WP1843;L1CAM interactions
TTDI01805;WP185;Integrin-mediated Cell Adhesion
TTDI01805;WP1864;Muscle contraction
TTDI01805;WP1883;Platelet Adhesion to exposed collagen
TTDI01805;WP1907;Semaphorin interactions
TTDI01805;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDI01805;WP2643;Nanoparticle-mediated activation of receptor signaling
TTDI01805;WP2911;miRNA targets in ECM and membrane receptors
TTDI01805;WP313;Signaling of Hepatocyte Growth Factor Receptor
TTDI01805;WP51;Regulation of Actin Cytoskeleton
TTDI01807;WP1873;NGF signalling via TRKA from the plasma membrane
TTDI01807;WP2377;Integrated Pancreatic Cancer Pathway
TTDI01807;WP2380;BDNF signaling pathway
TTDI01807;WP382;MAPK Signaling Pathway
TTDI01808;WP1449;Regulation of toll-like receptor signaling pathway
TTDI01808;WP2328;Allograft Rejection
TTDI01808;WP2873;Aryl Hydrocarbon Receptor Pathway
TTDI01808;WP2877;Vitamin D Receptor Pathway
TTDI01808;WP2882;Nuclear Receptors Meta-Pathway
TTDI01808;WP75;Toll-like receptor signaling pathway
TTDI01809;WP1833;Integrin cell surface interactions
TTDI01809;WP1843;L1CAM interactions
TTDI01809;WP185;Integrin-mediated Cell Adhesion
TTDI01809;WP1864;Muscle contraction
TTDI01809;WP1883;Platelet Adhesion to exposed collagen
TTDI01809;WP1907;Semaphorin interactions
TTDI01809;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDI01809;WP2643;Nanoparticle-mediated activation of receptor signaling
TTDI01809;WP2911;miRNA targets in ECM and membrane receptors
TTDI01809;WP313;Signaling of Hepatocyte Growth Factor Receptor
TTDI01809;WP51;Regulation of Actin Cytoskeleton
TTDI01817;WP1425;BMP Signalling and Regulation
TTDI01817;WP1591;Heart Development
TTDI01817;WP1984;Integrated Breast Cancer Pathway
TTDI01817;WP2760;Signaling by BMP
TTDI01817;WP2804;Hair Follicle Development: Induction (Part 1 of 3)
TTDI01817;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDI01817;WP2853;Endoderm Differentiation
TTDI01817;WP2857;Mesodermal Commitment Pathway
TTDI01817;WP2858;Ectoderm Differentiation
TTDI01817;WP474;Endochondral Ossification
TTDI01820;WP474;Endochondral Ossification
TTDI01821;WP2670;Iron uptake and transport
TTDI01825;WP138;Androgen receptor signaling pathway
TTDI01825;WP1797;Circadian Clock
TTDI01825;WP179;Cell Cycle
TTDI01825;WP1815;Factors involved in megakaryocyte development and platelet production
TTDI01825;WP1904;RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
TTDI01825;WP1984;Integrated Breast Cancer Pathway
TTDI01825;WP2261;Signaling Pathways in Glioblastoma
TTDI01825;WP2377;Integrated Pancreatic Cancer Pathway
TTDI01825;WP2586;Aryl Hydrocarbon Receptor
TTDI01825;WP2718;Signaling by NOTCH2
TTDI01825;WP2720;Signaling by NOTCH1
TTDI01825;WP2727;Regulation of Hypoxia-inducible Factor (HIF) by Oxygen
TTDI01825;WP2751;Transcriptional Regulation of White Adipocyte Differentiation
TTDI01825;WP2786;Pre-NOTCH Expression and Processing
TTDI01825;WP2794;Cytosolic sensors of pathogen-associated DNA
TTDI01825;WP2797;Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
TTDI01825;WP2873;Aryl Hydrocarbon Receptor Pathway
TTDI01825;WP2882;Nuclear Receptors Meta-Pathway
TTDI01825;WP304;Kit receptor signaling pathway
TTDI01825;WP366;TGF beta Signaling Pathway
TTDI01825;WP395;IL-4 Signaling Pathway
TTDI01825;WP399;Wnt Signaling Pathway and Pluripotency
TTDI01825;WP560;TGF Beta Signaling Pathway
TTDI01825;WP61;Notch Signaling Pathway
TTDI01825;WP706;SIDS Susceptibility Pathways
TTDI01826;WP2324;AGE/RAGE pathway
TTDI01826;WP2380;BDNF signaling pathway
TTDI01826;WP474;Endochondral Ossification
TTDI01869;WP176;Folate Metabolism
TTDI01869;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI01869;WP2848;Differentiation Pathway
TTDI01869;WP2849;Hematopoietic Stem Cell Differentiation
TTDI01869;WP530;Cytokines and Inflammatory Response
TTDI01904;WP1449;Regulation of toll-like receptor signaling pathway
TTDI01904;WP1799;Costimulation by the CD28 family
TTDI01904;WP2328;Allograft Rejection
TTDI01904;WP2572;Primary Focal Segmental Glomerulosclerosis FSGS
TTDI01904;WP2653;PIP3 activates AKT signaling
TTDI01904;WP453;Inflammatory Response Pathway
TTDI01904;WP75;Toll-like receptor signaling pathway
TTDI01905;WP1528;Physiological and Pathological Hypertrophy of the Heart
TTDI01905;WP1809;Effects of PIP2 hydrolysis
TTDI01905;WP1824;GPCR downstream signaling
TTDI01905;WP2012;miRs in Muscle Cell Differentiation
TTDI01905;WP2374;Oncostatin M Signaling Pathway
TTDI01905;WP289;Myometrial Relaxation and Contraction Pathways
TTDI01905;WP35;G Protein Signaling Pathways
TTDI01905;WP399;Wnt Signaling Pathway and Pluripotency
TTDI01905;WP428;Wnt Signaling Pathway
TTDI01905;WP536;Calcium Regulation in the Cardiac Cell
TTDI01905;WP666;Hypothetical Network for Drug Addiction
TTDI01907;WP138;Androgen receptor signaling pathway
TTDI01907;WP170;Nuclear Receptors
TTDI01907;WP1984;Integrated Breast Cancer Pathway
TTDI01907;WP2263;Prostate Cancer
TTDI01907;WP2377;Integrated Pancreatic Cancer Pathway
TTDI01907;WP706;SIDS Susceptibility Pathways
TTDI01916;WP1824;GPCR downstream signaling
TTDI01916;WP1825;GPCR ligand binding
TTDI01916;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDI01916;WP455;GPCRs, Class A Rhodopsin-like
TTDI01917;WP2727;Regulation of Hypoxia-inducible Factor (HIF) by Oxygen
TTDI01917;WP2848;Differentiation Pathway
TTDI01917;WP2849;Hematopoietic Stem Cell Differentiation
TTDI01917;WP581;EPO Receptor Signaling
TTDI01918;WP176;Folate Metabolism
TTDI01920;WP2658;HIV Life Cycle
TTDI01920;WP2684;Host Interactions of HIV factors
TTDI01921;WP1449;Regulation of toll-like receptor signaling pathway
TTDI01921;WP1835;Interferon alpha/beta signaling
TTDI01921;WP619;Type II interferon signaling (IFNG)
TTDI01921;WP75;Toll-like receptor signaling pathway
TTDI01922;WP12;Osteoclast Signaling
TTDI01922;WP1449;Regulation of toll-like receptor signaling pathway
TTDI01922;WP1835;Interferon alpha/beta signaling
TTDI01922;WP1904;RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
TTDI01922;WP262;EBV LMP1 signaling
TTDI01922;WP530;Cytokines and Inflammatory Response
TTDI01922;WP615;Senescence and Autophagy in Cancer
TTDI01922;WP619;Type II interferon signaling (IFNG)
TTDI01922;WP75;Toll-like receptor signaling pathway
TTDI01923;WP1892;Protein folding
TTDI01923;WP2272;Pathogenic Escherichia coli infection
TTDI01923;WP2359;Parkin-Ubiquitin Proteasomal System pathway
TTDI01931;WP127;IL-5 Signaling Pathway
TTDI01931;WP138;Androgen receptor signaling pathway
TTDI01931;WP1449;Regulation of toll-like receptor signaling pathway
TTDI01931;WP1528;Physiological and Pathological Hypertrophy of the Heart
TTDI01931;WP1772;Apoptosis Modulation and Signaling
TTDI01931;WP1845;MAPK targets/ Nuclear events mediated by MAP kinases
TTDI01931;WP195;IL-1 signaling pathway
TTDI01931;WP1984;Integrated Breast Cancer Pathway
TTDI01931;WP2018;RANKL/RANK Signaling Pathway
TTDI01931;WP2032;TSH signaling pathway
TTDI01931;WP2036;TWEAK Signaling Pathway
TTDI01931;WP2100;Arylhydrocarbon receptor (AhR) signaling pathway
TTDI01931;WP2263;Prostate Cancer
TTDI01931;WP231;TNF alpha Signaling Pathway
TTDI01931;WP2324;AGE/RAGE pathway
TTDI01931;WP2377;Integrated Pancreatic Cancer Pathway
TTDI01931;WP2380;BDNF signaling pathway
TTDI01931;WP23;B Cell Receptor Signaling Pathway
TTDI01931;WP2435;Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis
TTDI01931;WP2516;ATM Signaling Pathway
TTDI01931;WP2526;PDGF Pathway
TTDI01931;WP254;Apoptosis
TTDI01931;WP2571;Polycystic Kidney Disease Pathway
TTDI01931;WP2759;Fc epsilon receptor (FCERI) signaling
TTDI01931;WP2786;Pre-NOTCH Expression and Processing
TTDI01931;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDI01931;WP286;IL-3 Signaling Pathway
TTDI01931;WP2873;Aryl Hydrocarbon Receptor Pathway
TTDI01931;WP2881;Estrogen Receptor Pathway
TTDI01931;WP2882;Nuclear Receptors Meta-Pathway
TTDI01931;WP289;Myometrial Relaxation and Contraction Pathways
TTDI01931;WP28;Selenium Metabolism and Selenoproteins
TTDI01931;WP306;Focal Adhesion
TTDI01931;WP313;Signaling of Hepatocyte Growth Factor Receptor
TTDI01931;WP314;FAS pathway and Stress induction of HSP regulation
TTDI01931;WP3286;Copper homeostasis
TTDI01931;WP366;TGF beta Signaling Pathway
TTDI01931;WP382;MAPK Signaling Pathway
TTDI01931;WP399;Wnt Signaling Pathway and Pluripotency
TTDI01931;WP422;MAPK Cascade
TTDI01931;WP428;Wnt Signaling Pathway
TTDI01931;WP437;EGF/EGFR Signaling Pathway
TTDI01931;WP481;Insulin Signaling
TTDI01931;WP49;IL-2 Signaling Pathway
TTDI01931;WP560;TGF Beta Signaling Pathway
TTDI01931;WP615;Senescence and Autophagy in Cancer
TTDI01931;WP673;ErbB Signaling Pathway
TTDI01931;WP69;TCR Signaling Pathway
TTDI01931;WP706;SIDS Susceptibility Pathways
TTDI01931;WP710;DNA Damage Response (only ATM dependent)
TTDI01931;WP712;Estrogen signaling pathway
TTDI01931;WP75;Toll-like receptor signaling pathway
TTDI01932;WP1449;Regulation of toll-like receptor signaling pathway
TTDI01932;WP1799;Costimulation by the CD28 family
TTDI01932;WP2328;Allograft Rejection
TTDI01932;WP2653;PIP3 activates AKT signaling
TTDI01932;WP286;IL-3 Signaling Pathway
TTDI01932;WP453;Inflammatory Response Pathway
TTDI01932;WP75;Toll-like receptor signaling pathway
TTDI01933;WP1533;Vitamin B12 Metabolism
TTDI01933;WP15;Selenium Micronutrient Network
TTDI01933;WP176;Folate Metabolism
TTDI01933;WP1829;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
TTDI01933;WP1833;Integrin cell surface interactions
TTDI01933;WP2018;RANKL/RANK Signaling Pathway
TTDI01933;WP2332;Interleukin-11 Signaling Pathway
TTDI01933;WP2431;Spinal Cord Injury
TTDI01933;WP2806;Human Complement System
TTDI01933;WP2865;IL1 and megakaryotyces in obesity
TTDI01933;WP619;Type II interferon signaling (IFNG)
TTDI01934;WP1832;Integrin alphaIIb beta3 signaling
TTDI01934;WP1835;Interferon alpha/beta signaling
TTDI01934;WP1836;Interferon gamma signaling
TTDI01934;WP2034;Leptin signaling pathway
TTDI01934;WP2657;Growth hormone receptor signaling
TTDI01934;WP481;Insulin Signaling
TTDI01935;WP1839;Interleukin-1 signaling
TTDI01935;WP195;IL-1 signaling pathway
TTDI01935;WP2328;Allograft Rejection
TTDI01935;WP2431;Spinal Cord Injury
TTDI01935;WP2637;Structural Pathway of Interleukin 1 (IL-1)
TTDI01935;WP2849;Hematopoietic Stem Cell Differentiation
TTDI01935;WP314;FAS pathway and Stress induction of HSP regulation
TTDI01935;WP382;MAPK Signaling Pathway
TTDI01935;WP516;Hypertrophy Model
TTDI01935;WP530;Cytokines and Inflammatory Response
TTDI01935;WP615;Senescence and Autophagy in Cancer
TTDI01935;WP69;TCR Signaling Pathway
TTDI01935;WP706;SIDS Susceptibility Pathways
TTDI01939;WP1818;Formation of Fibrin Clot (Clotting Cascade)
TTDI01939;WP2806;Human Complement System
TTDI01940;WP2725;Collagen biosynthesis and modifying enzymes
TTDI01940;WP2769;Activation of Matrix Metalloproteinases
TTDI01940;WP2798;Assembly of collagen fibrils and other multimeric structures
TTDI01941;WP1817;Fatty acid, triacylglycerol, and ketone body metabolism
TTDI01941;WP2740;Glycerophospholipid biosynthesis
TTDI01941;WP325;Triacylglyceride Synthesis
TTDI01941;WP430;Statin Pathway
TTDI01941;WP716;Vitamin A and Carotenoid Metabolism
TTDI01943;WP43;Oxidation by Cytochrome P450
TTDI01944;WP1531;Vitamin D Metabolism
TTDI01944;WP1824;GPCR downstream signaling
TTDI01944;WP1825;GPCR ligand binding
TTDI01944;WP2877;Vitamin D Receptor Pathway
TTDI01944;WP322;Osteoblast Signaling
TTDI01944;WP474;Endochondral Ossification
TTDI01945;WP127;IL-5 Signaling Pathway
TTDI01945;WP1784;Apoptotic execution phase
TTDI01945;WP2038;Regulation of Microtubule Cytoskeleton
TTDI01945;WP2059;Alzheimers Disease
TTDI01945;WP2377;Integrated Pancreatic Cancer Pathway
TTDI01945;WP2380;BDNF signaling pathway
TTDI01945;WP304;Kit receptor signaling pathway
TTDI01945;WP3286;Copper homeostasis
TTDI01945;WP382;MAPK Signaling Pathway
TTDI01945;WP49;IL-2 Signaling Pathway
TTDI01945;WP61;Notch Signaling Pathway
TTDI01948;WP1851;Metabolism of nucleotides
TTDI01948;WP2446;Retinoblastoma (RB) in Cancer
TTDI01949;WP1793;Cell junction organization
TTDI01949;WP1976;Signalling by NGF
TTDI01949;WP2002;miR-targeted genes in epithelium - TarBase
TTDI01949;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDI01949;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI01949;WP2012;miRs in Muscle Cell Differentiation
TTDI01949;WP2261;Signaling Pathways in Glioblastoma
TTDI01949;WP2355;Corticotropin-releasing hormone
TTDI01949;WP35;G Protein Signaling Pathways
TTDI01949;WP399;Wnt Signaling Pathway and Pluripotency
TTDI01949;WP428;Wnt Signaling Pathway
TTDI01949;WP437;EGF/EGFR Signaling Pathway
TTDI01949;WP481;Insulin Signaling
TTDI01950;WP1784;Apoptotic execution phase
TTDI01950;WP1809;Effects of PIP2 hydrolysis
TTDI01950;WP1824;GPCR downstream signaling
TTDI01950;WP1868;Netrin-1 signaling
TTDI01950;WP1927;TCR signaling
TTDI01950;WP2012;miRs in Muscle Cell Differentiation
TTDI01950;WP2261;Signaling Pathways in Glioblastoma
TTDI01950;WP2355;Corticotropin-releasing hormone
TTDI01950;WP2759;Fc epsilon receptor (FCERI) signaling
TTDI01950;WP2877;Vitamin D Receptor Pathway
TTDI01950;WP289;Myometrial Relaxation and Contraction Pathways
TTDI01950;WP35;G Protein Signaling Pathways
TTDI01950;WP399;Wnt Signaling Pathway and Pluripotency
TTDI01950;WP428;Wnt Signaling Pathway
TTDI01950;WP481;Insulin Signaling
TTDI01950;WP536;Calcium Regulation in the Cardiac Cell
TTDI01950;WP69;TCR Signaling Pathway
TTDI01951;WP2858;Ectoderm Differentiation
TTDI01951;WP35;G Protein Signaling Pathways
TTDI01952;WP35;G Protein Signaling Pathways
TTDI01954;WP1775;Cell Cycle Checkpoints
TTDI01956;WP1797;Circadian Clock
TTDI01956;WP179;Cell Cycle
TTDI01956;WP1976;Signalling by NGF
TTDI01956;WP2064;Neural Crest Differentiation
TTDI01956;WP2751;Transcriptional Regulation of White Adipocyte Differentiation
TTDI01956;WP2797;Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
TTDI01960;WP2002;miR-targeted genes in epithelium - TarBase
TTDI01960;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI01960;WP2643;Nanoparticle-mediated activation of receptor signaling
TTDI01960;WP2725;Collagen biosynthesis and modifying enzymes
TTDI01960;WP2784;Binding and Uptake of Ligands by Scavenger Receptors
TTDI01960;WP2798;Assembly of collagen fibrils and other multimeric structures
TTDI01960;WP306;Focal Adhesion
TTDI01960;WP322;Osteoblast Signaling
TTDI01960;WP453;Inflammatory Response Pathway
TTDI01960;WP615;Senescence and Autophagy in Cancer
TTDI01961;WP1911;Signaling by FGFR
TTDI01961;WP2653;PIP3 activates AKT signaling
TTDI01961;WP2677;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
TTDI01961;WP2848;Differentiation Pathway
TTDI01961;WP382;MAPK Signaling Pathway
TTDI01961;WP51;Regulation of Actin Cytoskeleton
TTDI01963;WP2660;Abnormal metabolism in phenylketonuria
TTDI01963;WP2693;Metabolism of amino acids and derivatives
TTDI01963;WP550;Biogenic Amine Synthesis
TTDI01963;WP706;SIDS Susceptibility Pathways
TTDI01964;WP1818;Formation of Fibrin Clot (Clotting Cascade)
TTDI01964;WP272;Blood Clotting Cascade
TTDI01964;WP2806;Human Complement System
TTDI01965;WP1824;GPCR downstream signaling
TTDI01965;WP1825;GPCR ligand binding
TTDI01965;WP2669;Potassium Channels
TTDI01965;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDI01965;WP501;GPCRs, Class C Metabotropic glutamate, pheromone
TTDI01966;WP1434;Osteopontin Signaling
TTDI01966;WP1449;Regulation of toll-like receptor signaling pathway
TTDI01966;WP1533;Vitamin B12 Metabolism
TTDI01966;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDI01966;WP1559;TFs Regulate miRNAs related to cardiac hypertrophy
TTDI01966;WP15;Selenium Micronutrient Network
TTDI01966;WP176;Folate Metabolism
TTDI01966;WP1772;Apoptosis Modulation and Signaling
TTDI01966;WP1838;Interleukin-1 processing
TTDI01966;WP1839;Interleukin-1 signaling
TTDI01966;WP1904;RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
TTDI01966;WP1927;TCR signaling
TTDI01966;WP195;IL-1 signaling pathway
TTDI01966;WP1976;Signalling by NGF
TTDI01966;WP1984;Integrated Breast Cancer Pathway
TTDI01966;WP2018;RANKL/RANK Signaling Pathway
TTDI01966;WP2034;Leptin signaling pathway
TTDI01966;WP2036;TWEAK Signaling Pathway
TTDI01966;WP2064;Neural Crest Differentiation
TTDI01966;WP2112;IL17 signaling pathway
TTDI01966;WP2203;TSLP Signaling Pathway
TTDI01966;WP231;TNF alpha Signaling Pathway
TTDI01966;WP2324;AGE/RAGE pathway
TTDI01966;WP2355;Corticotropin-releasing hormone
TTDI01966;WP2374;Oncostatin M Signaling Pathway
TTDI01966;WP2377;Integrated Pancreatic Cancer Pathway
TTDI01966;WP2380;BDNF signaling pathway
TTDI01966;WP23;B Cell Receptor Signaling Pathway
TTDI01966;WP2435;Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis
TTDI01966;WP254;Apoptosis
TTDI01966;WP2583;T-Cell Receptor and Co-stimulatory Signaling
TTDI01966;WP2586;Aryl Hydrocarbon Receptor
TTDI01966;WP262;EBV LMP1 signaling
TTDI01966;WP2637;Structural Pathway of Interleukin 1 (IL-1)
TTDI01966;WP2656;TAK1 activates NFkB by phosphorylation and activation of IKKs complex
TTDI01966;WP2746;Signaling by the B Cell Receptor (BCR)
TTDI01966;WP2751;Transcriptional Regulation of White Adipocyte Differentiation
TTDI01966;WP2759;Fc epsilon receptor (FCERI) signaling
TTDI01966;WP2794;Cytosolic sensors of pathogen-associated DNA
TTDI01966;WP2795;Cardiac Hypertrophic Response
TTDI01966;WP2804;Hair Follicle Development: Induction (Part 1 of 3)
TTDI01966;WP2839;Hair Follicle Development: Organogenesis (Part 2 of 3)
TTDI01966;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDI01966;WP2864;Apoptosis-related network due to altered Notch3 in ovarian cancer
TTDI01966;WP2865;IL1 and megakaryotyces in obesity
TTDI01966;WP289;Myometrial Relaxation and Contraction Pathways
TTDI01966;WP28;Selenium Metabolism and Selenoproteins
TTDI01966;WP382;MAPK Signaling Pathway
TTDI01966;WP384;Apoptosis Modulation by HSP70
TTDI01966;WP395;IL-4 Signaling Pathway
TTDI01966;WP408;Oxidative Stress
TTDI01966;WP560;TGF Beta Signaling Pathway
TTDI01966;WP61;Notch Signaling Pathway
TTDI01966;WP69;TCR Signaling Pathway
TTDI01966;WP706;SIDS Susceptibility Pathways
TTDI01966;WP710;DNA Damage Response (only ATM dependent)
TTDI01966;WP712;Estrogen signaling pathway
TTDI01966;WP75;Toll-like receptor signaling pathway
TTDI01967;WP2703;Extracellular matrix organization
TTDI01967;WP2739;Amyloids
TTDI01967;WP2764;Lipid digestion, mobilization, and transport
TTDI01967;WP2776;Visual phototransduction
TTDI01969;WP2693;Metabolism of amino acids and derivatives
TTDI01969;WP465;Tryptophan metabolism
TTDI01969;WP550;Biogenic Amine Synthesis
TTDI01969;WP706;SIDS Susceptibility Pathways
TTDI01971;WP1885;Platelet homeostasis
TTDI01971;WP2669;Potassium Channels
TTDI01972;WP1858;Mitotic G1-G1/S phases
TTDI01972;WP2361;Gastric Cancer Network 1
TTDI01972;WP2363;Gastric cancer network 2
TTDI01972;WP2377;Integrated Pancreatic Cancer Pathway
TTDI01972;WP2446;Retinoblastoma (RB) in Cancer
TTDI01975;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDI01975;WP666;Hypothetical Network for Drug Addiction
TTDI01980;WP1885;Platelet homeostasis
TTDI01980;WP2669;Potassium Channels
TTDI01981;WP1885;Platelet homeostasis
TTDI01981;WP2669;Potassium Channels
TTDI01983;WP1425;BMP Signalling and Regulation
TTDI01983;WP1591;Heart Development
TTDI01983;WP236;Adipogenesis
TTDI01983;WP2380;BDNF signaling pathway
TTDI01983;WP2666;Elastic fibre formation
TTDI01983;WP2760;Signaling by BMP
TTDI01983;WP2895;Differentiation of white and brown adipocyte
TTDI01983;WP615;Senescence and Autophagy in Cancer
TTDI01985;WP117;GPCRs, Other
TTDI01985;WP1825;GPCR ligand binding
TTDI01985;WP24;Peptide GPCRs
TTDI01986;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDI01986;WP1910;Signaling by EGFR
TTDI01986;WP2377;Integrated Pancreatic Cancer Pathway
TTDI01986;WP2571;Polycystic Kidney Disease Pathway
TTDI01986;WP2593;JAK/STAT
TTDI01986;WP2653;PIP3 activates AKT signaling
TTDI01986;WP2780;Signaling by ERBB2
TTDI01986;WP2781;Signaling by ERBB4
TTDI01986;WP2795;Cardiac Hypertrophic Response
TTDI01986;WP2804;Hair Follicle Development: Induction (Part 1 of 3)
TTDI01986;WP2828;Bladder Cancer
TTDI01986;WP2848;Differentiation Pathway
TTDI01986;WP2849;Hematopoietic Stem Cell Differentiation
TTDI01986;WP306;Focal Adhesion
TTDI01986;WP382;MAPK Signaling Pathway
TTDI01986;WP437;EGF/EGFR Signaling Pathway
TTDI01986;WP51;Regulation of Actin Cytoskeleton
TTDI01986;WP560;TGF Beta Signaling Pathway
TTDI01986;WP673;ErbB Signaling Pathway
TTDI01987;WP2655;Activation of Chaperone Genes by ATF6-alpha
TTDI01987;WP2709;Trafficking and processing of endosomal TLR
TTDI01987;WP2784;Binding and Uptake of Ligands by Scavenger Receptors
TTDI01987;WP706;SIDS Susceptibility Pathways
TTDI01989;WP2743;Glycosaminoglycan metabolism
TTDI01990;WP1433;NOD pathway
TTDI01990;WP1839;Interleukin-1 signaling
TTDI01990;WP2656;TAK1 activates NFkB by phosphorylation and activation of IKKs complex
TTDI01990;WP2763;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
TTDI01990;WP2792;MAP kinase activation in TLR cascade
TTDI01993;WP179;Cell Cycle
TTDI01993;WP2848;Differentiation Pathway
TTDI01993;WP2849;Hematopoietic Stem Cell Differentiation
TTDI01993;WP304;Kit receptor signaling pathway
TTDI01994;WP1938;tRNA Aminoacylation
TTDI01994;WP2371;Parkinsons Disease Pathway
TTDI01997;WP2683;Influenza Life Cycle
TTDI02008;WP2355;Corticotropin-releasing hormone
TTDI02008;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02008;WP2380;BDNF signaling pathway
TTDI02008;WP23;B Cell Receptor Signaling Pathway
TTDI02008;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDI02008;WP289;Myometrial Relaxation and Contraction Pathways
TTDI02008;WP437;EGF/EGFR Signaling Pathway
TTDI02008;WP536;Calcium Regulation in the Cardiac Cell
TTDI02008;WP673;ErbB Signaling Pathway
TTDI02010;WP1799;Costimulation by the CD28 family
TTDI02010;WP1836;Interferon gamma signaling
TTDI02010;WP1927;TCR signaling
TTDI02010;WP2679;MHC class II antigen presentation
TTDI02011;WP1794;Cell surface interactions at the vascular wall
TTDI02011;WP1936;Transport of inorganic cations/anions and amino acids/oligopeptides
TTDI02012;WP2702;Mitochondrial Iron-Sulfur Cluster Biogenesis
TTDI02013;WP1984;Integrated Breast Cancer Pathway
TTDI02013;WP2100;Arylhydrocarbon receptor (AhR) signaling pathway
TTDI02013;WP236;Adipogenesis
TTDI02013;WP2586;Aryl Hydrocarbon Receptor
TTDI02013;WP2873;Aryl Hydrocarbon Receptor Pathway
TTDI02013;WP2882;Nuclear Receptors Meta-Pathway
TTDI02015;WP1403;AMPK Signaling
TTDI02015;WP1449;Regulation of toll-like receptor signaling pathway
TTDI02015;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDI02015;WP1559;TFs Regulate miRNAs related to cardiac hypertrophy
TTDI02015;WP185;Integrin-mediated Cell Adhesion
TTDI02015;WP1913;Signaling by Insulin receptor
TTDI02015;WP2018;RANKL/RANK Signaling Pathway
TTDI02015;WP2036;TWEAK Signaling Pathway
TTDI02015;WP2261;Signaling Pathways in Glioblastoma
TTDI02015;WP2677;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
TTDI02015;WP26;Signal Transduction of S1P Receptor
TTDI02015;WP2777;Translocation of GLUT4 to the Plasma Membrane
TTDI02015;WP2795;Cardiac Hypertrophic Response
TTDI02015;WP306;Focal Adhesion
TTDI02015;WP382;MAPK Signaling Pathway
TTDI02015;WP481;Insulin Signaling
TTDI02015;WP710;DNA Damage Response (only ATM dependent)
TTDI02015;WP75;Toll-like receptor signaling pathway
TTDI02016;WP1449;Regulation of toll-like receptor signaling pathway
TTDI02016;WP185;Integrin-mediated Cell Adhesion
TTDI02016;WP2261;Signaling Pathways in Glioblastoma
TTDI02016;WP2643;Nanoparticle-mediated activation of receptor signaling
TTDI02016;WP26;Signal Transduction of S1P Receptor
TTDI02016;WP306;Focal Adhesion
TTDI02016;WP382;MAPK Signaling Pathway
TTDI02016;WP673;ErbB Signaling Pathway
TTDI02016;WP710;DNA Damage Response (only ATM dependent)
TTDI02016;WP75;Toll-like receptor signaling pathway
TTDI02019;WP2864;Apoptosis-related network due to altered Notch3 in ovarian cancer
TTDI02019;WP98;Prostaglandin Synthesis and Regulation
TTDI02020;WP1533;Vitamin B12 Metabolism
TTDI02020;WP15;Selenium Micronutrient Network
TTDI02020;WP176;Folate Metabolism
TTDI02020;WP1780;ABC-family proteins mediated transport
TTDI02020;WP2764;Lipid digestion, mobilization, and transport
TTDI02020;WP2776;Visual phototransduction
TTDI02020;WP2784;Binding and Uptake of Ligands by Scavenger Receptors
TTDI02020;WP2797;Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
TTDI02020;WP2806;Human Complement System
TTDI02020;WP2878;PPAR Alpha Pathway
TTDI02020;WP2882;Nuclear Receptors Meta-Pathway
TTDI02020;WP430;Statin Pathway
TTDI02021;WP2788;Sphingolipid metabolism
TTDI02023;WP1530;miRNA Regulation of DNA Damage Response
TTDI02023;WP1775;Cell Cycle Checkpoints
TTDI02023;WP179;Cell Cycle
TTDI02023;WP1971;Integrated Cancer pathway
TTDI02023;WP1984;Integrated Breast Cancer Pathway
TTDI02023;WP2263;Prostate Cancer
TTDI02023;WP2731;Meiotic Synapsis
TTDI02023;WP707;DNA Damage Response
TTDI02024;WP1772;Apoptosis Modulation and Signaling
TTDI02024;WP1841;Intrinsic Pathway for Apoptosis
TTDI02024;WP2034;Leptin signaling pathway
TTDI02024;WP205;IL-7 Signaling Pathway
TTDI02024;WP231;TNF alpha Signaling Pathway
TTDI02024;WP2447;Amyotrophic lateral sclerosis (ALS)
TTDI02024;WP254;Apoptosis
TTDI02024;WP2763;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
TTDI02024;WP286;IL-3 Signaling Pathway
TTDI02024;WP364;IL-6 signaling pathway
TTDI02025;WP1772;Apoptosis Modulation and Signaling
TTDI02025;WP1784;Apoptotic execution phase
TTDI02025;WP2036;TWEAK Signaling Pathway
TTDI02025;WP231;TNF alpha Signaling Pathway
TTDI02025;WP254;Apoptosis
TTDI02025;WP2882;Nuclear Receptors Meta-Pathway
TTDI02025;WP306;Focal Adhesion
TTDI02026;WP1772;Apoptosis Modulation and Signaling
TTDI02026;WP2036;TWEAK Signaling Pathway
TTDI02026;WP231;TNF alpha Signaling Pathway
TTDI02026;WP254;Apoptosis
TTDI02026;WP2882;Nuclear Receptors Meta-Pathway
TTDI02026;WP306;Focal Adhesion
TTDI02030;WP3295;Chemical Compounds to monitor Proteins
TTDI02031;WP3295;Chemical Compounds to monitor Proteins
TTDI02032;WP3295;Chemical Compounds to monitor Proteins
TTDI02033;WP3295;Chemical Compounds to monitor Proteins
TTDI02034;WP1793;Cell junction organization
TTDI02034;WP2804;Hair Follicle Development: Induction (Part 1 of 3)
TTDI02035;WP15;Selenium Micronutrient Network
TTDI02035;WP176;Folate Metabolism
TTDI02035;WP1851;Metabolism of nucleotides
TTDI02035;WP2447;Amyotrophic lateral sclerosis (ALS)
TTDI02035;WP2824;Detoxification of Reactive Oxygen Species
TTDI02035;WP408;Oxidative Stress
TTDI02035;WP465;Tryptophan metabolism
TTDI02035;WP710;DNA Damage Response (only ATM dependent)
TTDI02036;WP1825;GPCR ligand binding
TTDI02036;WP2203;TSLP Signaling Pathway
TTDI02037;WP1449;Regulation of toll-like receptor signaling pathway
TTDI02037;WP1533;Vitamin B12 Metabolism
TTDI02037;WP1824;GPCR downstream signaling
TTDI02037;WP1825;GPCR ligand binding
TTDI02037;WP2036;TWEAK Signaling Pathway
TTDI02037;WP75;Toll-like receptor signaling pathway
TTDI02038;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDI02038;WP2849;Hematopoietic Stem Cell Differentiation
TTDI02040;WP1601;Fluoropyrimidine Activity
TTDI02040;WP1851;Metabolism of nucleotides
TTDI02042;WP1798;Complement cascade
TTDI02042;WP2806;Human Complement System
TTDI02042;WP558;Complement and Coagulation Cascades
TTDI02046;WP1531;Vitamin D Metabolism
TTDI02046;WP1879;Phase 1 - Functionalization of compounds
TTDI02046;WP2749;Metabolism of steroid hormones and vitamin D
TTDI02046;WP2877;Vitamin D Receptor Pathway
TTDI02046;WP299;Nuclear Receptors in Lipid Metabolism and Toxicity
TTDI02046;WP43;Oxidation by Cytochrome P450
TTDI02046;WP702;Metapathway biotransformation
TTDI02047;WP1788;Bile acid and bile salt metabolism
TTDI02047;WP1879;Phase 1 - Functionalization of compounds
TTDI02047;WP43;Oxidation by Cytochrome P450
TTDI02047;WP702;Metapathway biotransformation
TTDI02048;WP2203;TSLP Signaling Pathway
TTDI02049;WP2738;YAP1- and WWTR1 (TAZ)-stimulated gene expression
TTDI02049;WP2797;Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
TTDI02049;WP2804;Hair Follicle Development: Induction (Part 1 of 3)
TTDI02049;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDI02050;WP1798;Complement cascade
TTDI02050;WP1825;GPCR ligand binding
TTDI02050;WP2806;Human Complement System
TTDI02050;WP545;Complement Activation, Classical Pathway
TTDI02050;WP558;Complement and Coagulation Cascades
TTDI02051;WP1904;RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
TTDI02052;WP2671;Defensins
TTDI02052;WP2877;Vitamin D Receptor Pathway
TTDI02053;WP1864;Muscle contraction
TTDI02053;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDI02053;WP2703;Extracellular matrix organization
TTDI02053;WP2858;Ectoderm Differentiation
TTDI02053;WP383;Striated Muscle Contraction
TTDI02054;WP2693;Metabolism of amino acids and derivatives
TTDI02054;WP550;Biogenic Amine Synthesis
TTDI02054;WP727;Monoamine Transport
TTDI02055;WP1799;Costimulation by the CD28 family
TTDI02055;WP1836;Interferon gamma signaling
TTDI02055;WP1927;TCR signaling
TTDI02055;WP2328;Allograft Rejection
TTDI02055;WP2679;MHC class II antigen presentation
TTDI02055;WP2877;Vitamin D Receptor Pathway
TTDI02056;WP1530;miRNA Regulation of DNA Damage Response
TTDI02056;WP1545;miRNAs involved in DNA damage response
TTDI02056;WP179;Cell Cycle
TTDI02056;WP1841;Intrinsic Pathway for Apoptosis
TTDI02056;WP1858;Mitotic G1-G1/S phases
TTDI02056;WP1859;Mitotic G2-G2/M phases
TTDI02056;WP1971;Integrated Cancer pathway
TTDI02056;WP1984;Integrated Breast Cancer Pathway
TTDI02056;WP2002;miR-targeted genes in epithelium - TarBase
TTDI02056;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDI02056;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI02056;WP2032;TSH signaling pathway
TTDI02056;WP2261;Signaling Pathways in Glioblastoma
TTDI02056;WP2263;Prostate Cancer
TTDI02056;WP236;Adipogenesis
TTDI02056;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02056;WP2431;Spinal Cord Injury
TTDI02056;WP2446;Retinoblastoma (RB) in Cancer
TTDI02056;WP2586;Aryl Hydrocarbon Receptor
TTDI02056;WP2786;Pre-NOTCH Expression and Processing
TTDI02056;WP2815;Mammary gland development pathway - Involution (Stage 4 of 4)
TTDI02056;WP2828;Bladder Cancer
TTDI02056;WP437;EGF/EGFR Signaling Pathway
TTDI02056;WP45;G1 to S cell cycle control
TTDI02056;WP615;Senescence and Autophagy in Cancer
TTDI02056;WP707;DNA Damage Response
TTDI02057;WP1795;Cholesterol biosynthesis
TTDI02059;WP1835;Interferon alpha/beta signaling
TTDI02059;WP2032;TSH signaling pathway
TTDI02059;WP2374;Oncostatin M Signaling Pathway
TTDI02059;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02059;WP2380;BDNF signaling pathway
TTDI02059;WP2431;Spinal Cord Injury
TTDI02059;WP2882;Nuclear Receptors Meta-Pathway
TTDI02059;WP2884;NRF2 pathway
TTDI02059;WP34;Ovarian Infertility Genes
TTDI02059;WP481;Insulin Signaling
TTDI02059;WP706;SIDS Susceptibility Pathways
TTDI02059;WP734;Serotonin Receptor 4/6/7 and NR3C Signaling
TTDI02061;WP2882;Nuclear Receptors Meta-Pathway
TTDI02061;WP2884;NRF2 pathway
TTDI02062;WP2653;PIP3 activates AKT signaling
TTDI02062;WP2780;Signaling by ERBB2
TTDI02062;WP2781;Signaling by ERBB4
TTDI02062;WP673;ErbB Signaling Pathway
TTDI02063;WP2002;miR-targeted genes in epithelium - TarBase
TTDI02063;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDI02063;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI02063;WP2012;miRs in Muscle Cell Differentiation
TTDI02063;WP2023;Cell Differentiation - meta
TTDI02063;WP2369;Histone Modifications
TTDI02063;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02063;WP2853;Endoderm Differentiation
TTDI02063;WP2916;Interactome of polycomb repressive complex 2 (PRC2)
TTDI02065;WP1403;AMPK Signaling
TTDI02065;WP1848;Metabolism of carbohydrates
TTDI02068;WP2718;Signaling by NOTCH2
TTDI02068;WP2806;Human Complement System
TTDI02069;WP1824;GPCR downstream signaling
TTDI02069;WP1825;GPCR ligand binding
TTDI02069;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDI02069;WP455;GPCRs, Class A Rhodopsin-like
TTDI02070;WP1911;Signaling by FGFR
TTDI02070;WP2653;PIP3 activates AKT signaling
TTDI02070;WP2677;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
TTDI02070;WP474;Endochondral Ossification
TTDI02070;WP51;Regulation of Actin Cytoskeleton
TTDI02071;WP1982;SREBP signalling
TTDI02071;WP2586;Aryl Hydrocarbon Receptor
TTDI02071;WP51;Regulation of Actin Cytoskeleton
TTDI02075;WP399;Wnt Signaling Pathway and Pluripotency
TTDI02075;WP428;Wnt Signaling Pathway
TTDI02076;WP1824;GPCR downstream signaling
TTDI02076;WP2596;Gastric acid production
TTDI02076;WP2597;Secretion of Hydrochloric Acid in Parietal Cells
TTDI02076;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDI02078;WP2666;Elastic fibre formation
TTDI02078;WP2848;Differentiation Pathway
TTDI02079;WP1784;Apoptotic execution phase
TTDI02079;WP51;Regulation of Actin Cytoskeleton
TTDI02079;WP615;Senescence and Autophagy in Cancer
TTDI02081;WP2797;Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
TTDI02082;WP1872;Neurotransmitter uptake and Metabolism In Glial Cells
TTDI02082;WP231;TNF alpha Signaling Pathway
TTDI02082;WP2693;Metabolism of amino acids and derivatives
TTDI02083;WP1818;Formation of Fibrin Clot (Clotting Cascade)
TTDI02083;WP1823;GP1b-IX-V activation signalling
TTDI02083;WP1883;Platelet Adhesion to exposed collagen
TTDI02083;WP1884;Platelet Aggregation (Plug Formation)
TTDI02084;WP2776;Visual phototransduction
TTDI02085;WP1794;Cell surface interactions at the vascular wall
TTDI02085;WP1826;GPVI-mediated activation cascade
TTDI02085;WP1883;Platelet Adhesion to exposed collagen
TTDI02086;WP2359;Parkin-Ubiquitin Proteasomal System pathway
TTDI02086;WP2717;Mitochondrial Protein Import
TTDI02087;WP1903;Response to elevated platelet cytosolic Ca2+
TTDI02087;WP1939;Unfolded Protein Response
TTDI02087;WP2359;Parkin-Ubiquitin Proteasomal System pathway
TTDI02087;WP2655;Activation of Chaperone Genes by ATF6-alpha
TTDI02087;WP2864;Apoptosis-related network due to altered Notch3 in ovarian cancer
TTDI02087;WP382;MAPK Signaling Pathway
TTDI02088;WP2824;Detoxification of Reactive Oxygen Species
TTDI02088;WP2882;Nuclear Receptors Meta-Pathway
TTDI02088;WP2884;NRF2 pathway
TTDI02088;WP410;Diurnally Regulated Genes with Circadian Orthologs
TTDI02088;WP678;Arachidonate Epoxygenase / Epoxide Hydrolase
TTDI02088;WP702;Metapathway biotransformation
TTDI02090;WP2007;Iron metabolism in placenta
TTDI02091;WP2679;MHC class II antigen presentation
TTDI02092;WP2763;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
TTDI02093;WP69;TCR Signaling Pathway
TTDI02094;WP100;Glutathione metabolism
TTDI02094;WP1878;Peroxisomal lipid metabolism
TTDI02094;WP2002;miR-targeted genes in epithelium - TarBase
TTDI02094;WP2003;miR-targeted genes in leukocytes - TarBase
TTDI02094;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDI02094;WP2006;miR-targeted genes in squamous cell - TarBase
TTDI02094;WP2453;TCA Cycle and PDHc
TTDI02095;WP2766;The citric acid (TCA) cycle and respiratory electron transport
TTDI02095;WP78;TCA Cycle
TTDI02096;WP1449;Regulation of toll-like receptor signaling pathway
TTDI02096;WP1835;Interferon alpha/beta signaling
TTDI02096;WP75;Toll-like receptor signaling pathway
TTDI02104;WP138;Androgen receptor signaling pathway
TTDI02104;WP1815;Factors involved in megakaryocyte development and platelet production
TTDI02105;WP1829;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
TTDI02106;WP1829;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
TTDI02107;WP1829;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
TTDI02109;WP1926;Synthesis, Secretion, and Deacylation of Ghrelin
TTDI02109;WP1991;SRF and miRs in Smooth Muscle Differentiation and Proliferation
TTDI02109;WP2023;Cell Differentiation - meta
TTDI02109;WP2751;Transcriptional Regulation of White Adipocyte Differentiation
TTDI02109;WP2821;Transcriptional regulation of pluripotent stem cells
TTDI02109;WP2857;Mesodermal Commitment Pathway
TTDI02109;WP2877;Vitamin D Receptor Pathway
TTDI02110;WP2002;miR-targeted genes in epithelium - TarBase
TTDI02110;WP2003;miR-targeted genes in leukocytes - TarBase
TTDI02110;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDI02110;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI02110;WP2006;miR-targeted genes in squamous cell - TarBase
TTDI02110;WP534;Glycolysis and Gluconeogenesis
TTDI02111;WP2764;Lipid digestion, mobilization, and transport
TTDI02111;WP430;Statin Pathway
TTDI02113;WP1976;Signalling by NGF
TTDI02113;WP2380;BDNF signaling pathway
TTDI02116;WP1824;GPCR downstream signaling
TTDI02116;WP1825;GPCR ligand binding
TTDI02116;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDI02119;WP1845;MAPK targets/ Nuclear events mediated by MAP kinases
TTDI02119;WP1873;NGF signalling via TRKA from the plasma membrane
TTDI02119;WP195;IL-1 signaling pathway
TTDI02119;WP2038;Regulation of Microtubule Cytoskeleton
TTDI02119;WP2637;Structural Pathway of Interleukin 1 (IL-1)
TTDI02119;WP2650;Arachidonic acid metabolism
TTDI02119;WP2733;Regulation of mRNA Stability by Proteins that Bind AU-rich Elements
TTDI02119;WP2792;MAP kinase activation in TLR cascade
TTDI02119;WP314;FAS pathway and Stress induction of HSP regulation
TTDI02119;WP382;MAPK Signaling Pathway
TTDI02119;WP400;p38 MAPK Signaling Pathway
TTDI02119;WP722;Serotonin HTR1 Group and FOS Pathway
TTDI02119;WP732;Serotonin Receptor 2 and ELK-SRF/GATA4 signaling
TTDI02119;WP734;Serotonin Receptor 4/6/7 and NR3C Signaling
TTDI02122;WP1449;Regulation of toll-like receptor signaling pathway
TTDI02122;WP1798;Complement cascade
TTDI02122;WP2806;Human Complement System
TTDI02123;WP1824;GPCR downstream signaling
TTDI02123;WP1825;GPCR ligand binding
TTDI02123;WP24;Peptide GPCRs
TTDI02123;WP455;GPCRs, Class A Rhodopsin-like
TTDI02126;WP2001;miR-targeted genes in adipocytes - TarBase
TTDI02126;WP2002;miR-targeted genes in epithelium - TarBase
TTDI02126;WP2003;miR-targeted genes in leukocytes - TarBase
TTDI02126;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDI02126;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI02132;WP1797;Circadian Clock
TTDI02132;WP1857;Metabolism of water-soluble vitamins and cofactors
TTDI02132;WP236;Adipogenesis
TTDI02134;WP1822;Generic Transcription Pathway
TTDI02134;WP2002;miR-targeted genes in epithelium - TarBase
TTDI02134;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDI02134;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI02134;WP2064;Neural Crest Differentiation
TTDI02134;WP268;Notch Signaling Pathway
TTDI02134;WP2718;Signaling by NOTCH2
TTDI02134;WP2786;Pre-NOTCH Expression and Processing
TTDI02134;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDI02134;WP61;Notch Signaling Pathway
TTDI02135;WP1822;Generic Transcription Pathway
TTDI02135;WP2064;Neural Crest Differentiation
TTDI02135;WP268;Notch Signaling Pathway
TTDI02135;WP2722;Signaling by NOTCH3
TTDI02135;WP2786;Pre-NOTCH Expression and Processing
TTDI02135;WP61;Notch Signaling Pathway
TTDI02136;WP2431;Spinal Cord Injury
TTDI02136;WP408;Oxidative Stress
TTDI02137;WP1874;Nucleosome assembly
TTDI02137;WP2684;Host Interactions of HIV factors
TTDI02140;WP2380;BDNF signaling pathway
TTDI02141;WP2002;miR-targeted genes in epithelium - TarBase
TTDI02141;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDI02141;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI02141;WP2006;miR-targeted genes in squamous cell - TarBase
TTDI02141;WP2272;Pathogenic Escherichia coli infection
TTDI02143;WP1829;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
TTDI02143;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDI02143;WP2877;Vitamin D Receptor Pathway
TTDI02145;WP185;Integrin-mediated Cell Adhesion
TTDI02145;WP306;Focal Adhesion
TTDI02145;WP51;Regulation of Actin Cytoskeleton
TTDI02145;WP673;ErbB Signaling Pathway
TTDI02149;WP1916;Signaling by PDGF
TTDI02149;WP306;Focal Adhesion
TTDI02150;WP2002;miR-targeted genes in epithelium - TarBase
TTDI02150;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDI02150;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI02154;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDI02154;WP2870;Extracellular vesicle-mediated signaling in recipient cells
TTDI02157;WP2658;HIV Life Cycle
TTDI02157;WP2684;Host Interactions of HIV factors
TTDI02159;WP138;Androgen receptor signaling pathway
TTDI02159;WP1528;Physiological and Pathological Hypertrophy of the Heart
TTDI02159;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDI02159;WP1824;GPCR downstream signaling
TTDI02159;WP1826;GPVI-mediated activation cascade
TTDI02159;WP1873;NGF signalling via TRKA from the plasma membrane
TTDI02159;WP1907;Semaphorin interactions
TTDI02159;WP1917;Signaling by Rho GTPases
TTDI02159;WP1976;Signalling by NGF
TTDI02159;WP2034;Leptin signaling pathway
TTDI02159;WP2272;Pathogenic Escherichia coli infection
TTDI02159;WP2324;AGE/RAGE pathway
TTDI02159;WP2355;Corticotropin-releasing hormone
TTDI02159;WP2431;Spinal Cord Injury
TTDI02159;WP244;Alpha 6 Beta 4 signaling pathway
TTDI02159;WP2593;JAK/STAT
TTDI02159;WP2742;Signaling by TGF-beta Receptor Complex
TTDI02159;WP306;Focal Adhesion
TTDI02159;WP35;G Protein Signaling Pathways
TTDI02159;WP363;Wnt Signaling Pathway Netpath
TTDI02159;WP366;TGF beta Signaling Pathway
TTDI02159;WP399;Wnt Signaling Pathway and Pluripotency
TTDI02159;WP428;Wnt Signaling Pathway
TTDI02159;WP51;Regulation of Actin Cytoskeleton
TTDI02159;WP524;G13 Signaling Pathway
TTDI02159;WP710;DNA Damage Response (only ATM dependent)
TTDI02159;WP722;Serotonin HTR1 Group and FOS Pathway
TTDI02162;WP138;Androgen receptor signaling pathway
TTDI02162;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDI02162;WP1824;GPCR downstream signaling
TTDI02162;WP185;Integrin-mediated Cell Adhesion
TTDI02162;WP1907;Semaphorin interactions
TTDI02162;WP2034;Leptin signaling pathway
TTDI02162;WP2272;Pathogenic Escherichia coli infection
TTDI02162;WP2431;Spinal Cord Injury
TTDI02162;WP2593;JAK/STAT
TTDI02162;WP306;Focal Adhesion
TTDI02162;WP51;Regulation of Actin Cytoskeleton
TTDI02162;WP524;G13 Signaling Pathway
TTDI02164;WP1976;Signalling by NGF
TTDI02164;WP2002;miR-targeted genes in epithelium - TarBase
TTDI02164;WP2003;miR-targeted genes in leukocytes - TarBase
TTDI02164;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDI02164;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI02164;WP2006;miR-targeted genes in squamous cell - TarBase
TTDI02164;WP2431;Spinal Cord Injury
TTDI02166;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDI02166;WP2877;Vitamin D Receptor Pathway
TTDI02167;WP1824;GPCR downstream signaling
TTDI02167;WP1825;GPCR ligand binding
TTDI02167;WP26;Signal Transduction of S1P Receptor
TTDI02168;WP2882;Nuclear Receptors Meta-Pathway
TTDI02168;WP2884;NRF2 pathway
TTDI02171;WP1907;Semaphorin interactions
TTDI02172;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDI02173;WP2788;Sphingolipid metabolism
TTDI02174;WP1794;Cell surface interactions at the vascular wall
TTDI02174;WP1840;Interleukin-3, 5 and GM-CSF signaling
TTDI02174;WP1927;TCR signaling
TTDI02174;WP23;B Cell Receptor Signaling Pathway
TTDI02174;WP2732;Interleukin-2 signaling
TTDI02174;WP286;IL-3 Signaling Pathway
TTDI02174;WP304;Kit receptor signaling pathway
TTDI02174;WP395;IL-4 Signaling Pathway
TTDI02174;WP437;EGF/EGFR Signaling Pathway
TTDI02176;WP2715;Metabolism of non-coding RNA
TTDI02177;WP1533;Vitamin B12 Metabolism
TTDI02177;WP15;Selenium Micronutrient Network
TTDI02177;WP176;Folate Metabolism
TTDI02177;WP2824;Detoxification of Reactive Oxygen Species
TTDI02177;WP408;Oxidative Stress
TTDI02177;WP710;DNA Damage Response (only ATM dependent)
TTDI02179;WP1422;Sphingolipid Metabolism
TTDI02179;WP1892;Protein folding
TTDI02179;WP26;Signal Transduction of S1P Receptor
TTDI02180;WP2743;Glycosaminoglycan metabolism
TTDI02181;WP1843;L1CAM interactions
TTDI02181;WP1866;NCAM signaling for neurite out-growth
TTDI02181;WP1867;Nephrin interactions
TTDI02181;WP366;TGF beta Signaling Pathway
TTDI02181;WP706;SIDS Susceptibility Pathways
TTDI02182;WP1449;Regulation of toll-like receptor signaling pathway
TTDI02182;WP1839;Interleukin-1 signaling
TTDI02182;WP195;IL-1 signaling pathway
TTDI02182;WP1976;Signalling by NGF
TTDI02182;WP2018;RANKL/RANK Signaling Pathway
TTDI02182;WP2380;BDNF signaling pathway
TTDI02182;WP2864;Apoptosis-related network due to altered Notch3 in ovarian cancer
TTDI02182;WP2882;Nuclear Receptors Meta-Pathway
TTDI02182;WP2884;NRF2 pathway
TTDI02182;WP615;Senescence and Autophagy in Cancer
TTDI02183;WP1906;RNA Polymerase II Transcription
TTDI02183;WP2658;HIV Life Cycle
TTDI02184;WP127;IL-5 Signaling Pathway
TTDI02184;WP138;Androgen receptor signaling pathway
TTDI02184;WP1528;Physiological and Pathological Hypertrophy of the Heart
TTDI02184;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDI02184;WP1559;TFs Regulate miRNAs related to cardiac hypertrophy
TTDI02184;WP1873;NGF signalling via TRKA from the plasma membrane
TTDI02184;WP1916;Signaling by PDGF
TTDI02184;WP2023;Cell Differentiation - meta
TTDI02184;WP2029;Cell Differentiation - Index
TTDI02184;WP2032;TSH signaling pathway
TTDI02184;WP2034;Leptin signaling pathway
TTDI02184;WP2038;Regulation of Microtubule Cytoskeleton
TTDI02184;WP205;IL-7 Signaling Pathway
TTDI02184;WP2112;IL17 signaling pathway
TTDI02184;WP2203;TSLP Signaling Pathway
TTDI02184;WP2263;Prostate Cancer
TTDI02184;WP22;IL-9 Signaling Pathway
TTDI02184;WP2324;AGE/RAGE pathway
TTDI02184;WP2332;Interleukin-11 Signaling Pathway
TTDI02184;WP236;Adipogenesis
TTDI02184;WP2374;Oncostatin M Signaling Pathway
TTDI02184;WP2380;BDNF signaling pathway
TTDI02184;WP2526;PDGF Pathway
TTDI02184;WP2593;JAK/STAT
TTDI02184;WP2657;Growth hormone receptor signaling
TTDI02184;WP2704;Interleukin-6 signaling
TTDI02184;WP2713;Signaling by SCF-KIT
TTDI02184;WP2815;Mammary gland development pathway - Involution (Stage 4 of 4)
TTDI02184;WP2821;Transcriptional regulation of pluripotent stem cells
TTDI02184;WP2855;Dopaminergic Neurogenesis
TTDI02184;WP2868;TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer
TTDI02184;WP286;IL-3 Signaling Pathway
TTDI02184;WP2881;Estrogen Receptor Pathway
TTDI02184;WP2882;Nuclear Receptors Meta-Pathway
TTDI02184;WP304;Kit receptor signaling pathway
TTDI02184;WP313;Signaling of Hepatocyte Growth Factor Receptor
TTDI02184;WP364;IL-6 signaling pathway
TTDI02184;WP395;IL-4 Signaling Pathway
TTDI02184;WP437;EGF/EGFR Signaling Pathway
TTDI02184;WP49;IL-2 Signaling Pathway
TTDI02184;WP560;TGF Beta Signaling Pathway
TTDI02184;WP581;EPO Receptor Signaling
TTDI02184;WP585;Interferon type I signaling pathways
TTDI02184;WP61;Notch Signaling Pathway
TTDI02184;WP733;Serotonin Receptor 2 and STAT3 Signaling
TTDI02186;WP2059;Alzheimers Disease
TTDI02186;WP2359;Parkin-Ubiquitin Proteasomal System pathway
TTDI02186;WP2371;Parkinsons Disease Pathway
TTDI02186;WP2858;Ectoderm Differentiation
TTDI02188;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02190;WP1984;Integrated Breast Cancer Pathway
TTDI02190;WP2001;miR-targeted genes in adipocytes - TarBase
TTDI02190;WP2002;miR-targeted genes in epithelium - TarBase
TTDI02190;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDI02190;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI02190;WP2006;miR-targeted genes in squamous cell - TarBase
TTDI02190;WP2742;Signaling by TGF-beta Receptor Complex
TTDI02190;WP2870;Extracellular vesicle-mediated signaling in recipient cells
TTDI02190;WP2882;Nuclear Receptors Meta-Pathway
TTDI02190;WP2884;NRF2 pathway
TTDI02190;WP366;TGF beta Signaling Pathway
TTDI02190;WP382;MAPK Signaling Pathway
TTDI02190;WP560;TGF Beta Signaling Pathway
TTDI02191;WP1449;Regulation of toll-like receptor signaling pathway
TTDI02191;WP2272;Pathogenic Escherichia coli infection
TTDI02191;WP2775;Toll-Like Receptors Cascades
TTDI02191;WP2801;MyD88 cascade initiated on plasma membrane
TTDI02191;WP75;Toll-like receptor signaling pathway
TTDI02192;WP1449;Regulation of toll-like receptor signaling pathway
TTDI02192;WP2761;MyD88:Mal cascade initiated on plasma membrane
TTDI02192;WP2775;Toll-Like Receptors Cascades
TTDI02192;WP75;Toll-like receptor signaling pathway
TTDI02193;WP1742;TP53 Network
TTDI02193;WP1772;Apoptosis Modulation and Signaling
TTDI02193;WP1814;Extrinsic Pathway for Apoptosis
TTDI02193;WP254;Apoptosis
TTDI02194;WP2203;TSLP Signaling Pathway
TTDI02194;WP2877;Vitamin D Receptor Pathway
TTDI02195;WP1864;Muscle contraction
TTDI02195;WP383;Striated Muscle Contraction
TTDI02196;WP2036;TWEAK Signaling Pathway
TTDI02199;WP1530;miRNA Regulation of DNA Damage Response
TTDI02199;WP1772;Apoptosis Modulation and Signaling
TTDI02199;WP1814;Extrinsic Pathway for Apoptosis
TTDI02199;WP2059;Alzheimers Disease
TTDI02199;WP2328;Allograft Rejection
TTDI02199;WP236;Adipogenesis
TTDI02199;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02199;WP254;Apoptosis
TTDI02199;WP314;FAS pathway and Stress induction of HSP regulation
TTDI02199;WP382;MAPK Signaling Pathway
TTDI02199;WP384;Apoptosis Modulation by HSP70
TTDI02199;WP69;TCR Signaling Pathway
TTDI02199;WP707;DNA Damage Response
TTDI02200;WP1846;Membrane Trafficking
TTDI02200;WP2658;HIV Life Cycle
TTDI02201;WP1833;Integrin cell surface interactions
TTDI02201;WP1916;Signaling by PDGF
TTDI02201;WP2003;miR-targeted genes in leukocytes - TarBase
TTDI02201;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI02201;WP2006;miR-targeted genes in squamous cell - TarBase
TTDI02201;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02201;WP2787;Syndecan interactions
TTDI02201;WP2806;Human Complement System
TTDI02201;WP2828;Bladder Cancer
TTDI02201;WP2864;Apoptosis-related network due to altered Notch3 in ovarian cancer
TTDI02201;WP2911;miRNA targets in ECM and membrane receptors
TTDI02201;WP306;Focal Adhesion
TTDI02201;WP366;TGF beta Signaling Pathway
TTDI02201;WP453;Inflammatory Response Pathway
TTDI02201;WP560;TGF Beta Signaling Pathway
TTDI02201;WP615;Senescence and Autophagy in Cancer
TTDI02202;WP2003;miR-targeted genes in leukocytes - TarBase
TTDI02202;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDI02202;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI02204;WP98;Prostaglandin Synthesis and Regulation
TTDI02205;WP2572;Primary Focal Segmental Glomerulosclerosis FSGS
TTDI02208;WP1824;GPCR downstream signaling
TTDI02208;WP1825;GPCR ligand binding
TTDI02208;WP334;GPCRs, Class B Secretin-like
TTDI02208;WP706;SIDS Susceptibility Pathways
TTDI02209;WP2658;HIV Life Cycle
TTDI02209;WP2684;Host Interactions of HIV factors
TTDI02210;WP1824;GPCR downstream signaling
TTDI02210;WP1825;GPCR ligand binding
TTDI02210;WP1873;NGF signalling via TRKA from the plasma membrane
TTDI02210;WP706;SIDS Susceptibility Pathways
TTDI02211;WP1824;GPCR downstream signaling
TTDI02211;WP1825;GPCR ligand binding
TTDI02219;WP1873;NGF signalling via TRKA from the plasma membrane
TTDI02219;WP1976;Signalling by NGF
TTDI02219;WP2380;BDNF signaling pathway
TTDI02219;WP382;MAPK Signaling Pathway
TTDI02219;WP706;SIDS Susceptibility Pathways
TTDI02220;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDI02221;WP1927;TCR signaling
TTDI02221;WP2272;Pathogenic Escherichia coli infection
TTDI02221;WP2719;Fcgamma receptor (FCGR) dependent phagocytosis
TTDI02221;WP2806;Human Complement System
TTDI02221;WP51;Regulation of Actin Cytoskeleton
TTDI02221;WP524;G13 Signaling Pathway
TTDI02221;WP69;TCR Signaling Pathway
TTDI02222;WP1780;ABC-family proteins mediated transport
TTDI02222;WP2776;Visual phototransduction
TTDI02223;WP2652;Mitotic Prometaphase
TTDI02223;WP2757;Mitotic Metaphase and Anaphase
TTDI02226;WP1591;Heart Development
TTDI02226;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02226;WP2804;Hair Follicle Development: Induction (Part 1 of 3)
TTDI02226;WP2839;Hair Follicle Development: Organogenesis (Part 2 of 3)
TTDI02226;WP2848;Differentiation Pathway
TTDI02226;WP2855;Dopaminergic Neurogenesis
TTDI02226;WP2858;Ectoderm Differentiation
TTDI02226;WP47;Hedgehog Signaling Pathway
TTDI02228;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDI02228;WP1926;Synthesis, Secretion, and Deacylation of Ghrelin
TTDI02228;WP236;Adipogenesis
TTDI02228;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02228;WP2406;Cardiac Progenitor Differentiation
TTDI02228;WP254;Apoptosis
TTDI02228;WP2571;Polycystic Kidney Disease Pathway
TTDI02228;WP2677;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
TTDI02228;WP2795;Cardiac Hypertrophic Response
TTDI02228;WP2799;Regulation of Insulin-like Growth Factor (IGF) Transport and Uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
TTDI02228;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDI02228;WP2848;Differentiation Pathway
TTDI02228;WP306;Focal Adhesion
TTDI02228;WP474;Endochondral Ossification
TTDI02228;WP615;Senescence and Autophagy in Cancer
TTDI02235;WP1539;Angiogenesis
TTDI02235;WP1591;Heart Development
TTDI02235;WP1919;Signaling by VEGF
TTDI02235;WP1984;Integrated Breast Cancer Pathway
TTDI02235;WP2328;Allograft Rejection
TTDI02235;WP2374;Oncostatin M Signaling Pathway
TTDI02235;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02235;WP2435;Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis
TTDI02235;WP2586;Aryl Hydrocarbon Receptor
TTDI02235;WP259;Nifedipine Activity
TTDI02235;WP2727;Regulation of Hypoxia-inducible Factor (HIF) by Oxygen
TTDI02235;WP2828;Bladder Cancer
TTDI02235;WP2848;Differentiation Pathway
TTDI02235;WP306;Focal Adhesion
TTDI02235;WP474;Endochondral Ossification
TTDI02235;WP516;Hypertrophy Model
TTDI02235;WP706;SIDS Susceptibility Pathways
TTDI02236;WP117;GPCRs, Other
TTDI02236;WP1824;GPCR downstream signaling
TTDI02236;WP1825;GPCR ligand binding
TTDI02236;WP24;Peptide GPCRs
TTDI02236;WP2658;HIV Life Cycle
TTDI02236;WP455;GPCRs, Class A Rhodopsin-like
TTDI02236;WP69;TCR Signaling Pathway
TTDI02237;WP127;IL-5 Signaling Pathway
TTDI02237;WP1449;Regulation of toll-like receptor signaling pathway
TTDI02237;WP1826;GPVI-mediated activation cascade
TTDI02237;WP1832;Integrin alphaIIb beta3 signaling
TTDI02237;WP2018;RANKL/RANK Signaling Pathway
TTDI02237;WP23;B Cell Receptor Signaling Pathway
TTDI02237;WP2694;DAP12 interactions
TTDI02237;WP2719;Fcgamma receptor (FCGR) dependent phagocytosis
TTDI02237;WP2732;Interleukin-2 signaling
TTDI02237;WP2746;Signaling by the B Cell Receptor (BCR)
TTDI02237;WP2759;Fc epsilon receptor (FCERI) signaling
TTDI02237;WP286;IL-3 Signaling Pathway
TTDI02237;WP49;IL-2 Signaling Pathway
TTDI02239;WP1449;Regulation of toll-like receptor signaling pathway
TTDI02239;WP1782;APC/C-mediated degradation of cell cycle proteins
TTDI02239;WP179;Cell Cycle
TTDI02239;WP1859;Mitotic G2-G2/M phases
TTDI02239;WP1971;Integrated Cancer pathway
TTDI02239;WP1984;Integrated Breast Cancer Pathway
TTDI02239;WP2002;miR-targeted genes in epithelium - TarBase
TTDI02239;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDI02239;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI02239;WP2263;Prostate Cancer
TTDI02239;WP231;TNF alpha Signaling Pathway
TTDI02239;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02239;WP2652;Mitotic Prometaphase
TTDI02239;WP2654;Mitotic Prophase
TTDI02239;WP2757;Mitotic Metaphase and Anaphase
TTDI02239;WP2765;Mitotic Telophase/Cytokinesis
TTDI02245;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDI02245;WP2032;TSH signaling pathway
TTDI02245;WP2261;Signaling Pathways in Glioblastoma
TTDI02245;WP254;Apoptosis
TTDI02245;WP2677;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
TTDI02245;WP306;Focal Adhesion
TTDI02245;WP474;Endochondral Ossification
TTDI02245;WP481;Insulin Signaling
TTDI02245;WP615;Senescence and Autophagy in Cancer
TTDI02248;WP2007;Iron metabolism in placenta
TTDI02248;WP2670;Iron uptake and transport
TTDI02248;WP2848;Differentiation Pathway
TTDI02248;WP706;SIDS Susceptibility Pathways
TTDI02249;WP138;Androgen receptor signaling pathway
TTDI02249;WP1843;L1CAM interactions
TTDI02249;WP1910;Signaling by EGFR
TTDI02249;WP1984;Integrated Breast Cancer Pathway
TTDI02249;WP2002;miR-targeted genes in epithelium - TarBase
TTDI02249;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDI02249;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI02249;WP2100;Arylhydrocarbon receptor (AhR) signaling pathway
TTDI02249;WP2261;Signaling Pathways in Glioblastoma
TTDI02249;WP2324;AGE/RAGE pathway
TTDI02249;WP2363;Gastric cancer network 2
TTDI02249;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02249;WP2431;Spinal Cord Injury
TTDI02249;WP2586;Aryl Hydrocarbon Receptor
TTDI02249;WP2643;Nanoparticle-mediated activation of receptor signaling
TTDI02249;WP2653;PIP3 activates AKT signaling
TTDI02249;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDI02249;WP2780;Signaling by ERBB2
TTDI02249;WP2781;Signaling by ERBB4
TTDI02249;WP2804;Hair Follicle Development: Induction (Part 1 of 3)
TTDI02249;WP2828;Bladder Cancer
TTDI02249;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDI02249;WP2868;TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer
TTDI02249;WP2870;Extracellular vesicle-mediated signaling in recipient cells
TTDI02249;WP2873;Aryl Hydrocarbon Receptor Pathway
TTDI02249;WP2882;Nuclear Receptors Meta-Pathway
TTDI02249;WP306;Focal Adhesion
TTDI02249;WP382;MAPK Signaling Pathway
TTDI02249;WP437;EGF/EGFR Signaling Pathway
TTDI02249;WP51;Regulation of Actin Cytoskeleton
TTDI02249;WP673;ErbB Signaling Pathway
TTDI02255;WP1772;Apoptosis Modulation and Signaling
TTDI02255;WP1976;Signalling by NGF
TTDI02255;WP2371;Parkinsons Disease Pathway
TTDI02255;WP254;Apoptosis
TTDI02255;WP382;MAPK Signaling Pathway
TTDI02255;WP384;Apoptosis Modulation by HSP70
TTDI02256;WP117;GPCRs, Other
TTDI02256;WP1824;GPCR downstream signaling
TTDI02256;WP1825;GPCR ligand binding
TTDI02256;WP2877;Vitamin D Receptor Pathway
TTDI02256;WP455;GPCRs, Class A Rhodopsin-like
TTDI02256;WP536;Calcium Regulation in the Cardiac Cell
TTDI02256;WP58;Monoamine GPCRs
TTDI02259;WP1601;Fluoropyrimidine Activity
TTDI02259;WP1851;Metabolism of nucleotides
TTDI02259;WP2446;Retinoblastoma (RB) in Cancer
TTDI02259;WP404;Nucleotide Metabolism
TTDI02260;WP127;IL-5 Signaling Pathway
TTDI02260;WP1438;Influenza A virus infection
TTDI02260;WP1742;TP53 Network
TTDI02260;WP1772;Apoptosis Modulation and Signaling
TTDI02260;WP1841;Intrinsic Pathway for Apoptosis
TTDI02260;WP1971;Integrated Cancer pathway
TTDI02260;WP1984;Integrated Breast Cancer Pathway
TTDI02260;WP2003;miR-targeted genes in leukocytes - TarBase
TTDI02260;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDI02260;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI02260;WP2263;Prostate Cancer
TTDI02260;WP2332;Interleukin-11 Signaling Pathway
TTDI02260;WP2355;Corticotropin-releasing hormone
TTDI02260;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02260;WP2447;Amyotrophic lateral sclerosis (ALS)
TTDI02260;WP2509;Nanoparticle triggered autophagic cell death
TTDI02260;WP254;Apoptosis
TTDI02260;WP2763;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
TTDI02260;WP286;IL-3 Signaling Pathway
TTDI02260;WP304;Kit receptor signaling pathway
TTDI02260;WP306;Focal Adhesion
TTDI02260;WP314;FAS pathway and Stress induction of HSP regulation
TTDI02260;WP49;IL-2 Signaling Pathway
TTDI02260;WP615;Senescence and Autophagy in Cancer
TTDI02260;WP710;DNA Damage Response (only ATM dependent)
TTDI02260;WP712;Estrogen signaling pathway
TTDI02261;WP1818;Formation of Fibrin Clot (Clotting Cascade)
TTDI02261;WP272;Blood Clotting Cascade
TTDI02261;WP2806;Human Complement System
TTDI02261;WP558;Complement and Coagulation Cascades
TTDI02262;WP1604;Codeine and Morphine Metabolism
TTDI02262;WP206;Fatty Acid Omega Oxidation
TTDI02262;WP2289;Drug Induction of Bile Acid Pathway
TTDI02262;WP229;Irinotecan Pathway
TTDI02262;WP2536;Colchicine Metabolic Pathway
TTDI02262;WP259;Nifedipine Activity
TTDI02262;WP2646;Lidocaine metabolism
TTDI02262;WP2816;Felbamate Metabolism
TTDI02262;WP2874;Liver X Receptor Pathway
TTDI02262;WP2875;Constitutive Androstane Receptor Pathway
TTDI02262;WP2876;Pregnane X Receptor pathway
TTDI02262;WP2877;Vitamin D Receptor Pathway
TTDI02262;WP2879;Farnesoid X Receptor Pathway
TTDI02262;WP2882;Nuclear Receptors Meta-Pathway
TTDI02262;WP299;Nuclear Receptors in Lipid Metabolism and Toxicity
TTDI02262;WP43;Oxidation by Cytochrome P450
TTDI02262;WP465;Tryptophan metabolism
TTDI02262;WP691;Tamoxifen metabolism
TTDI02262;WP696;Benzo(a)pyrene metabolism
TTDI02262;WP697;Estrogen metabolism
TTDI02262;WP699;Aflatoxin B1 metabolism
TTDI02262;WP702;Metapathway biotransformation
TTDI02266;WP2764;Lipid digestion, mobilization, and transport
TTDI02268;WP127;IL-5 Signaling Pathway
TTDI02268;WP1530;miRNA Regulation of DNA Damage Response
TTDI02268;WP1545;miRNAs involved in DNA damage response
TTDI02268;WP1742;TP53 Network
TTDI02268;WP1858;Mitotic G1-G1/S phases
TTDI02268;WP1971;Integrated Cancer pathway
TTDI02268;WP1984;Integrated Breast Cancer Pathway
TTDI02268;WP2032;TSH signaling pathway
TTDI02268;WP205;IL-7 Signaling Pathway
TTDI02268;WP2064;Neural Crest Differentiation
TTDI02268;WP2203;TSLP Signaling Pathway
TTDI02268;WP2249;Metastatic brain tumor
TTDI02268;WP2263;Prostate Cancer
TTDI02268;WP2363;Gastric cancer network 2
TTDI02268;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02268;WP23;B Cell Receptor Signaling Pathway
TTDI02268;WP2431;Spinal Cord Injury
TTDI02268;WP2446;Retinoblastoma (RB) in Cancer
TTDI02268;WP254;Apoptosis
TTDI02268;WP2571;Polycystic Kidney Disease Pathway
TTDI02268;WP2586;Aryl Hydrocarbon Receptor
TTDI02268;WP2637;Structural Pathway of Interleukin 1 (IL-1)
TTDI02268;WP2720;Signaling by NOTCH1
TTDI02268;WP2755;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
TTDI02268;WP2772;S Phase
TTDI02268;WP2804;Hair Follicle Development: Induction (Part 1 of 3)
TTDI02268;WP2815;Mammary gland development pathway - Involution (Stage 4 of 4)
TTDI02268;WP2828;Bladder Cancer
TTDI02268;WP2839;Hair Follicle Development: Organogenesis (Part 2 of 3)
TTDI02268;WP2858;Ectoderm Differentiation
TTDI02268;WP2877;Vitamin D Receptor Pathway
TTDI02268;WP2878;PPAR Alpha Pathway
TTDI02268;WP2882;Nuclear Receptors Meta-Pathway
TTDI02268;WP363;Wnt Signaling Pathway Netpath
TTDI02268;WP366;TGF beta Signaling Pathway
TTDI02268;WP382;MAPK Signaling Pathway
TTDI02268;WP399;Wnt Signaling Pathway and Pluripotency
TTDI02268;WP400;p38 MAPK Signaling Pathway
TTDI02268;WP428;Wnt Signaling Pathway
TTDI02268;WP45;G1 to S cell cycle control
TTDI02268;WP49;IL-2 Signaling Pathway
TTDI02268;WP61;Notch Signaling Pathway
TTDI02268;WP673;ErbB Signaling Pathway
TTDI02268;WP707;DNA Damage Response
TTDI02268;WP710;DNA Damage Response (only ATM dependent)
TTDI02269;WP2038;Regulation of Microtubule Cytoskeleton
TTDI02269;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02269;WP2446;Retinoblastoma (RB) in Cancer
TTDI02269;WP382;MAPK Signaling Pathway
TTDI02269;WP437;EGF/EGFR Signaling Pathway
TTDI02270;WP2858;Ectoderm Differentiation
TTDI02271;WP2848;Differentiation Pathway
TTDI02273;WP127;IL-5 Signaling Pathway
TTDI02273;WP1794;Cell surface interactions at the vascular wall
TTDI02273;WP1799;Costimulation by the CD28 family
TTDI02273;WP1826;GPVI-mediated activation cascade
TTDI02273;WP1883;Platelet Adhesion to exposed collagen
TTDI02273;WP2018;RANKL/RANK Signaling Pathway
TTDI02273;WP2203;TSLP Signaling Pathway
TTDI02273;WP23;B Cell Receptor Signaling Pathway
TTDI02273;WP2657;Growth hormone receptor signaling
TTDI02273;WP2713;Signaling by SCF-KIT
TTDI02273;WP2746;Signaling by the B Cell Receptor (BCR)
TTDI02273;WP2759;Fc epsilon receptor (FCERI) signaling
TTDI02273;WP286;IL-3 Signaling Pathway
TTDI02273;WP304;Kit receptor signaling pathway
TTDI02274;WP127;IL-5 Signaling Pathway
TTDI02274;WP1449;Regulation of toll-like receptor signaling pathway
TTDI02274;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDI02274;WP1843;L1CAM interactions
TTDI02274;WP185;Integrin-mediated Cell Adhesion
TTDI02274;WP1911;Signaling by FGFR
TTDI02274;WP195;IL-1 signaling pathway
TTDI02274;WP2034;Leptin signaling pathway
TTDI02274;WP205;IL-7 Signaling Pathway
TTDI02274;WP2203;TSLP Signaling Pathway
TTDI02274;WP2261;Signaling Pathways in Glioblastoma
TTDI02274;WP2263;Prostate Cancer
TTDI02274;WP22;IL-9 Signaling Pathway
TTDI02274;WP2332;Interleukin-11 Signaling Pathway
TTDI02274;WP2374;Oncostatin M Signaling Pathway
TTDI02274;WP2380;BDNF signaling pathway
TTDI02274;WP23;B Cell Receptor Signaling Pathway
TTDI02274;WP2447;Amyotrophic lateral sclerosis (ALS)
TTDI02274;WP2636;Genes and (Common) Pathways Underlying Drug Addiction
TTDI02274;WP2637;Structural Pathway of Interleukin 1 (IL-1)
TTDI02274;WP2643;Nanoparticle-mediated activation of receptor signaling
TTDI02274;WP2735;RAF/MAP kinase cascade
TTDI02274;WP2792;MAP kinase activation in TLR cascade
TTDI02274;WP2795;Cardiac Hypertrophic Response
TTDI02274;WP2828;Bladder Cancer
TTDI02274;WP304;Kit receptor signaling pathway
TTDI02274;WP306;Focal Adhesion
TTDI02274;WP313;Signaling of Hepatocyte Growth Factor Receptor
TTDI02274;WP364;IL-6 signaling pathway
TTDI02274;WP366;TGF beta Signaling Pathway
TTDI02274;WP382;MAPK Signaling Pathway
TTDI02274;WP422;MAPK Cascade
TTDI02274;WP437;EGF/EGFR Signaling Pathway
TTDI02274;WP481;Insulin Signaling
TTDI02274;WP49;IL-2 Signaling Pathway
TTDI02274;WP51;Regulation of Actin Cytoskeleton
TTDI02274;WP581;EPO Receptor Signaling
TTDI02274;WP666;Hypothetical Network for Drug Addiction
TTDI02274;WP69;TCR Signaling Pathway
TTDI02274;WP722;Serotonin HTR1 Group and FOS Pathway
TTDI02274;WP732;Serotonin Receptor 2 and ELK-SRF/GATA4 signaling
TTDI02274;WP734;Serotonin Receptor 4/6/7 and NR3C Signaling
TTDI02274;WP75;Toll-like receptor signaling pathway
TTDI02276;WP138;Androgen receptor signaling pathway
TTDI02276;WP1539;Angiogenesis
TTDI02276;WP185;Integrin-mediated Cell Adhesion
TTDI02276;WP2018;RANKL/RANK Signaling Pathway
TTDI02276;WP2032;TSH signaling pathway
TTDI02276;WP2034;Leptin signaling pathway
TTDI02276;WP2035;FSH signaling pathway
TTDI02276;WP2038;Regulation of Microtubule Cytoskeleton
TTDI02276;WP2100;Arylhydrocarbon receptor (AhR) signaling pathway
TTDI02276;WP2203;TSLP Signaling Pathway
TTDI02276;WP2261;Signaling Pathways in Glioblastoma
TTDI02276;WP2324;AGE/RAGE pathway
TTDI02276;WP2332;Interleukin-11 Signaling Pathway
TTDI02276;WP2374;Oncostatin M Signaling Pathway
TTDI02276;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02276;WP2380;BDNF signaling pathway
TTDI02276;WP244;Alpha 6 Beta 4 signaling pathway
TTDI02276;WP2571;Polycystic Kidney Disease Pathway
TTDI02276;WP2586;Aryl Hydrocarbon Receptor
TTDI02276;WP2643;Nanoparticle-mediated activation of receptor signaling
TTDI02276;WP286;IL-3 Signaling Pathway
TTDI02276;WP2873;Aryl Hydrocarbon Receptor Pathway
TTDI02276;WP2876;Pregnane X Receptor pathway
TTDI02276;WP2882;Nuclear Receptors Meta-Pathway
TTDI02276;WP304;Kit receptor signaling pathway
TTDI02276;WP306;Focal Adhesion
TTDI02276;WP313;Signaling of Hepatocyte Growth Factor Receptor
TTDI02276;WP366;TGF beta Signaling Pathway
TTDI02276;WP437;EGF/EGFR Signaling Pathway
TTDI02276;WP581;EPO Receptor Signaling
TTDI02276;WP615;Senescence and Autophagy in Cancer
TTDI02276;WP61;Notch Signaling Pathway
TTDI02276;WP673;ErbB Signaling Pathway
TTDI02277;WP1794;Cell surface interactions at the vascular wall
TTDI02277;WP1799;Costimulation by the CD28 family
TTDI02277;WP1826;GPVI-mediated activation cascade
TTDI02277;WP185;Integrin-mediated Cell Adhesion
TTDI02277;WP1866;NCAM signaling for neurite out-growth
TTDI02277;WP1867;Nephrin interactions
TTDI02277;WP1868;Netrin-1 signaling
TTDI02277;WP1883;Platelet Adhesion to exposed collagen
TTDI02277;WP1907;Semaphorin interactions
TTDI02277;WP2034;Leptin signaling pathway
TTDI02277;WP205;IL-7 Signaling Pathway
TTDI02277;WP2203;TSLP Signaling Pathway
TTDI02277;WP2272;Pathogenic Escherichia coli infection
TTDI02277;WP2332;Interleukin-11 Signaling Pathway
TTDI02277;WP2380;BDNF signaling pathway
TTDI02277;WP23;B Cell Receptor Signaling Pathway
TTDI02277;WP2572;Primary Focal Segmental Glomerulosclerosis FSGS
TTDI02277;WP2583;T-Cell Receptor and Co-stimulatory Signaling
TTDI02277;WP2653;PIP3 activates AKT signaling
TTDI02277;WP2684;Host Interactions of HIV factors
TTDI02277;WP2694;DAP12 interactions
TTDI02277;WP2713;Signaling by SCF-KIT
TTDI02277;WP2746;Signaling by the B Cell Receptor (BCR)
TTDI02277;WP2759;Fc epsilon receptor (FCERI) signaling
TTDI02277;WP2858;Ectoderm Differentiation
TTDI02277;WP286;IL-3 Signaling Pathway
TTDI02277;WP304;Kit receptor signaling pathway
TTDI02277;WP306;Focal Adhesion
TTDI02277;WP49;IL-2 Signaling Pathway
TTDI02277;WP585;Interferon type I signaling pathways
TTDI02277;WP69;TCR Signaling Pathway
TTDI02278;WP1799;Costimulation by the CD28 family
TTDI02278;WP1927;TCR signaling
TTDI02278;WP2203;TSLP Signaling Pathway
TTDI02278;WP23;B Cell Receptor Signaling Pathway
TTDI02278;WP2583;T-Cell Receptor and Co-stimulatory Signaling
TTDI02278;WP2653;PIP3 activates AKT signaling
TTDI02278;WP2684;Host Interactions of HIV factors
TTDI02278;WP2694;DAP12 interactions
TTDI02278;WP2713;Signaling by SCF-KIT
TTDI02278;WP453;Inflammatory Response Pathway
TTDI02278;WP49;IL-2 Signaling Pathway
TTDI02278;WP585;Interferon type I signaling pathways
TTDI02278;WP61;Notch Signaling Pathway
TTDI02280;WP1907;Semaphorin interactions
TTDI02280;WP2002;miR-targeted genes in epithelium - TarBase
TTDI02280;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDI02280;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI02280;WP2006;miR-targeted genes in squamous cell - TarBase
TTDI02280;WP2261;Signaling Pathways in Glioblastoma
TTDI02280;WP2870;Extracellular vesicle-mediated signaling in recipient cells
TTDI02280;WP306;Focal Adhesion
TTDI02280;WP313;Signaling of Hepatocyte Growth Factor Receptor
TTDI02280;WP366;TGF beta Signaling Pathway
TTDI02281;WP1840;Interleukin-3, 5 and GM-CSF signaling
TTDI02281;WP205;IL-7 Signaling Pathway
TTDI02281;WP22;IL-9 Signaling Pathway
TTDI02281;WP2374;Oncostatin M Signaling Pathway
TTDI02281;WP2673;Interleukin-7 signaling
TTDI02281;WP2732;Interleukin-2 signaling
TTDI02281;WP395;IL-4 Signaling Pathway
TTDI02281;WP49;IL-2 Signaling Pathway
TTDI02282;WP1539;Angiogenesis
TTDI02282;WP1919;Signaling by VEGF
TTDI02282;WP2406;Cardiac Progenitor Differentiation
TTDI02282;WP259;Nifedipine Activity
TTDI02282;WP306;Focal Adhesion
TTDI02283;WP1907;Semaphorin interactions
TTDI02283;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI02283;WP2034;Leptin signaling pathway
TTDI02283;WP2261;Signaling Pathways in Glioblastoma
TTDI02283;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02283;WP2780;Signaling by ERBB2
TTDI02283;WP2828;Bladder Cancer
TTDI02283;WP2870;Extracellular vesicle-mediated signaling in recipient cells
TTDI02283;WP306;Focal Adhesion
TTDI02283;WP437;EGF/EGFR Signaling Pathway
TTDI02283;WP673;ErbB Signaling Pathway
TTDI02283;WP710;DNA Damage Response (only ATM dependent)
TTDI02284;WP185;Integrin-mediated Cell Adhesion
TTDI02284;WP1873;NGF signalling via TRKA from the plasma membrane
TTDI02284;WP1911;Signaling by FGFR
TTDI02284;WP1984;Integrated Breast Cancer Pathway
TTDI02284;WP2032;TSH signaling pathway
TTDI02284;WP2261;Signaling Pathways in Glioblastoma
TTDI02284;WP2355;Corticotropin-releasing hormone
TTDI02284;WP23;B Cell Receptor Signaling Pathway
TTDI02284;WP2571;Polycystic Kidney Disease Pathway
TTDI02284;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDI02284;WP2828;Bladder Cancer
TTDI02284;WP306;Focal Adhesion
TTDI02284;WP382;MAPK Signaling Pathway
TTDI02284;WP422;MAPK Cascade
TTDI02284;WP437;EGF/EGFR Signaling Pathway
TTDI02284;WP51;Regulation of Actin Cytoskeleton
TTDI02284;WP615;Senescence and Autophagy in Cancer
TTDI02284;WP712;Estrogen signaling pathway
TTDI02284;WP722;Serotonin HTR1 Group and FOS Pathway
TTDI02284;WP734;Serotonin Receptor 4/6/7 and NR3C Signaling
TTDI02286;WP2743;Glycosaminoglycan metabolism
TTDI02287;WP127;IL-5 Signaling Pathway
TTDI02287;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDI02287;WP1823;GP1b-IX-V activation signalling
TTDI02287;WP185;Integrin-mediated Cell Adhesion
TTDI02287;WP1895;Rap1 signalling
TTDI02287;WP2032;TSH signaling pathway
TTDI02287;WP2034;Leptin signaling pathway
TTDI02287;WP2035;FSH signaling pathway
TTDI02287;WP2036;TWEAK Signaling Pathway
TTDI02287;WP2197;Endothelin Pathways
TTDI02287;WP2261;Signaling Pathways in Glioblastoma
TTDI02287;WP2263;Prostate Cancer
TTDI02287;WP231;TNF alpha Signaling Pathway
TTDI02287;WP2324;AGE/RAGE pathway
TTDI02287;WP2332;Interleukin-11 Signaling Pathway
TTDI02287;WP2355;Corticotropin-releasing hormone
TTDI02287;WP2374;Oncostatin M Signaling Pathway
TTDI02287;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02287;WP2380;BDNF signaling pathway
TTDI02287;WP23;B Cell Receptor Signaling Pathway
TTDI02287;WP2446;Retinoblastoma (RB) in Cancer
TTDI02287;WP2526;PDGF Pathway
TTDI02287;WP2586;Aryl Hydrocarbon Receptor
TTDI02287;WP2643;Nanoparticle-mediated activation of receptor signaling
TTDI02287;WP2670;Iron uptake and transport
TTDI02287;WP2735;RAF/MAP kinase cascade
TTDI02287;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDI02287;WP2795;Cardiac Hypertrophic Response
TTDI02287;WP286;IL-3 Signaling Pathway
TTDI02287;WP2870;Extracellular vesicle-mediated signaling in recipient cells
TTDI02287;WP304;Kit receptor signaling pathway
TTDI02287;WP306;Focal Adhesion
TTDI02287;WP313;Signaling of Hepatocyte Growth Factor Receptor
TTDI02287;WP366;TGF beta Signaling Pathway
TTDI02287;WP382;MAPK Signaling Pathway
TTDI02287;WP422;MAPK Cascade
TTDI02287;WP437;EGF/EGFR Signaling Pathway
TTDI02287;WP481;Insulin Signaling
TTDI02287;WP49;IL-2 Signaling Pathway
TTDI02287;WP51;Regulation of Actin Cytoskeleton
TTDI02287;WP581;EPO Receptor Signaling
TTDI02287;WP615;Senescence and Autophagy in Cancer
TTDI02287;WP69;TCR Signaling Pathway
TTDI02287;WP732;Serotonin Receptor 2 and ELK-SRF/GATA4 signaling
TTDI02290;WP2586;Aryl Hydrocarbon Receptor
TTDI02290;WP2855;Dopaminergic Neurogenesis
TTDI02290;WP706;SIDS Susceptibility Pathways
TTDI02291;WP2703;Extracellular matrix organization
TTDI02291;WP2776;Visual phototransduction
TTDI02294;WP2715;Metabolism of non-coding RNA
TTDI02295;WP2776;Visual phototransduction
TTDI02295;WP716;Vitamin A and Carotenoid Metabolism
TTDI02296;WP2113;Type III interferon signaling
TTDI02297;WP1403;AMPK Signaling
TTDI02297;WP1449;Regulation of toll-like receptor signaling pathway
TTDI02297;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDI02297;WP1794;Cell surface interactions at the vascular wall
TTDI02297;WP1826;GPVI-mediated activation cascade
TTDI02297;WP1840;Interleukin-3, 5 and GM-CSF signaling
TTDI02297;WP1867;Nephrin interactions
TTDI02297;WP1873;NGF signalling via TRKA from the plasma membrane
TTDI02297;WP1913;Signaling by Insulin receptor
TTDI02297;WP1916;Signaling by PDGF
TTDI02297;WP1927;TCR signaling
TTDI02297;WP2261;Signaling Pathways in Glioblastoma
TTDI02297;WP2653;PIP3 activates AKT signaling
TTDI02297;WP2677;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
TTDI02297;WP2694;DAP12 interactions
TTDI02297;WP2719;Fcgamma receptor (FCGR) dependent phagocytosis
TTDI02297;WP2732;Interleukin-2 signaling
TTDI02297;WP2747;PI Metabolism
TTDI02297;WP2759;Fc epsilon receptor (FCERI) signaling
TTDI02297;WP306;Focal Adhesion
TTDI02297;WP481;Insulin Signaling
TTDI02297;WP51;Regulation of Actin Cytoskeleton
TTDI02297;WP524;G13 Signaling Pathway
TTDI02297;WP710;DNA Damage Response (only ATM dependent)
TTDI02297;WP75;Toll-like receptor signaling pathway
TTDI02298;WP1449;Regulation of toll-like receptor signaling pathway
TTDI02298;WP1533;Vitamin B12 Metabolism
TTDI02298;WP15;Selenium Micronutrient Network
TTDI02298;WP176;Folate Metabolism
TTDI02298;WP1838;Interleukin-1 processing
TTDI02298;WP1904;RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
TTDI02298;WP2018;RANKL/RANK Signaling Pathway
TTDI02298;WP2036;TWEAK Signaling Pathway
TTDI02298;WP2064;Neural Crest Differentiation
TTDI02298;WP2203;TSLP Signaling Pathway
TTDI02298;WP231;TNF alpha Signaling Pathway
TTDI02298;WP262;EBV LMP1 signaling
TTDI02298;WP2656;TAK1 activates NFkB by phosphorylation and activation of IKKs complex
TTDI02298;WP2794;Cytosolic sensors of pathogen-associated DNA
TTDI02298;WP2882;Nuclear Receptors Meta-Pathway
TTDI02298;WP706;SIDS Susceptibility Pathways
TTDI02298;WP710;DNA Damage Response (only ATM dependent)
TTDI02298;WP75;Toll-like receptor signaling pathway
TTDI02299;WP1584;Type II diabetes mellitus
TTDI02299;WP1873;NGF signalling via TRKA from the plasma membrane
TTDI02299;WP1913;Signaling by Insulin receptor
TTDI02299;WP1984;Integrated Breast Cancer Pathway
TTDI02299;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDI02299;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI02299;WP2034;Leptin signaling pathway
TTDI02299;WP2261;Signaling Pathways in Glioblastoma
TTDI02299;WP2324;AGE/RAGE pathway
TTDI02299;WP236;Adipogenesis
TTDI02299;WP2374;Oncostatin M Signaling Pathway
TTDI02299;WP2380;BDNF signaling pathway
TTDI02299;WP244;Alpha 6 Beta 4 signaling pathway
TTDI02299;WP2653;PIP3 activates AKT signaling
TTDI02299;WP2677;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
TTDI02299;WP395;IL-4 Signaling Pathway
TTDI02299;WP481;Insulin Signaling
TTDI02299;WP581;EPO Receptor Signaling
TTDI02299;WP585;Interferon type I signaling pathways
TTDI02299;WP710;DNA Damage Response (only ATM dependent)
TTDI02300;WP1864;Muscle contraction
TTDI02300;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDI02300;WP2703;Extracellular matrix organization
TTDI02300;WP2858;Ectoderm Differentiation
TTDI02300;WP383;Striated Muscle Contraction
TTDI02301;WP111;Electron Transport Chain
TTDI02301;WP1902;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.
TTDI02303;WP136;Phase I biotransformations, non P450
TTDI02306;WP2666;Elastic fibre formation
TTDI02306;WP2703;Extracellular matrix organization
TTDI02306;WP2870;Extracellular vesicle-mediated signaling in recipient cells
TTDI02306;WP2877;Vitamin D Receptor Pathway
TTDI02306;WP2882;Nuclear Receptors Meta-Pathway
TTDI02306;WP2884;NRF2 pathway
TTDI02306;WP382;MAPK Signaling Pathway
TTDI02306;WP400;p38 MAPK Signaling Pathway
TTDI02306;WP474;Endochondral Ossification
TTDI02308;WP1772;Apoptosis Modulation and Signaling
TTDI02308;WP2332;Interleukin-11 Signaling Pathway
TTDI02308;WP254;Apoptosis
TTDI02308;WP2652;Mitotic Prometaphase
TTDI02308;WP2757;Mitotic Metaphase and Anaphase
TTDI02308;WP2864;Apoptosis-related network due to altered Notch3 in ovarian cancer
TTDI02308;WP395;IL-4 Signaling Pathway
TTDI02311;WP127;IL-5 Signaling Pathway
TTDI02311;WP138;Androgen receptor signaling pathway
TTDI02311;WP1403;AMPK Signaling
TTDI02311;WP1449;Regulation of toll-like receptor signaling pathway
TTDI02311;WP1471;TOR Signaling
TTDI02311;WP1539;Angiogenesis
TTDI02311;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDI02311;WP1559;TFs Regulate miRNAs related to cardiac hypertrophy
TTDI02311;WP1850;Metabolism of nitric oxide
TTDI02311;WP185;Integrin-mediated Cell Adhesion
TTDI02311;WP195;IL-1 signaling pathway
TTDI02311;WP1971;Integrated Cancer pathway
TTDI02311;WP1982;SREBP signalling
TTDI02311;WP1984;Integrated Breast Cancer Pathway
TTDI02311;WP2018;RANKL/RANK Signaling Pathway
TTDI02311;WP2032;TSH signaling pathway
TTDI02311;WP2034;Leptin signaling pathway
TTDI02311;WP2035;FSH signaling pathway
TTDI02311;WP2036;TWEAK Signaling Pathway
TTDI02311;WP2038;Regulation of Microtubule Cytoskeleton
TTDI02311;WP205;IL-7 Signaling Pathway
TTDI02311;WP2112;IL17 signaling pathway
TTDI02311;WP2203;TSLP Signaling Pathway
TTDI02311;WP2261;Signaling Pathways in Glioblastoma
TTDI02311;WP2263;Prostate Cancer
TTDI02311;WP231;TNF alpha Signaling Pathway
TTDI02311;WP2324;AGE/RAGE pathway
TTDI02311;WP2332;Interleukin-11 Signaling Pathway
TTDI02311;WP2355;Corticotropin-releasing hormone
TTDI02311;WP2374;Oncostatin M Signaling Pathway
TTDI02311;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02311;WP2380;BDNF signaling pathway
TTDI02311;WP23;B Cell Receptor Signaling Pathway
TTDI02311;WP244;Alpha 6 Beta 4 signaling pathway
TTDI02311;WP254;Apoptosis
TTDI02311;WP2572;Primary Focal Segmental Glomerulosclerosis FSGS
TTDI02311;WP2583;T-Cell Receptor and Co-stimulatory Signaling
TTDI02311;WP2653;PIP3 activates AKT signaling
TTDI02311;WP26;Signal Transduction of S1P Receptor
TTDI02311;WP2733;Regulation of mRNA Stability by Proteins that Bind AU-rich Elements
TTDI02311;WP2777;Translocation of GLUT4 to the Plasma Membrane
TTDI02311;WP2795;Cardiac Hypertrophic Response
TTDI02311;WP2864;Apoptosis-related network due to altered Notch3 in ovarian cancer
TTDI02311;WP286;IL-3 Signaling Pathway
TTDI02311;WP2870;Extracellular vesicle-mediated signaling in recipient cells
TTDI02311;WP304;Kit receptor signaling pathway
TTDI02311;WP306;Focal Adhesion
TTDI02311;WP3286;Copper homeostasis
TTDI02311;WP363;Wnt Signaling Pathway Netpath
TTDI02311;WP364;IL-6 signaling pathway
TTDI02311;WP366;TGF beta Signaling Pathway
TTDI02311;WP382;MAPK Signaling Pathway
TTDI02311;WP395;IL-4 Signaling Pathway
TTDI02311;WP437;EGF/EGFR Signaling Pathway
TTDI02311;WP474;Endochondral Ossification
TTDI02311;WP481;Insulin Signaling
TTDI02311;WP49;IL-2 Signaling Pathway
TTDI02311;WP581;EPO Receptor Signaling
TTDI02311;WP61;Notch Signaling Pathway
TTDI02311;WP69;TCR Signaling Pathway
TTDI02311;WP710;DNA Damage Response (only ATM dependent)
TTDI02311;WP712;Estrogen signaling pathway
TTDI02311;WP75;Toll-like receptor signaling pathway
TTDI02313;WP455;GPCRs, Class A Rhodopsin-like
TTDI02313;WP554;ACE Inhibitor Pathway
TTDI02315;WP1530;miRNA Regulation of DNA Damage Response
TTDI02315;WP179;Cell Cycle
TTDI02315;WP1858;Mitotic G1-G1/S phases
TTDI02315;WP1971;Integrated Cancer pathway
TTDI02315;WP1984;Integrated Breast Cancer Pathway
TTDI02315;WP2032;TSH signaling pathway
TTDI02315;WP2261;Signaling Pathways in Glioblastoma
TTDI02315;WP2263;Prostate Cancer
TTDI02315;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02315;WP2431;Spinal Cord Injury
TTDI02315;WP2446;Retinoblastoma (RB) in Cancer
TTDI02315;WP2698;Meiotic Recombination
TTDI02315;WP2751;Transcriptional Regulation of White Adipocyte Differentiation
TTDI02315;WP2772;S Phase
TTDI02315;WP2828;Bladder Cancer
TTDI02315;WP2878;PPAR Alpha Pathway
TTDI02315;WP2882;Nuclear Receptors Meta-Pathway
TTDI02315;WP34;Ovarian Infertility Genes
TTDI02315;WP45;G1 to S cell cycle control
TTDI02315;WP707;DNA Damage Response
TTDI02316;WP1530;miRNA Regulation of DNA Damage Response
TTDI02316;WP1545;miRNAs involved in DNA damage response
TTDI02316;WP179;Cell Cycle
TTDI02316;WP1858;Mitotic G1-G1/S phases
TTDI02316;WP2002;miR-targeted genes in epithelium - TarBase
TTDI02316;WP2003;miR-targeted genes in leukocytes - TarBase
TTDI02316;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDI02316;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI02316;WP2249;Metastatic brain tumor
TTDI02316;WP2261;Signaling Pathways in Glioblastoma
TTDI02316;WP2446;Retinoblastoma (RB) in Cancer
TTDI02316;WP363;Wnt Signaling Pathway Netpath
TTDI02316;WP45;G1 to S cell cycle control
TTDI02316;WP707;DNA Damage Response
TTDI02317;WP12;Osteoclast Signaling
TTDI02317;WP1539;Angiogenesis
TTDI02317;WP1916;Signaling by PDGF
TTDI02317;WP2526;PDGF Pathway
TTDI02317;WP2653;PIP3 activates AKT signaling
TTDI02317;WP2703;Extracellular matrix organization
TTDI02317;WP2848;Differentiation Pathway
TTDI02317;WP2882;Nuclear Receptors Meta-Pathway
TTDI02317;WP2884;NRF2 pathway
TTDI02317;WP306;Focal Adhesion
TTDI02317;WP322;Osteoblast Signaling
TTDI02317;WP382;MAPK Signaling Pathway
TTDI02317;WP51;Regulation of Actin Cytoskeleton
TTDI02318;WP1840;Interleukin-3, 5 and GM-CSF signaling
TTDI02318;WP2328;Allograft Rejection
TTDI02318;WP2732;Interleukin-2 signaling
TTDI02318;WP2849;Hematopoietic Stem Cell Differentiation
TTDI02318;WP453;Inflammatory Response Pathway
TTDI02318;WP530;Cytokines and Inflammatory Response
TTDI02320;WP106;Alanine and aspartate metabolism
TTDI02320;WP2685;GABA synthesis, release, reuptake and degradation
TTDI02320;WP550;Biogenic Amine Synthesis
TTDI02321;WP1928;Telomere Maintenance
TTDI02321;WP2002;miR-targeted genes in epithelium - TarBase
TTDI02321;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDI02321;WP366;TGF beta Signaling Pathway
TTDI02322;WP1782;APC/C-mediated degradation of cell cycle proteins
TTDI02322;WP2002;miR-targeted genes in epithelium - TarBase
TTDI02322;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDI02322;WP2038;Regulation of Microtubule Cytoskeleton
TTDI02322;WP2652;Mitotic Prometaphase
TTDI02322;WP2757;Mitotic Metaphase and Anaphase
TTDI02323;WP1591;Heart Development
TTDI02323;WP1897;Regulation of beta-cell development
TTDI02323;WP1911;Signaling by FGFR
TTDI02323;WP2653;PIP3 activates AKT signaling
TTDI02323;WP2677;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
TTDI02323;WP2848;Differentiation Pathway
TTDI02323;WP51;Regulation of Actin Cytoskeleton
TTDI02324;WP2064;Neural Crest Differentiation
TTDI02324;WP2276;Glial Cell Differentiation
TTDI02324;WP2431;Spinal Cord Injury
TTDI02324;WP2637;Structural Pathway of Interleukin 1 (IL-1)
TTDI02324;WP422;MAPK Cascade
TTDI02325;WP1403;AMPK Signaling
TTDI02325;WP1530;miRNA Regulation of DNA Damage Response
TTDI02325;WP1545;miRNAs involved in DNA damage response
TTDI02325;WP1601;Fluoropyrimidine Activity
TTDI02325;WP1742;TP53 Network
TTDI02325;WP176;Folate Metabolism
TTDI02325;WP1772;Apoptosis Modulation and Signaling
TTDI02325;WP1775;Cell Cycle Checkpoints
TTDI02325;WP179;Cell Cycle
TTDI02325;WP1815;Factors involved in megakaryocyte development and platelet production
TTDI02325;WP1841;Intrinsic Pathway for Apoptosis
TTDI02325;WP1971;Integrated Cancer pathway
TTDI02325;WP1984;Integrated Breast Cancer Pathway
TTDI02325;WP2059;Alzheimers Disease
TTDI02325;WP2249;Metastatic brain tumor
TTDI02325;WP2261;Signaling Pathways in Glioblastoma
TTDI02325;WP2263;Prostate Cancer
TTDI02325;WP2363;Gastric cancer network 2
TTDI02325;WP2374;Oncostatin M Signaling Pathway
TTDI02325;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02325;WP2431;Spinal Cord Injury
TTDI02325;WP2446;Retinoblastoma (RB) in Cancer
TTDI02325;WP2447;Amyotrophic lateral sclerosis (ALS)
TTDI02325;WP2516;ATM Signaling Pathway
TTDI02325;WP254;Apoptosis
TTDI02325;WP2786;Pre-NOTCH Expression and Processing
TTDI02325;WP2815;Mammary gland development pathway - Involution (Stage 4 of 4)
TTDI02325;WP2828;Bladder Cancer
TTDI02325;WP3286;Copper homeostasis
TTDI02325;WP366;TGF beta Signaling Pathway
TTDI02325;WP382;MAPK Signaling Pathway
TTDI02325;WP399;Wnt Signaling Pathway and Pluripotency
TTDI02325;WP45;G1 to S cell cycle control
TTDI02325;WP4;Sandbox Pathway
TTDI02325;WP615;Senescence and Autophagy in Cancer
TTDI02325;WP673;ErbB Signaling Pathway
TTDI02325;WP707;DNA Damage Response
TTDI02325;WP710;DNA Damage Response (only ATM dependent)
TTDI02326;WP1824;GPCR downstream signaling
TTDI02326;WP1825;GPCR ligand binding
TTDI02326;WP2882;Nuclear Receptors Meta-Pathway
TTDI02326;WP289;Myometrial Relaxation and Contraction Pathways
TTDI02326;WP455;GPCRs, Class A Rhodopsin-like
TTDI02327;WP1910;Signaling by EGFR
TTDI02327;WP2059;Alzheimers Disease
TTDI02327;WP2718;Signaling by NOTCH2
TTDI02327;WP2721;Signaling by NOTCH4
TTDI02327;WP2722;Signaling by NOTCH3
TTDI02327;WP3286;Copper homeostasis
TTDI02327;WP516;Hypertrophy Model
TTDI02328;WP1539;Angiogenesis
TTDI02328;WP1797;Circadian Clock
TTDI02328;WP2324;AGE/RAGE pathway
TTDI02328;WP236;Adipogenesis
TTDI02328;WP2374;Oncostatin M Signaling Pathway
TTDI02328;WP2720;Signaling by NOTCH1
TTDI02328;WP2727;Regulation of Hypoxia-inducible Factor (HIF) by Oxygen
TTDI02328;WP2877;Vitamin D Receptor Pathway
TTDI02328;WP61;Notch Signaling Pathway
TTDI02328;WP706;SIDS Susceptibility Pathways
TTDI02330;WP1818;Formation of Fibrin Clot (Clotting Cascade)
TTDI02330;WP1984;Integrated Breast Cancer Pathway
TTDI02330;WP558;Complement and Coagulation Cascades
TTDI02333;WP1433;NOD pathway
TTDI02333;WP1772;Apoptosis Modulation and Signaling
TTDI02333;WP1841;Intrinsic Pathway for Apoptosis
TTDI02333;WP254;Apoptosis
TTDI02333;WP306;Focal Adhesion
TTDI02333;WP3286;Copper homeostasis
TTDI02334;WP1533;Vitamin B12 Metabolism
TTDI02334;WP15;Selenium Micronutrient Network
TTDI02334;WP176;Folate Metabolism
TTDI02334;WP2324;AGE/RAGE pathway
TTDI02334;WP2436;Dopamine metabolism
TTDI02334;WP2447;Amyotrophic lateral sclerosis (ALS)
TTDI02334;WP259;Nifedipine Activity
TTDI02334;WP2824;Detoxification of Reactive Oxygen Species
TTDI02334;WP3286;Copper homeostasis
TTDI02334;WP408;Oxidative Stress
TTDI02335;WP615;Senescence and Autophagy in Cancer
TTDI02338;WP61;Notch Signaling Pathway
TTDI02339;WP1799;Costimulation by the CD28 family
TTDI02339;WP1836;Interferon gamma signaling
TTDI02339;WP1927;TCR signaling
TTDI02339;WP2328;Allograft Rejection
TTDI02339;WP2679;MHC class II antigen presentation
TTDI02339;WP530;Cytokines and Inflammatory Response
TTDI02342;WP1824;GPCR downstream signaling
TTDI02342;WP1825;GPCR ligand binding
TTDI02342;WP334;GPCRs, Class B Secretin-like
TTDI02344;WP1601;Fluoropyrimidine Activity
TTDI02344;WP1851;Metabolism of nucleotides
TTDI02344;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02344;WP2446;Retinoblastoma (RB) in Cancer
TTDI02344;WP404;Nucleotide Metabolism
TTDI02346;WP2002;miR-targeted genes in epithelium - TarBase
TTDI02346;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDI02346;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI02346;WP2006;miR-targeted genes in squamous cell - TarBase
TTDI02346;WP2272;Pathogenic Escherichia coli infection
TTDI02348;WP1798;Complement cascade
TTDI02348;WP545;Complement Activation, Classical Pathway
TTDI02348;WP558;Complement and Coagulation Cascades
TTDI02350;WP106;Alanine and aspartate metabolism
TTDI02350;WP1848;Metabolism of carbohydrates
TTDI02350;WP2693;Metabolism of amino acids and derivatives
TTDI02350;WP534;Glycolysis and Gluconeogenesis
TTDI02351;WP2764;Lipid digestion, mobilization, and transport
TTDI02351;WP2776;Visual phototransduction
TTDI02352;WP1793;Cell junction organization
TTDI02353;WP474;Endochondral Ossification
TTDI02354;WP1798;Complement cascade
TTDI02354;WP2806;Human Complement System
TTDI02354;WP558;Complement and Coagulation Cascades
TTDI02355;WP1798;Complement cascade
TTDI02355;WP2806;Human Complement System
TTDI02355;WP558;Complement and Coagulation Cascades
TTDI02358;WP127;IL-5 Signaling Pathway
TTDI02358;WP1982;SREBP signalling
TTDI02358;WP1984;Integrated Breast Cancer Pathway
TTDI02358;WP2034;Leptin signaling pathway
TTDI02358;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02358;WP23;B Cell Receptor Signaling Pathway
TTDI02358;WP2583;T-Cell Receptor and Co-stimulatory Signaling
TTDI02358;WP2667;Activation of Chaperone Genes by XBP1(S)
TTDI02358;WP363;Wnt Signaling Pathway Netpath
TTDI02358;WP481;Insulin Signaling
TTDI02358;WP500;Glycogen Metabolism
TTDI02359;WP1852;Metabolism of porphyrins
TTDI02359;WP561;Heme Biosynthesis
TTDI02360;WP1793;Cell junction organization
TTDI02360;WP1833;Integrin cell surface interactions
TTDI02360;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDI02360;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI02360;WP244;Alpha 6 Beta 4 signaling pathway
TTDI02360;WP2798;Assembly of collagen fibrils and other multimeric structures
TTDI02360;WP306;Focal Adhesion
TTDI02360;WP453;Inflammatory Response Pathway
TTDI02361;WP1528;Physiological and Pathological Hypertrophy of the Heart
TTDI02361;WP236;Adipogenesis
TTDI02361;WP2374;Oncostatin M Signaling Pathway
TTDI02362;WP1798;Complement cascade
TTDI02362;WP2806;Human Complement System
TTDI02362;WP558;Complement and Coagulation Cascades
TTDI02363;WP2848;Differentiation Pathway
TTDI02363;WP382;MAPK Signaling Pathway
TTDI02364;WP2693;Metabolism of amino acids and derivatives
TTDI02365;WP138;Androgen receptor signaling pathway
TTDI02365;WP1433;NOD pathway
TTDI02365;WP1449;Regulation of toll-like receptor signaling pathway
TTDI02365;WP1471;TOR Signaling
TTDI02365;WP1528;Physiological and Pathological Hypertrophy of the Heart
TTDI02365;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDI02365;WP1799;Costimulation by the CD28 family
TTDI02365;WP1808;DSCAM interactions
TTDI02365;WP1815;Factors involved in megakaryocyte development and platelet production
TTDI02365;WP1826;GPVI-mediated activation cascade
TTDI02365;WP1843;L1CAM interactions
TTDI02365;WP185;Integrin-mediated Cell Adhesion
TTDI02365;WP1868;Netrin-1 signaling
TTDI02365;WP1907;Semaphorin interactions
TTDI02365;WP1918;Signaling by Robo receptor
TTDI02365;WP1976;Signalling by NGF
TTDI02365;WP1984;Integrated Breast Cancer Pathway
TTDI02365;WP2018;RANKL/RANK Signaling Pathway
TTDI02365;WP2034;Leptin signaling pathway
TTDI02365;WP2036;TWEAK Signaling Pathway
TTDI02365;WP2038;Regulation of Microtubule Cytoskeleton
TTDI02365;WP2290;RalA downstream regulated genes
TTDI02365;WP231;TNF alpha Signaling Pathway
TTDI02365;WP2324;AGE/RAGE pathway
TTDI02365;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02365;WP2380;BDNF signaling pathway
TTDI02365;WP23;B Cell Receptor Signaling Pathway
TTDI02365;WP2431;Spinal Cord Injury
TTDI02365;WP2447;Amyotrophic lateral sclerosis (ALS)
TTDI02365;WP244;Alpha 6 Beta 4 signaling pathway
TTDI02365;WP2593;JAK/STAT
TTDI02365;WP2694;DAP12 interactions
TTDI02365;WP2713;Signaling by SCF-KIT
TTDI02365;WP2719;Fcgamma receptor (FCGR) dependent phagocytosis
TTDI02365;WP2759;Fc epsilon receptor (FCERI) signaling
TTDI02365;WP2777;Translocation of GLUT4 to the Plasma Membrane
TTDI02365;WP2795;Cardiac Hypertrophic Response
TTDI02365;WP306;Focal Adhesion
TTDI02365;WP363;Wnt Signaling Pathway Netpath
TTDI02365;WP364;IL-6 signaling pathway
TTDI02365;WP366;TGF beta Signaling Pathway
TTDI02365;WP382;MAPK Signaling Pathway
TTDI02365;WP400;p38 MAPK Signaling Pathway
TTDI02365;WP428;Wnt Signaling Pathway
TTDI02365;WP437;EGF/EGFR Signaling Pathway
TTDI02365;WP481;Insulin Signaling
TTDI02365;WP51;Regulation of Actin Cytoskeleton
TTDI02365;WP524;G13 Signaling Pathway
TTDI02365;WP585;Interferon type I signaling pathways
TTDI02365;WP710;DNA Damage Response (only ATM dependent)
TTDI02365;WP75;Toll-like receptor signaling pathway
TTDI02366;WP1982;SREBP signalling
TTDI02366;WP2776;Visual phototransduction
TTDI02366;WP716;Vitamin A and Carotenoid Metabolism
TTDI02368;WP106;Alanine and aspartate metabolism
TTDI02368;WP2693;Metabolism of amino acids and derivatives
TTDI02370;WP2658;HIV Life Cycle
TTDI02370;WP2684;Host Interactions of HIV factors
TTDI02371;WP1927;TCR signaling
TTDI02371;WP2583;T-Cell Receptor and Co-stimulatory Signaling
TTDI02371;WP2593;JAK/STAT
TTDI02371;WP453;Inflammatory Response Pathway
TTDI02371;WP585;Interferon type I signaling pathways
TTDI02371;WP69;TCR Signaling Pathway
TTDI02372;WP1772;Apoptosis Modulation and Signaling
TTDI02372;WP1841;Intrinsic Pathway for Apoptosis
TTDI02372;WP1984;Integrated Breast Cancer Pathway
TTDI02372;WP254;Apoptosis
TTDI02372;WP710;DNA Damage Response (only ATM dependent)
TTDI02373;WP2007;Iron metabolism in placenta
TTDI02373;WP2670;Iron uptake and transport
TTDI02373;WP2848;Differentiation Pathway
TTDI02373;WP706;SIDS Susceptibility Pathways
TTDI02375;WP2806;Human Complement System
TTDI02377;WP2431;Spinal Cord Injury
TTDI02377;WP2854;Gene regulatory network modelling somitogenesis
TTDI02380;WP129;Matrix Metalloproteinases
TTDI02380;WP1449;Regulation of toll-like receptor signaling pathway
TTDI02380;WP1533;Vitamin B12 Metabolism
TTDI02380;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDI02380;WP15;Selenium Micronutrient Network
TTDI02380;WP176;Folate Metabolism
TTDI02380;WP1814;Extrinsic Pathway for Apoptosis
TTDI02380;WP2036;TWEAK Signaling Pathway
TTDI02380;WP231;TNF alpha Signaling Pathway
TTDI02380;WP2328;Allograft Rejection
TTDI02380;WP236;Adipogenesis
TTDI02380;WP2447;Amyotrophic lateral sclerosis (ALS)
TTDI02380;WP2513;Nanoparticle triggered regulated necrosis
TTDI02380;WP254;Apoptosis
TTDI02380;WP2586;Aryl Hydrocarbon Receptor
TTDI02380;WP2751;Transcriptional Regulation of White Adipocyte Differentiation
TTDI02380;WP2795;Cardiac Hypertrophic Response
TTDI02380;WP2864;Apoptosis-related network due to altered Notch3 in ovarian cancer
TTDI02380;WP314;FAS pathway and Stress induction of HSP regulation
TTDI02380;WP3297;EV release from cardiac cells and their functional effects
TTDI02380;WP382;MAPK Signaling Pathway
TTDI02380;WP530;Cytokines and Inflammatory Response
TTDI02380;WP560;TGF Beta Signaling Pathway
TTDI02380;WP706;SIDS Susceptibility Pathways
TTDI02380;WP727;Monoamine Transport
TTDI02380;WP75;Toll-like receptor signaling pathway
TTDI02382;WP1907;Semaphorin interactions
TTDI02382;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI02382;WP2034;Leptin signaling pathway
TTDI02382;WP2261;Signaling Pathways in Glioblastoma
TTDI02382;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02382;WP2780;Signaling by ERBB2
TTDI02382;WP2828;Bladder Cancer
TTDI02382;WP2870;Extracellular vesicle-mediated signaling in recipient cells
TTDI02382;WP306;Focal Adhesion
TTDI02382;WP437;EGF/EGFR Signaling Pathway
TTDI02382;WP673;ErbB Signaling Pathway
TTDI02382;WP710;DNA Damage Response (only ATM dependent)
TTDI02383;WP1471;TOR Signaling
TTDI02383;WP1831;Integration of energy metabolism
TTDI02383;WP1903;Response to elevated platelet cytosolic Ca2+
TTDI02383;WP1978;Opioid Signalling
TTDI02383;WP2012;miRs in Muscle Cell Differentiation
TTDI02383;WP2035;FSH signaling pathway
TTDI02383;WP2038;Regulation of Microtubule Cytoskeleton
TTDI02383;WP2197;Endothelin Pathways
TTDI02383;WP2261;Signaling Pathways in Glioblastoma
TTDI02383;WP2272;Pathogenic Escherichia coli infection
TTDI02383;WP2324;AGE/RAGE pathway
TTDI02383;WP2355;Corticotropin-releasing hormone
TTDI02383;WP2374;Oncostatin M Signaling Pathway
TTDI02383;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02383;WP2431;Spinal Cord Injury
TTDI02383;WP244;Alpha 6 Beta 4 signaling pathway
TTDI02383;WP2583;T-Cell Receptor and Co-stimulatory Signaling
TTDI02383;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDI02383;WP2688;DAG and IP3 signaling
TTDI02383;WP2713;Signaling by SCF-KIT
TTDI02383;WP2733;Regulation of mRNA Stability by Proteins that Bind AU-rich Elements
TTDI02383;WP2787;Syndecan interactions
TTDI02383;WP2795;Cardiac Hypertrophic Response
TTDI02383;WP2806;Human Complement System
TTDI02383;WP289;Myometrial Relaxation and Contraction Pathways
TTDI02383;WP304;Kit receptor signaling pathway
TTDI02383;WP35;G Protein Signaling Pathways
TTDI02383;WP363;Wnt Signaling Pathway Netpath
TTDI02383;WP399;Wnt Signaling Pathway and Pluripotency
TTDI02383;WP3;Transcriptional activation by NRF2
TTDI02383;WP428;Wnt Signaling Pathway
TTDI02383;WP437;EGF/EGFR Signaling Pathway
TTDI02383;WP481;Insulin Signaling
TTDI02383;WP536;Calcium Regulation in the Cardiac Cell
TTDI02383;WP673;ErbB Signaling Pathway
TTDI02384;WP2572;Primary Focal Segmental Glomerulosclerosis FSGS
TTDI02385;WP1530;miRNA Regulation of DNA Damage Response
TTDI02385;WP1545;miRNAs involved in DNA damage response
TTDI02385;WP1742;TP53 Network
TTDI02385;WP179;Cell Cycle
TTDI02385;WP1815;Factors involved in megakaryocyte development and platelet production
TTDI02385;WP1865;Myogenesis
TTDI02385;WP1918;Signaling by Robo receptor
TTDI02385;WP1984;Integrated Breast Cancer Pathway
TTDI02385;WP2038;Regulation of Microtubule Cytoskeleton
TTDI02385;WP2272;Pathogenic Escherichia coli infection
TTDI02385;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02385;WP2446;Retinoblastoma (RB) in Cancer
TTDI02385;WP2516;ATM Signaling Pathway
TTDI02385;WP2719;Fcgamma receptor (FCGR) dependent phagocytosis
TTDI02385;WP2864;Apoptosis-related network due to altered Notch3 in ovarian cancer
TTDI02385;WP437;EGF/EGFR Signaling Pathway
TTDI02385;WP673;ErbB Signaling Pathway
TTDI02385;WP707;DNA Damage Response
TTDI02385;WP710;DNA Damage Response (only ATM dependent)
TTDI02388;WP2870;Extracellular vesicle-mediated signaling in recipient cells
TTDI02388;WP2882;Nuclear Receptors Meta-Pathway
TTDI02388;WP2884;NRF2 pathway
TTDI02388;WP673;ErbB Signaling Pathway
TTDI02392;WP1530;miRNA Regulation of DNA Damage Response
TTDI02392;WP1742;TP53 Network
TTDI02392;WP1772;Apoptosis Modulation and Signaling
TTDI02392;WP1841;Intrinsic Pathway for Apoptosis
TTDI02392;WP1971;Integrated Cancer pathway
TTDI02392;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02392;WP254;Apoptosis
TTDI02392;WP707;DNA Damage Response
TTDI02392;WP710;DNA Damage Response (only ATM dependent)
TTDI02393;WP2035;FSH signaling pathway
TTDI02393;WP2643;Nanoparticle-mediated activation of receptor signaling
TTDI02393;WP673;ErbB Signaling Pathway
TTDI02394;WP1794;Cell surface interactions at the vascular wall
TTDI02394;WP1833;Integrin cell surface interactions
TTDI02394;WP1885;Platelet homeostasis
TTDI02395;WP51;Regulation of Actin Cytoskeleton
TTDI02396;WP1829;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
TTDI02397;WP1829;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
TTDI02398;WP1794;Cell surface interactions at the vascular wall
TTDI02403;WP1784;Apoptotic execution phase
TTDI02404;WP536;Calcium Regulation in the Cardiac Cell
TTDI02405;WP2777;Translocation of GLUT4 to the Plasma Membrane
TTDI02406;WP1892;Protein folding
TTDI02406;WP2272;Pathogenic Escherichia coli infection
TTDI02406;WP2359;Parkin-Ubiquitin Proteasomal System pathway
TTDI02406;WP410;Diurnally Regulated Genes with Circadian Orthologs
TTDI02409;WP1601;Fluoropyrimidine Activity
TTDI02409;WP1851;Metabolism of nucleotides
TTDI02410;WP1866;NCAM signaling for neurite out-growth
TTDI02410;WP2806;Human Complement System
TTDI02410;WP3286;Copper homeostasis
TTDI02412;WP15;Selenium Micronutrient Network
TTDI02412;WP28;Selenium Metabolism and Selenoproteins
TTDI02413;WP138;Androgen receptor signaling pathway
TTDI02413;WP1425;BMP Signalling and Regulation
TTDI02413;WP2023;Cell Differentiation - meta
TTDI02413;WP2332;Interleukin-11 Signaling Pathway
TTDI02413;WP2738;YAP1- and WWTR1 (TAZ)-stimulated gene expression
TTDI02413;WP2839;Hair Follicle Development: Organogenesis (Part 2 of 3)
TTDI02413;WP366;TGF beta Signaling Pathway
TTDI02413;WP474;Endochondral Ossification
TTDI02413;WP560;TGF Beta Signaling Pathway
TTDI02414;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDI02414;WP474;Endochondral Ossification
TTDI02414;WP560;TGF Beta Signaling Pathway
TTDI02414;WP706;SIDS Susceptibility Pathways
TTDI02416;WP236;Adipogenesis
TTDI02416;WP428;Wnt Signaling Pathway
TTDI02417;WP2665;Botulinum neurotoxicity
TTDI02419;WP2746;Signaling by the B Cell Receptor (BCR)
TTDI02419;WP437;EGF/EGFR Signaling Pathway
TTDI02419;WP481;Insulin Signaling
TTDI02419;WP69;TCR Signaling Pathway
TTDI02421;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDI02421;WP2877;Vitamin D Receptor Pathway
TTDI02421;WP289;Myometrial Relaxation and Contraction Pathways
TTDI02421;WP536;Calcium Regulation in the Cardiac Cell
TTDI02422;WP143;Fatty Acid Beta Oxidation
TTDI02422;WP325;Triacylglyceride Synthesis
TTDI02423;WP1794;Cell surface interactions at the vascular wall
TTDI02423;WP1909;Signal regulatory protein (SIRP) family interactions
TTDI02423;WP2431;Spinal Cord Injury
TTDI02426;WP2697;Fertilization
TTDI02427;WP12;Osteoclast Signaling
TTDI02427;WP1434;Osteopontin Signaling
TTDI02427;WP1455;Serotonin Transporter Activity
TTDI02427;WP1794;Cell surface interactions at the vascular wall
TTDI02427;WP1832;Integrin alphaIIb beta3 signaling
TTDI02427;WP1833;Integrin cell surface interactions
TTDI02427;WP1843;L1CAM interactions
TTDI02427;WP185;Integrin-mediated Cell Adhesion
TTDI02427;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDI02427;WP2572;Primary Focal Segmental Glomerulosclerosis FSGS
TTDI02427;WP2666;Elastic fibre formation
TTDI02427;WP2703;Extracellular matrix organization
TTDI02427;WP2787;Syndecan interactions
TTDI02427;WP2806;Human Complement System
TTDI02427;WP2849;Hematopoietic Stem Cell Differentiation
TTDI02427;WP306;Focal Adhesion
TTDI02427;WP322;Osteoblast Signaling
TTDI02427;WP366;TGF beta Signaling Pathway
TTDI02427;WP727;Monoamine Transport
TTDI02429;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02429;WP2791;Signaling by Activin
TTDI02429;WP2804;Hair Follicle Development: Induction (Part 1 of 3)
TTDI02429;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDI02429;WP2848;Differentiation Pathway
TTDI02429;WP560;TGF Beta Signaling Pathway
TTDI02430;WP15;Selenium Micronutrient Network
TTDI02431;WP138;Androgen receptor signaling pathway
TTDI02431;WP1797;Circadian Clock
TTDI02431;WP2706;Activation of Gene Expression by SREBP (SREBF)
TTDI02431;WP2738;YAP1- and WWTR1 (TAZ)-stimulated gene expression
TTDI02431;WP2751;Transcriptional Regulation of White Adipocyte Differentiation
TTDI02431;WP2797;Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
TTDI02432;WP1982;SREBP signalling
TTDI02432;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02432;WP2700;Latent infection of Homo sapiens with Mycobacterium tuberculosis
TTDI02432;WP2877;Vitamin D Receptor Pathway
TTDI02435;WP1840;Interleukin-3, 5 and GM-CSF signaling
TTDI02435;WP1910;Signaling by EGFR
TTDI02435;WP1911;Signaling by FGFR
TTDI02435;WP2018;RANKL/RANK Signaling Pathway
TTDI02435;WP2261;Signaling Pathways in Glioblastoma
TTDI02435;WP23;B Cell Receptor Signaling Pathway
TTDI02435;WP2704;Interleukin-6 signaling
TTDI02435;WP2713;Signaling by SCF-KIT
TTDI02435;WP2746;Signaling by the B Cell Receptor (BCR)
TTDI02435;WP286;IL-3 Signaling Pathway
TTDI02435;WP304;Kit receptor signaling pathway
TTDI02435;WP395;IL-4 Signaling Pathway
TTDI02435;WP437;EGF/EGFR Signaling Pathway
TTDI02435;WP481;Insulin Signaling
TTDI02435;WP49;IL-2 Signaling Pathway
TTDI02435;WP585;Interferon type I signaling pathways
TTDI02435;WP69;TCR Signaling Pathway
TTDI02436;WP1981;Thyroxine (Thyroid Hormone) Production
TTDI02436;WP2693;Metabolism of amino acids and derivatives
TTDI02436;WP2848;Differentiation Pathway
TTDI02436;WP2849;Hematopoietic Stem Cell Differentiation
TTDI02437;WP2002;miR-targeted genes in epithelium - TarBase
TTDI02437;WP2003;miR-targeted genes in leukocytes - TarBase
TTDI02437;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDI02437;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI02438;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDI02440;WP185;Integrin-mediated Cell Adhesion
TTDI02440;WP1984;Integrated Breast Cancer Pathway
TTDI02440;WP2038;Regulation of Microtubule Cytoskeleton
TTDI02440;WP2776;Visual phototransduction
TTDI02440;WP455;GPCRs, Class A Rhodopsin-like
TTDI02441;WP1825;GPCR ligand binding
TTDI02441;WP2877;Vitamin D Receptor Pathway
TTDI02441;WP334;GPCRs, Class B Secretin-like
TTDI02443;WP1533;Vitamin B12 Metabolism
TTDI02443;WP2749;Metabolism of steroid hormones and vitamin D
TTDI02443;WP2806;Human Complement System
TTDI02444;WP1533;Vitamin B12 Metabolism
TTDI02444;WP15;Selenium Micronutrient Network
TTDI02444;WP176;Folate Metabolism
TTDI02444;WP1982;SREBP signalling
TTDI02444;WP2011;SREBF and miR33 in cholesterol and lipid homeostasis
TTDI02444;WP2374;Oncostatin M Signaling Pathway
TTDI02444;WP2764;Lipid digestion, mobilization, and transport
TTDI02444;WP2776;Visual phototransduction
TTDI02444;WP399;Wnt Signaling Pathway and Pluripotency
TTDI02444;WP428;Wnt Signaling Pathway
TTDI02444;WP430;Statin Pathway
TTDI02444;WP710;DNA Damage Response (only ATM dependent)
TTDI02445;WP2675;Signaling by NODAL
TTDI02445;WP2760;Signaling by BMP
TTDI02445;WP2791;Signaling by Activin
TTDI02445;WP2857;Mesodermal Commitment Pathway
TTDI02446;WP1835;Interferon alpha/beta signaling
TTDI02446;WP615;Senescence and Autophagy in Cancer
TTDI02447;WP2714;Signaling by Hippo
TTDI02449;WP2799;Regulation of Insulin-like Growth Factor (IGF) Transport and Uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
TTDI02449;WP289;Myometrial Relaxation and Contraction Pathways
TTDI02450;WP1833;Integrin cell surface interactions
TTDI02450;WP185;Integrin-mediated Cell Adhesion
TTDI02450;WP306;Focal Adhesion
TTDI02452;WP170;Nuclear Receptors
TTDI02452;WP2797;Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
TTDI02452;WP391;Mitochondrial Gene Expression
TTDI02453;WP1584;Type II diabetes mellitus
TTDI02453;WP1873;NGF signalling via TRKA from the plasma membrane
TTDI02453;WP1913;Signaling by Insulin receptor
TTDI02453;WP1984;Integrated Breast Cancer Pathway
TTDI02453;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDI02453;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI02453;WP2034;Leptin signaling pathway
TTDI02453;WP2261;Signaling Pathways in Glioblastoma
TTDI02453;WP2324;AGE/RAGE pathway
TTDI02453;WP236;Adipogenesis
TTDI02453;WP2374;Oncostatin M Signaling Pathway
TTDI02453;WP2380;BDNF signaling pathway
TTDI02453;WP244;Alpha 6 Beta 4 signaling pathway
TTDI02453;WP2653;PIP3 activates AKT signaling
TTDI02453;WP2677;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
TTDI02453;WP395;IL-4 Signaling Pathway
TTDI02453;WP481;Insulin Signaling
TTDI02453;WP581;EPO Receptor Signaling
TTDI02453;WP585;Interferon type I signaling pathways
TTDI02453;WP710;DNA Damage Response (only ATM dependent)
TTDI02454;WP1978;Opioid Signalling
TTDI02454;WP2688;DAG and IP3 signaling
TTDI02454;WP35;G Protein Signaling Pathways
TTDI02455;WP2002;miR-targeted genes in epithelium - TarBase
TTDI02455;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDI02455;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI02455;WP2006;miR-targeted genes in squamous cell - TarBase
TTDI02456;WP1449;Regulation of toll-like receptor signaling pathway
TTDI02457;WP2780;Signaling by ERBB2
TTDI02457;WP437;EGF/EGFR Signaling Pathway
TTDI02460;WP2669;Potassium Channels
TTDI02463;WP1433;NOD pathway
TTDI02463;WP1449;Regulation of toll-like receptor signaling pathway
TTDI02463;WP1530;miRNA Regulation of DNA Damage Response
TTDI02463;WP1772;Apoptosis Modulation and Signaling
TTDI02463;WP1784;Apoptotic execution phase
TTDI02463;WP1814;Extrinsic Pathway for Apoptosis
TTDI02463;WP1841;Intrinsic Pathway for Apoptosis
TTDI02463;WP1904;RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
TTDI02463;WP1971;Integrated Cancer pathway
TTDI02463;WP1984;Integrated Breast Cancer Pathway
TTDI02463;WP2036;TWEAK Signaling Pathway
TTDI02463;WP2059;Alzheimers Disease
TTDI02463;WP2263;Prostate Cancer
TTDI02463;WP231;TNF alpha Signaling Pathway
TTDI02463;WP2324;AGE/RAGE pathway
TTDI02463;WP2328;Allograft Rejection
TTDI02463;WP2359;Parkin-Ubiquitin Proteasomal System pathway
TTDI02463;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02463;WP2513;Nanoparticle triggered regulated necrosis
TTDI02463;WP254;Apoptosis
TTDI02463;WP2752;MyD88-independent cascade
TTDI02463;WP314;FAS pathway and Stress induction of HSP regulation
TTDI02463;WP382;MAPK Signaling Pathway
TTDI02463;WP384;Apoptosis Modulation by HSP70
TTDI02463;WP707;DNA Damage Response
TTDI02463;WP75;Toll-like receptor signaling pathway
TTDI02464;WP1772;Apoptosis Modulation and Signaling
TTDI02464;WP1814;Extrinsic Pathway for Apoptosis
TTDI02464;WP231;TNF alpha Signaling Pathway
TTDI02464;WP254;Apoptosis
TTDI02464;WP314;FAS pathway and Stress induction of HSP regulation
TTDI02465;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDI02465;WP179;Cell Cycle
TTDI02465;WP1992;TarBasePathway
TTDI02465;WP2002;miR-targeted genes in epithelium - TarBase
TTDI02465;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDI02465;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI02465;WP2064;Neural Crest Differentiation
TTDI02465;WP2795;Cardiac Hypertrophic Response
TTDI02465;WP474;Endochondral Ossification
TTDI02468;WP1533;Vitamin B12 Metabolism
TTDI02468;WP15;Selenium Micronutrient Network
TTDI02468;WP176;Folate Metabolism
TTDI02468;WP1794;Cell surface interactions at the vascular wall
TTDI02468;WP1885;Platelet homeostasis
TTDI02468;WP2764;Lipid digestion, mobilization, and transport
TTDI02468;WP2776;Visual phototransduction
TTDI02468;WP2784;Binding and Uptake of Ligands by Scavenger Receptors
TTDI02468;WP430;Statin Pathway
TTDI02469;WP2700;Latent infection of Homo sapiens with Mycobacterium tuberculosis
TTDI02469;WP2796;Class I MHC mediated antigen processing & presentation
TTDI02469;WP619;Type II interferon signaling (IFNG)
TTDI02471;WP306;Focal Adhesion
TTDI02471;WP437;EGF/EGFR Signaling Pathway
TTDI02471;WP524;G13 Signaling Pathway
TTDI02472;WP1909;Signal regulatory protein (SIRP) family interactions
TTDI02472;WP205;IL-7 Signaling Pathway
TTDI02472;WP2263;Prostate Cancer
TTDI02472;WP2374;Oncostatin M Signaling Pathway
TTDI02472;WP2380;BDNF signaling pathway
TTDI02472;WP259;Nifedipine Activity
TTDI02472;WP2732;Interleukin-2 signaling
TTDI02472;WP2864;Apoptosis-related network due to altered Notch3 in ovarian cancer
TTDI02472;WP313;Signaling of Hepatocyte Growth Factor Receptor
TTDI02472;WP437;EGF/EGFR Signaling Pathway
TTDI02472;WP49;IL-2 Signaling Pathway
TTDI02472;WP69;TCR Signaling Pathway
TTDI02473;WP206;Fatty Acid Omega Oxidation
TTDI02473;WP2882;Nuclear Receptors Meta-Pathway
TTDI02473;WP2884;NRF2 pathway
TTDI02474;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDI02475;WP1824;GPCR downstream signaling
TTDI02475;WP1825;GPCR ligand binding
TTDI02475;WP334;GPCRs, Class B Secretin-like
TTDI02475;WP706;SIDS Susceptibility Pathways
TTDI02476;WP1916;Signaling by PDGF
TTDI02476;WP2263;Prostate Cancer
TTDI02476;WP2526;PDGF Pathway
TTDI02476;WP2583;T-Cell Receptor and Co-stimulatory Signaling
TTDI02476;WP313;Signaling of Hepatocyte Growth Factor Receptor
TTDI02476;WP382;MAPK Signaling Pathway
TTDI02476;WP437;EGF/EGFR Signaling Pathway
TTDI02476;WP581;EPO Receptor Signaling
TTDI02477;WP1591;Heart Development
TTDI02477;WP2064;Neural Crest Differentiation
TTDI02477;WP236;Adipogenesis
TTDI02477;WP2406;Cardiac Progenitor Differentiation
TTDI02477;WP2666;Elastic fibre formation
TTDI02477;WP2804;Hair Follicle Development: Induction (Part 1 of 3)
TTDI02477;WP2839;Hair Follicle Development: Organogenesis (Part 2 of 3)
TTDI02477;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDI02477;WP2848;Differentiation Pathway
TTDI02477;WP2857;Mesodermal Commitment Pathway
TTDI02477;WP2858;Ectoderm Differentiation
TTDI02477;WP2895;Differentiation of white and brown adipocyte
TTDI02477;WP560;TGF Beta Signaling Pathway
TTDI02478;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02478;WP2406;Cardiac Progenitor Differentiation
TTDI02478;WP2675;Signaling by NODAL
TTDI02478;WP2848;Differentiation Pathway
TTDI02478;WP2853;Endoderm Differentiation
TTDI02478;WP2857;Mesodermal Commitment Pathway
TTDI02479;WP2725;Collagen biosynthesis and modifying enzymes
TTDI02479;WP2798;Assembly of collagen fibrils and other multimeric structures
TTDI02481;WP1772;Apoptosis Modulation and Signaling
TTDI02481;WP2012;miRs in Muscle Cell Differentiation
TTDI02481;WP2788;Sphingolipid metabolism
TTDI02481;WP2795;Cardiac Hypertrophic Response
TTDI02481;WP289;Myometrial Relaxation and Contraction Pathways
TTDI02481;WP35;G Protein Signaling Pathways
TTDI02481;WP399;Wnt Signaling Pathway and Pluripotency
TTDI02481;WP428;Wnt Signaling Pathway
TTDI02481;WP536;Calcium Regulation in the Cardiac Cell
TTDI02482;WP2882;Nuclear Receptors Meta-Pathway
TTDI02484;WP2806;Human Complement System
TTDI02484;WP558;Complement and Coagulation Cascades
TTDI02487;WP1403;AMPK Signaling
TTDI02487;WP179;Cell Cycle
TTDI02487;WP1859;Mitotic G2-G2/M phases
TTDI02487;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02487;WP2446;Retinoblastoma (RB) in Cancer
TTDI02488;WP2784;Binding and Uptake of Ligands by Scavenger Receptors
TTDI02489;WP138;Androgen receptor signaling pathway
TTDI02489;WP1797;Circadian Clock
TTDI02489;WP179;Cell Cycle
TTDI02489;WP1815;Factors involved in megakaryocyte development and platelet production
TTDI02489;WP1904;RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
TTDI02489;WP1984;Integrated Breast Cancer Pathway
TTDI02489;WP2261;Signaling Pathways in Glioblastoma
TTDI02489;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02489;WP2586;Aryl Hydrocarbon Receptor
TTDI02489;WP2718;Signaling by NOTCH2
TTDI02489;WP2720;Signaling by NOTCH1
TTDI02489;WP2727;Regulation of Hypoxia-inducible Factor (HIF) by Oxygen
TTDI02489;WP2751;Transcriptional Regulation of White Adipocyte Differentiation
TTDI02489;WP2786;Pre-NOTCH Expression and Processing
TTDI02489;WP2794;Cytosolic sensors of pathogen-associated DNA
TTDI02489;WP2797;Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
TTDI02489;WP2873;Aryl Hydrocarbon Receptor Pathway
TTDI02489;WP2882;Nuclear Receptors Meta-Pathway
TTDI02489;WP304;Kit receptor signaling pathway
TTDI02489;WP366;TGF beta Signaling Pathway
TTDI02489;WP395;IL-4 Signaling Pathway
TTDI02489;WP399;Wnt Signaling Pathway and Pluripotency
TTDI02489;WP560;TGF Beta Signaling Pathway
TTDI02489;WP61;Notch Signaling Pathway
TTDI02489;WP706;SIDS Susceptibility Pathways
TTDI02490;WP1868;Netrin-1 signaling
TTDI02491;WP2669;Potassium Channels
TTDI02491;WP2849;Hematopoietic Stem Cell Differentiation
TTDI02491;WP706;SIDS Susceptibility Pathways
TTDI02492;WP1772;Apoptosis Modulation and Signaling
TTDI02492;WP1976;Signalling by NGF
TTDI02492;WP2371;Parkinsons Disease Pathway
TTDI02492;WP254;Apoptosis
TTDI02492;WP382;MAPK Signaling Pathway
TTDI02492;WP384;Apoptosis Modulation by HSP70
TTDI02493;WP1433;NOD pathway
TTDI02493;WP1530;miRNA Regulation of DNA Damage Response
TTDI02493;WP1772;Apoptosis Modulation and Signaling
TTDI02493;WP1841;Intrinsic Pathway for Apoptosis
TTDI02493;WP1896;Regulation of Apoptosis
TTDI02493;WP1971;Integrated Cancer pathway
TTDI02493;WP1984;Integrated Breast Cancer Pathway
TTDI02493;WP2059;Alzheimers Disease
TTDI02493;WP2263;Prostate Cancer
TTDI02493;WP231;TNF alpha Signaling Pathway
TTDI02493;WP2324;AGE/RAGE pathway
TTDI02493;WP2328;Allograft Rejection
TTDI02493;WP2355;Corticotropin-releasing hormone
TTDI02493;WP2371;Parkinsons Disease Pathway
TTDI02493;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02493;WP2447;Amyotrophic lateral sclerosis (ALS)
TTDI02493;WP254;Apoptosis
TTDI02493;WP2653;PIP3 activates AKT signaling
TTDI02493;WP314;FAS pathway and Stress induction of HSP regulation
TTDI02493;WP382;MAPK Signaling Pathway
TTDI02493;WP384;Apoptosis Modulation by HSP70
TTDI02493;WP707;DNA Damage Response
TTDI02494;WP1843;L1CAM interactions
TTDI02494;WP1919;Signaling by VEGF
TTDI02495;WP1824;GPCR downstream signaling
TTDI02495;WP1825;GPCR ligand binding
TTDI02495;WP501;GPCRs, Class C Metabotropic glutamate, pheromone
TTDI02496;WP1824;GPCR downstream signaling
TTDI02496;WP1825;GPCR ligand binding
TTDI02496;WP501;GPCRs, Class C Metabotropic glutamate, pheromone
TTDI02497;WP2059;Alzheimers Disease
TTDI02497;WP2380;BDNF signaling pathway
TTDI02497;WP2431;Spinal Cord Injury
TTDI02497;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDI02497;WP666;Hypothetical Network for Drug Addiction
TTDI02497;WP706;SIDS Susceptibility Pathways
TTDI02498;WP1833;Integrin cell surface interactions
TTDI02498;WP185;Integrin-mediated Cell Adhesion
TTDI02498;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDI02498;WP2911;miRNA targets in ECM and membrane receptors
TTDI02498;WP306;Focal Adhesion
TTDI02499;WP1829;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
TTDI02499;WP2796;Class I MHC mediated antigen processing & presentation
TTDI02500;WP1843;L1CAM interactions
TTDI02501;WP1793;Cell junction organization
TTDI02501;WP185;Integrin-mediated Cell Adhesion
TTDI02501;WP2572;Primary Focal Segmental Glomerulosclerosis FSGS
TTDI02501;WP306;Focal Adhesion
TTDI02501;WP405;Eukaryotic Transcription Initiation
TTDI02503;WP1840;Interleukin-3, 5 and GM-CSF signaling
TTDI02503;WP205;IL-7 Signaling Pathway
TTDI02503;WP22;IL-9 Signaling Pathway
TTDI02503;WP2673;Interleukin-7 signaling
TTDI02503;WP2732;Interleukin-2 signaling
TTDI02503;WP395;IL-4 Signaling Pathway
TTDI02503;WP453;Inflammatory Response Pathway
TTDI02503;WP49;IL-2 Signaling Pathway
TTDI02504;WP2703;Extracellular matrix organization
TTDI02505;WP2703;Extracellular matrix organization
TTDI02505;WP2806;Human Complement System
TTDI02506;WP1824;GPCR downstream signaling
TTDI02506;WP1825;GPCR ligand binding
TTDI02506;WP24;Peptide GPCRs
TTDI02506;WP455;GPCRs, Class A Rhodopsin-like
TTDI02507;WP1824;GPCR downstream signaling
TTDI02507;WP1825;GPCR ligand binding
TTDI02507;WP24;Peptide GPCRs
TTDI02508;WP1824;GPCR downstream signaling
TTDI02508;WP1825;GPCR ligand binding
TTDI02508;WP2882;Nuclear Receptors Meta-Pathway
TTDI02508;WP289;Myometrial Relaxation and Contraction Pathways
TTDI02508;WP455;GPCRs, Class A Rhodopsin-like
TTDI02509;WP1825;GPCR ligand binding
TTDI02509;WP2728;Incretin Synthesis, Secretion, and Inactivation
TTDI02510;WP1824;GPCR downstream signaling
TTDI02510;WP1825;GPCR ligand binding
TTDI02510;WP24;Peptide GPCRs
TTDI02510;WP2806;Human Complement System
TTDI02510;WP455;GPCRs, Class A Rhodopsin-like
TTDI02512;WP289;Myometrial Relaxation and Contraction Pathways
TTDI02513;WP1825;GPCR ligand binding
TTDI02513;WP455;GPCRs, Class A Rhodopsin-like
TTDI02514;WP455;GPCRs, Class A Rhodopsin-like
TTDI02515;WP455;GPCRs, Class A Rhodopsin-like
TTDI02516;WP1824;GPCR downstream signaling
TTDI02516;WP1825;GPCR ligand binding
TTDI02516;WP455;GPCRs, Class A Rhodopsin-like
TTDI02517;WP1824;GPCR downstream signaling
TTDI02517;WP1825;GPCR ligand binding
TTDI02517;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDI02518;WP1824;GPCR downstream signaling
TTDI02518;WP1825;GPCR ligand binding
TTDI02518;WP1908;Signal amplification
TTDI02518;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDI02518;WP455;GPCRs, Class A Rhodopsin-like
TTDI02518;WP80;Nucleotide GPCRs
TTDI02520;WP1824;GPCR downstream signaling
TTDI02520;WP1825;GPCR ligand binding
TTDI02520;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDI02520;WP455;GPCRs, Class A Rhodopsin-like
TTDI02521;WP1824;GPCR downstream signaling
TTDI02521;WP1825;GPCR ligand binding
TTDI02521;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDI02522;WP1824;GPCR downstream signaling
TTDI02522;WP1825;GPCR ligand binding
TTDI02522;WP247;Small Ligand GPCRs
TTDI02522;WP26;Signal Transduction of S1P Receptor
TTDI02523;WP1824;GPCR downstream signaling
TTDI02523;WP1825;GPCR ligand binding
TTDI02523;WP247;Small Ligand GPCRs
TTDI02523;WP26;Signal Transduction of S1P Receptor
TTDI02524;WP1824;GPCR downstream signaling
TTDI02524;WP1825;GPCR ligand binding
TTDI02524;WP24;Peptide GPCRs
TTDI02524;WP455;GPCRs, Class A Rhodopsin-like
TTDI02527;WP1866;NCAM signaling for neurite out-growth
TTDI02527;WP2328;Allograft Rejection
TTDI02527;WP2431;Spinal Cord Injury
TTDI02528;WP12;Osteoclast Signaling
TTDI02528;WP2018;RANKL/RANK Signaling Pathway
TTDI02529;WP1798;Complement cascade
TTDI02529;WP2806;Human Complement System
TTDI02533;WP706;SIDS Susceptibility Pathways
TTDI02534;WP1857;Metabolism of water-soluble vitamins and cofactors
TTDI02536;WP286;IL-3 Signaling Pathway
TTDI02539;WP167;Eicosanoid Synthesis
TTDI02539;WP236;Adipogenesis
TTDI02539;WP2650;Arachidonic acid metabolism
TTDI02539;WP98;Prostaglandin Synthesis and Regulation
TTDI02541;WP1449;Regulation of toll-like receptor signaling pathway
TTDI02541;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDI02541;WP1904;RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
TTDI02541;WP2752;MyD88-independent cascade
TTDI02541;WP2795;Cardiac Hypertrophic Response
TTDI02541;WP75;Toll-like receptor signaling pathway
TTDI02543;WP1449;Regulation of toll-like receptor signaling pathway
TTDI02543;WP185;Integrin-mediated Cell Adhesion
TTDI02543;WP2380;BDNF signaling pathway
TTDI02543;WP254;Apoptosis
TTDI02543;WP2637;Structural Pathway of Interleukin 1 (IL-1)
TTDI02543;WP2643;Nanoparticle-mediated activation of receptor signaling
TTDI02543;WP382;MAPK Signaling Pathway
TTDI02543;WP384;Apoptosis Modulation by HSP70
TTDI02543;WP399;Wnt Signaling Pathway and Pluripotency
TTDI02543;WP408;Oxidative Stress
TTDI02543;WP422;MAPK Cascade
TTDI02543;WP428;Wnt Signaling Pathway
TTDI02543;WP481;Insulin Signaling
TTDI02543;WP524;G13 Signaling Pathway
TTDI02543;WP710;DNA Damage Response (only ATM dependent)
TTDI02543;WP75;Toll-like receptor signaling pathway
TTDI02544;WP1449;Regulation of toll-like receptor signaling pathway
TTDI02544;WP1839;Interleukin-1 signaling
TTDI02544;WP195;IL-1 signaling pathway
TTDI02544;WP2324;AGE/RAGE pathway
TTDI02544;WP2637;Structural Pathway of Interleukin 1 (IL-1)
TTDI02544;WP2761;MyD88:Mal cascade initiated on plasma membrane
TTDI02544;WP2768;MyD88 dependent cascade initiated on endosome
TTDI02544;WP2801;MyD88 cascade initiated on plasma membrane
TTDI02544;WP75;Toll-like receptor signaling pathway
TTDI02546;WP2526;PDGF Pathway
TTDI02547;WP1794;Cell surface interactions at the vascular wall
TTDI02547;WP1840;Interleukin-3, 5 and GM-CSF signaling
TTDI02547;WP185;Integrin-mediated Cell Adhesion
TTDI02547;WP1866;NCAM signaling for neurite out-growth
TTDI02547;WP1873;NGF signalling via TRKA from the plasma membrane
TTDI02547;WP1910;Signaling by EGFR
TTDI02547;WP1911;Signaling by FGFR
TTDI02547;WP1913;Signaling by Insulin receptor
TTDI02547;WP1916;Signaling by PDGF
TTDI02547;WP2032;TSH signaling pathway
TTDI02547;WP2034;Leptin signaling pathway
TTDI02547;WP2261;Signaling Pathways in Glioblastoma
TTDI02547;WP2263;Prostate Cancer
TTDI02547;WP2290;RalA downstream regulated genes
TTDI02547;WP231;TNF alpha Signaling Pathway
TTDI02547;WP2332;Interleukin-11 Signaling Pathway
TTDI02547;WP2374;Oncostatin M Signaling Pathway
TTDI02547;WP2380;BDNF signaling pathway
TTDI02547;WP23;B Cell Receptor Signaling Pathway
TTDI02547;WP244;Alpha 6 Beta 4 signaling pathway
TTDI02547;WP2526;PDGF Pathway
TTDI02547;WP2586;Aryl Hydrocarbon Receptor
TTDI02547;WP2593;JAK/STAT
TTDI02547;WP2643;Nanoparticle-mediated activation of receptor signaling
TTDI02547;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDI02547;WP2677;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
TTDI02547;WP2694;DAP12 interactions
TTDI02547;WP2713;Signaling by SCF-KIT
TTDI02547;WP2732;Interleukin-2 signaling
TTDI02547;WP2735;RAF/MAP kinase cascade
TTDI02547;WP2746;Signaling by the B Cell Receptor (BCR)
TTDI02547;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDI02547;WP2759;Fc epsilon receptor (FCERI) signaling
TTDI02547;WP2780;Signaling by ERBB2
TTDI02547;WP2781;Signaling by ERBB4
TTDI02547;WP2828;Bladder Cancer
TTDI02547;WP286;IL-3 Signaling Pathway
TTDI02547;WP2870;Extracellular vesicle-mediated signaling in recipient cells
TTDI02547;WP304;Kit receptor signaling pathway
TTDI02547;WP306;Focal Adhesion
TTDI02547;WP313;Signaling of Hepatocyte Growth Factor Receptor
TTDI02547;WP35;G Protein Signaling Pathways
TTDI02547;WP400;p38 MAPK Signaling Pathway
TTDI02547;WP422;MAPK Cascade
TTDI02547;WP437;EGF/EGFR Signaling Pathway
TTDI02547;WP481;Insulin Signaling
TTDI02547;WP49;IL-2 Signaling Pathway
TTDI02547;WP560;TGF Beta Signaling Pathway
TTDI02547;WP615;Senescence and Autophagy in Cancer
TTDI02547;WP673;ErbB Signaling Pathway
TTDI02547;WP69;TCR Signaling Pathway
TTDI02547;WP710;DNA Damage Response (only ATM dependent)
TTDI02547;WP732;Serotonin Receptor 2 and ELK-SRF/GATA4 signaling
TTDI02550;WP1841;Intrinsic Pathway for Apoptosis
TTDI02550;WP2328;Allograft Rejection
TTDI02550;WP254;Apoptosis
TTDI02550;WP2718;Signaling by NOTCH2
TTDI02550;WP623;Oxidative phosphorylation
TTDI02551;WP2263;Prostate Cancer
TTDI02552;WP272;Blood Clotting Cascade
TTDI02553;WP2612;BMI1
TTDI02553;WP615;Senescence and Autophagy in Cancer
TTDI02555;WP2263;Prostate Cancer
TTDI02555;WP2749;Metabolism of steroid hormones and vitamin D
TTDI02555;WP496;Steroid Biosynthesis
TTDI02556;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDI02556;WP2002;miR-targeted genes in epithelium - TarBase
TTDI02556;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDI02556;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI02556;WP2839;Hair Follicle Development: Organogenesis (Part 2 of 3)
TTDI02556;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDI02556;WP2848;Differentiation Pathway
TTDI02556;WP2870;Extracellular vesicle-mediated signaling in recipient cells
TTDI02556;WP399;Wnt Signaling Pathway and Pluripotency
TTDI02556;WP428;Wnt Signaling Pathway
TTDI02556;WP710;DNA Damage Response (only ATM dependent)
TTDI02557;WP399;Wnt Signaling Pathway and Pluripotency
TTDI02557;WP428;Wnt Signaling Pathway
TTDI02557;WP710;DNA Damage Response (only ATM dependent)
TTDI02558;WP1824;GPCR downstream signaling
TTDI02558;WP1825;GPCR ligand binding
TTDI02558;WP2596;Gastric acid production
TTDI02558;WP364;IL-6 signaling pathway
TTDI02559;WP2693;Metabolism of amino acids and derivatives
TTDI02559;WP465;Tryptophan metabolism
TTDI02560;WP1824;GPCR downstream signaling
TTDI02560;WP1825;GPCR ligand binding
TTDI02562;WP2681;Uptake of Oxygen and Release of Carbon Dioxide by Erythrocytes
TTDI02562;WP2744;Uptake of Carbon Dioxide and Release of Oxygen by Erythrocytes
TTDI02562;WP2770;Reversible Hydration of Carbon Dioxide
TTDI02563;WP2693;Metabolism of amino acids and derivatives
TTDI02565;WP615;Senescence and Autophagy in Cancer
TTDI02566;WP179;Cell Cycle
TTDI02566;WP1841;Intrinsic Pathway for Apoptosis
TTDI02566;WP2777;Translocation of GLUT4 to the Plasma Membrane
TTDI02566;WP289;Myometrial Relaxation and Contraction Pathways
TTDI02566;WP536;Calcium Regulation in the Cardiac Cell
TTDI02566;WP706;SIDS Susceptibility Pathways
TTDI02567;WP138;Androgen receptor signaling pathway
TTDI02567;WP1897;Regulation of beta-cell development
TTDI02567;WP1984;Integrated Breast Cancer Pathway
TTDI02567;WP2034;Leptin signaling pathway
TTDI02567;WP2035;FSH signaling pathway
TTDI02567;WP2261;Signaling Pathways in Glioblastoma
TTDI02567;WP2324;AGE/RAGE pathway
TTDI02567;WP236;Adipogenesis
TTDI02567;WP23;B Cell Receptor Signaling Pathway
TTDI02567;WP2853;Endoderm Differentiation
TTDI02567;WP2875;Constitutive Androstane Receptor Pathway
TTDI02567;WP2876;Pregnane X Receptor pathway
TTDI02567;WP2877;Vitamin D Receptor Pathway
TTDI02567;WP2882;Nuclear Receptors Meta-Pathway
TTDI02567;WP3286;Copper homeostasis
TTDI02567;WP437;EGF/EGFR Signaling Pathway
TTDI02567;WP481;Insulin Signaling
TTDI02567;WP673;ErbB Signaling Pathway
TTDI02568;WP2064;Neural Crest Differentiation
TTDI02569;WP1984;Integrated Breast Cancer Pathway
TTDI02569;WP2693;Metabolism of amino acids and derivatives
TTDI02569;WP497;Urea cycle and metabolism of amino groups
TTDI02570;WP1848;Metabolism of carbohydrates
TTDI02570;WP690;Polyol Pathway
TTDI02572;WP2697;Fertilization
TTDI02572;WP2877;Vitamin D Receptor Pathway
TTDI02575;WP2706;Activation of Gene Expression by SREBP (SREBF)
TTDI02581;WP2784;Binding and Uptake of Ligands by Scavenger Receptors
TTDI02583;WP2290;RalA downstream regulated genes
TTDI02583;WP437;EGF/EGFR Signaling Pathway
TTDI02585;WP1831;Integration of energy metabolism
TTDI02585;WP2669;Potassium Channels
TTDI02586;WP2059;Alzheimers Disease
TTDI02590;WP179;Cell Cycle
TTDI02590;WP2064;Neural Crest Differentiation
TTDI02590;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02591;WP2670;Iron uptake and transport
TTDI02592;WP2670;Iron uptake and transport
TTDI02593;WP2669;Potassium Channels
TTDI02593;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDI02593;WP35;G Protein Signaling Pathways
TTDI02593;WP536;Calcium Regulation in the Cardiac Cell
TTDI02594;WP2669;Potassium Channels
TTDI02594;WP268;Notch Signaling Pathway
TTDI02594;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDI02594;WP536;Calcium Regulation in the Cardiac Cell
TTDI02595;WP2693;Metabolism of amino acids and derivatives
TTDI02596;WP558;Complement and Coagulation Cascades
TTDI02598;WP2698;Meiotic Recombination
TTDI02598;WP34;Ovarian Infertility Genes
TTDI02598;WP531;Mismatch repair
TTDI02599;WP167;Eicosanoid Synthesis
TTDI02599;WP2650;Arachidonic acid metabolism
TTDI02600;WP2002;miR-targeted genes in epithelium - TarBase
TTDI02600;WP2003;miR-targeted genes in leukocytes - TarBase
TTDI02600;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDI02600;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI02600;WP2006;miR-targeted genes in squamous cell - TarBase
TTDI02600;WP2882;Nuclear Receptors Meta-Pathway
TTDI02600;WP2884;NRF2 pathway
TTDI02600;WP3;Transcriptional activation by NRF2
TTDI02600;WP408;Oxidative Stress
TTDI02601;WP1984;Integrated Breast Cancer Pathway
TTDI02602;WP138;Androgen receptor signaling pathway
TTDI02602;WP1794;Cell surface interactions at the vascular wall
TTDI02602;WP1850;Metabolism of nitric oxide
TTDI02602;WP185;Integrin-mediated Cell Adhesion
TTDI02602;WP2764;Lipid digestion, mobilization, and transport
TTDI02602;WP306;Focal Adhesion
TTDI02602;WP366;TGF beta Signaling Pathway
TTDI02602;WP437;EGF/EGFR Signaling Pathway
TTDI02604;WP615;Senescence and Autophagy in Cancer
TTDI02605;WP15;Selenium Micronutrient Network
TTDI02605;WP2485;NAD Biosynthesis II (from tryptophan)
TTDI02605;WP2693;Metabolism of amino acids and derivatives
TTDI02606;WP1935;Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds
TTDI02607;WP1935;Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds
TTDI02607;WP2007;Iron metabolism in placenta
TTDI02607;WP2670;Iron uptake and transport
TTDI02607;WP3286;Copper homeostasis
TTDI02609;WP195;IL-1 signaling pathway
TTDI02609;WP2637;Structural Pathway of Interleukin 1 (IL-1)
TTDI02611;WP1879;Phase 1 - Functionalization of compounds
TTDI02611;WP2693;Metabolism of amino acids and derivatives
TTDI02612;WP2679;MHC class II antigen presentation
TTDI02612;WP2749;Metabolism of steroid hormones and vitamin D
TTDI02613;WP2727;Regulation of Hypoxia-inducible Factor (HIF) by Oxygen
TTDI02614;WP2788;Sphingolipid metabolism
TTDI02616;WP1530;miRNA Regulation of DNA Damage Response
TTDI02616;WP1545;miRNAs involved in DNA damage response
TTDI02616;WP1775;Cell Cycle Checkpoints
TTDI02616;WP179;Cell Cycle
TTDI02616;WP1858;Mitotic G1-G1/S phases
TTDI02616;WP1898;Regulation of DNA replication
TTDI02616;WP1925;Synthesis of DNA
TTDI02616;WP1971;Integrated Cancer pathway
TTDI02616;WP2002;miR-targeted genes in epithelium - TarBase
TTDI02616;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDI02616;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI02616;WP2032;TSH signaling pathway
TTDI02616;WP205;IL-7 Signaling Pathway
TTDI02616;WP2100;Arylhydrocarbon receptor (AhR) signaling pathway
TTDI02616;WP2261;Signaling Pathways in Glioblastoma
TTDI02616;WP2374;Oncostatin M Signaling Pathway
TTDI02616;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02616;WP2431;Spinal Cord Injury
TTDI02616;WP2446;Retinoblastoma (RB) in Cancer
TTDI02616;WP2572;Primary Focal Segmental Glomerulosclerosis FSGS
TTDI02616;WP2586;Aryl Hydrocarbon Receptor
TTDI02616;WP2772;S Phase
TTDI02616;WP2864;Apoptosis-related network due to altered Notch3 in ovarian cancer
TTDI02616;WP2873;Aryl Hydrocarbon Receptor Pathway
TTDI02616;WP2877;Vitamin D Receptor Pathway
TTDI02616;WP2882;Nuclear Receptors Meta-Pathway
TTDI02616;WP34;Ovarian Infertility Genes
TTDI02616;WP45;G1 to S cell cycle control
TTDI02616;WP615;Senescence and Autophagy in Cancer
TTDI02616;WP673;ErbB Signaling Pathway
TTDI02616;WP707;DNA Damage Response
TTDI02616;WP710;DNA Damage Response (only ATM dependent)
TTDI02617;WP716;Vitamin A and Carotenoid Metabolism
TTDI02620;WP1824;GPCR downstream signaling
TTDI02620;WP1825;GPCR ligand binding
TTDI02620;WP706;SIDS Susceptibility Pathways
TTDI02621;WP1926;Synthesis, Secretion, and Deacylation of Ghrelin
TTDI02622;WP1907;Semaphorin interactions
TTDI02622;WP2059;Alzheimers Disease
TTDI02622;WP2380;BDNF signaling pathway
TTDI02623;WP1861;mRNA Capping
TTDI02623;WP1906;RNA Polymerase II Transcription
TTDI02623;WP2658;HIV Life Cycle
TTDI02623;WP411;mRNA Processing
TTDI02626;WP176;Folate Metabolism
TTDI02626;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI02626;WP2848;Differentiation Pathway
TTDI02626;WP2849;Hematopoietic Stem Cell Differentiation
TTDI02626;WP530;Cytokines and Inflammatory Response
TTDI02628;WP2112;IL17 signaling pathway
TTDI02634;WP69;TCR Signaling Pathway
TTDI02635;WP1793;Cell junction organization
TTDI02635;WP1794;Cell surface interactions at the vascular wall
TTDI02635;WP1833;Integrin cell surface interactions
TTDI02635;WP2742;Signaling by TGF-beta Receptor Complex
TTDI02639;WP1449;Regulation of toll-like receptor signaling pathway
TTDI02639;WP1839;Interleukin-1 signaling
TTDI02639;WP1927;TCR signaling
TTDI02639;WP195;IL-1 signaling pathway
TTDI02639;WP2018;RANKL/RANK Signaling Pathway
TTDI02639;WP2036;TWEAK Signaling Pathway
TTDI02639;WP2112;IL17 signaling pathway
TTDI02639;WP231;TNF alpha Signaling Pathway
TTDI02639;WP23;B Cell Receptor Signaling Pathway
TTDI02639;WP262;EBV LMP1 signaling
TTDI02639;WP2637;Structural Pathway of Interleukin 1 (IL-1)
TTDI02639;WP2656;TAK1 activates NFkB by phosphorylation and activation of IKKs complex
TTDI02639;WP2746;Signaling by the B Cell Receptor (BCR)
TTDI02639;WP2752;MyD88-independent cascade
TTDI02639;WP2759;Fc epsilon receptor (FCERI) signaling
TTDI02639;WP2761;MyD88:Mal cascade initiated on plasma membrane
TTDI02639;WP2763;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
TTDI02639;WP2768;MyD88 dependent cascade initiated on endosome
TTDI02639;WP2792;MAP kinase activation in TLR cascade
TTDI02639;WP2795;Cardiac Hypertrophic Response
TTDI02639;WP2801;MyD88 cascade initiated on plasma membrane
TTDI02639;WP288;NLR Proteins
TTDI02639;WP314;FAS pathway and Stress induction of HSP regulation
TTDI02639;WP363;Wnt Signaling Pathway Netpath
TTDI02639;WP364;IL-6 signaling pathway
TTDI02639;WP366;TGF beta Signaling Pathway
TTDI02639;WP382;MAPK Signaling Pathway
TTDI02639;WP399;Wnt Signaling Pathway and Pluripotency
TTDI02639;WP400;p38 MAPK Signaling Pathway
TTDI02639;WP481;Insulin Signaling
TTDI02639;WP69;TCR Signaling Pathway
TTDI02639;WP710;DNA Damage Response (only ATM dependent)
TTDI02639;WP75;Toll-like receptor signaling pathway
TTDI02640;WP1911;Signaling by FGFR
TTDI02640;WP2653;PIP3 activates AKT signaling
TTDI02640;WP2677;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
TTDI02640;WP51;Regulation of Actin Cytoskeleton
TTDI02641;WP410;Diurnally Regulated Genes with Circadian Orthologs
TTDI02645;WP2857;Mesodermal Commitment Pathway
TTDI02646;WP1809;Effects of PIP2 hydrolysis
TTDI02646;WP1824;GPCR downstream signaling
TTDI02646;WP2740;Glycerophospholipid biosynthesis
TTDI02646;WP2764;Lipid digestion, mobilization, and transport
TTDI02647;WP2743;Glycosaminoglycan metabolism
TTDI02648;WP1843;L1CAM interactions
TTDI02649;WP2113;Type III interferon signaling
TTDI02652;WP2839;Hair Follicle Development: Organogenesis (Part 2 of 3)
TTDI02652;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDI02652;WP2853;Endoderm Differentiation
TTDI02652;WP2855;Dopaminergic Neurogenesis
TTDI02652;WP47;Hedgehog Signaling Pathway
TTDI02653;WP1889;Processing of Capped Intron-Containing Pre-mRNA
TTDI02653;WP2683;Influenza Life Cycle
TTDI02653;WP411;mRNA Processing
TTDI02654;WP2064;Neural Crest Differentiation
TTDI02654;WP2877;Vitamin D Receptor Pathway
TTDI02654;WP53;ID signaling pathway
TTDI02655;WP1835;Interferon alpha/beta signaling
TTDI02655;WP1904;RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
TTDI02655;WP2672;ISG15 antiviral mechanism
TTDI02655;WP619;Type II interferon signaling (IFNG)
TTDI02656;WP366;TGF beta Signaling Pathway
TTDI02657;WP2857;Mesodermal Commitment Pathway
TTDI02658;WP2679;MHC class II antigen presentation
TTDI02659;WP129;Matrix Metalloproteinases
TTDI02659;WP2324;AGE/RAGE pathway
TTDI02659;WP2769;Activation of Matrix Metalloproteinases
TTDI02660;WP129;Matrix Metalloproteinases
TTDI02660;WP1434;Osteopontin Signaling
TTDI02660;WP1539;Angiogenesis
TTDI02660;WP2036;TWEAK Signaling Pathway
TTDI02660;WP2324;AGE/RAGE pathway
TTDI02660;WP2431;Spinal Cord Injury
TTDI02660;WP2708;Degradation of collagen
TTDI02660;WP2769;Activation of Matrix Metalloproteinases
TTDI02660;WP2815;Mammary gland development pathway - Involution (Stage 4 of 4)
TTDI02660;WP2865;IL1 and megakaryotyces in obesity
TTDI02660;WP474;Endochondral Ossification
TTDI02661;WP1775;Cell Cycle Checkpoints
TTDI02662;WP1533;Vitamin B12 Metabolism
TTDI02662;WP15;Selenium Micronutrient Network
TTDI02662;WP176;Folate Metabolism
TTDI02662;WP2324;AGE/RAGE pathway
TTDI02662;WP2436;Dopamine metabolism
TTDI02662;WP2447;Amyotrophic lateral sclerosis (ALS)
TTDI02662;WP259;Nifedipine Activity
TTDI02662;WP2824;Detoxification of Reactive Oxygen Species
TTDI02662;WP3286;Copper homeostasis
TTDI02662;WP408;Oxidative Stress
TTDI02663;WP2059;Alzheimers Disease
TTDI02663;WP2359;Parkin-Ubiquitin Proteasomal System pathway
TTDI02663;WP2371;Parkinsons Disease Pathway
TTDI02663;WP2858;Ectoderm Differentiation
TTDI02666;WP1775;Cell Cycle Checkpoints
TTDI02666;WP179;Cell Cycle
TTDI02666;WP1815;Factors involved in megakaryocyte development and platelet production
TTDI02666;WP1858;Mitotic G1-G1/S phases
TTDI02666;WP1859;Mitotic G2-G2/M phases
TTDI02666;WP1984;Integrated Breast Cancer Pathway
TTDI02666;WP2446;Retinoblastoma (RB) in Cancer
TTDI02666;WP2772;S Phase
TTDI02666;WP45;G1 to S cell cycle control
TTDI02667;WP2007;Iron metabolism in placenta
TTDI02675;WP2799;Regulation of Insulin-like Growth Factor (IGF) Transport and Uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
TTDI02675;WP289;Myometrial Relaxation and Contraction Pathways
TTDI02676;WP2799;Regulation of Insulin-like Growth Factor (IGF) Transport and Uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
TTDI02676;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDI02676;WP2877;Vitamin D Receptor Pathway
TTDI02676;WP289;Myometrial Relaxation and Contraction Pathways
TTDI02676;WP615;Senescence and Autophagy in Cancer
TTDI02677;WP1818;Formation of Fibrin Clot (Clotting Cascade)
TTDI02677;WP272;Blood Clotting Cascade
TTDI02677;WP2806;Human Complement System
TTDI02677;WP558;Complement and Coagulation Cascades
TTDI02678;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDI02678;WP1559;TFs Regulate miRNAs related to cardiac hypertrophy
TTDI02678;WP179;Cell Cycle
TTDI02678;WP2328;Allograft Rejection
TTDI02678;WP2332;Interleukin-11 Signaling Pathway
TTDI02678;WP2355;Corticotropin-releasing hormone
TTDI02678;WP236;Adipogenesis
TTDI02678;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02678;WP2406;Cardiac Progenitor Differentiation
TTDI02678;WP2431;Spinal Cord Injury
TTDI02678;WP2572;Primary Focal Segmental Glomerulosclerosis FSGS
TTDI02678;WP2666;Elastic fibre formation
TTDI02678;WP2703;Extracellular matrix organization
TTDI02678;WP2742;Signaling by TGF-beta Receptor Complex
TTDI02678;WP2751;Transcriptional Regulation of White Adipocyte Differentiation
TTDI02678;WP2771;Host Interactions with Influenza Factors
TTDI02678;WP2787;Syndecan interactions
TTDI02678;WP2795;Cardiac Hypertrophic Response
TTDI02678;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDI02678;WP2848;Differentiation Pathway
TTDI02678;WP2849;Hematopoietic Stem Cell Differentiation
TTDI02678;WP2853;Endoderm Differentiation
TTDI02678;WP2855;Dopaminergic Neurogenesis
TTDI02678;WP286;IL-3 Signaling Pathway
TTDI02678;WP2870;Extracellular vesicle-mediated signaling in recipient cells
TTDI02678;WP2873;Aryl Hydrocarbon Receptor Pathway
TTDI02678;WP2877;Vitamin D Receptor Pathway
TTDI02678;WP2882;Nuclear Receptors Meta-Pathway
TTDI02678;WP2884;NRF2 pathway
TTDI02678;WP366;TGF beta Signaling Pathway
TTDI02678;WP382;MAPK Signaling Pathway
TTDI02678;WP474;Endochondral Ossification
TTDI02678;WP530;Cytokines and Inflammatory Response
TTDI02678;WP554;ACE Inhibitor Pathway
TTDI02678;WP560;TGF Beta Signaling Pathway
TTDI02678;WP615;Senescence and Autophagy in Cancer
TTDI02678;WP69;TCR Signaling Pathway
TTDI02678;WP710;DNA Damage Response (only ATM dependent)
TTDI02680;WP1495;Glycine Metabolism
TTDI02680;WP1533;Vitamin B12 Metabolism
TTDI02680;WP1589;Folate-Alcohol and Cancer Pathway
TTDI02680;WP15;Selenium Micronutrient Network
TTDI02680;WP1601;Fluoropyrimidine Activity
TTDI02680;WP176;Folate Metabolism
TTDI02680;WP1857;Metabolism of water-soluble vitamins and cofactors
TTDI02680;WP2190;One carbon donor
TTDI02680;WP241;One Carbon Metabolism
TTDI02680;WP2525;Trans-sulfuration and one carbon metabolism
TTDI02681;WP1829;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
TTDI02681;WP2328;Allograft Rejection
TTDI02681;WP453;Inflammatory Response Pathway
TTDI02684;WP127;IL-5 Signaling Pathway
TTDI02684;WP1794;Cell surface interactions at the vascular wall
TTDI02684;WP1866;NCAM signaling for neurite out-growth
TTDI02684;WP1873;NGF signalling via TRKA from the plasma membrane
TTDI02684;WP1910;Signaling by EGFR
TTDI02684;WP1911;Signaling by FGFR
TTDI02684;WP1913;Signaling by Insulin receptor
TTDI02684;WP1916;Signaling by PDGF
TTDI02684;WP1984;Integrated Breast Cancer Pathway
TTDI02684;WP2002;miR-targeted genes in epithelium - TarBase
TTDI02684;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDI02684;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI02684;WP2261;Signaling Pathways in Glioblastoma
TTDI02684;WP2290;RalA downstream regulated genes
TTDI02684;WP231;TNF alpha Signaling Pathway
TTDI02684;WP2374;Oncostatin M Signaling Pathway
TTDI02684;WP2377;Integrated Pancreatic Cancer Pathway
TTDI02684;WP2586;Aryl Hydrocarbon Receptor
TTDI02684;WP2643;Nanoparticle-mediated activation of receptor signaling
TTDI02684;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDI02684;WP2677;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
TTDI02684;WP2694;DAP12 interactions
TTDI02684;WP2713;Signaling by SCF-KIT
TTDI02684;WP2735;RAF/MAP kinase cascade
TTDI02684;WP2746;Signaling by the B Cell Receptor (BCR)
TTDI02684;WP2759;Fc epsilon receptor (FCERI) signaling
TTDI02684;WP2780;Signaling by ERBB2
TTDI02684;WP2781;Signaling by ERBB4
TTDI02684;WP2870;Extracellular vesicle-mediated signaling in recipient cells
TTDI02684;WP35;G Protein Signaling Pathways
TTDI02684;WP382;MAPK Signaling Pathway
TTDI02684;WP422;MAPK Cascade
TTDI02684;WP437;EGF/EGFR Signaling Pathway
TTDI02684;WP51;Regulation of Actin Cytoskeleton
TTDI02684;WP673;ErbB Signaling Pathway
TTDI02684;WP710;DNA Damage Response (only ATM dependent)
TTDI02684;WP732;Serotonin Receptor 2 and ELK-SRF/GATA4 signaling
TTDI02685;WP1591;Heart Development
TTDI02685;WP2005;miR-targeted genes in muscle cell - TarBase
TTDI02685;WP2261;Signaling Pathways in Glioblastoma
TTDI02685;WP2864;Apoptosis-related network due to altered Notch3 in ovarian cancer
TTDI02685;WP673;ErbB Signaling Pathway
TTDI02686;WP395;IL-4 Signaling Pathway
TTDI02686;WP453;Inflammatory Response Pathway
TTDNC00348;WP1904;RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
TTDNC00348;WP195;IL-1 signaling pathway
TTDNC00348;WP231;TNF alpha Signaling Pathway
TTDNC00348;WP2380;BDNF signaling pathway
TTDNC00348;WP2526;PDGF Pathway
TTDNC00348;WP254;Apoptosis
TTDNC00348;WP2571;Polycystic Kidney Disease Pathway
TTDNC00348;WP2637;Structural Pathway of Interleukin 1 (IL-1)
TTDNC00348;WP2759;Fc epsilon receptor (FCERI) signaling
TTDNC00348;WP2761;MyD88:Mal cascade initiated on plasma membrane
TTDNC00348;WP2768;MyD88 dependent cascade initiated on endosome
TTDNC00348;WP2795;Cardiac Hypertrophic Response
TTDNC00348;WP2801;MyD88 cascade initiated on plasma membrane
TTDNC00348;WP314;FAS pathway and Stress induction of HSP regulation
TTDNC00348;WP382;MAPK Signaling Pathway
TTDNC00348;WP384;Apoptosis Modulation by HSP70
TTDNC00348;WP400;p38 MAPK Signaling Pathway
TTDNC00348;WP422;MAPK Cascade
TTDNC00348;WP437;EGF/EGFR Signaling Pathway
TTDNC00348;WP481;Insulin Signaling
TTDNC00348;WP585;Interferon type I signaling pathways
TTDNC00348;WP710;DNA Damage Response (only ATM dependent)
TTDNC00348;WP722;Serotonin HTR1 Group and FOS Pathway
TTDNC00370;WP2406;Cardiac Progenitor Differentiation
TTDNC00370;WP2572;Primary Focal Segmental Glomerulosclerosis FSGS
TTDNC00370;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDNC00370;WP2848;Differentiation Pathway
TTDNC00370;WP2853;Endoderm Differentiation
TTDNC00370;WP2857;Mesodermal Commitment Pathway
TTDNC00371;WP2328;Allograft Rejection
TTDNC00372;WP1833;Integrin cell surface interactions
TTDNC00372;WP1843;L1CAM interactions
TTDNC00372;WP185;Integrin-mediated Cell Adhesion
TTDNC00372;WP1864;Muscle contraction
TTDNC00372;WP1883;Platelet Adhesion to exposed collagen
TTDNC00372;WP1907;Semaphorin interactions
TTDNC00372;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDNC00372;WP2643;Nanoparticle-mediated activation of receptor signaling
TTDNC00372;WP2911;miRNA targets in ECM and membrane receptors
TTDNC00372;WP313;Signaling of Hepatocyte Growth Factor Receptor
TTDNC00372;WP51;Regulation of Actin Cytoskeleton
TTDNC00373;WP12;Osteoclast Signaling
TTDNC00373;WP1449;Regulation of toll-like receptor signaling pathway
TTDNC00373;WP1835;Interferon alpha/beta signaling
TTDNC00373;WP585;Interferon type I signaling pathways
TTDNC00373;WP75;Toll-like receptor signaling pathway
TTDNC00376;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDNC00376;WP706;SIDS Susceptibility Pathways
TTDNC00380;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDNC00380;WP2005;miR-targeted genes in muscle cell - TarBase
TTDNC00380;WP2006;miR-targeted genes in squamous cell - TarBase
TTDNC00381;WP1602;Nicotine Activity on Dopaminergic Neurons
TTDNC00381;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDNC00381;WP706;SIDS Susceptibility Pathways
TTDNC00385;WP1591;Heart Development
TTDNC00385;WP1919;Signaling by VEGF
TTDNC00385;WP306;Focal Adhesion
TTDNC00387;WP138;Androgen receptor signaling pathway
TTDNC00387;WP1539;Angiogenesis
TTDNC00387;WP1797;Circadian Clock
TTDNC00387;WP1815;Factors involved in megakaryocyte development and platelet production
TTDNC00387;WP1822;Generic Transcription Pathway
TTDNC00387;WP1904;RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
TTDNC00387;WP231;TNF alpha Signaling Pathway
TTDNC00387;WP2377;Integrated Pancreatic Cancer Pathway
TTDNC00387;WP268;Notch Signaling Pathway
TTDNC00387;WP2706;Activation of Gene Expression by SREBP (SREBF)
TTDNC00387;WP2720;Signaling by NOTCH1
TTDNC00387;WP2727;Regulation of Hypoxia-inducible Factor (HIF) by Oxygen
TTDNC00387;WP2738;YAP1- and WWTR1 (TAZ)-stimulated gene expression
TTDNC00387;WP2751;Transcriptional Regulation of White Adipocyte Differentiation
TTDNC00387;WP2786;Pre-NOTCH Expression and Processing
TTDNC00387;WP2794;Cytosolic sensors of pathogen-associated DNA
TTDNC00387;WP2797;Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
TTDNC00387;WP364;IL-6 signaling pathway
TTDNC00387;WP366;TGF beta Signaling Pathway
TTDNC00387;WP399;Wnt Signaling Pathway and Pluripotency
TTDNC00387;WP560;TGF Beta Signaling Pathway
TTDNC00387;WP706;SIDS Susceptibility Pathways
TTDNC00388;WP1403;AMPK Signaling
TTDNC00388;WP1449;Regulation of toll-like receptor signaling pathway
TTDNC00388;WP1539;Angiogenesis
TTDNC00388;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDNC00388;WP1794;Cell surface interactions at the vascular wall
TTDNC00388;WP1799;Costimulation by the CD28 family
TTDNC00388;WP1824;GPCR downstream signaling
TTDNC00388;WP1826;GPVI-mediated activation cascade
TTDNC00388;WP1840;Interleukin-3, 5 and GM-CSF signaling
TTDNC00388;WP1867;Nephrin interactions
TTDNC00388;WP1873;NGF signalling via TRKA from the plasma membrane
TTDNC00388;WP1910;Signaling by EGFR
TTDNC00388;WP1911;Signaling by FGFR
TTDNC00388;WP1913;Signaling by Insulin receptor
TTDNC00388;WP1916;Signaling by PDGF
TTDNC00388;WP1927;TCR signaling
TTDNC00388;WP1982;SREBP signalling
TTDNC00388;WP2032;TSH signaling pathway
TTDNC00388;WP2038;Regulation of Microtubule Cytoskeleton
TTDNC00388;WP2203;TSLP Signaling Pathway
TTDNC00388;WP2261;Signaling Pathways in Glioblastoma
TTDNC00388;WP2263;Prostate Cancer
TTDNC00388;WP2377;Integrated Pancreatic Cancer Pathway
TTDNC00388;WP2653;PIP3 activates AKT signaling
TTDNC00388;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDNC00388;WP2677;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
TTDNC00388;WP2694;DAP12 interactions
TTDNC00388;WP2713;Signaling by SCF-KIT
TTDNC00388;WP2719;Fcgamma receptor (FCGR) dependent phagocytosis
TTDNC00388;WP2732;Interleukin-2 signaling
TTDNC00388;WP2747;PI Metabolism
TTDNC00388;WP2759;Fc epsilon receptor (FCERI) signaling
TTDNC00388;WP2780;Signaling by ERBB2
TTDNC00388;WP2781;Signaling by ERBB4
TTDNC00388;WP2865;IL1 and megakaryotyces in obesity
TTDNC00388;WP306;Focal Adhesion
TTDNC00388;WP313;Signaling of Hepatocyte Growth Factor Receptor
TTDNC00388;WP3286;Copper homeostasis
TTDNC00388;WP395;IL-4 Signaling Pathway
TTDNC00388;WP3;Transcriptional activation by NRF2
TTDNC00388;WP481;Insulin Signaling
TTDNC00388;WP51;Regulation of Actin Cytoskeleton
TTDNC00388;WP524;G13 Signaling Pathway
TTDNC00388;WP710;DNA Damage Response (only ATM dependent)
TTDNC00388;WP712;Estrogen signaling pathway
TTDNC00388;WP722;Serotonin HTR1 Group and FOS Pathway
TTDNC00388;WP75;Toll-like receptor signaling pathway
TTDNC00389;WP1866;NCAM signaling for neurite out-growth
TTDNC00389;WP2355;Corticotropin-releasing hormone
TTDNC00392;WP2380;BDNF signaling pathway
TTDNC00392;WP2853;Endoderm Differentiation
TTDNC00392;WP2857;Mesodermal Commitment Pathway
TTDNC00393;WP1403;AMPK Signaling
TTDNC00395;WP231;TNF alpha Signaling Pathway
TTDNC00395;WP2877;Vitamin D Receptor Pathway
TTDNC00397;WP2064;Neural Crest Differentiation
TTDNC00397;WP268;Notch Signaling Pathway
TTDNC00397;WP2718;Signaling by NOTCH2
TTDNC00397;WP2720;Signaling by NOTCH1
TTDNC00397;WP2721;Signaling by NOTCH4
TTDNC00397;WP2722;Signaling by NOTCH3
TTDNC00397;WP61;Notch Signaling Pathway
TTDNC00406;WP69;TCR Signaling Pathway
TTDNC00407;WP2038;Regulation of Microtubule Cytoskeleton
TTDNC00407;WP2377;Integrated Pancreatic Cancer Pathway
TTDNC00407;WP2446;Retinoblastoma (RB) in Cancer
TTDNC00407;WP382;MAPK Signaling Pathway
TTDNC00407;WP437;EGF/EGFR Signaling Pathway
TTDNC00408;WP3286;Copper homeostasis
TTDNC00411;WP1530;miRNA Regulation of DNA Damage Response
TTDNC00411;WP1545;miRNAs involved in DNA damage response
TTDNC00411;WP179;Cell Cycle
TTDNC00411;WP1841;Intrinsic Pathway for Apoptosis
TTDNC00411;WP1858;Mitotic G1-G1/S phases
TTDNC00411;WP1859;Mitotic G2-G2/M phases
TTDNC00411;WP1971;Integrated Cancer pathway
TTDNC00411;WP1984;Integrated Breast Cancer Pathway
TTDNC00411;WP2002;miR-targeted genes in epithelium - TarBase
TTDNC00411;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDNC00411;WP2005;miR-targeted genes in muscle cell - TarBase
TTDNC00411;WP2032;TSH signaling pathway
TTDNC00411;WP2261;Signaling Pathways in Glioblastoma
TTDNC00411;WP2263;Prostate Cancer
TTDNC00411;WP236;Adipogenesis
TTDNC00411;WP2377;Integrated Pancreatic Cancer Pathway
TTDNC00411;WP2431;Spinal Cord Injury
TTDNC00411;WP2446;Retinoblastoma (RB) in Cancer
TTDNC00411;WP2586;Aryl Hydrocarbon Receptor
TTDNC00411;WP2786;Pre-NOTCH Expression and Processing
TTDNC00411;WP2815;Mammary gland development pathway - Involution (Stage 4 of 4)
TTDNC00411;WP2828;Bladder Cancer
TTDNC00411;WP437;EGF/EGFR Signaling Pathway
TTDNC00411;WP45;G1 to S cell cycle control
TTDNC00411;WP615;Senescence and Autophagy in Cancer
TTDNC00411;WP707;DNA Damage Response
TTDNC00412;WP1835;Interferon alpha/beta signaling
TTDNC00412;WP2113;Type III interferon signaling
TTDNC00412;WP2332;Interleukin-11 Signaling Pathway
TTDNC00412;WP2374;Oncostatin M Signaling Pathway
TTDNC00412;WP364;IL-6 signaling pathway
TTDNC00412;WP395;IL-4 Signaling Pathway
TTDNC00412;WP585;Interferon type I signaling pathways
TTDNC00415;WP1591;Heart Development
TTDNC00415;WP1822;Generic Transcription Pathway
TTDNC00415;WP1897;Regulation of beta-cell development
TTDNC00415;WP2002;miR-targeted genes in epithelium - TarBase
TTDNC00415;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDNC00415;WP2005;miR-targeted genes in muscle cell - TarBase
TTDNC00415;WP2064;Neural Crest Differentiation
TTDNC00415;WP2361;Gastric Cancer Network 1
TTDNC00415;WP2406;Cardiac Progenitor Differentiation
TTDNC00415;WP2572;Primary Focal Segmental Glomerulosclerosis FSGS
TTDNC00415;WP268;Notch Signaling Pathway
TTDNC00415;WP2720;Signaling by NOTCH1
TTDNC00415;WP2786;Pre-NOTCH Expression and Processing
TTDNC00415;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDNC00415;WP2848;Differentiation Pathway
TTDNC00415;WP2849;Hematopoietic Stem Cell Differentiation
TTDNC00415;WP2853;Endoderm Differentiation
TTDNC00415;WP2854;Gene regulatory network modelling somitogenesis
TTDNC00415;WP61;Notch Signaling Pathway
TTDNC00419;WP1539;Angiogenesis
TTDNC00419;WP1794;Cell surface interactions at the vascular wall
TTDNC00420;WP2653;PIP3 activates AKT signaling
TTDNC00420;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDNC00420;WP2780;Signaling by ERBB2
TTDNC00420;WP2781;Signaling by ERBB4
TTDNC00420;WP2865;IL1 and megakaryotyces in obesity
TTDNC00420;WP2882;Nuclear Receptors Meta-Pathway
TTDNC00420;WP2884;NRF2 pathway
TTDNC00420;WP516;Hypertrophy Model
TTDNC00420;WP673;ErbB Signaling Pathway
TTDNC00422;WP2377;Integrated Pancreatic Cancer Pathway
TTDNC00424;WP2889;Oxytocin signaling
TTDNC00425;WP1843;L1CAM interactions
TTDNC00425;WP231;TNF alpha Signaling Pathway
TTDNC00425;WP2380;BDNF signaling pathway
TTDNC00425;WP2652;Mitotic Prometaphase
TTDNC00426;WP1794;Cell surface interactions at the vascular wall
TTDNC00426;WP1833;Integrin cell surface interactions
TTDNC00426;WP1843;L1CAM interactions
TTDNC00426;WP185;Integrin-mediated Cell Adhesion
TTDNC00426;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDNC00426;WP2666;Elastic fibre formation
TTDNC00426;WP2703;Extracellular matrix organization
TTDNC00426;WP306;Focal Adhesion
TTDNC00433;WP2261;Signaling Pathways in Glioblastoma
TTDNC00433;WP26;Signal Transduction of S1P Receptor
TTDNC00433;WP2747;PI Metabolism
TTDNC00433;WP437;EGF/EGFR Signaling Pathway
TTDNC00433;WP51;Regulation of Actin Cytoskeleton
TTDNC00433;WP710;DNA Damage Response (only ATM dependent)
TTDNC00439;WP1799;Costimulation by the CD28 family
TTDNC00439;WP1836;Interferon gamma signaling
TTDNC00439;WP1927;TCR signaling
TTDNC00439;WP2679;MHC class II antigen presentation
TTDNC00441;WP1848;Metabolism of carbohydrates
TTDNC00441;WP1935;Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds
TTDNC00441;WP2882;Nuclear Receptors Meta-Pathway
TTDNC00441;WP2884;NRF2 pathway
TTDNC00442;WP1788;Bile acid and bile salt metabolism
TTDNC00444;WP1831;Integration of energy metabolism
TTDNC00444;WP325;Triacylglyceride Synthesis
TTDNC00446;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDNC00446;WP2005;miR-targeted genes in muscle cell - TarBase
TTDNC00447;WP1539;Angiogenesis
TTDNC00447;WP1794;Cell surface interactions at the vascular wall
TTDNC00447;WP363;Wnt Signaling Pathway Netpath
TTDNC00454;WP1824;GPCR downstream signaling
TTDNC00454;WP1825;GPCR ligand binding
TTDNC00454;WP455;GPCRs, Class A Rhodopsin-like
TTDNC00454;WP58;Monoamine GPCRs
TTDNC00454;WP706;SIDS Susceptibility Pathways
TTDNC00454;WP722;Serotonin HTR1 Group and FOS Pathway
TTDNC00460;WP2203;TSLP Signaling Pathway
TTDNC00462;WP1824;GPCR downstream signaling
TTDNC00462;WP1825;GPCR ligand binding
TTDNC00462;WP2197;Endothelin Pathways
TTDNC00462;WP334;GPCRs, Class B Secretin-like
TTDNC00463;WP1799;Costimulation by the CD28 family
TTDNC00464;WP1829;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
TTDNC00468;WP1799;Costimulation by the CD28 family
TTDNC00474;WP1798;Complement cascade
TTDNC00474;WP1824;GPCR downstream signaling
TTDNC00474;WP1825;GPCR ligand binding
TTDNC00474;WP2328;Allograft Rejection
TTDNC00474;WP2431;Spinal Cord Injury
TTDNC00474;WP2806;Human Complement System
TTDNC00474;WP545;Complement Activation, Classical Pathway
TTDNC00475;WP2203;TSLP Signaling Pathway
TTDNC00485;WP2728;Incretin Synthesis, Secretion, and Inactivation
TTDNC00486;WP558;Complement and Coagulation Cascades
TTDNC00489;WP1799;Costimulation by the CD28 family
TTDNC00489;WP2583;T-Cell Receptor and Co-stimulatory Signaling
TTDNC00490;WP3297;EV release from cardiac cells and their functional effects
TTDNC00490;WP673;ErbB Signaling Pathway
TTDNC00492;WP2369;Histone Modifications
TTDNC00498;WP2849;Hematopoietic Stem Cell Differentiation
TTDNC00498;WP2858;Ectoderm Differentiation
TTDNC00499;WP3286;Copper homeostasis
TTDNC00502;WP1772;Apoptosis Modulation and Signaling
TTDNC00502;WP1814;Extrinsic Pathway for Apoptosis
TTDNC00502;WP2059;Alzheimers Disease
TTDNC00502;WP231;TNF alpha Signaling Pathway
TTDNC00502;WP2377;Integrated Pancreatic Cancer Pathway
TTDNC00502;WP2447;Amyotrophic lateral sclerosis (ALS)
TTDNC00502;WP2513;Nanoparticle triggered regulated necrosis
TTDNC00502;WP254;Apoptosis
TTDNC00502;WP2795;Cardiac Hypertrophic Response
TTDNC00502;WP384;Apoptosis Modulation by HSP70
TTDNC00502;WP453;Inflammatory Response Pathway
TTDNC00504;WP1799;Costimulation by the CD28 family
TTDNC00504;WP1829;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
TTDNC00504;WP1927;TCR signaling
TTDNC00504;WP2719;Fcgamma receptor (FCGR) dependent phagocytosis
TTDNC00504;WP69;TCR Signaling Pathway
TTDNC00506;WP1848;Metabolism of carbohydrates
TTDNC00506;WP1935;Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds
TTDNC00506;WP2882;Nuclear Receptors Meta-Pathway
TTDNC00506;WP2884;NRF2 pathway
TTDNC00511;WP35;G Protein Signaling Pathways
TTDNC00512;WP1926;Synthesis, Secretion, and Deacylation of Ghrelin
TTDNC00512;WP2865;IL1 and megakaryotyces in obesity
TTDNC00515;WP170;Nuclear Receptors
TTDNC00515;WP1797;Circadian Clock
TTDNC00515;WP236;Adipogenesis
TTDNC00515;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDNC00515;WP2853;Endoderm Differentiation
TTDNC00515;WP2882;Nuclear Receptors Meta-Pathway
TTDNC00515;WP706;SIDS Susceptibility Pathways
TTDNC00515;WP734;Serotonin Receptor 4/6/7 and NR3C Signaling
TTDNC00518;WP1824;GPCR downstream signaling
TTDNC00518;WP1825;GPCR ligand binding
TTDNC00518;WP24;Peptide GPCRs
TTDNC00518;WP2806;Human Complement System
TTDNC00518;WP558;Complement and Coagulation Cascades
TTDNC00520;WP1829;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
TTDNC00525;WP2377;Integrated Pancreatic Cancer Pathway
TTDNC00527;WP117;GPCRs, Other
TTDNC00527;WP1824;GPCR downstream signaling
TTDNC00527;WP1825;GPCR ligand binding
TTDNC00527;WP24;Peptide GPCRs
TTDNC00527;WP2848;Differentiation Pathway
TTDNC00527;WP455;GPCRs, Class A Rhodopsin-like
TTDNC00529;WP1471;TOR Signaling
TTDNC00529;WP1799;Costimulation by the CD28 family
TTDNC00529;WP2653;PIP3 activates AKT signaling
TTDNC00529;WP585;Interferon type I signaling pathways
TTDNC00532;WP1935;Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds
TTDNC00532;WP2007;Iron metabolism in placenta
TTDNC00532;WP2670;Iron uptake and transport
TTDNC00539;WP1911;Signaling by FGFR
TTDNC00539;WP2064;Neural Crest Differentiation
TTDNC00539;WP2828;Bladder Cancer
TTDNC00539;WP474;Endochondral Ossification
TTDNC00539;WP51;Regulation of Actin Cytoskeleton
TTDNC00542;WP179;Cell Cycle
TTDNC00542;WP2064;Neural Crest Differentiation
TTDNC00542;WP2858;Ectoderm Differentiation
TTDNC00553;WP1584;Type II diabetes mellitus
TTDNC00553;WP1784;Apoptotic execution phase
TTDNC00553;WP1809;Effects of PIP2 hydrolysis
TTDNC00553;WP1824;GPCR downstream signaling
TTDNC00553;WP1978;Opioid Signalling
TTDNC00553;WP2012;miRs in Muscle Cell Differentiation
TTDNC00553;WP2261;Signaling Pathways in Glioblastoma
TTDNC00553;WP2324;AGE/RAGE pathway
TTDNC00553;WP2355;Corticotropin-releasing hormone
TTDNC00553;WP2374;Oncostatin M Signaling Pathway
TTDNC00553;WP2380;BDNF signaling pathway
TTDNC00553;WP23;B Cell Receptor Signaling Pathway
TTDNC00553;WP244;Alpha 6 Beta 4 signaling pathway
TTDNC00553;WP2688;DAG and IP3 signaling
TTDNC00553;WP2733;Regulation of mRNA Stability by Proteins that Bind AU-rich Elements
TTDNC00553;WP289;Myometrial Relaxation and Contraction Pathways
TTDNC00553;WP35;G Protein Signaling Pathways
TTDNC00553;WP364;IL-6 signaling pathway
TTDNC00553;WP382;MAPK Signaling Pathway
TTDNC00553;WP399;Wnt Signaling Pathway and Pluripotency
TTDNC00553;WP428;Wnt Signaling Pathway
TTDNC00553;WP437;EGF/EGFR Signaling Pathway
TTDNC00553;WP481;Insulin Signaling
TTDNC00553;WP536;Calcium Regulation in the Cardiac Cell
TTDNC00553;WP619;Type II interferon signaling (IFNG)
TTDNC00553;WP69;TCR Signaling Pathway
TTDNC00569;WP241;One Carbon Metabolism
TTDNC00572;WP237;Glucocorticoid & Mineralcorticoid Metabolism
TTDNC00572;WP2749;Metabolism of steroid hormones and vitamin D
TTDNC00572;WP43;Oxidation by Cytochrome P450
TTDNC00572;WP554;ACE Inhibitor Pathway
TTDNC00572;WP702;Metapathway biotransformation
TTDNC00574;WP1824;GPCR downstream signaling
TTDNC00574;WP1825;GPCR ligand binding
TTDNC00574;WP2431;Spinal Cord Injury
TTDNC00574;WP24;Peptide GPCRs
TTDNC00574;WP2671;Defensins
TTDNC00574;WP455;GPCRs, Class A Rhodopsin-like
TTDNC00576;WP1533;Vitamin B12 Metabolism
TTDNC00576;WP15;Selenium Micronutrient Network
TTDNC00576;WP176;Folate Metabolism
TTDNC00576;WP1831;Integration of energy metabolism
TTDNC00576;WP1897;Regulation of beta-cell development
TTDNC00576;WP1913;Signaling by Insulin receptor
TTDNC00576;WP1926;Synthesis, Secretion, and Deacylation of Ghrelin
TTDNC00576;WP1946;Cori Cycle
TTDNC00576;WP1982;SREBP signalling
TTDNC00576;WP2324;AGE/RAGE pathway
TTDNC00576;WP236;Adipogenesis
TTDNC00576;WP2406;Cardiac Progenitor Differentiation
TTDNC00576;WP2509;Nanoparticle triggered autophagic cell death
TTDNC00576;WP2736;Insulin Processing
TTDNC00576;WP2848;Differentiation Pathway
TTDNC00576;WP615;Senescence and Autophagy in Cancer
TTDNC00578;WP1848;Metabolism of carbohydrates
TTDNC00578;WP1935;Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds
TTDNC00578;WP2882;Nuclear Receptors Meta-Pathway
TTDNC00578;WP2884;NRF2 pathway
TTDNC00579;WP1935;Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds
TTDNC00579;WP2882;Nuclear Receptors Meta-Pathway
TTDNC00579;WP2884;NRF2 pathway
TTDNC00581;WP2764;Lipid digestion, mobilization, and transport
TTDNC00581;WP430;Statin Pathway
TTDNC00584;WP205;IL-7 Signaling Pathway
TTDNC00584;WP2673;Interleukin-7 signaling
TTDNC00584;WP530;Cytokines and Inflammatory Response
TTDNC00585;WP2112;IL17 signaling pathway
TTDNC00586;WP1864;Muscle contraction
TTDNC00586;WP383;Striated Muscle Contraction
TTDNC00589;WP1794;Cell surface interactions at the vascular wall
TTDNC00589;WP1829;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
TTDNC00589;WP1833;Integrin cell surface interactions
TTDNC00589;WP185;Integrin-mediated Cell Adhesion
TTDNC00589;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDNC00589;WP306;Focal Adhesion
TTDNC00597;WP2333;Trans-sulfuration pathway
TTDNC00597;WP241;One Carbon Metabolism
TTDNC00597;WP2446;Retinoblastoma (RB) in Cancer
TTDNC00597;WP2525;Trans-sulfuration and one carbon metabolism
TTDNC00602;WP2729;Metabolism of Angiotensinogen to Angiotensins
TTDNC00602;WP554;ACE Inhibitor Pathway
TTDNC00604;WP1772;Apoptosis Modulation and Signaling
TTDNC00604;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDNC00608;WP1824;GPCR downstream signaling
TTDNC00608;WP1825;GPCR ligand binding
TTDNC00608;WP24;Peptide GPCRs
TTDNC00608;WP455;GPCRs, Class A Rhodopsin-like
TTDNC00613;WP127;IL-5 Signaling Pathway
TTDNC00613;WP1449;Regulation of toll-like receptor signaling pathway
TTDNC00613;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDNC00613;WP1843;L1CAM interactions
TTDNC00613;WP185;Integrin-mediated Cell Adhesion
TTDNC00613;WP1911;Signaling by FGFR
TTDNC00613;WP195;IL-1 signaling pathway
TTDNC00613;WP2034;Leptin signaling pathway
TTDNC00613;WP205;IL-7 Signaling Pathway
TTDNC00613;WP2203;TSLP Signaling Pathway
TTDNC00613;WP2261;Signaling Pathways in Glioblastoma
TTDNC00613;WP2263;Prostate Cancer
TTDNC00613;WP22;IL-9 Signaling Pathway
TTDNC00613;WP2332;Interleukin-11 Signaling Pathway
TTDNC00613;WP2374;Oncostatin M Signaling Pathway
TTDNC00613;WP2380;BDNF signaling pathway
TTDNC00613;WP23;B Cell Receptor Signaling Pathway
TTDNC00613;WP2447;Amyotrophic lateral sclerosis (ALS)
TTDNC00613;WP2636;Genes and (Common) Pathways Underlying Drug Addiction
TTDNC00613;WP2637;Structural Pathway of Interleukin 1 (IL-1)
TTDNC00613;WP2643;Nanoparticle-mediated activation of receptor signaling
TTDNC00613;WP2735;RAF/MAP kinase cascade
TTDNC00613;WP2792;MAP kinase activation in TLR cascade
TTDNC00613;WP2795;Cardiac Hypertrophic Response
TTDNC00613;WP2828;Bladder Cancer
TTDNC00613;WP304;Kit receptor signaling pathway
TTDNC00613;WP306;Focal Adhesion
TTDNC00613;WP313;Signaling of Hepatocyte Growth Factor Receptor
TTDNC00613;WP364;IL-6 signaling pathway
TTDNC00613;WP366;TGF beta Signaling Pathway
TTDNC00613;WP382;MAPK Signaling Pathway
TTDNC00613;WP422;MAPK Cascade
TTDNC00613;WP437;EGF/EGFR Signaling Pathway
TTDNC00613;WP481;Insulin Signaling
TTDNC00613;WP49;IL-2 Signaling Pathway
TTDNC00613;WP51;Regulation of Actin Cytoskeleton
TTDNC00613;WP581;EPO Receptor Signaling
TTDNC00613;WP666;Hypothetical Network for Drug Addiction
TTDNC00613;WP69;TCR Signaling Pathway
TTDNC00613;WP722;Serotonin HTR1 Group and FOS Pathway
TTDNC00613;WP732;Serotonin Receptor 2 and ELK-SRF/GATA4 signaling
TTDNC00613;WP734;Serotonin Receptor 4/6/7 and NR3C Signaling
TTDNC00613;WP75;Toll-like receptor signaling pathway
TTDNC00616;WP2764;Lipid digestion, mobilization, and transport
TTDNC00616;WP2776;Visual phototransduction
TTDNC00616;WP2878;PPAR Alpha Pathway
TTDNC00616;WP2882;Nuclear Receptors Meta-Pathway
TTDNC00616;WP430;Statin Pathway
TTDNC00621;WP1911;Signaling by FGFR
TTDNC00621;WP2653;PIP3 activates AKT signaling
TTDNC00621;WP2677;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
TTDNC00621;WP51;Regulation of Actin Cytoskeleton
TTDNC00625;WP2675;Signaling by NODAL
TTDNC00625;WP2760;Signaling by BMP
TTDNC00625;WP2791;Signaling by Activin
TTDNC00625;WP2857;Mesodermal Commitment Pathway
TTDNC00630;WP1873;NGF signalling via TRKA from the plasma membrane
TTDNC00630;WP2377;Integrated Pancreatic Cancer Pathway
TTDNC00630;WP2380;BDNF signaling pathway
TTDNC00630;WP382;MAPK Signaling Pathway
TTDNC00634;WP23;B Cell Receptor Signaling Pathway
TTDNC00634;WP2746;Signaling by the B Cell Receptor (BCR)
TTDNC00645;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDNC00645;WP2035;FSH signaling pathway
TTDNC00645;WP2377;Integrated Pancreatic Cancer Pathway
TTDNC00645;WP2380;BDNF signaling pathway
TTDNC00645;WP2431;Spinal Cord Injury
TTDNC00645;WP382;MAPK Signaling Pathway
TTDNC00645;WP706;SIDS Susceptibility Pathways
TTDNC00648;WP1842;Kinesins
TTDNC00648;WP2679;MHC class II antigen presentation
TTDNC00650;WP2431;Spinal Cord Injury
TTDNC00650;WP2733;Regulation of mRNA Stability by Proteins that Bind AU-rich Elements
TTDNC00651;WP1824;GPCR downstream signaling
TTDNC00651;WP1825;GPCR ligand binding
TTDNC00651;WP247;Small Ligand GPCRs
TTDNC00651;WP455;GPCRs, Class A Rhodopsin-like
TTDNC00651;WP98;Prostaglandin Synthesis and Regulation
TTDNC00653;WP1824;GPCR downstream signaling
TTDNC00653;WP1825;GPCR ligand binding
TTDNC00653;WP1831;Integration of energy metabolism
TTDNC00653;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDNC00653;WP2728;Incretin Synthesis, Secretion, and Inactivation
TTDNC00653;WP455;GPCRs, Class A Rhodopsin-like
TTDNC00658;WP1824;GPCR downstream signaling
TTDNC00658;WP1825;GPCR ligand binding
TTDNC00658;WP1978;Opioid Signalling
TTDNC00658;WP24;Peptide GPCRs
TTDNC00658;WP455;GPCRs, Class A Rhodopsin-like
TTDNC00658;WP69;TCR Signaling Pathway
TTDNC00667;WP1824;GPCR downstream signaling
TTDNC00667;WP1825;GPCR ligand binding
TTDNC00667;WP24;Peptide GPCRs
TTDNC00667;WP455;GPCRs, Class A Rhodopsin-like
TTDNC00670;WP2703;Extracellular matrix organization
TTDNC00670;WP2776;Visual phototransduction
TTDNC00671;WP558;Complement and Coagulation Cascades
TTDNC00676;WP23;B Cell Receptor Signaling Pathway
TTDNC00676;WP2806;Human Complement System
TTDNC00676;WP558;Complement and Coagulation Cascades
TTDNC00677;WP2788;Sphingolipid metabolism
TTDNR00643;WP1528;Physiological and Pathological Hypertrophy of the Heart
TTDNR00643;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDNR00643;WP1824;GPCR downstream signaling
TTDNR00643;WP1825;GPCR ligand binding
TTDNR00643;WP236;Adipogenesis
TTDNR00643;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDNR00643;WP2729;Metabolism of Angiotensinogen to Angiotensins
TTDNR00643;WP2797;Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
TTDNR00643;WP364;IL-6 signaling pathway
TTDNR00643;WP554;ACE Inhibitor Pathway
TTDNR00643;WP727;Monoamine Transport
TTDNR00648;WP129;Matrix Metalloproteinases
TTDNR00648;WP1794;Cell surface interactions at the vascular wall
TTDNR00648;WP1833;Integrin cell surface interactions
TTDNR00648;WP2766;The citric acid (TCA) cycle and respiratory electron transport
TTDNR00649;WP2380;BDNF signaling pathway
TTDNR00649;WP706;SIDS Susceptibility Pathways
TTDNR00652;WP1528;Physiological and Pathological Hypertrophy of the Heart
TTDNR00652;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDNR00671;WP1859;Mitotic G2-G2/M phases
TTDNR00671;WP2652;Mitotic Prometaphase
TTDNR00671;WP2658;HIV Life Cycle
TTDNR00671;WP2683;Influenza Life Cycle
TTDNR00671;WP2684;Host Interactions of HIV factors
TTDNR00671;WP2733;Regulation of mRNA Stability by Proteins that Bind AU-rich Elements
TTDNR00671;WP2742;Signaling by TGF-beta Receptor Complex
TTDNR00671;WP2757;Mitotic Metaphase and Anaphase
TTDNR00702;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDNR00702;WP2572;Primary Focal Segmental Glomerulosclerosis FSGS
TTDNR00702;WP2804;Hair Follicle Development: Induction (Part 1 of 3)
TTDNR00702;WP363;Wnt Signaling Pathway Netpath
TTDNR00702;WP399;Wnt Signaling Pathway and Pluripotency
TTDNR00702;WP428;Wnt Signaling Pathway
TTDNR00709;WP1808;DSCAM interactions
TTDNR00709;WP1868;Netrin-1 signaling
TTDNR00709;WP2431;Spinal Cord Injury
TTDNR00714;WP2100;Arylhydrocarbon receptor (AhR) signaling pathway
TTDNR00714;WP2435;Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis
TTDNR00714;WP2586;Aryl Hydrocarbon Receptor
TTDNR00714;WP2857;Mesodermal Commitment Pathway
TTDNR00714;WP2873;Aryl Hydrocarbon Receptor Pathway
TTDNR00714;WP2882;Nuclear Receptors Meta-Pathway
TTDNR00714;WP2884;NRF2 pathway
TTDNR00714;WP3;Transcriptional activation by NRF2
TTDNR00714;WP408;Oxidative Stress
TTDNR00726;WP2586;Aryl Hydrocarbon Receptor
TTDNR00726;WP2751;Transcriptional Regulation of White Adipocyte Differentiation
TTDNR00726;WP2761;MyD88:Mal cascade initiated on plasma membrane
TTDNR00726;WP2775;Toll-Like Receptors Cascades
TTDNR00726;WP2784;Binding and Uptake of Ligands by Scavenger Receptors
TTDNR00726;WP2796;Class I MHC mediated antigen processing & presentation
TTDNR00726;WP2797;Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
TTDNR00726;WP716;Vitamin A and Carotenoid Metabolism
TTDNR00746;WP2849;Hematopoietic Stem Cell Differentiation
TTDNR00764;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDNR00764;WP2005;miR-targeted genes in muscle cell - TarBase
TTDNR00764;WP2006;miR-targeted genes in squamous cell - TarBase
TTDNS00536;WP117;GPCRs, Other
TTDNS00536;WP1825;GPCR ligand binding
TTDNS00536;WP2377;Integrated Pancreatic Cancer Pathway
TTDNS00536;WP2804;Hair Follicle Development: Induction (Part 1 of 3)
TTDNS00536;WP2839;Hair Follicle Development: Organogenesis (Part 2 of 3)
TTDNS00536;WP47;Hedgehog Signaling Pathway
TTDNS00537;WP117;GPCRs, Other
TTDNS00537;WP1824;GPCR downstream signaling
TTDNS00537;WP1825;GPCR ligand binding
TTDNS00537;WP247;Small Ligand GPCRs
TTDNS00537;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDNS00537;WP455;GPCRs, Class A Rhodopsin-like
TTDNS00537;WP98;Prostaglandin Synthesis and Regulation
TTDNS00541;WP1887;Post-translational modification: synthesis of GPI-anchored proteins
TTDNS00541;WP410;Diurnally Regulated Genes with Circadian Orthologs
TTDNS00542;WP1539;Angiogenesis
TTDNS00542;WP1591;Heart Development
TTDNS00542;WP1919;Signaling by VEGF
TTDNS00542;WP1984;Integrated Breast Cancer Pathway
TTDNS00542;WP2328;Allograft Rejection
TTDNS00542;WP2374;Oncostatin M Signaling Pathway
TTDNS00542;WP2377;Integrated Pancreatic Cancer Pathway
TTDNS00542;WP2435;Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis
TTDNS00542;WP2586;Aryl Hydrocarbon Receptor
TTDNS00542;WP259;Nifedipine Activity
TTDNS00542;WP2727;Regulation of Hypoxia-inducible Factor (HIF) by Oxygen
TTDNS00542;WP2828;Bladder Cancer
TTDNS00542;WP2848;Differentiation Pathway
TTDNS00542;WP306;Focal Adhesion
TTDNS00542;WP474;Endochondral Ossification
TTDNS00542;WP516;Hypertrophy Model
TTDNS00542;WP706;SIDS Susceptibility Pathways
TTDNS00544;WP1824;GPCR downstream signaling
TTDNS00544;WP1825;GPCR ligand binding
TTDNS00544;WP334;GPCRs, Class B Secretin-like
TTDNS00564;WP1982;SREBP signalling
TTDNS00564;WP2377;Integrated Pancreatic Cancer Pathway
TTDNS00564;WP2700;Latent infection of Homo sapiens with Mycobacterium tuberculosis
TTDNS00564;WP2877;Vitamin D Receptor Pathway
TTDNS00582;WP1824;GPCR downstream signaling
TTDNS00582;WP1825;GPCR ligand binding
TTDNS00582;WP2597;Secretion of Hydrochloric Acid in Parietal Cells
TTDNS00582;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDNS00582;WP455;GPCRs, Class A Rhodopsin-like
TTDNS00582;WP51;Regulation of Actin Cytoskeleton
TTDNS00582;WP536;Calcium Regulation in the Cardiac Cell
TTDNS00582;WP58;Monoamine GPCRs
TTDNS00592;WP1530;miRNA Regulation of DNA Damage Response
TTDNS00592;WP1545;miRNAs involved in DNA damage response
TTDNS00592;WP1742;TP53 Network
TTDNS00592;WP179;Cell Cycle
TTDNS00592;WP1815;Factors involved in megakaryocyte development and platelet production
TTDNS00592;WP1865;Myogenesis
TTDNS00592;WP1918;Signaling by Robo receptor
TTDNS00592;WP1984;Integrated Breast Cancer Pathway
TTDNS00592;WP2038;Regulation of Microtubule Cytoskeleton
TTDNS00592;WP2272;Pathogenic Escherichia coli infection
TTDNS00592;WP2377;Integrated Pancreatic Cancer Pathway
TTDNS00592;WP2446;Retinoblastoma (RB) in Cancer
TTDNS00592;WP2516;ATM Signaling Pathway
TTDNS00592;WP2719;Fcgamma receptor (FCGR) dependent phagocytosis
TTDNS00592;WP2864;Apoptosis-related network due to altered Notch3 in ovarian cancer
TTDNS00592;WP437;EGF/EGFR Signaling Pathway
TTDNS00592;WP673;ErbB Signaling Pathway
TTDNS00592;WP707;DNA Damage Response
TTDNS00592;WP710;DNA Damage Response (only ATM dependent)
TTDNS00593;WP2586;Aryl Hydrocarbon Receptor
TTDNS00593;WP2855;Dopaminergic Neurogenesis
TTDNS00593;WP706;SIDS Susceptibility Pathways
TTDNS00597;WP2431;Spinal Cord Injury
TTDNS00605;WP1780;ABC-family proteins mediated transport
TTDNS00611;WP127;IL-5 Signaling Pathway
TTDNS00611;WP1835;Interferon alpha/beta signaling
TTDNS00611;WP1836;Interferon gamma signaling
TTDNS00611;WP1840;Interleukin-3, 5 and GM-CSF signaling
TTDNS00611;WP1971;Integrated Cancer pathway
TTDNS00611;WP1984;Integrated Breast Cancer Pathway
TTDNS00611;WP2032;TSH signaling pathway
TTDNS00611;WP2034;Leptin signaling pathway
TTDNS00611;WP205;IL-7 Signaling Pathway
TTDNS00611;WP2112;IL17 signaling pathway
TTDNS00611;WP2113;Type III interferon signaling
TTDNS00611;WP2203;TSLP Signaling Pathway
TTDNS00611;WP2263;Prostate Cancer
TTDNS00611;WP22;IL-9 Signaling Pathway
TTDNS00611;WP2332;Interleukin-11 Signaling Pathway
TTDNS00611;WP2374;Oncostatin M Signaling Pathway
TTDNS00611;WP2526;PDGF Pathway
TTDNS00611;WP2593;JAK/STAT
TTDNS00611;WP2673;Interleukin-7 signaling
TTDNS00611;WP2732;Interleukin-2 signaling
TTDNS00611;WP2868;TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer
TTDNS00611;WP286;IL-3 Signaling Pathway
TTDNS00611;WP364;IL-6 signaling pathway
TTDNS00611;WP395;IL-4 Signaling Pathway
TTDNS00611;WP437;EGF/EGFR Signaling Pathway
TTDNS00611;WP49;IL-2 Signaling Pathway
TTDNS00611;WP560;TGF Beta Signaling Pathway
TTDNS00611;WP585;Interferon type I signaling pathways
TTDNS00611;WP619;Type II interferon signaling (IFNG)
TTDR00006;WP1824;GPCR downstream signaling
TTDR00006;WP1825;GPCR ligand binding
TTDR00006;WP1981;Thyroxine (Thyroid Hormone) Production
TTDR00006;WP2032;TSH signaling pathway
TTDR00006;WP2035;FSH signaling pathway
TTDR00006;WP2691;Peptide hormone biosynthesis
TTDR00006;WP2693;Metabolism of amino acids and derivatives
TTDR00006;WP2749;Metabolism of steroid hormones and vitamin D
TTDR00007;WP1604;Codeine and Morphine Metabolism
TTDR00007;WP2289;Drug Induction of Bile Acid Pathway
TTDR00007;WP2328;Allograft Rejection
TTDR00007;WP2377;Integrated Pancreatic Cancer Pathway
TTDR00007;WP2489;Multi Drug Resistance Protein 1 (Glycoprotein 1) Regulation
TTDR00007;WP2712;Abacavir transport and metabolism
TTDR00007;WP2875;Constitutive Androstane Receptor Pathway
TTDR00007;WP2876;Pregnane X Receptor pathway
TTDR00007;WP2877;Vitamin D Receptor Pathway
TTDR00007;WP2882;Nuclear Receptors Meta-Pathway
TTDR00007;WP299;Nuclear Receptors in Lipid Metabolism and Toxicity
TTDR00008;WP100;Glutathione metabolism
TTDR00008;WP134;Pentose Phosphate Pathway
TTDR00008;WP1848;Metabolism of carbohydrates
TTDR00008;WP1946;Cori Cycle
TTDR00008;WP2002;miR-targeted genes in epithelium - TarBase
TTDR00008;WP2003;miR-targeted genes in leukocytes - TarBase
TTDR00008;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDR00008;WP2005;miR-targeted genes in muscle cell - TarBase
TTDR00008;WP2877;Vitamin D Receptor Pathway
TTDR00008;WP2882;Nuclear Receptors Meta-Pathway
TTDR00008;WP2884;NRF2 pathway
TTDR00008;WP692;Sulfation Biotransformation Reaction
TTDR00010;WP465;Tryptophan metabolism
TTDR00011;WP1824;GPCR downstream signaling
TTDR00011;WP1825;GPCR ligand binding
TTDR00011;WP24;Peptide GPCRs
TTDR00011;WP2806;Human Complement System
TTDR00011;WP455;GPCRs, Class A Rhodopsin-like
TTDR00012;WP1840;Interleukin-3, 5 and GM-CSF signaling
TTDR00012;WP2732;Interleukin-2 signaling
TTDR00012;WP286;IL-3 Signaling Pathway
TTDR00018;WP1795;Cholesterol biosynthesis
TTDR00018;WP465;Tryptophan metabolism
TTDR00020;WP1604;Codeine and Morphine Metabolism
TTDR00020;WP2289;Drug Induction of Bile Acid Pathway
TTDR00020;WP229;Irinotecan Pathway
TTDR00020;WP2875;Constitutive Androstane Receptor Pathway
TTDR00020;WP2876;Pregnane X Receptor pathway
TTDR00020;WP2882;Nuclear Receptors Meta-Pathway
TTDR00020;WP2884;NRF2 pathway
TTDR00020;WP299;Nuclear Receptors in Lipid Metabolism and Toxicity
TTDR00029;WP129;Matrix Metalloproteinases
TTDR00029;WP2324;AGE/RAGE pathway
TTDR00029;WP2769;Activation of Matrix Metalloproteinases
TTDR00029;WP399;Wnt Signaling Pathway and Pluripotency
TTDR00032;WP2848;Differentiation Pathway
TTDR00033;WP2650;Arachidonic acid metabolism
TTDR00033;WP696;Benzo(a)pyrene metabolism
TTDR00033;WP702;Metapathway biotransformation
TTDR00035;WP706;SIDS Susceptibility Pathways
TTDR00081;WP1824;GPCR downstream signaling
TTDR00081;WP1825;GPCR ligand binding
TTDR00081;WP1908;Signal amplification
TTDR00081;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDR00081;WP455;GPCRs, Class A Rhodopsin-like
TTDR00081;WP80;Nucleotide GPCRs
TTDR00082;WP111;Electron Transport Chain
TTDR00082;WP1902;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.
TTDR00082;WP236;Adipogenesis
TTDR00083;WP111;Electron Transport Chain
TTDR00083;WP1902;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.
TTDR00084;WP111;Electron Transport Chain
TTDR00084;WP1902;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.
TTDR00084;WP410;Diurnally Regulated Genes with Circadian Orthologs
TTDR00085;WP382;MAPK Signaling Pathway
TTDR00086;WP176;Folate Metabolism
TTDR00086;WP2328;Allograft Rejection
TTDR00086;WP2431;Spinal Cord Injury
TTDR00086;WP395;IL-4 Signaling Pathway
TTDR00086;WP453;Inflammatory Response Pathway
TTDR00086;WP530;Cytokines and Inflammatory Response
TTDR00088;WP1840;Interleukin-3, 5 and GM-CSF signaling
TTDR00088;WP2328;Allograft Rejection
TTDR00088;WP2732;Interleukin-2 signaling
TTDR00088;WP2849;Hematopoietic Stem Cell Differentiation
TTDR00088;WP453;Inflammatory Response Pathway
TTDR00088;WP530;Cytokines and Inflammatory Response
TTDR00094;WP134;Pentose Phosphate Pathway
TTDR00094;WP1831;Integration of energy metabolism
TTDR00094;WP1848;Metabolism of carbohydrates
TTDR00109;WP1824;GPCR downstream signaling
TTDR00109;WP1825;GPCR ligand binding
TTDR00109;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDR00109;WP455;GPCRs, Class A Rhodopsin-like
TTDR00111;WP1824;GPCR downstream signaling
TTDR00111;WP1825;GPCR ligand binding
TTDR00111;WP1929;Thrombin signalling through proteinase activated receptors (PARs)
TTDR00111;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDR00111;WP455;GPCRs, Class A Rhodopsin-like
TTDR00116;WP179;Cell Cycle
TTDR00116;WP1859;Mitotic G2-G2/M phases
TTDR00116;WP1971;Integrated Cancer pathway
TTDR00116;WP1984;Integrated Breast Cancer Pathway
TTDR00116;WP2263;Prostate Cancer
TTDR00116;WP2446;Retinoblastoma (RB) in Cancer
TTDR00116;WP382;MAPK Signaling Pathway
TTDR00116;WP615;Senescence and Autophagy in Cancer
TTDR00117;WP1904;RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
TTDR00117;WP195;IL-1 signaling pathway
TTDR00117;WP231;TNF alpha Signaling Pathway
TTDR00117;WP2380;BDNF signaling pathway
TTDR00117;WP2526;PDGF Pathway
TTDR00117;WP254;Apoptosis
TTDR00117;WP2571;Polycystic Kidney Disease Pathway
TTDR00117;WP2637;Structural Pathway of Interleukin 1 (IL-1)
TTDR00117;WP2759;Fc epsilon receptor (FCERI) signaling
TTDR00117;WP2761;MyD88:Mal cascade initiated on plasma membrane
TTDR00117;WP2768;MyD88 dependent cascade initiated on endosome
TTDR00117;WP2795;Cardiac Hypertrophic Response
TTDR00117;WP2801;MyD88 cascade initiated on plasma membrane
TTDR00117;WP314;FAS pathway and Stress induction of HSP regulation
TTDR00117;WP382;MAPK Signaling Pathway
TTDR00117;WP384;Apoptosis Modulation by HSP70
TTDR00117;WP400;p38 MAPK Signaling Pathway
TTDR00117;WP422;MAPK Cascade
TTDR00117;WP437;EGF/EGFR Signaling Pathway
TTDR00117;WP481;Insulin Signaling
TTDR00117;WP585;Interferon type I signaling pathways
TTDR00117;WP710;DNA Damage Response (only ATM dependent)
TTDR00117;WP722;Serotonin HTR1 Group and FOS Pathway
TTDR00118;WP24;Peptide GPCRs
TTDR00118;WP455;GPCRs, Class A Rhodopsin-like
TTDR00119;WP1824;GPCR downstream signaling
TTDR00119;WP1825;GPCR ligand binding
TTDR00119;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDR00135;WP2197;Endothelin Pathways
TTDR00135;WP2355;Corticotropin-releasing hormone
TTDR00135;WP706;SIDS Susceptibility Pathways
TTDR00138;WP2328;Allograft Rejection
TTDR00138;WP530;Cytokines and Inflammatory Response
TTDR00138;WP706;SIDS Susceptibility Pathways
TTDR00141;WP127;IL-5 Signaling Pathway
TTDR00141;WP176;Folate Metabolism
TTDR00141;WP1840;Interleukin-3, 5 and GM-CSF signaling
TTDR00141;WP2100;Arylhydrocarbon receptor (AhR) signaling pathway
TTDR00141;WP2328;Allograft Rejection
TTDR00141;WP2355;Corticotropin-releasing hormone
TTDR00141;WP2431;Spinal Cord Injury
TTDR00141;WP2583;T-Cell Receptor and Co-stimulatory Signaling
TTDR00141;WP2732;Interleukin-2 signaling
TTDR00141;WP2873;Aryl Hydrocarbon Receptor Pathway
TTDR00141;WP2882;Nuclear Receptors Meta-Pathway
TTDR00141;WP453;Inflammatory Response Pathway
TTDR00141;WP49;IL-2 Signaling Pathway
TTDR00141;WP530;Cytokines and Inflammatory Response
TTDR00147;WP1449;Regulation of toll-like receptor signaling pathway
TTDR00147;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDR00147;WP195;IL-1 signaling pathway
TTDR00147;WP2018;RANKL/RANK Signaling Pathway
TTDR00147;WP2261;Signaling Pathways in Glioblastoma
TTDR00147;WP231;TNF alpha Signaling Pathway
TTDR00147;WP2637;Structural Pathway of Interleukin 1 (IL-1)
TTDR00147;WP2759;Fc epsilon receptor (FCERI) signaling
TTDR00147;WP2795;Cardiac Hypertrophic Response
TTDR00147;WP382;MAPK Signaling Pathway
TTDR00147;WP422;MAPK Cascade
TTDR00147;WP481;Insulin Signaling
TTDR00147;WP673;ErbB Signaling Pathway
TTDR00147;WP75;Toll-like receptor signaling pathway
TTDR00148;WP127;IL-5 Signaling Pathway
TTDR00148;WP1434;Osteopontin Signaling
TTDR00148;WP1449;Regulation of toll-like receptor signaling pathway
TTDR00148;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDR00148;WP1843;L1CAM interactions
TTDR00148;WP185;Integrin-mediated Cell Adhesion
TTDR00148;WP1911;Signaling by FGFR
TTDR00148;WP195;IL-1 signaling pathway
TTDR00148;WP2018;RANKL/RANK Signaling Pathway
TTDR00148;WP2032;TSH signaling pathway
TTDR00148;WP2034;Leptin signaling pathway
TTDR00148;WP205;IL-7 Signaling Pathway
TTDR00148;WP2197;Endothelin Pathways
TTDR00148;WP2203;TSLP Signaling Pathway
TTDR00148;WP2261;Signaling Pathways in Glioblastoma
TTDR00148;WP2263;Prostate Cancer
TTDR00148;WP22;IL-9 Signaling Pathway
TTDR00148;WP2324;AGE/RAGE pathway
TTDR00148;WP2332;Interleukin-11 Signaling Pathway
TTDR00148;WP2355;Corticotropin-releasing hormone
TTDR00148;WP2374;Oncostatin M Signaling Pathway
TTDR00148;WP2377;Integrated Pancreatic Cancer Pathway
TTDR00148;WP2380;BDNF signaling pathway
TTDR00148;WP23;B Cell Receptor Signaling Pathway
TTDR00148;WP2526;PDGF Pathway
TTDR00148;WP2586;Aryl Hydrocarbon Receptor
TTDR00148;WP259;Nifedipine Activity
TTDR00148;WP2636;Genes and (Common) Pathways Underlying Drug Addiction
TTDR00148;WP2637;Structural Pathway of Interleukin 1 (IL-1)
TTDR00148;WP2643;Nanoparticle-mediated activation of receptor signaling
TTDR00148;WP2735;RAF/MAP kinase cascade
TTDR00148;WP2792;MAP kinase activation in TLR cascade
TTDR00148;WP2795;Cardiac Hypertrophic Response
TTDR00148;WP2828;Bladder Cancer
TTDR00148;WP286;IL-3 Signaling Pathway
TTDR00148;WP304;Kit receptor signaling pathway
TTDR00148;WP306;Focal Adhesion
TTDR00148;WP313;Signaling of Hepatocyte Growth Factor Receptor
TTDR00148;WP364;IL-6 signaling pathway
TTDR00148;WP366;TGF beta Signaling Pathway
TTDR00148;WP382;MAPK Signaling Pathway
TTDR00148;WP422;MAPK Cascade
TTDR00148;WP437;EGF/EGFR Signaling Pathway
TTDR00148;WP481;Insulin Signaling
TTDR00148;WP49;IL-2 Signaling Pathway
TTDR00148;WP51;Regulation of Actin Cytoskeleton
TTDR00148;WP581;EPO Receptor Signaling
TTDR00148;WP615;Senescence and Autophagy in Cancer
TTDR00148;WP666;Hypothetical Network for Drug Addiction
TTDR00148;WP673;ErbB Signaling Pathway
TTDR00148;WP69;TCR Signaling Pathway
TTDR00148;WP712;Estrogen signaling pathway
TTDR00148;WP722;Serotonin HTR1 Group and FOS Pathway
TTDR00148;WP732;Serotonin Receptor 2 and ELK-SRF/GATA4 signaling
TTDR00148;WP734;Serotonin Receptor 4/6/7 and NR3C Signaling
TTDR00148;WP75;Toll-like receptor signaling pathway
TTDR00151;WP1818;Formation of Fibrin Clot (Clotting Cascade)
TTDR00151;WP272;Blood Clotting Cascade
TTDR00151;WP2762;PTM: gamma carboxylation, hypusine formation and arylsulfatase activation
TTDR00151;WP2806;Human Complement System
TTDR00151;WP558;Complement and Coagulation Cascades
TTDR00152;WP1403;AMPK Signaling
TTDR00152;WP1530;miRNA Regulation of DNA Damage Response
TTDR00152;WP1775;Cell Cycle Checkpoints
TTDR00152;WP1782;APC/C-mediated degradation of cell cycle proteins
TTDR00152;WP179;Cell Cycle
TTDR00152;WP1858;Mitotic G1-G1/S phases
TTDR00152;WP1859;Mitotic G2-G2/M phases
TTDR00152;WP2446;Retinoblastoma (RB) in Cancer
TTDR00152;WP2516;ATM Signaling Pathway
TTDR00152;WP2652;Mitotic Prometaphase
TTDR00152;WP2654;Mitotic Prophase
TTDR00152;WP45;G1 to S cell cycle control
TTDR00152;WP707;DNA Damage Response
TTDR00154;WP1848;Metabolism of carbohydrates
TTDR00157;WP117;GPCRs, Other
TTDR00157;WP1824;GPCR downstream signaling
TTDR00157;WP1825;GPCR ligand binding
TTDR00157;WP455;GPCRs, Class A Rhodopsin-like
TTDR00157;WP58;Monoamine GPCRs
TTDR00157;WP734;Serotonin Receptor 4/6/7 and NR3C Signaling
TTDR00159;WP1938;tRNA Aminoacylation
TTDR00164;WP1603;Nicotine Activity on Chromaffin Cells
TTDR00164;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDR00164;WP706;SIDS Susceptibility Pathways
TTDR00171;WP1851;Metabolism of nucleotides
TTDR00171;WP2197;Endothelin Pathways
TTDR00172;WP2740;Glycerophospholipid biosynthesis
TTDR00172;WP528;Acetylcholine Synthesis
TTDR00173;WP1602;Nicotine Activity on Dopaminergic Neurons
TTDR00173;WP1824;GPCR downstream signaling
TTDR00173;WP1831;Integration of energy metabolism
TTDR00173;WP1978;Opioid Signalling
TTDR00173;WP2032;TSH signaling pathway
TTDR00173;WP2662;Regulation of Water Balance by Renal Aquaporins
TTDR00173;WP2688;DAG and IP3 signaling
TTDR00173;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDR00173;WP289;Myometrial Relaxation and Contraction Pathways
TTDR00173;WP35;G Protein Signaling Pathways
TTDR00173;WP536;Calcium Regulation in the Cardiac Cell
TTDR00181;WP2870;Extracellular vesicle-mediated signaling in recipient cells
TTDR00181;WP2882;Nuclear Receptors Meta-Pathway
TTDR00181;WP2884;NRF2 pathway
TTDR00181;WP673;ErbB Signaling Pathway
TTDR00184;WP1824;GPCR downstream signaling
TTDR00184;WP1825;GPCR ligand binding
TTDR00184;WP24;Peptide GPCRs
TTDR00184;WP455;GPCRs, Class A Rhodopsin-like
TTDR00197;WP2729;Metabolism of Angiotensinogen to Angiotensins
TTDR00197;WP554;ACE Inhibitor Pathway
TTDR00199;WP1584;Type II diabetes mellitus
TTDR00199;WP1831;Integration of energy metabolism
TTDR00199;WP2267;Synaptic Vesicle Pathway
TTDR00199;WP536;Calcium Regulation in the Cardiac Cell
TTDR00200;WP1831;Integration of energy metabolism
TTDR00200;WP536;Calcium Regulation in the Cardiac Cell
TTDR00202;WP1530;miRNA Regulation of DNA Damage Response
TTDR00202;WP1545;miRNAs involved in DNA damage response
TTDR00202;WP1775;Cell Cycle Checkpoints
TTDR00202;WP179;Cell Cycle
TTDR00202;WP1858;Mitotic G1-G1/S phases
TTDR00202;WP1971;Integrated Cancer pathway
TTDR00202;WP1984;Integrated Breast Cancer Pathway
TTDR00202;WP2263;Prostate Cancer
TTDR00202;WP2446;Retinoblastoma (RB) in Cancer
TTDR00202;WP2516;ATM Signaling Pathway
TTDR00202;WP2772;S Phase
TTDR00202;WP45;G1 to S cell cycle control
TTDR00202;WP707;DNA Damage Response
TTDR00205;WP1449;Regulation of toll-like receptor signaling pathway
TTDR00205;WP1824;GPCR downstream signaling
TTDR00205;WP1825;GPCR ligand binding
TTDR00205;WP2203;TSLP Signaling Pathway
TTDR00205;WP2328;Allograft Rejection
TTDR00205;WP2355;Corticotropin-releasing hormone
TTDR00205;WP2431;Spinal Cord Injury
TTDR00205;WP262;EBV LMP1 signaling
TTDR00205;WP2753;Activation of Genes by ATF4
TTDR00205;WP2828;Bladder Cancer
TTDR00205;WP286;IL-3 Signaling Pathway
TTDR00205;WP615;Senescence and Autophagy in Cancer
TTDR00205;WP706;SIDS Susceptibility Pathways
TTDR00205;WP75;Toll-like receptor signaling pathway
TTDR00208;WP1530;miRNA Regulation of DNA Damage Response
TTDR00208;WP1775;Cell Cycle Checkpoints
TTDR00208;WP179;Cell Cycle
TTDR00208;WP1859;Mitotic G2-G2/M phases
TTDR00208;WP2377;Integrated Pancreatic Cancer Pathway
TTDR00208;WP2516;ATM Signaling Pathway
TTDR00208;WP707;DNA Damage Response
TTDR00208;WP727;Monoamine Transport
TTDR00209;WP2681;Uptake of Oxygen and Release of Carbon Dioxide by Erythrocytes
TTDR00209;WP2744;Uptake of Carbon Dioxide and Release of Oxygen by Erythrocytes
TTDR00209;WP2770;Reversible Hydration of Carbon Dioxide
TTDR00210;WP2770;Reversible Hydration of Carbon Dioxide
TTDR00211;WP2727;Regulation of Hypoxia-inducible Factor (HIF) by Oxygen
TTDR00211;WP2770;Reversible Hydration of Carbon Dioxide
TTDR00211;WP2877;Vitamin D Receptor Pathway
TTDR00212;WP2002;miR-targeted genes in epithelium - TarBase
TTDR00212;WP2003;miR-targeted genes in leukocytes - TarBase
TTDR00212;WP2005;miR-targeted genes in muscle cell - TarBase
TTDR00212;WP2770;Reversible Hydration of Carbon Dioxide
TTDR00213;WP2770;Reversible Hydration of Carbon Dioxide
TTDR00217;WP1794;Cell surface interactions at the vascular wall
TTDR00217;WP1829;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
TTDR00217;WP1833;Integrin cell surface interactions
TTDR00217;WP185;Integrin-mediated Cell Adhesion
TTDR00217;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDR00217;WP306;Focal Adhesion
TTDR00219;WP1851;Metabolism of nucleotides
TTDR00219;WP2853;Endoderm Differentiation
TTDR00219;WP2857;Mesodermal Commitment Pathway
TTDR00219;WP404;Nucleotide Metabolism
TTDR00221;WP185;Integrin-mediated Cell Adhesion
TTDR00221;WP1984;Integrated Breast Cancer Pathway
TTDR00221;WP2038;Regulation of Microtubule Cytoskeleton
TTDR00221;WP2776;Visual phototransduction
TTDR00221;WP455;GPCRs, Class A Rhodopsin-like
TTDR00222;WP106;Alanine and aspartate metabolism
TTDR00222;WP1848;Metabolism of carbohydrates
TTDR00222;WP2333;Trans-sulfuration pathway
TTDR00222;WP2693;Metabolism of amino acids and derivatives
TTDR00222;WP534;Glycolysis and Gluconeogenesis
TTDR00224;WP1787;Base Excision Repair
TTDR00224;WP179;Cell Cycle
TTDR00224;WP1858;Mitotic G1-G1/S phases
TTDR00224;WP1925;Synthesis of DNA
TTDR00224;WP1928;Telomere Maintenance
TTDR00224;WP1980;Nucleotide Excision Repair
TTDR00224;WP2377;Integrated Pancreatic Cancer Pathway
TTDR00224;WP2446;Retinoblastoma (RB) in Cancer
TTDR00224;WP2572;Primary Focal Segmental Glomerulosclerosis FSGS
TTDR00224;WP259;Nifedipine Activity
TTDR00224;WP2772;S Phase
TTDR00224;WP437;EGF/EGFR Signaling Pathway
TTDR00224;WP45;G1 to S cell cycle control
TTDR00224;WP466;DNA Replication
TTDR00224;WP531;Mismatch repair
TTDR00224;WP615;Senescence and Autophagy in Cancer
TTDR00225;WP1533;Vitamin B12 Metabolism
TTDR00225;WP15;Selenium Micronutrient Network
TTDR00225;WP176;Folate Metabolism
TTDR00225;WP1982;SREBP signalling
TTDR00225;WP2011;SREBF and miR33 in cholesterol and lipid homeostasis
TTDR00225;WP2374;Oncostatin M Signaling Pathway
TTDR00225;WP2764;Lipid digestion, mobilization, and transport
TTDR00225;WP2776;Visual phototransduction
TTDR00225;WP399;Wnt Signaling Pathway and Pluripotency
TTDR00225;WP428;Wnt Signaling Pathway
TTDR00225;WP430;Statin Pathway
TTDR00225;WP710;DNA Damage Response (only ATM dependent)
TTDR00226;WP1495;Glycine Metabolism
TTDR00226;WP1533;Vitamin B12 Metabolism
TTDR00226;WP176;Folate Metabolism
TTDR00226;WP241;One Carbon Metabolism
TTDR00226;WP2525;Trans-sulfuration and one carbon metabolism
TTDR00231;WP1601;Fluoropyrimidine Activity
TTDR00231;WP1851;Metabolism of nucleotides
TTDR00233;WP127;IL-5 Signaling Pathway
TTDR00233;WP1449;Regulation of toll-like receptor signaling pathway
TTDR00233;WP2203;TSLP Signaling Pathway
TTDR00233;WP23;B Cell Receptor Signaling Pathway
TTDR00233;WP2694;DAP12 interactions
TTDR00233;WP2746;Signaling by the B Cell Receptor (BCR)
TTDR00233;WP2761;MyD88:Mal cascade initiated on plasma membrane
TTDR00233;WP304;Kit receptor signaling pathway
TTDR00234;WP167;Eicosanoid Synthesis
TTDR00234;WP2650;Arachidonic acid metabolism
TTDR00238;WP1403;AMPK Signaling
TTDR00238;WP2034;Leptin signaling pathway
TTDR00239;WP167;Eicosanoid Synthesis
TTDR00239;WP2650;Arachidonic acid metabolism
TTDR00242;WP1879;Phase 1 - Functionalization of compounds
TTDR00242;WP2001;miR-targeted genes in adipocytes - TarBase
TTDR00242;WP2002;miR-targeted genes in epithelium - TarBase
TTDR00242;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDR00242;WP2005;miR-targeted genes in muscle cell - TarBase
TTDR00242;WP2100;Arylhydrocarbon receptor (AhR) signaling pathway
TTDR00242;WP2542;Sulindac Metabolic Pathway
TTDR00242;WP2586;Aryl Hydrocarbon Receptor
TTDR00242;WP2873;Aryl Hydrocarbon Receptor Pathway
TTDR00242;WP2881;Estrogen Receptor Pathway
TTDR00242;WP2882;Nuclear Receptors Meta-Pathway
TTDR00242;WP43;Oxidation by Cytochrome P450
TTDR00242;WP465;Tryptophan metabolism
TTDR00242;WP691;Tamoxifen metabolism
TTDR00242;WP696;Benzo(a)pyrene metabolism
TTDR00242;WP697;Estrogen metabolism
TTDR00242;WP702;Metapathway biotransformation
TTDR00249;WP2693;Metabolism of amino acids and derivatives
TTDR00249;WP497;Urea cycle and metabolism of amino groups
TTDR00250;WP1434;Osteopontin Signaling
TTDR00250;WP1449;Regulation of toll-like receptor signaling pathway
TTDR00250;WP1533;Vitamin B12 Metabolism
TTDR00250;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDR00250;WP1559;TFs Regulate miRNAs related to cardiac hypertrophy
TTDR00250;WP15;Selenium Micronutrient Network
TTDR00250;WP176;Folate Metabolism
TTDR00250;WP1772;Apoptosis Modulation and Signaling
TTDR00250;WP1838;Interleukin-1 processing
TTDR00250;WP1839;Interleukin-1 signaling
TTDR00250;WP1904;RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
TTDR00250;WP1927;TCR signaling
TTDR00250;WP195;IL-1 signaling pathway
TTDR00250;WP1976;Signalling by NGF
TTDR00250;WP1984;Integrated Breast Cancer Pathway
TTDR00250;WP2018;RANKL/RANK Signaling Pathway
TTDR00250;WP2034;Leptin signaling pathway
TTDR00250;WP2036;TWEAK Signaling Pathway
TTDR00250;WP2064;Neural Crest Differentiation
TTDR00250;WP2112;IL17 signaling pathway
TTDR00250;WP2203;TSLP Signaling Pathway
TTDR00250;WP231;TNF alpha Signaling Pathway
TTDR00250;WP2324;AGE/RAGE pathway
TTDR00250;WP2355;Corticotropin-releasing hormone
TTDR00250;WP2374;Oncostatin M Signaling Pathway
TTDR00250;WP2377;Integrated Pancreatic Cancer Pathway
TTDR00250;WP2380;BDNF signaling pathway
TTDR00250;WP23;B Cell Receptor Signaling Pathway
TTDR00250;WP2435;Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis
TTDR00250;WP254;Apoptosis
TTDR00250;WP2583;T-Cell Receptor and Co-stimulatory Signaling
TTDR00250;WP2586;Aryl Hydrocarbon Receptor
TTDR00250;WP262;EBV LMP1 signaling
TTDR00250;WP2637;Structural Pathway of Interleukin 1 (IL-1)
TTDR00250;WP2656;TAK1 activates NFkB by phosphorylation and activation of IKKs complex
TTDR00250;WP2746;Signaling by the B Cell Receptor (BCR)
TTDR00250;WP2751;Transcriptional Regulation of White Adipocyte Differentiation
TTDR00250;WP2759;Fc epsilon receptor (FCERI) signaling
TTDR00250;WP2794;Cytosolic sensors of pathogen-associated DNA
TTDR00250;WP2795;Cardiac Hypertrophic Response
TTDR00250;WP2804;Hair Follicle Development: Induction (Part 1 of 3)
TTDR00250;WP2839;Hair Follicle Development: Organogenesis (Part 2 of 3)
TTDR00250;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDR00250;WP2864;Apoptosis-related network due to altered Notch3 in ovarian cancer
TTDR00250;WP2865;IL1 and megakaryotyces in obesity
TTDR00250;WP289;Myometrial Relaxation and Contraction Pathways
TTDR00250;WP28;Selenium Metabolism and Selenoproteins
TTDR00250;WP382;MAPK Signaling Pathway
TTDR00250;WP384;Apoptosis Modulation by HSP70
TTDR00250;WP395;IL-4 Signaling Pathway
TTDR00250;WP408;Oxidative Stress
TTDR00250;WP560;TGF Beta Signaling Pathway
TTDR00250;WP61;Notch Signaling Pathway
TTDR00250;WP69;TCR Signaling Pathway
TTDR00250;WP706;SIDS Susceptibility Pathways
TTDR00250;WP710;DNA Damage Response (only ATM dependent)
TTDR00250;WP712;Estrogen signaling pathway
TTDR00250;WP75;Toll-like receptor signaling pathway
TTDR00251;WP1601;Fluoropyrimidine Activity
TTDR00251;WP1851;Metabolism of nucleotides
TTDR00251;WP2828;Bladder Cancer
TTDR00252;WP2406;Cardiac Progenitor Differentiation
TTDR00252;WP254;Apoptosis
TTDR00252;WP2677;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
TTDR00252;WP2799;Regulation of Insulin-like Growth Factor (IGF) Transport and Uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
TTDR00252;WP474;Endochondral Ossification
TTDR00261;WP1824;GPCR downstream signaling
TTDR00261;WP1825;GPCR ligand binding
TTDR00261;WP1879;Phase 1 - Functionalization of compounds
TTDR00261;WP1978;Opioid Signalling
TTDR00261;WP2355;Corticotropin-releasing hormone
TTDR00261;WP2691;Peptide hormone biosynthesis
TTDR00261;WP2693;Metabolism of amino acids and derivatives
TTDR00261;WP2749;Metabolism of steroid hormones and vitamin D
TTDR00262;WP1797;Circadian Clock
TTDR00262;WP1824;GPCR downstream signaling
TTDR00262;WP1825;GPCR ligand binding
TTDR00262;WP2662;Regulation of Water Balance by Renal Aquaporins
TTDR00262;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDR00262;WP706;SIDS Susceptibility Pathways
TTDR00265;WP1533;Vitamin B12 Metabolism
TTDR00265;WP15;Selenium Micronutrient Network
TTDR00265;WP176;Folate Metabolism
TTDR00265;WP2324;AGE/RAGE pathway
TTDR00265;WP2436;Dopamine metabolism
TTDR00265;WP2447;Amyotrophic lateral sclerosis (ALS)
TTDR00265;WP259;Nifedipine Activity
TTDR00265;WP2824;Detoxification of Reactive Oxygen Species
TTDR00265;WP3286;Copper homeostasis
TTDR00265;WP408;Oxidative Stress
TTDR00268;WP1897;Regulation of beta-cell development
TTDR00268;WP236;Adipogenesis
TTDR00268;WP2877;Vitamin D Receptor Pathway
TTDR00269;WP1403;AMPK Signaling
TTDR00269;WP170;Nuclear Receptors
TTDR00269;WP2377;Integrated Pancreatic Cancer Pathway
TTDR00269;WP2857;Mesodermal Commitment Pathway
TTDR00270;WP170;Nuclear Receptors
TTDR00270;WP2797;Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
TTDR00270;WP391;Mitochondrial Gene Expression
TTDR00273;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDR00273;WP1799;Costimulation by the CD28 family
TTDR00273;WP1824;GPCR downstream signaling
TTDR00273;WP1826;GPVI-mediated activation cascade
TTDR00273;WP185;Integrin-mediated Cell Adhesion
TTDR00273;WP1913;Signaling by Insulin receptor
TTDR00273;WP1927;TCR signaling
TTDR00273;WP2032;TSH signaling pathway
TTDR00273;WP2261;Signaling Pathways in Glioblastoma
TTDR00273;WP2332;Interleukin-11 Signaling Pathway
TTDR00273;WP2380;BDNF signaling pathway
TTDR00273;WP23;B Cell Receptor Signaling Pathway
TTDR00273;WP2653;PIP3 activates AKT signaling
TTDR00273;WP2677;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
TTDR00273;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDR00273;WP2759;Fc epsilon receptor (FCERI) signaling
TTDR00273;WP2795;Cardiac Hypertrophic Response
TTDR00273;WP306;Focal Adhesion
TTDR00273;WP437;EGF/EGFR Signaling Pathway
TTDR00273;WP481;Insulin Signaling
TTDR00273;WP69;TCR Signaling Pathway
TTDR00273;WP722;Serotonin HTR1 Group and FOS Pathway
TTDR00274;WP136;Phase I biotransformations, non P450
TTDR00274;WP1601;Fluoropyrimidine Activity
TTDR00274;WP229;Irinotecan Pathway
TTDR00274;WP2645;Heroin metabolism
TTDR00274;WP2882;Nuclear Receptors Meta-Pathway
TTDR00274;WP2884;NRF2 pathway
TTDR00275;WP1403;AMPK Signaling
TTDR00275;WP1817;Fatty acid, triacylglycerol, and ketone body metabolism
TTDR00275;WP1982;SREBP signalling
TTDR00275;WP2034;Leptin signaling pathway
TTDR00275;WP2355;Corticotropin-releasing hormone
TTDR00275;WP2593;JAK/STAT
TTDR00275;WP2706;Activation of Gene Expression by SREBP (SREBF)
TTDR00275;WP2853;Endoderm Differentiation
TTDR00275;WP2857;Mesodermal Commitment Pathway
TTDR00275;WP357;Fatty Acid Biosynthesis
TTDR00276;WP1833;Integrin cell surface interactions
TTDR00276;WP1843;L1CAM interactions
TTDR00276;WP185;Integrin-mediated Cell Adhesion
TTDR00276;WP1883;Platelet Adhesion to exposed collagen
TTDR00276;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDR00276;WP2005;miR-targeted genes in muscle cell - TarBase
TTDR00276;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDR00276;WP2332;Interleukin-11 Signaling Pathway
TTDR00276;WP2703;Extracellular matrix organization
TTDR00276;WP2806;Human Complement System
TTDR00276;WP306;Focal Adhesion
TTDR00276;WP366;TGF beta Signaling Pathway
TTDR00277;WP1434;Osteopontin Signaling
TTDR00277;WP1794;Cell surface interactions at the vascular wall
TTDR00277;WP1833;Integrin cell surface interactions
TTDR00277;WP1843;L1CAM interactions
TTDR00277;WP185;Integrin-mediated Cell Adhesion
TTDR00277;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDR00277;WP2572;Primary Focal Segmental Glomerulosclerosis FSGS
TTDR00277;WP2666;Elastic fibre formation
TTDR00277;WP2703;Extracellular matrix organization
TTDR00277;WP2787;Syndecan interactions
TTDR00277;WP2796;Class I MHC mediated antigen processing & presentation
TTDR00277;WP306;Focal Adhesion
TTDR00277;WP322;Osteoblast Signaling
TTDR00280;WP1824;GPCR downstream signaling
TTDR00280;WP1978;Opioid Signalling
TTDR00280;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDR00280;WP2688;DAG and IP3 signaling
TTDR00280;WP47;Hedgehog Signaling Pathway
TTDR00283;WP1449;Regulation of toll-like receptor signaling pathway
TTDR00283;WP2272;Pathogenic Escherichia coli infection
TTDR00283;WP2752;MyD88-independent cascade
TTDR00283;WP2761;MyD88:Mal cascade initiated on plasma membrane
TTDR00283;WP2775;Toll-Like Receptors Cascades
TTDR00283;WP2877;Vitamin D Receptor Pathway
TTDR00283;WP382;MAPK Signaling Pathway
TTDR00283;WP51;Regulation of Actin Cytoskeleton
TTDR00283;WP75;Toll-like receptor signaling pathway
TTDR00284;WP1829;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
TTDR00284;WP2328;Allograft Rejection
TTDR00284;WP453;Inflammatory Response Pathway
TTDR00288;WP1533;Vitamin B12 Metabolism
TTDR00288;WP15;Selenium Micronutrient Network
TTDR00288;WP176;Folate Metabolism
TTDR00288;WP2011;SREBF and miR33 in cholesterol and lipid homeostasis
TTDR00288;WP2764;Lipid digestion, mobilization, and transport
TTDR00288;WP2797;Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
TTDR00288;WP299;Nuclear Receptors in Lipid Metabolism and Toxicity
TTDR00288;WP430;Statin Pathway
TTDR00293;WP1820;Gap junction trafficking and regulation
TTDR00293;WP1992;TarBasePathway
TTDR00293;WP2002;miR-targeted genes in epithelium - TarBase
TTDR00293;WP2005;miR-targeted genes in muscle cell - TarBase
TTDR00293;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDR00293;WP2355;Corticotropin-releasing hormone
TTDR00293;WP2431;Spinal Cord Injury
TTDR00293;WP289;Myometrial Relaxation and Contraction Pathways
TTDR00293;WP363;Wnt Signaling Pathway Netpath
TTDR00293;WP437;EGF/EGFR Signaling Pathway
TTDR00293;WP536;Calcium Regulation in the Cardiac Cell
TTDR00293;WP706;SIDS Susceptibility Pathways
TTDR00296;WP1530;miRNA Regulation of DNA Damage Response
TTDR00296;WP1602;Nicotine Activity on Dopaminergic Neurons
TTDR00296;WP1815;Factors involved in megakaryocyte development and platelet production
TTDR00296;WP1907;Semaphorin interactions
TTDR00296;WP1978;Opioid Signalling
TTDR00296;WP2059;Alzheimers Disease
TTDR00296;WP2380;BDNF signaling pathway
TTDR00296;WP707;DNA Damage Response
TTDR00298;WP1822;Generic Transcription Pathway
TTDR00298;WP1982;SREBP signalling
TTDR00298;WP2720;Signaling by NOTCH1
TTDR00298;WP2751;Transcriptional Regulation of White Adipocyte Differentiation
TTDR00298;WP2755;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
TTDR00298;WP2797;Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
TTDR00311;WP2719;Fcgamma receptor (FCGR) dependent phagocytosis
TTDR00321;WP1824;GPCR downstream signaling
TTDR00321;WP1825;GPCR ligand binding
TTDR00321;WP501;GPCRs, Class C Metabotropic glutamate, pheromone
TTDR00322;WP1840;Interleukin-3, 5 and GM-CSF signaling
TTDR00322;WP2732;Interleukin-2 signaling
TTDR00322;WP2849;Hematopoietic Stem Cell Differentiation
TTDR00322;WP530;Cytokines and Inflammatory Response
TTDR00334;WP1449;Regulation of toll-like receptor signaling pathway
TTDR00334;WP195;IL-1 signaling pathway
TTDR00334;WP2018;RANKL/RANK Signaling Pathway
TTDR00334;WP2036;TWEAK Signaling Pathway
TTDR00334;WP2203;TSLP Signaling Pathway
TTDR00334;WP231;TNF alpha Signaling Pathway
TTDR00334;WP2324;AGE/RAGE pathway
TTDR00334;WP2355;Corticotropin-releasing hormone
TTDR00334;WP2374;Oncostatin M Signaling Pathway
TTDR00334;WP2377;Integrated Pancreatic Cancer Pathway
TTDR00334;WP2380;BDNF signaling pathway
TTDR00334;WP23;B Cell Receptor Signaling Pathway
TTDR00334;WP2516;ATM Signaling Pathway
TTDR00334;WP2593;JAK/STAT
TTDR00334;WP2637;Structural Pathway of Interleukin 1 (IL-1)
TTDR00334;WP2643;Nanoparticle-mediated activation of receptor signaling
TTDR00334;WP306;Focal Adhesion
TTDR00334;WP363;Wnt Signaling Pathway Netpath
TTDR00334;WP366;TGF beta Signaling Pathway
TTDR00334;WP382;MAPK Signaling Pathway
TTDR00334;WP399;Wnt Signaling Pathway and Pluripotency
TTDR00334;WP428;Wnt Signaling Pathway
TTDR00334;WP437;EGF/EGFR Signaling Pathway
TTDR00334;WP481;Insulin Signaling
TTDR00334;WP560;TGF Beta Signaling Pathway
TTDR00334;WP69;TCR Signaling Pathway
TTDR00334;WP710;DNA Damage Response (only ATM dependent)
TTDR00334;WP712;Estrogen signaling pathway
TTDR00334;WP75;Toll-like receptor signaling pathway
TTDR00337;WP195;IL-1 signaling pathway
TTDR00337;WP2380;BDNF signaling pathway
TTDR00337;WP382;MAPK Signaling Pathway
TTDR00337;WP422;MAPK Cascade
TTDR00337;WP437;EGF/EGFR Signaling Pathway
TTDR00337;WP481;Insulin Signaling
TTDR00339;WP400;p38 MAPK Signaling Pathway
TTDR00339;WP481;Insulin Signaling
TTDR00340;WP481;Insulin Signaling
TTDR00347;WP12;Osteoclast Signaling
TTDR00347;WP2743;Glycosaminoglycan metabolism
TTDR00347;WP35;G Protein Signaling Pathways
TTDR00347;WP51;Regulation of Actin Cytoskeleton
TTDR00349;WP2431;Spinal Cord Injury
TTDR00350;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDR00350;WP2877;Vitamin D Receptor Pathway
TTDR00352;WP1449;Regulation of toll-like receptor signaling pathway
TTDR00352;WP1528;Physiological and Pathological Hypertrophy of the Heart
TTDR00352;WP1808;DSCAM interactions
TTDR00352;WP1865;Myogenesis
TTDR00352;WP1873;NGF signalling via TRKA from the plasma membrane
TTDR00352;WP2371;Parkinsons Disease Pathway
TTDR00352;WP2637;Structural Pathway of Interleukin 1 (IL-1)
TTDR00352;WP2643;Nanoparticle-mediated activation of receptor signaling
TTDR00352;WP2733;Regulation of mRNA Stability by Proteins that Bind AU-rich Elements
TTDR00352;WP2792;MAP kinase activation in TLR cascade
TTDR00352;WP395;IL-4 Signaling Pathway
TTDR00352;WP481;Insulin Signaling
TTDR00352;WP75;Toll-like receptor signaling pathway
TTDR00355;WP1904;RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
TTDR00355;WP2672;ISG15 antiviral mechanism
TTDR00356;WP1403;AMPK Signaling
TTDR00356;WP1449;Regulation of toll-like receptor signaling pathway
TTDR00356;WP1539;Angiogenesis
TTDR00356;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDR00356;WP1794;Cell surface interactions at the vascular wall
TTDR00356;WP1799;Costimulation by the CD28 family
TTDR00356;WP1824;GPCR downstream signaling
TTDR00356;WP1826;GPVI-mediated activation cascade
TTDR00356;WP1840;Interleukin-3, 5 and GM-CSF signaling
TTDR00356;WP1867;Nephrin interactions
TTDR00356;WP1873;NGF signalling via TRKA from the plasma membrane
TTDR00356;WP1910;Signaling by EGFR
TTDR00356;WP1911;Signaling by FGFR
TTDR00356;WP1913;Signaling by Insulin receptor
TTDR00356;WP1916;Signaling by PDGF
TTDR00356;WP1927;TCR signaling
TTDR00356;WP1982;SREBP signalling
TTDR00356;WP2032;TSH signaling pathway
TTDR00356;WP2038;Regulation of Microtubule Cytoskeleton
TTDR00356;WP2203;TSLP Signaling Pathway
TTDR00356;WP2261;Signaling Pathways in Glioblastoma
TTDR00356;WP2263;Prostate Cancer
TTDR00356;WP2377;Integrated Pancreatic Cancer Pathway
TTDR00356;WP2653;PIP3 activates AKT signaling
TTDR00356;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDR00356;WP2677;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
TTDR00356;WP2694;DAP12 interactions
TTDR00356;WP2713;Signaling by SCF-KIT
TTDR00356;WP2719;Fcgamma receptor (FCGR) dependent phagocytosis
TTDR00356;WP2732;Interleukin-2 signaling
TTDR00356;WP2747;PI Metabolism
TTDR00356;WP2759;Fc epsilon receptor (FCERI) signaling
TTDR00356;WP2780;Signaling by ERBB2
TTDR00356;WP2781;Signaling by ERBB4
TTDR00356;WP2865;IL1 and megakaryotyces in obesity
TTDR00356;WP306;Focal Adhesion
TTDR00356;WP313;Signaling of Hepatocyte Growth Factor Receptor
TTDR00356;WP3286;Copper homeostasis
TTDR00356;WP395;IL-4 Signaling Pathway
TTDR00356;WP3;Transcriptional activation by NRF2
TTDR00356;WP481;Insulin Signaling
TTDR00356;WP51;Regulation of Actin Cytoskeleton
TTDR00356;WP524;G13 Signaling Pathway
TTDR00356;WP710;DNA Damage Response (only ATM dependent)
TTDR00356;WP712;Estrogen signaling pathway
TTDR00356;WP722;Serotonin HTR1 Group and FOS Pathway
TTDR00356;WP75;Toll-like receptor signaling pathway
TTDR00363;WP500;Glycogen Metabolism
TTDR00372;WP127;IL-5 Signaling Pathway
TTDR00372;WP1434;Osteopontin Signaling
TTDR00372;WP1449;Regulation of toll-like receptor signaling pathway
TTDR00372;WP1528;Physiological and Pathological Hypertrophy of the Heart
TTDR00372;WP1539;Angiogenesis
TTDR00372;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDR00372;WP1584;Type II diabetes mellitus
TTDR00372;WP1591;Heart Development
TTDR00372;WP1781;Advanced glycosylation endproduct receptor signaling
TTDR00372;WP1843;L1CAM interactions
TTDR00372;WP185;Integrin-mediated Cell Adhesion
TTDR00372;WP1911;Signaling by FGFR
TTDR00372;WP1929;Thrombin signalling through proteinase activated receptors (PARs)
TTDR00372;WP195;IL-1 signaling pathway
TTDR00372;WP1978;Opioid Signalling
TTDR00372;WP1984;Integrated Breast Cancer Pathway
TTDR00372;WP2018;RANKL/RANK Signaling Pathway
TTDR00372;WP2032;TSH signaling pathway
TTDR00372;WP2034;Leptin signaling pathway
TTDR00372;WP2035;FSH signaling pathway
TTDR00372;WP2036;TWEAK Signaling Pathway
TTDR00372;WP2059;Alzheimers Disease
TTDR00372;WP205;IL-7 Signaling Pathway
TTDR00372;WP2112;IL17 signaling pathway
TTDR00372;WP2197;Endothelin Pathways
TTDR00372;WP2203;TSLP Signaling Pathway
TTDR00372;WP2261;Signaling Pathways in Glioblastoma
TTDR00372;WP2263;Prostate Cancer
TTDR00372;WP22;IL-9 Signaling Pathway
TTDR00372;WP231;TNF alpha Signaling Pathway
TTDR00372;WP2324;AGE/RAGE pathway
TTDR00372;WP2332;Interleukin-11 Signaling Pathway
TTDR00372;WP2355;Corticotropin-releasing hormone
TTDR00372;WP2374;Oncostatin M Signaling Pathway
TTDR00372;WP2377;Integrated Pancreatic Cancer Pathway
TTDR00372;WP2380;BDNF signaling pathway
TTDR00372;WP23;B Cell Receptor Signaling Pathway
TTDR00372;WP2431;Spinal Cord Injury
TTDR00372;WP244;Alpha 6 Beta 4 signaling pathway
TTDR00372;WP2526;PDGF Pathway
TTDR00372;WP2586;Aryl Hydrocarbon Receptor
TTDR00372;WP259;Nifedipine Activity
TTDR00372;WP262;EBV LMP1 signaling
TTDR00372;WP2636;Genes and (Common) Pathways Underlying Drug Addiction
TTDR00372;WP2637;Structural Pathway of Interleukin 1 (IL-1)
TTDR00372;WP2643;Nanoparticle-mediated activation of receptor signaling
TTDR00372;WP26;Signal Transduction of S1P Receptor
TTDR00372;WP2735;RAF/MAP kinase cascade
TTDR00372;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDR00372;WP2759;Fc epsilon receptor (FCERI) signaling
TTDR00372;WP2792;MAP kinase activation in TLR cascade
TTDR00372;WP2795;Cardiac Hypertrophic Response
TTDR00372;WP2828;Bladder Cancer
TTDR00372;WP2864;Apoptosis-related network due to altered Notch3 in ovarian cancer
TTDR00372;WP2868;TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer
TTDR00372;WP286;IL-3 Signaling Pathway
TTDR00372;WP304;Kit receptor signaling pathway
TTDR00372;WP306;Focal Adhesion
TTDR00372;WP313;Signaling of Hepatocyte Growth Factor Receptor
TTDR00372;WP363;Wnt Signaling Pathway Netpath
TTDR00372;WP364;IL-6 signaling pathway
TTDR00372;WP366;TGF beta Signaling Pathway
TTDR00372;WP382;MAPK Signaling Pathway
TTDR00372;WP395;IL-4 Signaling Pathway
TTDR00372;WP422;MAPK Cascade
TTDR00372;WP437;EGF/EGFR Signaling Pathway
TTDR00372;WP481;Insulin Signaling
TTDR00372;WP49;IL-2 Signaling Pathway
TTDR00372;WP51;Regulation of Actin Cytoskeleton
TTDR00372;WP581;EPO Receptor Signaling
TTDR00372;WP615;Senescence and Autophagy in Cancer
TTDR00372;WP666;Hypothetical Network for Drug Addiction
TTDR00372;WP673;ErbB Signaling Pathway
TTDR00372;WP69;TCR Signaling Pathway
TTDR00372;WP710;DNA Damage Response (only ATM dependent)
TTDR00372;WP712;Estrogen signaling pathway
TTDR00372;WP716;Vitamin A and Carotenoid Metabolism
TTDR00372;WP722;Serotonin HTR1 Group and FOS Pathway
TTDR00372;WP732;Serotonin Receptor 2 and ELK-SRF/GATA4 signaling
TTDR00372;WP734;Serotonin Receptor 4/6/7 and NR3C Signaling
TTDR00372;WP75;Toll-like receptor signaling pathway
TTDR00373;WP127;IL-5 Signaling Pathway
TTDR00373;WP1434;Osteopontin Signaling
TTDR00373;WP1449;Regulation of toll-like receptor signaling pathway
TTDR00373;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDR00373;WP1772;Apoptosis Modulation and Signaling
TTDR00373;WP1781;Advanced glycosylation endproduct receptor signaling
TTDR00373;WP1843;L1CAM interactions
TTDR00373;WP1905;RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription
TTDR00373;WP1911;Signaling by FGFR
TTDR00373;WP1913;Signaling by Insulin receptor
TTDR00373;WP1929;Thrombin signalling through proteinase activated receptors (PARs)
TTDR00373;WP195;IL-1 signaling pathway
TTDR00373;WP2018;RANKL/RANK Signaling Pathway
TTDR00373;WP2032;TSH signaling pathway
TTDR00373;WP2034;Leptin signaling pathway
TTDR00373;WP2035;FSH signaling pathway
TTDR00373;WP2036;TWEAK Signaling Pathway
TTDR00373;WP2059;Alzheimers Disease
TTDR00373;WP205;IL-7 Signaling Pathway
TTDR00373;WP2112;IL17 signaling pathway
TTDR00373;WP2203;TSLP Signaling Pathway
TTDR00373;WP2261;Signaling Pathways in Glioblastoma
TTDR00373;WP2263;Prostate Cancer
TTDR00373;WP22;IL-9 Signaling Pathway
TTDR00373;WP231;TNF alpha Signaling Pathway
TTDR00373;WP2324;AGE/RAGE pathway
TTDR00373;WP2332;Interleukin-11 Signaling Pathway
TTDR00373;WP2355;Corticotropin-releasing hormone
TTDR00373;WP2374;Oncostatin M Signaling Pathway
TTDR00373;WP2377;Integrated Pancreatic Cancer Pathway
TTDR00373;WP2380;BDNF signaling pathway
TTDR00373;WP2431;Spinal Cord Injury
TTDR00373;WP244;Alpha 6 Beta 4 signaling pathway
TTDR00373;WP2526;PDGF Pathway
TTDR00373;WP2636;Genes and (Common) Pathways Underlying Drug Addiction
TTDR00373;WP2637;Structural Pathway of Interleukin 1 (IL-1)
TTDR00373;WP26;Signal Transduction of S1P Receptor
TTDR00373;WP2735;RAF/MAP kinase cascade
TTDR00373;WP2759;Fc epsilon receptor (FCERI) signaling
TTDR00373;WP2792;MAP kinase activation in TLR cascade
TTDR00373;WP2795;Cardiac Hypertrophic Response
TTDR00373;WP2868;TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer
TTDR00373;WP286;IL-3 Signaling Pathway
TTDR00373;WP304;Kit receptor signaling pathway
TTDR00373;WP313;Signaling of Hepatocyte Growth Factor Receptor
TTDR00373;WP364;IL-6 signaling pathway
TTDR00373;WP382;MAPK Signaling Pathway
TTDR00373;WP395;IL-4 Signaling Pathway
TTDR00373;WP422;MAPK Cascade
TTDR00373;WP481;Insulin Signaling
TTDR00373;WP49;IL-2 Signaling Pathway
TTDR00373;WP51;Regulation of Actin Cytoskeleton
TTDR00373;WP560;TGF Beta Signaling Pathway
TTDR00373;WP581;EPO Receptor Signaling
TTDR00373;WP666;Hypothetical Network for Drug Addiction
TTDR00373;WP69;TCR Signaling Pathway
TTDR00373;WP722;Serotonin HTR1 Group and FOS Pathway
TTDR00373;WP732;Serotonin Receptor 2 and ELK-SRF/GATA4 signaling
TTDR00373;WP734;Serotonin Receptor 4/6/7 and NR3C Signaling
TTDR00373;WP75;Toll-like receptor signaling pathway
TTDR00374;WP2032;TSH signaling pathway
TTDR00374;WP437;EGF/EGFR Signaling Pathway
TTDR00375;WP1824;GPCR downstream signaling
TTDR00375;WP1825;GPCR ligand binding
TTDR00375;WP24;Peptide GPCRs
TTDR00375;WP455;GPCRs, Class A Rhodopsin-like
TTDR00381;WP1817;Fatty acid, triacylglycerol, and ketone body metabolism
TTDR00381;WP2797;Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
TTDR00381;WP311;Synthesis and Degradation of Ketone Bodies
TTDR00387;WP1824;GPCR downstream signaling
TTDR00387;WP1825;GPCR ligand binding
TTDR00387;WP2355;Corticotropin-releasing hormone
TTDR00387;WP289;Myometrial Relaxation and Contraction Pathways
TTDR00389;WP1824;GPCR downstream signaling
TTDR00389;WP1825;GPCR ligand binding
TTDR00389;WP1981;Thyroxine (Thyroid Hormone) Production
TTDR00389;WP2032;TSH signaling pathway
TTDR00389;WP2035;FSH signaling pathway
TTDR00389;WP2691;Peptide hormone biosynthesis
TTDR00389;WP2693;Metabolism of amino acids and derivatives
TTDR00389;WP2749;Metabolism of steroid hormones and vitamin D
TTDR00395;WP1794;Cell surface interactions at the vascular wall
TTDR00395;WP1818;Formation of Fibrin Clot (Clotting Cascade)
TTDR00395;WP2877;Vitamin D Receptor Pathway
TTDR00395;WP2882;Nuclear Receptors Meta-Pathway
TTDR00395;WP558;Complement and Coagulation Cascades
TTDR00396;WP1818;Formation of Fibrin Clot (Clotting Cascade)
TTDR00396;WP558;Complement and Coagulation Cascades
TTDR00397;WP138;Androgen receptor signaling pathway
TTDR00397;WP1530;miRNA Regulation of DNA Damage Response
TTDR00397;WP1545;miRNAs involved in DNA damage response
TTDR00397;WP1984;Integrated Breast Cancer Pathway
TTDR00397;WP2002;miR-targeted genes in epithelium - TarBase
TTDR00397;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDR00397;WP2005;miR-targeted genes in muscle cell - TarBase
TTDR00397;WP2034;Leptin signaling pathway
TTDR00397;WP205;IL-7 Signaling Pathway
TTDR00397;WP2261;Signaling Pathways in Glioblastoma
TTDR00397;WP2263;Prostate Cancer
TTDR00397;WP2377;Integrated Pancreatic Cancer Pathway
TTDR00397;WP2431;Spinal Cord Injury
TTDR00397;WP2446;Retinoblastoma (RB) in Cancer
TTDR00397;WP2571;Polycystic Kidney Disease Pathway
TTDR00397;WP2772;S Phase
TTDR00397;WP2786;Pre-NOTCH Expression and Processing
TTDR00397;WP2828;Bladder Cancer
TTDR00397;WP2839;Hair Follicle Development: Organogenesis (Part 2 of 3)
TTDR00397;WP2857;Mesodermal Commitment Pathway
TTDR00397;WP2877;Vitamin D Receptor Pathway
TTDR00397;WP2878;PPAR Alpha Pathway
TTDR00397;WP2882;Nuclear Receptors Meta-Pathway
TTDR00397;WP306;Focal Adhesion
TTDR00397;WP3286;Copper homeostasis
TTDR00397;WP363;Wnt Signaling Pathway Netpath
TTDR00397;WP366;TGF beta Signaling Pathway
TTDR00397;WP399;Wnt Signaling Pathway and Pluripotency
TTDR00397;WP428;Wnt Signaling Pathway
TTDR00397;WP45;G1 to S cell cycle control
TTDR00397;WP61;Notch Signaling Pathway
TTDR00397;WP673;ErbB Signaling Pathway
TTDR00397;WP707;DNA Damage Response
TTDR00397;WP710;DNA Damage Response (only ATM dependent)
TTDR00404;WP2718;Signaling by NOTCH2
TTDR00405;WP1824;GPCR downstream signaling
TTDR00405;WP1825;GPCR ligand binding
TTDR00405;WP24;Peptide GPCRs
TTDR00405;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDR00405;WP2877;Vitamin D Receptor Pathway
TTDR00405;WP455;GPCRs, Class A Rhodopsin-like
TTDR00405;WP51;Regulation of Actin Cytoskeleton
TTDR00405;WP554;ACE Inhibitor Pathway
TTDR00405;WP558;Complement and Coagulation Cascades
TTDR00406;WP1818;Formation of Fibrin Clot (Clotting Cascade)
TTDR00406;WP1824;GPCR downstream signaling
TTDR00406;WP1825;GPCR ligand binding
TTDR00406;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDR00406;WP2877;Vitamin D Receptor Pathway
TTDR00406;WP554;ACE Inhibitor Pathway
TTDR00406;WP558;Complement and Coagulation Cascades
TTDR00411;WP1533;Vitamin B12 Metabolism
TTDR00411;WP2059;Alzheimers Disease
TTDR00411;WP2764;Lipid digestion, mobilization, and transport
TTDR00411;WP2776;Visual phototransduction
TTDR00411;WP2784;Binding and Uptake of Ligands by Scavenger Receptors
TTDR00411;WP2864;Apoptosis-related network due to altered Notch3 in ovarian cancer
TTDR00411;WP430;Statin Pathway
TTDR00414;WP2693;Metabolism of amino acids and derivatives
TTDR00415;WP1423;Ganglio Sphingolipid Metabolism
TTDR00418;WP2593;JAK/STAT
TTDR00418;WP2657;Growth hormone receptor signaling
TTDR00418;WP2678;Prolactin receptor signaling
TTDR00418;WP3297;EV release from cardiac cells and their functional effects
TTDR00418;WP98;Prostaglandin Synthesis and Regulation
TTDR00420;WP170;Nuclear Receptors
TTDR00420;WP2011;SREBF and miR33 in cholesterol and lipid homeostasis
TTDR00420;WP236;Adipogenesis
TTDR00420;WP2874;Liver X Receptor Pathway
TTDR00420;WP2878;PPAR Alpha Pathway
TTDR00420;WP2882;Nuclear Receptors Meta-Pathway
TTDR00420;WP299;Nuclear Receptors in Lipid Metabolism and Toxicity
TTDR00421;WP170;Nuclear Receptors
TTDR00421;WP1982;SREBP signalling
TTDR00430;WP1794;Cell surface interactions at the vascular wall
TTDR00430;WP1909;Signal regulatory protein (SIRP) family interactions
TTDR00430;WP2431;Spinal Cord Injury
TTDR00432;WP1824;GPCR downstream signaling
TTDR00432;WP1825;GPCR ligand binding
TTDR00432;WP2728;Incretin Synthesis, Secretion, and Inactivation
TTDR00433;WP1433;NOD pathway
TTDR00433;WP1449;Regulation of toll-like receptor signaling pathway
TTDR00433;WP1530;miRNA Regulation of DNA Damage Response
TTDR00433;WP1772;Apoptosis Modulation and Signaling
TTDR00433;WP1784;Apoptotic execution phase
TTDR00433;WP1814;Extrinsic Pathway for Apoptosis
TTDR00433;WP1841;Intrinsic Pathway for Apoptosis
TTDR00433;WP1904;RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
TTDR00433;WP1971;Integrated Cancer pathway
TTDR00433;WP1984;Integrated Breast Cancer Pathway
TTDR00433;WP2036;TWEAK Signaling Pathway
TTDR00433;WP2059;Alzheimers Disease
TTDR00433;WP2263;Prostate Cancer
TTDR00433;WP231;TNF alpha Signaling Pathway
TTDR00433;WP2324;AGE/RAGE pathway
TTDR00433;WP2328;Allograft Rejection
TTDR00433;WP2359;Parkin-Ubiquitin Proteasomal System pathway
TTDR00433;WP2377;Integrated Pancreatic Cancer Pathway
TTDR00433;WP2513;Nanoparticle triggered regulated necrosis
TTDR00433;WP254;Apoptosis
TTDR00433;WP2752;MyD88-independent cascade
TTDR00433;WP314;FAS pathway and Stress induction of HSP regulation
TTDR00433;WP382;MAPK Signaling Pathway
TTDR00433;WP384;Apoptosis Modulation by HSP70
TTDR00433;WP707;DNA Damage Response
TTDR00433;WP75;Toll-like receptor signaling pathway
TTDR00434;WP1433;NOD pathway
TTDR00434;WP1772;Apoptosis Modulation and Signaling
TTDR00434;WP1838;Interleukin-1 processing
TTDR00434;WP2359;Parkin-Ubiquitin Proteasomal System pathway
TTDR00434;WP2447;Amyotrophic lateral sclerosis (ALS)
TTDR00434;WP254;Apoptosis
TTDR00434;WP2763;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
TTDR00434;WP382;MAPK Signaling Pathway
TTDR00440;WP1530;miRNA Regulation of DNA Damage Response
TTDR00440;WP1772;Apoptosis Modulation and Signaling
TTDR00440;WP1784;Apoptotic execution phase
TTDR00440;WP1841;Intrinsic Pathway for Apoptosis
TTDR00440;WP1896;Regulation of Apoptosis
TTDR00440;WP1971;Integrated Cancer pathway
TTDR00440;WP1976;Signalling by NGF
TTDR00440;WP1984;Integrated Breast Cancer Pathway
TTDR00440;WP2036;TWEAK Signaling Pathway
TTDR00440;WP2059;Alzheimers Disease
TTDR00440;WP2263;Prostate Cancer
TTDR00440;WP231;TNF alpha Signaling Pathway
TTDR00440;WP2324;AGE/RAGE pathway
TTDR00440;WP2328;Allograft Rejection
TTDR00440;WP2355;Corticotropin-releasing hormone
TTDR00440;WP2371;Parkinsons Disease Pathway
TTDR00440;WP2374;Oncostatin M Signaling Pathway
TTDR00440;WP2377;Integrated Pancreatic Cancer Pathway
TTDR00440;WP2380;BDNF signaling pathway
TTDR00440;WP2431;Spinal Cord Injury
TTDR00440;WP2447;Amyotrophic lateral sclerosis (ALS)
TTDR00440;WP254;Apoptosis
TTDR00440;WP2714;Signaling by Hippo
TTDR00440;WP314;FAS pathway and Stress induction of HSP regulation
TTDR00440;WP3286;Copper homeostasis
TTDR00440;WP382;MAPK Signaling Pathway
TTDR00440;WP384;Apoptosis Modulation by HSP70
TTDR00440;WP706;SIDS Susceptibility Pathways
TTDR00440;WP707;DNA Damage Response
TTDR00441;WP2764;Lipid digestion, mobilization, and transport
TTDR00441;WP2776;Visual phototransduction
TTDR00441;WP2797;Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
TTDR00441;WP2878;PPAR Alpha Pathway
TTDR00441;WP2882;Nuclear Receptors Meta-Pathway
TTDR00441;WP430;Statin Pathway
TTDR00441;WP558;Complement and Coagulation Cascades
TTDR00443;WP1885;Platelet homeostasis
TTDR00443;WP1908;Signal amplification
TTDR00443;WP1978;Opioid Signalling
TTDR00443;WP2324;AGE/RAGE pathway
TTDR00443;WP2377;Integrated Pancreatic Cancer Pathway
TTDR00443;WP2526;PDGF Pathway
TTDR00443;WP2650;Arachidonic acid metabolism
TTDR00443;WP2740;Glycerophospholipid biosynthesis
TTDR00443;WP400;p38 MAPK Signaling Pathway
TTDR00443;WP98;Prostaglandin Synthesis and Regulation
TTDR00444;WP2059;Alzheimers Disease
TTDR00444;WP268;Notch Signaling Pathway
TTDR00444;WP61;Notch Signaling Pathway
TTDR00445;WP1976;Signalling by NGF
TTDR00445;WP2059;Alzheimers Disease
TTDR00445;WP268;Notch Signaling Pathway
TTDR00445;WP2718;Signaling by NOTCH2
TTDR00445;WP2720;Signaling by NOTCH1
TTDR00445;WP2721;Signaling by NOTCH4
TTDR00445;WP2722;Signaling by NOTCH3
TTDR00445;WP2781;Signaling by ERBB4
TTDR00445;WP61;Notch Signaling Pathway
TTDR00446;WP2739;Amyloids
TTDR00446;WP2806;Human Complement System
TTDR00451;WP1533;Vitamin B12 Metabolism
TTDR00451;WP15;Selenium Micronutrient Network
TTDR00451;WP176;Folate Metabolism
TTDR00451;WP1825;GPCR ligand binding
TTDR00451;WP195;IL-1 signaling pathway
TTDR00451;WP2036;TWEAK Signaling Pathway
TTDR00451;WP231;TNF alpha Signaling Pathway
TTDR00451;WP2374;Oncostatin M Signaling Pathway
TTDR00451;WP2431;Spinal Cord Injury
TTDR00451;WP2753;Activation of Genes by ATF4
TTDR00451;WP2865;IL1 and megakaryotyces in obesity
TTDR00451;WP2882;Nuclear Receptors Meta-Pathway
TTDR00457;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDR00458;WP236;Adipogenesis
TTDR00458;WP2374;Oncostatin M Signaling Pathway
TTDR00459;WP1928;Telomere Maintenance
TTDR00459;WP2002;miR-targeted genes in epithelium - TarBase
TTDR00459;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDR00459;WP366;TGF beta Signaling Pathway
TTDR00466;WP1978;Opioid Signalling
TTDR00466;WP2882;Nuclear Receptors Meta-Pathway
TTDR00466;WP289;Myometrial Relaxation and Contraction Pathways
TTDR00466;WP35;G Protein Signaling Pathways
TTDR00470;WP1832;Integrin alphaIIb beta3 signaling
TTDR00470;WP1840;Interleukin-3, 5 and GM-CSF signaling
TTDR00470;WP185;Integrin-mediated Cell Adhesion
TTDR00470;WP1873;NGF signalling via TRKA from the plasma membrane
TTDR00470;WP1913;Signaling by Insulin receptor
TTDR00470;WP1916;Signaling by PDGF
TTDR00470;WP2263;Prostate Cancer
TTDR00470;WP2377;Integrated Pancreatic Cancer Pathway
TTDR00470;WP23;B Cell Receptor Signaling Pathway
TTDR00470;WP2719;Fcgamma receptor (FCGR) dependent phagocytosis
TTDR00470;WP304;Kit receptor signaling pathway
TTDR00470;WP306;Focal Adhesion
TTDR00470;WP313;Signaling of Hepatocyte Growth Factor Receptor
TTDR00470;WP382;MAPK Signaling Pathway
TTDR00470;WP437;EGF/EGFR Signaling Pathway
TTDR00470;WP481;Insulin Signaling
TTDR00470;WP51;Regulation of Actin Cytoskeleton
TTDR00470;WP585;Interferon type I signaling pathways
TTDR00470;WP673;ErbB Signaling Pathway
TTDR00470;WP69;TCR Signaling Pathway
TTDR00473;WP1434;Osteopontin Signaling
TTDR00473;WP1794;Cell surface interactions at the vascular wall
TTDR00473;WP1833;Integrin cell surface interactions
TTDR00473;WP1843;L1CAM interactions
TTDR00473;WP185;Integrin-mediated Cell Adhesion
TTDR00473;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDR00473;WP2572;Primary Focal Segmental Glomerulosclerosis FSGS
TTDR00473;WP2666;Elastic fibre formation
TTDR00473;WP2703;Extracellular matrix organization
TTDR00473;WP2787;Syndecan interactions
TTDR00473;WP2796;Class I MHC mediated antigen processing & presentation
TTDR00473;WP306;Focal Adhesion
TTDR00473;WP322;Osteoblast Signaling
TTDR00476;WP2751;Transcriptional Regulation of White Adipocyte Differentiation
TTDR00476;WP2764;Lipid digestion, mobilization, and transport
TTDR00478;WP2377;Integrated Pancreatic Cancer Pathway
TTDR00478;WP2380;BDNF signaling pathway
TTDR00484;WP12;Osteoclast Signaling
TTDR00484;WP1434;Osteopontin Signaling
TTDR00484;WP1449;Regulation of toll-like receptor signaling pathway
TTDR00484;WP1833;Integrin cell surface interactions
TTDR00484;WP1916;Signaling by PDGF
TTDR00484;WP2380;BDNF signaling pathway
TTDR00484;WP2703;Extracellular matrix organization
TTDR00484;WP2806;Human Complement System
TTDR00484;WP2877;Vitamin D Receptor Pathway
TTDR00484;WP306;Focal Adhesion
TTDR00484;WP474;Endochondral Ossification
TTDR00484;WP560;TGF Beta Signaling Pathway
TTDR00484;WP75;Toll-like receptor signaling pathway
TTDR00489;WP138;Androgen receptor signaling pathway
TTDR00489;WP1984;Integrated Breast Cancer Pathway
TTDR00489;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDR00489;WP2005;miR-targeted genes in muscle cell - TarBase
TTDR00489;WP2751;Transcriptional Regulation of White Adipocyte Differentiation
TTDR00489;WP2797;Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
TTDR00489;WP2876;Pregnane X Receptor pathway
TTDR00489;WP2882;Nuclear Receptors Meta-Pathway
TTDR00489;WP437;EGF/EGFR Signaling Pathway
TTDR00489;WP710;DNA Damage Response (only ATM dependent)
TTDR00498;WP1449;Regulation of toll-like receptor signaling pathway
TTDR00498;WP1824;GPCR downstream signaling
TTDR00498;WP1825;GPCR ligand binding
TTDR00498;WP2431;Spinal Cord Injury
TTDR00498;WP619;Type II interferon signaling (IFNG)
TTDR00498;WP75;Toll-like receptor signaling pathway
TTDR00503;WP138;Androgen receptor signaling pathway
TTDR00503;WP2263;Prostate Cancer
TTDR00505;WP185;Integrin-mediated Cell Adhesion
TTDR00505;WP2059;Alzheimers Disease
TTDR00505;WP2377;Integrated Pancreatic Cancer Pathway
TTDR00505;WP306;Focal Adhesion
TTDR00511;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDR00511;WP1559;TFs Regulate miRNAs related to cardiac hypertrophy
TTDR00511;WP179;Cell Cycle
TTDR00511;WP2328;Allograft Rejection
TTDR00511;WP2332;Interleukin-11 Signaling Pathway
TTDR00511;WP2355;Corticotropin-releasing hormone
TTDR00511;WP236;Adipogenesis
TTDR00511;WP2377;Integrated Pancreatic Cancer Pathway
TTDR00511;WP2406;Cardiac Progenitor Differentiation
TTDR00511;WP2431;Spinal Cord Injury
TTDR00511;WP2572;Primary Focal Segmental Glomerulosclerosis FSGS
TTDR00511;WP2666;Elastic fibre formation
TTDR00511;WP2703;Extracellular matrix organization
TTDR00511;WP2742;Signaling by TGF-beta Receptor Complex
TTDR00511;WP2751;Transcriptional Regulation of White Adipocyte Differentiation
TTDR00511;WP2771;Host Interactions with Influenza Factors
TTDR00511;WP2787;Syndecan interactions
TTDR00511;WP2795;Cardiac Hypertrophic Response
TTDR00511;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDR00511;WP2848;Differentiation Pathway
TTDR00511;WP2849;Hematopoietic Stem Cell Differentiation
TTDR00511;WP2853;Endoderm Differentiation
TTDR00511;WP2855;Dopaminergic Neurogenesis
TTDR00511;WP286;IL-3 Signaling Pathway
TTDR00511;WP2870;Extracellular vesicle-mediated signaling in recipient cells
TTDR00511;WP2873;Aryl Hydrocarbon Receptor Pathway
TTDR00511;WP2877;Vitamin D Receptor Pathway
TTDR00511;WP2882;Nuclear Receptors Meta-Pathway
TTDR00511;WP2884;NRF2 pathway
TTDR00511;WP366;TGF beta Signaling Pathway
TTDR00511;WP382;MAPK Signaling Pathway
TTDR00511;WP474;Endochondral Ossification
TTDR00511;WP530;Cytokines and Inflammatory Response
TTDR00511;WP554;ACE Inhibitor Pathway
TTDR00511;WP560;TGF Beta Signaling Pathway
TTDR00511;WP615;Senescence and Autophagy in Cancer
TTDR00511;WP69;TCR Signaling Pathway
TTDR00511;WP710;DNA Damage Response (only ATM dependent)
TTDR00513;WP2002;miR-targeted genes in epithelium - TarBase
TTDR00513;WP2003;miR-targeted genes in leukocytes - TarBase
TTDR00513;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDR00513;WP2005;miR-targeted genes in muscle cell - TarBase
TTDR00513;WP2006;miR-targeted genes in squamous cell - TarBase
TTDR00513;WP2059;Alzheimers Disease
TTDR00513;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDR00513;WP2197;Endothelin Pathways
TTDR00513;WP289;Myometrial Relaxation and Contraction Pathways
TTDR00513;WP536;Calcium Regulation in the Cardiac Cell
TTDR00518;WP1781;Advanced glycosylation endproduct receptor signaling
TTDR00518;WP1784;Apoptotic execution phase
TTDR00518;WP1904;RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
TTDR00518;WP2446;Retinoblastoma (RB) in Cancer
TTDR00518;WP2656;TAK1 activates NFkB by phosphorylation and activation of IKKs complex
TTDR00518;WP2794;Cytosolic sensors of pathogen-associated DNA
TTDR00518;WP710;DNA Damage Response (only ATM dependent)
TTDR00519;WP2332;Interleukin-11 Signaling Pathway
TTDR00519;WP2377;Integrated Pancreatic Cancer Pathway
TTDR00519;WP2848;Differentiation Pathway
TTDR00519;WP2882;Nuclear Receptors Meta-Pathway
TTDR00519;WP530;Cytokines and Inflammatory Response
TTDR00525;WP2703;Extracellular matrix organization
TTDR00525;WP2743;Glycosaminoglycan metabolism
TTDR00525;WP399;Wnt Signaling Pathway and Pluripotency
TTDR00525;WP615;Senescence and Autophagy in Cancer
TTDR00526;WP1533;Vitamin B12 Metabolism
TTDR00526;WP1589;Folate-Alcohol and Cancer Pathway
TTDR00526;WP15;Selenium Micronutrient Network
TTDR00526;WP176;Folate Metabolism
TTDR00526;WP2333;Trans-sulfuration pathway
TTDR00526;WP2525;Trans-sulfuration and one carbon metabolism
TTDR00526;WP2693;Metabolism of amino acids and derivatives
TTDR00526;WP2877;Vitamin D Receptor Pathway
TTDR00529;WP1851;Metabolism of nucleotides
TTDR00530;WP1824;GPCR downstream signaling
TTDR00530;WP1825;GPCR ligand binding
TTDR00530;WP24;Peptide GPCRs
TTDR00530;WP455;GPCRs, Class A Rhodopsin-like
TTDR00531;WP2729;Metabolism of Angiotensinogen to Angiotensins
TTDR00534;WP1824;GPCR downstream signaling
TTDR00534;WP1825;GPCR ligand binding
TTDR00534;WP24;Peptide GPCRs
TTDR00544;WP1843;L1CAM interactions
TTDR00544;WP2669;Potassium Channels
TTDR00545;WP117;GPCRs, Other
TTDR00545;WP1824;GPCR downstream signaling
TTDR00545;WP1825;GPCR ligand binding
TTDR00545;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDR00554;WP170;Nuclear Receptors
TTDR00554;WP2355;Corticotropin-releasing hormone
TTDR00554;WP2855;Dopaminergic Neurogenesis
TTDR00556;WP1533;Vitamin B12 Metabolism
TTDR00556;WP15;Selenium Micronutrient Network
TTDR00556;WP176;Folate Metabolism
TTDR00556;WP1797;Circadian Clock
TTDR00556;WP1802;Dissolution of Fibrin Clot
TTDR00556;WP236;Adipogenesis
TTDR00556;WP2374;Oncostatin M Signaling Pathway
TTDR00556;WP2703;Extracellular matrix organization
TTDR00556;WP272;Blood Clotting Cascade
TTDR00556;WP2755;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
TTDR00556;WP558;Complement and Coagulation Cascades
TTDR00556;WP560;TGF Beta Signaling Pathway
TTDR00556;WP615;Senescence and Autophagy in Cancer
TTDR00557;WP1584;Type II diabetes mellitus
TTDR00557;WP1826;GPVI-mediated activation cascade
TTDR00557;WP195;IL-1 signaling pathway
TTDR00557;WP2012;miRs in Muscle Cell Differentiation
TTDR00557;WP2261;Signaling Pathways in Glioblastoma
TTDR00557;WP231;TNF alpha Signaling Pathway
TTDR00557;WP2324;AGE/RAGE pathway
TTDR00557;WP2328;Allograft Rejection
TTDR00557;WP2742;Signaling by TGF-beta Receptor Complex
TTDR00557;WP289;Myometrial Relaxation and Contraction Pathways
TTDR00557;WP35;G Protein Signaling Pathways
TTDR00557;WP382;MAPK Signaling Pathway
TTDR00557;WP399;Wnt Signaling Pathway and Pluripotency
TTDR00557;WP428;Wnt Signaling Pathway
TTDR00557;WP437;EGF/EGFR Signaling Pathway
TTDR00557;WP481;Insulin Signaling
TTDR00557;WP536;Calcium Regulation in the Cardiac Cell
TTDR00562;WP117;GPCRs, Other
TTDR00562;WP1824;GPCR downstream signaling
TTDR00562;WP1825;GPCR ligand binding
TTDR00562;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDR00564;WP1824;GPCR downstream signaling
TTDR00564;WP1825;GPCR ligand binding
TTDR00564;WP455;GPCRs, Class A Rhodopsin-like
TTDR00564;WP58;Monoamine GPCRs
TTDR00564;WP722;Serotonin HTR1 Group and FOS Pathway
TTDR00565;WP1824;GPCR downstream signaling
TTDR00565;WP1825;GPCR ligand binding
TTDR00565;WP455;GPCRs, Class A Rhodopsin-like
TTDR00565;WP58;Monoamine GPCRs
TTDR00567;WP1539;Angiogenesis
TTDR00567;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDR00567;WP1911;Signaling by FGFR
TTDR00567;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDR00567;WP2005;miR-targeted genes in muscle cell - TarBase
TTDR00567;WP2006;miR-targeted genes in squamous cell - TarBase
TTDR00567;WP2064;Neural Crest Differentiation
TTDR00567;WP2377;Integrated Pancreatic Cancer Pathway
TTDR00567;WP2406;Cardiac Progenitor Differentiation
TTDR00567;WP2653;PIP3 activates AKT signaling
TTDR00567;WP2677;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
TTDR00567;WP2703;Extracellular matrix organization
TTDR00567;WP2787;Syndecan interactions
TTDR00567;WP2795;Cardiac Hypertrophic Response
TTDR00567;WP2848;Differentiation Pathway
TTDR00567;WP474;Endochondral Ossification
TTDR00567;WP51;Regulation of Actin Cytoskeleton
TTDR00571;WP2002;miR-targeted genes in epithelium - TarBase
TTDR00571;WP2003;miR-targeted genes in leukocytes - TarBase
TTDR00571;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDR00571;WP2005;miR-targeted genes in muscle cell - TarBase
TTDR00580;WP1824;GPCR downstream signaling
TTDR00580;WP1825;GPCR ligand binding
TTDR00580;WP247;Small Ligand GPCRs
TTDR00580;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDR00580;WP289;Myometrial Relaxation and Contraction Pathways
TTDR00587;WP2263;Prostate Cancer
TTDR00587;WP2749;Metabolism of steroid hormones and vitamin D
TTDR00587;WP496;Steroid Biosynthesis
TTDR00593;WP170;Nuclear Receptors
TTDR00593;WP1797;Circadian Clock
TTDR00593;WP236;Adipogenesis
TTDR00593;WP2797;Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
TTDR00593;WP706;SIDS Susceptibility Pathways
TTDR00611;WP1907;Semaphorin interactions
TTDR00611;WP1927;TCR signaling
TTDR00611;WP23;B Cell Receptor Signaling Pathway
TTDR00611;WP581;EPO Receptor Signaling
TTDR00611;WP585;Interferon type I signaling pathways
TTDR00615;WP100;Glutathione metabolism
TTDR00615;WP1880;Phase II conjugation
TTDR00615;WP2333;Trans-sulfuration pathway
TTDR00615;WP2525;Trans-sulfuration and one carbon metabolism
TTDR00615;WP2693;Metabolism of amino acids and derivatives
TTDR00615;WP2882;Nuclear Receptors Meta-Pathway
TTDR00615;WP2884;NRF2 pathway
TTDR00615;WP3;Transcriptional activation by NRF2
TTDR00620;WP1831;Integration of energy metabolism
TTDR00620;WP1866;NCAM signaling for neurite out-growth
TTDR00620;WP2059;Alzheimers Disease
TTDR00620;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDR00620;WP536;Calcium Regulation in the Cardiac Cell
TTDR00624;WP1804;DNA Damage Reversal
TTDR00626;WP1794;Cell surface interactions at the vascular wall
TTDR00626;WP1936;Transport of inorganic cations/anions and amino acids/oligopeptides
TTDR00626;WP2873;Aryl Hydrocarbon Receptor Pathway
TTDR00626;WP2882;Nuclear Receptors Meta-Pathway
TTDR00630;WP167;Eicosanoid Synthesis
TTDR00630;WP2650;Arachidonic acid metabolism
TTDR00634;WP2797;Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
TTDR00634;WP2878;PPAR Alpha Pathway
TTDR00634;WP2882;Nuclear Receptors Meta-Pathway
TTDR00634;WP28;Selenium Metabolism and Selenoproteins
TTDR00650;WP1794;Cell surface interactions at the vascular wall
TTDR00650;WP1829;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
TTDR00650;WP1833;Integrin cell surface interactions
TTDR00650;WP185;Integrin-mediated Cell Adhesion
TTDR00650;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDR00650;WP306;Focal Adhesion
TTDR00661;WP2766;The citric acid (TCA) cycle and respiratory electron transport
TTDR00661;WP78;TCA Cycle
TTDR00662;WP1848;Metabolism of carbohydrates
TTDR00663;WP2864;Apoptosis-related network due to altered Notch3 in ovarian cancer
TTDR00663;WP706;SIDS Susceptibility Pathways
TTDR00668;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDR00668;WP2406;Cardiac Progenitor Differentiation
TTDR00668;WP2780;Signaling by ERBB2
TTDR00668;WP2781;Signaling by ERBB4
TTDR00668;WP2795;Cardiac Hypertrophic Response
TTDR00668;WP2864;Apoptosis-related network due to altered Notch3 in ovarian cancer
TTDR00668;WP2882;Nuclear Receptors Meta-Pathway
TTDR00668;WP2884;NRF2 pathway
TTDR00668;WP673;ErbB Signaling Pathway
TTDR00669;WP138;Androgen receptor signaling pathway
TTDR00669;WP1539;Angiogenesis
TTDR00669;WP1784;Apoptotic execution phase
TTDR00669;WP1832;Integrin alphaIIb beta3 signaling
TTDR00669;WP185;Integrin-mediated Cell Adhesion
TTDR00669;WP1866;NCAM signaling for neurite out-growth
TTDR00669;WP1868;Netrin-1 signaling
TTDR00669;WP2018;RANKL/RANK Signaling Pathway
TTDR00669;WP2034;Leptin signaling pathway
TTDR00669;WP2355;Corticotropin-releasing hormone
TTDR00669;WP244;Alpha 6 Beta 4 signaling pathway
TTDR00669;WP2572;Primary Focal Segmental Glomerulosclerosis FSGS
TTDR00669;WP2593;JAK/STAT
TTDR00669;WP2643;Nanoparticle-mediated activation of receptor signaling
TTDR00669;WP2864;Apoptosis-related network due to altered Notch3 in ovarian cancer
TTDR00669;WP306;Focal Adhesion
TTDR00669;WP313;Signaling of Hepatocyte Growth Factor Receptor
TTDR00669;WP366;TGF beta Signaling Pathway
TTDR00669;WP437;EGF/EGFR Signaling Pathway
TTDR00669;WP51;Regulation of Actin Cytoskeleton
TTDR00669;WP673;ErbB Signaling Pathway
TTDR00673;WP1824;GPCR downstream signaling
TTDR00673;WP1825;GPCR ligand binding
TTDR00673;WP247;Small Ligand GPCRs
TTDR00673;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDR00673;WP455;GPCRs, Class A Rhodopsin-like
TTDR00673;WP98;Prostaglandin Synthesis and Regulation
TTDR00683;WP1833;Integrin cell surface interactions
TTDR00683;WP2703;Extracellular matrix organization
TTDR00683;WP2787;Syndecan interactions
TTDR00683;WP306;Focal Adhesion
TTDR00683;WP366;TGF beta Signaling Pathway
TTDR00688;WP2377;Integrated Pancreatic Cancer Pathway
TTDR00688;WP2572;Primary Focal Segmental Glomerulosclerosis FSGS
TTDR00692;WP2764;Lipid digestion, mobilization, and transport
TTDR00696;WP474;Endochondral Ossification
TTDR00697;WP2877;Vitamin D Receptor Pathway
TTDR00697;WP474;Endochondral Ossification
TTDR00707;WP2691;Peptide hormone biosynthesis
TTDR00712;WP1939;Unfolded Protein Response
TTDR00712;WP1982;SREBP signalling
TTDR00712;WP2686;Regulation of Cholesterol Biosynthesis by SREBP (SREBF)
TTDR00713;WP138;Androgen receptor signaling pathway
TTDR00713;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDR00713;WP1591;Heart Development
TTDR00713;WP1865;Myogenesis
TTDR00713;WP1984;Integrated Breast Cancer Pathway
TTDR00713;WP2003;miR-targeted genes in leukocytes - TarBase
TTDR00713;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDR00713;WP2005;miR-targeted genes in muscle cell - TarBase
TTDR00713;WP2036;TWEAK Signaling Pathway
TTDR00713;WP2064;Neural Crest Differentiation
TTDR00713;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDR00713;WP2272;Pathogenic Escherichia coli infection
TTDR00713;WP2355;Corticotropin-releasing hormone
TTDR00713;WP2363;Gastric cancer network 2
TTDR00713;WP236;Adipogenesis
TTDR00713;WP2377;Integrated Pancreatic Cancer Pathway
TTDR00713;WP2380;BDNF signaling pathway
TTDR00713;WP2572;Primary Focal Segmental Glomerulosclerosis FSGS
TTDR00713;WP2794;Cytosolic sensors of pathogen-associated DNA
TTDR00713;WP2804;Hair Follicle Development: Induction (Part 1 of 3)
TTDR00713;WP2839;Hair Follicle Development: Organogenesis (Part 2 of 3)
TTDR00713;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDR00713;WP2853;Endoderm Differentiation
TTDR00713;WP2858;Ectoderm Differentiation
TTDR00713;WP2870;Extracellular vesicle-mediated signaling in recipient cells
TTDR00713;WP306;Focal Adhesion
TTDR00713;WP363;Wnt Signaling Pathway Netpath
TTDR00713;WP399;Wnt Signaling Pathway and Pluripotency
TTDR00713;WP428;Wnt Signaling Pathway
TTDR00713;WP560;TGF Beta Signaling Pathway
TTDR00713;WP706;SIDS Susceptibility Pathways
TTDR00713;WP710;DNA Damage Response (only ATM dependent)
TTDR00716;WP1784;Apoptotic execution phase
TTDR00716;WP2776;Visual phototransduction
TTDR00722;WP1794;Cell surface interactions at the vascular wall
TTDR00722;WP1829;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
TTDR00722;WP2806;Human Complement System
TTDR00730;WP2849;Hematopoietic Stem Cell Differentiation
TTDR00731;WP1824;GPCR downstream signaling
TTDR00731;WP1825;GPCR ligand binding
TTDR00731;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDR00731;WP455;GPCRs, Class A Rhodopsin-like
TTDR00731;WP80;Nucleotide GPCRs
TTDR00732;WP2693;Metabolism of amino acids and derivatives
TTDR00732;WP497;Urea cycle and metabolism of amino groups
TTDR00734;WP1798;Complement cascade
TTDR00734;WP2572;Primary Focal Segmental Glomerulosclerosis FSGS
TTDR00734;WP2806;Human Complement System
TTDR00734;WP558;Complement and Coagulation Cascades
TTDR00745;WP1781;Advanced glycosylation endproduct receptor signaling
TTDR00745;WP1904;RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
TTDR00745;WP2324;AGE/RAGE pathway
TTDR00745;WP2656;TAK1 activates NFkB by phosphorylation and activation of IKKs complex
TTDR00745;WP2794;Cytosolic sensors of pathogen-associated DNA
TTDR00745;WP2882;Nuclear Receptors Meta-Pathway
TTDR00745;WP2884;NRF2 pathway
TTDR00755;WP117;GPCRs, Other
TTDR00755;WP1824;GPCR downstream signaling
TTDR00755;WP1825;GPCR ligand binding
TTDR00755;WP501;GPCRs, Class C Metabotropic glutamate, pheromone
TTDR00763;WP1824;GPCR downstream signaling
TTDR00763;WP1825;GPCR ligand binding
TTDR00763;WP24;Peptide GPCRs
TTDR00763;WP455;GPCRs, Class A Rhodopsin-like
TTDR00774;WP1851;Metabolism of nucleotides
TTDR00776;WP1403;AMPK Signaling
TTDR00776;WP1584;Type II diabetes mellitus
TTDR00776;WP1828;Hexose transport
TTDR00776;WP1946;Cori Cycle
TTDR00776;WP236;Adipogenesis
TTDR00776;WP2751;Transcriptional Regulation of White Adipocyte Differentiation
TTDR00776;WP2777;Translocation of GLUT4 to the Plasma Membrane
TTDR00776;WP2877;Vitamin D Receptor Pathway
TTDR00776;WP2882;Nuclear Receptors Meta-Pathway
TTDR00776;WP2884;NRF2 pathway
TTDR00776;WP481;Insulin Signaling
TTDR00776;WP534;Glycolysis and Gluconeogenesis
TTDR00777;WP1824;GPCR downstream signaling
TTDR00777;WP1825;GPCR ligand binding
TTDR00777;WP2197;Endothelin Pathways
TTDR00784;WP100;Glutathione metabolism
TTDR00784;WP2003;miR-targeted genes in leukocytes - TarBase
TTDR00784;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDR00784;WP2005;miR-targeted genes in muscle cell - TarBase
TTDR00784;WP2006;miR-targeted genes in squamous cell - TarBase
TTDR00784;WP2406;Cardiac Progenitor Differentiation
TTDR00784;WP2729;Metabolism of Angiotensinogen to Angiotensins
TTDR00786;WP138;Androgen receptor signaling pathway
TTDR00786;WP1530;miRNA Regulation of DNA Damage Response
TTDR00786;WP1545;miRNAs involved in DNA damage response
TTDR00786;WP179;Cell Cycle
TTDR00786;WP1858;Mitotic G1-G1/S phases
TTDR00786;WP2032;TSH signaling pathway
TTDR00786;WP2261;Signaling Pathways in Glioblastoma
TTDR00786;WP2359;Parkin-Ubiquitin Proteasomal System pathway
TTDR00786;WP2371;Parkinsons Disease Pathway
TTDR00786;WP2377;Integrated Pancreatic Cancer Pathway
TTDR00786;WP2446;Retinoblastoma (RB) in Cancer
TTDR00786;WP2877;Vitamin D Receptor Pathway
TTDR00786;WP45;G1 to S cell cycle control
TTDR00786;WP53;ID signaling pathway
TTDR00786;WP707;DNA Damage Response
TTDR00790;WP2865;IL1 and megakaryotyces in obesity
TTDR00790;WP2877;Vitamin D Receptor Pathway
TTDR00794;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDR00794;WP1864;Muscle contraction
TTDR00794;WP2197;Endothelin Pathways
TTDR00794;WP306;Focal Adhesion
TTDR00794;WP51;Regulation of Actin Cytoskeleton
TTDR00795;WP2751;Transcriptional Regulation of White Adipocyte Differentiation
TTDR00795;WP2797;Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
TTDR00795;WP2882;Nuclear Receptors Meta-Pathway
TTDR00802;WP1824;GPCR downstream signaling
TTDR00802;WP1825;GPCR ligand binding
TTDR00802;WP247;Small Ligand GPCRs
TTDR00802;WP455;GPCRs, Class A Rhodopsin-like
TTDR00802;WP98;Prostaglandin Synthesis and Regulation
TTDR00804;WP1781;Advanced glycosylation endproduct receptor signaling
TTDR00804;WP2324;AGE/RAGE pathway
TTDR00804;WP2431;Spinal Cord Injury
TTDR00805;WP2740;Glycerophospholipid biosynthesis
TTDR00805;WP528;Acetylcholine Synthesis
TTDR00806;WP1843;L1CAM interactions
TTDR00806;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDR00808;WP1824;GPCR downstream signaling
TTDR00808;WP1825;GPCR ligand binding
TTDR00808;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDR00808;WP2005;miR-targeted genes in muscle cell - TarBase
TTDR00808;WP2328;Allograft Rejection
TTDR00808;WP2781;Signaling by ERBB4
TTDR00808;WP3297;EV release from cardiac cells and their functional effects
TTDR00811;WP1788;Bile acid and bile salt metabolism
TTDR00811;WP1878;Peroxisomal lipid metabolism
TTDR00811;WP1941;Peroxisomal beta-oxidation of tetracosanoyl-CoA
TTDR00811;WP2263;Prostate Cancer
TTDR00811;WP2724;alpha-linolenic (omega3) and linoleic (omega6) acid metabolism
TTDR00811;WP496;Steroid Biosynthesis
TTDR00813;WP1449;Regulation of toll-like receptor signaling pathway
TTDR00813;WP2671;Defensins
TTDR00813;WP2761;MyD88:Mal cascade initiated on plasma membrane
TTDR00813;WP2775;Toll-Like Receptors Cascades
TTDR00813;WP2806;Human Complement System
TTDR00813;WP2865;IL1 and megakaryotyces in obesity
TTDR00813;WP75;Toll-like receptor signaling pathway
TTDR00821;WP1824;GPCR downstream signaling
TTDR00821;WP1825;GPCR ligand binding
TTDR00821;WP501;GPCRs, Class C Metabotropic glutamate, pheromone
TTDR00823;WP516;Hypertrophy Model
TTDR00824;WP1926;Synthesis, Secretion, and Deacylation of Ghrelin
TTDR00824;WP2691;Peptide hormone biosynthesis
TTDR00824;WP2693;Metabolism of amino acids and derivatives
TTDR00824;WP2728;Incretin Synthesis, Secretion, and Inactivation
TTDR00824;WP2736;Insulin Processing
TTDR00825;WP2736;Insulin Processing
TTDR00830;WP1793;Cell junction organization
TTDR00831;WP2764;Lipid digestion, mobilization, and transport
TTDR00847;WP1814;Extrinsic Pathway for Apoptosis
TTDR00847;WP1910;Signaling by EGFR
TTDR00847;WP1976;Signalling by NGF
TTDR00847;WP2059;Alzheimers Disease
TTDR00847;WP2380;BDNF signaling pathway
TTDR00847;WP2657;Growth hormone receptor signaling
TTDR00847;WP268;Notch Signaling Pathway
TTDR00847;WP2781;Signaling by ERBB4
TTDR00847;WP3286;Copper homeostasis
TTDR00847;WP61;Notch Signaling Pathway
TTDR00848;WP2762;PTM: gamma carboxylation, hypusine formation and arylsulfatase activation
TTDR00858;WP1927;TCR signaling
TTDR00858;WP2583;T-Cell Receptor and Co-stimulatory Signaling
TTDR00858;WP69;TCR Signaling Pathway
TTDR00866;WP1795;Cholesterol biosynthesis
TTDR00866;WP197;Cholesterol Biosynthesis
TTDR00866;WP1982;SREBP signalling
TTDR00866;WP2706;Activation of Gene Expression by SREBP (SREBF)
TTDR00868;WP1591;Heart Development
TTDR00868;WP1822;Generic Transcription Pathway
TTDR00868;WP1897;Regulation of beta-cell development
TTDR00868;WP2002;miR-targeted genes in epithelium - TarBase
TTDR00868;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDR00868;WP2005;miR-targeted genes in muscle cell - TarBase
TTDR00868;WP2064;Neural Crest Differentiation
TTDR00868;WP2361;Gastric Cancer Network 1
TTDR00868;WP2406;Cardiac Progenitor Differentiation
TTDR00868;WP2572;Primary Focal Segmental Glomerulosclerosis FSGS
TTDR00868;WP268;Notch Signaling Pathway
TTDR00868;WP2720;Signaling by NOTCH1
TTDR00868;WP2786;Pre-NOTCH Expression and Processing
TTDR00868;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDR00868;WP2848;Differentiation Pathway
TTDR00868;WP2849;Hematopoietic Stem Cell Differentiation
TTDR00868;WP2853;Endoderm Differentiation
TTDR00868;WP2854;Gene regulatory network modelling somitogenesis
TTDR00868;WP61;Notch Signaling Pathway
TTDR00879;WP690;Polyol Pathway
TTDR00884;WP306;Focal Adhesion
TTDR00884;WP437;EGF/EGFR Signaling Pathway
TTDR00903;WP2380;BDNF signaling pathway
TTDR00903;WP2669;Potassium Channels
TTDR00910;WP134;Pentose Phosphate Pathway
TTDR00910;WP1848;Metabolism of carbohydrates
TTDR00910;WP2882;Nuclear Receptors Meta-Pathway
TTDR00910;WP2884;NRF2 pathway
TTDR00917;WP1403;AMPK Signaling
TTDR00917;WP143;Fatty Acid Beta Oxidation
TTDR00917;WP236;Adipogenesis
TTDR00917;WP2764;Lipid digestion, mobilization, and transport
TTDR00917;WP325;Triacylglyceride Synthesis
TTDR00917;WP481;Insulin Signaling
TTDR00921;WP1449;Regulation of toll-like receptor signaling pathway
TTDR00921;WP1825;GPCR ligand binding
TTDR00921;WP615;Senescence and Autophagy in Cancer
TTDR00921;WP75;Toll-like receptor signaling pathway
TTDR00922;WP1530;miRNA Regulation of DNA Damage Response
TTDR00922;WP1807;Double-Strand Break Repair
TTDR00922;WP186;Homologous recombination
TTDR00922;WP1984;Integrated Breast Cancer Pathway
TTDR00922;WP2377;Integrated Pancreatic Cancer Pathway
TTDR00922;WP2516;ATM Signaling Pathway
TTDR00922;WP2698;Meiotic Recombination
TTDR00922;WP707;DNA Damage Response
TTDR00925;WP1911;Signaling by FGFR
TTDR00925;WP2377;Integrated Pancreatic Cancer Pathway
TTDR00925;WP2653;PIP3 activates AKT signaling
TTDR00925;WP2677;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
TTDR00925;WP2839;Hair Follicle Development: Organogenesis (Part 2 of 3)
TTDR00925;WP2848;Differentiation Pathway
TTDR00925;WP51;Regulation of Actin Cytoskeleton
TTDR00926;WP1591;Heart Development
TTDR00926;WP1919;Signaling by VEGF
TTDR00926;WP306;Focal Adhesion
TTDR00927;WP1449;Regulation of toll-like receptor signaling pathway
TTDR00927;WP2272;Pathogenic Escherichia coli infection
TTDR00927;WP2752;MyD88-independent cascade
TTDR00927;WP2761;MyD88:Mal cascade initiated on plasma membrane
TTDR00927;WP2775;Toll-Like Receptors Cascades
TTDR00927;WP75;Toll-like receptor signaling pathway
TTDR00928;WP1449;Regulation of toll-like receptor signaling pathway
TTDR00928;WP185;Integrin-mediated Cell Adhesion
TTDR00928;WP2380;BDNF signaling pathway
TTDR00928;WP254;Apoptosis
TTDR00928;WP2637;Structural Pathway of Interleukin 1 (IL-1)
TTDR00928;WP2643;Nanoparticle-mediated activation of receptor signaling
TTDR00928;WP382;MAPK Signaling Pathway
TTDR00928;WP384;Apoptosis Modulation by HSP70
TTDR00928;WP399;Wnt Signaling Pathway and Pluripotency
TTDR00928;WP408;Oxidative Stress
TTDR00928;WP422;MAPK Cascade
TTDR00928;WP428;Wnt Signaling Pathway
TTDR00928;WP481;Insulin Signaling
TTDR00928;WP524;G13 Signaling Pathway
TTDR00928;WP710;DNA Damage Response (only ATM dependent)
TTDR00928;WP75;Toll-like receptor signaling pathway
TTDR00930;WP1403;AMPK Signaling
TTDR00930;WP1449;Regulation of toll-like receptor signaling pathway
TTDR00930;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDR00930;WP1840;Interleukin-3, 5 and GM-CSF signaling
TTDR00930;WP2261;Signaling Pathways in Glioblastoma
TTDR00930;WP2643;Nanoparticle-mediated activation of receptor signaling
TTDR00930;WP2653;PIP3 activates AKT signaling
TTDR00930;WP2732;Interleukin-2 signaling
TTDR00930;WP2746;Signaling by the B Cell Receptor (BCR)
TTDR00930;WP2747;PI Metabolism
TTDR00930;WP286;IL-3 Signaling Pathway
TTDR00930;WP306;Focal Adhesion
TTDR00930;WP395;IL-4 Signaling Pathway
TTDR00930;WP481;Insulin Signaling
TTDR00930;WP51;Regulation of Actin Cytoskeleton
TTDR00930;WP524;G13 Signaling Pathway
TTDR00930;WP585;Interferon type I signaling pathways
TTDR00930;WP710;DNA Damage Response (only ATM dependent)
TTDR00930;WP75;Toll-like receptor signaling pathway
TTDR00943;WP1824;GPCR downstream signaling
TTDR00943;WP1825;GPCR ligand binding
TTDR00947;WP1533;Vitamin B12 Metabolism
TTDR00947;WP15;Selenium Micronutrient Network
TTDR00947;WP176;Folate Metabolism
TTDR00947;WP1797;Circadian Clock
TTDR00947;WP1818;Formation of Fibrin Clot (Clotting Cascade)
TTDR00947;WP272;Blood Clotting Cascade
TTDR00947;WP2762;PTM: gamma carboxylation, hypusine formation and arylsulfatase activation
TTDR00947;WP558;Complement and Coagulation Cascades
TTDR00950;WP15;Selenium Micronutrient Network
TTDR00950;WP2485;NAD Biosynthesis II (from tryptophan)
TTDR00950;WP2693;Metabolism of amino acids and derivatives
TTDR00950;WP465;Tryptophan metabolism
TTDR00956;WP1851;Metabolism of nucleotides
TTDR00957;WP176;Folate Metabolism
TTDR00957;WP1880;Phase II conjugation
TTDR00957;WP2333;Trans-sulfuration pathway
TTDR00957;WP241;One Carbon Metabolism
TTDR00957;WP2525;Trans-sulfuration and one carbon metabolism
TTDR00957;WP2693;Metabolism of amino acids and derivatives
TTDR00959;WP2693;Metabolism of amino acids and derivatives
TTDR00965;WP1824;GPCR downstream signaling
TTDR00965;WP1825;GPCR ligand binding
TTDR00965;WP501;GPCRs, Class C Metabotropic glutamate, pheromone
TTDR00967;WP1787;Base Excision Repair
TTDR00967;WP2032;TSH signaling pathway
TTDR00967;WP2431;Spinal Cord Injury
TTDR00968;WP1772;Apoptosis Modulation and Signaling
TTDR00968;WP1971;Integrated Cancer pathway
TTDR00968;WP231;TNF alpha Signaling Pathway
TTDR00968;WP2355;Corticotropin-releasing hormone
TTDR00968;WP2377;Integrated Pancreatic Cancer Pathway
TTDR00968;WP2447;Amyotrophic lateral sclerosis (ALS)
TTDR00968;WP382;MAPK Signaling Pathway
TTDR00968;WP400;p38 MAPK Signaling Pathway
TTDR00968;WP481;Insulin Signaling
TTDR00977;WP1815;Factors involved in megakaryocyte development and platelet production
TTDR00977;WP1831;Integration of energy metabolism
TTDR00977;WP1978;Opioid Signalling
TTDR00977;WP2012;miRs in Muscle Cell Differentiation
TTDR00977;WP2662;Regulation of Water Balance by Renal Aquaporins
TTDR00977;WP2688;DAG and IP3 signaling
TTDR00977;WP2857;Mesodermal Commitment Pathway
TTDR00977;WP289;Myometrial Relaxation and Contraction Pathways
TTDR00977;WP35;G Protein Signaling Pathways
TTDR00977;WP536;Calcium Regulation in the Cardiac Cell
TTDR00977;WP706;SIDS Susceptibility Pathways
TTDR00978;WP1815;Factors involved in megakaryocyte development and platelet production
TTDR00978;WP1831;Integration of energy metabolism
TTDR00978;WP1859;Mitotic G2-G2/M phases
TTDR00978;WP1978;Opioid Signalling
TTDR00978;WP2012;miRs in Muscle Cell Differentiation
TTDR00978;WP2662;Regulation of Water Balance by Renal Aquaporins
TTDR00978;WP2688;DAG and IP3 signaling
TTDR00978;WP289;Myometrial Relaxation and Contraction Pathways
TTDR00978;WP35;G Protein Signaling Pathways
TTDR00978;WP536;Calcium Regulation in the Cardiac Cell
TTDR00978;WP706;SIDS Susceptibility Pathways
TTDR00989;WP1495;Glycine Metabolism
TTDR00989;WP1533;Vitamin B12 Metabolism
TTDR00989;WP1589;Folate-Alcohol and Cancer Pathway
TTDR00989;WP15;Selenium Micronutrient Network
TTDR00989;WP1601;Fluoropyrimidine Activity
TTDR00989;WP176;Folate Metabolism
TTDR00989;WP1857;Metabolism of water-soluble vitamins and cofactors
TTDR00989;WP2190;One carbon donor
TTDR00989;WP241;One Carbon Metabolism
TTDR00989;WP2525;Trans-sulfuration and one carbon metabolism
TTDR00995;WP1946;Cori Cycle
TTDR00995;WP2059;Alzheimers Disease
TTDR00995;WP534;Glycolysis and Gluconeogenesis
TTDR00995;WP706;SIDS Susceptibility Pathways
TTDR00998;WP1984;Integrated Breast Cancer Pathway
TTDR00998;WP2377;Integrated Pancreatic Cancer Pathway
TTDR00998;WP2742;Signaling by TGF-beta Receptor Complex
TTDR00998;WP2795;Cardiac Hypertrophic Response
TTDR00998;WP2870;Extracellular vesicle-mediated signaling in recipient cells
TTDR00998;WP366;TGF beta Signaling Pathway
TTDR00998;WP382;MAPK Signaling Pathway
TTDR00998;WP400;p38 MAPK Signaling Pathway
TTDR00998;WP560;TGF Beta Signaling Pathway
TTDR01001;WP1936;Transport of inorganic cations/anions and amino acids/oligopeptides
TTDR01001;WP1981;Thyroxine (Thyroid Hormone) Production
TTDR01001;WP2693;Metabolism of amino acids and derivatives
TTDR01001;WP2882;Nuclear Receptors Meta-Pathway
TTDR01001;WP2884;NRF2 pathway
TTDR01004;WP1817;Fatty acid, triacylglycerol, and ketone body metabolism
TTDR01004;WP1831;Integration of energy metabolism
TTDR01004;WP1982;SREBP signalling
TTDR01004;WP2366;Butyrate-induced histone acetylation
TTDR01004;WP2453;TCA Cycle and PDHc
TTDR01004;WP357;Fatty Acid Biosynthesis
TTDR01006;WP1433;NOD pathway
TTDR01006;WP1530;miRNA Regulation of DNA Damage Response
TTDR01006;WP1772;Apoptosis Modulation and Signaling
TTDR01006;WP1841;Intrinsic Pathway for Apoptosis
TTDR01006;WP1896;Regulation of Apoptosis
TTDR01006;WP1971;Integrated Cancer pathway
TTDR01006;WP1984;Integrated Breast Cancer Pathway
TTDR01006;WP2059;Alzheimers Disease
TTDR01006;WP2263;Prostate Cancer
TTDR01006;WP231;TNF alpha Signaling Pathway
TTDR01006;WP2324;AGE/RAGE pathway
TTDR01006;WP2328;Allograft Rejection
TTDR01006;WP2355;Corticotropin-releasing hormone
TTDR01006;WP2371;Parkinsons Disease Pathway
TTDR01006;WP2377;Integrated Pancreatic Cancer Pathway
TTDR01006;WP2447;Amyotrophic lateral sclerosis (ALS)
TTDR01006;WP254;Apoptosis
TTDR01006;WP2653;PIP3 activates AKT signaling
TTDR01006;WP314;FAS pathway and Stress induction of HSP regulation
TTDR01006;WP382;MAPK Signaling Pathway
TTDR01006;WP384;Apoptosis Modulation by HSP70
TTDR01006;WP707;DNA Damage Response
TTDR01018;WP1857;Metabolism of water-soluble vitamins and cofactors
TTDR01028;WP2693;Metabolism of amino acids and derivatives
TTDR01031;WP2572;Primary Focal Segmental Glomerulosclerosis FSGS
TTDR01035;WP236;Adipogenesis
TTDR01035;WP2406;Cardiac Progenitor Differentiation
TTDR01042;WP2670;Iron uptake and transport
TTDR01042;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDR01044;WP1824;GPCR downstream signaling
TTDR01044;WP1825;GPCR ligand binding
TTDR01044;WP24;Peptide GPCRs
TTDR01044;WP455;GPCRs, Class A Rhodopsin-like
TTDR01045;WP1824;GPCR downstream signaling
TTDR01045;WP1825;GPCR ligand binding
TTDR01045;WP24;Peptide GPCRs
TTDR01045;WP455;GPCRs, Class A Rhodopsin-like
TTDR01048;WP1926;Synthesis, Secretion, and Deacylation of Ghrelin
TTDR01048;WP236;Adipogenesis
TTDR01048;WP2657;Growth hormone receptor signaling
TTDR01048;WP2678;Prolactin receptor signaling
TTDR01048;WP474;Endochondral Ossification
TTDR01056;WP1824;GPCR downstream signaling
TTDR01056;WP1825;GPCR ligand binding
TTDR01056;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDR01056;WP455;GPCRs, Class A Rhodopsin-like
TTDR01057;WP1793;Cell junction organization
TTDR01057;WP1833;Integrin cell surface interactions
TTDR01057;WP244;Alpha 6 Beta 4 signaling pathway
TTDR01057;WP2798;Assembly of collagen fibrils and other multimeric structures
TTDR01057;WP306;Focal Adhesion
TTDR01059;WP2324;AGE/RAGE pathway
TTDR01059;WP2784;Binding and Uptake of Ligands by Scavenger Receptors
TTDR01066;WP1794;Cell surface interactions at the vascular wall
TTDR01066;WP1976;Signalling by NGF
TTDR01066;WP2276;Glial Cell Differentiation
TTDR01066;WP2431;Spinal Cord Injury
TTDR01073;WP1531;Vitamin D Metabolism
TTDR01073;WP170;Nuclear Receptors
TTDR01073;WP1797;Circadian Clock
TTDR01073;WP236;Adipogenesis
TTDR01073;WP2377;Integrated Pancreatic Cancer Pathway
TTDR01073;WP2706;Activation of Gene Expression by SREBP (SREBF)
TTDR01073;WP2738;YAP1- and WWTR1 (TAZ)-stimulated gene expression
TTDR01073;WP2751;Transcriptional Regulation of White Adipocyte Differentiation
TTDR01073;WP2797;Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
TTDR01073;WP2874;Liver X Receptor Pathway
TTDR01073;WP2875;Constitutive Androstane Receptor Pathway
TTDR01073;WP2876;Pregnane X Receptor pathway
TTDR01073;WP2877;Vitamin D Receptor Pathway
TTDR01073;WP2878;PPAR Alpha Pathway
TTDR01073;WP2879;Farnesoid X Receptor Pathway
TTDR01073;WP2882;Nuclear Receptors Meta-Pathway
TTDR01073;WP2884;NRF2 pathway
TTDR01073;WP716;Vitamin A and Carotenoid Metabolism
TTDR01075;WP170;Nuclear Receptors
TTDR01075;WP236;Adipogenesis
TTDR01075;WP716;Vitamin A and Carotenoid Metabolism
TTDR01076;WP2776;Visual phototransduction
TTDR01100;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDR01100;WP241;One Carbon Metabolism
TTDR01100;WP2525;Trans-sulfuration and one carbon metabolism
TTDR01100;WP2853;Endoderm Differentiation
TTDR01100;WP2857;Mesodermal Commitment Pathway
TTDR01101;WP1840;Interleukin-3, 5 and GM-CSF signaling
TTDR01101;WP205;IL-7 Signaling Pathway
TTDR01101;WP2203;TSLP Signaling Pathway
TTDR01101;WP2328;Allograft Rejection
TTDR01101;WP2732;Interleukin-2 signaling
TTDR01101;WP453;Inflammatory Response Pathway
TTDR01101;WP49;IL-2 Signaling Pathway
TTDR01110;WP2446;Retinoblastoma (RB) in Cancer
TTDR01112;WP1794;Cell surface interactions at the vascular wall
TTDR01112;WP2806;Human Complement System
TTDR01120;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDR01120;WP2877;Vitamin D Receptor Pathway
TTDR01123;WP69;TCR Signaling Pathway
TTDR01130;WP706;SIDS Susceptibility Pathways
TTDR01132;WP1828;Hexose transport
TTDR01132;WP1848;Metabolism of carbohydrates
TTDR01133;WP1843;L1CAM interactions
TTDR01133;WP2038;Regulation of Microtubule Cytoskeleton
TTDR01133;WP288;NLR Proteins
TTDR01133;WP3;Transcriptional activation by NRF2
TTDR01134;WP1449;Regulation of toll-like receptor signaling pathway
TTDR01134;WP1815;Factors involved in megakaryocyte development and platelet production
TTDR01134;WP1904;RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
TTDR01134;WP254;Apoptosis
TTDR01134;WP2672;ISG15 antiviral mechanism
TTDR01134;WP2752;MyD88-independent cascade
TTDR01134;WP2794;Cytosolic sensors of pathogen-associated DNA
TTDR01134;WP75;Toll-like receptor signaling pathway
TTDR01138;WP2776;Visual phototransduction
TTDR01142;WP1530;miRNA Regulation of DNA Damage Response
TTDR01142;WP179;Cell Cycle
TTDR01142;WP1807;Double-Strand Break Repair
TTDR01142;WP2263;Prostate Cancer
TTDR01142;WP2446;Retinoblastoma (RB) in Cancer
TTDR01142;WP2794;Cytosolic sensors of pathogen-associated DNA
TTDR01142;WP314;FAS pathway and Stress induction of HSP regulation
TTDR01142;WP438;Non-homologous end joining
TTDR01142;WP707;DNA Damage Response
TTDR01148;WP2700;Latent infection of Homo sapiens with Mycobacterium tuberculosis
TTDR01153;WP1798;Complement cascade
TTDR01153;WP1824;GPCR downstream signaling
TTDR01153;WP1825;GPCR ligand binding
TTDR01153;WP1829;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
TTDR01153;WP2328;Allograft Rejection
TTDR01153;WP2806;Human Complement System
TTDR01153;WP545;Complement Activation, Classical Pathway
TTDR01153;WP558;Complement and Coagulation Cascades
TTDR01156;WP179;Cell Cycle
TTDR01156;WP1815;Factors involved in megakaryocyte development and platelet production
TTDR01156;WP1905;RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription
TTDR01156;WP1976;Signalling by NGF
TTDR01156;WP2064;Neural Crest Differentiation
TTDR01156;WP268;Notch Signaling Pathway
TTDR01156;WP61;Notch Signaling Pathway
TTDR01164;WP2846;PCSK9-mediated LDLR degradation
TTDR01165;WP1824;GPCR downstream signaling
TTDR01165;WP1825;GPCR ligand binding
TTDR01165;WP1836;Interferon gamma signaling
TTDR01165;WP247;Small Ligand GPCRs
TTDR01165;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDR01165;WP455;GPCRs, Class A Rhodopsin-like
TTDR01167;WP179;Cell Cycle
TTDR01167;WP2064;Neural Crest Differentiation
TTDR01167;WP2858;Ectoderm Differentiation
TTDR01170;WP1794;Cell surface interactions at the vascular wall
TTDR01170;WP1829;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
TTDR01170;WP1833;Integrin cell surface interactions
TTDR01170;WP185;Integrin-mediated Cell Adhesion
TTDR01170;WP2775;Toll-Like Receptors Cascades
TTDR01170;WP2806;Human Complement System
TTDR01170;WP306;Focal Adhesion
TTDR01177;WP2670;Iron uptake and transport
TTDR01177;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDR01178;WP2670;Iron uptake and transport
TTDR01178;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDR01179;WP2882;Nuclear Receptors Meta-Pathway
TTDR01179;WP2884;NRF2 pathway
TTDR01179;WP727;Monoamine Transport
TTDR01180;WP1824;GPCR downstream signaling
TTDR01180;WP1825;GPCR ligand binding
TTDR01180;WP1831;Integration of energy metabolism
TTDR01180;WP1884;Platelet Aggregation (Plug Formation)
TTDR01180;WP455;GPCRs, Class A Rhodopsin-like
TTDR01180;WP58;Monoamine GPCRs
TTDR01185;WP1870;Neurotransmitter Clearance In The Synaptic Cleft
TTDR01185;WP1879;Phase 1 - Functionalization of compounds
TTDR01185;WP206;Fatty Acid Omega Oxidation
TTDR01185;WP465;Tryptophan metabolism
TTDR01187;WP1601;Fluoropyrimidine Activity
TTDR01187;WP1851;Metabolism of nucleotides
TTDR01191;WP170;Nuclear Receptors
TTDR01191;WP2377;Integrated Pancreatic Cancer Pathway
TTDR01191;WP2857;Mesodermal Commitment Pathway
TTDR01191;WP299;Nuclear Receptors in Lipid Metabolism and Toxicity
TTDR01191;WP716;Vitamin A and Carotenoid Metabolism
TTDR01193;WP117;GPCRs, Other
TTDR01193;WP1824;GPCR downstream signaling
TTDR01193;WP1825;GPCR ligand binding
TTDR01194;WP117;GPCRs, Other
TTDR01194;WP1824;GPCR downstream signaling
TTDR01194;WP1825;GPCR ligand binding
TTDR01194;WP455;GPCRs, Class A Rhodopsin-like
TTDR01194;WP58;Monoamine GPCRs
TTDR01194;WP722;Serotonin HTR1 Group and FOS Pathway
TTDR01197;WP1824;GPCR downstream signaling
TTDR01197;WP1825;GPCR ligand binding
TTDR01197;WP24;Peptide GPCRs
TTDR01197;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDR01197;WP455;GPCRs, Class A Rhodopsin-like
TTDR01201;WP1857;Metabolism of water-soluble vitamins and cofactors
TTDR01202;WP2741;Inositol phosphate metabolism
TTDR01203;WP2650;Arachidonic acid metabolism
TTDR01203;WP678;Arachidonate Epoxygenase / Epoxide Hydrolase
TTDR01203;WP702;Metapathway biotransformation
TTDR01206;WP1433;NOD pathway
TTDR01206;WP1434;Osteopontin Signaling
TTDR01206;WP1449;Regulation of toll-like receptor signaling pathway
TTDR01206;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDR01206;WP1584;Type II diabetes mellitus
TTDR01206;WP1772;Apoptosis Modulation and Signaling
TTDR01206;WP1839;Interleukin-1 signaling
TTDR01206;WP1904;RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
TTDR01206;WP1927;TCR signaling
TTDR01206;WP195;IL-1 signaling pathway
TTDR01206;WP1976;Signalling by NGF
TTDR01206;WP2018;RANKL/RANK Signaling Pathway
TTDR01206;WP2034;Leptin signaling pathway
TTDR01206;WP2036;TWEAK Signaling Pathway
TTDR01206;WP2112;IL17 signaling pathway
TTDR01206;WP231;TNF alpha Signaling Pathway
TTDR01206;WP2324;AGE/RAGE pathway
TTDR01206;WP2332;Interleukin-11 Signaling Pathway
TTDR01206;WP2380;BDNF signaling pathway
TTDR01206;WP23;B Cell Receptor Signaling Pathway
TTDR01206;WP2435;Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis
TTDR01206;WP254;Apoptosis
TTDR01206;WP2571;Polycystic Kidney Disease Pathway
TTDR01206;WP262;EBV LMP1 signaling
TTDR01206;WP2637;Structural Pathway of Interleukin 1 (IL-1)
TTDR01206;WP2656;TAK1 activates NFkB by phosphorylation and activation of IKKs complex
TTDR01206;WP2746;Signaling by the B Cell Receptor (BCR)
TTDR01206;WP2752;MyD88-independent cascade
TTDR01206;WP2759;Fc epsilon receptor (FCERI) signaling
TTDR01206;WP2761;MyD88:Mal cascade initiated on plasma membrane
TTDR01206;WP2763;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
TTDR01206;WP2768;MyD88 dependent cascade initiated on endosome
TTDR01206;WP2794;Cytosolic sensors of pathogen-associated DNA
TTDR01206;WP2795;Cardiac Hypertrophic Response
TTDR01206;WP2801;MyD88 cascade initiated on plasma membrane
TTDR01206;WP2804;Hair Follicle Development: Induction (Part 1 of 3)
TTDR01206;WP288;NLR Proteins
TTDR01206;WP382;MAPK Signaling Pathway
TTDR01206;WP395;IL-4 Signaling Pathway
TTDR01206;WP481;Insulin Signaling
TTDR01206;WP69;TCR Signaling Pathway
TTDR01206;WP712;Estrogen signaling pathway
TTDR01206;WP75;Toll-like receptor signaling pathway
TTDR01214;WP2882;Nuclear Receptors Meta-Pathway
TTDR01214;WP2884;NRF2 pathway
TTDR01216;WP12;Osteoclast Signaling
TTDR01216;WP1539;Angiogenesis
TTDR01216;WP1916;Signaling by PDGF
TTDR01216;WP2526;PDGF Pathway
TTDR01216;WP2653;PIP3 activates AKT signaling
TTDR01216;WP2703;Extracellular matrix organization
TTDR01216;WP2848;Differentiation Pathway
TTDR01216;WP2882;Nuclear Receptors Meta-Pathway
TTDR01216;WP2884;NRF2 pathway
TTDR01216;WP306;Focal Adhesion
TTDR01216;WP322;Osteoblast Signaling
TTDR01216;WP382;MAPK Signaling Pathway
TTDR01216;WP51;Regulation of Actin Cytoskeleton
TTDR01217;WP1916;Signaling by PDGF
TTDR01217;WP2261;Signaling Pathways in Glioblastoma
TTDR01217;WP2526;PDGF Pathway
TTDR01217;WP2653;PIP3 activates AKT signaling
TTDR01217;WP306;Focal Adhesion
TTDR01217;WP322;Osteoblast Signaling
TTDR01217;WP382;MAPK Signaling Pathway
TTDR01217;WP51;Regulation of Actin Cytoskeleton
TTDR01222;WP2725;Collagen biosynthesis and modifying enzymes
TTDR01224;WP2681;Uptake of Oxygen and Release of Carbon Dioxide by Erythrocytes
TTDR01224;WP2744;Uptake of Carbon Dioxide and Release of Oxygen by Erythrocytes
TTDR01224;WP2770;Reversible Hydration of Carbon Dioxide
TTDR01227;WP170;Nuclear Receptors
TTDR01227;WP2849;Hematopoietic Stem Cell Differentiation
TTDR01227;WP706;SIDS Susceptibility Pathways
TTDR01229;WP1851;Metabolism of nucleotides
TTDR01229;WP2002;miR-targeted genes in epithelium - TarBase
TTDR01229;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDR01229;WP2005;miR-targeted genes in muscle cell - TarBase
TTDR01229;WP2848;Differentiation Pathway
TTDR01233;WP1533;Vitamin B12 Metabolism
TTDR01233;WP15;Selenium Micronutrient Network
TTDR01233;WP176;Folate Metabolism
TTDR01233;WP1802;Dissolution of Fibrin Clot
TTDR01233;WP272;Blood Clotting Cascade
TTDR01233;WP474;Endochondral Ossification
TTDR01233;WP558;Complement and Coagulation Cascades
TTDR01233;WP615;Senescence and Autophagy in Cancer
TTDR01234;WP2849;Hematopoietic Stem Cell Differentiation
TTDR01234;WP530;Cytokines and Inflammatory Response
TTDR01236;WP1831;Integration of energy metabolism
TTDR01236;WP2669;Potassium Channels
TTDR01237;WP1866;NCAM signaling for neurite out-growth
TTDR01237;WP2806;Human Complement System
TTDR01237;WP3286;Copper homeostasis
TTDR01240;WP176;Folate Metabolism
TTDR01240;WP1851;Metabolism of nucleotides
TTDR01240;WP241;One Carbon Metabolism
TTDR01247;WP1824;GPCR downstream signaling
TTDR01247;WP1825;GPCR ligand binding
TTDR01247;WP24;Peptide GPCRs
TTDR01247;WP455;GPCRs, Class A Rhodopsin-like
TTDR01250;WP2035;FSH signaling pathway
TTDR01250;WP2670;Iron uptake and transport
TTDR01250;WP481;Insulin Signaling
TTDR01251;WP1919;Signaling by VEGF
TTDR01251;WP306;Focal Adhesion
TTDR01253;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDR01256;WP2670;Iron uptake and transport
TTDR01257;WP2670;Iron uptake and transport
TTDR01259;WP2059;Alzheimers Disease
TTDR01259;WP2380;BDNF signaling pathway
TTDR01259;WP2431;Spinal Cord Injury
TTDR01259;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDR01259;WP666;Hypothetical Network for Drug Addiction
TTDR01259;WP706;SIDS Susceptibility Pathways
TTDR01263;WP127;IL-5 Signaling Pathway
TTDR01263;WP1591;Heart Development
TTDR01263;WP1794;Cell surface interactions at the vascular wall
TTDR01263;WP1799;Costimulation by the CD28 family
TTDR01263;WP1835;Interferon alpha/beta signaling
TTDR01263;WP1840;Interleukin-3, 5 and GM-CSF signaling
TTDR01263;WP1868;Netrin-1 signaling
TTDR01263;WP1885;Platelet homeostasis
TTDR01263;WP1909;Signal regulatory protein (SIRP) family interactions
TTDR01263;WP1910;Signaling by EGFR
TTDR01263;WP1911;Signaling by FGFR
TTDR01263;WP1916;Signaling by PDGF
TTDR01263;WP195;IL-1 signaling pathway
TTDR01263;WP2034;Leptin signaling pathway
TTDR01263;WP2203;TSLP Signaling Pathway
TTDR01263;WP2253;Pilocytic astrocytoma
TTDR01263;WP2263;Prostate Cancer
TTDR01263;WP2332;Interleukin-11 Signaling Pathway
TTDR01263;WP2374;Oncostatin M Signaling Pathway
TTDR01263;WP2380;BDNF signaling pathway
TTDR01263;WP23;B Cell Receptor Signaling Pathway
TTDR01263;WP244;Alpha 6 Beta 4 signaling pathway
TTDR01263;WP2526;PDGF Pathway
TTDR01263;WP2593;JAK/STAT
TTDR01263;WP2653;PIP3 activates AKT signaling
TTDR01263;WP2677;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
TTDR01263;WP2678;Prolactin receptor signaling
TTDR01263;WP2704;Interleukin-6 signaling
TTDR01263;WP2713;Signaling by SCF-KIT
TTDR01263;WP2752;MyD88-independent cascade
TTDR01263;WP286;IL-3 Signaling Pathway
TTDR01263;WP304;Kit receptor signaling pathway
TTDR01263;WP313;Signaling of Hepatocyte Growth Factor Receptor
TTDR01263;WP364;IL-6 signaling pathway
TTDR01263;WP395;IL-4 Signaling Pathway
TTDR01263;WP437;EGF/EGFR Signaling Pathway
TTDR01263;WP481;Insulin Signaling
TTDR01263;WP49;IL-2 Signaling Pathway
TTDR01263;WP585;Interferon type I signaling pathways
TTDR01263;WP619;Type II interferon signaling (IFNG)
TTDR01263;WP69;TCR Signaling Pathway
TTDR01265;WP1591;Heart Development
TTDR01265;WP2005;miR-targeted genes in muscle cell - TarBase
TTDR01265;WP2261;Signaling Pathways in Glioblastoma
TTDR01265;WP2864;Apoptosis-related network due to altered Notch3 in ovarian cancer
TTDR01265;WP673;ErbB Signaling Pathway
TTDR01266;WP129;Matrix Metalloproteinases
TTDR01266;WP2769;Activation of Matrix Metalloproteinases
TTDR01269;WP237;Glucocorticoid & Mineralcorticoid Metabolism
TTDR01269;WP98;Prostaglandin Synthesis and Regulation
TTDR01270;WP1584;Type II diabetes mellitus
TTDR01270;WP1831;Integration of energy metabolism
TTDR01270;WP2669;Potassium Channels
TTDR01273;WP170;Nuclear Receptors
TTDR01273;WP2289;Drug Induction of Bile Acid Pathway
TTDR01273;WP2876;Pregnane X Receptor pathway
TTDR01273;WP2882;Nuclear Receptors Meta-Pathway
TTDR01273;WP299;Nuclear Receptors in Lipid Metabolism and Toxicity
TTDR01293;WP1846;Membrane Trafficking
TTDR01293;WP2007;Iron metabolism in placenta
TTDR01293;WP2670;Iron uptake and transport
TTDR01293;WP2784;Binding and Uptake of Ligands by Scavenger Receptors
TTDR01293;WP2882;Nuclear Receptors Meta-Pathway
TTDR01293;WP2884;NRF2 pathway
TTDR01298;WP2839;Hair Follicle Development: Organogenesis (Part 2 of 3)
TTDR01298;WP2855;Dopaminergic Neurogenesis
TTDR01298;WP47;Hedgehog Signaling Pathway
TTDR01341;WP179;Cell Cycle
TTDR01341;WP1858;Mitotic G1-G1/S phases
TTDR01341;WP1859;Mitotic G2-G2/M phases
TTDR01341;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDR01341;WP2005;miR-targeted genes in muscle cell - TarBase
TTDR01341;WP2006;miR-targeted genes in squamous cell - TarBase
TTDR01341;WP2249;Metastatic brain tumor
TTDR01341;WP23;B Cell Receptor Signaling Pathway
TTDR01341;WP2446;Retinoblastoma (RB) in Cancer
TTDR01341;WP2786;Pre-NOTCH Expression and Processing
TTDR01341;WP45;G1 to S cell cycle control
TTDR01342;WP1910;Signaling by EGFR
TTDR01342;WP2059;Alzheimers Disease
TTDR01342;WP2718;Signaling by NOTCH2
TTDR01342;WP2721;Signaling by NOTCH4
TTDR01342;WP2722;Signaling by NOTCH3
TTDR01342;WP3286;Copper homeostasis
TTDR01342;WP516;Hypertrophy Model
TTDR01343;WP1984;Integrated Breast Cancer Pathway
TTDR01343;WP2742;Signaling by TGF-beta Receptor Complex
TTDR01343;WP2755;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
TTDR01343;WP2760;Signaling by BMP
TTDR01343;WP2864;Apoptosis-related network due to altered Notch3 in ovarian cancer
TTDR01343;WP366;TGF beta Signaling Pathway
TTDR01343;WP560;TGF Beta Signaling Pathway
TTDR01344;WP2526;PDGF Pathway
TTDR01345;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDR01345;WP1799;Costimulation by the CD28 family
TTDR01345;WP1824;GPCR downstream signaling
TTDR01345;WP1826;GPVI-mediated activation cascade
TTDR01345;WP185;Integrin-mediated Cell Adhesion
TTDR01345;WP1913;Signaling by Insulin receptor
TTDR01345;WP1927;TCR signaling
TTDR01345;WP2032;TSH signaling pathway
TTDR01345;WP2261;Signaling Pathways in Glioblastoma
TTDR01345;WP2332;Interleukin-11 Signaling Pathway
TTDR01345;WP2380;BDNF signaling pathway
TTDR01345;WP23;B Cell Receptor Signaling Pathway
TTDR01345;WP2653;PIP3 activates AKT signaling
TTDR01345;WP2677;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
TTDR01345;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDR01345;WP2759;Fc epsilon receptor (FCERI) signaling
TTDR01345;WP2795;Cardiac Hypertrophic Response
TTDR01345;WP306;Focal Adhesion
TTDR01345;WP437;EGF/EGFR Signaling Pathway
TTDR01345;WP481;Insulin Signaling
TTDR01345;WP69;TCR Signaling Pathway
TTDR01345;WP722;Serotonin HTR1 Group and FOS Pathway
TTDR01346;WP1433;NOD pathway
TTDR01346;WP1839;Interleukin-1 signaling
TTDR01346;WP1927;TCR signaling
TTDR01346;WP1976;Signalling by NGF
TTDR01346;WP2656;TAK1 activates NFkB by phosphorylation and activation of IKKs complex
TTDR01346;WP2763;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
TTDR01346;WP2792;MAP kinase activation in TLR cascade
TTDR01346;WP2864;Apoptosis-related network due to altered Notch3 in ovarian cancer
TTDR01346;WP314;FAS pathway and Stress induction of HSP regulation
TTDR01346;WP69;TCR Signaling Pathway
TTDR01347;WP1425;BMP Signalling and Regulation
TTDR01347;WP1449;Regulation of toll-like receptor signaling pathway
TTDR01347;WP1984;Integrated Breast Cancer Pathway
TTDR01347;WP2377;Integrated Pancreatic Cancer Pathway
TTDR01347;WP2760;Signaling by BMP
TTDR01347;WP2857;Mesodermal Commitment Pathway
TTDR01347;WP560;TGF Beta Signaling Pathway
TTDR01352;WP1817;Fatty acid, triacylglycerol, and ketone body metabolism
TTDR01352;WP2740;Glycerophospholipid biosynthesis
TTDR01352;WP325;Triacylglyceride Synthesis
TTDR01352;WP430;Statin Pathway
TTDR01352;WP716;Vitamin A and Carotenoid Metabolism
TTDR01355;WP1533;Vitamin B12 Metabolism
TTDR01355;WP15;Selenium Micronutrient Network
TTDR01355;WP176;Folate Metabolism
TTDR01355;WP2324;AGE/RAGE pathway
TTDR01355;WP2436;Dopamine metabolism
TTDR01355;WP2447;Amyotrophic lateral sclerosis (ALS)
TTDR01355;WP259;Nifedipine Activity
TTDR01355;WP2824;Detoxification of Reactive Oxygen Species
TTDR01355;WP3286;Copper homeostasis
TTDR01355;WP408;Oxidative Stress
TTDR01356;WP1794;Cell surface interactions at the vascular wall
TTDR01356;WP1840;Interleukin-3, 5 and GM-CSF signaling
TTDR01356;WP185;Integrin-mediated Cell Adhesion
TTDR01356;WP1866;NCAM signaling for neurite out-growth
TTDR01356;WP1873;NGF signalling via TRKA from the plasma membrane
TTDR01356;WP1910;Signaling by EGFR
TTDR01356;WP1911;Signaling by FGFR
TTDR01356;WP1913;Signaling by Insulin receptor
TTDR01356;WP1916;Signaling by PDGF
TTDR01356;WP2032;TSH signaling pathway
TTDR01356;WP2034;Leptin signaling pathway
TTDR01356;WP2261;Signaling Pathways in Glioblastoma
TTDR01356;WP2263;Prostate Cancer
TTDR01356;WP2290;RalA downstream regulated genes
TTDR01356;WP231;TNF alpha Signaling Pathway
TTDR01356;WP2332;Interleukin-11 Signaling Pathway
TTDR01356;WP2374;Oncostatin M Signaling Pathway
TTDR01356;WP2380;BDNF signaling pathway
TTDR01356;WP23;B Cell Receptor Signaling Pathway
TTDR01356;WP244;Alpha 6 Beta 4 signaling pathway
TTDR01356;WP2526;PDGF Pathway
TTDR01356;WP2586;Aryl Hydrocarbon Receptor
TTDR01356;WP2593;JAK/STAT
TTDR01356;WP2643;Nanoparticle-mediated activation of receptor signaling
TTDR01356;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDR01356;WP2677;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
TTDR01356;WP2694;DAP12 interactions
TTDR01356;WP2713;Signaling by SCF-KIT
TTDR01356;WP2732;Interleukin-2 signaling
TTDR01356;WP2735;RAF/MAP kinase cascade
TTDR01356;WP2746;Signaling by the B Cell Receptor (BCR)
TTDR01356;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDR01356;WP2759;Fc epsilon receptor (FCERI) signaling
TTDR01356;WP2780;Signaling by ERBB2
TTDR01356;WP2781;Signaling by ERBB4
TTDR01356;WP2828;Bladder Cancer
TTDR01356;WP286;IL-3 Signaling Pathway
TTDR01356;WP2870;Extracellular vesicle-mediated signaling in recipient cells
TTDR01356;WP304;Kit receptor signaling pathway
TTDR01356;WP306;Focal Adhesion
TTDR01356;WP313;Signaling of Hepatocyte Growth Factor Receptor
TTDR01356;WP35;G Protein Signaling Pathways
TTDR01356;WP400;p38 MAPK Signaling Pathway
TTDR01356;WP422;MAPK Cascade
TTDR01356;WP437;EGF/EGFR Signaling Pathway
TTDR01356;WP481;Insulin Signaling
TTDR01356;WP49;IL-2 Signaling Pathway
TTDR01356;WP560;TGF Beta Signaling Pathway
TTDR01356;WP615;Senescence and Autophagy in Cancer
TTDR01356;WP673;ErbB Signaling Pathway
TTDR01356;WP69;TCR Signaling Pathway
TTDR01356;WP710;DNA Damage Response (only ATM dependent)
TTDR01356;WP732;Serotonin Receptor 2 and ELK-SRF/GATA4 signaling
TTDR01357;WP1533;Vitamin B12 Metabolism
TTDR01357;WP15;Selenium Micronutrient Network
TTDR01357;WP176;Folate Metabolism
TTDR01357;WP1780;ABC-family proteins mediated transport
TTDR01357;WP2764;Lipid digestion, mobilization, and transport
TTDR01357;WP2776;Visual phototransduction
TTDR01357;WP2784;Binding and Uptake of Ligands by Scavenger Receptors
TTDR01357;WP2797;Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
TTDR01357;WP2806;Human Complement System
TTDR01357;WP2878;PPAR Alpha Pathway
TTDR01357;WP2882;Nuclear Receptors Meta-Pathway
TTDR01357;WP430;Statin Pathway
TTDR01358;WP1533;Vitamin B12 Metabolism
TTDR01358;WP15;Selenium Micronutrient Network
TTDR01358;WP176;Folate Metabolism
TTDR01358;WP1798;Complement cascade
TTDR01358;WP2806;Human Complement System
TTDR01358;WP364;IL-6 signaling pathway
TTDR01360;WP1533;Vitamin B12 Metabolism
TTDR01360;WP15;Selenium Micronutrient Network
TTDR01360;WP176;Folate Metabolism
TTDR01360;WP1794;Cell surface interactions at the vascular wall
TTDR01360;WP1885;Platelet homeostasis
TTDR01360;WP2764;Lipid digestion, mobilization, and transport
TTDR01360;WP2776;Visual phototransduction
TTDR01360;WP2784;Binding and Uptake of Ligands by Scavenger Receptors
TTDR01360;WP430;Statin Pathway
TTDR01361;WP1907;Semaphorin interactions
TTDR01361;WP2005;miR-targeted genes in muscle cell - TarBase
TTDR01361;WP2034;Leptin signaling pathway
TTDR01361;WP2261;Signaling Pathways in Glioblastoma
TTDR01361;WP2377;Integrated Pancreatic Cancer Pathway
TTDR01361;WP2780;Signaling by ERBB2
TTDR01361;WP2828;Bladder Cancer
TTDR01361;WP2870;Extracellular vesicle-mediated signaling in recipient cells
TTDR01361;WP306;Focal Adhesion
TTDR01361;WP437;EGF/EGFR Signaling Pathway
TTDR01361;WP673;ErbB Signaling Pathway
TTDR01361;WP710;DNA Damage Response (only ATM dependent)
TTDR01362;WP12;Osteoclast Signaling
TTDR01362;WP1434;Osteopontin Signaling
TTDR01362;WP1455;Serotonin Transporter Activity
TTDR01362;WP1794;Cell surface interactions at the vascular wall
TTDR01362;WP1832;Integrin alphaIIb beta3 signaling
TTDR01362;WP1833;Integrin cell surface interactions
TTDR01362;WP1843;L1CAM interactions
TTDR01362;WP185;Integrin-mediated Cell Adhesion
TTDR01362;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDR01362;WP2572;Primary Focal Segmental Glomerulosclerosis FSGS
TTDR01362;WP2666;Elastic fibre formation
TTDR01362;WP2703;Extracellular matrix organization
TTDR01362;WP2787;Syndecan interactions
TTDR01362;WP2806;Human Complement System
TTDR01362;WP2849;Hematopoietic Stem Cell Differentiation
TTDR01362;WP306;Focal Adhesion
TTDR01362;WP322;Osteoblast Signaling
TTDR01362;WP366;TGF beta Signaling Pathway
TTDR01362;WP727;Monoamine Transport
TTDR01363;WP127;IL-5 Signaling Pathway
TTDR01363;WP138;Androgen receptor signaling pathway
TTDR01363;WP1449;Regulation of toll-like receptor signaling pathway
TTDR01363;WP1528;Physiological and Pathological Hypertrophy of the Heart
TTDR01363;WP1772;Apoptosis Modulation and Signaling
TTDR01363;WP1845;MAPK targets/ Nuclear events mediated by MAP kinases
TTDR01363;WP195;IL-1 signaling pathway
TTDR01363;WP1984;Integrated Breast Cancer Pathway
TTDR01363;WP2018;RANKL/RANK Signaling Pathway
TTDR01363;WP2032;TSH signaling pathway
TTDR01363;WP2036;TWEAK Signaling Pathway
TTDR01363;WP2100;Arylhydrocarbon receptor (AhR) signaling pathway
TTDR01363;WP2263;Prostate Cancer
TTDR01363;WP231;TNF alpha Signaling Pathway
TTDR01363;WP2324;AGE/RAGE pathway
TTDR01363;WP2377;Integrated Pancreatic Cancer Pathway
TTDR01363;WP2380;BDNF signaling pathway
TTDR01363;WP23;B Cell Receptor Signaling Pathway
TTDR01363;WP2435;Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis
TTDR01363;WP2516;ATM Signaling Pathway
TTDR01363;WP2526;PDGF Pathway
TTDR01363;WP254;Apoptosis
TTDR01363;WP2571;Polycystic Kidney Disease Pathway
TTDR01363;WP2759;Fc epsilon receptor (FCERI) signaling
TTDR01363;WP2786;Pre-NOTCH Expression and Processing
TTDR01363;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDR01363;WP286;IL-3 Signaling Pathway
TTDR01363;WP2873;Aryl Hydrocarbon Receptor Pathway
TTDR01363;WP2881;Estrogen Receptor Pathway
TTDR01363;WP2882;Nuclear Receptors Meta-Pathway
TTDR01363;WP289;Myometrial Relaxation and Contraction Pathways
TTDR01363;WP28;Selenium Metabolism and Selenoproteins
TTDR01363;WP306;Focal Adhesion
TTDR01363;WP313;Signaling of Hepatocyte Growth Factor Receptor
TTDR01363;WP314;FAS pathway and Stress induction of HSP regulation
TTDR01363;WP3286;Copper homeostasis
TTDR01363;WP366;TGF beta Signaling Pathway
TTDR01363;WP382;MAPK Signaling Pathway
TTDR01363;WP399;Wnt Signaling Pathway and Pluripotency
TTDR01363;WP422;MAPK Cascade
TTDR01363;WP428;Wnt Signaling Pathway
TTDR01363;WP437;EGF/EGFR Signaling Pathway
TTDR01363;WP481;Insulin Signaling
TTDR01363;WP49;IL-2 Signaling Pathway
TTDR01363;WP560;TGF Beta Signaling Pathway
TTDR01363;WP615;Senescence and Autophagy in Cancer
TTDR01363;WP673;ErbB Signaling Pathway
TTDR01363;WP69;TCR Signaling Pathway
TTDR01363;WP706;SIDS Susceptibility Pathways
TTDR01363;WP710;DNA Damage Response (only ATM dependent)
TTDR01363;WP712;Estrogen signaling pathway
TTDR01363;WP75;Toll-like receptor signaling pathway
TTDR01368;WP1889;Processing of Capped Intron-Containing Pre-mRNA
TTDR01368;WP2683;Influenza Life Cycle
TTDR01368;WP411;mRNA Processing
TTDR01369;WP15;Selenium Micronutrient Network
TTDR01369;WP167;Eicosanoid Synthesis
TTDR01369;WP2650;Arachidonic acid metabolism
TTDR01369;WP2877;Vitamin D Receptor Pathway
TTDR01370;WP185;Integrin-mediated Cell Adhesion
TTDR01370;WP1984;Integrated Breast Cancer Pathway
TTDR01370;WP2261;Signaling Pathways in Glioblastoma
TTDR01370;WP306;Focal Adhesion
TTDR01370;WP422;MAPK Cascade
TTDR01370;WP673;ErbB Signaling Pathway
TTDR01371;WP1794;Cell surface interactions at the vascular wall
TTDR01371;WP1829;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
TTDR01371;WP1833;Integrin cell surface interactions
TTDR01371;WP185;Integrin-mediated Cell Adhesion
TTDR01371;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDR01371;WP306;Focal Adhesion
TTDR01372;WP236;Adipogenesis
TTDR01372;WP2431;Spinal Cord Injury
TTDR01373;WP185;Integrin-mediated Cell Adhesion
TTDR01373;WP1873;NGF signalling via TRKA from the plasma membrane
TTDR01373;WP1911;Signaling by FGFR
TTDR01373;WP1984;Integrated Breast Cancer Pathway
TTDR01373;WP2032;TSH signaling pathway
TTDR01373;WP2261;Signaling Pathways in Glioblastoma
TTDR01373;WP2355;Corticotropin-releasing hormone
TTDR01373;WP23;B Cell Receptor Signaling Pathway
TTDR01373;WP2571;Polycystic Kidney Disease Pathway
TTDR01373;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDR01373;WP2828;Bladder Cancer
TTDR01373;WP306;Focal Adhesion
TTDR01373;WP382;MAPK Signaling Pathway
TTDR01373;WP422;MAPK Cascade
TTDR01373;WP437;EGF/EGFR Signaling Pathway
TTDR01373;WP51;Regulation of Actin Cytoskeleton
TTDR01373;WP615;Senescence and Autophagy in Cancer
TTDR01373;WP712;Estrogen signaling pathway
TTDR01373;WP722;Serotonin HTR1 Group and FOS Pathway
TTDR01373;WP734;Serotonin Receptor 4/6/7 and NR3C Signaling
TTDR01374;WP1794;Cell surface interactions at the vascular wall
TTDR01374;WP231;TNF alpha Signaling Pathway
TTDR01374;WP2806;Human Complement System
TTDR01375;WP1602;Nicotine Activity on Dopaminergic Neurons
TTDR01375;WP1815;Factors involved in megakaryocyte development and platelet production
TTDR01375;WP1831;Integration of energy metabolism
TTDR01375;WP1859;Mitotic G2-G2/M phases
TTDR01375;WP1978;Opioid Signalling
TTDR01375;WP1982;SREBP signalling
TTDR01375;WP2012;miRs in Muscle Cell Differentiation
TTDR01375;WP2035;FSH signaling pathway
TTDR01375;WP2038;Regulation of Microtubule Cytoskeleton
TTDR01375;WP2436;Dopamine metabolism
TTDR01375;WP2662;Regulation of Water Balance by Renal Aquaporins
TTDR01375;WP2688;DAG and IP3 signaling
TTDR01375;WP2806;Human Complement System
TTDR01375;WP2857;Mesodermal Commitment Pathway
TTDR01375;WP286;IL-3 Signaling Pathway
TTDR01375;WP289;Myometrial Relaxation and Contraction Pathways
TTDR01375;WP35;G Protein Signaling Pathways
TTDR01375;WP382;MAPK Signaling Pathway
TTDR01375;WP474;Endochondral Ossification
TTDR01375;WP536;Calcium Regulation in the Cardiac Cell
TTDR01375;WP666;Hypothetical Network for Drug Addiction
TTDR01375;WP706;SIDS Susceptibility Pathways
TTDR01375;WP712;Estrogen signaling pathway
TTDR01376;WP1589;Folate-Alcohol and Cancer Pathway
TTDR01376;WP2001;miR-targeted genes in adipocytes - TarBase
TTDR01376;WP2002;miR-targeted genes in epithelium - TarBase
TTDR01376;WP2003;miR-targeted genes in leukocytes - TarBase
TTDR01376;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDR01376;WP2005;miR-targeted genes in muscle cell - TarBase
TTDR01376;WP2112;IL17 signaling pathway
TTDR01376;WP236;Adipogenesis
TTDR01376;WP2374;Oncostatin M Signaling Pathway
TTDR01376;WP2751;Transcriptional Regulation of White Adipocyte Differentiation
TTDR01376;WP2895;Differentiation of white and brown adipocyte
TTDR01376;WP34;Ovarian Infertility Genes
TTDR01376;WP395;IL-4 Signaling Pathway
TTDR01376;WP3;Transcriptional activation by NRF2
TTDR01376;WP410;Diurnally Regulated Genes with Circadian Orthologs
TTDR01376;WP615;Senescence and Autophagy in Cancer
TTDR01376;WP706;SIDS Susceptibility Pathways
TTDR01377;WP1829;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
TTDR01377;WP1833;Integrin cell surface interactions
TTDR01377;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDR01377;WP2006;miR-targeted genes in squamous cell - TarBase
TTDR01377;WP2018;RANKL/RANK Signaling Pathway
TTDR01378;WP2002;miR-targeted genes in epithelium - TarBase
TTDR01378;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDR01378;WP2005;miR-targeted genes in muscle cell - TarBase
TTDR01378;WP2006;miR-targeted genes in squamous cell - TarBase
TTDR01378;WP2272;Pathogenic Escherichia coli infection
TTDR01379;WP1809;Effects of PIP2 hydrolysis
TTDR01379;WP1824;GPCR downstream signaling
TTDR01379;WP2012;miRs in Muscle Cell Differentiation
TTDR01379;WP2261;Signaling Pathways in Glioblastoma
TTDR01379;WP2374;Oncostatin M Signaling Pathway
TTDR01379;WP289;Myometrial Relaxation and Contraction Pathways
TTDR01379;WP35;G Protein Signaling Pathways
TTDR01379;WP382;MAPK Signaling Pathway
TTDR01379;WP399;Wnt Signaling Pathway and Pluripotency
TTDR01379;WP428;Wnt Signaling Pathway
TTDR01379;WP481;Insulin Signaling
TTDR01379;WP536;Calcium Regulation in the Cardiac Cell
TTDR01380;WP1530;miRNA Regulation of DNA Damage Response
TTDR01380;WP1772;Apoptosis Modulation and Signaling
TTDR01380;WP1814;Extrinsic Pathway for Apoptosis
TTDR01380;WP2059;Alzheimers Disease
TTDR01380;WP2328;Allograft Rejection
TTDR01380;WP236;Adipogenesis
TTDR01380;WP2377;Integrated Pancreatic Cancer Pathway
TTDR01380;WP254;Apoptosis
TTDR01380;WP314;FAS pathway and Stress induction of HSP regulation
TTDR01380;WP382;MAPK Signaling Pathway
TTDR01380;WP384;Apoptosis Modulation by HSP70
TTDR01380;WP69;TCR Signaling Pathway
TTDR01380;WP707;DNA Damage Response
TTDR01381;WP1449;Regulation of toll-like receptor signaling pathway
TTDR01381;WP2328;Allograft Rejection
TTDR01381;WP2806;Human Complement System
TTDR01381;WP2877;Vitamin D Receptor Pathway
TTDR01381;WP288;NLR Proteins
TTDR01381;WP453;Inflammatory Response Pathway
TTDR01381;WP75;Toll-like receptor signaling pathway
TTDR01383;WP1824;GPCR downstream signaling
TTDR01383;WP1908;Signal amplification
TTDR01383;WP1929;Thrombin signalling through proteinase activated receptors (PARs)
TTDR01383;WP2355;Corticotropin-releasing hormone
TTDR01383;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDR01383;WP35;G Protein Signaling Pathways
TTDR01383;WP536;Calcium Regulation in the Cardiac Cell
TTDR01384;WP1449;Regulation of toll-like receptor signaling pathway
TTDR01384;WP1799;Costimulation by the CD28 family
TTDR01384;WP2328;Allograft Rejection
TTDR01384;WP2572;Primary Focal Segmental Glomerulosclerosis FSGS
TTDR01384;WP2653;PIP3 activates AKT signaling
TTDR01384;WP453;Inflammatory Response Pathway
TTDR01384;WP75;Toll-like receptor signaling pathway
TTDR01385;WP127;IL-5 Signaling Pathway
TTDR01385;WP1449;Regulation of toll-like receptor signaling pathway
TTDR01385;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDR01385;WP1843;L1CAM interactions
TTDR01385;WP185;Integrin-mediated Cell Adhesion
TTDR01385;WP1911;Signaling by FGFR
TTDR01385;WP195;IL-1 signaling pathway
TTDR01385;WP2034;Leptin signaling pathway
TTDR01385;WP205;IL-7 Signaling Pathway
TTDR01385;WP2203;TSLP Signaling Pathway
TTDR01385;WP2261;Signaling Pathways in Glioblastoma
TTDR01385;WP2263;Prostate Cancer
TTDR01385;WP22;IL-9 Signaling Pathway
TTDR01385;WP2332;Interleukin-11 Signaling Pathway
TTDR01385;WP2374;Oncostatin M Signaling Pathway
TTDR01385;WP2380;BDNF signaling pathway
TTDR01385;WP23;B Cell Receptor Signaling Pathway
TTDR01385;WP2447;Amyotrophic lateral sclerosis (ALS)
TTDR01385;WP2636;Genes and (Common) Pathways Underlying Drug Addiction
TTDR01385;WP2637;Structural Pathway of Interleukin 1 (IL-1)
TTDR01385;WP2643;Nanoparticle-mediated activation of receptor signaling
TTDR01385;WP2735;RAF/MAP kinase cascade
TTDR01385;WP2792;MAP kinase activation in TLR cascade
TTDR01385;WP2795;Cardiac Hypertrophic Response
TTDR01385;WP2828;Bladder Cancer
TTDR01385;WP304;Kit receptor signaling pathway
TTDR01385;WP306;Focal Adhesion
TTDR01385;WP313;Signaling of Hepatocyte Growth Factor Receptor
TTDR01385;WP364;IL-6 signaling pathway
TTDR01385;WP366;TGF beta Signaling Pathway
TTDR01385;WP382;MAPK Signaling Pathway
TTDR01385;WP422;MAPK Cascade
TTDR01385;WP437;EGF/EGFR Signaling Pathway
TTDR01385;WP481;Insulin Signaling
TTDR01385;WP49;IL-2 Signaling Pathway
TTDR01385;WP51;Regulation of Actin Cytoskeleton
TTDR01385;WP581;EPO Receptor Signaling
TTDR01385;WP666;Hypothetical Network for Drug Addiction
TTDR01385;WP69;TCR Signaling Pathway
TTDR01385;WP722;Serotonin HTR1 Group and FOS Pathway
TTDR01385;WP732;Serotonin Receptor 2 and ELK-SRF/GATA4 signaling
TTDR01385;WP734;Serotonin Receptor 4/6/7 and NR3C Signaling
TTDR01385;WP75;Toll-like receptor signaling pathway
TTDR01386;WP170;Nuclear Receptors
TTDR01386;WP1982;SREBP signalling
TTDR01386;WP236;Adipogenesis
TTDR01386;WP2751;Transcriptional Regulation of White Adipocyte Differentiation
TTDR01386;WP2797;Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
TTDR01386;WP2895;Differentiation of white and brown adipocyte
TTDR01386;WP299;Nuclear Receptors in Lipid Metabolism and Toxicity
TTDR01386;WP363;Wnt Signaling Pathway Netpath
TTDR01387;WP127;IL-5 Signaling Pathway
TTDR01387;WP138;Androgen receptor signaling pathway
TTDR01387;WP1528;Physiological and Pathological Hypertrophy of the Heart
TTDR01387;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDR01387;WP1559;TFs Regulate miRNAs related to cardiac hypertrophy
TTDR01387;WP1873;NGF signalling via TRKA from the plasma membrane
TTDR01387;WP1916;Signaling by PDGF
TTDR01387;WP2023;Cell Differentiation - meta
TTDR01387;WP2029;Cell Differentiation - Index
TTDR01387;WP2032;TSH signaling pathway
TTDR01387;WP2034;Leptin signaling pathway
TTDR01387;WP2038;Regulation of Microtubule Cytoskeleton
TTDR01387;WP205;IL-7 Signaling Pathway
TTDR01387;WP2112;IL17 signaling pathway
TTDR01387;WP2203;TSLP Signaling Pathway
TTDR01387;WP2263;Prostate Cancer
TTDR01387;WP22;IL-9 Signaling Pathway
TTDR01387;WP2324;AGE/RAGE pathway
TTDR01387;WP2332;Interleukin-11 Signaling Pathway
TTDR01387;WP236;Adipogenesis
TTDR01387;WP2374;Oncostatin M Signaling Pathway
TTDR01387;WP2380;BDNF signaling pathway
TTDR01387;WP2526;PDGF Pathway
TTDR01387;WP2593;JAK/STAT
TTDR01387;WP2657;Growth hormone receptor signaling
TTDR01387;WP2704;Interleukin-6 signaling
TTDR01387;WP2713;Signaling by SCF-KIT
TTDR01387;WP2815;Mammary gland development pathway - Involution (Stage 4 of 4)
TTDR01387;WP2821;Transcriptional regulation of pluripotent stem cells
TTDR01387;WP2855;Dopaminergic Neurogenesis
TTDR01387;WP2868;TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer
TTDR01387;WP286;IL-3 Signaling Pathway
TTDR01387;WP2881;Estrogen Receptor Pathway
TTDR01387;WP2882;Nuclear Receptors Meta-Pathway
TTDR01387;WP304;Kit receptor signaling pathway
TTDR01387;WP313;Signaling of Hepatocyte Growth Factor Receptor
TTDR01387;WP364;IL-6 signaling pathway
TTDR01387;WP395;IL-4 Signaling Pathway
TTDR01387;WP437;EGF/EGFR Signaling Pathway
TTDR01387;WP49;IL-2 Signaling Pathway
TTDR01387;WP560;TGF Beta Signaling Pathway
TTDR01387;WP581;EPO Receptor Signaling
TTDR01387;WP585;Interferon type I signaling pathways
TTDR01387;WP61;Notch Signaling Pathway
TTDR01387;WP733;Serotonin Receptor 2 and STAT3 Signaling
TTDR01388;WP1449;Regulation of toll-like receptor signaling pathway
TTDR01388;WP1799;Costimulation by the CD28 family
TTDR01388;WP1839;Interleukin-1 signaling
TTDR01388;WP2002;miR-targeted genes in epithelium - TarBase
TTDR01388;WP2003;miR-targeted genes in leukocytes - TarBase
TTDR01388;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDR01388;WP2006;miR-targeted genes in squamous cell - TarBase
TTDR01388;WP231;TNF alpha Signaling Pathway
TTDR01388;WP2637;Structural Pathway of Interleukin 1 (IL-1)
TTDR01388;WP382;MAPK Signaling Pathway
TTDR01388;WP481;Insulin Signaling
TTDR01388;WP69;TCR Signaling Pathway
TTDR01388;WP75;Toll-like receptor signaling pathway
TTDR01389;WP1449;Regulation of toll-like receptor signaling pathway
TTDR01389;WP1799;Costimulation by the CD28 family
TTDR01389;WP2328;Allograft Rejection
TTDR01389;WP2653;PIP3 activates AKT signaling
TTDR01389;WP286;IL-3 Signaling Pathway
TTDR01389;WP453;Inflammatory Response Pathway
TTDR01389;WP75;Toll-like receptor signaling pathway
TTDR01390;WP1403;AMPK Signaling
TTDR01390;WP1449;Regulation of toll-like receptor signaling pathway
TTDR01390;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDR01390;WP1794;Cell surface interactions at the vascular wall
TTDR01390;WP1826;GPVI-mediated activation cascade
TTDR01390;WP1840;Interleukin-3, 5 and GM-CSF signaling
TTDR01390;WP1867;Nephrin interactions
TTDR01390;WP1873;NGF signalling via TRKA from the plasma membrane
TTDR01390;WP1913;Signaling by Insulin receptor
TTDR01390;WP1916;Signaling by PDGF
TTDR01390;WP1927;TCR signaling
TTDR01390;WP2261;Signaling Pathways in Glioblastoma
TTDR01390;WP2653;PIP3 activates AKT signaling
TTDR01390;WP2677;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
TTDR01390;WP2694;DAP12 interactions
TTDR01390;WP2719;Fcgamma receptor (FCGR) dependent phagocytosis
TTDR01390;WP2732;Interleukin-2 signaling
TTDR01390;WP2747;PI Metabolism
TTDR01390;WP2759;Fc epsilon receptor (FCERI) signaling
TTDR01390;WP306;Focal Adhesion
TTDR01390;WP481;Insulin Signaling
TTDR01390;WP51;Regulation of Actin Cytoskeleton
TTDR01390;WP524;G13 Signaling Pathway
TTDR01390;WP710;DNA Damage Response (only ATM dependent)
TTDR01390;WP75;Toll-like receptor signaling pathway
TTDR01391;WP1449;Regulation of toll-like receptor signaling pathway
TTDR01391;WP195;IL-1 signaling pathway
TTDR01391;WP2018;RANKL/RANK Signaling Pathway
TTDR01391;WP2036;TWEAK Signaling Pathway
TTDR01391;WP2203;TSLP Signaling Pathway
TTDR01391;WP231;TNF alpha Signaling Pathway
TTDR01391;WP2324;AGE/RAGE pathway
TTDR01391;WP2355;Corticotropin-releasing hormone
TTDR01391;WP2374;Oncostatin M Signaling Pathway
TTDR01391;WP2377;Integrated Pancreatic Cancer Pathway
TTDR01391;WP2380;BDNF signaling pathway
TTDR01391;WP23;B Cell Receptor Signaling Pathway
TTDR01391;WP2516;ATM Signaling Pathway
TTDR01391;WP2593;JAK/STAT
TTDR01391;WP2637;Structural Pathway of Interleukin 1 (IL-1)
TTDR01391;WP2643;Nanoparticle-mediated activation of receptor signaling
TTDR01391;WP306;Focal Adhesion
TTDR01391;WP363;Wnt Signaling Pathway Netpath
TTDR01391;WP366;TGF beta Signaling Pathway
TTDR01391;WP382;MAPK Signaling Pathway
TTDR01391;WP399;Wnt Signaling Pathway and Pluripotency
TTDR01391;WP428;Wnt Signaling Pathway
TTDR01391;WP437;EGF/EGFR Signaling Pathway
TTDR01391;WP481;Insulin Signaling
TTDR01391;WP560;TGF Beta Signaling Pathway
TTDR01391;WP69;TCR Signaling Pathway
TTDR01391;WP710;DNA Damage Response (only ATM dependent)
TTDR01391;WP712;Estrogen signaling pathway
TTDR01391;WP75;Toll-like receptor signaling pathway
TTDR01393;WP1772;Apoptosis Modulation and Signaling
TTDR01393;WP1814;Extrinsic Pathway for Apoptosis
TTDR01393;WP2328;Allograft Rejection
TTDR01393;WP2377;Integrated Pancreatic Cancer Pathway
TTDR01393;WP254;Apoptosis
TTDR01393;WP314;FAS pathway and Stress induction of HSP regulation
TTDR01393;WP382;MAPK Signaling Pathway
TTDR01393;WP384;Apoptosis Modulation by HSP70
TTDR01393;WP710;DNA Damage Response (only ATM dependent)
TTDR01394;WP127;IL-5 Signaling Pathway
TTDR01394;WP1982;SREBP signalling
TTDR01394;WP1984;Integrated Breast Cancer Pathway
TTDR01394;WP2034;Leptin signaling pathway
TTDR01394;WP2377;Integrated Pancreatic Cancer Pathway
TTDR01394;WP23;B Cell Receptor Signaling Pathway
TTDR01394;WP2583;T-Cell Receptor and Co-stimulatory Signaling
TTDR01394;WP2667;Activation of Chaperone Genes by XBP1(S)
TTDR01394;WP363;Wnt Signaling Pathway Netpath
TTDR01394;WP481;Insulin Signaling
TTDR01394;WP500;Glycogen Metabolism
TTDR01395;WP1842;Kinesins
TTDR01395;WP2679;MHC class II antigen presentation
TTDR01396;WP1772;Apoptosis Modulation and Signaling
TTDR01396;WP1784;Apoptotic execution phase
TTDR01396;WP2371;Parkinsons Disease Pathway
TTDR01396;WP254;Apoptosis
TTDR01396;WP314;FAS pathway and Stress induction of HSP regulation
TTDR01396;WP382;MAPK Signaling Pathway
TTDR01396;WP384;Apoptosis Modulation by HSP70
TTDR01397;WP138;Androgen receptor signaling pathway
TTDR01397;WP1927;TCR signaling
TTDR01397;WP1971;Integrated Cancer pathway
TTDR01397;WP1984;Integrated Breast Cancer Pathway
TTDR01397;WP2034;Leptin signaling pathway
TTDR01397;WP2038;Regulation of Microtubule Cytoskeleton
TTDR01397;WP2261;Signaling Pathways in Glioblastoma
TTDR01397;WP2263;Prostate Cancer
TTDR01397;WP2377;Integrated Pancreatic Cancer Pathway
TTDR01397;WP2583;T-Cell Receptor and Co-stimulatory Signaling
TTDR01397;WP2653;PIP3 activates AKT signaling
TTDR01397;WP2741;Inositol phosphate metabolism
TTDR01397;WP2747;PI Metabolism
TTDR01397;WP306;Focal Adhesion
TTDR01397;WP313;Signaling of Hepatocyte Growth Factor Receptor
TTDR01397;WP3286;Copper homeostasis
TTDR01397;WP437;EGF/EGFR Signaling Pathway
TTDR01397;WP481;Insulin Signaling
TTDR01397;WP615;Senescence and Autophagy in Cancer
TTDR01397;WP710;DNA Damage Response (only ATM dependent)
TTDR01398;WP138;Androgen receptor signaling pathway
TTDR01398;WP1528;Physiological and Pathological Hypertrophy of the Heart
TTDR01398;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDR01398;WP1824;GPCR downstream signaling
TTDR01398;WP1826;GPVI-mediated activation cascade
TTDR01398;WP1873;NGF signalling via TRKA from the plasma membrane
TTDR01398;WP1907;Semaphorin interactions
TTDR01398;WP1917;Signaling by Rho GTPases
TTDR01398;WP1976;Signalling by NGF
TTDR01398;WP2034;Leptin signaling pathway
TTDR01398;WP2272;Pathogenic Escherichia coli infection
TTDR01398;WP2324;AGE/RAGE pathway
TTDR01398;WP2355;Corticotropin-releasing hormone
TTDR01398;WP2431;Spinal Cord Injury
TTDR01398;WP244;Alpha 6 Beta 4 signaling pathway
TTDR01398;WP2593;JAK/STAT
TTDR01398;WP2742;Signaling by TGF-beta Receptor Complex
TTDR01398;WP306;Focal Adhesion
TTDR01398;WP35;G Protein Signaling Pathways
TTDR01398;WP363;Wnt Signaling Pathway Netpath
TTDR01398;WP366;TGF beta Signaling Pathway
TTDR01398;WP399;Wnt Signaling Pathway and Pluripotency
TTDR01398;WP428;Wnt Signaling Pathway
TTDR01398;WP51;Regulation of Actin Cytoskeleton
TTDR01398;WP524;G13 Signaling Pathway
TTDR01398;WP710;DNA Damage Response (only ATM dependent)
TTDR01398;WP722;Serotonin HTR1 Group and FOS Pathway
TTDR01399;WP138;Androgen receptor signaling pathway
TTDR01399;WP1530;miRNA Regulation of DNA Damage Response
TTDR01399;WP1742;TP53 Network
TTDR01399;WP1775;Cell Cycle Checkpoints
TTDR01399;WP179;Cell Cycle
TTDR01399;WP1971;Integrated Cancer pathway
TTDR01399;WP1984;Integrated Breast Cancer Pathway
TTDR01399;WP2261;Signaling Pathways in Glioblastoma
TTDR01399;WP2263;Prostate Cancer
TTDR01399;WP2377;Integrated Pancreatic Cancer Pathway
TTDR01399;WP2446;Retinoblastoma (RB) in Cancer
TTDR01399;WP2516;ATM Signaling Pathway
TTDR01399;WP254;Apoptosis
TTDR01399;WP2653;PIP3 activates AKT signaling
TTDR01399;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDR01399;WP2828;Bladder Cancer
TTDR01399;WP3286;Copper homeostasis
TTDR01399;WP45;G1 to S cell cycle control
TTDR01399;WP465;Tryptophan metabolism
TTDR01399;WP615;Senescence and Autophagy in Cancer
TTDR01399;WP673;ErbB Signaling Pathway
TTDR01399;WP707;DNA Damage Response
TTDR01399;WP710;DNA Damage Response (only ATM dependent)
TTDR01400;WP1530;miRNA Regulation of DNA Damage Response
TTDR01400;WP1545;miRNAs involved in DNA damage response
TTDR01400;WP179;Cell Cycle
TTDR01400;WP1841;Intrinsic Pathway for Apoptosis
TTDR01400;WP1858;Mitotic G1-G1/S phases
TTDR01400;WP1859;Mitotic G2-G2/M phases
TTDR01400;WP1971;Integrated Cancer pathway
TTDR01400;WP1984;Integrated Breast Cancer Pathway
TTDR01400;WP2002;miR-targeted genes in epithelium - TarBase
TTDR01400;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDR01400;WP2005;miR-targeted genes in muscle cell - TarBase
TTDR01400;WP2032;TSH signaling pathway
TTDR01400;WP2261;Signaling Pathways in Glioblastoma
TTDR01400;WP2263;Prostate Cancer
TTDR01400;WP236;Adipogenesis
TTDR01400;WP2377;Integrated Pancreatic Cancer Pathway
TTDR01400;WP2431;Spinal Cord Injury
TTDR01400;WP2446;Retinoblastoma (RB) in Cancer
TTDR01400;WP2586;Aryl Hydrocarbon Receptor
TTDR01400;WP2786;Pre-NOTCH Expression and Processing
TTDR01400;WP2815;Mammary gland development pathway - Involution (Stage 4 of 4)
TTDR01400;WP2828;Bladder Cancer
TTDR01400;WP437;EGF/EGFR Signaling Pathway
TTDR01400;WP45;G1 to S cell cycle control
TTDR01400;WP615;Senescence and Autophagy in Cancer
TTDR01400;WP707;DNA Damage Response
TTDR01401;WP1528;Physiological and Pathological Hypertrophy of the Heart
TTDR01401;WP1809;Effects of PIP2 hydrolysis
TTDR01401;WP1824;GPCR downstream signaling
TTDR01401;WP2012;miRs in Muscle Cell Differentiation
TTDR01401;WP2374;Oncostatin M Signaling Pathway
TTDR01401;WP289;Myometrial Relaxation and Contraction Pathways
TTDR01401;WP35;G Protein Signaling Pathways
TTDR01401;WP399;Wnt Signaling Pathway and Pluripotency
TTDR01401;WP428;Wnt Signaling Pathway
TTDR01401;WP536;Calcium Regulation in the Cardiac Cell
TTDR01401;WP666;Hypothetical Network for Drug Addiction
TTDR01402;WP1784;Apoptotic execution phase
TTDR01402;WP1809;Effects of PIP2 hydrolysis
TTDR01402;WP1824;GPCR downstream signaling
TTDR01402;WP1868;Netrin-1 signaling
TTDR01402;WP1927;TCR signaling
TTDR01402;WP2012;miRs in Muscle Cell Differentiation
TTDR01402;WP2261;Signaling Pathways in Glioblastoma
TTDR01402;WP2355;Corticotropin-releasing hormone
TTDR01402;WP2759;Fc epsilon receptor (FCERI) signaling
TTDR01402;WP2877;Vitamin D Receptor Pathway
TTDR01402;WP289;Myometrial Relaxation and Contraction Pathways
TTDR01402;WP35;G Protein Signaling Pathways
TTDR01402;WP399;Wnt Signaling Pathway and Pluripotency
TTDR01402;WP428;Wnt Signaling Pathway
TTDR01402;WP481;Insulin Signaling
TTDR01402;WP536;Calcium Regulation in the Cardiac Cell
TTDR01402;WP69;TCR Signaling Pathway
TTDR01403;WP1584;Type II diabetes mellitus
TTDR01403;WP1826;GPVI-mediated activation cascade
TTDR01403;WP195;IL-1 signaling pathway
TTDR01403;WP2012;miRs in Muscle Cell Differentiation
TTDR01403;WP2261;Signaling Pathways in Glioblastoma
TTDR01403;WP231;TNF alpha Signaling Pathway
TTDR01403;WP2324;AGE/RAGE pathway
TTDR01403;WP2328;Allograft Rejection
TTDR01403;WP2742;Signaling by TGF-beta Receptor Complex
TTDR01403;WP289;Myometrial Relaxation and Contraction Pathways
TTDR01403;WP35;G Protein Signaling Pathways
TTDR01403;WP382;MAPK Signaling Pathway
TTDR01403;WP399;Wnt Signaling Pathway and Pluripotency
TTDR01403;WP428;Wnt Signaling Pathway
TTDR01403;WP437;EGF/EGFR Signaling Pathway
TTDR01403;WP481;Insulin Signaling
TTDR01403;WP536;Calcium Regulation in the Cardiac Cell
TTDR01404;WP1584;Type II diabetes mellitus
TTDR01404;WP1784;Apoptotic execution phase
TTDR01404;WP1809;Effects of PIP2 hydrolysis
TTDR01404;WP1824;GPCR downstream signaling
TTDR01404;WP1978;Opioid Signalling
TTDR01404;WP2012;miRs in Muscle Cell Differentiation
TTDR01404;WP2261;Signaling Pathways in Glioblastoma
TTDR01404;WP2324;AGE/RAGE pathway
TTDR01404;WP2355;Corticotropin-releasing hormone
TTDR01404;WP2374;Oncostatin M Signaling Pathway
TTDR01404;WP2380;BDNF signaling pathway
TTDR01404;WP23;B Cell Receptor Signaling Pathway
TTDR01404;WP244;Alpha 6 Beta 4 signaling pathway
TTDR01404;WP2688;DAG and IP3 signaling
TTDR01404;WP2733;Regulation of mRNA Stability by Proteins that Bind AU-rich Elements
TTDR01404;WP289;Myometrial Relaxation and Contraction Pathways
TTDR01404;WP35;G Protein Signaling Pathways
TTDR01404;WP364;IL-6 signaling pathway
TTDR01404;WP382;MAPK Signaling Pathway
TTDR01404;WP399;Wnt Signaling Pathway and Pluripotency
TTDR01404;WP428;Wnt Signaling Pathway
TTDR01404;WP437;EGF/EGFR Signaling Pathway
TTDR01404;WP481;Insulin Signaling
TTDR01404;WP536;Calcium Regulation in the Cardiac Cell
TTDR01404;WP619;Type II interferon signaling (IFNG)
TTDR01404;WP69;TCR Signaling Pathway
TTDR01405;WP1772;Apoptosis Modulation and Signaling
TTDR01405;WP1841;Intrinsic Pathway for Apoptosis
TTDR01405;WP2034;Leptin signaling pathway
TTDR01405;WP205;IL-7 Signaling Pathway
TTDR01405;WP231;TNF alpha Signaling Pathway
TTDR01405;WP2447;Amyotrophic lateral sclerosis (ALS)
TTDR01405;WP254;Apoptosis
TTDR01405;WP2763;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
TTDR01405;WP286;IL-3 Signaling Pathway
TTDR01405;WP364;IL-6 signaling pathway
TTDR01406;WP138;Androgen receptor signaling pathway
TTDR01406;WP1897;Regulation of beta-cell development
TTDR01406;WP1984;Integrated Breast Cancer Pathway
TTDR01406;WP2034;Leptin signaling pathway
TTDR01406;WP2035;FSH signaling pathway
TTDR01406;WP2261;Signaling Pathways in Glioblastoma
TTDR01406;WP2324;AGE/RAGE pathway
TTDR01406;WP236;Adipogenesis
TTDR01406;WP23;B Cell Receptor Signaling Pathway
TTDR01406;WP2853;Endoderm Differentiation
TTDR01406;WP2875;Constitutive Androstane Receptor Pathway
TTDR01406;WP2876;Pregnane X Receptor pathway
TTDR01406;WP2877;Vitamin D Receptor Pathway
TTDR01406;WP2882;Nuclear Receptors Meta-Pathway
TTDR01406;WP3286;Copper homeostasis
TTDR01406;WP437;EGF/EGFR Signaling Pathway
TTDR01406;WP481;Insulin Signaling
TTDR01406;WP673;ErbB Signaling Pathway
TTDR01407;WP1772;Apoptosis Modulation and Signaling
TTDR01407;WP2858;Ectoderm Differentiation
TTDR01409;WP1904;RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
TTDR01409;WP195;IL-1 signaling pathway
TTDR01409;WP231;TNF alpha Signaling Pathway
TTDR01409;WP2380;BDNF signaling pathway
TTDR01409;WP2526;PDGF Pathway
TTDR01409;WP254;Apoptosis
TTDR01409;WP2571;Polycystic Kidney Disease Pathway
TTDR01409;WP2637;Structural Pathway of Interleukin 1 (IL-1)
TTDR01409;WP2759;Fc epsilon receptor (FCERI) signaling
TTDR01409;WP2761;MyD88:Mal cascade initiated on plasma membrane
TTDR01409;WP2768;MyD88 dependent cascade initiated on endosome
TTDR01409;WP2795;Cardiac Hypertrophic Response
TTDR01409;WP2801;MyD88 cascade initiated on plasma membrane
TTDR01409;WP314;FAS pathway and Stress induction of HSP regulation
TTDR01409;WP382;MAPK Signaling Pathway
TTDR01409;WP384;Apoptosis Modulation by HSP70
TTDR01409;WP400;p38 MAPK Signaling Pathway
TTDR01409;WP422;MAPK Cascade
TTDR01409;WP437;EGF/EGFR Signaling Pathway
TTDR01409;WP481;Insulin Signaling
TTDR01409;WP585;Interferon type I signaling pathways
TTDR01409;WP710;DNA Damage Response (only ATM dependent)
TTDR01409;WP722;Serotonin HTR1 Group and FOS Pathway
TTDR01410;WP1772;Apoptosis Modulation and Signaling
TTDR01410;WP2036;TWEAK Signaling Pathway
TTDR01410;WP231;TNF alpha Signaling Pathway
TTDR01410;WP254;Apoptosis
TTDR01410;WP2882;Nuclear Receptors Meta-Pathway
TTDR01410;WP306;Focal Adhesion
TTDR01411;WP107;Translation Factors
TTDR01412;WP138;Androgen receptor signaling pathway
TTDR01412;WP410;Diurnally Regulated Genes with Circadian Orthologs
TTDR01413;WP1433;NOD pathway
TTDR01413;WP1449;Regulation of toll-like receptor signaling pathway
TTDR01413;WP1530;miRNA Regulation of DNA Damage Response
TTDR01413;WP1772;Apoptosis Modulation and Signaling
TTDR01413;WP1784;Apoptotic execution phase
TTDR01413;WP1814;Extrinsic Pathway for Apoptosis
TTDR01413;WP1841;Intrinsic Pathway for Apoptosis
TTDR01413;WP1904;RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
TTDR01413;WP1971;Integrated Cancer pathway
TTDR01413;WP1984;Integrated Breast Cancer Pathway
TTDR01413;WP2036;TWEAK Signaling Pathway
TTDR01413;WP2059;Alzheimers Disease
TTDR01413;WP2263;Prostate Cancer
TTDR01413;WP231;TNF alpha Signaling Pathway
TTDR01413;WP2324;AGE/RAGE pathway
TTDR01413;WP2328;Allograft Rejection
TTDR01413;WP2359;Parkin-Ubiquitin Proteasomal System pathway
TTDR01413;WP2377;Integrated Pancreatic Cancer Pathway
TTDR01413;WP2513;Nanoparticle triggered regulated necrosis
TTDR01413;WP254;Apoptosis
TTDR01413;WP2752;MyD88-independent cascade
TTDR01413;WP314;FAS pathway and Stress induction of HSP regulation
TTDR01413;WP382;MAPK Signaling Pathway
TTDR01413;WP384;Apoptosis Modulation by HSP70
TTDR01413;WP707;DNA Damage Response
TTDR01413;WP75;Toll-like receptor signaling pathway
TTDR01414;WP3297;EV release from cardiac cells and their functional effects
TTDR01414;WP673;ErbB Signaling Pathway
TTDR01415;WP1425;BMP Signalling and Regulation
TTDR01415;WP1539;Angiogenesis
TTDR01415;WP1591;Heart Development
TTDR01415;WP1984;Integrated Breast Cancer Pathway
TTDR01415;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDR01415;WP2006;miR-targeted genes in squamous cell - TarBase
TTDR01415;WP2064;Neural Crest Differentiation
TTDR01415;WP2760;Signaling by BMP
TTDR01415;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDR01415;WP2857;Mesodermal Commitment Pathway
TTDR01415;WP2895;Differentiation of white and brown adipocyte
TTDR01415;WP560;TGF Beta Signaling Pathway
TTDR01416;WP1539;Angiogenesis
TTDR01416;WP1797;Circadian Clock
TTDR01416;WP2324;AGE/RAGE pathway
TTDR01416;WP236;Adipogenesis
TTDR01416;WP2374;Oncostatin M Signaling Pathway
TTDR01416;WP2720;Signaling by NOTCH1
TTDR01416;WP2727;Regulation of Hypoxia-inducible Factor (HIF) by Oxygen
TTDR01416;WP2877;Vitamin D Receptor Pathway
TTDR01416;WP61;Notch Signaling Pathway
TTDR01416;WP706;SIDS Susceptibility Pathways
TTDR01417;WP2853;Endoderm Differentiation
TTDR01417;WP382;MAPK Signaling Pathway
TTDR01418;WP481;Insulin Signaling
TTDR01420;WP1782;APC/C-mediated degradation of cell cycle proteins
TTDR01420;WP2002;miR-targeted genes in epithelium - TarBase
TTDR01420;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDR01420;WP2038;Regulation of Microtubule Cytoskeleton
TTDR01420;WP2652;Mitotic Prometaphase
TTDR01420;WP2757;Mitotic Metaphase and Anaphase
TTDR01422;WP1839;Interleukin-1 signaling
TTDR01422;WP195;IL-1 signaling pathway
TTDR01422;WP231;TNF alpha Signaling Pathway
TTDR01422;WP262;EBV LMP1 signaling
TTDR01422;WP2637;Structural Pathway of Interleukin 1 (IL-1)
TTDR01422;WP422;MAPK Cascade
TTDR01422;WP437;EGF/EGFR Signaling Pathway
TTDR01422;WP481;Insulin Signaling
TTDR01423;WP236;Adipogenesis
TTDR01423;WP2727;Regulation of Hypoxia-inducible Factor (HIF) by Oxygen
TTDR01423;WP2821;Transcriptional regulation of pluripotent stem cells
TTDR01425;WP2670;Iron uptake and transport
TTDR01425;WP2781;Signaling by ERBB4
TTDR01425;WP366;TGF beta Signaling Pathway
TTDR01426;WP1449;Regulation of toll-like receptor signaling pathway
TTDR01426;WP1839;Interleukin-1 signaling
TTDR01426;WP195;IL-1 signaling pathway
TTDR01426;WP2324;AGE/RAGE pathway
TTDR01426;WP2637;Structural Pathway of Interleukin 1 (IL-1)
TTDR01426;WP2761;MyD88:Mal cascade initiated on plasma membrane
TTDR01426;WP2768;MyD88 dependent cascade initiated on endosome
TTDR01426;WP2801;MyD88 cascade initiated on plasma membrane
TTDR01426;WP75;Toll-like receptor signaling pathway
TTDR01427;WP1901;Regulatory RNA pathways
TTDR01427;WP2338;miRNA Biogenesis
TTDR01427;WP2805;RNA interference
TTDR01427;WP2943;Hypoxia-mediated EMT and Stemness
TTDR01427;WP411;mRNA Processing
TTDR01430;WP268;Notch Signaling Pathway
TTDR01430;WP2718;Signaling by NOTCH2
TTDR01430;WP2720;Signaling by NOTCH1
TTDR01430;WP2721;Signaling by NOTCH4
TTDR01430;WP2722;Signaling by NOTCH3
TTDR01430;WP61;Notch Signaling Pathway
TTDR01431;WP1449;Regulation of toll-like receptor signaling pathway
TTDR01431;WP185;Integrin-mediated Cell Adhesion
TTDR01431;WP2261;Signaling Pathways in Glioblastoma
TTDR01431;WP2643;Nanoparticle-mediated activation of receptor signaling
TTDR01431;WP26;Signal Transduction of S1P Receptor
TTDR01431;WP306;Focal Adhesion
TTDR01431;WP382;MAPK Signaling Pathway
TTDR01431;WP673;ErbB Signaling Pathway
TTDR01431;WP710;DNA Damage Response (only ATM dependent)
TTDR01431;WP75;Toll-like receptor signaling pathway
TTDR01432;WP195;IL-1 signaling pathway
TTDR01432;WP2380;BDNF signaling pathway
TTDR01432;WP382;MAPK Signaling Pathway
TTDR01432;WP422;MAPK Cascade
TTDR01432;WP437;EGF/EGFR Signaling Pathway
TTDR01432;WP481;Insulin Signaling
TTDR01433;WP1832;Integrin alphaIIb beta3 signaling
TTDR01433;WP185;Integrin-mediated Cell Adhesion
TTDR01433;WP1864;Muscle contraction
TTDR01433;WP1907;Semaphorin interactions
TTDR01433;WP2572;Primary Focal Segmental Glomerulosclerosis FSGS
TTDR01433;WP2643;Nanoparticle-mediated activation of receptor signaling
TTDR01433;WP2667;Activation of Chaperone Genes by XBP1(S)
TTDR01433;WP306;Focal Adhesion
TTDR01434;WP12;Osteoclast Signaling
TTDR01434;WP2018;RANKL/RANK Signaling Pathway
TTDR01436;WP170;Nuclear Receptors
TTDR01436;WP1797;Circadian Clock
TTDR01436;WP236;Adipogenesis
TTDR01436;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDR01436;WP2853;Endoderm Differentiation
TTDR01436;WP2882;Nuclear Receptors Meta-Pathway
TTDR01436;WP706;SIDS Susceptibility Pathways
TTDR01436;WP734;Serotonin Receptor 4/6/7 and NR3C Signaling
TTDR01437;WP1832;Integrin alphaIIb beta3 signaling
TTDR01437;WP1835;Interferon alpha/beta signaling
TTDR01437;WP1836;Interferon gamma signaling
TTDR01437;WP2034;Leptin signaling pathway
TTDR01437;WP2657;Growth hormone receptor signaling
TTDR01437;WP481;Insulin Signaling
TTDR01438;WP1911;Signaling by FGFR
TTDR01438;WP2653;PIP3 activates AKT signaling
TTDR01438;WP2677;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
TTDR01438;WP51;Regulation of Actin Cytoskeleton
TTDR01439;WP2846;PCSK9-mediated LDLR degradation
TTDR01440;WP1824;GPCR downstream signaling
TTDR01440;WP1825;GPCR ligand binding
TTDS00002;WP1824;GPCR downstream signaling
TTDS00002;WP1825;GPCR ligand binding
TTDS00002;WP2597;Secretion of Hydrochloric Acid in Parietal Cells
TTDS00002;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDS00002;WP455;GPCRs, Class A Rhodopsin-like
TTDS00002;WP51;Regulation of Actin Cytoskeleton
TTDS00002;WP536;Calcium Regulation in the Cardiac Cell
TTDS00002;WP58;Monoamine GPCRs
TTDS00003;WP117;GPCRs, Other
TTDS00003;WP1824;GPCR downstream signaling
TTDS00003;WP1825;GPCR ligand binding
TTDS00003;WP455;GPCRs, Class A Rhodopsin-like
TTDS00003;WP51;Regulation of Actin Cytoskeleton
TTDS00003;WP536;Calcium Regulation in the Cardiac Cell
TTDS00003;WP58;Monoamine GPCRs
TTDS00003;WP706;SIDS Susceptibility Pathways
TTDS00004;WP117;GPCRs, Other
TTDS00004;WP1824;GPCR downstream signaling
TTDS00004;WP1825;GPCR ligand binding
TTDS00004;WP1831;Integration of energy metabolism
TTDS00004;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDS00004;WP455;GPCRs, Class A Rhodopsin-like
TTDS00004;WP51;Regulation of Actin Cytoskeleton
TTDS00004;WP536;Calcium Regulation in the Cardiac Cell
TTDS00004;WP58;Monoamine GPCRs
TTDS00005;WP1824;GPCR downstream signaling
TTDS00005;WP1825;GPCR ligand binding
TTDS00005;WP455;GPCRs, Class A Rhodopsin-like
TTDS00005;WP51;Regulation of Actin Cytoskeleton
TTDS00005;WP536;Calcium Regulation in the Cardiac Cell
TTDS00005;WP58;Monoamine GPCRs
TTDS00006;WP1824;GPCR downstream signaling
TTDS00006;WP1825;GPCR ligand binding
TTDS00006;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDS00006;WP455;GPCRs, Class A Rhodopsin-like
TTDS00006;WP51;Regulation of Actin Cytoskeleton
TTDS00006;WP536;Calcium Regulation in the Cardiac Cell
TTDS00006;WP58;Monoamine GPCRs
TTDS00007;WP1539;Angiogenesis
TTDS00007;WP1919;Signaling by VEGF
TTDS00007;WP306;Focal Adhesion
TTDS00008;WP1539;Angiogenesis
TTDS00008;WP1919;Signaling by VEGF
TTDS00008;WP2406;Cardiac Progenitor Differentiation
TTDS00008;WP259;Nifedipine Activity
TTDS00008;WP306;Focal Adhesion
TTDS00011;WP1824;GPCR downstream signaling
TTDS00011;WP1825;GPCR ligand binding
TTDS00011;WP2636;Genes and (Common) Pathways Underlying Drug Addiction
TTDS00011;WP455;GPCRs, Class A Rhodopsin-like
TTDS00011;WP58;Monoamine GPCRs
TTDS00011;WP666;Hypothetical Network for Drug Addiction
TTDS00012;WP1602;Nicotine Activity on Dopaminergic Neurons
TTDS00012;WP1824;GPCR downstream signaling
TTDS00012;WP1825;GPCR ligand binding
TTDS00012;WP2636;Genes and (Common) Pathways Underlying Drug Addiction
TTDS00012;WP455;GPCRs, Class A Rhodopsin-like
TTDS00012;WP58;Monoamine GPCRs
TTDS00012;WP666;Hypothetical Network for Drug Addiction
TTDS00013;WP117;GPCRs, Other
TTDS00013;WP1602;Nicotine Activity on Dopaminergic Neurons
TTDS00013;WP1824;GPCR downstream signaling
TTDS00013;WP1825;GPCR ligand binding
TTDS00013;WP455;GPCRs, Class A Rhodopsin-like
TTDS00013;WP58;Monoamine GPCRs
TTDS00015;WP1824;GPCR downstream signaling
TTDS00015;WP1825;GPCR ligand binding
TTDS00015;WP455;GPCRs, Class A Rhodopsin-like
TTDS00015;WP58;Monoamine GPCRs
TTDS00017;WP1870;Neurotransmitter Clearance In The Synaptic Cleft
TTDS00017;WP1935;Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds
TTDS00017;WP2371;Parkinsons Disease Pathway
TTDS00017;WP2855;Dopaminergic Neurogenesis
TTDS00017;WP2882;Nuclear Receptors Meta-Pathway
TTDS00017;WP2884;NRF2 pathway
TTDS00017;WP727;Monoamine Transport
TTDS00022;WP1824;GPCR downstream signaling
TTDS00022;WP1825;GPCR ligand binding
TTDS00022;WP2669;Potassium Channels
TTDS00022;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDS00022;WP501;GPCRs, Class C Metabotropic glutamate, pheromone
TTDS00024;WP106;Alanine and aspartate metabolism
TTDS00024;WP2685;GABA synthesis, release, reuptake and degradation
TTDS00029;WP1403;AMPK Signaling
TTDS00029;WP1824;GPCR downstream signaling
TTDS00029;WP1825;GPCR ligand binding
TTDS00029;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDS00029;WP2877;Vitamin D Receptor Pathway
TTDS00029;WP455;GPCRs, Class A Rhodopsin-like
TTDS00029;WP536;Calcium Regulation in the Cardiac Cell
TTDS00029;WP58;Monoamine GPCRs
TTDS00030;WP117;GPCRs, Other
TTDS00030;WP1824;GPCR downstream signaling
TTDS00030;WP1825;GPCR ligand binding
TTDS00030;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDS00030;WP455;GPCRs, Class A Rhodopsin-like
TTDS00030;WP536;Calcium Regulation in the Cardiac Cell
TTDS00030;WP58;Monoamine GPCRs
TTDS00032;WP1824;GPCR downstream signaling
TTDS00032;WP1825;GPCR ligand binding
TTDS00032;WP1831;Integration of energy metabolism
TTDS00032;WP1884;Platelet Aggregation (Plug Formation)
TTDS00032;WP455;GPCRs, Class A Rhodopsin-like
TTDS00032;WP58;Monoamine GPCRs
TTDS00036;WP1824;GPCR downstream signaling
TTDS00036;WP1825;GPCR ligand binding
TTDS00036;WP2197;Endothelin Pathways
TTDS00036;WP455;GPCRs, Class A Rhodopsin-like
TTDS00036;WP536;Calcium Regulation in the Cardiac Cell
TTDS00036;WP58;Monoamine GPCRs
TTDS00037;WP117;GPCRs, Other
TTDS00037;WP1824;GPCR downstream signaling
TTDS00037;WP1825;GPCR ligand binding
TTDS00037;WP2877;Vitamin D Receptor Pathway
TTDS00037;WP455;GPCRs, Class A Rhodopsin-like
TTDS00037;WP536;Calcium Regulation in the Cardiac Cell
TTDS00037;WP58;Monoamine GPCRs
TTDS00040;WP15;Selenium Micronutrient Network
TTDS00040;WP167;Eicosanoid Synthesis
TTDS00040;WP1879;Phase 1 - Functionalization of compounds
TTDS00040;WP2650;Arachidonic acid metabolism
TTDS00040;WP98;Prostaglandin Synthesis and Regulation
TTDS00041;WP15;Selenium Micronutrient Network
TTDS00041;WP167;Eicosanoid Synthesis
TTDS00041;WP2377;Integrated Pancreatic Cancer Pathway
TTDS00041;WP2431;Spinal Cord Injury
TTDS00041;WP2435;Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis
TTDS00041;WP2586;Aryl Hydrocarbon Receptor
TTDS00041;WP2650;Arachidonic acid metabolism
TTDS00041;WP2882;Nuclear Receptors Meta-Pathway
TTDS00041;WP98;Prostaglandin Synthesis and Regulation
TTDS00043;WP117;GPCRs, Other
TTDS00043;WP1824;GPCR downstream signaling
TTDS00043;WP1825;GPCR ligand binding
TTDS00043;WP24;Peptide GPCRs
TTDS00043;WP2597;Secretion of Hydrochloric Acid in Parietal Cells
TTDS00043;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDS00043;WP455;GPCRs, Class A Rhodopsin-like
TTDS00044;WP2597;Secretion of Hydrochloric Acid in Parietal Cells
TTDS00044;WP2670;Iron uptake and transport
TTDS00045;WP2670;Iron uptake and transport
TTDS00054;WP2685;GABA synthesis, release, reuptake and degradation
TTDS00056;WP15;Selenium Micronutrient Network
TTDS00056;WP1851;Metabolism of nucleotides
TTDS00056;WP1995;Effects of Nitric Oxide
TTDS00056;WP408;Oxidative Stress
TTDS00059;WP1851;Metabolism of nucleotides
TTDS00060;WP696;Benzo(a)pyrene metabolism
TTDS00060;WP702;Metapathway biotransformation
TTDS00065;WP2740;Glycerophospholipid biosynthesis
TTDS00066;WP143;Fatty Acid Beta Oxidation
TTDS00066;WP1982;SREBP signalling
TTDS00066;WP2001;miR-targeted genes in adipocytes - TarBase
TTDS00066;WP2003;miR-targeted genes in leukocytes - TarBase
TTDS00066;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDS00066;WP2005;miR-targeted genes in muscle cell - TarBase
TTDS00066;WP2059;Alzheimers Disease
TTDS00066;WP236;Adipogenesis
TTDS00066;WP2586;Aryl Hydrocarbon Receptor
TTDS00066;WP2751;Transcriptional Regulation of White Adipocyte Differentiation
TTDS00066;WP2764;Lipid digestion, mobilization, and transport
TTDS00066;WP2776;Visual phototransduction
TTDS00066;WP325;Triacylglyceride Synthesis
TTDS00066;WP430;Statin Pathway
TTDS00066;WP716;Vitamin A and Carotenoid Metabolism
TTDS00073;WP170;Nuclear Receptors
TTDS00073;WP236;Adipogenesis
TTDS00073;WP2377;Integrated Pancreatic Cancer Pathway
TTDS00073;WP299;Nuclear Receptors in Lipid Metabolism and Toxicity
TTDS00073;WP716;Vitamin A and Carotenoid Metabolism
TTDS00075;WP170;Nuclear Receptors
TTDS00075;WP2853;Endoderm Differentiation
TTDS00075;WP2857;Mesodermal Commitment Pathway
TTDS00075;WP299;Nuclear Receptors in Lipid Metabolism and Toxicity
TTDS00075;WP716;Vitamin A and Carotenoid Metabolism
TTDS00076;WP2657;Growth hormone receptor signaling
TTDS00076;WP2678;Prolactin receptor signaling
TTDS00076;WP474;Endochondral Ossification
TTDS00077;WP1832;Integrin alphaIIb beta3 signaling
TTDS00077;WP1833;Integrin cell surface interactions
TTDS00077;WP1843;L1CAM interactions
TTDS00077;WP185;Integrin-mediated Cell Adhesion
TTDS00077;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDS00077;WP2703;Extracellular matrix organization
TTDS00077;WP2806;Human Complement System
TTDS00077;WP2849;Hematopoietic Stem Cell Differentiation
TTDS00077;WP306;Focal Adhesion
TTDS00078;WP1600;Nicotine Metabolism
TTDS00078;WP1857;Metabolism of water-soluble vitamins and cofactors
TTDS00078;WP1995;Effects of Nitric Oxide
TTDS00078;WP465;Tryptophan metabolism
TTDS00079;WP2377;Integrated Pancreatic Cancer Pathway
TTDS00086;WP1824;GPCR downstream signaling
TTDS00086;WP1825;GPCR ligand binding
TTDS00086;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDS00086;WP395;IL-4 Signaling Pathway
TTDS00086;WP455;GPCRs, Class A Rhodopsin-like
TTDS00086;WP58;Monoamine GPCRs
TTDS00087;WP1824;GPCR downstream signaling
TTDS00087;WP1825;GPCR ligand binding
TTDS00087;WP2597;Secretion of Hydrochloric Acid in Parietal Cells
TTDS00087;WP455;GPCRs, Class A Rhodopsin-like
TTDS00087;WP58;Monoamine GPCRs
TTDS00089;WP702;Metapathway biotransformation
TTDS00089;WP704;Methylation Pathways
TTDS00092;WP1851;Metabolism of nucleotides
TTDS00095;WP138;Androgen receptor signaling pathway
TTDS00095;WP179;Cell Cycle
TTDS00095;WP1815;Factors involved in megakaryocyte development and platelet production
TTDS00095;WP1858;Mitotic G1-G1/S phases
TTDS00095;WP1905;RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription
TTDS00095;WP1976;Signalling by NGF
TTDS00095;WP1984;Integrated Breast Cancer Pathway
TTDS00095;WP2036;TWEAK Signaling Pathway
TTDS00095;WP2064;Neural Crest Differentiation
TTDS00095;WP2446;Retinoblastoma (RB) in Cancer
TTDS00095;WP268;Notch Signaling Pathway
TTDS00095;WP2755;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
TTDS00095;WP2864;Apoptosis-related network due to altered Notch3 in ovarian cancer
TTDS00095;WP364;IL-6 signaling pathway
TTDS00095;WP366;TGF beta Signaling Pathway
TTDS00095;WP61;Notch Signaling Pathway
TTDS00095;WP706;SIDS Susceptibility Pathways
TTDS00098;WP1824;GPCR downstream signaling
TTDS00098;WP1825;GPCR ligand binding
TTDS00098;WP455;GPCRs, Class A Rhodopsin-like
TTDS00098;WP58;Monoamine GPCRs
TTDS00098;WP706;SIDS Susceptibility Pathways
TTDS00098;WP722;Serotonin HTR1 Group and FOS Pathway
TTDS00099;WP1824;GPCR downstream signaling
TTDS00099;WP1825;GPCR ligand binding
TTDS00099;WP455;GPCRs, Class A Rhodopsin-like
TTDS00099;WP58;Monoamine GPCRs
TTDS00099;WP722;Serotonin HTR1 Group and FOS Pathway
TTDS00100;WP1824;GPCR downstream signaling
TTDS00100;WP1825;GPCR ligand binding
TTDS00100;WP455;GPCRs, Class A Rhodopsin-like
TTDS00100;WP58;Monoamine GPCRs
TTDS00100;WP722;Serotonin HTR1 Group and FOS Pathway
TTDS00103;WP117;GPCRs, Other
TTDS00103;WP1824;GPCR downstream signaling
TTDS00103;WP1825;GPCR ligand binding
TTDS00103;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDS00103;WP455;GPCRs, Class A Rhodopsin-like
TTDS00103;WP58;Monoamine GPCRs
TTDS00103;WP706;SIDS Susceptibility Pathways
TTDS00103;WP732;Serotonin Receptor 2 and ELK-SRF/GATA4 signaling
TTDS00103;WP733;Serotonin Receptor 2 and STAT3 Signaling
TTDS00104;WP1824;GPCR downstream signaling
TTDS00104;WP1825;GPCR ligand binding
TTDS00104;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDS00104;WP455;GPCRs, Class A Rhodopsin-like
TTDS00104;WP58;Monoamine GPCRs
TTDS00104;WP732;Serotonin Receptor 2 and ELK-SRF/GATA4 signaling
TTDS00105;WP1824;GPCR downstream signaling
TTDS00105;WP1825;GPCR ligand binding
TTDS00105;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDS00105;WP455;GPCRs, Class A Rhodopsin-like
TTDS00105;WP58;Monoamine GPCRs
TTDS00105;WP732;Serotonin Receptor 2 and ELK-SRF/GATA4 signaling
TTDS00107;WP1824;GPCR downstream signaling
TTDS00107;WP1825;GPCR ligand binding
TTDS00107;WP455;GPCRs, Class A Rhodopsin-like
TTDS00107;WP58;Monoamine GPCRs
TTDS00107;WP734;Serotonin Receptor 4/6/7 and NR3C Signaling
TTDS00109;WP1824;GPCR downstream signaling
TTDS00109;WP1825;GPCR ligand binding
TTDS00109;WP24;Peptide GPCRs
TTDS00109;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDS00109;WP455;GPCRs, Class A Rhodopsin-like
TTDS00111;WP1824;GPCR downstream signaling
TTDS00111;WP1825;GPCR ligand binding
TTDS00111;WP24;Peptide GPCRs
TTDS00111;WP2662;Regulation of Water Balance by Renal Aquaporins
TTDS00111;WP455;GPCRs, Class A Rhodopsin-like
TTDS00112;WP15;Selenium Micronutrient Network
TTDS00112;WP167;Eicosanoid Synthesis
TTDS00112;WP2650;Arachidonic acid metabolism
TTDS00112;WP2877;Vitamin D Receptor Pathway
TTDS00113;WP1824;GPCR downstream signaling
TTDS00113;WP1825;GPCR ligand binding
TTDS00113;WP1908;Signal amplification
TTDS00113;WP455;GPCRs, Class A Rhodopsin-like
TTDS00115;WP2749;Metabolism of steroid hormones and vitamin D
TTDS00115;WP690;Polyol Pathway
TTDS00115;WP702;Metapathway biotransformation
TTDS00117;WP1936;Transport of inorganic cations/anions and amino acids/oligopeptides
TTDS00118;WP1602;Nicotine Activity on Dopaminergic Neurons
TTDS00118;WP1871;Neurotransmitter Release Cycle
TTDS00118;WP2267;Synaptic Vesicle Pathway
TTDS00118;WP2855;Dopaminergic Neurogenesis
TTDS00122;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDS00123;WP2059;Alzheimers Disease
TTDS00123;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDS00123;WP666;Hypothetical Network for Drug Addiction
TTDS00126;WP1824;GPCR downstream signaling
TTDS00126;WP1825;GPCR ligand binding
TTDS00126;WP1978;Opioid Signalling
TTDS00126;WP24;Peptide GPCRs
TTDS00126;WP455;GPCRs, Class A Rhodopsin-like
TTDS00126;WP69;TCR Signaling Pathway
TTDS00127;WP1824;GPCR downstream signaling
TTDS00127;WP1825;GPCR ligand binding
TTDS00127;WP24;Peptide GPCRs
TTDS00127;WP455;GPCRs, Class A Rhodopsin-like
TTDS00128;WP1824;GPCR downstream signaling
TTDS00128;WP1825;GPCR ligand binding
TTDS00128;WP24;Peptide GPCRs
TTDS00128;WP455;GPCRs, Class A Rhodopsin-like
TTDS00129;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDS00129;WP2006;miR-targeted genes in squamous cell - TarBase
TTDS00131;WP129;Matrix Metalloproteinases
TTDS00131;WP1449;Regulation of toll-like receptor signaling pathway
TTDS00131;WP1533;Vitamin B12 Metabolism
TTDS00131;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDS00131;WP15;Selenium Micronutrient Network
TTDS00131;WP176;Folate Metabolism
TTDS00131;WP1814;Extrinsic Pathway for Apoptosis
TTDS00131;WP2036;TWEAK Signaling Pathway
TTDS00131;WP231;TNF alpha Signaling Pathway
TTDS00131;WP2328;Allograft Rejection
TTDS00131;WP236;Adipogenesis
TTDS00131;WP2447;Amyotrophic lateral sclerosis (ALS)
TTDS00131;WP2513;Nanoparticle triggered regulated necrosis
TTDS00131;WP254;Apoptosis
TTDS00131;WP2586;Aryl Hydrocarbon Receptor
TTDS00131;WP2751;Transcriptional Regulation of White Adipocyte Differentiation
TTDS00131;WP2795;Cardiac Hypertrophic Response
TTDS00131;WP2864;Apoptosis-related network due to altered Notch3 in ovarian cancer
TTDS00131;WP314;FAS pathway and Stress induction of HSP regulation
TTDS00131;WP3297;EV release from cardiac cells and their functional effects
TTDS00131;WP382;MAPK Signaling Pathway
TTDS00131;WP530;Cytokines and Inflammatory Response
TTDS00131;WP560;TGF Beta Signaling Pathway
TTDS00131;WP706;SIDS Susceptibility Pathways
TTDS00131;WP727;Monoamine Transport
TTDS00131;WP75;Toll-like receptor signaling pathway
TTDS00134;WP2059;Alzheimers Disease
TTDS00138;WP1455;Serotonin Transporter Activity
TTDS00138;WP1772;Apoptosis Modulation and Signaling
TTDS00138;WP1839;Interleukin-1 signaling
TTDS00138;WP195;IL-1 signaling pathway
TTDS00138;WP2377;Integrated Pancreatic Cancer Pathway
TTDS00138;WP2431;Spinal Cord Injury
TTDS00138;WP2637;Structural Pathway of Interleukin 1 (IL-1)
TTDS00138;WP2865;IL1 and megakaryotyces in obesity
TTDS00138;WP382;MAPK Signaling Pathway
TTDS00138;WP516;Hypertrophy Model
TTDS00138;WP727;Monoamine Transport
TTDS00139;WP1840;Interleukin-3, 5 and GM-CSF signaling
TTDS00139;WP205;IL-7 Signaling Pathway
TTDS00139;WP2203;TSLP Signaling Pathway
TTDS00139;WP2328;Allograft Rejection
TTDS00139;WP2732;Interleukin-2 signaling
TTDS00139;WP453;Inflammatory Response Pathway
TTDS00139;WP49;IL-2 Signaling Pathway
TTDS00140;WP2377;Integrated Pancreatic Cancer Pathway
TTDS00140;WP528;Acetylcholine Synthesis
TTDS00140;WP550;Biogenic Amine Synthesis
TTDS00140;WP727;Monoamine Transport
TTDS00141;WP1602;Nicotine Activity on Dopaminergic Neurons
TTDS00141;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDS00141;WP706;SIDS Susceptibility Pathways
TTDS00143;WP229;Irinotecan Pathway
TTDS00144;WP581;EPO Receptor Signaling
TTDS00147;WP2669;Potassium Channels
TTDS00147;WP2849;Hematopoietic Stem Cell Differentiation
TTDS00147;WP706;SIDS Susceptibility Pathways
TTDS00148;WP1992;TarBasePathway
TTDS00148;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDS00148;WP2005;miR-targeted genes in muscle cell - TarBase
TTDS00148;WP2669;Potassium Channels
TTDS00148;WP706;SIDS Susceptibility Pathways
TTDS00149;WP2669;Potassium Channels
TTDS00150;WP2669;Potassium Channels
TTDS00150;WP268;Notch Signaling Pathway
TTDS00150;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDS00150;WP536;Calcium Regulation in the Cardiac Cell
TTDS00153;WP2002;miR-targeted genes in epithelium - TarBase
TTDS00153;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDS00153;WP2005;miR-targeted genes in muscle cell - TarBase
TTDS00153;WP2006;miR-targeted genes in squamous cell - TarBase
TTDS00158;WP2670;Iron uptake and transport
TTDS00158;WP2882;Nuclear Receptors Meta-Pathway
TTDS00161;WP1603;Nicotine Activity on Chromaffin Cells
TTDS00161;WP1866;NCAM signaling for neurite out-growth
TTDS00164;WP1824;GPCR downstream signaling
TTDS00164;WP1825;GPCR ligand binding
TTDS00164;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDS00164;WP501;GPCRs, Class C Metabotropic glutamate, pheromone
TTDS00168;WP1824;GPCR downstream signaling
TTDS00168;WP1825;GPCR ligand binding
TTDS00168;WP247;Small Ligand GPCRs
TTDS00168;WP34;Ovarian Infertility Genes
TTDS00168;WP455;GPCRs, Class A Rhodopsin-like
TTDS00168;WP98;Prostaglandin Synthesis and Regulation
TTDS00169;WP117;GPCRs, Other
TTDS00169;WP1824;GPCR downstream signaling
TTDS00169;WP1825;GPCR ligand binding
TTDS00169;WP247;Small Ligand GPCRs
TTDS00169;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDS00169;WP455;GPCRs, Class A Rhodopsin-like
TTDS00169;WP98;Prostaglandin Synthesis and Regulation
TTDS00170;WP1824;GPCR downstream signaling
TTDS00170;WP1825;GPCR ligand binding
TTDS00170;WP1885;Platelet homeostasis
TTDS00170;WP2197;Endothelin Pathways
TTDS00170;WP247;Small Ligand GPCRs
TTDS00170;WP455;GPCRs, Class A Rhodopsin-like
TTDS00170;WP98;Prostaglandin Synthesis and Regulation
TTDS00171;WP1539;Angiogenesis
TTDS00171;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDS00171;WP1911;Signaling by FGFR
TTDS00171;WP2064;Neural Crest Differentiation
TTDS00171;WP2261;Signaling Pathways in Glioblastoma
TTDS00171;WP2795;Cardiac Hypertrophic Response
TTDS00171;WP2804;Hair Follicle Development: Induction (Part 1 of 3)
TTDS00171;WP2839;Hair Follicle Development: Organogenesis (Part 2 of 3)
TTDS00171;WP2858;Ectoderm Differentiation
TTDS00171;WP51;Regulation of Actin Cytoskeleton
TTDS00175;WP2683;Influenza Life Cycle
TTDS00181;WP2729;Metabolism of Angiotensinogen to Angiotensins
TTDS00181;WP554;ACE Inhibitor Pathway
TTDS00183;WP1824;GPCR downstream signaling
TTDS00183;WP1825;GPCR ligand binding
TTDS00183;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDS00183;WP455;GPCRs, Class A Rhodopsin-like
TTDS00186;WP1824;GPCR downstream signaling
TTDS00186;WP1825;GPCR ligand binding
TTDS00186;WP455;GPCRs, Class A Rhodopsin-like
TTDS00186;WP80;Nucleotide GPCRs
TTDS00187;WP117;GPCRs, Other
TTDS00187;WP1824;GPCR downstream signaling
TTDS00187;WP1825;GPCR ligand binding
TTDS00187;WP1873;NGF signalling via TRKA from the plasma membrane
TTDS00187;WP455;GPCRs, Class A Rhodopsin-like
TTDS00187;WP727;Monoamine Transport
TTDS00187;WP80;Nucleotide GPCRs
TTDS00188;WP1824;GPCR downstream signaling
TTDS00188;WP1825;GPCR ligand binding
TTDS00188;WP455;GPCRs, Class A Rhodopsin-like
TTDS00188;WP80;Nucleotide GPCRs
TTDS00189;WP117;GPCRs, Other
TTDS00189;WP455;GPCRs, Class A Rhodopsin-like
TTDS00189;WP80;Nucleotide GPCRs
TTDS00191;WP2355;Corticotropin-releasing hormone
TTDS00191;WP2513;Nanoparticle triggered regulated necrosis
TTDS00191;WP2755;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
TTDS00191;WP314;FAS pathway and Stress induction of HSP regulation
TTDS00192;WP2377;Integrated Pancreatic Cancer Pathway
TTDS00192;WP2586;Aryl Hydrocarbon Receptor
TTDS00192;WP2650;Arachidonic acid metabolism
TTDS00194;WP1824;GPCR downstream signaling
TTDS00194;WP1825;GPCR ligand binding
TTDS00194;WP2431;Spinal Cord Injury
TTDS00194;WP24;Peptide GPCRs
TTDS00194;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDS00194;WP706;SIDS Susceptibility Pathways
TTDS00195;WP1403;AMPK Signaling
TTDS00195;WP197;Cholesterol Biosynthesis
TTDS00195;WP1982;SREBP signalling
TTDS00195;WP1984;Integrated Breast Cancer Pathway
TTDS00195;WP2011;SREBF and miR33 in cholesterol and lipid homeostasis
TTDS00195;WP2706;Activation of Gene Expression by SREBP (SREBF)
TTDS00195;WP2797;Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
TTDS00195;WP430;Statin Pathway
TTDS00198;WP117;GPCRs, Other
TTDS00198;WP1824;GPCR downstream signaling
TTDS00198;WP1825;GPCR ligand binding
TTDS00198;WP2197;Endothelin Pathways
TTDS00198;WP24;Peptide GPCRs
TTDS00198;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDS00198;WP455;GPCRs, Class A Rhodopsin-like
TTDS00198;WP98;Prostaglandin Synthesis and Regulation
TTDS00199;WP1824;GPCR downstream signaling
TTDS00199;WP1825;GPCR ligand binding
TTDS00199;WP2197;Endothelin Pathways
TTDS00199;WP24;Peptide GPCRs
TTDS00199;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDS00199;WP455;GPCRs, Class A Rhodopsin-like
TTDS00199;WP98;Prostaglandin Synthesis and Regulation
TTDS00202;WP1533;Vitamin B12 Metabolism
TTDS00202;WP15;Selenium Micronutrient Network
TTDS00202;WP176;Folate Metabolism
TTDS00202;WP1794;Cell surface interactions at the vascular wall
TTDS00202;WP1818;Formation of Fibrin Clot (Clotting Cascade)
TTDS00202;WP1824;GPCR downstream signaling
TTDS00202;WP1825;GPCR ligand binding
TTDS00202;WP1884;Platelet Aggregation (Plug Formation)
TTDS00202;WP1929;Thrombin signalling through proteinase activated receptors (PARs)
TTDS00202;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDS00202;WP272;Blood Clotting Cascade
TTDS00202;WP2762;PTM: gamma carboxylation, hypusine formation and arylsulfatase activation
TTDS00202;WP2799;Regulation of Insulin-like Growth Factor (IGF) Transport and Uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
TTDS00202;WP2865;IL1 and megakaryotyces in obesity
TTDS00202;WP51;Regulation of Actin Cytoskeleton
TTDS00202;WP558;Complement and Coagulation Cascades
TTDS00203;WP1818;Formation of Fibrin Clot (Clotting Cascade)
TTDS00203;WP272;Blood Clotting Cascade
TTDS00203;WP2762;PTM: gamma carboxylation, hypusine formation and arylsulfatase activation
TTDS00203;WP2806;Human Complement System
TTDS00203;WP558;Complement and Coagulation Cascades
TTDS00204;WP1818;Formation of Fibrin Clot (Clotting Cascade)
TTDS00204;WP272;Blood Clotting Cascade
TTDS00204;WP558;Complement and Coagulation Cascades
TTDS00205;WP1818;Formation of Fibrin Clot (Clotting Cascade)
TTDS00205;WP272;Blood Clotting Cascade
TTDS00205;WP558;Complement and Coagulation Cascades
TTDS00206;WP554;ACE Inhibitor Pathway
TTDS00209;WP1403;AMPK Signaling
TTDS00209;WP1471;TOR Signaling
TTDS00209;WP1913;Signaling by Insulin receptor
TTDS00209;WP1982;SREBP signalling
TTDS00209;WP2011;SREBF and miR33 in cholesterol and lipid homeostasis
TTDS00209;WP2034;Leptin signaling pathway
TTDS00209;WP2380;BDNF signaling pathway
TTDS00209;WP2593;JAK/STAT
TTDS00209;WP2748;Energy dependent regulation of mTOR by LKB1-AMPK
TTDS00209;WP481;Insulin Signaling
TTDS00230;WP167;Eicosanoid Synthesis
TTDS00234;WP1843;L1CAM interactions
TTDS00234;WP1846;Membrane Trafficking
TTDS00234;WP2359;Parkin-Ubiquitin Proteasomal System pathway
TTDS00234;WP2685;GABA synthesis, release, reuptake and degradation
TTDS00234;WP2733;Regulation of mRNA Stability by Proteins that Bind AU-rich Elements
TTDS00234;WP382;MAPK Signaling Pathway
TTDS00234;WP410;Diurnally Regulated Genes with Circadian Orthologs
TTDS00241;WP1879;Phase 1 - Functionalization of compounds
TTDS00241;WP2263;Prostate Cancer
TTDS00241;WP237;Glucocorticoid & Mineralcorticoid Metabolism
TTDS00241;WP2749;Metabolism of steroid hormones and vitamin D
TTDS00241;WP43;Oxidation by Cytochrome P450
TTDS00241;WP496;Steroid Biosynthesis
TTDS00241;WP702;Metapathway biotransformation
TTDS00242;WP170;Nuclear Receptors
TTDS00242;WP1984;Integrated Breast Cancer Pathway
TTDS00242;WP2005;miR-targeted genes in muscle cell - TarBase
TTDS00242;WP2034;Leptin signaling pathway
TTDS00242;WP2377;Integrated Pancreatic Cancer Pathway
TTDS00242;WP2586;Aryl Hydrocarbon Receptor
TTDS00242;WP2593;JAK/STAT
TTDS00242;WP2781;Signaling by ERBB4
TTDS00242;WP2881;Estrogen Receptor Pathway
TTDS00242;WP2882;Nuclear Receptors Meta-Pathway
TTDS00242;WP712;Estrogen signaling pathway
TTDS00245;WP170;Nuclear Receptors
TTDS00245;WP2781;Signaling by ERBB4
TTDS00245;WP34;Ovarian Infertility Genes
TTDS00247;WP138;Androgen receptor signaling pathway
TTDS00247;WP1539;Angiogenesis
TTDS00247;WP185;Integrin-mediated Cell Adhesion
TTDS00247;WP2018;RANKL/RANK Signaling Pathway
TTDS00247;WP2032;TSH signaling pathway
TTDS00247;WP2034;Leptin signaling pathway
TTDS00247;WP2035;FSH signaling pathway
TTDS00247;WP2038;Regulation of Microtubule Cytoskeleton
TTDS00247;WP2100;Arylhydrocarbon receptor (AhR) signaling pathway
TTDS00247;WP2203;TSLP Signaling Pathway
TTDS00247;WP2261;Signaling Pathways in Glioblastoma
TTDS00247;WP2324;AGE/RAGE pathway
TTDS00247;WP2332;Interleukin-11 Signaling Pathway
TTDS00247;WP2374;Oncostatin M Signaling Pathway
TTDS00247;WP2377;Integrated Pancreatic Cancer Pathway
TTDS00247;WP2380;BDNF signaling pathway
TTDS00247;WP244;Alpha 6 Beta 4 signaling pathway
TTDS00247;WP2571;Polycystic Kidney Disease Pathway
TTDS00247;WP2586;Aryl Hydrocarbon Receptor
TTDS00247;WP2643;Nanoparticle-mediated activation of receptor signaling
TTDS00247;WP286;IL-3 Signaling Pathway
TTDS00247;WP2873;Aryl Hydrocarbon Receptor Pathway
TTDS00247;WP2876;Pregnane X Receptor pathway
TTDS00247;WP2882;Nuclear Receptors Meta-Pathway
TTDS00247;WP304;Kit receptor signaling pathway
TTDS00247;WP306;Focal Adhesion
TTDS00247;WP313;Signaling of Hepatocyte Growth Factor Receptor
TTDS00247;WP366;TGF beta Signaling Pathway
TTDS00247;WP437;EGF/EGFR Signaling Pathway
TTDS00247;WP581;EPO Receptor Signaling
TTDS00247;WP615;Senescence and Autophagy in Cancer
TTDS00247;WP61;Notch Signaling Pathway
TTDS00247;WP673;ErbB Signaling Pathway
TTDS00249;WP1907;Semaphorin interactions
TTDS00249;WP2005;miR-targeted genes in muscle cell - TarBase
TTDS00249;WP2034;Leptin signaling pathway
TTDS00249;WP2261;Signaling Pathways in Glioblastoma
TTDS00249;WP2377;Integrated Pancreatic Cancer Pathway
TTDS00249;WP2780;Signaling by ERBB2
TTDS00249;WP2828;Bladder Cancer
TTDS00249;WP2870;Extracellular vesicle-mediated signaling in recipient cells
TTDS00249;WP306;Focal Adhesion
TTDS00249;WP437;EGF/EGFR Signaling Pathway
TTDS00249;WP673;ErbB Signaling Pathway
TTDS00249;WP710;DNA Damage Response (only ATM dependent)
TTDS00250;WP170;Nuclear Receptors
TTDS00250;WP2377;Integrated Pancreatic Cancer Pathway
TTDS00250;WP34;Ovarian Infertility Genes
TTDS00250;WP706;SIDS Susceptibility Pathways
TTDS00251;WP1531;Vitamin D Metabolism
TTDS00251;WP170;Nuclear Receptors
TTDS00251;WP2289;Drug Induction of Bile Acid Pathway
TTDS00251;WP2877;Vitamin D Receptor Pathway
TTDS00251;WP2882;Nuclear Receptors Meta-Pathway
TTDS00251;WP299;Nuclear Receptors in Lipid Metabolism and Toxicity
TTDS00251;WP34;Ovarian Infertility Genes
TTDS00252;WP1879;Phase 1 - Functionalization of compounds
TTDS00252;WP1984;Integrated Breast Cancer Pathway
TTDS00252;WP2035;FSH signaling pathway
TTDS00252;WP2749;Metabolism of steroid hormones and vitamin D
TTDS00252;WP34;Ovarian Infertility Genes
TTDS00252;WP43;Oxidation by Cytochrome P450
TTDS00252;WP465;Tryptophan metabolism
TTDS00252;WP702;Metapathway biotransformation
TTDS00253;WP1824;GPCR downstream signaling
TTDS00253;WP1825;GPCR ligand binding
TTDS00253;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDS00254;WP1824;GPCR downstream signaling
TTDS00254;WP1825;GPCR ligand binding
TTDS00254;WP24;Peptide GPCRs
TTDS00254;WP34;Ovarian Infertility Genes
TTDS00254;WP455;GPCRs, Class A Rhodopsin-like
TTDS00256;WP2324;AGE/RAGE pathway
TTDS00256;WP2380;BDNF signaling pathway
TTDS00256;WP474;Endochondral Ossification
TTDS00258;WP1824;GPCR downstream signaling
TTDS00258;WP1825;GPCR ligand binding
TTDS00258;WP322;Osteoblast Signaling
TTDS00258;WP334;GPCRs, Class B Secretin-like
TTDS00258;WP474;Endochondral Ossification
TTDS00264;WP1824;GPCR downstream signaling
TTDS00264;WP1825;GPCR ligand binding
TTDS00264;WP24;Peptide GPCRs
TTDS00264;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDS00264;WP2889;Oxytocin signaling
TTDS00264;WP289;Myometrial Relaxation and Contraction Pathways
TTDS00264;WP455;GPCRs, Class A Rhodopsin-like
TTDS00265;WP1403;AMPK Signaling
TTDS00265;WP1471;TOR Signaling
TTDS00265;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDS00265;WP1584;Type II diabetes mellitus
TTDS00265;WP1799;Costimulation by the CD28 family
TTDS00265;WP1913;Signaling by Insulin receptor
TTDS00265;WP1982;SREBP signalling
TTDS00265;WP1984;Integrated Breast Cancer Pathway
TTDS00265;WP2011;SREBF and miR33 in cholesterol and lipid homeostasis
TTDS00265;WP2018;RANKL/RANK Signaling Pathway
TTDS00265;WP2032;TSH signaling pathway
TTDS00265;WP2034;Leptin signaling pathway
TTDS00265;WP2035;FSH signaling pathway
TTDS00265;WP2203;TSLP Signaling Pathway
TTDS00265;WP2263;Prostate Cancer
TTDS00265;WP2374;Oncostatin M Signaling Pathway
TTDS00265;WP2380;BDNF signaling pathway
TTDS00265;WP244;Alpha 6 Beta 4 signaling pathway
TTDS00265;WP2571;Polycystic Kidney Disease Pathway
TTDS00265;WP2653;PIP3 activates AKT signaling
TTDS00265;WP2677;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
TTDS00265;WP2795;Cardiac Hypertrophic Response
TTDS00265;WP2870;Extracellular vesicle-mediated signaling in recipient cells
TTDS00265;WP363;Wnt Signaling Pathway Netpath
TTDS00265;WP437;EGF/EGFR Signaling Pathway
TTDS00265;WP481;Insulin Signaling
TTDS00265;WP585;Interferon type I signaling pathways
TTDS00265;WP615;Senescence and Autophagy in Cancer
TTDS00265;WP673;ErbB Signaling Pathway
TTDS00267;WP1824;GPCR downstream signaling
TTDS00267;WP1825;GPCR ligand binding
TTDS00267;WP2328;Allograft Rejection
TTDS00267;WP24;Peptide GPCRs
TTDS00267;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDS00267;WP455;GPCRs, Class A Rhodopsin-like
TTDS00267;WP554;ACE Inhibitor Pathway
TTDS00269;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDS00269;WP2032;TSH signaling pathway
TTDS00269;WP2261;Signaling Pathways in Glioblastoma
TTDS00269;WP254;Apoptosis
TTDS00269;WP2677;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
TTDS00269;WP306;Focal Adhesion
TTDS00269;WP474;Endochondral Ossification
TTDS00269;WP481;Insulin Signaling
TTDS00269;WP615;Senescence and Autophagy in Cancer
TTDS00270;WP2002;miR-targeted genes in epithelium - TarBase
TTDS00270;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDS00270;WP2005;miR-targeted genes in muscle cell - TarBase
TTDS00270;WP2406;Cardiac Progenitor Differentiation
TTDS00270;WP2653;PIP3 activates AKT signaling
TTDS00270;WP2713;Signaling by SCF-KIT
TTDS00270;WP2848;Differentiation Pathway
TTDS00270;WP304;Kit receptor signaling pathway
TTDS00272;WP2289;Drug Induction of Bile Acid Pathway
TTDS00272;WP2879;Farnesoid X Receptor Pathway
TTDS00272;WP2882;Nuclear Receptors Meta-Pathway
TTDS00272;WP299;Nuclear Receptors in Lipid Metabolism and Toxicity
TTDS00273;WP117;GPCRs, Other
TTDS00273;WP1824;GPCR downstream signaling
TTDS00273;WP1825;GPCR ligand binding
TTDS00273;WP24;Peptide GPCRs
TTDS00273;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDS00275;WP127;IL-5 Signaling Pathway
TTDS00275;WP138;Androgen receptor signaling pathway
TTDS00275;WP1528;Physiological and Pathological Hypertrophy of the Heart
TTDS00275;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDS00275;WP1559;TFs Regulate miRNAs related to cardiac hypertrophy
TTDS00275;WP1873;NGF signalling via TRKA from the plasma membrane
TTDS00275;WP1916;Signaling by PDGF
TTDS00275;WP2023;Cell Differentiation - meta
TTDS00275;WP2029;Cell Differentiation - Index
TTDS00275;WP2032;TSH signaling pathway
TTDS00275;WP2034;Leptin signaling pathway
TTDS00275;WP2038;Regulation of Microtubule Cytoskeleton
TTDS00275;WP205;IL-7 Signaling Pathway
TTDS00275;WP2112;IL17 signaling pathway
TTDS00275;WP2203;TSLP Signaling Pathway
TTDS00275;WP2263;Prostate Cancer
TTDS00275;WP22;IL-9 Signaling Pathway
TTDS00275;WP2324;AGE/RAGE pathway
TTDS00275;WP2332;Interleukin-11 Signaling Pathway
TTDS00275;WP236;Adipogenesis
TTDS00275;WP2374;Oncostatin M Signaling Pathway
TTDS00275;WP2380;BDNF signaling pathway
TTDS00275;WP2526;PDGF Pathway
TTDS00275;WP2593;JAK/STAT
TTDS00275;WP2657;Growth hormone receptor signaling
TTDS00275;WP2704;Interleukin-6 signaling
TTDS00275;WP2713;Signaling by SCF-KIT
TTDS00275;WP2815;Mammary gland development pathway - Involution (Stage 4 of 4)
TTDS00275;WP2821;Transcriptional regulation of pluripotent stem cells
TTDS00275;WP2855;Dopaminergic Neurogenesis
TTDS00275;WP2868;TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer
TTDS00275;WP286;IL-3 Signaling Pathway
TTDS00275;WP2881;Estrogen Receptor Pathway
TTDS00275;WP2882;Nuclear Receptors Meta-Pathway
TTDS00275;WP304;Kit receptor signaling pathway
TTDS00275;WP313;Signaling of Hepatocyte Growth Factor Receptor
TTDS00275;WP364;IL-6 signaling pathway
TTDS00275;WP395;IL-4 Signaling Pathway
TTDS00275;WP437;EGF/EGFR Signaling Pathway
TTDS00275;WP49;IL-2 Signaling Pathway
TTDS00275;WP560;TGF Beta Signaling Pathway
TTDS00275;WP581;EPO Receptor Signaling
TTDS00275;WP585;Interferon type I signaling pathways
TTDS00275;WP61;Notch Signaling Pathway
TTDS00275;WP733;Serotonin Receptor 2 and STAT3 Signaling
TTDS00278;WP1788;Bile acid and bile salt metabolism
TTDS00278;WP2289;Drug Induction of Bile Acid Pathway
TTDS00278;WP2879;Farnesoid X Receptor Pathway
TTDS00278;WP2882;Nuclear Receptors Meta-Pathway
TTDS00278;WP299;Nuclear Receptors in Lipid Metabolism and Toxicity
TTDS00280;WP35;G Protein Signaling Pathways
TTDS00282;WP2769;Activation of Matrix Metalloproteinases
TTDS00283;WP170;Nuclear Receptors
TTDS00283;WP1797;Circadian Clock
TTDS00283;WP236;Adipogenesis
TTDS00283;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDS00283;WP2853;Endoderm Differentiation
TTDS00283;WP2882;Nuclear Receptors Meta-Pathway
TTDS00283;WP706;SIDS Susceptibility Pathways
TTDS00283;WP734;Serotonin Receptor 4/6/7 and NR3C Signaling
TTDS00285;WP2882;Nuclear Receptors Meta-Pathway
TTDS00285;WP2884;NRF2 pathway
TTDS00285;WP558;Complement and Coagulation Cascades
TTDS00286;WP1824;GPCR downstream signaling
TTDS00286;WP1825;GPCR ligand binding
TTDS00286;WP24;Peptide GPCRs
TTDS00286;WP455;GPCRs, Class A Rhodopsin-like
TTDS00287;WP2670;Iron uptake and transport
TTDS00288;WP1857;Metabolism of water-soluble vitamins and cofactors
TTDS00288;WP229;Irinotecan Pathway
TTDS00288;WP2650;Arachidonic acid metabolism
TTDS00289;WP1455;Serotonin Transporter Activity
TTDS00289;WP1870;Neurotransmitter Clearance In The Synaptic Cleft
TTDS00289;WP1871;Neurotransmitter Release Cycle
TTDS00289;WP1879;Phase 1 - Functionalization of compounds
TTDS00289;WP2436;Dopamine metabolism
TTDS00289;WP408;Oxidative Stress
TTDS00289;WP550;Biogenic Amine Synthesis
TTDS00289;WP706;SIDS Susceptibility Pathways
TTDS00291;WP1848;Metabolism of carbohydrates
TTDS00292;WP1403;AMPK Signaling
TTDS00292;WP1533;Vitamin B12 Metabolism
TTDS00292;WP1584;Type II diabetes mellitus
TTDS00292;WP15;Selenium Micronutrient Network
TTDS00292;WP176;Folate Metabolism
TTDS00292;WP1913;Signaling by Insulin receptor
TTDS00292;WP2324;AGE/RAGE pathway
TTDS00292;WP2509;Nanoparticle triggered autophagic cell death
TTDS00292;WP481;Insulin Signaling
TTDS00292;WP710;DNA Damage Response (only ATM dependent)
TTDS00295;WP1403;AMPK Signaling
TTDS00295;WP1772;Apoptosis Modulation and Signaling
TTDS00295;WP1817;Fatty acid, triacylglycerol, and ketone body metabolism
TTDS00295;WP1831;Integration of energy metabolism
TTDS00295;WP1857;Metabolism of water-soluble vitamins and cofactors
TTDS00295;WP1982;SREBP signalling
TTDS00295;WP2011;SREBF and miR33 in cholesterol and lipid homeostasis
TTDS00295;WP2706;Activation of Gene Expression by SREBP (SREBF)
TTDS00295;WP2874;Liver X Receptor Pathway
TTDS00295;WP2882;Nuclear Receptors Meta-Pathway
TTDS00295;WP357;Fatty Acid Biosynthesis
TTDS00301;WP1601;Fluoropyrimidine Activity
TTDS00301;WP1851;Metabolism of nucleotides
TTDS00301;WP2002;miR-targeted genes in epithelium - TarBase
TTDS00301;WP2003;miR-targeted genes in leukocytes - TarBase
TTDS00301;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDS00301;WP2005;miR-targeted genes in muscle cell - TarBase
TTDS00301;WP2377;Integrated Pancreatic Cancer Pathway
TTDS00301;WP241;One Carbon Metabolism
TTDS00301;WP2446;Retinoblastoma (RB) in Cancer
TTDS00301;WP2525;Trans-sulfuration and one carbon metabolism
TTDS00306;WP2681;Uptake of Oxygen and Release of Carbon Dioxide by Erythrocytes
TTDS00306;WP2744;Uptake of Carbon Dioxide and Release of Oxygen by Erythrocytes
TTDS00306;WP2770;Reversible Hydration of Carbon Dioxide
TTDS00308;WP1859;Mitotic G2-G2/M phases
TTDS00308;WP2272;Pathogenic Escherichia coli infection
TTDS00308;WP2359;Parkin-Ubiquitin Proteasomal System pathway
TTDS00311;WP1449;Regulation of toll-like receptor signaling pathway
TTDS00311;WP2709;Trafficking and processing of endosomal TLR
TTDS00311;WP2768;MyD88 dependent cascade initiated on endosome
TTDS00311;WP2775;Toll-Like Receptors Cascades
TTDS00311;WP75;Toll-like receptor signaling pathway
TTDS00323;WP1794;Cell surface interactions at the vascular wall
TTDS00323;WP2593;JAK/STAT
TTDS00323;WP2658;HIV Life Cycle
TTDS00323;WP2684;Host Interactions of HIV factors
TTDS00323;WP2746;Signaling by the B Cell Receptor (BCR)
TTDS00326;WP117;GPCRs, Other
TTDS00326;WP1824;GPCR downstream signaling
TTDS00326;WP1825;GPCR ligand binding
TTDS00326;WP24;Peptide GPCRs
TTDS00326;WP2658;HIV Life Cycle
TTDS00326;WP455;GPCRs, Class A Rhodopsin-like
TTDS00326;WP69;TCR Signaling Pathway
TTDS00328;WP716;Vitamin A and Carotenoid Metabolism
TTDS00334;WP117;GPCRs, Other
TTDS00334;WP1824;GPCR downstream signaling
TTDS00334;WP1825;GPCR ligand binding
TTDS00334;WP2380;BDNF signaling pathway
TTDS00334;WP247;Small Ligand GPCRs
TTDS00334;WP455;GPCRs, Class A Rhodopsin-like
TTDS00336;WP1533;Vitamin B12 Metabolism
TTDS00336;WP15;Selenium Micronutrient Network
TTDS00336;WP176;Folate Metabolism
TTDS00336;WP1788;Bile acid and bile salt metabolism
TTDS00336;WP1937;Transport of vitamins, nucleosides, and related molecules
TTDS00336;WP2764;Lipid digestion, mobilization, and transport
TTDS00336;WP2784;Binding and Uptake of Ligands by Scavenger Receptors
TTDS00336;WP2806;Human Complement System
TTDS00337;WP1995;Effects of Nitric Oxide
TTDS00337;WP2324;AGE/RAGE pathway
TTDS00337;WP2431;Spinal Cord Injury
TTDS00337;WP619;Type II interferon signaling (IFNG)
TTDS00338;WP170;Nuclear Receptors
TTDS00338;WP1982;SREBP signalling
TTDS00338;WP236;Adipogenesis
TTDS00338;WP2751;Transcriptional Regulation of White Adipocyte Differentiation
TTDS00338;WP2797;Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
TTDS00338;WP2895;Differentiation of white and brown adipocyte
TTDS00338;WP299;Nuclear Receptors in Lipid Metabolism and Toxicity
TTDS00338;WP363;Wnt Signaling Pathway Netpath
TTDS00340;WP170;Nuclear Receptors
TTDS00340;WP1797;Circadian Clock
TTDS00340;WP2011;SREBF and miR33 in cholesterol and lipid homeostasis
TTDS00340;WP236;Adipogenesis
TTDS00340;WP2706;Activation of Gene Expression by SREBP (SREBF)
TTDS00340;WP2738;YAP1- and WWTR1 (TAZ)-stimulated gene expression
TTDS00340;WP2751;Transcriptional Regulation of White Adipocyte Differentiation
TTDS00340;WP2797;Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
TTDS00340;WP2878;PPAR Alpha Pathway
TTDS00340;WP2881;Estrogen Receptor Pathway
TTDS00340;WP2882;Nuclear Receptors Meta-Pathway
TTDS00340;WP299;Nuclear Receptors in Lipid Metabolism and Toxicity
TTDS00341;WP1879;Phase 1 - Functionalization of compounds
TTDS00341;WP2436;Dopamine metabolism
TTDS00341;WP465;Tryptophan metabolism
TTDS00342;WP1852;Metabolism of porphyrins
TTDS00342;WP561;Heme Biosynthesis
TTDS00346;WP185;Integrin-mediated Cell Adhesion
TTDS00346;WP1873;NGF signalling via TRKA from the plasma membrane
TTDS00346;WP1911;Signaling by FGFR
TTDS00346;WP1984;Integrated Breast Cancer Pathway
TTDS00346;WP2032;TSH signaling pathway
TTDS00346;WP2261;Signaling Pathways in Glioblastoma
TTDS00346;WP2355;Corticotropin-releasing hormone
TTDS00346;WP23;B Cell Receptor Signaling Pathway
TTDS00346;WP2571;Polycystic Kidney Disease Pathway
TTDS00346;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDS00346;WP2828;Bladder Cancer
TTDS00346;WP306;Focal Adhesion
TTDS00346;WP382;MAPK Signaling Pathway
TTDS00346;WP422;MAPK Cascade
TTDS00346;WP437;EGF/EGFR Signaling Pathway
TTDS00346;WP51;Regulation of Actin Cytoskeleton
TTDS00346;WP615;Senescence and Autophagy in Cancer
TTDS00346;WP712;Estrogen signaling pathway
TTDS00346;WP722;Serotonin HTR1 Group and FOS Pathway
TTDS00346;WP734;Serotonin Receptor 4/6/7 and NR3C Signaling
TTDS00348;WP2586;Aryl Hydrocarbon Receptor
TTDS00348;WP2855;Dopaminergic Neurogenesis
TTDS00348;WP706;SIDS Susceptibility Pathways
TTDS00350;WP1530;miRNA Regulation of DNA Damage Response
TTDS00350;WP1545;miRNAs involved in DNA damage response
TTDS00350;WP1742;TP53 Network
TTDS00350;WP179;Cell Cycle
TTDS00350;WP1815;Factors involved in megakaryocyte development and platelet production
TTDS00350;WP1865;Myogenesis
TTDS00350;WP1918;Signaling by Robo receptor
TTDS00350;WP1984;Integrated Breast Cancer Pathway
TTDS00350;WP2038;Regulation of Microtubule Cytoskeleton
TTDS00350;WP2272;Pathogenic Escherichia coli infection
TTDS00350;WP2377;Integrated Pancreatic Cancer Pathway
TTDS00350;WP2446;Retinoblastoma (RB) in Cancer
TTDS00350;WP2516;ATM Signaling Pathway
TTDS00350;WP2719;Fcgamma receptor (FCGR) dependent phagocytosis
TTDS00350;WP2864;Apoptosis-related network due to altered Notch3 in ovarian cancer
TTDS00350;WP437;EGF/EGFR Signaling Pathway
TTDS00350;WP673;ErbB Signaling Pathway
TTDS00350;WP707;DNA Damage Response
TTDS00350;WP710;DNA Damage Response (only ATM dependent)
TTDS00351;WP170;Nuclear Receptors
TTDS00351;WP2289;Drug Induction of Bile Acid Pathway
TTDS00351;WP2875;Constitutive Androstane Receptor Pathway
TTDS00351;WP2882;Nuclear Receptors Meta-Pathway
TTDS00351;WP299;Nuclear Receptors in Lipid Metabolism and Toxicity
TTDS00355;WP138;Androgen receptor signaling pathway
TTDS00355;WP1843;L1CAM interactions
TTDS00355;WP1910;Signaling by EGFR
TTDS00355;WP1984;Integrated Breast Cancer Pathway
TTDS00355;WP2002;miR-targeted genes in epithelium - TarBase
TTDS00355;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDS00355;WP2005;miR-targeted genes in muscle cell - TarBase
TTDS00355;WP2100;Arylhydrocarbon receptor (AhR) signaling pathway
TTDS00355;WP2261;Signaling Pathways in Glioblastoma
TTDS00355;WP2324;AGE/RAGE pathway
TTDS00355;WP2363;Gastric cancer network 2
TTDS00355;WP2377;Integrated Pancreatic Cancer Pathway
TTDS00355;WP2431;Spinal Cord Injury
TTDS00355;WP2586;Aryl Hydrocarbon Receptor
TTDS00355;WP2643;Nanoparticle-mediated activation of receptor signaling
TTDS00355;WP2653;PIP3 activates AKT signaling
TTDS00355;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDS00355;WP2780;Signaling by ERBB2
TTDS00355;WP2781;Signaling by ERBB4
TTDS00355;WP2804;Hair Follicle Development: Induction (Part 1 of 3)
TTDS00355;WP2828;Bladder Cancer
TTDS00355;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDS00355;WP2868;TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer
TTDS00355;WP2870;Extracellular vesicle-mediated signaling in recipient cells
TTDS00355;WP2873;Aryl Hydrocarbon Receptor Pathway
TTDS00355;WP2882;Nuclear Receptors Meta-Pathway
TTDS00355;WP306;Focal Adhesion
TTDS00355;WP382;MAPK Signaling Pathway
TTDS00355;WP437;EGF/EGFR Signaling Pathway
TTDS00355;WP51;Regulation of Actin Cytoskeleton
TTDS00355;WP673;ErbB Signaling Pathway
TTDS00357;WP1403;AMPK Signaling
TTDS00357;WP1817;Fatty acid, triacylglycerol, and ketone body metabolism
TTDS00357;WP2034;Leptin signaling pathway
TTDS00357;WP2380;BDNF signaling pathway
TTDS00357;WP2593;JAK/STAT
TTDS00357;WP2706;Activation of Gene Expression by SREBP (SREBF)
TTDS00357;WP357;Fatty Acid Biosynthesis
TTDS00360;WP2703;Extracellular matrix organization
TTDS00361;WP1602;Nicotine Activity on Dopaminergic Neurons
TTDS00361;WP2371;Parkinsons Disease Pathway
TTDS00361;WP2436;Dopamine metabolism
TTDS00361;WP2693;Metabolism of amino acids and derivatives
TTDS00361;WP2855;Dopaminergic Neurogenesis
TTDS00361;WP465;Tryptophan metabolism
TTDS00361;WP550;Biogenic Amine Synthesis
TTDS00361;WP706;SIDS Susceptibility Pathways
TTDS00362;WP1870;Neurotransmitter Clearance In The Synaptic Cleft
TTDS00362;WP1880;Phase II conjugation
TTDS00362;WP2436;Dopamine metabolism
TTDS00362;WP550;Biogenic Amine Synthesis
TTDS00362;WP697;Estrogen metabolism
TTDS00362;WP702;Metapathway biotransformation
TTDS00362;WP704;Methylation Pathways
TTDS00363;WP1528;Physiological and Pathological Hypertrophy of the Heart
TTDS00363;WP1544;MicroRNAs in cardiomyocyte hypertrophy
TTDS00363;WP1978;Opioid Signalling
TTDS00363;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDS00363;WP2005;miR-targeted genes in muscle cell - TarBase
TTDS00363;WP2059;Alzheimers Disease
TTDS00363;WP2431;Spinal Cord Injury
TTDS00363;WP2447;Amyotrophic lateral sclerosis (ALS)
TTDS00363;WP2583;T-Cell Receptor and Co-stimulatory Signaling
TTDS00363;WP2746;Signaling by the B Cell Receptor (BCR)
TTDS00363;WP2759;Fc epsilon receptor (FCERI) signaling
TTDS00363;WP2795;Cardiac Hypertrophic Response
TTDS00363;WP35;G Protein Signaling Pathways
TTDS00363;WP382;MAPK Signaling Pathway
TTDS00363;WP391;Mitochondrial Gene Expression
TTDS00365;WP1602;Nicotine Activity on Dopaminergic Neurons
TTDS00365;WP2371;Parkinsons Disease Pathway
TTDS00365;WP2436;Dopamine metabolism
TTDS00365;WP2693;Metabolism of amino acids and derivatives
TTDS00365;WP2855;Dopaminergic Neurogenesis
TTDS00365;WP550;Biogenic Amine Synthesis
TTDS00365;WP706;SIDS Susceptibility Pathways
TTDS00365;WP727;Monoamine Transport
TTDS00367;WP138;Androgen receptor signaling pathway
TTDS00367;WP170;Nuclear Receptors
TTDS00367;WP1984;Integrated Breast Cancer Pathway
TTDS00367;WP2263;Prostate Cancer
TTDS00367;WP2377;Integrated Pancreatic Cancer Pathway
TTDS00367;WP706;SIDS Susceptibility Pathways
TTDS00368;WP1794;Cell surface interactions at the vascular wall
TTDS00372;WP197;Cholesterol Biosynthesis
TTDS00372;WP1982;SREBP signalling
TTDS00372;WP2706;Activation of Gene Expression by SREBP (SREBF)
TTDS00373;WP2436;Dopamine metabolism
TTDS00377;WP2788;Sphingolipid metabolism
TTDS00378;WP558;Complement and Coagulation Cascades
TTDS00380;WP1981;Thyroxine (Thyroid Hormone) Production
TTDS00380;WP2693;Metabolism of amino acids and derivatives
TTDS00380;WP2848;Differentiation Pathway
TTDS00380;WP2849;Hematopoietic Stem Cell Differentiation
TTDS00381;WP170;Nuclear Receptors
TTDS00381;WP474;Endochondral Ossification
TTDS00390;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDS00390;WP2005;miR-targeted genes in muscle cell - TarBase
TTDS00392;WP1533;Vitamin B12 Metabolism
TTDS00392;WP15;Selenium Micronutrient Network
TTDS00392;WP176;Folate Metabolism
TTDS00392;WP1802;Dissolution of Fibrin Clot
TTDS00392;WP272;Blood Clotting Cascade
TTDS00392;WP2769;Activation of Matrix Metalloproteinases
TTDS00392;WP2799;Regulation of Insulin-like Growth Factor (IGF) Transport and Uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
TTDS00392;WP2806;Human Complement System
TTDS00392;WP558;Complement and Coagulation Cascades
TTDS00393;WP1824;GPCR downstream signaling
TTDS00393;WP1825;GPCR ligand binding
TTDS00393;WP247;Small Ligand GPCRs
TTDS00393;WP455;GPCRs, Class A Rhodopsin-like
TTDS00394;WP117;GPCRs, Other
TTDS00394;WP1824;GPCR downstream signaling
TTDS00394;WP1825;GPCR ligand binding
TTDS00394;WP24;Peptide GPCRs
TTDS00394;WP455;GPCRs, Class A Rhodopsin-like
TTDS00394;WP706;SIDS Susceptibility Pathways
TTDS00395;WP1824;GPCR downstream signaling
TTDS00395;WP1825;GPCR ligand binding
TTDS00395;WP1908;Signal amplification
TTDS00395;WP247;Small Ligand GPCRs
TTDS00395;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDS00395;WP455;GPCRs, Class A Rhodopsin-like
TTDS00398;WP2762;PTM: gamma carboxylation, hypusine formation and arylsulfatase activation
TTDS00399;WP2670;Iron uptake and transport
TTDS00399;WP706;SIDS Susceptibility Pathways
TTDS00400;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDS00401;WP404;Nucleotide Metabolism
TTDS00402;WP2406;Cardiac Progenitor Differentiation
TTDS00402;WP706;SIDS Susceptibility Pathways
TTDS00403;WP2670;Iron uptake and transport
TTDS00403;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDS00403;WP706;SIDS Susceptibility Pathways
TTDS00405;WP111;Electron Transport Chain
TTDS00405;WP1831;Integration of energy metabolism
TTDS00405;WP2267;Synaptic Vesicle Pathway
TTDS00405;WP2684;Host Interactions of HIV factors
TTDS00405;WP706;SIDS Susceptibility Pathways
TTDS00406;WP1794;Cell surface interactions at the vascular wall
TTDS00406;WP1799;Costimulation by the CD28 family
TTDS00406;WP1826;GPVI-mediated activation cascade
TTDS00406;WP185;Integrin-mediated Cell Adhesion
TTDS00406;WP1866;NCAM signaling for neurite out-growth
TTDS00406;WP1867;Nephrin interactions
TTDS00406;WP1868;Netrin-1 signaling
TTDS00406;WP1883;Platelet Adhesion to exposed collagen
TTDS00406;WP1907;Semaphorin interactions
TTDS00406;WP2034;Leptin signaling pathway
TTDS00406;WP205;IL-7 Signaling Pathway
TTDS00406;WP2203;TSLP Signaling Pathway
TTDS00406;WP2272;Pathogenic Escherichia coli infection
TTDS00406;WP2332;Interleukin-11 Signaling Pathway
TTDS00406;WP2380;BDNF signaling pathway
TTDS00406;WP23;B Cell Receptor Signaling Pathway
TTDS00406;WP2572;Primary Focal Segmental Glomerulosclerosis FSGS
TTDS00406;WP2583;T-Cell Receptor and Co-stimulatory Signaling
TTDS00406;WP2653;PIP3 activates AKT signaling
TTDS00406;WP2684;Host Interactions of HIV factors
TTDS00406;WP2694;DAP12 interactions
TTDS00406;WP2713;Signaling by SCF-KIT
TTDS00406;WP2746;Signaling by the B Cell Receptor (BCR)
TTDS00406;WP2759;Fc epsilon receptor (FCERI) signaling
TTDS00406;WP2858;Ectoderm Differentiation
TTDS00406;WP286;IL-3 Signaling Pathway
TTDS00406;WP304;Kit receptor signaling pathway
TTDS00406;WP306;Focal Adhesion
TTDS00406;WP49;IL-2 Signaling Pathway
TTDS00406;WP585;Interferon type I signaling pathways
TTDS00406;WP69;TCR Signaling Pathway
TTDS00407;WP1799;Costimulation by the CD28 family
TTDS00407;WP1927;TCR signaling
TTDS00407;WP2203;TSLP Signaling Pathway
TTDS00407;WP23;B Cell Receptor Signaling Pathway
TTDS00407;WP2583;T-Cell Receptor and Co-stimulatory Signaling
TTDS00407;WP2653;PIP3 activates AKT signaling
TTDS00407;WP2684;Host Interactions of HIV factors
TTDS00407;WP2694;DAP12 interactions
TTDS00407;WP2713;Signaling by SCF-KIT
TTDS00407;WP453;Inflammatory Response Pathway
TTDS00407;WP49;IL-2 Signaling Pathway
TTDS00407;WP585;Interferon type I signaling pathways
TTDS00407;WP61;Notch Signaling Pathway
TTDS00408;WP1799;Costimulation by the CD28 family
TTDS00408;WP2203;TSLP Signaling Pathway
TTDS00408;WP2332;Interleukin-11 Signaling Pathway
TTDS00408;WP2713;Signaling by SCF-KIT
TTDS00409;WP1864;Muscle contraction
TTDS00409;WP383;Striated Muscle Contraction
TTDS00410;WP2670;Iron uptake and transport
TTDS00410;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDS00412;WP2669;Potassium Channels
TTDS00413;WP1866;NCAM signaling for neurite out-growth
TTDS00413;WP2355;Corticotropin-releasing hormone
TTDS00414;WP1603;Nicotine Activity on Chromaffin Cells
TTDS00414;WP1831;Integration of energy metabolism
TTDS00414;WP1866;NCAM signaling for neurite out-growth
TTDS00414;WP2059;Alzheimers Disease
TTDS00414;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDS00414;WP536;Calcium Regulation in the Cardiac Cell
TTDS00415;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDS00415;WP2005;miR-targeted genes in muscle cell - TarBase
TTDS00415;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDS00417;WP2002;miR-targeted genes in epithelium - TarBase
TTDS00417;WP2003;miR-targeted genes in leukocytes - TarBase
TTDS00417;WP2004;miR-targeted genes in lymphocytes - TarBase
TTDS00417;WP2005;miR-targeted genes in muscle cell - TarBase
TTDS00417;WP2725;Collagen biosynthesis and modifying enzymes
TTDS00418;WP1604;Codeine and Morphine Metabolism
TTDS00418;WP206;Fatty Acid Omega Oxidation
TTDS00418;WP2289;Drug Induction of Bile Acid Pathway
TTDS00418;WP229;Irinotecan Pathway
TTDS00418;WP2536;Colchicine Metabolic Pathway
TTDS00418;WP259;Nifedipine Activity
TTDS00418;WP2646;Lidocaine metabolism
TTDS00418;WP2816;Felbamate Metabolism
TTDS00418;WP2874;Liver X Receptor Pathway
TTDS00418;WP2875;Constitutive Androstane Receptor Pathway
TTDS00418;WP2876;Pregnane X Receptor pathway
TTDS00418;WP2877;Vitamin D Receptor Pathway
TTDS00418;WP2879;Farnesoid X Receptor Pathway
TTDS00418;WP2882;Nuclear Receptors Meta-Pathway
TTDS00418;WP299;Nuclear Receptors in Lipid Metabolism and Toxicity
TTDS00418;WP43;Oxidation by Cytochrome P450
TTDS00418;WP465;Tryptophan metabolism
TTDS00418;WP691;Tamoxifen metabolism
TTDS00418;WP696;Benzo(a)pyrene metabolism
TTDS00418;WP697;Estrogen metabolism
TTDS00418;WP699;Aflatoxin B1 metabolism
TTDS00418;WP702;Metapathway biotransformation
TTDS00419;WP1879;Phase 1 - Functionalization of compounds
TTDS00419;WP2355;Corticotropin-releasing hormone
TTDS00419;WP237;Glucocorticoid & Mineralcorticoid Metabolism
TTDS00419;WP2749;Metabolism of steroid hormones and vitamin D
TTDS00419;WP43;Oxidation by Cytochrome P450
TTDS00419;WP702;Metapathway biotransformation
TTDS00419;WP98;Prostaglandin Synthesis and Regulation
TTDS00420;WP2355;Corticotropin-releasing hormone
TTDS00420;WP2749;Metabolism of steroid hormones and vitamin D
TTDS00420;WP43;Oxidation by Cytochrome P450
TTDS00420;WP702;Metapathway biotransformation
TTDS00421;WP1601;Fluoropyrimidine Activity
TTDS00421;WP1851;Metabolism of nucleotides
TTDS00421;WP2446;Retinoblastoma (RB) in Cancer
TTDS00421;WP404;Nucleotide Metabolism
TTDS00422;WP1824;GPCR downstream signaling
TTDS00422;WP1825;GPCR ligand binding
TTDS00422;WP247;Small Ligand GPCRs
TTDS00422;WP455;GPCRs, Class A Rhodopsin-like
TTDS00424;WP1885;Platelet homeostasis
TTDS00426;WP15;Selenium Micronutrient Network
TTDS00426;WP2693;Metabolism of amino acids and derivatives
TTDS00426;WP28;Selenium Metabolism and Selenoproteins
TTDS00427;WP1913;Signaling by Insulin receptor
TTDS00427;WP2670;Iron uptake and transport
TTDS00427;WP2700;Latent infection of Homo sapiens with Mycobacterium tuberculosis
TTDS00428;WP2670;Iron uptake and transport
TTDS00428;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDS00429;WP143;Fatty Acid Beta Oxidation
TTDS00429;WP325;Triacylglyceride Synthesis
TTDS00431;WP2669;Potassium Channels
TTDS00431;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDS00432;WP1848;Metabolism of carbohydrates
TTDS00432;WP1850;Metabolism of nitric oxide
TTDS00432;WP1864;Muscle contraction
TTDS00432;WP1978;Opioid Signalling
TTDS00432;WP2688;DAG and IP3 signaling
TTDS00432;WP2741;Inositol phosphate metabolism
TTDS00432;WP2746;Signaling by the B Cell Receptor (BCR)
TTDS00432;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDS00432;WP2759;Fc epsilon receptor (FCERI) signaling
TTDS00432;WP2776;Visual phototransduction
TTDS00432;WP2777;Translocation of GLUT4 to the Plasma Membrane
TTDS00433;WP1403;AMPK Signaling
TTDS00433;WP143;Fatty Acid Beta Oxidation
TTDS00433;WP1797;Circadian Clock
TTDS00433;WP2797;Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
TTDS00433;WP2878;PPAR Alpha Pathway
TTDS00433;WP2882;Nuclear Receptors Meta-Pathway
TTDS00433;WP368;Mitochondrial LC-Fatty Acid Beta-Oxidation
TTDS00433;WP706;SIDS Susceptibility Pathways
TTDS00435;WP1798;Complement cascade
TTDS00435;WP1824;GPCR downstream signaling
TTDS00435;WP1825;GPCR ligand binding
TTDS00435;WP2328;Allograft Rejection
TTDS00435;WP2431;Spinal Cord Injury
TTDS00435;WP2806;Human Complement System
TTDS00435;WP545;Complement Activation, Classical Pathway
TTDS00437;WP1852;Metabolism of porphyrins
TTDS00437;WP561;Heme Biosynthesis
TTDS00438;WP117;GPCRs, Other
TTDS00438;WP1824;GPCR downstream signaling
TTDS00438;WP1825;GPCR ligand binding
TTDS00438;WP2035;FSH signaling pathway
TTDS00438;WP24;Peptide GPCRs
TTDS00438;WP34;Ovarian Infertility Genes
TTDS00438;WP455;GPCRs, Class A Rhodopsin-like
TTDS00439;WP1824;GPCR downstream signaling
TTDS00439;WP1825;GPCR ligand binding
TTDS00439;WP1831;Integration of energy metabolism
TTDS00439;WP2664;Gastrin-CREB signalling pathway via PKC and MAPK
TTDS00439;WP334;GPCRs, Class B Secretin-like
TTDS00440;WP1824;GPCR downstream signaling
TTDS00440;WP1825;GPCR ligand binding
TTDS00440;WP1831;Integration of energy metabolism
TTDS00440;WP334;GPCRs, Class B Secretin-like
TTDS00441;WP241;One Carbon Metabolism
TTDS00442;WP1840;Interleukin-3, 5 and GM-CSF signaling
TTDS00442;WP2732;Interleukin-2 signaling
TTDS00444;WP1794;Cell surface interactions at the vascular wall
TTDS00444;WP1829;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
TTDS00444;WP1833;Integrin cell surface interactions
TTDS00444;WP185;Integrin-mediated Cell Adhesion
TTDS00444;WP306;Focal Adhesion
TTDS00445;WP1794;Cell surface interactions at the vascular wall
TTDS00445;WP1829;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
TTDS00445;WP1833;Integrin cell surface interactions
TTDS00445;WP185;Integrin-mediated Cell Adhesion
TTDS00445;WP2118;Arrhythmogenic Right Ventricular Cardiomyopathy
TTDS00445;WP306;Focal Adhesion
TTDS00446;WP117;GPCRs, Other
TTDS00446;WP1824;GPCR downstream signaling
TTDS00446;WP1825;GPCR ligand binding
TTDS00446;WP334;GPCRs, Class B Secretin-like
TTDS00447;WP1433;NOD pathway
TTDS00447;WP1449;Regulation of toll-like receptor signaling pathway
TTDS00447;WP1455;Serotonin Transporter Activity
TTDS00447;WP1533;Vitamin B12 Metabolism
TTDS00447;WP15;Selenium Micronutrient Network
TTDS00447;WP176;Folate Metabolism
TTDS00447;WP1839;Interleukin-1 signaling
TTDS00447;WP195;IL-1 signaling pathway
TTDS00447;WP2034;Leptin signaling pathway
TTDS00447;WP2059;Alzheimers Disease
TTDS00447;WP2328;Allograft Rejection
TTDS00447;WP2431;Spinal Cord Injury
TTDS00447;WP2849;Hematopoietic Stem Cell Differentiation
TTDS00447;WP2865;IL1 and megakaryotyces in obesity
TTDS00447;WP2873;Aryl Hydrocarbon Receptor Pathway
TTDS00447;WP2882;Nuclear Receptors Meta-Pathway
TTDS00447;WP289;Myometrial Relaxation and Contraction Pathways
TTDS00447;WP382;MAPK Signaling Pathway
TTDS00447;WP530;Cytokines and Inflammatory Response
TTDS00447;WP615;Senescence and Autophagy in Cancer
TTDS00447;WP619;Type II interferon signaling (IFNG)
TTDS00447;WP69;TCR Signaling Pathway
TTDS00447;WP706;SIDS Susceptibility Pathways
TTDS00447;WP727;Monoamine Transport
TTDS00447;WP75;Toll-like receptor signaling pathway
TTDS00448;WP2708;Degradation of collagen
TTDS00448;WP2806;Human Complement System
TTDS00448;WP2840;Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
TTDS00449;WP2059;Alzheimers Disease
TTDS00449;WP2572;Primary Focal Segmental Glomerulosclerosis FSGS
TTDS00449;WP2729;Metabolism of Angiotensinogen to Angiotensins
TTDS00451;WP2729;Metabolism of Angiotensinogen to Angiotensins
TTDS00451;WP554;ACE Inhibitor Pathway
TTDS00452;WP1824;GPCR downstream signaling
TTDS00452;WP1825;GPCR ligand binding
TTDS00452;WP1981;Thyroxine (Thyroid Hormone) Production
TTDS00452;WP2032;TSH signaling pathway
TTDS00452;WP24;Peptide GPCRs
TTDS00453;WP1449;Regulation of toll-like receptor signaling pathway
TTDS00453;WP1799;Costimulation by the CD28 family
TTDS00453;WP2328;Allograft Rejection
TTDS00453;WP2572;Primary Focal Segmental Glomerulosclerosis FSGS
TTDS00453;WP2653;PIP3 activates AKT signaling
TTDS00453;WP453;Inflammatory Response Pathway
TTDS00453;WP75;Toll-like receptor signaling pathway
TTDS00466;WP1817;Fatty acid, triacylglycerol, and ketone body metabolism
TTDS00466;WP2740;Glycerophospholipid biosynthesis
TTDS00466;WP325;Triacylglyceride Synthesis
TTDS00466;WP430;Statin Pathway
TTDS00466;WP716;Vitamin A and Carotenoid Metabolism
TTDS00467;WP1818;Formation of Fibrin Clot (Clotting Cascade)
TTDS00467;WP558;Complement and Coagulation Cascades
TTDS00469;WP111;Electron Transport Chain
TTDS00469;WP1902;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.
TTDS00469;WP623;Oxidative phosphorylation
TTDS00470;WP1794;Cell surface interactions at the vascular wall
TTDS00470;WP1818;Formation of Fibrin Clot (Clotting Cascade)
TTDS00470;WP2762;PTM: gamma carboxylation, hypusine formation and arylsulfatase activation
TTDS00470;WP558;Complement and Coagulation Cascades
TTDS00471;WP1799;Costimulation by the CD28 family
TTDS00471;WP1836;Interferon gamma signaling
TTDS00471;WP1927;TCR signaling
TTDS00471;WP2679;MHC class II antigen presentation
TTDS00473;WP1799;Costimulation by the CD28 family
TTDS00473;WP1829;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
TTDS00473;WP1927;TCR signaling
TTDS00473;WP69;TCR Signaling Pathway
TTDS00475;WP1604;Codeine and Morphine Metabolism
TTDS00475;WP206;Fatty Acid Omega Oxidation
TTDS00475;WP2640;Aripiprazole Metabolic Pathway
TTDS00475;WP2877;Vitamin D Receptor Pathway
TTDS00475;WP43;Oxidation by Cytochrome P450
TTDS00475;WP691;Tamoxifen metabolism
TTDS00475;WP702;Metapathway biotransformation
TTDS00476;WP2693;Metabolism of amino acids and derivatives
TTDS00476;WP465;Tryptophan metabolism
TTDS00477;WP1836;Interferon gamma signaling
TTDS00477;WP619;Type II interferon signaling (IFNG)
TTDS00480;WP23;B Cell Receptor Signaling Pathway
TTDS00482;WP1533;Vitamin B12 Metabolism
TTDS00482;WP1817;Fatty acid, triacylglycerol, and ketone body metabolism
TTDS00482;WP1857;Metabolism of water-soluble vitamins and cofactors
TTDS00484;WP2759;Fc epsilon receptor (FCERI) signaling
TTDS00484;WP2865;IL1 and megakaryotyces in obesity
TTDS00485;WP1824;GPCR downstream signaling
TTDS00485;WP1825;GPCR ligand binding
TTDS00485;WP2018;RANKL/RANK Signaling Pathway
TTDS00485;WP334;GPCRs, Class B Secretin-like
TTDS00486;WP2762;PTM: gamma carboxylation, hypusine formation and arylsulfatase activation
TTDS00490;WP1449;Regulation of toll-like receptor signaling pathway
TTDS00490;WP1799;Costimulation by the CD28 family
TTDS00490;WP2328;Allograft Rejection
TTDS00490;WP2653;PIP3 activates AKT signaling
TTDS00490;WP286;IL-3 Signaling Pathway
TTDS00490;WP453;Inflammatory Response Pathway
TTDS00490;WP75;Toll-like receptor signaling pathway
TTDS00491;WP1824;GPCR downstream signaling
TTDS00491;WP1825;GPCR ligand binding
TTDS00491;WP334;GPCRs, Class B Secretin-like
TTDS00492;WP12;Osteoclast Signaling
TTDS00492;WP1449;Regulation of toll-like receptor signaling pathway
TTDS00492;WP1835;Interferon alpha/beta signaling
TTDS00492;WP585;Interferon type I signaling pathways
TTDS00492;WP75;Toll-like receptor signaling pathway
TTDS00495;WP2743;Glycosaminoglycan metabolism
TTDS00496;WP1831;Integration of energy metabolism
TTDS00496;WP1871;Neurotransmitter Release Cycle
TTDS00496;WP2267;Synaptic Vesicle Pathway
TTDS00496;WP2665;Botulinum neurotoxicity
TTDS00496;WP2685;GABA synthesis, release, reuptake and degradation
TTDS00496;WP481;Insulin Signaling
TTDS00496;WP706;SIDS Susceptibility Pathways
TTDS00497;WP1824;GPCR downstream signaling
TTDS00497;WP1825;GPCR ligand binding
TTDS00497;WP706;SIDS Susceptibility Pathways
TTDS00498;WP1533;Vitamin B12 Metabolism
TTDS00498;WP15;Selenium Micronutrient Network
TTDS00498;WP176;Folate Metabolism
TTDS00498;WP1815;Factors involved in megakaryocyte development and platelet production
TTDS00498;WP2681;Uptake of Oxygen and Release of Carbon Dioxide by Erythrocytes
TTDS00498;WP2744;Uptake of Carbon Dioxide and Release of Oxygen by Erythrocytes
TTDS00498;WP2784;Binding and Uptake of Ligands by Scavenger Receptors
TTDS00499;WP2032;TSH signaling pathway
TTDS00499;WP289;Myometrial Relaxation and Contraction Pathways
TTDS00499;WP35;G Protein Signaling Pathways
TTDS00500;WP1824;GPCR downstream signaling
TTDS00500;WP1831;Integration of energy metabolism
TTDS00500;WP1978;Opioid Signalling
TTDS00500;WP2662;Regulation of Water Balance by Renal Aquaporins
TTDS00500;WP2688;DAG and IP3 signaling
TTDS00500;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDS00500;WP289;Myometrial Relaxation and Contraction Pathways
TTDS00500;WP35;G Protein Signaling Pathways
TTDS00500;WP536;Calcium Regulation in the Cardiac Cell
TTDS00500;WP666;Hypothetical Network for Drug Addiction
TTDS00501;WP2332;Interleukin-11 Signaling Pathway
TTDS00515;WP2431;Spinal Cord Injury
TTDS00515;WP2719;Fcgamma receptor (FCGR) dependent phagocytosis
TTDS00520;WP2754;Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
TTDS00520;WP706;SIDS Susceptibility Pathways
TTDS00521;WP2704;Interleukin-6 signaling
TTDS00521;WP2848;Differentiation Pathway
TTDS00521;WP364;IL-6 signaling pathway
TTDS00521;WP615;Senescence and Autophagy in Cancer
TTDS00521;WP706;SIDS Susceptibility Pathways
TTDS00524;WP1884;Platelet Aggregation (Plug Formation)
TTDS00525;WP1824;GPCR downstream signaling
TTDS00525;WP1825;GPCR ligand binding
TTDS00525;WP24;Peptide GPCRs
TTDS00525;WP455;GPCRs, Class A Rhodopsin-like
TTDS00525;WP554;ACE Inhibitor Pathway
TTDS00529;WP2267;Synaptic Vesicle Pathway
TTDS00529;WP536;Calcium Regulation in the Cardiac Cell
TTDS00531;WP1817;Fatty acid, triacylglycerol, and ketone body metabolism
TTDS00531;WP2740;Glycerophospholipid biosynthesis
TTDS00531;WP325;Triacylglyceride Synthesis
